note_id
stringlengths
13
15
subject_id
int64
10M
20M
hadm_id
int64
20M
30M
note_type
stringclasses
1 value
note_seq
int64
2
133
charttime
stringlengths
19
19
storetime
stringlengths
19
19
text
stringlengths
1.56k
52.7k
19706413-DS-6
19,706,413
22,191,865
DS
6
2179-02-28 00:00:00
2179-03-01 06:39:00
Name: ___ Unit No: ___ Admission Date: ___ Discharge Date: ___ Date of Birth: ___ Sex: M Service: MEDICINE Allergies: clindamycin Attending: ___. Chief Complaint: Weakness, Lethargy, Shoulder tic Major Surgical or Invasive Procedure: None History of Present Illness: Mr. ___ is a ___ yo M with history of bipolar affective disorder, prior psychiatric hospitalizations, history of 2 past overdoses, h/o tardive dyskinesia, presenting with one week of global weakness, gait difficulty, drooling, voice changes, L shoulder tics over the past week or so in the setting of recent starting and then weaning off of clozapine. Patient started clozapine about a month ago. Patient stopped medication on ___ due to side effects after taper per psych. He notes not sleeping well. By ___ had progression of weakness, as well as pain in L shoulder, legs, and neck. No fevers/chills. Was seen first in the ___, then ___ ___ on ___ night, given valium for muscle spasm for L shoulder. Was unsteady and was observed overnight. On ___, was home and fell x 2 getting up from seated position. Hit his head, no LOC. Was seen again at ___ ___ night, and was discharged after lab work with plan for EMG today. No SI/HI, notes difficulty sleeping, and feeling more irritable. Other medication changes include recently starting clonazepam TID, started after prescribed valium this past weekend. Takes lithium for bipolar, takes ingrezza, an anticholinergic as well. Past Medical History: Bipolar Disorder h/o multiple prior psych hospitalizations h/o total thyroidectomy taking Synthroid early childhood seizures Social History: ___ Family History: Father with bipolar disorder Maternal grandfather with PD No history Autoimmune disorders Physical Exam: ADMISSION PHYSICAL EXAM: ======================== VS: 100.0 131/87 70 16 95% RA GENERAL: resting in bed, slightly diaphoretic HEENT: AT/NC, EOMI, PERRL, anicteric sclera, pink conjunctiva, MMM NECK: supple, no JVD, no nuchal rigidity HEART: RRR, S1/S2, no murmurs, gallops, or rubs LUNGS: CTAB, no wheezes, rales, rhonchi, breathing comfortably without use of accessory muscles ABDOMEN: nondistended, +BS, nontender EXTREMITIES: no cyanosis, clubbing, or edema. L shoulder with frequent tics. good ROM but decreased due to weakness. Some pain on palpation of L shoulder. No deformity PULSES: 2+ DP pulses bilaterally NEURO: A&Ox3, slow to initiate response in movement and speaking. Mild dysarthria. Can follow commands. PERRL. Frequent L shoulder movements. No tremor. Very slow movements. ___ strength in bilateral IP, with ankle flexion and extension, and at knees. ___ upper strength on exam. Normal sensation throughout SKIN: warm and well perfused, no excoriations or lesions, no rashes DISCHARGE PHYSICAL EXAM: ======================== VS: 98.6, 112/70, 66, 18, 94% RA GENERAL: flat affect, walking, NAD, not in apparent pain, occasional jerks of left shoulder HEENT: AT/NC, EOMI, PERRL, no JVD HEART: RRR, no m/r/g, nl s1/s2 LUNGS: CTA b/l, no w/r/c ABDOMEN: BS normoactive, S/ND/NT EXTREMITIES: WWP, non-edematous, 2+ pulses NEURO: A&Ox3, follows commands, bradykinetic, intermittent mild dysarthria, no tremor. ___ hip strength, equal b/l 4+/5 UE, ___ strength (except hip), equal b/l 1+ reflexes, no asymmetry Light touch intact CNII-XII intact Tone mildly increased, no cogwheeling Pertinent Results: ADMISSION LABS: =============== ___ 01:25PM BLOOD WBC-8.6 RBC-4.22* Hgb-12.3* Hct-38.9* MCV-92 MCH-29.1 MCHC-31.6* RDW-13.2 RDWSD-45.0 Plt ___ ___ 01:25PM BLOOD Neuts-64.7 ___ Monos-7.3 Eos-8.1* Baso-0.7 Im ___ AbsNeut-5.55 AbsLymp-1.63 AbsMono-0.63 AbsEos-0.70* AbsBaso-0.06 ___ 01:25PM BLOOD Glucose-94 UreaN-23* Creat-0.9 Na-145 K-4.0 Cl-106 HCO3-25 AnGap-14 ___ 01:25PM BLOOD CK(CPK)-271 ___ 01:25PM BLOOD TSH-2.4 DISCHARGE LABS: =============== ___ 07:00AM BLOOD ALT-55* AST-35 LD(LDH)-184 CK(CPK)-225 AlkPhos-76 TotBili-0.2 ___ 07:00AM BLOOD Albumin-4.2 Calcium-9.7 Phos-4.2 Mg-2.4 ___ 01:25PM BLOOD CRP-1.7 ___ 01:25PM BLOOD ASA-NEG Ethanol-NEG Acetmnp-NEG Bnzodzp-NEG Barbitr-NEG Tricycl-NEG ___ 07:15AM BLOOD WBC-7.2 RBC-4.44* Hgb-13.0* Hct-41.5 MCV-94 MCH-29.3 MCHC-31.3* RDW-13.2 RDWSD-45.4 Plt ___ ___ 07:15AM BLOOD Glucose-82 UreaN-15 Creat-0.8 Na-146 K-4.2 Cl-109* HCO3-25 AnGap-12 ___ 07:15AM BLOOD Calcium-9.5 Phos-3.9 Mg-2.2 ___ 07:00AM BLOOD ___ CRP-1.6 ___ 07:00AM BLOOD Lithium-1.3 IMAGING: ======== ___ non-Contrast Mildly motion degraded exam without acute intracranial process. Brief Hospital Course: Mr. ___ is a ___ man with a history of bipolar disorder, multiple past psychiatric hospitalizations and tardive dyskinesia who presented with global weakness, lethargy, dysarthria and tics in the setting of recently being started and weaned off of Clozaril. ACUTE ISSUES: ============= # Global weakness, Lethargy # Akathesia, Parkinsonism Patient presented with recent start and weaning of Clozaril and a long history of various antiepileptics and antipsychotics. He was noted to be bradykinetic, having masked facies, shuffling gait, but no cogwheel rigidity consistent with drug-induced parkinsonism. He also had twitching, restlessness particularly in the legs, dysarthria consistent with akathisia. Both point extraparametal symptoms likely from Clozaril. There is no signs or symptoms of neuroleptic malignant syndrome. His lithium was mildly elevated in the emergency department but this was not timed correctly and his overall constellation of symptoms were not suggestive of lithium toxicity. Nonetheless his dosing was decreased. Psychiatry was consulted who adjusted his medications and physical therapy was included to help rebuild strength and balance. He showed improvement in weakness and was walking around the hall on day of discharge. He was discharged to physical therapy with close follow-up from psychiatry to evaluate for improvement in symptoms. # Proximal muscle weakness Notably on presentation the patient was hoarding and was found on exam to have more pronounced proximal muscle weakness. Urology was consulted and given initial lack of improvement MRI spine was ordered which did not show any explanatory lesions. His ___, CK, CRP were normal pointing away from a myositis picture. TSH normal not likely cause of myopathy. He is set up with follow-up with neurology for improvement with physical therapy and plan for EMG as an outpatient if there is no recovery. # Bipolar disorder Patient's mood was overall stable. His outpatient psychiatrist was on inpatient consults and adjust his medications accordingly. CHRONIC ISSUES: =============== # Thyroidectomy # Hypothyroidism Patient's TSH was within normal range and he was continued on his Synthroid without problems. This was not felt to be related to current presentation. TSH 2.4 on admission. ==================== TRANSITIONAL ISSUES: ==================== [ ] Medications Changed -- Lithium dose decreased -- Klonipin dose decreased [ ] Please follow up with PCP [ ] Please follow up with Neurology -- Appointment with Dr. ___ Scheduled -- Evaluate proximal muscle weakness, consider EMG if persistent [ ] Please follow up with Psychiatry -- Dr. ___ ___ Treatment Plan: Progress functional mobility: bed mobility, transfers, gait, stair negotiation Balance training: standing dynamic Therex: AROM therex standing Pt/caregiver education RE: fall risk, benefits of OOB mobility, D/C planning Recommendations for Nursing: -Encourage independence with ADLs and functional mobility as pt is at risk for deconditioning -OOB to chair ___ with S -Amb 3x/day with S -Please use chair alarm when pt OOB ================ FULL CODE ___ (mother) ___ >30 minutes were spent on this complicated discharge Medications on Admission: The Preadmission Medication list is accurate and complete. 1. Lithium Carbonate 600 mg PO QAM 2. Lithium Carbonate 900 mg PO QHS 3. ClonazePAM 0.5 mg PO BID 4. ClonazePAM 1 mg PO QHS 5. Levothyroxine Sodium 250 mcg PO DAILY 6. Ingrezza (valbenazine) 80 mg oral Daily 7. milk thistle unknown mg oral BID Discharge Medications: 1. ClonazePAM 0.5 mg PO QHS:PRN anxiety 2. Lithium Carbonate 600 mg PO BID 3. Ingrezza (valbenazine) 80 mg oral Daily 4. Levothyroxine Sodium 250 mcg PO DAILY 5. milk thistle unknown oral BID Discharge Disposition: Home With Service Facility: ___ Discharge Diagnosis: Extrapyramidal Symptoms from Anti-Psychotics Generalized Weakness Bipolar Disorder Supratherapeutic Lithium Discharge Condition: Mental Status: Clear and coherent. Level of Consciousness: Alert and interactive. Activity Status: Ambulatory - requires assistance or aid (walker or cane). Discharge Instructions: Dear Mr. ___, It was a pleasure taking care of you at ___. WHY DID YOU COME TO THE HOSPITAL? - You came to the hospital because you were having significant weakness and jerking of your shoulder. WHAT HAPPENED WHILE YOU WERE HERE? - You were tested for causes of these symptoms and seen by specialists (Neurology and Psychiatry). - Your medication regimen was adjusted to help reduce potential side effects. - Physical therapy evaluated you and helped create a plan to build your strength back up. WHAT SHOULD YOU DO WHEN YOU LEAVE THE HOSPITAL? - Please continue to take all of your medications as directed, and follow up with all of your doctors. Again, it was a pleasure taking care of you! Sincerely, Your ___ Team Followup Instructions: ___
19706808-DS-13
19,706,808
24,738,579
DS
13
2139-06-07 00:00:00
2139-06-07 15:27:00
Name: ___ Unit No: ___ Admission Date: ___ Discharge Date: ___ Date of Birth: ___ Sex: M Service: SURGERY Allergies: No Known Allergies / Adverse Drug Reactions Attending: ___ ___ Complaint: perforated diverticulitis-abdominal pain Major Surgical or Invasive Procedure: ___: CT-guided drainage of pericolonic collection ___: CT-guided drainage of pericolonic collection History of Present Illness: ___ presenting with abdominal pain, diarrhea and pelvic abscess on CT. Symptoms began 5 days ago with crampy, generalized pelvic pain. Pain was intermittent with episodes lasting approximately 15 minutes at first, then gradually to an hour as time progressed. On ___ he developed non-bloody diarrhea and presented to ___ ED where he was given medication for "spasms" and discharged. He presented to his gastroenterologist today when symptoms did not abate over the weekend, and a CT was performed which showed diverticulosis and a large pelvic abscess with associated inflammation, at which point he was transferred to ___. He states he has had approximately 6 similar episodes that were self-limited over the last ___ years. These were often associated with dairy intake, so he was being evaluated for lactose intolerance, which is why he was seeing a gastroenterologist. He endorses difficulty initiating urination, nausea, fever, chills and presyncope with BMs. He denies nausea, visual changes, dyspnea, cough, SOB, rash, ecchymosis and paresthesia. Past Medical History: GERD Social History: ___ Family History: Diverticulitis - Mother IBS - Sister ___ - Brother ___ overload - MGM Skin CA No bleeding, clotting, IBD or colorectal cancers Physical Exam: VSS GEN: Well appearing, comfortable, in NAD HEENT: NCAT, EOMI, anicteric CV: RRR, No JVD PULM: normal excursion, no respiratory distress ABD: Abdomen soft, less tender in lower quadrants,non-distended. No rebound or guarding. Drain in place with sanguineous purulent fluid EXT: WWP, no CCE, 2+ B/L radial NEURO: A&Ox3, no focal neurologic deficits PSYCH: normal judgment/insight, normal memory, normal mood/affect Pertinent Results: See OMR for all lab and imaging results. Brief Hospital Course: Mr. ___ presented to the ED following a CT scan with his gastroenterologist demonstrating perforated diverticulitis complicated by pelvic abscess. He was subsequently admitted to the colorectal service with plan for ___ drainage of the abscess. ___ discovered two separate drainable pockets which were each drained over two consecutive days. 5.5 cc sero sanguinous fluid and 10 cc bloody-purulent fluid were removed respectively, with a drain left in place. Gram stains were negative with cultures currently pending. Overall the patient tolerated the procedures well, with further details in the ___ imaging notes. By discharge Mr. ___ was hemodynamically stable, ambulating well, tolerating a regular diet with low residues (low fiber no seeds/nuts/etc.), and moving his bowels appropriately. Pain was controlled and the patient expressed overall readiness for discharge. The patient will be discharged on Augmentin 875 mg BID for 14 days with follow up in place with the CRS to consider future sigmoid colectomy once this acute episode has resolved. He has his ___ drain in place to be managed with ___ services. Social Issues Causing a Delay in Discharge: [ ] Delay in organization of ___ services [ ] Difficulty finding appropriate rehab hospital disposition. [ ] Lack of insurance coverage for ___ services [ ] Lack of insurance coverage for prescribed medications. [ ] Family not agreeable to discharge plan. [ ] Patient knowledge deficit related to ileostomy delaying dispo [x] No social factors contributing in delay of discharge. Medications on Admission: The Preadmission Medication list is accurate and complete. 1. Pantoprazole 40 mg PO Q24H Discharge Medications: 1. Amoxicillin-Clavulanic Acid ___ mg PO Q12H Duration: 14 Days RX *amoxicillin-pot clavulanate 875 mg-125 mg 1 tablet(s) by mouth Every twelve (12) hours Disp #*30 Tablet Refills:*0 2. OxyCODONE (Immediate Release) 5 mg PO Q4H:PRN Pain - Moderate Please take lowest effective dose RX *oxycodone 5 mg 1 tablet(s) by mouth every six (6) hours Disp #*10 Tablet Refills:*0 3. Pantoprazole 40 mg PO Q24H Discharge Disposition: Home With Service Facility: ___ Discharge Diagnosis: Perforated diverticulitis Discharge Condition: Mental Status: Clear and coherent. Level of Consciousness: Alert and interactive. Activity Status: Ambulatory - Independent. Discharge Instructions: Dear Mr. ___, You were admitted to the ___ with abdominal pain and underwent a CT scan that revealed perforated diverticulitis with fluid collections. You were brought to interventional radiology where the collection was drained and a drain was left in place. You are now ready to be discharged home with oral antibiotics. Please call your doctor or nurse practitioner or return to the Emergency Department for any of the following: *You experience new chest pain, pressure, squeezing or tightness. *New or worsening cough, shortness of breath, or wheeze. *If you are vomiting and cannot keep down fluids or your medications. *You are getting dehydrated due to continued vomiting, diarrhea, or other reasons. Signs of dehydration include dry mouth, rapid heartbeat, or feeling dizzy or faint when standing. *You see blood or dark/black material when you vomit or have a bowel movement. *You experience burning when you urinate, have blood in your urine, or experience a discharge. *Your pain in not improving within ___ hours or is not gone within 24 hours. Call or return immediately if your pain is getting worse or changes location or moving to your chest or back. *You have shaking chills, or fever greater than 101.5 degrees Fahrenheit or 38 degrees Celsius. *Any change in your symptoms, or any new symptoms that concern you. Please resume all regular home medications, unless specifically advised not to take a particular medication. Also, please take any new medications as prescribed. Drain Information You will also be going home with your interventional radiology right drain, which will be removed at your post-op visit. You will have ___ services that will help attend to your drain. Please look at the site every day for signs of infection (increased redness or pain, swelling, odor, yellow or bloody discharge, warm to touch, fever). Maintain suction of the bulb. Note color, consistency, and amount of fluid in the drain. Call the doctor, ___, or ___ nurse if the amount increases significantly or changes in character. Be sure to empty the drain frequently. Record the output, if instructed to do so. You may shower; wash the area gently with warm, soapy water. Keep the insertion site clean and dry otherwise. Avoid swimming, baths, hot tubs; do not submerge yourself in water. Make sure to keep the drain attached securely to your body to prevent pulling or dislocation. Please flush drain three times a day. Flush 5cc normal saline into yourself and then flush 5cc into the tubing of the drain. Drain care: Flush with 10cc sterile saline to patient and aspirate back. You may do this three times per day. Do not continue to flush if the volume out is significantly less than the volume in. If there is pain with flushing this may mean that the abscess cavity has collapsed. Troubleshooting: If catheter stops draining suddenly: 1) Check that the stopcock is open. 2) Remove dressing carefully and inspect to make sure that there is no kink in the catheter. 3) Inspect to be sure that there is no debris blocking the catheter. If there is, then firmly flush 5 cc of sterile saline into the catheter towards the patient. Pain It is expected that you will have pain after surgery, this will gradually improve over the first week or so you are home. You should continue to take 2 Extra Strength Tylenol (___) for pain every 8 hours around the clock. Please do not take more than 3000mg of Tylenol in 24 hours or any other medications that contain Tylenol such as cold medication. Do not drink alcohol while taking Tylenol. Thank you for allowing us to participate in your care, we wish you all the best! Followup Instructions: ___
19706867-DS-6
19,706,867
29,577,112
DS
6
2154-03-20 00:00:00
2154-03-20 14:16:00
Name: ___ Unit No: ___ Admission Date: ___ Discharge Date: ___ Date of Birth: ___ Sex: M Service: MEDICINE Allergies: Penicillins Attending: ___ Chief Complaint: chest pain Major Surgical or Invasive Procedure: None History of Present Illness: Mr. ___ is an ___ year old gentleman with history of HTN, HLD, DM2, severe aortic stenosis ___ 0.9, velocity 5.2m/s), and h/o CVA who presents with chest pain. Yesterday morning, patient was doing his morning exercises, lifting weights. He finished his shower and then experienced right-sided chest tightness. He has never had this kind of pain before. He rates it a ___ and non-radiating. He says he was sitting down at the time of the onset of chest pain and continued to eat his breakfast and the pain resolved spontaneously in about ___ minutes. He denies any dyspnea associated with the pain, denies any diaphoresis, n/v. He denies any DOE, PND, or orthopnea. His wife was concerned and booked him an urgent care appointment. EKG at the PCP office was concerning for new onset afib. Given his history and story of CP with exertion, he was thus referred to the ED. In the ED, initial vital signs were: 98.3 56 121/90 16 99% RA - Exam was notable for: ___ holosystolic murmur, no ___ edema - Labs were notable for: mild anemia 10.8/33.7, INR 1.0, Cr 1.9 (baseline 1.5-1.8), Trop T 0.22-> 0.47 proBNP 1685, INR 1.0 - Imaging: CXR showed No acute intrathoracic process. - The patient was given: full dose ASA and started on heparin gtt - EKG showed NSR, normal axis, normal intervals, no concerning ischemic chages - Consults: Atrius Cardiology was consulted, however unclear if recs were given based on documentations Vitals on transfer: 97.9 56 129/45 14 100% RA On the floor patient is feeling well and remains chest pain free. He has no current complaints. ROS: positive per HPI, otherwise negative. Past Medical History: 1. CARDIAC RISK FACTORS: +hypertension, +dyslipidemia, +diabetes 2. CARDIAC HISTORY: - CABG: None - PERCUTANEOUS CORONARY INTERVENTIONS: None - PACING/ICD: None 3. OTHER PAST MEDICAL HISTORY: CEREBROVASC DISEASE, UNSPEC Aortic valve stenosis COLONIC ADENOMA TREMOR Type 2 diabetes, controlled, with renal manifestation Hydrocephalus Hypercholesteremia CKD (chronic kidney disease) stage 3, GFR ___ ml/min Benign hypertension with chronic kidney disease, stage III Hypothyroidism Aortic insufficiency New onset a-fib Social History: ___ Family History: No family history of early MI, arrhythmia, cardiomyopathies, or sudden cardiac death. Physical Exam: ======================= ADMISSION PHYSICAL EXAM ======================= VS: 97.5 143/63 59 18 100% RA GENERAL: Pleasant, well-appearing, in no apparent distress. HEENT - normocephalic, atraumatic, no conjunctival pallor or scleral icterus, PERRLA, EOMI, OP clear. NECK: Supple, no LAD, no thyromegaly, JVP flat. CARDIAC: RRR, normal S1/S2, III/VI crescendo/decrescendo murmur obliterating S2 heard throughout precordium PULMONARY: Clear to auscultation bilaterally, without wheezes or rhonchi. ABDOMEN: Normal bowel sounds, soft, non-tender, non-distended, no organomegaly. EXTREMITIES: Warm, well-perfused, no cyanosis, clubbing or edema. SKIN: Without rash. NEUROLOGIC: A&Ox3, CN II-XII grossly normal, normal sensation, with strength ___ throughout. ======================= DISCHARGE PHYSICAL EXAM ======================= VS: T 98.4 F BP 113/53 mmHg P 63 RR 17 O2 99% RA General: Pleasant, elderly man appearing younger than his stated age in NAD. HEENT: PERRL; EOMs intact. Anicteric sclerae. Neck: Supple, no JVD. CV: RRR, loud systolic crescendo-descrescedo murmur radiating to carotids. No rubs or gallops. Pulm: CTA b/l; no wheezes, rhonchi, or rales. Abd: Soft, non-tender, non-distended, NABS. Ext: No edema. Warm and well-perfused. 2+ pulses. Neuro: A&Ox3. CNs II-XII grossly intact. Pertinent Results: ============== ADMISSION LABS ============== ___ 06:55PM BLOOD WBC-9.9 RBC-3.70* Hgb-10.8* Hct-33.7* MCV-91 MCH-29.2 MCHC-32.0 RDW-14.1 RDWSD-47.0* Plt ___ ___ 06:55PM BLOOD Neuts-65.9 ___ Monos-7.4 Eos-3.0 Baso-0.4 Im ___ AbsNeut-6.53* AbsLymp-2.27 AbsMono-0.73 AbsEos-0.30 AbsBaso-0.04 ___ 06:55PM BLOOD ___ PTT-28.1 ___ ___ 06:55PM BLOOD Glucose-116* UreaN-46* Creat-1.9* Na-134 K-4.3 Cl-97 HCO3-23 AnGap-18 ___ 06:55PM BLOOD cTropnT-0.22* proBNP-1685* ============ INTERIM LABS ============ ___ 01:00AM BLOOD cTropnT-0.47* ___ 06:29AM BLOOD CK-MB-11* MB Indx-6.7* cTropnT-0.42* ============== DISCHARGE LABS ============== ___ 05:05AM BLOOD WBC-8.4 RBC-3.72* Hgb-11.0* Hct-34.3* MCV-92 MCH-29.6 MCHC-32.1 RDW-14.2 RDWSD-47.8* Plt ___ ___ 05:05AM BLOOD Glucose-94 UreaN-35* Creat-1.5* Na-138 K-4.6 Cl-105 HCO3-22 AnGap-16 ___ 05:05AM BLOOD Calcium-9.6 Phos-4.2 Mg-2.1 =============== IMAGING/STUDIES =============== CHEST (PA & LAT) (___): FINDINGS: PA and lateral views of the chest provided. No convincing evidence for pneumonia or edema. No large effusion or pneumothorax. There is subtle increase in reticular markings in the left lower lobe which may reflect the sequelae of chronic aspiration in the correct clinical setting. Cardiomediastinal silhouette appears within normal limits. Bony structures are intact. Mild scarring projects over the left upper lung. IMPRESSION: No acute intrathoracic process. ECHO (___): Findings LEFT ATRIUM: Mildly increased LA volume index. RIGHT ATRIUM/INTERATRIAL SEPTUM: Normal RA size. LEFT VENTRICLE: Mild symmetric LVH with normal cavity size and regional/global systolic function (LVEF>55%). Diastolic function could not be assessed. RIGHT VENTRICLE: Normal RV chamber size and free wall motion. AORTIC VALVE: Three aortic valve leaflets. Moderately thickened aortic valve leaflets. Severe AS (area <1.0cm2). Mild (1+) AR. MITRAL VALVE: Mildly thickened mitral valve leaflets. No MVP. Moderate mitral annular calcification. Mild thickening of mitral valve chordae. Calcified tips of papillary muscles. Minimally increased gradient consistent with trivial MS. ___ (1+) MR. [Due to acoustic shadowing, the severity of MR may be significantly UNDERestimated.] TRICUSPID VALVE: Mildly thickened tricuspid valve leaflets. Mild [1+] TR. Mild PA systolic hypertension. PERICARDIUM: No pericardial effusion. GENERAL COMMENTS: Suboptimal image quality - poor echo windows. Conclusions The left atrial volume index is mildly increased. There is mild symmetric left ventricular hypertrophy with normal cavity size and regional/global systolic function (LVEF>55%). Diastolic function could not be assessed. Right ventricular chamber size and free wall motion are normal. There are three aortic valve leaflets. The aortic valve leaflets are moderately thickened/calcific. There is severe aortic valve stenosis (valve area <1.0cm2). Mild (1+) aortic regurgitation is seen. The mitral valve leaflets are mildly thickened. There is no mitral valve prolapse. There is a minimally increased gradient consistent with trivial mitral stenosis due to mitral annular calcification. Mild (1+) mitral regurgitation is seen. [Due to acoustic shadowing, the severity of mitral regurgitation may be significantly UNDERestimated.] The tricuspid valve leaflets are mildly thickened. There is mild pulmonary artery systolic hypertension. There is no pericardial effusion. IMPRESSION: Severe calcific aortic stenosis with mild aortic regurgitation. Mild symmetric left ventricular hypertrophy with preserved global and regional biventricular systolic function. Mild mitral regurgitation. Mild pulmonary hypertension. Brief Hospital Course: Mr. ___ is an ___ y/o man with a history of hypertension, hyperlipidemia, type 2 diabetes mellitus, severe aortic stenosis (aortic valve area 0.9), and stroke, who presented with chest pain and found to have NSTEMI. . # NSTEMI. Troponins peaked at 0.49. After discussion with the patient, he chose medical management instead of PCI. He was treated with full dose aspirin x1 and heparin drip for 48 hours. His atorvastatin was increased to 80 mg daily and lisinopril continued at 5 mg daily. He was initiated on metoprolol succinate 12.5 mg qhs. . # Atrial tachyarrhythmia. Prior to admission, he was found to have an atrial tachyarrhythmia, initially concerning for atrial fibrillation, which appeared to be more consistent with multiple premature atrial complexes. He will have outpatient event monitoring to follow-up. . # ___. He was found to have an acute kidney injury with a Cr of 1.9. This was thought to be pre-renal in the setting of an acute event, and his creatinine improved to his baseline of 1.5. . ============== CHRONIC ISSUES ============== # Severe aortic stenosis. ___ 0.9. He noted that he did not want to pursue intervention, and he had no evidence of heart failure on examination. He was restarted on his home torsemide once his kidney function had returned to baseline. # Hypothyroidism. He was continued on his home levothyroxine. # Type 2 diabetes mellitus. He was placed on an insulin sliding scale. # Hypertension. He was continued on amlodipine and lisinopril. . =================== TRANSITIONAL ISSUES =================== # Discharge Cr: 1.5 # Medication changes. Atorvastatin increased to 80 mg daily. Started on metoprolol succinate 12.5 mg qhs. # Event monitoring. Would advise outpatient event monitoring for further work-up of atrial tachyarrhythmia. # Travel. Mr. ___ is planning for overseas travel this ___; please re-evaluate suitability for this and provide a physician's note if he needs to cancel his trip. # CODE: FULL # CONTACT: wife ___ ___ ___ on Admission: The Preadmission Medication list is accurate and complete. 1. Lisinopril 5 mg PO DAILY 2. GlipiZIDE XL 2.5 mg PO DAILY 3. Atorvastatin 20 mg PO QPM 4. Levothyroxine Sodium 50 mcg PO DAILY 5. Torsemide 2.5 mg PO 3X/WEEK (___) 6. Amlodipine 10 mg PO DAILY 7. Aspirin 81 mg PO DAILY 8. Ferrous Sulfate 325 mg PO BID Discharge Medications: 1. Metoprolol Succinate XL 12.5 mg PO QHS Hold for lightheadedness and dizziness RX *metoprolol succinate 25 mg 0.5 (One half) tablet(s) by mouth Every night Disp #*30 Tablet Refills:*0 2. Amlodipine 10 mg PO DAILY 3. Aspirin 81 mg PO DAILY 4. Atorvastatin 80 mg PO QPM RX *atorvastatin 80 mg 1 (one) tablet(s) by mouth daily Disp #*30 Tablet Refills:*0 5. Levothyroxine Sodium 50 mcg PO DAILY 6. Lisinopril 5 mg PO DAILY 7. Torsemide 2.5 mg PO 3X/WEEK (___) 8. Ferrous Sulfate 325 mg PO BID 9. GlipiZIDE XL 2.5 mg PO DAILY Discharge Disposition: Home Discharge Diagnosis: ================= PRIMARY DIAGNOSES ================= - non-ST segment elevation myocardial infarction - atrial tachyarrhythmia - severe aortic stenosis - acute kidney injury on chronic kidney disease =================== SECONDARY DIAGNOSES =================== - hypothyroidism - type 2 diabetes mellitus - hypertension Discharge Condition: Mental Status: Clear and coherent. Level of Consciousness: Alert and interactive. Activity Status: Ambulatory - Independent. Discharge Instructions: Dear Mr. ___, It was a pleasure caring for you at ___ ___. You were admitted because you had a heart attack (known as an NSTEMI). We discussed the possibility of intervention, but your preference was management with medications. You did well and had no complications. The dose of your atorvastatin has been increased to 80 mg daily. You have also been started on a new medication called metoprolol, which you will take at night, to control your heart rate and to help after your heart attack. It is important that you call your physician if you have any symptoms of lightheadedness, dizziness, or chest pain. Please continue to take all medications as prescribed. Your discharge follow-up appointments are outlined below. We wish you the very best! Warmly, Your ___ Team Followup Instructions: ___
19706867-DS-7
19,706,867
28,901,451
DS
7
2154-03-25 00:00:00
2154-03-28 17:30:00
Name: ___ Unit No: ___ Admission Date: ___ Discharge Date: ___ Date of Birth: ___ Sex: M Service: MEDICINE Allergies: Penicillins Attending: ___ Chief Complaint: Lightheadedness Major Surgical or Invasive Procedure: Cardiac catheterization ___ ___ to RCA ___ History of Present Illness: ___ hx severe AS, CAD, CVA, HTN, HLD, DM, ___. Recently admitted for NSTEMI, medically managed. Declined PCI/TAVR, discharged home, brought to ___ ED after debilitating symptoms and now reconsidering procedures. He was discharged earlier today after admission ___ for NSTEMI. Took shower at home and got dizzy, weak, appeared pale and diaphoretic. No chest pain/discomfort/tightness, no numbness/asymmetric weakness, no facial droop or slurred speech. Patient was offered PCI and TAVR previously and did not want them therefore unclear what benefit admission would have in absence of ACS, however patient now amenable to further workup in anticipation of intervention for severe AS. In the ED, initial vital signs were: 97.9 64 176/78 18 97% RA. - Labs notable for: trop 0.43 which is similar to prior ___ and CK-MB negative. Cr 1.6 which is baseline. WBC 12.5, bicarb 19. - Imaging/studies: EKG unchanged - The patient was given: 324 ASA - Consults: ED providers discussed with ___ attending. Admitted for workup. Admitted to Cardiology for reevaluation. Vitals prior to transfer were: 97.9 59 120/49 14 99% RA. Upon arrival to the floor, he recounts the history above. He states that he completed his shower, he felt as though all the energy had been drained from his body and felt very tired. He denies any chest pain, dyspnea, LH, dizziness. He is here because "my wife and daughter made me come in." Says he spoke to another doctor in the ED "who convinced me to do the procedure." ======================= REVIEW OF SYSTEMS: Per HPI. Denies headache, visual changes, pharyngitis, rhinorrhea, nasal congestion, cough, fevers, chills, sweats, weight loss, abdominal pain, nausea, vomiting, diarrhea, constipation, hematochezia, dysuria, rash, paresthesias, and weakness. ======================= Past Medical History: 1. CARDIAC RISK FACTORS: +hypertension, +dyslipidemia, +diabetes 2. CARDIAC HISTORY: - CABG: None - PERCUTANEOUS CORONARY INTERVENTIONS: None - PACING/ICD: None 3. OTHER PAST MEDICAL HISTORY: CEREBROVASC DISEASE, UNSPEC Aortic valve stenosis COLONIC ADENOMA TREMOR Type 2 diabetes, controlled, with renal manifestation Hydrocephalus Hypercholesteremia ___ (chronic kidney disease) stage 3, GFR ___ ml/min Benign hypertension with chronic kidney disease, stage III Hypothyroidism Aortic insufficiency New onset a-fib Social History: ___ Family History: No family history of early MI, arrhythmia, cardiomyopathies, or sudden cardiac death. Physical Exam: ADMISSION PHYSICAL EXAM: ========================== VITALS: 98.6 138/42 66 18 100/ra Genl: comfortable, NAD HEENT: no icterus, PERRLA, MMM, no OP lesions Neck: no JVP, no LAD Cor: RRR. loud midpeaking SEM over the precordium a/w carotid parvus et tardus; s2 is inaudible. Pulm: no incr WOB, CTAB Abd: soft, ntnd Neuro: AOx3, no focal sensory or motor deficits in bilat ___ MSK: ___ without edema, 2+ distal pulses Skin: no obvious rashes or lesions on torso, UEs, ___ ___ PHYSICAL EXAM: ========================= VITALS: Tm 98.0 140/88 52 20 100% 2.5L Weight on admission: 78.5kg GENERAL: Sleeping, but arousable, well-appearing, in NAD HEENT - NCAT, no conjunctival pallor or scleral icterus, right eye opacified. left pupil round 2 mm, left EOMI, OP clear. NECK: Supple, no LAD, no thyromegaly, JVP ~9 cm CARDIAC: RRR, normal S1/S2, no murmurs rubs or gallops. 1+ DP pulses bilaterally PULMONARY: Scattered wheezes posteriorly, decreased BS @ bases, poor expiratory air movement ABDOMEN: NABS, soft, non-tender, non-distended, no organomegaly. GU: ___ scrotal edema, foley in place with clear ~1L clear urine EXTREMITIES: Warm, well-perfused, no cyanosis, clubbing. 1+ edema over anterior shins to knees bilaterally. SKIN: Without rash. NEUROLOGIC: A&Ox3 (self, ___, year). Follows commands. Moves all extremities to command/spontaneously. Pertinent Results: ADMISSION LABS: =============== ___ 05:05AM BLOOD WBC-8.4 RBC-3.72* Hgb-11.0* Hct-34.3* MCV-92 MCH-29.6 MCHC-32.1 RDW-14.2 RDWSD-47.8* Plt ___ ___ 05:05AM BLOOD Glucose-94 UreaN-35* Creat-1.5* Na-138 K-4.6 Cl-105 HCO3-22 AnGap-16 ___ 05:29PM BLOOD cTropnT-0.43* ___ 11:40PM BLOOD CK-MB-4 cTropnT-0.35* ___ 05:29PM BLOOD CK(CPK)-136 ___ 05:05AM BLOOD Calcium-9.6 Phos-4.2 Mg-2.1 DISCHARGE LABS: ================ ___ Cardiovascular ECG Sinus brady, otherwise Normal ___ 06:10AM BLOOD WBC-10.5* RBC-2.99* Hgb-8.8* Hct-26.8* MCV-90 MCH-29.4 MCHC-32.8 RDW-14.0 RDWSD-46.3 Plt ___ ___ 06:10AM BLOOD Glucose-105* UreaN-28* Creat-1.5* Na-133 K-4.2 Cl-101 HCO3-22 AnGap-14 ___ 06:10AM BLOOD Calcium-9.0 Phos-3.9 Mg-2.0 IMAGING and OTHER STUDIES: ============================= ___ Cardiac cath Impressions: 1. Severe aortic stenosis 2. Three vessel coronary artery disease 3. Successful drug eluting ___ in the mid RCA 4. Residual coronary disease in the LAD, distal PDA, and LCx Recommendations 1. Dual antiplatelet therapy for at least ___ year. 2. Staged PCI of LAD. 3. TAVR following revascularization. ___ CT chest 1. 3.1 cm mixed attenuation mass in the left upper lobe is consistent with primary lung adenocarcinoma. Consider PET-CT for staging purposes if warranted clinically. 2. Other smaller appear ground-glass opacities in the left upper lobe are nonspecific but could potentially represent multicentric disease. 3. Heavily calcified aortic valve, consistent with history of severe aortic stenosis. Atheromatous calcifications of the thoracic aorta as detailed above. These images are available for review. 4. Severe diffuse coronary artery calcifications. 5. Trace left pleural effusion. ___ Cardiovascular ECHO Left Ventricle - Ejection Fraction: 55% >= 55% Aortic Valve - Peak Velocity: *4.3 m/sec <= 2.0 m/sec Aortic Valve - Peak Gradient: *73 mm Hg < 20 mm Hg Aortic Valve - Valve Area: *0.7 cm2 >= 3.0 cm2 CONCLUSION: The left atrial volume index is mildly increased. There is mild symmetric left ventricular hypertrophy with normal cavity size and regional/global systolic function (LVEF>55%). Diastolic function could not be assessed. Right ventricular chamber size and free wall motion are normal. There are three aortic valve leaflets. The aortic valve leaflets are moderately thickened/calcific. There is severe aortic valve stenosis (valve area <1.0cm2). Mild (1+) aortic regurgitation is seen. The mitral valve leaflets are mildly thickened. There is no mitral valve prolapse. There is a minimally increased gradient consistent with trivial mitral stenosis due to mitral annular calcification. Mild (1+) mitral regurgitation is seen. [Due to acoustic shadowing, the severity of mitral regurgitation may be significantly UNDERestimated.] The tricuspid valve leaflets are mildly thickened. There is mild pulmonary artery systolic hypertension. There is no pericardial effusion. IMPRESSION: Severe calcific aortic stenosis with mild aortic regurgitation. Mild symmetric left ventricular hypertrophy with preserved global and regional biventricular systolic function. Mild mitral regurgitation. Mild pulmonary hypertension. ___ Cardiovascular ECG Sinus rhythm. Tall peaked T waves in the precordial leads may be consistent with ischemia or hyperkalemia. Clinical correlation is suggested. No previous tracing available for comparison. ___ Cardiovascular ECG Sinus brady, otherwise normal ECG Brief Hospital Course: Summary ___ hx severe AS ___ 0.9, velocity 5.2m/s), CAD, CVA, HTN, HLD, DM, ___, was recently admitted for NSTEMI, medically managed, declined PCI/TAVR, discharged home, brought to ___ ED after debilitating symptoms. Underwent TAVR workup including cardiac catheterization with DES placed to RCA. Was also incidentally found to a have lung mass. Will continue work up as an outpatient. Acute issues # New lung mass Concern for malignancy based on CT appearance. Alternatively could be due to previous TB infection or granuloma, however less likely. Discussed with PCP that we recommend a PET CT and MRI head for workup. TAVR w/u on hold pending results of lung mass etiology and patient goals of care. Also has IP follow up for potential bronchoscopy and biopsy pending above results. # Severe aortic stenosis: Recently admitted with NSTEMI and cardiac symptoms thought ___ AS. During recent admission, offered PCI/TAVR and did not want to pursue intervention. However, given symptoms, pt returned to ___ just after admission for reconsideration of procedure. Underwent cardiac catheterization with RCA and LAD lesions. Had ___ placed in RCA. Patient will need to continue Plavix ___ year at least. Continued metoprolol, torsemide and lisinopril. # CAD s/p NSTEMI: during recent admission. Medically managed with ASA, heparin gtt, atorva, B-blocker. Underwent cardiac cath this admission with DES to RCA as above. Also found to have LAD lesion which will be addressed by cardiology. Continue Plavix for ___ year at least. Continued ASA, atorvastatin, metoprolol and lisinopril. # Atrial tachyarrhythmia vs fibrillation: Patient was sent in from office as patient was in Afib, confirmed on EKG. Patient with atrial arrhythmia most c/w multiple PACs on recent admission. Prior to last admission, he was found to have an atrial tachyarrhythmia, initially concerning for atrial fibrillation, which appeared to be more consistent with multiple premature atrial complexes. Started 3mg warfarin daily for anticoagulation prior to discharge. Chronic issues # ___ v ___: pt's BUN/Cr appear elevated on recent labs; attributed to ___ during last admission. Unclear baseline renal function, last creatinine of 1.5. Initially held home lisinopril but was able to restart prior to discharge. # T2DM: A1C 6.0 this admission. Held glipizide while admitted nd put on HISS. # Hypothyroidism: continued home levothyroxine. # Hypertension: continued amlodipine 10mg daily and lisinopril 5mg daily. # Vitamins: continued home iron. Transitional Issues - Patient was evaluated by physical therapy and recommended for acute rehab placement. - ___ on ___ and will need to continue Plavix for at least ___ year. It should not be stopped without approval from his cardiologist. - At PCP office pt was found to be in afib. On admission and during stay he remained in sinus rhythm. He was started on 3mg daily Coumadin on discharge for anticoagulation but may need to hold this for potential procedures in the next several weeks. He should have his INR checked in 2 days and dose adjusted accordingly. - Discussed work up of lung mass with his PCP and recommend obtaining a PET-CT and a brain MRI. - Patient will follow with Dr. ___ Dr. ___ TAVR workup. - He will follow with IP in clinic for possibly biopsy of mass pending PET and MRI findings. # CONTACT: Daughter HCP ___ ___ # CODE STATUS: Full, confirmed Medications on Admission: The Preadmission Medication list may be inaccurate and requires futher investigation. 1. Metoprolol Succinate XL 12.5 mg PO QHS 2. Amlodipine 10 mg PO DAILY 3. Aspirin 81 mg PO DAILY 4. Atorvastatin 80 mg PO QPM 5. Levothyroxine Sodium 50 mcg PO DAILY 6. Lisinopril 5 mg PO DAILY 7. Torsemide 2.5 mg PO 3X/WEEK (___) 8. Ferrous Sulfate 325 mg PO BID 9. GlipiZIDE XL 2.5 mg PO DAILY Discharge Medications: 1. Amlodipine 10 mg PO DAILY 2. Aspirin 81 mg PO DAILY 3. Atorvastatin 80 mg PO QPM 4. Levothyroxine Sodium 50 mcg PO DAILY 5. Lisinopril 5 mg PO DAILY 6. Torsemide 2.5 mg PO 3X/WEEK (___) 7. Clopidogrel 75 mg PO DAILY 8. Ferrous Sulfate 325 mg PO BID 9. GlipiZIDE XL 2.5 mg PO DAILY 10. Metoprolol Succinate XL 12.5 mg PO QHS 11. Warfarin 3 mg PO DAILY16 Discharge Disposition: Extended Care Facility: ___ Discharge Diagnosis: Primary Diagnosis: Severe and symptomatic Aortic Stenosis Lung Mass Secondary diagnosis: Coronary artery disease with new ___ placement ___ Hypothyroidism Discharge Condition: Mental Status: Clear and coherent. Level of Consciousness: Alert and interactive. Activity Status: Ambulatory - Independent. Discharge Instructions: Dear Mr. ___, You were admitted to ___ on ___ after you felt lightheaded and dizzy. Your EKG did not show any new signs of a heart attack. You were assessed for TAVR placement and underwent a cardiac catheterization where a drug-eluting ___ was placed. There was an additional blockage that may need to be corrected in the future. During your work up we also found a new lung mass. Currently we do not know the cause of this mass, but our concern is that it could be lung cancer. You will need to follow up with your PCP and other doctors for additional testing to find out the cause of this mass. You were found to have a heart rhythm called atrial fibrillation. For this reason we started a medication called Coumadin to prevent strokes. It is important to have your blood levels checked while on this medication. It was a pleasure taking care of you, best of luck. Your ___ medical team Followup Instructions: ___
19707206-DS-18
19,707,206
20,151,691
DS
18
2118-10-07 00:00:00
2118-10-09 15:15:00
Name: ___ Unit No: ___ Admission Date: ___ Discharge Date: ___ Date of Birth: ___ Sex: M Service: MEDICINE Allergies: Penicillins Attending: ___ Chief Complaint: Cough Major Surgical or Invasive Procedure: None History of Present Illness: Mr. ___ is a ___ male with history of hypertension, hyperlipidemia, CAD, and recently diagnosed multiple myeloma s/p XRT to right clavicular head and currently on RVD who presents with URI symptoms, admitted for observation. Having coughing from day prior to admission, intermittently productive of white or clear sputum. Mild exertional dyspnea. No sick contacts. Denies fevers, chills, dark or rusty sputum, wheezing, dyspnea at rest, orthopnea, PND, chest pain, abdominal pain, n/v/d, rash, leg swelling, or leg pain. On arrival to the floor, patient reports continued dry cough, but says that it improved with duonebs in the ED. No longer having productive cough, and not currently dyspnea. Neck pain present but comparable to baseline. Denies subjective fevers, chills, night sweats, chest pain, abdominal pain, n/v/d, rash, or other symptoms. Past Medical History: PAST ONCOLOGIC HISTORY: Mr. ___ is a ___ yr old male with a past medical hx positive for HTN, HLD, CAD, who presented to clinic in late ___ for evaluation after finding concerning elevation in paraprotein. Mr. ___ reports that in ___ he was at ___ with his grand children riding ___ when the ride jerked and he "felt my neck snap". Over the next several weeks the pain persisted and he developed a large lump over his right clavicle. He was seen by his PCP in late ___ were an xray of his neck was obtained. No fracture or lesion was noted. Given ongoing pain Mr. ___ was refereed to Orthopedic medicine in early ___ where an MRI was preformed. The MRI did show that although he had no fracture in his neck he did have a nonspecific lesion in his clavicle warranting further work up which included SPEP, FLC, and quantitative immunoglobulin. He was found to have a moniclonial protein at the time of dx to be 4872 MG/DL, Free kappa 523.5, IgG 6550, Calcium 11.1, T protein 11.7, B2M 4.0, LDH 123 and HgB 11.1. Further work up reveled the following: bone marrow findings showed Plasma cells comprise 35% of the total aspirate count. By immunohistochemistry, ___ highlights numerous interstitial plasma cells comprising approximately 70% of the total core cellularity, they are kappa restricted by kappa and lambda light chain immunostains. Cytogeneics FISH: POSITIVE for MONOSOMY 13 and GAIN of CHROMOSOMES 5, 9 and 15. Approximately 90% of interphase bone marrow plasma cells examined after enrichment by magnetic separation had abnormal probe signals pattern consistent with monosomy 13 and gain of chromosomes 5, 9 and 15. These findings suggest a hyperdiploid karyotype. There was no evidence of the other cytogenetic findings commonly observed in plasma cells neoplasms. These include gain of 1q, rearrangement of the IGH gene and deletion of the TP53 gene. Based on the International Staging System (ISS) Mr. ___ is considered a stage II as he is neither stage I (B2M <3.5 mg/L and serum albumin greater than or equal to 3.5 g/dL) or stage III (B2M greater than or equal to 5.5mg/L). Given the above findings patient was initiated on RVD therapy. - ___: C1D1 Velcade/Dex/Radiation Therapy - ___: C2D1 RVD PAST MEDICAL HISTORY HYPERLIPIDEMIA HYPERTENSION CORONARY ARTERY DISEASE ERECTILE DYSFUNCTION OBESITY SKIN CANCERS OBSTRUCTIVE SLEEP APNEA KNEE PAIN BENIGN PROSTATIC HYPERTROPHY RIGHT SHOULDER PAIN ___ Surgical History (Last Verified ___ by ___, MD): UMBILICAL HERNIA ___ s/p repair APPENDECTOMY ___ HEMORRHOIDECTOMY ___ Social History: ___ Family History: Family History (Last Verified ___ by ___, MD): Relative Status Age Problem Onset Comments Mother ___ ___ BONE CANCER Sister GLOMERULONEPHRITIS at age ___ CHRONIC KIDNEY DISEASE Comments: no known history of early MI, no knonw history of colon or prostate cancer Physical Exam: Temp: 97.9 PO BP: 148/82 HR: 56 RR: 16 O2 sat: 96% O2 delivery: RA Dyspnea: 0 RASS: 0 Pain Score: ___ GENERAL: WDWN older man in NAD HEENT: NCAT, sclerae anicteric, normal conjunctivae, PERRL, EOMI, oropharynx clear CARDIAC: RRR, normal s1/s2, no m/r/g LUNG: CTAB, no increased work of breathing ABD: Soft, non-tender, non-distended, normoactive BS EXT: Warm, DP pulses 2+ bilaterally, no edema NEURO: A&Ox3, CNII-XII intact, strength ___ in upper and lower extremities bilaterally, sensation intact throughout SKIN: No significant rashes Pertinent Results: ___ 02:17PM OTHER BODY FLUID FluAPCR-NEGATIVE FluBPCR-NEGATIVE ___ 12:31PM GLUCOSE-249* UREA N-25* CREAT-1.0 SODIUM-135 POTASSIUM-3.8 CHLORIDE-98 TOTAL CO2-23 ANION GAP-14 ___ 12:31PM estGFR-Using this ___ 12:31PM WBC-7.6 RBC-3.40* HGB-10.7* HCT-33.9* MCV-100* MCH-31.5 MCHC-31.6* RDW-18.4* RDWSD-67.2* ___ 12:31PM NEUTS-73.8* LYMPHS-11.0* MONOS-13.1* EOS-0.0* BASOS-0.1 NUC RBCS-0.4* IM ___ AbsNeut-5.64 AbsLymp-0.84* AbsMono-1.00* AbsEos-0.00* AbsBaso-0.01 ___ 12:31PM PLT COUNT-152 Brief Hospital Course: Mr. ___ is a ___ male with history of hypertension, hyperlipidemia, CAD, and recently diagnosed multiple myeloma s/p XRT to right clavicular head and currently on RVD who presents with URI symptoms, admitted for observation. # URI # Cough 1 day of cough productive of clear sputum, exertional dyspnea. Flu negative. CXR clear. No new EKG changes. No chest pain, pleuritic discomfort, tachycardia, evidence of DVT on exam. Afebrile, hemodynamically stable, no leukocytosis, non-neutropenic. Clinical history and work-up to date suggestive of viral URI, will monitor inpatient given oncologic history. Symptoms improved with duonebs. Continued home Bactrim for PCP ___. # Multiple Myeloma: Monocloncal IgG MM diagnosed ___. S/p XRTx5 to clavicle head. On C2 RVD, D1 ___. Continued home acyclovir, Bactrim prophylaxis # Anemia/Thrombocytopenia: Secondary to myeloma and chemotherapy. Hgb comparable to recent baseline. Platelets have been downtrending, but remaining WNL. # Cancer-Related Pain Continued home oxycontin and oxycodone PRN CHRONIC ISSUES Continued home metoclopramide # Hypertension Continued home nifedipine, metoprolol, and HCTZ # Hyperlipidemia Continued home simvastatin, ASA Medications on Admission: The Preadmission Medication list is accurate and complete. 1. Acyclovir 400 mg PO Q12H 2. Aspirin 81 mg PO DAILY 3. Hydrochlorothiazide 25 mg PO DAILY 4. Metoprolol Succinate XL 50 mg PO DAILY 5. NIFEdipine (Extended Release) 30 mg PO DAILY 6. Omeprazole 40 mg PO BID 7. OxyCODONE (Immediate Release) 5 mg PO Q8H:PRN Pain - Moderate 8. OxyCODONE SR (OxyconTIN) 10 mg PO QHS 9. Simvastatin 80 mg PO QPM 10. Sulfameth/Trimethoprim SS 1 TAB PO DAILY 11. Metoclopramide 10 mg PO QIDACHS possible gastroparesis 12. Phosphorus 500 mg PO BID Discharge Medications: 1. Albuterol Inhaler ___ PUFF IH Q6H:PRN WHEEZE/ COUGH RX *albuterol sulfate 90 mcg ___ puffs IH every 6 hours as needed Disp #*1 Inhaler Refills:*0 2. Azithromycin 250 mg PO Q24H Duration: 4 Days start on ___ RX *azithromycin 250 mg 1 tablet(s) by mouth once a day Disp #*4 Tablet Refills:*0 3. Acyclovir 400 mg PO Q12H 4. Aspirin 81 mg PO DAILY 5. Hydrochlorothiazide 25 mg PO DAILY 6. Metoclopramide 10 mg PO QIDACHS possible gastroparesis 7. Metoprolol Succinate XL 50 mg PO DAILY 8. NIFEdipine (Extended Release) 30 mg PO DAILY 9. Omeprazole 40 mg PO BID 10. OxyCODONE (Immediate Release) 5 mg PO Q8H:PRN Pain - Moderate 11. OxyCODONE SR (OxyconTIN) 10 mg PO QHS 12. Phosphorus 500 mg PO BID 13. Simvastatin 80 mg PO QPM 14. Sulfameth/Trimethoprim SS 1 TAB PO DAILY Discharge Disposition: Home Discharge Diagnosis: VIRAL URI Discharge Condition: Mental Status: Clear and coherent. Level of Consciousness: Alert and interactive. Activity Status: Ambulatory - Independent. Discharge Instructions: Dear Mr. ___, It was a privilege caring of you at ___. WHY WAS I IN THE HOSPITAL? - You were admitted for monitoring for a respiratory infection WHAT HAPPENED TO ME IN THE HOSPITAL? - You had a chest X ray, which showed no evidence of pneumonia - You received nebulizers to help with your breathing - Your vital signs and labs were monitored - You improved and were well enough to go home WHAT SHOULD I DO AFTER I LEAVE THE HOSPITAL? - Continue to take all your medicines and keep your appointments. - take azithromycin 250mg daily for 4 days starting on ___. - do not take Revlemid until your oncologist tells you to restart it. We wish you the best. Sincerely, Your ___ Team Followup Instructions: ___
19707206-DS-20
19,707,206
25,778,560
DS
20
2119-02-06 00:00:00
2119-02-06 15:11:00
Name: ___ Unit No: ___ Admission Date: ___ Discharge Date: ___ Date of Birth: ___ Sex: M Service: MEDICINE Allergies: Penicillins Attending: ___. Chief Complaint: chest pain and back pain with associated SOB Major Surgical or Invasive Procedure: pheresis line placement: ___ History of Present Illness: Patient is a ___ male with a history of multiple myeloma, diabetes presenting with back pain and chest pain. He said the pain started at 11 ___ the night of presentation, he reports the pain as being higher up in his back and radiates across his chest. He denies any recent trauma, the pain came on while he was laying in bed. He says the pain comes on in spasms, describes as ___ in severity. Has never felt pain like this before. HE is scheduled to get stem cell transfusion on ___. Reports SOB with the chest and back pain. Took oxycodone when the pain started with no relief. Past Medical History: PAST MEDICAL HISTORY HYPERLIPIDEMIA HYPERTENSION CORONARY ARTERY DISEASE ERECTILE DYSFUNCTION OBESITY SKIN CANCERS OBSTRUCTIVE SLEEP APNEA KNEE PAIN BENIGN PROSTATIC HYPERTROPHY RIGHT SHOULDER PAIN NASH Surgical History (Last Verified ___ by ___, MD): UMBILICAL HERNIA ___ s/p repair APPENDECTOMY ___ HEMORRHOIDECTOMY ___ PAST ONCOLOGIC HISTORY (per OMR): - ___: Cycle 1 Velcade/Dexamethasone - ___: Radiation therapy to right clavicle head, 5 treatments - ___ - ___: Admission for increasing neck pain. Felt more musculoskeletal. - ___ - ___: Admission for reduced appetite, dyspepsia & abdominal bloating. EGD showed nonspecific cobblestoning of the proximal duodenum, with biopsies showing enteritis; started on high-dose PPI and standing Reglan with meals (for possible Velcade-induced gastroparesis). Symptoms improved. - ___: Cycle 2 Velcade, Revlimid 25 mg D ___, Dexamethasone. Delayed for nausea and concern for delayed motility - ___ - ___: Admission for cough/URI. Treated with Z-pak and inhalers. - ___: Cycle 3 Velcade, Revlimid 25 mg D ___, Dexamethasone - ___: Fever; cough with Influenza B; treated with Tamiflu - ___: Cycle 4 Velcade, Revlimid 25 mg D ___, Dexamethasone - ___: Cycle 5 Velcade HELD d/t increasing neuropathies. Revlimid 25 mg x 14 days with weekly Dexamethasone. Social History: ___ Family History: -mother deceased at age ___ r/t bone cancer -sister dx with glomerulonephritis at age ___ Physical Exam: ADMISSION PHYSICAL EXAM ======================== 24 HR Data (last updated ___ @ 1723) Temp: 98.0 (Tm 98.0), BP: 148/75, HR: 70, O2 sat: 97%, O2 delivery: RA, Wt: 198.5 lb/90.04 kg GENERAL: pacing in room, appears comfortable, no acute distress, pleasant EYES: Pupils equally round reactive to light, anicteric sclera HEENT: Oropharynx clear, no lesions, moist mucous membranes NECK: Supple, normal range of motion LUNGS: Clear to auscultation bilaterally without any wheezes rales or rhonchi. Breathing even and non-labored. CV: Regular rate and rhythm no murmurs rubs or gallops normal distal perfusion no edema ABD: Soft nontender nondistended normoactive bowel sounds, no rebound or guarding EXT: No deformity, normal muscle bulk SKIN: Warm dry, no rash NEURO: Alert and oriented x3, fluent speech LINES: PIV DISCHARGE PHYSICAL EXAM ======================== Temp: 97.8, BP: 142/79, HR: 62, O2 sat: 95%, O2 delivery: RA, Wt: 198.5 lb/90.04 kg GENERAL: lying down in phresis unit, appears comfortable, no acute distress, pleasant EYES: Pupils equally round reactive to light, anicteric sclera HEENT: Oropharynx clear, no lesions, moist mucous membranes NECK: Supple, normal range of motion LUNGS: Clear to auscultation bilaterally without any wheezes rales or rhonchi. Breathing even and non-labored. CV: Regular rate and rhythm no murmurs rubs or gallops normal distal perfusion no edema ABD: Soft nontender nondistended normoactive bowel sounds, no rebound or guarding EXT: No deformity, normal muscle bulk SKIN: Warm dry, no rash NEURO: Alert and oriented x3, fluent speech LINES: tunneled pheresis line-CDI Pertinent Results: ADMISSION LABS ==================== ___ 03:27AM BLOOD WBC-0.6* RBC-4.19* Hgb-12.7* Hct-39.1* MCV-93 MCH-30.3 MCHC-32.5 RDW-14.7 RDWSD-50.3* Plt Ct-44* ___ 03:27AM BLOOD Neuts-0* Lymphs-75* Monos-10 Eos-8* Baso-1 Atyps-4* Myelos-2* AbsNeut-0.00* AbsLymp-0.47* AbsMono-0.06* AbsEos-0.05 AbsBaso-0.01 ___ 03:27AM BLOOD Poiklo-1+* Ovalocy-1+* Tear Dr-1+* RBC Mor-SLIDE REVI ___ 03:27AM BLOOD ___ PTT-30.9 ___ ___ 03:27AM BLOOD Plt Smr-VERY LOW* Plt Ct-44* ___ 03:27AM BLOOD Glucose-135* UreaN-19 Creat-1.2 Na-141 K-4.1 Cl-103 HCO3-25 AnGap-13 ___ 06:38AM BLOOD b2micro-2.0 DISCHARGE LABS ==================== ___ 12:00AM BLOOD WBC-17.7* RBC-3.39* Hgb-10.3* Hct-31.5* MCV-93 MCH-30.4 MCHC-32.7 RDW-15.4 RDWSD-52.2* Plt Ct-51* ___ 12:00AM BLOOD Neuts-62 Bands-30* Lymphs-3* Monos-0* Eos-1 Baso-0 Atyps-1* Metas-1* Myelos-2* NRBC-0.6* AbsNeut-16.28* AbsLymp-0.71* AbsMono-0.00* AbsEos-0.18 AbsBaso-0.00* ___ 12:00AM BLOOD Anisocy-1+* Poiklo-1+* Polychr-1+* Ellipto-1+* RBC Mor-SLIDE REVI ___ 12:00AM BLOOD Plt Smr-VERY LOW* Plt Ct-51* ___ 12:00AM BLOOD Glucose-82 UreaN-10 Creat-0.9 Na-146 K-3.5 Cl-103 HCO3-26 AnGap-17 ___ 12:00AM BLOOD ALT-10 AST-21 LD(LDH)-443* AlkPhos-100 TotBili-0.3 ___ 12:00AM BLOOD Albumin-4.0 Calcium-9.7 Phos-3.0 Mg-1.8 ___ 12:00AM BLOOD Brief Hospital Course: Mr. ___ is a pleasant ___ year-old male with hx of CAD, HTN, DL, OSA, ID-T2DM, and MM s/p Velcade, Dex, and Revlimid recently admitted from ___ for stem cell mobilization with Cytoxan. He presented to ED ___ with severe lower back, chest pain and associated SOB after beginning high-dose neupogen 960mcg daily on ___ in preparation for stem cell collection ___. #BACK AND HIP PAIN: #SOB (resolved): Presented with severe chest and back pain with associated SOB. Concern for PE especially as hypercoagulability is common in patients with MM vs. aortic dissection vs. ACS vs. bony pain secondary to GCSF. ACS less likely given NSR EKG and negative troponin. CXR showed no signs of aortic arch widening concerning for aortic dissection. CTA with no evidence of PE. Therefore, given above findings, pain in likely consistent with bony pain secondary to neupogen especially in the setting of administration of 960mcg neupogen daily since ___. Pain improves with PRN IV dilaudid now not requiring off neupogen. Discharged home to resume prior pain management regimen with PRN oxycodone. #IGG KAPPA MULTIPLE MYELOMA: #NEUTROPENIA: Presented in late ___ with 3 month history of neck pain, prompting imaging which showed concerning lesions for multiple myeloma. Work up was notable for a monoclonal IgG Kappa with one marrow biopsy confirming this diagnosis with plasma cells comprising approximately 70% of the total core cellularity. He received XRT to the right clavicle lesions and was initiated on treatment with RVD(Revlimid held with ___ cycle d/t ongoing XRT). He has received 4 cycles of treatment with an excellent response to his treatment based on monoclonal protein and free kappa levels. Treatment has been complicated by steroid induced diabetes as well as painful neuropathy of his legs. Velcade was held for Cycle 5 and he completed the 14 days of Revlimid(last dose on ___. As he has had an excellent response, the plan is to reassess his disease and move forward with autologous transplant. Bone marrow biopsy for disease assessment with marked decrease in involvement(< 5%). PET scan with decreased burden of disease. He received high dose Cytoxan for stem cell mobilization on ___, likely the etiology for neutropenia. He was discharged home ___ with instruction to administer daily 480mcg neupogen x6 days then to increase to 960mcg x3 days beginning on ___. He received 960mcg neupogen SC daily through ___. Now s/p pheresis line placement and stem cell collection ___, with collection >16. Continues on monthly Zometa outpatient per outpatient recs, last given ___. Levofloxacin prophylaxis discontinued ___ as no longer neutropenic. F/U scheduled with Dr. ___ admission for auto-SCT ___. #BOWEL IRREGULARITY (Resolved): No further episodes now constipated likely from narcotics. On admission patient reported 1 episode of loose stool ___ AM. Not associated with fevers, abdominal pain or cramping. Typical bowel pattern is formed BM Q3-4 days per patient. CHRONIC/RESOLVED ISSUES ============================= #NEUROPATHY: Marked increase in neuropathies of lower legs in the setting of Velcade and Revlimid. Most likely exacerbated by lumbar disc disease and diabetes. Requiring increasing amounts of Oxycodone, 2 tablets, now every 4 hours. Has now tapered off gabapentin as he felt it did not help and pain persisted. Prior to admission for acute pain, his pain regimen consisted of oxycodone, ___ tablets every ___ hours as needed for pain. Will continue home pain management regimen at discharge. #Abnormal uptake on Prostate noted on PET scan: Followed by Dr. ___. PSA in 3 range. Was supposed to get MRI for further evaluation and holding off on invasive procedures as able but not able to get MRI with the leg pain (could not lie still). #STEROID INDUCED DIABETES: Home regimen consisted of metformin, Lantus and Humalog sliding scale insulin. Better control without steroids. Restarted metformin at discharge. #SCC: Skin lesion biopsied which shows SCC extending to margins. Had surgical re-excision with no residual cancer and well healed area. CORE MEASURES =================== # CODE: Presumed Full # EMERGENCY CONTACT: ___ Relationship: Wife Phone number: ___ # DISPO: discharge to home ___ to follow up with Dr. ___ in clinic prior to admission for auto-SCT on ___. TRANSITIONAL ISSUES [ ] Patient will be seen by Dr. ___ prior to admission for auto-SCT-patient to be called with this appointment and time. Medications on Admission: The Preadmission Medication list is accurate and complete. 1. Acyclovir 400 mg PO Q12H 2. Cyanocobalamin 1000 mcg PO DAILY 3. Metoprolol Succinate XL 50 mg PO DAILY 4. NIFEdipine (Extended Release) 30 mg PO DAILY 5. Omeprazole 40 mg PO BID 6. OxyCODONE (Immediate Release) 10 mg PO Q4H:PRN Pain - Moderate 7. Pyridoxine 50 mg PO DAILY 8. Sulfameth/Trimethoprim SS 1 TAB PO DAILY 9. Hydrochlorothiazide 25 mg PO DAILY 10. LevoFLOXacin 500 mg PO Q24H 11. MetFORMIN (Glucophage) 500 mg PO BID 12. Filgrastim-sndz 480 mcg SC Q24H 13. Glargine 38 Units Breakfast Insulin SC Sliding Scale using HUM Insulin Discharge Medications: 1. Glargine 38 Units Breakfast Insulin SC Sliding Scale using HUM Insulin 2. Acyclovir 400 mg PO Q12H 3. Cyanocobalamin 1000 mcg PO DAILY 4. Hydrochlorothiazide 25 mg PO DAILY 5. MetFORMIN (Glucophage) 500 mg PO BID 6. Metoprolol Succinate XL 50 mg PO DAILY 7. NIFEdipine (Extended Release) 30 mg PO DAILY 8. Omeprazole 40 mg PO BID 9. OxyCODONE (Immediate Release) 10 mg PO Q4H:PRN Pain - Moderate 10. Pyridoxine 50 mg PO DAILY 11. Sulfameth/Trimethoprim SS 1 TAB PO DAILY Discharge Disposition: Home With Service Facility: ___ Discharge Diagnosis: PRIMARY DIAGNOSIS ================== MULTIPLE MYELOMA ACUTE PAIN SECONDARY DIAGNOSIS ===================== STEROID INDUCED DIABETES Discharge Condition: Mental Status: Clear and coherent. Level of Consciousness: Alert and interactive. Activity Status: Ambulatory - Independent. Discharge Instructions: Dear Mr. ___. You were admitted for evaluation of acute chest and back pain likely due to neupogen bony pain. You improved with pain medication and underwent stem cell collection on ___ which you tolerated..... Please follow up with Dr. ___ as stated below. It was a pleasure taking care of you. Sincerely, Your ___ Care Team Followup Instructions: ___
19707324-DS-9
19,707,324
21,359,297
DS
9
2168-11-01 00:00:00
2168-11-02 13:22:00
Name: ___ Unit No: ___ Admission Date: ___ Discharge Date: ___ Date of Birth: ___ Sex: M Service: MEDICINE Allergies: No Known Allergies / Adverse Drug Reactions Attending: ___. Chief Complaint: Shortness of breath Major Surgical or Invasive Procedure: Dual chamber St. ___ Pacemaker (___) History of Present Illness: ___ with h/o atrial fibrillation (on rivaroxaban) presented with dyspnea x 5 days. Denied orthopnea, uses CPAP at night. Last night when he got up to use the bathroom he felt dyspneic. Denies chest pain. He reports eating salty foods lately and his weight has gone up a few pounds. ___ edema is chronic and improved. He usually takes 40 po lasix in am and 20 in pm and took 40mg today. He reports having nightsweats twice this week, none last night. Denies fevers/chills, abdominal pain. Past Medical History: CAD s/p PCI of mLAD (4x18 mm Cypher) DMII Hyperlipidemia Pulmonic stenosis with 8-10 mm Hg mean gradient, congenital with balloon in ___, stable on Echocardiography Atrial fibrillation and atrial ectopy - cardioverted ___ Obesity OSA Hypothyroidism dCHF Social History: ___ Family History: Male cousin at died ___ of MI - other CAD at advanced ages, mother died at ___ of ALS and father died at ___ yo with prostate cancer Physical Exam: ADMISSION: VS: T97.8 HR 34 BP 151/44 RR 20 SPO2 97% GEN: obese gentleman, sitting on side of bed, NAD HEENT: MMM, PERRL PULM: CTAB, no wheezes CV: Bradycardia, no murmurs Abd: soft, non-tender, +BS Ext: warm, well-perfused DISCHARGE: GEN: obese gentleman, sitting on side of bed, NAD HEENT: MMM, PERRL PULM: CTAB, no wheezes CV: RRR, no murmurs Abd: soft, non-tender, +BS Ext: warm, well-perfused Pertinent Results: ___ 07:00PM BLOOD WBC-8.2 RBC-4.52* Hgb-14.7 Hct-42.9 MCV-95 MCH-32.6* MCHC-34.4 RDW-14.8 Plt ___ ___ 07:01AM BLOOD WBC-8.0 RBC-4.33* Hgb-13.9* Hct-41.5 MCV-96 MCH-32.1* MCHC-33.5 RDW-13.8 Plt ___ ___ 07:00PM BLOOD ___ PTT-41.6* ___ ___ 07:01AM BLOOD ___ PTT-37.0* ___ ___ 07:00PM BLOOD Glucose-183* UreaN-59* Creat-1.5* Na-135 K-5.1 Cl-102 HCO3-20* AnGap-18 ___ 07:01AM BLOOD Glucose-136* UreaN-34* Creat-1.0 Na-139 K-4.0 Cl-110* HCO3-20* AnGap-13 ___ 07:00PM BLOOD proBNP-2298* ___ 07:00PM BLOOD cTropnT-0.01 ___ 07:00PM BLOOD Calcium-9.5 Phos-4.8* Mg-2.8* ___ 07:01AM BLOOD Calcium-9.1 Phos-2.7 Mg-2.1 ___ 07:00PM BLOOD Lactate-1.9 K-4.8 EKG ___ Sinus rhythm. High degree A-V block is suggested. Compared to the previous tracing of ___ A-V block is now seen. ___ ___ EKG ___ Sinus rhythm. Complete heart block is suggested. Clinical correlation is suggested. Compared to the previous tracing complete heart block is now suggested. ___ ___ CXR ___ IMPRESSION: Interval placement of a dual lead left-sided pacing device with the leads terminating over the expected location of the right atrium and right ventricle, respectively. The heart remains stably enlarged. There is stable enlargement of the pulmonary artery suggesting underlying pulmonary arterial hypertension. The interstitium is more prominent as compared to ___ which suggests superimposed mild interstitial edema. Clinical correlation is recommended. Status post median sternotomy. No pneumothorax. Minimal blunting of both costophrenic angles may reflect tiny effusions or pleural thickening. Brief Hospital Course: ___ with h/o atrial fibrillation (on rivaroxaban, cardioverted ___, CAD s/p PCI of mLAD (4x18 mm Cypher), last stress ___ w/ no anginal sx or EKG changes, congenital pulmonic stenosis (last echo w/ severe pulmonic regurg), CHF on home lasix (40am/20pm) presents with dyspnea x 5 days and is found to be in thrid degree heart block. He had a dual chamber pacemaker placed and his symptoms improved and VSS. He needs follow up with device clinic regarding pacemaker in one week. He was started on Keflex for antibiotic prophylaxis after pacemaker placement and needs to continue it for two more days after discharge. Medications on Admission: The Preadmission Medication list is accurate and complete. 1. AcetaZOLamide 250 mg PO HS 2. Rivaroxaban 20 mg PO DAILY 3. Atorvastatin 10 mg PO QPM 4. detemir 40 Units Bedtime novolog 8 Units Breakfast novolog 14 Units Lunch novolog 14 Units Dinner 5. Furosemide 40 mg PO AM 6. Aspirin 81 mg PO BID 7. Levothyroxine Sodium 175 mcg PO DAILY 8. Furosemide 20 mg PO ___ 9. Lisinopril 10 mg PO DAILY 10. MetFORMIN XR (Glucophage XR) 1000 mg PO BID Discharge Medications: 1. AcetaZOLamide 250 mg PO HS 2. Aspirin 81 mg PO BID 3. Atorvastatin 10 mg PO QPM 4. Furosemide 40 mg PO AM 5. Furosemide 20 mg PO ___ 6. detemir 40 Units Bedtime novolog 8 Units Breakfast novolog 14 Units Lunch novolog 14 Units Dinner 7. Levothyroxine Sodium 175 mcg PO DAILY 8. Lisinopril 10 mg PO DAILY 9. Rivaroxaban 20 mg PO DAILY 10. MetFORMIN XR (Glucophage XR) 1000 mg PO BID Do Not Crush 11. Cephalexin 250 mg PO Q6H Duration: 2 Days RX *cephalexin 250 mg 1 capsule(s) by mouth every six (6) hours Disp #*9 Capsule Refills:*0 Discharge Disposition: Home Discharge Diagnosis: Primary: Complete heart block Secondary: CAD, Afib, chronic diastolic CHF Discharge Condition: Mental Status: Clear and coherent. Level of Consciousness: Alert and interactive. Activity Status: Ambulatory - Independent. Discharge Instructions: Mr. ___, It was a pleasure taking care of you at ___. You were admitted with shortness of breath and were found to be in complete heart block. You received a pacemaker and your symptoms improved. You should follow up with the pacemaker clinic and with your primary care provider this week. Regards, Your ___ Team Followup Instructions: ___
19707603-DS-3
19,707,603
22,625,317
DS
3
2128-03-20 00:00:00
2128-03-24 22:07:00
Name: ___ Unit No: ___ Admission Date: ___ Discharge Date: ___ Date of Birth: ___ Sex: F Service: SURGERY Allergies: hydroxychloroquine / lisinopril / simvastatin Attending: ___. Chief Complaint: nausea vomit anorexia abdominal pain Major Surgical or Invasive Procedure: ERCP - sphincterotomy and stent placement ___ - drainage of fluid collection History of Present Illness: Ms. ___ is a ___ with diabetes mellitus type 2, hypertension,hyperlipidemia, and morbid obesity who initially presented on ___ for surgical management of acute cholecystitis. She underwent laparoscopic cholecystectomy without complication that same day and was discharged on POD2 after an uneventful postoperative course. She was started on ciprofloxacin and metronidazole during her stay due to findings of marked inflammation and partially gangrenous gallbladder intraoperatively and discharged with prescriptions to complete a 5 day total course. She re-presents today to the ED with symptoms of anorexia, nausea, and vomiting for 3 days. She has RUQ abdominal pain that has not improved since discharge. She has not been able to regularly take her discharge medications, including an inability to complete her course of antibiotics or pain medications. When she has been able to take her prescribed oxycodone, she feels it does not improve her pain. She has been passing flatus and having loose bowel movements. She denies symptoms of fever, chills, SOB, or chest pain. Past Medical History: Hypertension Diabetes mellitus, type II Hyperlipidemia Morbid obesity Rheumatoid arthritis Social History: ___ Family History: - CVA - DM, II - Breast Cancer Physical Exam: Temp 98.1 BP 135 / 84 HR 86 RR 20 Sat02:98% General: lying in bed, no acute distress HEENT: No scleral icterus, mucous membrane is moist Cardio: Regular rate and rhythm Pulmonary: No increased work of breathing Abdomen: mildly distended, tender in RUQ and epigastrium, ___ drain in place Extremities: Warm and well-perfused, chronic scar to the right medial malleolus Pertinent Results: ___ 04:40AM BLOOD WBC-7.8 RBC-3.93 Hgb-12.3 Hct-37.5 MCV-95 MCH-31.3 MCHC-32.8 RDW-14.6 RDWSD-50.5* Plt ___ ___ 04:10AM BLOOD WBC-9.7 RBC-3.81* Hgb-11.9 Hct-36.2 MCV-95 MCH-31.2 MCHC-32.9 RDW-14.6 RDWSD-49.6* Plt ___ ___ 04:57AM BLOOD WBC-9.7 RBC-3.91 Hgb-11.9 Hct-37.3 MCV-95 MCH-30.4 MCHC-31.9* RDW-14.6 RDWSD-50.0* Plt ___ ___ 10:37AM BLOOD WBC-11.7* RBC-4.18 Hgb-12.8 Hct-39.0 MCV-93 MCH-30.6 MCHC-32.8 RDW-14.6 RDWSD-49.2* Plt ___ ___ 10:37AM BLOOD Neuts-74.5* Lymphs-8.9* Monos-11.9 Eos-3.5 Baso-0.4 Im ___ AbsNeut-8.74* AbsLymp-1.04* AbsMono-1.39* AbsEos-0.41 AbsBaso-0.05 ___ 04:40AM BLOOD Plt ___ ___ 04:10AM BLOOD Plt ___ ___ 04:57AM BLOOD Plt ___ ___ 04:57AM BLOOD ___ PTT-28.0 ___ ___ 10:37AM BLOOD Plt ___ ___ 04:40AM BLOOD Glucose-109* UreaN-7 Creat-0.6 Na-144 K-4.1 Cl-105 HCO3-26 AnGap-13 ___ 04:10AM BLOOD Glucose-131* UreaN-8 Creat-0.6 Na-144 K-3.7 Cl-105 HCO3-29 AnGap-10 ___ 04:57AM BLOOD Glucose-139* UreaN-10 Creat-0.6 Na-142 K-4.4 Cl-105 HCO3-26 AnGap-11 ___ 10:37AM BLOOD Glucose-171* UreaN-11 Creat-0.7 Na-142 K-4.4 Cl-101 HCO3-28 AnGap-13 ___ 04:40AM BLOOD ALT-39 AST-33 AlkPhos-134* TotBili-0.5 ___ 04:10AM BLOOD ALT-45* AST-34 AlkPhos-139* TotBili-0.5 ___ 04:57AM BLOOD ALT-57* AST-51* AlkPhos-143* TotBili-0.6 ___ 10:37AM BLOOD ALT-69* AST-62* AlkPhos-155* TotBili-0.8 ___ 04:56AM BLOOD CK-MB-1 cTropnT-<0.01 ___ 04:40AM BLOOD Calcium-7.6* Phos-2.9 Mg-1.7 ___ 04:10AM BLOOD Calcium-7.9* Phos-3.1 Mg-1.9 ___ 04:57AM BLOOD Calcium-8.0* Phos-3.4 Mg-1.8 ___ 10:37AM BLOOD Albumin-3.1* ___ 10:48AM BLOOD Lactate-1.3 Brief Hospital Course: Mrs. ___ was admitted on ___ when she presented with anorexia, nausea, vomiting for 3 days and right upper quadrant abdominal pain that has not improved since discharge she underwent a laparoscopic cholecystectomy for acute cholecystitis on ___. An ultrasound on the day of admission showed a perihepatic hypoechoic collection measuring up to 7.1 cm with internal hyperechoic echoes suggesting a complex fluid collection likely representing hematoma versus biloma. No biliary dilation identified to suggest retained biliary stone. Patient was kept n.p.o. and was hydrated with IV fluids. She was started on Cipro/Flagyl, pain was well managed. She was scheduled to undergo ERCP. On ___ she underwent an ERCP in which a sphincterotomy was performed and a stent was placed, she was scheduled for stent pull in 4 weeks. On ___ interventional radiology performed a CT-guided drainage of fluid collection in the gallbladder fossa, approximately 100 cc of serosanguineous fluid was aspirated with a sample sent for microbiology evaluation. Patient tolerated well the procedure and there were no immediate postprocedural complications. On ___ patient was advanced to a regular diet and all medicines were converted to p.o. Drain output was followed-up closely and patient described the pain as only mild and graded it ___. On ___ patient reported 4 episodes of loose stools which were sent for testing for C. difficile, results came back negative patient reported pain has decreased significantly, although her night she complained of lower chest and epigastric pain with no arm radiation and EKG was ordered along with troponins, both came back normal. Patient was educated on how to take care of the drain, as well as how to measure output, she was instructed of warning signs and to please call if drainage increased significantly. She was tolerating oral medication, managing pain well, and comfortable taking care of during. Patient was discharged on ___ Medications on Admission: The Preadmission Medication list is accurate and complete. 1. FoLIC Acid 1 mg PO DAILY 2. glimepiride 8 mg oral DAILY 3. Ibuprofen 800 mg PO DAILY:PRN Pain - Mild 4. Ketoconazole 2% 1 Appl TP BID 5. Lantus U-100 Insulin (insulin glargine) 100 unit/mL subcutaneous QHS 6. Losartan Potassium 100 mg PO DAILY 7. MetFORMIN (Glucophage) 1000 mg PO BID 8. Methotrexate 7.5 mg PO 1X/WEEK (___) 9. Methotrexate 10 mg PO 1X/WEEK (___) 10. Pravastatin 20 mg PO QPM 11. OxyCODONE (Immediate Release) ___ mg PO Q4H:PRN Pain - Moderate 12. Acetaminophen 1000 mg PO Q8H 13. Docusate Sodium 100 mg PO BID Discharge Medications: 1. Acetaminophen 1000 mg PO Q8H 2. Docusate Sodium 100 mg PO BID 3. FoLIC Acid 1 mg PO DAILY 4. glimepiride 8 mg oral DAILY 5. Ibuprofen 800 mg PO DAILY:PRN Pain - Mild 6. Ketoconazole 2% 1 Appl TP BID 7. Lantus U-100 Insulin (insulin glargine) 100 unit/mL subcutaneous QHS 8. Losartan Potassium 100 mg PO DAILY 9. MetFORMIN (Glucophage) 1000 mg PO BID 10. Methotrexate 10 mg PO 1X/WEEK (___) 11. Methotrexate 7.5 mg PO 1X/WEEK (___) 12. OxyCODONE (Immediate Release) ___ mg PO Q4H:PRN Pain - Moderate RX *oxycodone 5 mg 1 tablet(s) by mouth q6h prn Disp #*20 Tablet Refills:*0 13. Pravastatin 20 mg PO QPM Discharge Disposition: Home With Service Facility: ___ Discharge Diagnosis: Drained cystic duct leak Discharge Condition: Mental Status: Clear and coherent. Level of Consciousness: Alert and interactive. Activity Status: Ambulatory - Independent. Discharge Instructions: Dear ___, ___ was a pleasure taking care of you here at ___ ___. You were admitted to our hospital for abdominal pain and nausea following your laparoscopic cholecystectomy on ___. You were found to have an a cystic duct leak which was drained by interventional radiology and you are going home with a drain. You have recovered and are now ready to be discharged to home. Please follow the recommendations below to ensure a speedy and uneventful recovery. ACTIVITY: - Do not drive until you have stopped taking pain medicine and feel you could respond in an emergency. - You may climb stairs. - You may go outside, but avoid traveling long distances until you see your surgeon at your next visit. - You may start some light exercise when you feel comfortable. - Heavy exercise may be started after 6 weeks, but use common sense and go slowly at first. - You may resume sexual activity unless your doctor has told you otherwise. HOW YOU MAY FEEL: - You may feel weak or "washed out" for 6 weeks. You might want to nap often. Simple tasks may exhaust you. - You may have a sore throat because of a tube that was in your throat during the endoscopy. YOUR BOWELS: - Constipation is a common side effect of medicine such as Percocet or codeine. If needed, you may take a stool softener (such as Colace, one capsule) or gentle laxative (such as milk of magnesia, 1 tbs) twice a day. You can get both of these medicines without a prescription. - If you go 48 hours without a bowel movement, or have pain moving the bowels, call your surgeon. - After some operations, diarrhea can occur. If you get diarrhea, don't take anti-diarrhea medicines. Drink plenty of fluids and see if it goes away. If it does not go away, or is severe and you feel ill, please call your surgeon. PAIN MANAGEMENT: - Your pain should get better day by day. If you find the pain is getting worse instead of better, please contact your surgeon. If you experience any of the following, please contact your surgeon: - sharp pain or any severe pain that lasts several hours - pain that is getting worse over time - pain accompanied by fever of more than 101 - a drastic change in nature or quality of your pain MEDICATIONS: - Take all the medicines you were on before the operation just as you did before, unless you have been told differently. - If you have any questions about what medicine to take or not to take, please call your surgeon. DRAIN CARE: You are being discharged with drains in place. Drain care is a clean procedure. Wash your hands with soap and warm water before performing your drain care, which you should do ___ times a day. Try to empty the drain at the same time each day. Pull the stopper out of the bottle and empty the drainage fluid into the measuring cup. Record the amount of fluid on the record sheet, and reestablish drain suction. Clean around the drain site(s) where the tubing exits the skin with soap and water. Be sure to secure your drains so they don't hang down loosely and pull out. -Strip the drain tubing, empty the bulb(s), and record the output ___ times a day as described above. -Keep a written record of the daily amount from each drain and bring this to every follow up appointment. Your drains will be removed once the output tapers off to an acceptable amount. Followup Instructions: ___
19707824-DS-13
19,707,824
24,196,542
DS
13
2161-03-15 00:00:00
2161-03-15 16:56:00
Name: ___ Unit No: ___ Admission Date: ___ Discharge Date: ___ Date of Birth: ___ Sex: F Service: ___ Allergies: ___ Attending: ___. Chief Complaint: Dyspnea Major Surgical or Invasive Procedure: None History of Present Illness: Ms. ___ is a ___ with history of dementia, COPD, HFpEF (last EF 50% ___, CAD s/p CABG, Afib, and CKD who presents for persistent nausea/vomiting. Per history obtained in ED, patient has had persistent nausea/vomiting for the past few days with up to 20 episodes of emesis/day. She has been taking Zofran (prescribed by PCP) with little effect and has been unable to keep down food/fluids. Additionally, she has been experiencing mild shortness of breath that is worse with episodes of emesis and cough productive of black phlegm. She denies abdominal pain and have been having normal bowel movements without melena/hematochezia. She denies fevers, headaches, or sick contacts. In the ED, initial Vitals: T 97.8 HR 78 BP 131/72 RR 22 O2 91% Exam notable for: - General: Appears comfortably on 4L NC - Cardiac: Irregular rhythm, normal rate, no m/r/g - Pulmonary: Diminished breath sounds at bases - Abdomen: Moderately distended, nontender, no rebound/guarding - Ext: 1+ pitting edema in b/l ___ Labs notable for: - WBC 6.8, Hgb 9.0 - Ca125 512, CEA 3.8 - BUN 37, Cr 2.0 - pro-BNP 7456 - Flu A/B negative - trop 0.06 --> 0.07 - pH 7.___ - UA tr protein Imaging: - ___ CT abdomen/pelvis w/o contrast 1. 3.7 cm soft tissue mass in left adnexa is incompletely assessed on this nonenhanced exam but is suspicious for underlying malignancy. 2. Large volume ascites with peritoneal soft tissue nodularity which may reflect peritoneal carcinomatosis. 3. Enlarged periaortic lymph node measures up to 1.2 cm. 4. 1.4 cm right lower pole hyperdense renal lesion is incompletely evaluated on this nonenhanced exam. If it would alter management this may be further evaluated with nonemergent renal ultrasound or MRI. 5. 4.2 cm infrarenal abdominal aortic aneurysm. 6. Compression deformities of the L2 and L3 vertebral bodies are age indeterminate. 7. Small bilateral pleural effusions. 8. Nodular opacities in the bilateral lung bases are nonspecific with differential considerations including pneumonia, aspiration, metastases or a combination. - ___ CXR 1. Interval worsening of moderate pulmonary edema. Small bilateral pleural effusions appear similar. 2. More focal opacities in the lung bases may reflect atelectasis, though underlying infection or aspiration is not excluded. Follow up radiographs after diuresis are suggested. Consults: - Ob/Gyn: Concern for mullerian cancer, recommend checking Ca-125, Ca ___, CEA. Consider CTPA to evaluated for PE and therapeutic paracentesis for symptom control Interventions notable for: - Ondansetron, Promethazine - Zosyn, Vancomycin ROS: Positives as per HPI; otherwise negative Past Medical History: 1. CAD s/p CABG in ___ with a LIMA graft to LAD, and SVG to circumflex marginal and RCA 2. Hypertension 3. Hyperlipidemia 4. Hemorrhoids s/p banding in ___ 5. GERD 6. Gastric Ulcer 7. Hypothyroidism 8. Osteoporosis 9. COPD 10. Left TKR 11. Chronic Back Pain 12. Hearing Loss 13. Cataracts 14. ORIF right hip fracture in ___ Social History: ___ Family History: Non-contributory Physical Exam: ADMISSION: VS: Afebrile BP 127/78 88 20 93-95% 4L NC GEN: Elderly woman, laying in bed comfortably, in NAD HEENT: NC/AT, EOMI, dry MM CV: Irregular rhythm, regular rate, II/VI systolic murmur RESP: Decreased breath sounds in bases with dullness to percussion GI: Distended, firm, nontender to palpation, no appreciable fluid wave EXT: Trace-1+ pitting edema in b/l ___: Warm, well-perfused, no rashes NEURO: Alert, oriented to self, moving all extremities with purpose DISCHARGE: Vitals: none GEN: Elderly woman, laying in bed comfortably, in NAD HEENT: NC/AT RESP: Decreased breath sounds in bases with dullness to percussion GI: deferred EXT: deferred SKIN: no rashes Pertinent Results: ADMISSION: ___ 05:37PM BLOOD WBC-6.9 RBC-3.17* Hgb-9.0* Hct-30.4* MCV-96 MCH-28.4 MCHC-29.6* RDW-17.2* RDWSD-60.3* Plt ___ ___ 05:37PM BLOOD Neuts-85.2* Lymphs-6.8* Monos-6.7 Eos-0.0* Baso-0.3 Im ___ AbsNeut-5.86 AbsLymp-0.47* AbsMono-0.46 AbsEos-0.00* AbsBaso-0.02 ___ 05:37PM BLOOD ___ PTT-25.7 ___ ___ 05:37PM BLOOD Glucose-116* UreaN-37* Creat-2.0* Na-140 K-4.4 Cl-91* HCO3-33* AnGap-16 ___ 05:37PM BLOOD ALT-6 AST-20 CK(CPK)-38 AlkPhos-85 TotBili-0.3 ___ 05:37PM BLOOD CK-MB-2 cTropnT-0.06* proBNP-7456* ___ 05:37PM BLOOD Albumin-3.5 ___ 05:37PM BLOOD CEA-3.8 CA125-512* ___ 03:16AM BLOOD Type-CENTRAL VE pO2-36* pCO2-57* pH-7.40 calTCO2-37* Base XS-7 ___ 05:37PM BLOOD CA ___ -PND ADDITIONAL LABS: ___ 12:00AM BLOOD cTropnT-0.07* proBNP-9644* ___ 02:14PM BLOOD Type-ART pO2-71* pCO2-60* pH-7.40 calTCO2-39* Base XS-___BDOMEN ___ FINDINGS: LOWER CHEST: Small bilateral pleural effusions are incompletely evaluated. These are associated with overlying compressive atelectasis. Scattered areas of nodular opacification are seen in the bilateral visualized lung bases. No pericardial effusion is seen. Extensive coronary artery calcifications are noted. ABDOMEN: HEPATOBILIARY: The liver demonstrates homogeneous attenuation throughout. There is some nodular contour of the liver which may be secondary to the ascites. Multiple hypoattenuating hepatic lesions are poorly evaluated on current exam and measure up to 2.4 x 2.1 cm in the right hepatic lobe (02:13). Some may reflect hepatic cysts/biliary hamartomas and others are not well characterized. There is no evidence of intrahepatic or extrahepatic biliary dilatation. The gallbladder contains gallstones without wall thickening or evidence of inflammation. PANCREAS: The pancreas has normal attenuation throughout, without evidence of focal lesions within the limitations of an unenhanced scan. There is no pancreatic ductal dilatation. SPLEEN: The spleen shows normal size and attenuation throughout, without evidence of focal lesions. ADRENALS: The right and left adrenal glands are normal in size and shape. URINARY: Bilateral kidneys are symmetrically atrophic. There is a 1.4 x 1.4 cm right lower pole hyperdense renal lesion which is incompletely evaluated on this nonenhanced scan (601:41). There is no hydronephrosis. There is no nephrolithiasis. GASTROINTESTINAL: The stomach is unremarkable. No evidence of bowel obstruction. Small and large bowel loops are otherwise unremarkable. The appendix is not visualized. Large volume ascites. Scattered ill-defined areas of peritoneal soft tissue density are seen through out the peritoneum including the left upper quadrant where they measure up to 3.3 x 1.9 cm (601:34) the soft tissue densities are also seen extending into the anterior abdominal wall in the left periumbilical space (02:45) PELVIS: The urinary bladder and distal ureters are unremarkable. There is moderate volume fluid in the pelvis. REPRODUCTIVE ORGANS: The uterus is unremarkable. There is a 3.7 x 3.3 cm soft tissue mass in the left adnexal (02:54). No definite right adnexal lesions are identified. LYMPH NODES: Enlarged retroperitoneal lymph nodes measure up to 1.2 cm in short axis at the left parrot aortic station (02:29). No mesenteric lymphadenopathy. There is no pelvic or inguinal lymphadenopathy. VASCULAR: Aneurysmal dilatation of the infrarenal abdominal aorta up to 4.2 x 3.5 cm. Extensive atherosclerotic disease is noted. BONES: Patient is status post fixation for a right femoral fracture with demonstration of a displaced lesser trochanteric fracture fragment. Chronic fracture deformity of the inferior and superior left pubic ramus are also seen. Compression deformities of the L2 and L3 vertebral bodies are age indeterminate. Multilevel degenerative changes of the thoracolumbar spine are moderate to severe. No aggressive osseous lesions are identified. SOFT TISSUES: Soft tissue density seen to the left of the umbilicus. IMPRESSION: 1. 3.7 cm soft tissue mass in left adnexa is incompletely assessed on this nonenhanced exam but is suspicious for underlying malignancy. 2. Large volume ascites with peritoneal soft tissue nodularity which may reflect peritoneal carcinomatosis. 3. Enlarged periaortic lymph node measures up to 1.2 cm. 4. 1.4 cm right lower pole hyperdense renal lesion is incompletely evaluated on this nonenhanced exam. If it would alter management this may be further evaluated with nonemergent renal ultrasound or MRI. 5. 4.2 cm infrarenal abdominal aortic aneurysm. 6. Compression deformities of the L2 and L3 vertebral bodies are age indeterminate. 7. Small bilateral pleural effusions. 8. Nodular opacities in the bilateral lung bases are nonspecific with differential considerations including pneumonia, aspiration, metastases, or a combination. Brief Hospital Course: SUMMARY: ======== Ms. ___ is a ___ with history of dementia, COPD, HFpEF (last EF 50% ___, CAD s/p CABG, Afib, and CKD who presents for persistent nausea/vomiting, found to have an adnexal mass and findings concerning for peritoneal carcinomatosis. She opted for comfort care only and is discharged to hospice. TRANSITIONAL: ============= [] Started CMO, only give medications that make the patient comfortable ACUTE: ====== # Adnexal mass # Concern for peritoneal carcinomatosis # Goals of care The patient presented with persistent nausea/vomiting, SOB, abdominal distention consistent with findings of peritoneal carcinomatosis on CT. After lengthy goals of care discussion with family, the decision was made to pursue only comfort-focused care. They had been looking into transitioning to hospice and are interested in more information about this. SW was consulted. Medications were transitioned to symptomatic management with opioids for air hunger, in addition to nebs, Zofran, Tylenol, as needed for pain. She was made comfort measures only and discharged to hospice on ___. # Hypoxia Etiology likely multifactorial in the setting of large volume ascites compressing diaphragm, small pleural effusions, and possible metastatic disease in chest. The patient underwent a therapeutic paracentesis on ___. Otherwise treated with opioids as above. # ___ on CKD Baseline unclear but with last Cr 1.5 in ___. This was likely pre-renal in the setting of poor PO intake/emesis. Given comfort focused care, we stopped trending labs. # NSTEMI Likely due to demand ischemia; currently with no active chest pain. No further management required. CHRONIC: ======== # HFpEF - Held medications in light of comfort-focused care. # COPD Not on home oxygen. No evidence of COPD exacerbation. Albuterol nebs PRN as above # Atrial fibrillation In afib with controlled rates. Held eloquis in light of comfort-focused care CONTACT Name of health care proxy: ___ Relationship: son Phone number: ___ CODE: Comfort measures only, DNR/DNI Medications on Admission: The Preadmission Medication list may be inaccurate and requires futher investigation. 1. Acetaminophen 325 mg PO Q6H:PRN Pain - Mild/Fever 2. Denosumab (Prolia) 60 mg SC Q6 MONTHS 3. Torsemide 60 mg PO DAILY 4. ALPRAZolam 0.5 mg PO 1 TAB QAM, 1 TAB NOON, 2 TABS QHS 5. aspirin 81 mg oral DAILY 6. Atorvastatin 40 mg PO QPM 7. Citalopram 10 mg PO DAILY 8. Docusate Sodium 100 mg PO BID:PRN Constipation - Third Line 9. Fish Oil (Omega 3) 1000 mg PO BID 10. Isosorbide Mononitrate (Extended Release) 30 mg PO DAILY 11. Levothyroxine Sodium 75 mcg PO DAILY 12. Lidocaine 5% Patch 1 PTCH TD QAM 13. Mirtazapine 30 mg PO QHS 14. Multivitamins 1 TAB PO DAILY 15. Omeprazole 20 mg PO DAILY 16. Polyethylene Glycol 17 g PO DAILY:PRN constipation 17. Alvesco (ciclesonide) 80 mcg/actuation inhalation 2 puffs once a day 18. Calcitrate-Vitamin D (calcium citrate-vitamin D3) 315-250 mg-unit oral BID 19. Hydrocortisone Acetate Suppository ___ TIMES DAILY AS NEEDED 20. ProAir HFA (albuterol sulfate) 90 mcg/actuation inhalation 1 to 2 puffs every 6 hours prn 21. Restasis 0.05 % ophthalmic (eye) 1 drop in each eye q12h 22. Alvesco (ciclesonide) 80 mcg/actuation inhalation DAILY 23. Salmeterol Xinafoate Diskus (50 mcg) 1 INH IH Q12H Discharge Medications: 1. Albuterol 0.083% Neb Soln 1 NEB IH Q6H:PRN SOB 2. Aluminum-Magnesium Hydrox.-Simethicone ___ mL PO QID:PRN abdominal discomfort 3. Bisacodyl 10 mg PO/PR DAILY:PRN Constipation 4. HYDROmorphone (Dilaudid) 0.5-1 mg IV Q2H:PRN air hunger/pain 5. Ondansetron ___ mg IV Q8H:PRN Nausea/Vomiting - First Line Reason for PRN duplicate override: Alternating agents for similar severity 6. OxyCODONE (Immediate Release) 2.5-5 mg PO Q2H:PRN air hunger 7. Sarna Lotion 1 Appl TP QID:PRN Itching 8. Senna 8.6 mg PO BID:PRN Constipation 9. Acetaminophen 1000 mg PO Q6H:PRN Pain - Mild/Fever 10. ALPRAZolam 0.5 mg PO TID:PRN anxiety 11. Torsemide 60 mg PO DAILY:PRN volume overload, shortness of breath can take for comfort/prevention of fluid overload for comfort 12. Mirtazapine 30 mg PO QHS 13. Polyethylene Glycol 17 g PO DAILY:PRN constipation Discharge Disposition: Home With Service Facility: ___ Discharge Diagnosis: PRIMARY DIAGNOSIS: ================= Peritoneal carcinomatosis Acute hypoxemic respiratory failure Acute kidney injury Non-ST elevation myocardial infarction SECONDARY DIAGNOSES: ===================== Heart failure with preserved ejection fraction Chronic obstructive pulmonary disease Atrial fibrillation Discharge Condition: Mental Status: Confused - sometimes. Level of Consciousness: Alert and interactive. Activity Status: Out of Bed with assistance to chair or wheelchair. Discharge Instructions: Dear Ms. ___, WHY WERE YOU ADMITTED TO THE HOSPITAL? - You were admitted to the hospital because you were short of breath WHAT HAPPENED WHILE YOU WERE IN THE HOSPITAL? - You were found to have findings concerning for a new cancer. - You improved and were ready to leave the hospital. WHAT DO YOU NEED TO DO WHEN YOU LEAVE THE HOSPITAL? - Please take all of your medications as prescribed and go to your follow up appointments with your doctors ___ below) - Weigh yourself every morning, before you eat or take your medications. Call your doctor if your weight increases by more than 3 pounds - Please maintain a low salt diet and monitor your fluid intake - Seek medical attention if you have new or concerning symptoms It was a pleasure participating in your care. We wish you the best! - Your ___ Care Team Followup Instructions: ___
19707837-DS-17
19,707,837
21,193,920
DS
17
2153-02-05 00:00:00
2153-02-05 19:59:00
Name: ___ Unit No: ___ Admission Date: ___ Discharge Date: ___ Date of Birth: ___ Sex: M Service: MEDICINE Allergies: No Known Allergies / Adverse Drug Reactions Attending: ___. Chief Complaint: Chest pain Major Surgical or Invasive Procedure: Blood transfusion, total 4 units History of Present Illness: ___ y/o male with history of multiple myeloma presenting with 6 month history of exertional chest pain and fatigue. Patient reports substernal chest pain for the last 6 months that has worsened over the last 4 days. Pain is described as achy, substernal without radiation into the back, arms or jaw. Exertional and non-pleuritic, resolves with rest. Reports lightheadedness with standing. Reports calf pain with ___ mile walk or climing one flight of stairs. Denies shortness of breath. Reports bright red blood per rectum for the last several months secondary to hemorrhoids. Patient returned from 6 month trip to native ___ on ___. Saw PCP for this complaint on ___, Hb 5.3, told to come to ED. Denies ASA, Plavix or Coumadin. No Hx CAD. No recent stress. Never had cath. Denies smoking hx. On arrival to the ED, patient's vitals were HR 64 BP 129/65 RR 20 SaO2 100% RA. His breath sounds were clear on exam. His labs were significant for H/H 5.5/18, WBC 2.0, Trop <.01, Na 130, Cr 1.8, INR 1.5, D-Dimer 1297, stool guaiac negative. NCCT chest showed lytic lesions of the spine and ribs consistent with his multiple myeloma. On the floor, vs were: T 97.8 P 67 BP 143/62 R 16 O2 sat 100 RA. Patient looks well, has no present complaints. Denies current chest pain. Past Medical History: Multiple myeloma hemorrhoids DM-II BPH s/p TURP Social History: ___ Family History: No cancer or heart disease Physical Exam: ADMISSION PHYSICAL EXAM: General: Alert, oriented, no acute distress HEENT: Sclera anicteric, MMM, poor dentition Neck: supple, JVP not elevated, no LAD Lungs: Clear to auscultation bilaterally, no wheezes, rales, rhonchi CV: Regular rate and rhythm, normal S1 + S2, no murmurs, rubs, gallops Abdomen: soft, non-tender, non-distended, bowel sounds present, no rebound tenderness or guarding, no organomegaly Ext: Warm, well perfused, 2+ pulses, no clubbing, cyanosis or edema DISCHARGE PHYSICAL EXAM: General: Alert, oriented, no acute distress HEENT: Sclera anicteric, MMM, poor dentition Neck: supple, JVP not elevated, no LAD Lungs: Mild stridor and wheeze throughout. No rales, rhonchi CV: Regular rate and rhythm, normal S1 + S2, no murmurs, rubs, gallops Abdomen: soft, non-tender, non-distended, bowel sounds present, no rebound tenderness or guarding, no organomegaly Ext: Warm, well perfused, 2+ pulses, no clubbing, cyanosis or edema Pertinent Results: ADMISSION LABS: ___ 01:43PM BLOOD WBC-2.0* RBC-1.57* Hgb-5.5* Hct-18.0* MCV-115* MCH-35.2* MCHC-30.6* RDW-15.8* Plt ___ ___ 01:43PM BLOOD Neuts-50.7 Lymphs-43.6* Monos-3.0 Eos-1.6 Baso-1.1 ___ 01:43PM BLOOD ___ PTT-35.3 ___ ___ 01:43PM BLOOD Glucose-93 UreaN-29* Creat-1.8* Na-130* K-4.4 Cl-102 HCO3-24 AnGap-8 ___ 01:43PM BLOOD LD(LDH)-351* ___ 01:43PM BLOOD Calcium-8.6 Phos-3.9 Mg-2.0 Iron-58 ___ 01:43PM BLOOD calTIBC-151* VitB12-363 Ferritn-195 TRF-116* ___ 02:28PM BLOOD D-Dimer-1297* DISCHARGE LABS: ___ 07:00AM BLOOD WBC-2.2* RBC-2.75*# Hgb-9.0*# Hct-27.4*# MCV-100* MCH-32.5* MCHC-32.6 RDW-21.9* Plt ___ ___ 07:00AM BLOOD Neuts-47.3* Lymphs-48.3* Monos-3.6 Eos-0.2 Baso-0.5 ___ 07:00AM BLOOD Glucose-64* UreaN-24* Creat-1.7* Na-130* K-3.7 Cl-103 HCO3-24 AnGap-7* ___ 07:00AM BLOOD TotProt-13.7* Calcium-8.6 Phos-3.8 Mg-1.9 IMPORTANT LABS ___ 06:10AM BLOOD b2micro-10.9* ___ 10:12PM URINE Blood-NEG Nitrite-NEG Protein-30 Glucose-NEG Ketone-NEG Bilirub-NEG Urobiln-NEG pH-6.0 Leuks-NEG ___ 10:12PM URINE Hours-RANDOM Creat-96 Na-112 K-61 Cl-128 TotProt-66 Prot/Cr-0.7* STUDIES ___ CXR: 1. Ill-defined contour of the aortic knob. In setting of chest pain, CT should be considered to further assess. Alternatively if low suspicion for acute aortic syndrome, repeat with PA and lateral views can be performed. 2. Increased opacity projecting over the upper lungs, left greater than right likely technical due to overlying soft tissues but can be further clarified by a PA and lateral. 3. Osseous findings compatible with patient's known multiple myeloma. ___ CT Chest 1. No findings to explain patient's chest x-ray abnormality which was likely projectional. No mediastinal hematoma. 2. Diffuse lytic lesions throughout the bones compatible the patient's history of for multiple myeloma. T11 compression deformity which may be old. Soft tissue extension along lesion of the anterior right seventh rib. Brief Hospital Course: ___ y/o male with history of multiple myeloma presenting with 6 month history of exertional chest pain and fatigue in setting of acute on chronic anemia. hemoglobin of 5.5 improved to 9.0 after 4 units of PRBCs. # Chest Pain. Patient with reports of exertional chest pain over preceding months. In house pain attributed to demand in setting of acute on chronic anemia. No concern for acute plaque rupture. Pain resolved after transfusion. Patient deferred further cardiac work-up. # Acute on Chronic Anemia: Likely secondary to underproduction in setting of known, untreated multiple myeloma and renal dysfunction. Per PCP documentation, HCT noted to gradually downtrending over months. On admission Hgb 5.0 which increased to 9.0 after transfusion of 4 units. No signs of GI bleeding in house (guaiac negative) Iron studies wnl. Patient was started on B-12 and folate, given macrocytosis. [] Continue to trend as an outpatient [] Repeat CBC/Chem7 on ___, results will be faxed to PCP. # Multiple Myeloma: Patient with documented history MM. Seen by heme onc and after discssion patient declined treatment. On admission, evidence of disease progression as CT demonstrates obvious lytic bone lesions on CT. Beta2micro elevated at 10.9, which correlates to stage III multiple myeloma, from ~3 at last check. In house, patient continues to decline treatment, but we talked at length about other treatments, such as bisphosphonates to slow progress of bone lesions as well as intermittent transfusions to prevent recurrent chest pain. The patient agreed to consider supportive therapy as outpatient. [] Follow-up pending SPEP/UPEP [] Follow up with primary care and oncology was arranged. [] Discuss use of bisphosphonates #Renal Insuffiency: Patient with baseline renal insuffiency (1.3-1.4 in ___. ON admission, Cr was 1.8. Likely secondary to multiple myeloma. Cr improved slightly to 1.7 after 4u PRBC. # Diabetes: Patient does not take his prescribed metformin. His glucose was not elevated during this admission. # Full Code Medications on Admission: The Preadmission Medication list is accurate and complete. 1. This patient is not taking any preadmission medications Discharge Medications: 1. FoLIC Acid 1 mg PO DAILY RX *folic acid 1 mg 1 tablet(s) by mouth every day Disp #*30 Tablet Refills:*0 2. Cyanocobalamin 100 mcg PO DAILY RX *cyanocobalamin (vitamin B-12) 100 mcg 1 tablet(s) by mouth every day Disp #*30 Tablet Refills:*0 3. Ferrous Sulfate 325 mg PO DAILY RX *ferrous sulfate 325 mg (65 mg iron) 1 tablet(s) by mouth every day Disp #*30 Tablet Refills:*0 4. Outpatient Lab Work Please check chem7 and CBC Fax to PCP ___: ___ ICD___.0 Discharge Disposition: Home Discharge Diagnosis: Primary: Anemia Secondary: Multiple Myelomma Discharge Condition: Mental Status: Clear and coherent. Level of Consciousness: Alert and interactive. Activity Status: Ambulatory - Independent. Discharge Instructions: Dear Mr. ___, You came to ___ because you were experiencing fatigue and chest pain and the doctor at your urgent care found your blood counts to be very low. We believe this anemia to be due to your multiple myeloma. You received a transfusion of 2 units of blood overnight on your first night and your symptoms improved significantly. Your laboratory tests still showed that you were still anemic. You were transfused two more units of blood. We have made an appointmnet with the Oncologist to discuss whether you should have treatment for the multiple myelomma. He will also be able to help with treating symptoms if you do not want to undergo treatment for multiple myelomma. Please have your labs drawn on ___. ___ MDs Followup Instructions: ___
19707837-DS-18
19,707,837
23,416,030
DS
18
2153-04-27 00:00:00
2153-04-27 17:45:00
Name: ___ Unit No: ___ Admission Date: ___ Discharge Date: ___ Date of Birth: ___ Sex: M Service: MEDICINE Allergies: No Known Allergies / Adverse Drug Reactions Attending: ___. Chief Complaint: anemia Major Surgical or Invasive Procedure: None. History of Present Illness: ___ w/untreated multiple myeloma presents with worsening of his chronic anemia. Pt found to have Hgb 5.9 Hct 17.7 on routine labs at ___ office yesterday and was instructed to present to ED for transfusion. Pt denies hematochezia, hematemesis, melena, hematuria. No SOB, CP, LH or palp. Does endorse feeling "less energetic". Pt required transfusions in ___ and ___, no prior adverse reactions to transfusions. Pt has previously refused all treatment from oncology for multiple myeloma but now states he is considering treatment if it will keep him from having to come to the hospital so frequently because he is old and wants some quality time at home. In ED pt received 1u pRBC. ROS: +as above, otherwise reviewed and negative Past Medical History: Multiple myeloma - c/b CKD and compression fractures hemorrhoids DM-II BPH s/p TURP Osteoporosis Glaucoma Social History: ___ Family History: No cancer or heart disease Physical Exam: Vitals: T:98.4 BP:130/60 P:82 R:18 O2:97% PAIN: 0 General: nad Lungs: clear CV: rrr no m/r/g Abdomen: bowel sounds present, soft, nt/nd Ext: no e/c/c Skin: no rash Neuro: alert, follows commands Pertinent Results: ___ 06:00PM GLUCOSE-119* UREA N-40* CREAT-2.4* SODIUM-126* POTASSIUM-4.6 CHLORIDE-101 TOTAL CO2-24 ANION GAP-6* ___ 06:00PM estGFR-Using this ___ 06:00PM CALCIUM-9.5 PHOSPHATE-4.4 MAGNESIUM-2.1 ___ 06:00PM WBC-2.2* RBC-1.92* HGB-6.1* HCT-18.5* MCV-97 MCH-31.9 MCHC-33.1 RDW-18.3* ___ 06:00PM NEUTS-37.2* LYMPHS-58.6* MONOS-2.9 EOS-0.6 BASOS-0.8 ___ 06:00PM HYPOCHROM-2+ ANISOCYT-1+ POIKILOCY-NORMAL MACROCYT-OCCASIONAL MICROCYT-NORMAL POLYCHROM-NORMAL ___ 06:00PM PLT SMR-LOW PLT COUNT-104* ___ 06:00PM ___ PTT-38.3* ___ Brief Hospital Course: ASSESSMENT AND PLAN: ___ w/untreated multiple myeloma presents with worsening of his chronic anemia Heme/onc: Untreated multiple myeloma complicated by anemia, renal failure, hypercalcemia and multiple fractures. Anemia due to myeloma, no signs of active bleeding. He adamantly refuses any chemotherpy or other treatment for the myeloma and has repeatedly said the same since his diagnosis. He does agree to transfusion. He does not want palliative care referall. -Received 4 units of pRBC, hematocrit increased from 18.5 to 25.6, his symptoms of chest pressure and fatigue resolved. -Discussed with PCP trying outpatient transfusion through a transfusion center. Hyponatremia: chronic, currently lower than baseline likely due to intravascular depeltion from anemia, improved with transfusion. Acute on Chronic Kidney Disease: baseline Cr ~2.0, acute worsening likely ___ anemia, improved with transfusion. - transfuse as above DM2: hold metformin, SSI while hospitalized BPH: cont home meds FEN: diabetic diet PPX: TEDs ACCESS: piv DNR/DNI: discussed with pt on admission. He reports he would like to "go peacefully. If I'm gonna go, I'm gonna go. There's no need to drag it out and be in pain." CONTACT: son/HCP DISPO: medicine, pending above Medications on Admission: The Preadmission Medication list is accurate and complete. 1. Calcitonin Salmon 200 UNIT NAS DAILY 2. FoLIC Acid 1 mg PO DAILY 3. Ferrous Sulfate 325 mg PO DAILY 4. Cyanocobalamin 1000 mcg PO DAILY 5. Latanoprost 0.005% Ophth. Soln. 1 DROP BOTH EYES HS 6. Dorzolamide 2%/Timolol 0.5% Ophth. 1 DROP BOTH EYES BID 7. Brimonidine Tartrate 0.15% Ophth. 1 DROP BOTH EYES BID 8. MetFORMIN (Glucophage) 500 mg PO BID 9. Tamsulosin 0.4 mg PO DAILY 10. Multivitamins 1 TAB PO DAILY 11. Aspirin 81 mg PO DAILY Discharge Medications: 1. Brimonidine Tartrate 0.15% Ophth. 1 DROP BOTH EYES BID 2. Calcitonin Salmon 200 UNIT NAS DAILY 3. Cyanocobalamin 1000 mcg PO DAILY 4. Dorzolamide 2%/Timolol 0.5% Ophth. 1 DROP BOTH EYES BID 5. Ferrous Sulfate 325 mg PO DAILY 6. FoLIC Acid 1 mg PO DAILY 7. Latanoprost 0.005% Ophth. Soln. 1 DROP BOTH EYES HS 8. Multivitamins 1 TAB PO DAILY 9. Tamsulosin 0.4 mg PO DAILY 10. Aspirin 81 mg PO DAILY 11. MetFORMIN (Glucophage) 500 mg PO BID Discharge Disposition: Home Discharge Diagnosis: Anemia secondary to multiple myeloma. Discharge Condition: Mental Status: Clear and coherent. Level of Consciousness: Alert and interactive. Activity Status: Ambulatory - Independent. Discharge Instructions: You were admitted for worsening anemia (low red blood cells). You were given 4 units of red blood cells. You should follow-up closely with your primary care physician and continue to discuss starting treatment for your multiple myeloma and to discuss outpatient blood transfusions. Followup Instructions: ___
19707837-DS-19
19,707,837
24,840,198
DS
19
2153-06-13 00:00:00
2153-06-13 17:51:00
Name: ___ Unit No: ___ Admission Date: ___ Discharge Date: ___ Date of Birth: ___ Sex: M Service: MEDICINE Allergies: No Known Allergies / Adverse Drug Reactions Attending: ___ ___ Complaint: Fever Major Surgical or Invasive Procedure: Foley Catheter Placement on ___ in ___ ED History of Present Illness: PRIMARY DIAGNOSIS: multiple myeloma PRIMARY HEME/ONC PROVIDER: Dr ___ CHIEF COMPLAINT: fever HISTORY OF PRESENT ILLNESS: Mr ___ is an ___ yr old male with multiple myeloma who thus far has elected for no treatment other than intermittent transfusions, last at ___ ___. He was seen at ___ clinic ___ at which time reported his chronic pain in back and hands, Hgb 6.7. Had rising Ca and Cr and was started on zometa 3mg as well as velcade and dex. He presented to ___ ED today with new fever to 102 overnight in early am. Was febrile on arrival. Complained of cough as well as pain in R shoulder. Was given dose of vancomycin, cefepime for possible L lower infiltrate. Shoulder xray showed no acute fracture or focal lytic lesion. Noted to have Hgb 5.2 with 8pt HCT drop from 2 weeks ago, guiac stool was negative, he was transfused 2 U PRBC and tolerated well. Initial VS in ED 16:19 101.2 90 106/47 24 98% RA On arrival to floor temp improved to 100.3. Pt states that the day after chemo (___) he got weak after coming back from store with his son, ___ get up stairs and sons had to carry him. In am ___ get out of bed due to generalized waekness and had fever so EMS called. Denies focal weakness of arms/legs, numbness, HA. Denies lightheadedness, fall or syncope or chest pain. Denies DOE. Has cough for few months, unchanged, denies sputum production. No sore throat, rash, dysuria. Sometimes has dribbling before he can get to restroom, reportedly had difficulty urinating in ED and foley was placed. Does have new eye drainage and redness, R eye irritated, not painful, no change in vision has glaucoma. No known sick contacst. Has been eating/drinking ok, no nausea/emesis/diarrhea. REVIEW OF SYSTEMS: GENERAL: + fever as above, no chills or rigors HEENT: No mouth sores, odynophagia, sinus tenderness, rhinorrhea, or congestion. CARDS: No chest pain, chest pressure, exertional symptoms, or palpitations. PULM: + cough as above, no shortness of breath, hemoptysis, or wheezing. GI: No nausea, vomiting, diarrhea, or abdominal pain. No hematochezia, or melena. GU: No dysuria, hematuruia or frequency. +hx BPH MSK: + R shoulder pain. Denies neck pain or other joint pain DERM: Denies rashes, itching, or skin breakdown. NEURO: No headache, visual changes, numbness, paresthesias, focal weakness HEME: No bleeding or clotting Past Medical History: PAST ONCOLOGIC HISTORY: per ___ records He has refused treatment since he was first diagnosed with IgG myeloma in ___ with an IgG level of 4 gms, anemia (hct 32) and bence ___ proteinuria. BM done by Dr ___ showed 30% plasma cells. Treatment with melphelan/Pred was offered but denied. He was seen in ___ by Dr ___ at the ___ who also recommended treatment, at that time with Velcade, decadron and more recently by Dr ___ in ___ and ___, again declining chemotherapy. His anemia has worsened and he agreed to transfusions which were done last ___ (4 units) and again in mid ___ when he received 1 unit rbc in the ___ ER. He has longstanding pain in his back and legs and hands and has bony involvement by plain films with compression fractures of T11 noted on a metastatic series ___ year ago with mult lucencies in other bones. Decided in ___ that he is willing to consider treatment, but also wants to be able to spend ___ months in ___ during the ___. He has refused biphosphonates for his bone disease but did try calcitonin nasal spray in the fall which was associated with some epistaxis and he stopped using it. Started plan for weekly velcade/dex ___ PAST MEDICAL HISTORY: Multiple myeloma - c/b CKD and compression fractures hemorrhoids DM-II BPH s/p TURP Osteoporosis Glaucoma Social History: -Tobacco: never -Alcohol: rare -Illicits: never -Work: ___ -Lives with: wife, son, daughter -___: no assist -ADLs: independent -IADLs: independent From ___ originally, moved to ___ in ___. -Tobacco: never -Alcohol: rare -Illicits: never -Work: ___ -Lives with: wife, son, daughter -___: no assist -ADLs: independent -IADLs: independent From ___ originally, moved to ___ in ___. Retired ___ ___. 5 children. No alc, no cigs. Lives with wife and 2 of his children. Family History: No family history of malignancy or heart disease Physical Exam: ADMISSION EXAM: General: NAD VITAL SIGNS: 100.3 123/63 83 21 100%RA HEENT: MM tachy, tongue with thrush, no OP lesions, Neck: supple, no JVD CV: RR, NL S1S2 no S3S4 or MRG PULM: CTAB ABD: BS+, soft, NTND, no masses EXT: warm well perfused, no edema, 3cm soft tissue mass just proximal to L olecranon process nontender. R shoulder tender over ant humerus not bicep/forearm. No spinal tenderness. no other joint tenderness, no joint effusions SKIN: No rashes or skin breakdown NEURO: alert and oriented x 4, ___, EOMI, no nystagmus, face symmetric, no tongue deviation, full hand grip, shoulder shrug and bicep flexion, full toe dorsiflexion and hip flexion against resistance bilateral, sensation intact to light touch, no clonus DISCHARGE EXAM: VITALS = 98.1, 74-86, 103-132/58-76, 18, 100% on RA, ___ Pain/Dyspnea, 156.8 lb, Ins 1250, Outs 1750 General: NAD HEENT: MMM, tongue with thrush, no OP lesions, poor dentition, neck supple, no JVD CV: RR, NL S1S2 no S3S4 or MRG PULM: CTAB aside from transmitted upper airway sounds ABD: BS+, soft, NTND, no masses EXT: warm well perfused, no edema, 3cm soft tissue mass just proximal to L olecranon process nontender. R shoulder tender over ant humerus not bicep/forearm. No spinal tenderness. no other joint tenderness, no joint effusions SKIN: No rashes or skin breakdown NEURO: alert and oriented x 4, ___, EOMI, no nystagmus, face symmetric, no tongue deviation, full hand grip, shoulder shrug and bicep flexion, full toe dorsiflexion and hip flexion against resistance bilateral, sensation intact to light touch, no clonus, left arm full ROM and ___ strength, right arm ___ strength but can only abduct 60 degrees with 15 degree forward movement Pertinent Results: ADMISSION LABS: UA <1 rbc 1 wbc lactate 1.0 128 104 68 72 AGap=6 3.4 21 3.3 Ca: 8.7 Mg: 1.7 P: 2.7 ALT: 17 AP: 33 Tbili: 0.4 Alb: AST: 24 LDH: 142 wbc 2.0 hgb 5.2 plt 73 N:62.2 L:33.5 M:3.4 E:0.8 Bas:0.2 ___ ___ - free kappa 1060, free lambda low, albumin 2, tot prot 15, Cr 2.44, Ca ___ IMAGING: R SHOULDER FINDINGS: No fracture or dislocation is identified. The humeral head is well situated within the glenoid fossa. There is diffuse permeative appearance of the proximal humerus, likely reflecting underlying for history of multiple myeloma. Moderate to severe for degenerative changes are seen at the acromioclavicular joint. The coracoclavicular interval is normal. Mild pulmonary edema is visualized in the right lung. CXR - FINDINGS: No focal consolidation is identified. There is mild atelectasis at the left lung base. There is mild pulmonary vascular congestion without overt pulmonary edema. The cardiomediastinal silhouette is unchanged. Again seen is tortuosity of the descending thoracic aorta. There is no pleural effusion or pneumothorax. Acute kyphosis with lower thoracic vertebral body compression deformities are again noted. Known diffuse lytic lesions are better assessed on prior CT from ___. Visualized upper abdomen is unremarkable. DISCHARGE LABS: ___ 08:15AM BLOOD WBC-1.8* RBC-2.38* Hgb-7.1* Hct-20.9* MCV-88 MCH-30.0 MCHC-34.1 RDW-19.8* Plt Ct-81* ___ 07:55AM BLOOD Neuts-53.7 Lymphs-42.2* Monos-2.9 Eos-0.8 Baso-0.4 ___ 08:00AM BLOOD Ret Aut-0.6* ___ 08:15AM BLOOD Glucose-77 UreaN-34* Creat-1.4* Na-135 K-3.7 Cl-110* HCO3-24 AnGap-5* ___ 08:15AM BLOOD Calcium-7.6* Phos-1.9* Mg-2.1 ___ 07:46PM OTHER BODY FLUID FluAPCR-NEGATIVE FluBPCR-NEGATIVE Urine Culture No Growth Blood Cultures NGTD Brief Hospital Course: ___, an ___ yo M PMHx Multiple Myeloma complicated by hypercalcemia, pathologic fractures, and severe pancytopenia requiring transfusion, presented after recent start of bortezomib/zolendronic acid/dexamethasone therapy on ___ with fever of 102 along with right shoulder pain (going on for several weeks, difficultly with abduction and anterior motion with pain, X-ray negative for fracture, permeative appearance from multiple myeloma), conjunctivitis (nonpurulent, good vision, given ciprofloxacin eye drops), cough (CXR final read negative for infiltrate, resolved), and anemia (Hgb 5.2, given 3 total units of pRBCs, further held off due to concern for causing hyperviscosity syndrome). He was initially given vancomycin/cefepime in the ED, but received no antibiotics subsequently. He was afebrile after arrival and he remained asymptomatic aside from improving right shoulder pain/range of motion. He had several morning episode of asymptomatic hypoglycemia with normal cortisol level. He was discharged to followup with his outpatient oncology provider for more chemotherapy. # Fever/SIRS - Patient with borderline neutropenia (___ 1200), low IgG. no localizing source aside from conjunctivitis. Patient has cough but chronic for two weeks, no new infiltrate on CXR. Does have poor dentition and thrush. UA unremarkable. Given vanco/cefepime in ED for possible ___ narrow to ceftriaxone, follow cultures. Flu PCR negative and cultures negative or no growth at time of discharge. Can have a febrile reaction to zolendronic acid on ___. Ceftriaxone was discontinued on ___. Patient had no further fevers off antibiotics >24 hours. He was continued on ciprofloxacin eye drops for a ___nd he can continue his multiple myeloma chemotherapy. # Multiple Myeloma (IgG) and Severe Anemia: Dx ___ has declined any treatment until just recently. Started velcade 1.3mg/m2 w/ dex ___ on ___. Total Protein 17. Due to poor PO intake, nutrition consult recommended regular diet with Ensure Plus TID and MVI+minerals. He received 3 total units of pRBCs with good response with Hgb>7. Baseline Hgb ___ since ___ myeloma and exacerbated by CKD, retic. on folate and iron supp, latter with unclear benefit given recent transfusions thus will not continue on admission. Also may have component of hemolysis with prior low hapto, mild elevated LD. Will repeat hemolysis labs, consider DAT but less likely AIHA. Completed 2U PRBCs in ED, transfuse for Hgb <7. Given 1 unit pRBCs on ___. ___ require scheduled transfusions in future but holding at the moment due to concern for hyperviscosity syndrome (no symptoms during hospitalization). # Right Shoulder Pain: With limited RUE adduction. Occurred about 1 week ago in setting of odd sleeping position. ___ UE Strength limited by pain but RUE unable to abduct more than 30 degrees or so. 2+ reflexes in UE bilaterally. X-Ray shoulder negative for fracture. Differential includes peripheral nerve injury, rotator cuff injury, or muscular injury. In past patient hesitant to try narcotics, but NSAIDs contraindicated with renal function and not getting much relief with APAP at home. Started 2.5-5mg PO oxycodone q6 hours prn pain (no tramadol due to likely increased analgesia requirement, avoiding APAP due to fever masking) and well as lidocaine patch. ___ Consult recommended home ___ (was able to walk with walker) and his symptoms improved but did not resolve over the course of this hospital stay. Could consider MRI Shoulder if patient clinically worsens. # CKD w/ ___: Suspect worsening myeloma kidney w/ markedly elevated free kappa but no prior for comparison so trend unknown, also w/ possible prerenal event w/ SIRS past 24hrs. Denies NSAID use, no other nephrotoxins. Will continue gentle IV hydration overnight and also received PRBCs as above. Improved from Cr 3.3 to 1.4 on discharge. # Hypoglycemia: Glu 57 on AM Lytes on ___. Could be Fanconi Syndrome or adrenal insufficiency in setting of poor PO intake. AM cortisol was within normal limits and no AM hypoglycemia ___. Team encouraged nocturnal high protein/fat snack as late at night as possible to avoid AM hypoglycemia. # Hypercalcemia: Ca 8.7 corrected to >10 with albumin 1.9. Will hold zolendronic acid for the time being given possible febrile reaction. = CHRONIC ISSUES = # T2DM: Has been off metformin past year, Hgb A1C nl. On daily ASA, if platelet count worsens in future risk would outweigh benefits. Has been hypoglycemic off any diabetes medications. # BPH: On tamsulosin and Foley placed in ED due to concern of urinary retention. Foley removed on ___ @ 15:30 with no further urinary retention. # Constipation: Chronic stable issue exacerbated by iron supplementation but controlled in the hospital. = TRANSITIONAL ISSUES = - Consider zolendronic dose reduction or elimination from regimen - Make sure outpatient ___ is assisting patient with mobility and right upper extremity movement (discharged with rolling walker, lidocaine patch, could consider right shoulder MRI if pain worsens or fails to improve) - Please check a chem-7 on ___ (discharged on PO Phosphorus due to persistently low phosphorus ___ to Fanconi's from myeloma) - Code Status: DNI (but CPR, defibrillation is acceptable) - Emergency Contact: ___. (son, HCP) at ___ - Followup Tests: Blood Cultures x2 (no growth to date on discharge) Medications on Admission: The Preadmission Medication list is accurate and complete. 1. Brimonidine Tartrate 0.15% Ophth. 1 DROP BOTH EYES BID 2. Calcitonin Salmon 200 UNIT NAS DAILY 3. Cyanocobalamin 1000 mcg PO DAILY 4. Dorzolamide 2%/Timolol 0.5% Ophth. 1 DROP BOTH EYES BID 5. Ferrous Sulfate 325 mg PO DAILY 6. FoLIC Acid 1 mg PO DAILY 7. Latanoprost 0.005% Ophth. Soln. 1 DROP BOTH EYES HS 8. Multivitamins 1 TAB PO DAILY 9. Tamsulosin 0.4 mg PO DAILY 10. Aspirin 81 mg PO DAILY 11. Acyclovir 400 mg PO BID Discharge Medications: 1. Walker Rolling Walker ICD9: Difficult Ambulating 719.7 Prognosis: Good Length of Need: 13 Months 2. Lidocaine 5% Patch 1 PTCH TD QAM RX *lidocaine [Lidoderm] 5 % (700 mg/patch) place one patch every morning Disp #*30 Patch Refills:*0 3. Ferrous Sulfate 325 mg PO DAILY 4. Acyclovir 400 mg PO BID 5. Aspirin 81 mg PO DAILY 6. Brimonidine Tartrate 0.15% Ophth. 1 DROP BOTH EYES BID 7. Calcitonin Salmon 200 UNIT NAS DAILY 8. Cyanocobalamin 1000 mcg PO DAILY 9. Dorzolamide 2%/Timolol 0.5% Ophth. 1 DROP BOTH EYES BID 10. FoLIC Acid 1 mg PO DAILY 11. Latanoprost 0.005% Ophth. Soln. 1 DROP BOTH EYES HS 12. Tamsulosin 0.4 mg PO DAILY 13. Phosphorus 500 mg PO BID RX *sod phos,di & mono-K phos mono [K-Phos-Neutral] 250 mg 2 tablet(s) by mouth twice daily Disp #*28 Tablet Refills:*0 14. OxycoDONE (Immediate Release) 2.5-5 mg PO Q6H:PRN Pain RX *oxycodone 5 mg ___ tablet(s) by mouth every 6 hours Disp #*30 Tablet Refills:*0 15. Senna 8.6 mg PO BID:PRN constipation RX *sennosides [senna] 8.6 mg 1 capsule by mouth twice daily Disp #*30 Capsule Refills:*0 16. Multivitamins W/minerals 1 TAB PO DAILY RX *multivitamin,tx-minerals [Vitamins & Minerals] 1 tablet(s) by mouth daily Disp #*30 Tablet Refills:*0 17. Ciprofloxacin 0.3% Ophth Soln ___ DROP BOTH EYES QID Duration: 5 Days Last Day ___ RX *ciprofloxacin 0.3 % 1 drop both eyes 4 times per day Refills:*0 18. Docusate Sodium 100 mg PO BID RX *docusate sodium 100 mg 1 capsule(s) by mouth twice a day Disp #*60 Capsule Refills:*0 Discharge Disposition: Home With Service Facility: ___ Discharge Diagnosis: PRIMARY: Febrile Reaction to Zolendronic Acid Multiple Myeloma complicated by hypercalcemia, fractures, and anemia requiring transfusion Conjunctivitis SECONDARY: Right Shoulder Pain Hypoglycemia Discharge Condition: Mental Status: Clear and coherent. Level of Consciousness: Alert and interactive. Activity Status: Ambulatory - requires assistance or aid (walker or cane). Discharge Instructions: Dear Mr. ___, It was a pleasure to take care of you at ___ ___. You were admitted because you were having fevers and had recently started chemotherapy for your Multiple Myeloma. We determined that this was likely a reaction to the zolendronate (Zometa(R)) medication you were taking to reduce your blood calcium. You had no other signs or symptoms of infection and you went >24 hours without a fever off all antibiotics. Physical Therapy evaluated you and felt you could go home with Physical Therapy services and a rolling walker. Best of luck to you in your future health. Please take all medications as prescribed (we will give you a prescription for the lidocaine patch and try to get a prior authorization for this and you will see how expensive it is and go from there), attend all doctors ___ as ___, eat a high protein/fat snack (such as peanut butter-containing food) to avoid low blood sugar in the morning, and call a doctor if you have any questions or concerns. Sincerely, Your ___ Care Team Followup Instructions: ___
19708049-DS-11
19,708,049
23,446,669
DS
11
2190-03-18 00:00:00
2190-03-18 17:41:00
Name: ___ Unit No: ___ Admission Date: ___ Discharge Date: ___ Date of Birth: ___ Sex: F Service: MEDICINE Allergies: No Known Allergies / Adverse Drug Reactions Attending: ___. Chief Complaint: lethargy Major Surgical or Invasive Procedure: None History of Present Illness: PRIMARY ONCOLOGIST: ___ PRIMARY DIAGNOSIS: Stage IIIC triple negative breast cancer TREATMENT REGIMEN: adjuvant taxol (on hold) HISTORY OF PRESENTING ILLNESS: ___ w/ CKD, T2DM, iCVA c/b L hemiparesis, and stage IIIc triple negative breast cancer now in disease remission s/p adjuvant taxol (has completed 7 cycles, no further cycles planned), recent admissions for sepsis from cellulitis and polymicrobial BSI who is admitted for ___, weakness over the last 24 hrs. She does not have any new localizing symptoms, mainly less interactive w/ less PO intake. In the ED, she was found to have UTI and was given Cefepime in addition to IV Vanc. VS hr ___, BP 110s-130s, 100% Ra. Tmax ___. She had two recent admissions: 1. admitted from ___ for management of RLE cellulitis. Her hospital course was complicated by acute urinary retention, electrolyte abnormalities, acute neurologic changes felt to be recrudence of old stroke, and neutropenia with fever. She was ultimately discharged on clindamycin to complete therapy for her cellulitis. Her aspirin was also changed to Plavix during this admission. 2. admitted ___ to ___ for lichenoid drug eruption and polymicrobial BSI and had PORT removed, also found to have UTI and fungemia. discharged on vanc/fluc. she had a PICC Placed c/b DVT. REVIEW OF SYSTEMS: Unable to fully obtrain due to depressed MS. ___ Medical History: PAST ONCOLOGIC HISTORY: -___: Reportedly first noticed R breast mass and was treated w abx in ___ for possible cellulitis -___: Admitted to ___ for hypoglycemia. R breast mass noted and Breast Surg Onc, Dr. ___ -___: Right Breast US - At ___ o'clock 13 cm from the nipple there is a 4.3 by 5.3 x 3.5 cm irregular hypoechoic mass with minimal internal vascularity. Internal cystic spaces are noted. This correlates well with the area of clinical concern. No additional abnormalities are identified in the right breast. The right axilla was scanned and markedly abnormal lymph nodes were identified measuring up to 2.1 cm with loss of the fatty hilum. -___: CT Chest w/o contrast - 5.1 cm right breast mass w/level 1 and 2 axillary lymphadenopathy. No distal mets. -___: CT Abdomen and Pelvis - no abdominopelvic mets. -___: US guided core bx of the Right Breast mass- Path: grade 3 invasive ductal carcinoma with necrosis and lymphoplasmactyic infiltrate, 15mm in this limited sample, RECEPTORS - ER<1%, PR 0%, HER2 neg on IHC (FISH negative w ratio of 1.1) -___: US guided FNA of R axillary node-Path-metastatic adenocarcinoma c/w breast primary -___: TTE-EF 55%, Mild LV hypertrophy -___: Bilateral diagnostic mammogram - Tissue density: B. RIGHT breast: In the posterior upper outer right breast there is a 6 x 5.8 x 4.9 cm mass which corresponds to the biopsied mass on ___. There are benign vascular calcifications. No additional suspicious mass, architectural distortion or grouped calcifications. LEFT breast: There are 2 masses in the lower medial left breast that are stable dating back to ___ and are benign. There are benign calcifications in the left breast and vascular calcifications which are benign. There is no suspicious mass, architectural distortion or suspicious grouped micro-calcifications. -___: PET scan -There is an approximately 5.4 x 4.3 x 5.2 cm right breast mass with SUV max of 24.4, an approximately 3.4 x 2.0 x 2.8 cm right axillary lymph node with SUV max of 22.8, and an approximately 1.5 x 1.0 cm right sub pectoral lymph node with SUV max of 3.3. Diffuse uptake in the esophagus compatible with esophagitis. No FDG avid lesions are seen in abdomen or pelvis. A gallstone and a 3.1 x 3.0 cm cyst in the upper pole of the right kidney are noted. No FDG avid lesions are seen in the musculoskeletal system. IMPRESSION: A large intensely FDG-avid mass is seen in the right breast compatible with the know right breast cancer. There is a large intensely FDG-avid mass in the right axilla and a smaller FDG-avid lesion in the subpectoral region compatible with lymph node metastases. There is no evidence of distant FDG-avid disease. -___: Seen by Dr. ___ in cards and had stress test that showed potential reversible defect -___: Cardiac cath showing 30% L main and 80% OMB obstruction. No intervention. Med management. Per Dr. ___ to proceed w anthracycline chemo -___: C1 ddAC with Neulasta onbody injector. -___: patient admitted for febrile neutropenia with pancytopenia; needed 2 units pRBC. Became afebrile on broad spectrum abx; no source found; had 6 days of IV abx. During hospital stay she had an episode of R sided weakness, dysarthria, confusion. Neuro was called, initial concern for stroke but MRI brain did not show it. She also had acute on chronic renal failure w creatinine increasing from baseline of 1.4 to 1.7 on day of admission to up to 2.5; was seen by nephrology and discharged when cr was stable around 2.5 -___: Another hospital stay as Cr went up to 3.6 as outpt. Seen by Renal thought to have post ATN ___. Given gentle hydration and discharged when cr downtrending -___: C2 of AC with 30% dose reduction + neulasta support -___: C3 of AC (same dose as C2) -___: C4 of AC (same dose as C2/3) -___: R Wire localized partial mastectomy+ ALND with lymphaticovenous bypass procedure-path-2.1 cm residual grade 3 invasive ductal carcinoma, treatment effect noted, ___ LN, no LVI, posterior margin at 1mm, all other margins >5mm; ___. Repeat ER neg, PR neg, HER2 neg by IHC and FISH -___: Adjuvant taxol, week 1 -___: Week 2 taxol -___: Week 3 taxol -___: Week 4 taxol -___: Week 5 taxol -___: Week 6 taxol -___: Week 7 taxol -___: Admitted to ___ for management of RLE cellulitis PAST MEDICAL HISTORY: - R breast cancer stage IIIC, triple negative TREATMENT TO-DATE: 1. Neoadjuvant chemo, sp ddAC X4 cycles: ___ 2. R lumpectomy + ALND: ___ - ___ - Hx of CVA in ___ with resultant Left hemiparesis; wheelchair bound - T2DM with complications of nephropathy - CKD w baseline Cr of 1.7-2.0 - Hypertension - Hyperlipidemia - Osteoarthritis - Hx of Sepsis in ___ sp R arm cellulitis - Chronic mild anemia w baseline Hgb ~10 likely ___ CKD - L eye blindness - Bilateral cataract surgery -___ - Excision of R thigh lipoma ___ - Hysterectomy w/o oophorectomy for uterine fibroids Social History: ___ Family History: Sister died of some sort of cancer in her ___. Daughter died of postpartum CVA Physical Exam: ADMISSION VS: 97.5 PO 152 / 80 111 18 100 Ra GENERAL: Pleasant woman, in no distress, lying in bed comfortably and intermittently sleepy but awakens easily, voice slurred, ___ speakign only HEENT: Anicteric, OP clear. Pupils reactive, cataract CARDIAC: RRR, normal s1/s2, no m/r/g. LUNG: Appears in no respiratory distress, clear to auscultation bilaterally, no crackles, wheezes, or rhonchi. ABD: Soft, non-tender, non-distended, normal bowel sounds, no hepatomegaly, no splenomegaly. EXT: Much improved from prior admission, erythema/ NEURO: notable for chronic L hemiparesis. R upper and lower motor extremity notable for slightly weak handgrip and inability to move RLE toes. Is is oriented to person, place, pressure ulcers on both heels wrapped. DISCHARGE 98.0 PO 128 / 80 102 18 98 Ra GENERAL: Pleasant woman, in no distress, sitting in chair comfortably, alert, ___ speaking only HEENT: Anicteric, OP clear. Pupils reactive, cataract CARDIAC: RRR, normal s1/s2, no m/r/g. LUNG: Appears in no respiratory distress, clear to auscultation bilaterally, no crackles, wheezes, or rhonchi. ABD: Soft, non-tender, non-distended, normal bowel sounds, no hepatomegaly, no splenomegaly. EXT: pressure ulcers on both heels wrapped in gauze, no drainage, clean/dry NEURO: notable for chronic L hemiparesis. R upper and lower motor extremity notable for slightly weak handgrip and inability to move RLE toes. Oriented to person, place Pertinent Results: ADMISSION LABS ___ 09:10AM BLOOD WBC-9.7 RBC-3.14* Hgb-9.3* Hct-29.6* MCV-94 MCH-29.6 MCHC-31.4* RDW-17.9* RDWSD-61.7* Plt ___ ___ 09:10AM BLOOD Neuts-77.3* Lymphs-10.0* Monos-7.4 Eos-3.4 Baso-0.5 Im ___ AbsNeut-7.53* AbsLymp-0.97* AbsMono-0.72 AbsEos-0.33 AbsBaso-0.05 ___ 09:10AM BLOOD ___ PTT-31.0 ___ ___ 09:10AM BLOOD Glucose-114* UreaN-27* Creat-1.6* Na-137 K-4.3 Cl-100 HCO3-23 AnGap-14 ___ 09:10AM BLOOD ALT-22 AST-47* LD(LDH)-239 AlkPhos-102 TotBili-0.2 ___ 09:10AM BLOOD Albumin-2.9* Calcium-9.5 Phos-4.6* Mg-2.1 CXR ___ Compared to the examination from 1 day prior, vascular congestion has resolved. No new consolidation is seen. Cardiomediastinal silhouette and hilar contours are stable. There is no large effusion or pneumothorax. No acute findings. A left-sided midline is seen. CXR ___ IMPRESSION: Compared to chest radiographs since ___ most recently ___ at 15:28. Left PIC line still ends in the right internal jugular vein. Heart is mildly enlarged. Lungs clear. No pleural abnormality. CT HEAD ___ IMPRESSION: 1. No acute intracranial abnormality on noncontrast head CT. Specifically, no evidence of intracranial hemorrhage. 2. Stable sequelae of prior infarctions, as described above. ___ 7:40 pm URINE **FINAL REPORT ___ URINE CULTURE (Final ___: PSEUDOMONAS AERUGINOSA. 10,000-100,000 CFU/mL. SENSITIVITIES: MIC expressed in MCG/ML _________________________________________________________ PSEUDOMONAS AERUGINOSA | CEFEPIME-------------- 4 S CEFTAZIDIME----------- 4 S CIPROFLOXACIN---------<=0.25 S GENTAMICIN------------ <=1 S MEROPENEM-------------<=0.25 S PIPERACILLIN/TAZO----- 16 S TOBRAMYCIN------------ <=1 S ___ 06:50AM BLOOD WBC-8.4 RBC-2.87* Hgb-8.5* Hct-26.8* MCV-93 MCH-29.6 MCHC-31.7* RDW-17.9* RDWSD-61.3* Plt ___ ___ 06:50AM BLOOD Glucose-115* UreaN-13 Creat-1.1 Na-141 K-4.1 Cl-105 HCO3-23 AnGap-13 Brief Hospital Course: Ms. ___ is a ___ yo woman with CKD, T2DM, iCVA c/b L hemiparesis, and stage IIIc triple negative breast cancer now in disease remission s/p adjuvant taxol (has completed 7 cycles, no further cycles planned), recent admissions for sepsis from cellulitis and polymicrobial BSI who was admitted for ___, generalized weakness, found to have UTI and urinary retention course complicated by poor UOP and acute medication induced somnolence Lethargy with generalized weakness: This was related to continued decline from her previous hospitalizations with deconditioning. Her dtr stated she has not been the same since then. It could also be due to new infection (UTI), with ___. Otherwise there did not appear to be any clear derangements. Treated ___ and UTI with ___ consult for home with maximal services. By discharge, daughter was reporting some increased strength and energy though far from where she was months ago. Pseudomonas UTI: ___: h/o Urinary retention: She did not seem to have classic symptoms for UTI but her lethargy may be related. UA+, several risk factors for UTI. Urine cx grew pseudomonas. Started Cefepime day 1 = ___ and completed a 7 day course. Monitored PVR for retention with intermittent straight cath but ultimately required a Foley catheter. Urology follow up is recommended after discharge and scheduled. Acute encephalopathy with confusional state: Somnolent on ___ after dose of Remeron for appetite stimulant at night. ABD, labs, CT head negative. Over the course of several hours she improved. She appears to be quite sensitive to psychoactive medications and these should be started with extreme caution. This resolved over 24 hrs. Chronic pressure ulcers: Appreciate wound care input. ___ and frequent turning. E. faecalis Bloodstream infection (___) C. glabrata Bloodstream infection (___) S. epidermidis Bloodstream infection (___) C. albicans UTI (___) Nidus of infection likely skin breakdown during period of neutropenia vs PORT. ID consulted and started on broad spectrum antibiotics. Port was removed on ___. Fundoscopy by ophthalmology ruled out endophthalmitis. Based on speciation and sensitivities was narrowed to vancomycin and fluconazole to be completed on ___. - f/u surveillance blood cultures Acute LUE DVT: LUE PICC malpositioned: Poor peripheral venous access: Underwent port removal due to polymicrobial BSI. Had LUE PICC placed on ___. On ___ swelling was noted in LUE and near occlusive DVT was found in brachial vein. Patient started on enoxaparin. On ___ during episode of dyspnea CXR incidentally found tip of LUE PICC in R jugular vein. LUE PICC replaced by ___ on ___. Given difficulty/discomfort and concern for injection at sites with poor skin integrity patient was switched to apixaban 5mg bid. She now has PICC tip positioned in R subclavian/IJ vein. Attempts were made to reposition the PICC non invasively without success. Ordered to have PICC converted to a midline Prior CVA with chronic deficits: Baseline neurologic exam documented previously, appears at neurologic baseline with exception of generalized weakness - continued Plavix - cont baclofen for the spasms Breast Cancer: She is s/p neoadjuvant ddAC X4, right partial mastectomy + ALND and adjuvant taxol. She is now without any macroscopic disease and does not plan to receive any further chemotherapy at this time per family and multiple discussions on prior admission. - f/u Dr ___ as outpatient ___ of care: Patient has been expressing frustration with her condition and care. She refused to come to hospital until daughter promised no more chemo. She has also expressed a desire for less aggressive treatment and she specifically brought up intubation (unsure if this arose in a different context). Changed code status to DNR/DNI and encouraged her to discuss whether she would want planned XRT with oncologist. Anemia: stable, Likely multifactorial from CKD, prior chemo Type 2 Diabetes Mellitus: ISS, back to sitagliptin on d/c CAD: Not having any anginal symptoms, continued statin HTN: no longer on antihypertensives EMERGENCY CONTACT HCP: Name of health care proxy: ___ Relationship: daughter Cell phone: ___ ___ on Admission: The Preadmission Medication list is accurate and complete. 1. Baclofen 10 mg PO TID 2. Acetaminophen ___ mg PO BID:PRN Pain - Mild 3. Clopidogrel 75 mg PO DAILY 4. Ondansetron ___ mg PO Q8H:PRN nausea/vomiting 5. Rosuvastatin Calcium 40 mg PO QPM 6. Senna 8.6 mg PO BID:PRN constipation 7. Vitamin D 1000 UNIT PO DAILY 8. Calcium 500 + D (D3) (calcium carbonate-vitamin D3) 500 mg(1,250mg) -125 unit oral BID 9. linaGLIPtin 5 mg oral DAILY:PRN BS>150 10. Apixaban 5 mg PO BID 11. GuaiFENesin ER 600 mg PO Q12H 12. Guaifenesin-Dextromethorphan 5 mL PO Q6H:PRN cough 13. Triamcinolone Acetonide 0.1% Cream 1 Appl TP BID 14. Vancomycin 750 mg IV Q 24H 15. Albuterol 0.083% Neb Soln 1 NEB IH Q6H:PRN wheezing/shortness of breath 16. HYDROmorphone (Dilaudid) ___ mg PO Q4H:PRN Pain - Moderate Reason for PRN duplicate override: Alternating agents for similar severity Discharge Medications: 1. Acetaminophen ___ mg PO BID:PRN Pain - Mild 2. Albuterol 0.083% Neb Soln 1 NEB IH Q6H:PRN wheezing/shortness of breath 3. Apixaban 5 mg PO BID 4. Baclofen 10 mg PO TID 5. Calcium 500 + D (D3) (calcium carbonate-vitamin D3) 500 mg(1,250mg) -125 unit oral BID 6. Clopidogrel 75 mg PO DAILY 7. GuaiFENesin ER 600 mg PO Q12H 8. Guaifenesin-Dextromethorphan 5 mL PO Q6H:PRN cough 9. HYDROmorphone (Dilaudid) ___ mg PO Q4H:PRN Pain - Moderate Reason for PRN duplicate override: Alternating agents for similar severity 10. linaGLIPtin 5 mg oral DAILY:PRN BS>150 11. Ondansetron ___ mg PO Q8H:PRN nausea/vomiting 12. Rosuvastatin Calcium 40 mg PO QPM 13. Senna 8.6 mg PO BID:PRN constipation 14. Triamcinolone Acetonide 0.1% Cream 1 Appl TP BID 15. Vitamin D 1000 UNIT PO DAILY Discharge Disposition: Home With Service Facility: ___ Discharge Diagnosis: Genealized weakness/lethargy Acute encephalopathy Pseudomonas UTI ARF PICC assoc DVT Breast cancer Acute confusional state Discharge Condition: Mental Status: Clear and coherent (speech slurred) Level of Consciousness: Lethargic but arousable. Activity Status: Out of Bed with assistance to chair or wheelchair. Discharge Instructions: Dear Ms. ___, You were admitted with lethargy after a recent hospitalization. We found mild kidney injury and UTI. With treatment you improved. You continued your other chronic medications and worked with physical therapy. You will be discharegd with a Foley catheter in place and will follow up with urology. Close follow up with your PCP and oncologist is recommended after discharge as well. It was a pleasure taking care of you. Sincerely, Your ___ team Followup Instructions: ___
19708049-DS-13
19,708,049
27,854,422
DS
13
2190-05-03 00:00:00
2190-05-03 20:00:00
Name: ___ Unit No: ___ Admission Date: ___ Discharge Date: ___ Date of Birth: ___ Sex: F Service: MEDICINE Allergies: No Known Allergies / Adverse Drug Reactions Attending: ___ Chief Complaint: lethargy, intermittent confusion Major Surgical or Invasive Procedure: None History of Present Illness: HISTORY OF PRESENTING ILLNESS: ___ w/ CAD, HTN, CKD, T2DM, iCVA c/b residual L hemiparesis, and stage IIIc triple negative breast cancer in disease remission s/p adjuvant taxol (has completed 7 cycles, no further cycles planned), just started adjuvant XRT, and multiple admissions for lethargy attributed to various infections, including port associated polymicrobial BSI, who is admitted for intermittent confusion and hallucinations over the last 2 days. She does not have any new localizing symptoms. She is taking her meds and eating well. No F/C, no N/V, no diarrhea, no CP/SOB. No new c/o asides from her chronic leg pain for which she takes baclofen TID. In the ED, she was AOx3 but sleepy. UA was suggestive of UTI so she was started on Meropenem. MS seemed to improve while she was there. When I spoke w/ her daughter, ___, she confirmed she is more concerned about the hallucinations. Started yesterday out of the blue w/o any new sx. She was up all night w/ hallucinations and she was sleepy today from not sleeping all night and the hallucinations worsened. ___ noted that this Has never occurred before. No new medications asides melatonin which started last week, which was when she last took a dose.Taking baclofen TID. Of note, she has had multiple recent admissions: 1. admitted from ___ for management of RLE cellulitis. Her hospital course was complicated by acute urinary retention, electrolyte abnormalities, acute neurologic changes felt to be recrudescence of old stroke, and neutropenia with fever. She was ultimately discharged on clindamycin to complete therapy for her cellulitis. Her aspirin was also changed to Plavix during this admission. 2. admitted ___ to ___ for lichenoid drug eruption and polymicrobial BSI and had PORT removed, also found to have UTI and fungemia. discharged on vanc/fluc. she had a PICC Placed c/b DVT. 3. admitted ___ to ___ for lethargy, found to have spuedomonas UTI and ___. 4. admitted ___ to ___ for weakness soft stools found to have c.diff colitis REVIEW OF SYSTEMS: 10 point ros reviewed in detail and negative except for what is mentioned above Past Medical History: RECENT PAST MEDICAL HISTORY L breast cancer (T2N0M0 triple-negative IDC, s/p neoadjuvant ddAC, R lumpectomy/ALND ___, adjuvant taxol) taxol-induced lichen planus of lower extremities with extensive skin breakdown Polymicrobial bacteremia and fungemia in setting of this skin breakdown; s/p IV vanc/fluc Line-associated DVT, on Eliquis UTI (pseudomonas) Urinary retention, currently with indwelling Foley Decuibitus ulcer Increasing malnutrition and FTT to the setting of the above history OTHER PAST MEDICAL HISTORY CKD CAD (30% LM, 80% OM) CVA in ___ with resultant Left hemiparesis; wheelchair bound DM2 Hypertension Hyperlipidemia Osteoarthritis L eye blindness s/p TAH/BSO for fibroids Social History: ___ Family History: Sister died of some sort of cancer in her ___. Daughter died of postpartum CVA Physical Exam: ADMISSION PHYSICAL EXAM: ========================== VS: 97.5 PO 152 / 80 111 18 100 Ra GENERAL: Pleasant woman, in no distress, lying in bed comfortably and intermittently having hallucinations HEENT: Anicteric, OP clear. Pupils reactive CARDIAC: RRR, normal s1/s2, no m/r/g. LUNG: Appears in no respiratory distress, clear to auscultation bilaterally, no crackles, wheezes, or rhonchi. ABD: Soft, non-tender, non-distended, normal bowel sounds, no hepatomegaly, no splenomegaly. EXT: Rash from prior admission much improved w/o erythema NEURO: Quite sleepy limiting exam, notable for chronic L hemiparesis. Strength intact in RLE/RUE but ___. AOX3 ACCESS: ___ c/d/I DISCHARGE PHYSICAL EXAM: ======================== VS: 97.9, 118 / 68, 94, 20, 100% RA GENERAL: Pleasant woman, in no distress, lying in bed comfortably and intermittently having hallucinations HEENT: Anicteric, OP clear. Pupils reactive CARDIAC: RRR, normal s1/s2, no m/r/g. LUNG: Appears in no respiratory distress, clear to auscultation bilaterally, no crackles, wheezes, or rhonchi. ABD: Soft, non-tender, non-distended, normal bowel sounds, no hepatomegaly, no splenomegaly. EXT: Rash from prior admission much improved w/o erythema NEURO: Quite sleepy limiting exam, notable for chronic L hemiparesis. Strength intact in RLE/RUE but ___. AOX3 ACCESS: ___ c/d/i Pertinent Results: ADMISSION LABS: ================= ___ 05:20PM BLOOD WBC: 4.4 RBC: 3.15* Hgb: 9.7* Hct: 31.9* MCV: 101* MCH: 30.8 MCHC: 30.4* RDW: 16.2* RDWSD: 59.6* Plt Ct: 219 ___ 05:20PM BLOOD Neuts: 61.1 Lymphs: ___ Monos: 7.7 Eos: 3.6 Baso: 0.5 Im ___: 0.2 AbsNeut: 2.70 AbsLymp: 1.19* AbsMono: 0.34 AbsEos: 0.16 AbsBaso: 0.02 ___ 05:20PM BLOOD Glucose: 91 UreaN: 23* Creat: 1.5* Na: 142 K: 5.7* Cl: 101 HCO3: 24 AnGap: 17 ___ 05:49PM BLOOD Lactate: 2.0 K: 5.4* STUDIES: ======== ___ CT HEAD W/ & W/O CONTRA IMPRESSION: 1. No acute intracranial abnormality, no hemorrhage. No evidence of intracranial metastasis. 2. Stable sequela of prior infarctions as described above. ___ CHEST (PA & LAT) IMPRESSION: No acute cardiopulmonary abnormality. DISCHARGE LABS: ================ ___ 08:05AM BLOOD WBC-5.0 RBC-2.68* Hgb-8.2* Hct-26.0* MCV-97 MCH-30.6 MCHC-31.5* RDW-15.9* RDWSD-56.7* Plt ___ ___ 08:05AM BLOOD Glucose-79 UreaN-22* Creat-1.3* Na-140 K-4.4 Cl-103 HCO3-21* AnGap-16 ___ 08:05AM BLOOD Calcium-8.9 Phos-4.4 Mg-1.7 ___ 07:59AM BLOOD VitB12-823 Folate-19 ___ 07:59AM BLOOD TSH-1.5 ___ 07:59AM BLOOD Free T4-1.0 Brief Hospital Course: PATIENT SUMMARY: ___ w/ CAD, HTN, CKD, T2DM, iCVA c/b residual L hemiparesis, and stage IIIc triple negative breast cancer in disease remission s/p adjuvant taxol (7 TRIALS,LAST ___, recently started adjuvant XRT at ___, w/ multiple admissions (2x ___, 2x ___ for lethargy attributed to various infections, who p/w auditory and visual hallucinations for two days, found to have ___. ACUTE ISSUES: # Hallucinations Pt w known propensity to become delirious as presenting symptom of infection. It was suspect that current hallucinations may be due to delirium from UTI ___ syndrome vs metabolic from ___. CXR was clear and EKG non-acute. Neuro exam non-focal aside from known L hemiplegia. Daughter/care taker reports pt recently has had declining coordinating and tremor in right extremity over recent days. Non-con head CT was unchanged from prior. Folate, B12, and TSH were normal. UCx w fecal contamination, patient given 2d meropenam which was then discontinued as she no longer had altered mental status or any symptoms or lab signs of infection. She recovered to her neurologic baseline per her daughter without further intervention and was discharged to follow-up with PCP. # Recent C.diff infection Was treated for first c.diff infection earlier in ___, through ___. While on meropenem, patient was given PO vancomycin for ppx. However, there is no evidence that continuing this ppx in patients with only one episode of cdiff reduces the risk of recurrence. Because of this and the fact that she had only received 2d antibiotics, decision made not to send home on ppx for cdiff. # Acute kidney injury on chronic kidney disease Recent baseline Cr around 1.0, when patient was admitted was 1.5. Decreased to 1.3 after IVF and po intake in hospital. Likely due to increased metabolic demand. # Many recent infections # E. faecalis bloodstream infection (___) # C. glabrata bloodstream infection (___) # S. epidermidis bloodstream infection (___) # C. albicans UTI (___) Nidus of infections likely skin breakdown during period of neutropenia vs PORT. Port was removed on ___ and sacral ulcer healing well. No evidence of further infection this hospitalization. # LUE PICC-associated DVT Noted during hospitalization in ___, associated w PICC. S/p close to 3mo apixaban, discussed w outpatient oncologist and decided that she did not need to continue on this medication. # L hemiparesis # History of CVA Hx of CVA in ___ with resultant Left hemiparesis; wheelchair bound. Baseline neurologic exam documented previously, on admission appeared at neurologic baseline with exception of generalized weakness and difficulty feeding herself. Resolved during admission and patient at baseline per daughter. CHRONIC ISSUES # Breast Cancer Dxed in ___. She is s/p neoadjuvant ddAC X4, right partial mastectomy + ALND and adjuvant taxol. She is now without any macroscopic disease and does not plan to receive any further chemotherapy. # CAD: continued home statin, Plavix # Macrocytic anemia: stable, likely multifactorial from CKD, B12 and folate normal, MMA pending at time of discharge. # Type 2 Diabetes Mellitus: maintained on sliding scale while inpatient, restarted home sitagliptin upon discharge. TRANSITIONAL ISSUES [] F/u MMA levels, if positive consider starting folate supplementation [] F/u blood cultures (NGTD at time of discharge) [] Continue radiation therapy outpatient [] Apixaban discontinued as patient s/p 3mo treatment for PICC-associated DVT and PICC was removed. CODE: DNR/DNI confirmed w/ daughter on admission CONTACT/HCP: ___, daughter ___ Medications on Admission: The Preadmission Medication list is accurate and complete. 1. Acetaminophen 1000 mg PO TID 2. Apixaban 5 mg PO BID 3. Baclofen 10 mg PO TID 4. Clopidogrel 75 mg PO DAILY 5. Rosuvastatin Calcium 40 mg PO QPM 6. Senna 8.6 mg PO BID:PRN constipation 7. Vitamin D 1000 UNIT PO DAILY 8. Calcium 500 + D (D3) (calcium carbonate-vitamin D3) 500 mg(1,250mg) -125 unit oral BID 9. linaGLIPtin 5 mg oral DAILY:PRN BS>150 10. Ondansetron ___ mg PO Q8H:PRN nausea/vomiting 11. Ascorbic Acid ___ mg PO BID 12. Zinc Sulfate 220 mg PO DAILY 13. Lidocaine Jelly 2% 1 Appl TP TID 14. Lidocaine 5% Patch 1 PTCH TD QAM Discharge Medications: 1. Baclofen 10 mg PO TID:PRN Muscle Spasms 2. Acetaminophen 1000 mg PO TID 3. Ascorbic Acid ___ mg PO BID 4. Calcium 500 + D (D3) (calcium carbonate-vitamin D3) 500 mg(1,250mg) -125 unit oral BID 5. Clopidogrel 75 mg PO DAILY 6. Lidocaine 5% Patch 1 PTCH TD QAM 7. Lidocaine Jelly 2% 1 Appl TP TID 8. linaGLIPtin 5 mg oral DAILY:PRN BS>150 9. Ondansetron ___ mg PO Q8H:PRN nausea/vomiting 10. Rosuvastatin Calcium 40 mg PO QPM 11. Senna 8.6 mg PO BID:PRN constipation 12. Vitamin D 1000 UNIT PO DAILY 13. Zinc Sulfate 220 mg PO DAILY Discharge Disposition: Home With Service Facility: ___ Discharge Diagnosis: Primary Diagnosis: - Altered Mental Status - Hallucinations - Acute kidney injury Secondary Diagnosis: - Recent C.diff infection - Breast cancer - Type 2 diabetes mellitus - Macrocytic anemia - Chronic decubitus ulcers, present on admission Discharge Condition: Mental Status: Clear and coherent. Level of Consciousness: Alert and interactive. Activity Status: Out of Bed with assistance to chair or wheelchair. Discharge Instructions: Dear ___, It was a pleasure caring for you at ___. WHY WAS I IN THE HOSPITAL? - You were hospitalized because you had altered mental status. WHAT HAPPENED TO ME IN THE HOSPITAL? - While you were hospitalized you were worked up for infections, started on antibiotics given your frequent history of infections associated with altered mental status. - We did not find any evidence of infection and your confusion improved, so we stopped your antibiotics. - You were also worked up for new brain injuries, which we did not find evidence for. - You were treated with radiation therapy for your breast cancer. WHAT SHOULD I DO AFTER I LEAVE THE HOSPITAL? - Continue to take all your medicines and keep your appointments. - Follow up with your primary oncologist in ___ weeks We wish you the best! Sincerely, Your ___ Team Followup Instructions: ___
19708049-DS-5
19,708,049
21,793,489
DS
5
2189-07-03 00:00:00
2189-07-05 16:15:00
Name: ___ Unit No: ___ Admission Date: ___ Discharge Date: ___ Date of Birth: ___ Sex: F Service: MEDICINE Allergies: No Known Allergies / Adverse Drug Reactions Attending: ___. Chief Complaint: hypoglycemia and breast mass Major Surgical or Invasive Procedure: FNA, core biopsy, clip placement History of Present Illness: History Obtained From: [X] Patient [X] Family/Friend [ ] Interpreter [ ] Other: medical records PRIMARY CARE PHYSICIAN: ___. ___ CHIEF COMPLAINT: Hypoglycemia, R breast mass HISTORY OF PRESENT ILLNESS: Ms. ___ is a ___ woman with PMH diabetes on glimepiride and linagliptin, osteoarthritis, HTN, who is presenting with hypoglycemia. Her AM glucose today was 34, her daughter tried to give her food and juice but she wasn't able to take it so she was brought to clinic where she was given oral glucose gel x2 with improvement to 117. She was brought by ambulance to ___ and given additional glucose gel en route. Pertinent ED course: Glucose 49 on arrival, received juice and amp of D50. She was alert and oriented, noted to have a 5x5 cm firm R breast mass with erythema and tenderness. Per daughter this was present two months ago. She was seen by ___ who recommended a Humalog sliding scale, given ceftriaxone for R breast lesion concerning for cellulitis. In the ED, initial VS ___ at 11:123 were: T 97.6 F BP 152/76 HR 94 RR 18 Sat O2 98% on RA Upon arrival to the floor, the patient was stable, lying comfortably with her daughter ___ and granddaughter at the bedside. She reports her breast mass appeared around ___ and was first noted by her daughter as a round, firm lesion without erythema or outer skin involvement. It was stable in size and persisted over the next two months during which time she visited ___. In ___, she saw a local physician who prescribed her an unknown medication (daughter and patient cannot recall). She arrived back to the ___. on ___ with worsening of the mass, and daughter noted there to be new erythema. Patient says pain is ___ in her R breast (ranges from 1 to ___ and worsens with palpation. Her last mammogram was one year ago and was negative for malignant process per family. She was asymptomatic during this time until yesterday night when she experienced significant chills and night sweats. She has otherwise been afebrile. REVIEW OF SYSTEMS: Patient endorses sweats/chills yesterday evening, knee pain bilaterally R>L, L shoulder pain, constipation (last bowel movement 2 days ago). Patient denies headache, vision changes (cannot open L eye at baseline since stroke), nausea/vomiting, fever, chest pain, dyspnea, abdominal pain, or bowel or bladder changes. 10-point ROS otherwise negative except as noted in HPI. Past Medical History: Sepsis secondary to R arm cellulitis in ___ (tx Abx inpt 15 days) T2DM diagnosed ___ years ago, no known complications Left sided CVA ___ (residual left sided face/body weakness) Osteoarthritis Knee pain bilaterally R>L s/p cataract surgery (R and L eyes) ___ s/p R thigh excision of benign mass s/p hysterectomy Social History: ___ Family History: non-contributory Physical Exam: ADMISSION PHYSICAL EXAM: VITALS: T 99.2 F BP 155/73 HR 99 RR 18 O2 Sat 97% RA FSBG 189 GENERAL: Well developed, well nourished, alert and cooperative, lying comfortably, and appears to be in no acute distress. HEAD: normocephalic. EYES: Unable to open L eye at baseline. R eye PERRL, EOMI. R eye vision is grossly intact. ENT: Hearing grossly intact. No nasal discharge. Oral cavity and pharynx normal. No inflammation, swelling, exudate, or lesions. NECK: Neck supple, non-tender without lymphadenopathy, masses or thyromegaly. CHEST: R breast mass, round, 6 x 6 x 2 cm firm mass, warm, erythematous, potentially fixed to underlying tissues. R axillary lymphadenopathy. No nipple discharge. CV: Tachycardic. Normal S1 and S2. No S3, S4 or murmurs. Rhythm is regular. There is no peripheral edema, cyanosis or pallor. Extremities are warm and well perfused. Capillary refill is less than 2 seconds. RESP: Clear to auscultation and percussion without rales, rhonchi, wheezing or diminished breath sounds. Decreased respiratory effort. ABDOMEN: Obese. Positive bowel sounds. Soft, nondistended, nontender. No guarding or rebound. No masses. MSK: Tenderness with palpation of knees bilaterally, R>L. Adequately aligned spine. ROM intact spine and extremities. No joint erythema. Normal muscular development. Wheelchair bound. EXTREMITIES: R first digit amputation. No other significant deformity or joint abnormality. No edema. Peripheral pulses intact, 2+ DP and ___ bilaterally. No varicosities. NEURO: L sided hemiparesis with L facial droop. R sided CN II-XII intact. Strength and sensation 4+ on R, 2+ on L. Reflexes 2+ throughout. SKIN: Skin normal color, texture and turgor with no lesions or eruptions. PSYCH: Alert, oriented to person, place, and time. DISCHARGE PHYSICAL EXAM: VITALS: 98.1 132/74 82 18% on 93 Ra Incontinent, urine not recorded accurately GENERAL: Hemiparetic, no acute distress, conversant HEENT: L eye permanently mostly closed, pupils reactive NECK: supple CV: RRR. Normal S1 and S2. No MRG RESP: CTAB ABDOMEN: ND/NT, active bs MSK: Tenderness with palpation of knees bilaterally, L>R EXTREMITIES: R first digit amputation. No other significant deformity or joint abnormality. No c/c/e NEURO: L sided hemiparesis with L facial droop. R sided CN II-XII intact. Sensation intact throughout. BREAST: bandaged biopsy site with tenderness to palpation + site for clip placement Pertinent Results: ADMISSION LABS: =============== FSBG: 55 -> 49 -> 62 -> 111 -> 158 WBC: 10.9 -> 11.9 Diff: 81% PMNs, 11% lymphos, Abs PMN 9.68 Hgb: 11.5 -> 10.9 Hct: 37.3 -> 34.3 ESR 78 Glc: 57 BUN: 22 CR: 2.1 (baseline 1.5-2) CA ___ = 30 (<38 U/mL) Urine: +protein 100, trace blood, urine casts 3, rare mucous Microbiology - Urine culture NGTD BLOOD CULTURES ___: STAPHYLOCOCCUS EPIDERMIDIS. Isolated from only one set in the previous five days. SENSITIVITIES PERFORMED PER ___ ___ (___) ___. FINAL SENSITIVITIES. Staphylococcus species may develop resistance during prolonged therapy with quinolones. Therefore, isolates that are initially susceptible may become resistant within three to four days after initiation of therapy. Testing of repeat isolates may be warranted. STAPHYLOCOCCUS, COAGULASE NEGATIVE. SECOND MORPHOLOGY. FINAL SENSITIVITIES. Staphylococcus species may develop resistance during prolonged therapy with quinolones. Therefore, isolates that are initially susceptible may become resistant within three to four days after initiation of therapy. Testing of repeat isolates may be warranted. STAPHYLOCOCCUS SCHLEIFERI. FINAL SENSITIVITIES. Staphylococcus species may develop resistance during prolonged therapy with quinolones. Therefore, isolates that are initially susceptible may become resistant within three to four days after initiation of therapy. Testing of repeat isolates may be warranted. BLOOD CULTURES ___: NGTD BLOOD CULTURES ___: NGTD ECG/Telemetry - Per report Rate: 110, PR: 178, QRS: 86, QT: 336, QTc: 423 Sinus tachycardia with an incomplete right bundle-branch block. Inferior Q waves consistent with prior inferior myocardial infarction with early anterior R wave transition suggesting posterior involvement. Diffuse non-specific ST segment flattening in the inferolateral leads. Slight respiratory variation in QRS morphology. Borderline left axis deviation. No prior tracing for comparison. Radiology: CXR ___: No acute cardiopulmonary process Breast ultrasound ___: FINDINGS: The right breast was scanned in its entirety with special attention paid to the area of clinical concern. At ___ o'clock 13 cm from the nipple there is a 4.3 by 5.3 x 3.5 cm irregular hypoechoic mass with minimal internal vascularity. Internal cystic spaces are noted. This correlates well with the area of clinical concern. No additional abnormalities are identified in the right breast. The right axilla was scanned and markedly abnormal lymph nodes were identified measuring up to 2.1 cm with loss of the fatty hilum. Due to difficulty with patient positioning, the left breast was not scanned by ultrasound at this visit. IMPRESSION: Highly suspicious right breast mass and axillary lymph nodes. CT Chest ___: FINDINGS: NECK, THORACIC INLET, AXILLAE, CHEST WALL: Partially visualized thyroid is unremarkable. Supraclavicular and left axillary lymph nodes are nonenlarged. Multiple abnormal enlarged right level 1 axillary lymph nodes measure up to 2.3 x 1.7 cm (03:25). Level 2 axillary nodes measure up to 0.9 cm in short axis however demonstrate loss of central fatty hilum (03:15) and are suspicious for disease involvement. Along the right lateral chest wall is a 5.1 x 4 cm irregular mass. (03:40). UPPER ABDOMEN: Please refer to dedicated CT abdomen/pelvis for details. MEDIASTINUM: Mediastinal lymph nodes are nonenlarged. No anterior mediastinal mass. HILA: Hilar lymph nodes are nonenlarged. HEART and PERICARDIUM: Small pericardial effusion noted. The heart is normal in size. Mild coronary artery and aortic valvular calcifications are noted. PLEURA: No pleural effusion or pleural calcification. No pneumothorax. LUNG: 1. PARENCHYMA: Bibasilar atelectasis is noted. No suspicious mass. 2. AIRWAYS: The airways patent to the segmental level. No bronchiectasis. 3. VESSELS: Thoracic aorta is normal in caliber without aneurysmal dilatation. Main pulmonary artery is normal in caliber. CHEST CAGE: Soft tissues are otherwise unremarkable. No focal lytic or blastic osseous lesions suspicious for malignancy. There are severe degenerative changes throughout the right glenohumeral joint (series 3, image 11). IMPRESSION: 1. 5.1 cm right breast mass with right level 1 and level 2 axillary lymphadenopathy. No distal metastasis. 2. Small pericardial effusion. CT Abdomen & Pelvis ___: LOWER CHEST: Please refer to separate report of CT chest performed on the same day for description of the thoracic findings. ABDOMEN: HEPATOBILIARY: The liver is diffusely hyperdense and otherwise homogeneous in attenuation throughout. There is no evidence of focal lesions within the limitations of an unenhanced scan. There is no evidence of intrahepatic or extrahepatic biliary dilatation. The gallbladder notable for cholelithiasis without gallbladder wall edema or gallbladder distension. PANCREAS: The pancreas has normal attenuation throughout, without evidence of focal lesions within the limitations of an unenhanced scan. There is no pancreatic ductal dilatation. There is no peripancreatic stranding. SPLEEN: The spleen shows normal size and attenuation throughout, without evidence of focal lesions. ADRENALS: The right and left adrenal glands are normal in size and shape. URINARY: Bilateral renal cysts are noted measuring 2.4 in the right upper pole and 1.6 cm in left lower pole. The kidneys are otherwise of normal and symmetric size. There is no evidence of worrisome renal lesions within the limitations of an unenhanced scan. There is nohydronephrosis. There is no nephrolithiasis. There is no perinephric abnormality. GASTROINTESTINAL: The stomach is unremarkable. Small bowel loops demonstrate normal caliber and wall thickness throughout. The colon and rectum are within normal limits. The appendix is not visualized, however no secondary signs of acute appendicitis. PELVIS: The urinary bladder and distal ureters are unremarkable. There is no free fluid in the pelvis. REPRODUCTIVE ORGANS: No large adnexal mass. Uterus is surgically absent. LYMPH NODES: Few subcentimeter inguinal lymph nodes are likely reactive measuring up to 1 cm in short axis (03:17). 0.6 cm portacaval node is likely reactive (03:45). No pelvic, inguinal, retroperitoneal, or mesenteric lymph node enlargement by CT size criteria. VASCULAR: There is no abdominal aortic aneurysm. Moderate atherosclerotic disease is noted. BONES: 0.7 cm subtle lucency within the right iliac wing (3: 87) is likely degenerative. There is no evidence of worrisome osseous lesions or acute fracture. SOFT TISSUES: 2.9 x 1.3 cm area fat stranding along the right gluteal subcutaneous tissues is likely posttraumatic in nature (3:83). The abdominal and pelvic wall is otherwise within normal limits. IMPRESSION: 1. No abdominopelvic metastasis. 2. Cholelithiasis. 3. Please refer to separate CT chest report for findings regarding the thorax. FNA ___. POSITIVE FOR MALIGNANT CELLS. - Metastatic adenocarcinoma consistent with breast primary, see note. - Lymphocytes consistent with lymph node sampling. Note: The prepared cell block has high tumor cellularity. The tumor cells in the specimen morphologically resemble those in the concurrent breast biopsy ___, reviewed). Notable for Hb 10.1, Cr 1.7 Brief Hospital Course: Ms. ___ is a ___ woman with past medical history of diabetes (on glimepiride and linagliptin), osteoarthritis, hypertension who is presenting with hypoglycemia and right breast mass concerning for breast malignancy. #Hypoglycemia Patient's glucose was 49 on arrival. She received juice and an amp of D50 to good effect. She was seen by ___ who recommended a Humalog sliding scale. The hypoglycemic event was likely multi-factorial in nature, precipitated by poor oral intake, acute on chronic renal kidney disease, and sulfonylurea usage. Her blood sugars remained stable for the remainder of the hospitalization. She was discharged on just the Tradjenta 5 mg, holding the glimepiride 1 mg PO at breakfast until further evaluation as outpatient. - BG profile: ___: prehospital-34, 55, 117. ED: 71, 55, 55, 49, 62, 111, 150s, 189, 165 ___: 100, 101, 98, 144, 123 #Breast mass: Breast mass is highly concerning for a primary breast malignancy given the indolent course. Prior mammograms have been negative except for stable left simple septated cysts for 4+ years. Patient was seen by breast surgery service who performed an ultrasound, core biopsy, FNA, and placed clip. Ms. ___ also had a CT chest/abdomen/pelvis that showed a 5.1 cm right breast mass with right level 1 and level 2 axillary lymphadenopathy. It also revealed a small pericardial effusion, most likely in the setting of malignancy. There was no evidence of abdominopelvic metastasis. #Leukocytosis, right breast mass with erythema and tenderness in setting of history of cellulitis, found to have staph bacteremia. Patient was initially started on ceftriaxone for concern for breast abscess, and was then started on 750 mg IV Q48H vancomycin given staph bacteremia. Did not find source of possible skin infection on exam. Urine cultures were negative. No evidence of abscess on CT scan. The blood cultures from ___ came back as coag negative staph, the leukocytosis resolved, and the second blood cultures were negative. There are pending blood cultures from ___ that need to be followed. There is a high likelihood of blood culture contamination, and since the second blood cultures, we discontinued the Vancomycin. Initial leukocytosis most likely reactive in the setting of suspected breast malignancy. -Patient received 1 dose ceftriaxone on presentation for concern of breast abscess -Patient received 2 doses of vancomycin 750 mg IV Q48H for coag neg staph bacteremia #Acute on chronic kidney disease: Creatinine peaked at 2.3, and resolved with IV fluids to baseline Cr 1.7. Urine with 3 granular casts. Cr bump was most likely pre-renal in the setting of poor oral intake. #Breast Mass Pain/knee pain -Tylenol PRN for pain -Tramadol 50 mg PO BID prn for pain CHRONIC/STABLE PROBLEMS: #HTN: SBPS low 90's-150/50-80s on just amlodipine -Amlodipine 5 mg PO QD -Holding Nifedipine CR 60 mg PO QD #CVA: Given history of stroke in ___ with significant residual deficits and high risk for hypercoagulability, reasonable to continue home regimen and administer SC heparin for ppx. -Aspirin 81 mg PO QD -Rosuvastatin calcium 40 mg -Heparin SC #Dementia: Patient is alert and oriented with family at bedside -Monitor with appropriate precautions in place #Osteoporosis: -Calcium carbonate 500 mg PO BID -Vitamin D3 5000 units PO QD #Xerophthalmia: -Artificial tears PRN TRANSITIONAL ISSUES: Cr 1.7 on discharge (2.1 on admission) Hb on discharge 10.1 (10.9 on admission) WBC 8.0 on discharge (11.9 on admission) LDH 344; CEA 8.5; CA ___ 30 (wnl) [ ] Hypoglycemia on oral home medications in setting ___ and ___ oral intake. Per ___ recs, holding glimepiride and discharge just on Tradjenta until outpatient follow-up. See BG trend above. [ ] Held home nifedipine until follow-up with PCP given controlled BPs on amlodipine alone and concern for hypotension (SBPs to ___ [ ] Likely anemia of chronic disease in the setting of chronic kidney disease. It dropped a point over hospital course and needs further evaluation. [ ] Pericardial effusion most likely in setting of malignancy, may consider ECHO as outpatient [ ] Blood culture follow-up from ___ to rule out blood infection ___ coag negative staph, ___ negative) [ ] Cholelithiasis, incidentally seen on CT, asymptomatic MEDICATIONS HELD AT DISCHARGE Glimepiride Nifedipine Medications on Admission: The Preadmission Medication list is accurate and complete. 1. Tradjenta (linagliptin) 5 mg oral DAILY 2. Rosuvastatin Calcium 40 mg PO QPM 3. Acetaminophen ___ mg PO Q12H:PRN Pain - Mild 4. glimepiride 1 mg oral BREAKFAST 5. Aspirin 81 mg PO DAILY 6. amLODIPine 5 mg PO DAILY HTN 7. Artificial Tears ___ DROP BOTH EYES PRN Dry eyes 8. Calcium Carbonate 500 mg PO BID Osteoporosis 9. NIFEdipine (Extended Release) 60 mg PO DAILY HTN 10. TraMADol 50 mg PO BID:PRN Pain - Moderate 11. Senna 8.6 mg PO BID:PRN Constipation 12. Docusate Sodium 100 mg PO BID Constipation Discharge Medications: 1. Acetaminophen ___ mg PO Q12H:PRN Pain - Mild 2. amLODIPine 5 mg PO DAILY HTN 3. Artificial Tears ___ DROP BOTH EYES PRN Dry eyes 4. Aspirin 81 mg PO DAILY 5. Calcium Carbonate 500 mg PO BID Osteoporosis 6. Docusate Sodium 100 mg PO BID Constipation 7. Rosuvastatin Calcium 40 mg PO QPM 8. Senna 8.6 mg PO BID:PRN Constipation 9. Tradjenta (linagliptin) 5 mg oral DAILY 10. TraMADol 50 mg PO BID:PRN Pain - Moderate 11. HELD- glimepiride 1 mg oral BREAKFAST This medication was held. Do not restart glimepiride until see PCP. 12. HELD- NIFEdipine (Extended Release) 60 mg PO DAILY HTN This medication was held. Do not restart NIFEdipine (Extended Release) until see PCP. Discharge Disposition: Home With Service Facility: ___ Discharge Diagnosis: Masa de ___ Hypoglycemia Staph Bacteremia, likely contaminant Acute Renal Failure Discharge Condition: Mental Status: Clear and coherent. Level of Consciousness: Alert and interactive. Activity Status: Out of Bed with assistance to chair or wheelchair. Discharge Instructions: Querida Sra. ___, Gracias por escoger ___ para ___. Ud tenia bajo nivel de ___ descubrimos ___ masa ___. Empezemos ___ de ___ masa; este ___ ___ a continuar el 4 de ___ ___ de ___. Recibio antibioticos para ___ un ___ ___ tambien. Abajo es ___ de sus citas y sus medicaciones. Followup Instructions: ___
19708049-DS-6
19,708,049
25,217,916
DS
6
2189-08-24 00:00:00
2189-08-24 17:46:00
Name: ___ Unit No: ___ Admission Date: ___ Discharge Date: ___ Date of Birth: ___ Sex: F Service: MEDICINE Allergies: No Known Allergies / Adverse Drug Reactions Attending: ___ Chief Complaint: Fevers Major Surgical or Invasive Procedure: None History of Present Illness: ___ PRIMARY ONCOLOGIST: Cardiology: ___, MD PRIMARY CARE PHYSICIAN: ___, MD, MPH PRIMARY DIAGNOSIS: stage III breast cancer TREATMENT REGIMEN: ddAC ___ CC: fever, diarrhea HISTORY OF PRESENTING ILLNESS: Mrs. ___ is a ___ year-old lady with stage III breast cancer who was started on ddAC ___ who presents with fever and diarrhea found to be neutropenic. Seen in clinic today to receive c1d8 ddAC but patient reported having had two large loose bowel movements the night prior. Temperature in clinic was 100.4 and HR in 110s. Patient received filgrastim in clinic prior to ED transfer. ED initial vitals were 100.5 103 151/66 16 99% RA Tmax 101.8 Prior to transfer vitals were 99.5 105 142/76 16 99% RA Exam in the ED showed : "Tachycardic, normotensive, febrile Cachectic, CTABL, S/NT/ND, No B/L edema. No visible rashes, port appears clean" ED work-up significant for: -CBC: WBC: 0.5*. HGB: 9.5*. Plt Count: 96*. Neuts%: 2*. -Chemistry: Na: 134* . K: 4.6. Cl: 93*. CO2: 27. BUN: 26*. Creat: 1.3*. Ca: 9.9. Mg: 1.9. PO4: 3.5. -LFTs: ALT: 9. AST: 18. Alk Phos: 73. Total Bili: 0.7. -CXR: "Low lung volumes with probable bibasilar atelectasis, though early infection is difficult to exclude. Probable mild pulmonary vascular congestion without frank pulmonary edema." -Flu A/B PCR: negative ED management significant for: -Medications: 2L NS, APAP 1g x1, vancomycin 1g, cefepime 2g x1 On arrival to the floor, patient reports feeling mild non-productive cough and sore throat. Last diarrhea episode last night, has not had any since last time. Patient denies night sweats, headache, vision changes, dizziness/lightheadedness, weakness/numbnesss, shortness of breath, hemoptysis, chest pain, palpitations, abdominal pain, nausea/vomiting, diarrhea, hematemesis, hematochezia/melena, dysuria, hematuria, and new rashes. Past Medical History: PAST ONCOLOGIC HISTORY (Per OMR, reviewed): - ___: Reportedly first noticed R breast mass and was treated w abx in ___ for possible cellulitis - ___: Admitted to ___ for hypoglycemia. R breast mass noted and Breast Surg Onc, Dr. ___ -___: Right Breast US - At ___ o'clock 13 cm from the nipple there is a 4.3 by 5.3 x 3.5 cm irregular hypoechoic mass with minimal internal vascularity. Internal cystic spaces are noted. This correlates well with the area of clinical concern. No additional abnormalities are identified in the right breast. The right axilla was scanned and markedly abnormal lymph nodes were identified measuring up to 2.1 cm with loss of the fatty hilum. - ___: CT Chest w/o contrast - 5.1 cm right breast mass w/level 1 and 2 axillary lymphadenopathy. No distal mets. - ___: CT Abdomen and Pelvis - no abdominopelvic mets. - ___: US guided core bx of the Right Breast mass- Path: grade 3 invasive ductal carcinoma with necrosis and lymphoplasmactyic infiltrate, 15mm in this limited sample, RECEPTORS - ER<1%, PR 0%, HER2 neg on IHC (FISH negative w ratio of 1.1) - ___: US guided FNA of R axillary node-Path-metastatic adenocarcinoma c/w breast primary - ___: TTE-EF 55%, Mild LV hypertrophy - ___: Bilateral diagnostic mammogram - Tissue density: B. RIGHT breast: In the posterior upper outer right breast there is a 6 x 5.8 x 4.9 cm mass which corresponds to the biopsied mass on ___. There are benign vascular calcifications. No additional suspicious mass, architectural distortion or grouped calcifications. LEFT breast: There are 2 masses in the lower medial left breast that are stable dating back to ___ and are benign. There are benign calcifications in the left breast and vascular calcifications which are benign. There is no suspicious mass, architectural distortion or suspicious grouped micro-calcifications. - ___: PET scan -There is an approximately 5.4 x 4.3 x 5.2 cm right breast mass with SUV max of 24.4, an approximately 3.4 x 2.0 x 2.8 cm right axillary lymph node with SUV max of 22.8, and an approximately 1.5 x 1.0 cm right sub pectoral lymph node with SUV max of 3.3. Diffuse uptake in the esophagus compatible with esophagitis. No FDG avid lesions are seen in abdomen or pelvis. A gallstone and a 3.1 x 3.0 cm cyst in the upper pole of the right kidney are noted. No FDG avid lesions are seen in the musculoskeletal system. IMPRESSION: There is no evidence of distant FDG-avid disease. - ___: Seen by Dr. ___ in cards and had stress test that showed potential reversible defect - ___: Cardiac cath showing 30% L main and 80% OMB obstruction. No intervention. Med management. Per Dr. ___ to proceed w anthracycline chemo - ___: C1D1 DDAC PAST MEDICAL HISTORY (Per OMR, reviewed): 1. Hx of CVA in ___ with resultant Left hemiparesis; wheelchair bound 2. T2DM with complications of nephropathy 3. CKD w baseline Cr of 1.7-2.0 4. Hypertension 5. Hyperlipidemia 6. Osteoarthritis 7. Hx of Sepsis in ___ sp R arm cellulitis 8. Chronic mild anemia w baseline Hgb ~10 likely ___ CKD 9. L eye blindness Social History: ___ Family History: non-contributory Physical Exam: VITAL SIGNS: 98.9 PO 130 / 76 93 18 96 Ra General: NAD, resting in bed w/ family bedside HEENT: MMM, + lingual thrush CV: RR, NL S1S2 no S3S4, no MRG PULM: CTAB, respirations unlabored ABD: BS+, soft, NTND LIMBS: No ___ SKIN: No rashes on extremities, L chest port site intact w/o erythema NEURO: ___ RUE but has difficulty maintaining arm elevated w/o flapping, LUE contracture, L hemiplegia baseline, able to lift R leg off 4+/5, + dysmetria R hand, + dysarthria per family, no drooling, AOx3, speech otherwise fluent and comprehendible and appropriate per daughter Pertinent Results: CXR ___ FINDINGS: Left Port-A-Cath terminates in the cavoatrial junction. Heart size is mildly enlarged and mediastinal and hilar contours are unchanged. Hypoinflation of the lungs. Left hemidiaphragm is not well defined and is suspicious for pneumonia. In addition equivocal consolidation versus atelectasis also noted in the right lower lobe. No signs of pulmonary congestion. IMPRESSION: in the presence of partial inspiration bibasilar opacifications are concerning for atelectasis or developing pneumonia. Carotid US ___ FINDINGS: RIGHT: The right carotid vasculature has mild heterogeneous atherosclerotic plaque. The peak systolic velocity in the right common carotid artery is 66 cm/sec. The peak systolic velocities in the proximal, mid, and distal right internal carotid artery are 79, 37, and 39 cm/sec, respectively. The peak end diastolic velocity in the right internal carotid artery is 12 cm/sec. The ICA/CCA ratio is 1.2. The external carotid artery has peak systolic velocity of 75 cm/sec. The vertebral artery is patent with antegrade flow. LEFT: The left carotid vasculature has mild heterogeneous atherosclerotic plaque. The peak systolic velocity in the left common carotid artery is 78 cm/sec. The peak systolic velocities in the proximal, mid, and distal left internal carotid artery are 33, 39, and 35 cm/sec, respectively. The peak end diastolic velocity in the left internal carotid artery is 14 cm/sec. The ICA/CCA ratio is 0.5. The external carotid artery has peak systolic velocity of 116 cm/sec. The vertebral artery is patent with antegrade flow. IMPRESSION: There is less than 40% stenosis within the internal carotid arteries bilaterally. TTE ___ Conclusions The left atrium is normal in size. There is mild symmetric left ventricular hypertrophy with normal cavity size and global systolic function (LVEF>55%). Due to suboptimal technical quality, a focal wall motion abnormality cannot be fully excluded. Right ventricular chamber size and free wall motion are normal. The aortic valve leaflets (?#) appear structurally normal with good leaflet excursion. There is no aortic valve stenosis. No aortic regurgitation is seen. The mitral valve appears structurally normal with trivial mitral regurgitation. There is no mitral valve prolapse. The estimated pulmonary artery systolic pressure is high normal. There is a trivial/physiologic circumferential pericardial effusion. IMPRESSION: Suboptimal image quality. Mild symmetric left ventricular hypertrophy with preserved global biventricular systolic function. No valvular pathology or pathologic flow identified. No definite structural cardiac source of embolism identified. Compared with the prior study (images reviewed) of ___, the findings are similar. MRI/MRA Brain/Neck ___ FINDINGS: MRI Brain: There is no evidence of acute intracranial hemorrhage, edema, masses, mass effect, midline shift or slowed diffusion to suggest acute infarction. Chronic right MCA infarction involving the right frontal lobe, insula, and basal ganglia, with associated volume loss. There also chronic infarctions in the bilateral cerebellum. Wallerian degeneration right brainstem. Confluent periventricular, deep, and subcortical white matter T2/FLAIR hyperintensities are likely sequelae of severe chronic small vessel ischemic disease. MRA brain: There is moderate severe right and moderate left cavernous segment ICA narrowing. Moderate right and mild left M1 segment narrowing. Right A1 segment is hypoplastic or occluded.. Widely patent left A1, A-comm supplying both PCAs. Moderate narrowing distal left V4 segment. Diminished flow related enhancement in the right V4 segment. Moderate to severe narrowing left P2 segment. Mild-to-moderate narrowing left P3 segment moderate to severe narrowing right P3 segment. The intracranial vertebral and internal carotid arteries and their major branches appear patent without evidence of occlusion, or aneurysm formation. Incidentally, the distal cervical left internal carotid artery is tortuous (7:21). MRA neck: Motion artifact and aliasing limit evaluation of the proximal common carotid and vertebral arteries. The distal common carotid and vertebral arteries appear patent, without evidence of stenosis or occlusion.. Widely patent left proximal ICA without narrowing by NASCET criteria. Motion artifact limits evaluation of the proximal right ICA. Origins of the great vessels, subclavian and vertebral arteries are not well evaluated, due to motion. Small left pleural effusion partially seen. IMPRESSION: 1. No evidence of acute intracranial hemorrhage or infarction. 2. Extensive intracranial atherosclerotic disease involving anterior, posterior circulation. No occlusion. No aneurysm.. 3. Motion artifact limits evaluation of the neck vessels. ___ ___ IMPRESSION: 1. Suggestion of gray-white matter differentiation loss in the left frontal lobe, consider acute infarct. 2. Chronic right hemispheric, right basal ganglia and cerebellar infarct. 3. Severe chronic small vessel ischemic changes. Generalized brain parenchymal atrophy. RECOMMENDATION(S): Brain MRI without contrast, if indicated. NOTIFICATION: The updated impression and recommendations were communicated via telephone by Dr. ___ to Dr. ___ at 11:15 on ___, 10 min after discovery. Renal US ___ FINDINGS: The right kidney measures 9.2 cm. There is a large simple cyst in the upper pole of the right kidney measuring 3.1 x 3.9 x 3.1 cm. The left kidney measures 10.0 cm. There is a simple cyst in the interpolar region of the left kidney measuring 1.8 x 2.5 x 1.9 cm. There is no hydronephrosis, stones, or masses bilaterally. Normal cortical echogenicity and corticomedullary differentiation are seen bilaterally. The bladder is only minimally distended and can not be fully assessed on the current study. IMPRESSION: Normal renal ultrasound with bilateral simple cysts. No evidence of hydronephrosis bilaterally. CXR ___ FINDINGS: Left-sided Port-A-Cath tip terminates at the SVC/right atrial junction. Lung volumes are low. Heart size remains mildly enlarged. The mediastinal and hilar contours are similar. Crowding of bronchovascular structures is present with probable mild pulmonary vascular congestion. Bibasilar patchy opacities likely reflect areas of atelectasis. No focal consolidation, pleural effusion or pneumothorax is present. No acute osseous abnormalities detected. IMPRESSION: Low lung volumes with probable bibasilar atelectasis, though early infection is difficult to exclude. Probable mild pulmonary vascular congestion without frank pulmonary edema. ___ 07:48PM OTHER BODY FLUID FluAPCR-NEGATIVE FluBPCR-NEGATIVE Brief Hospital Course: ___ w/ CAD, CVA ___ w/ residual L hemiparesis (wheelchair bound), T2DM, HTN, DL, CKD III, L eye blindness, and stage III breast cancer dx ___, started on ddAC ___ who p/w to clinic on ___ for C1D8 ddAC where she c/o fever and two large loose bowel movements, found to be neutropenic and febrile to 102.0F. She improved w/ broad spectrum abx w/o any source identified. She improved rapidly but renal function and Platelet count declined and unfortunately developed new stroke on ___ but symptoms also improved w/o radiographic e/o stroke (but too prolonged to be TIA). # New Slurred Speech # New R hemiparesis Unfortunately patient developed acute sx of dysarthria and R hemiparesis in am ___. She was not hypotensive. Had head CT and MRI which did not reveal any acute infarctions or hemorrhage. Sx seem to be waxing and waning but significantly improved. No obvious infection and trops negative. Was seen by the neurology service and felt that it is most likely a small CVA not visible on MRI. Her aspirin was increased to full dose. She did not have any evidence of afib on telemetry. - increased ASA 81 to 325 mg now that TCP improved - stopped amlodipine and nifedipine as SBP 120s-130s off all bp meds [ ] cont outpatient ___ and OT and ST [ ] mechanical soft and nectar thickened liquid # Febrile neutropenia: # Sepsis She was admitted for sepsis and febrile neutropenia. Etiology of her fevers undetermined at this time. Her ANC <500 and w/ fevers up to 102.0F. She denied sore throat or mouth pain, denied any new cough. She had diarrhea but resolved PTA. No abd pain. CXR not suggestive of PNA. UA not suggestive of UTI. Currently pt feels/appears much improved since admission. Malaria ag negative. She was treated w/ Vanc and Cefepime. - Cefepime 2g q8h, ___, end ___ and no further fevers since - Received pegfilgrastim which failed, filgrastim last dose ___ - pt had low grade temps of 99 on day of discharge w/o e/o infection, likely from leukocytosis post neupogen # Diarrhea: She Had 2 episodes of loose stools PTA. No abdominal pain and has not had any further bowel movements since however starting to recur. C.diff negative. # Stage 3 breast cancer: Received c1d1 ddAC w/ resulting severe neutropenia. C1d8 held given F&N. - Likely to require dose reduction for next infusion - Dr ___, will see her in clinic # Hypertension: Does not recall hypertension medications but carvedilol 6.25 and amlodipine 5 mg were verified during cardiology appointments. We held her BP meds due to the CVA to allow permissive hypertension but her SBP remained in the 120s-130s and did not feel she needed any antihypertensives on discharge. # Type 2 Diabetes Mellitus: We continued her diabetes medications. - Linagliptin NF - Lispro SS # CAD, CVA Not having any anginal symptoms - cont aspirin - cont home Rosuvastatin - holding carvedilol # Anemia: likely from antineoplastic therapy. Labs and smear reviewed by oncology consult service and not c/w hemolysis. - s/p 2U PRBC ___ with appropriate bump from 6.9 to 8.9 # Thrombocytopenia: Likely from antineoplastic therapy, however the decline in plt and hg counts accelerated, possibly due to sepsis. Plt dropped PTA so unlikely HIT. Smear and labs not c/w hemolysis. Nadired at 58 and rose to 188 on day of discharge # ATN: Seen by nephrology. Cr peaked at 2.5 and platuead. Non-oliguric. She had foley placed to measure her ins/outs closely as she was incontinent. She was seen by neprhology who felt this rise in Creatinine is due to ATN from sepsis and possible transient hypotension. She maintained excellent urine output. [ ] f/u renal function on ___ [ ] f/u K level ___ - discharged on 10 mEq bid x 3 days per recs by nephrology # Hypokalemia: likely related to urine output, repleted. K on discharge 3.1 # Hypomagnesemia: likely from chemo/diarrhea, repleted # Osteoporosis: on calcium, vit d # Xerophthalmia: cont artificial tears # Hyponatremia: mild, and improving w/ po intake FEN: Heart Healthy mechanical soft diet ACCESS: Left Chest wall port CODE STATUS: Confirmed DNR/DNI Surrogate/emergency contact: ___ (daughter) ___ DISPO: HOME w/ ___ BILLING: >30 min spent coordinating care for discharge ______________ ___, D.O. Heme/___ Hospitalist ___ Medications on Admission: The Preadmission Medication list is accurate and complete. 1. Ondansetron 4 mg PO Q8H:PRN nausea 2. Acetaminophen 500 mg PO BID:PRN Pain - Mild 3. linagliptin 5 mg oral DAILY 4. Aspirin 81 mg PO DAILY 5. Artificial Tears ___ DROP BOTH EYES PRN Dry eyes 6. Calcium Carbonate 500 mg PO BID Osteoporosis 7. amLODIPine 5 mg PO DAILY HTN 8. Docusate Sodium 100 mg PO BID:PRN Constipation 9. Rosuvastatin Calcium 40 mg PO QPM 10. Senna 8.6 mg PO BID:PRN Constipation 11. TraMADol 50 mg PO BID cancer pain 12. glimepiride 1 mg oral BREAKFAST 13. NIFEdipine (Extended Release) 60 mg PO DAILY HTN Discharge Disposition: Home With Service Facility: ___ Discharge Diagnosis: Stage 3 breast cancer Febrile Neutropenia Pancytopenia Ischemic Stroke Coronary artery disease T2DM HTN DL CKD III Hypokalemia Discharge Condition: Mental Status: Clear and coherent. Level of Consciousness: Alert and interactive. Activity Status: Bedbound. Discharge Instructions: Dear ___, ___ was a pleasure caring for you at ___ ___. You were admitted because you were having fevers and diarrhea. You improved with IV antibiotics. You were treated with IV antibiotics and Neupogen to help boost your white blood cells. You had symptoms of a stroke while you were in the hospital on ___ but they are improving. You had a brain MRI and CT scan which did not reveal stroke. You were seen by the neurology team as well. We felt that your symptoms are most consistent with a stroke and recommend that you increase your dose of aspirin to 3 baby aspirins rather than 1 every day while your platelets can handle it. You will need to have your labs checked on ___. Regards, Your ___ team Followup Instructions: ___
19708804-DS-19
19,708,804
26,038,085
DS
19
2147-07-25 00:00:00
2147-07-28 12:52:00
Name: ___ Unit No: ___ Admission Date: ___ Discharge Date: ___ Date of Birth: ___ Sex: F Service: UROLOGY Allergies: No Known Allergies / Adverse Drug Reactions Attending: ___. Chief Complaint: flank pain Major Surgical or Invasive Procedure: Cystoscopy Bilateral retrograde pyelogram Bilateral stent placement History of Present Illness: ___ is a ___ y/o female with a history of nephrolithiasis for which she was evaluated by Dr. ___ in clinic yesterday. She has a history of low back pain, but about a week ago developed severe left sided back and flank pain. A UA showed hematuria and this prompted a CT scan. That revealed several small right sided stones and a 2-3 mm left proximal ureteral stone. She has been managing her pain, which has migrated anteriorly and towards the bladder, with tylenol, NSAID's and tramadol reasonably well. She is also taking flomax. This has never happened before. She has never seen a urologist and she does not normally have issues with hematuria or UTI's. This AM, she awoke with new onset right flank pain more severe than her left flank pain which was not managed with her medication regimen. She took a relative's ___ pill and subsequently had nausea with emesis. She presented to the ED for further evaluation and management. Urology consulted for likely admission. Past Medical History: PAST MEDICAL HISTORY: LOW BACK PAIN MIGRAINE HEADACHES OBESITY OVERWEIGHT TOBACCO ABUSE PAST SURGICAL HISTORY: None Social History: ___ Family History: Non-contributory Physical Exam: AVSS NAD Unlabored breathing Abdomen obese, soft, NT, ND, No guarding or rebound tenderness, no CVAT bilaterally No calf tenderness bilaterally, ext wwp, ambulating Pertinent Results: ___ 06:50AM BLOOD WBC-9.2 RBC-4.45 Hgb-13.0 Hct-39.8 MCV-90 MCH-29.2 MCHC-32.7 RDW-13.4 Plt ___ ___ 07:20PM BLOOD WBC-17.6* RBC-5.02 Hgb-14.7 Hct-44.8 MCV-89 MCH-29.4 MCHC-32.9 RDW-13.0 Plt ___ ___ 07:20PM BLOOD Neuts-88.1* Lymphs-8.3* Monos-3.2 Eos-0.1 Baso-0.3 ___ 06:50AM BLOOD Glucose-89 UreaN-6 Creat-0.7 Na-140 K-3.9 Cl-110* HCO3-25 AnGap-9 ___ 07:20PM BLOOD Glucose-83 UreaN-8 Creat-0.8 Na-143 K-4.4 Cl-111* HCO3-21* AnGap-15 ___ 06:50AM BLOOD Mg-1.9 ___ ___ 7:20 ___ RENAL U.S. Clip # ___ Reason: Please evaluate for stones and hydronephrosis bilaterally UNDERLYING MEDICAL CONDITION: History: ___ with known left-sided kidney stones but right-sided flank pain. REASON FOR THIS EXAMINATION: Please evaluate for stones and hydronephrosis bilaterally Wet Read: ___ WED ___ 7:57 ___ 1. right pelvic fullness extending into proximal ureter is new from ___. no frank right hydronephrosis. no stones or mass seen. 2. normal left kidney. Wet Read Audit # 1 Final Report INDICATION: Right-sided flank pain. Known left kidney stones. COMPARISON: US ___, CT ___. FINDINGS: The right kidney is 13.5 cm and the left kidney is 11.7 cm. Right pelvic fullness extending into the proximal ureter without frank hydronephrosis is new from ___. No stone or mass is identified. Postvoid, right pelvic fullness remains. The left kidney is normal without hydronephrosis, stone, or mass identified. The study is performed with a partially full, normal-appearing bladder. IMPRESSION: 1. Mild right pelviectasis extending into the proximal ureter is new from ___. Given right flank pain and small stones seen on prior CT, this may reflect passing of a small stone. No frank hydronephrosis. 2. Normal left kidney. Urine culture (two): mixed flora Brief Hospital Course: ___ was admitted to Dr. ___ service for pain control and antiemesis. She was taken to the OR for cystoscopy, bilateral retrograde pyelograms, and bilateral stent placement. No concerning intraoperative events occurred; please see dictated operative note for details. He patient received ___ antibiotic prophylaxis. The patient's postoperative course was uncomplicated. She was observed overnight for stent symptoms. She remained a-febrile throughout his hospital stay. On POD1 at discharge, the patient had pain well controlled with oral pain medications, was tolerating regular diet, ambulating without assistance, and voiding without difficulty. She was given pyridium and oral pain medications on discharge with explicit instructions to follow up for definitive stone managment in several days. Prior to discharge home all of her questions were answered as were those of her mother and as requested a work note through her surgery date (scheduled ___ was provided. Medications on Admission: Ibuprofen Tramadol Fluticasone Flomax Discharge Medications: 1. Diazepam 5 mg PO Q8H:PRN stent irritation RX *diazepam 5 mg 1 tab by mouth every eight (8) hours Disp #*15 Tablet Refills:*0 2. Docusate Sodium 100 mg PO BID RX *docusate sodium 100 mg 1 capsule(s) by mouth twice a day Disp #*60 Capsule Refills:*0 3. Hydrocodone-Acetaminophen (5mg-500mg) 1 TAB PO Q6H:PRN pain RX *hydrocodone-acetaminophen 5 mg-500 mg 1 tablet(s) by mouth every six (6) hours Disp #*30 Tablet Refills:*0 4. Phenazopyridine 100 mg PO Q8H:PRN dysuria Duration: 3 Days RX *phenazopyridine 100 mg 1 tablet(s) by mouth every eight (8) hours Disp #*9 Tablet Refills:*0 5. Tamsulosin 0.4 mg PO HS RX *tamsulosin 0.4 mg 1 capsule(s) by mouth at bedtime Disp #*30 Capsule Refills:*0 Discharge Disposition: Home Discharge Diagnosis: Nephrolithiasis Discharge Condition: Mental Status: Clear and coherent. Level of Consciousness: Alert and interactive. Activity Status: Ambulatory - Independent. Discharge Instructions: -You can expect to see occasional blood in your urine and to possibly experience some urgency and frequency over the next month; this may be related to the passage of stone fragments or the indwelling ureteral stent (if there is one). -The kidney stone may or may not have been removed AND/or there may fragments/others still in the process of passing. -You may experience some pain associated with spasm of your ureter. This is normal. Take the narcotic pain medication as prescribed if additional pain relief is needed. -Ureteral stents MUST be removed or exchanged and therefore it is IMPERATIVE that you follow-up as directed. -Do not lift anything heavier than a phone book (10 pounds) -You may continue to periodically see small amounts of blood in your urine--this is normal and will gradually improve -Resume all of your pre-admission medications, except HOLD aspirin until you see your urologist in follow-up AND your foley has been removed (if not already done) ***-You may or may not have passed all your stones ****Ureteral stent *** -You MAY be discharged home with a medication called PYRIDIUM that will help with the "burning" pain you may experience when voiding. This medication may turn your urine bright orange. -Colace has been prescribed to avoid post surgical constipation and constipation related to narcotic pain medication. Discontinue if loose stool or diarrhea develops. Colace is a stool softener, NOT a laxative, and available over the counter. The generic name is DOCUSATE SODIUM. It is recommended that you use this medication. -Do not eat constipating foods for ___ weeks, drink plenty of fluids to keep hydrated -No vigorous physical activity or sports for 4 weeks and while Foley catheter is in place. -Tylenol should be your first line pain medication, a narcotic pain medication has been prescribed for breakthrough pain >4. Replace Tylenol with narcotic pain medication. -Max daily Tylenol (acetaminophen) dose is 4 grams from ALL sources, note that narcotic pain medication also contains Tylenol -Do not drive or drink alcohol while taking narcotics and do not operate dangerous machinery. Also, if the Foley catheter and Leg Bag are in place--Do NOT drive (you may be a passenger). Followup Instructions: ___
19708804-DS-20
19,708,804
26,910,541
DS
20
2147-08-20 00:00:00
2147-08-21 18:25:00
Name: ___ Unit No: ___ Admission Date: ___ Discharge Date: ___ Date of Birth: ___ Sex: F Service: UROLOGY Allergies: No Known Allergies / Adverse Drug Reactions Attending: ___. Chief Complaint: right flank pain Major Surgical or Invasive Procedure: NONE DURING THIS ADMISSION History of Present Illness: ___ is a ___ y/o female with a history of nephrolithiasis s/p urgent bilateral stent placement for flank pain on ___ and subsequent ureteroscopy laser lithotripsy ___. Her right stent was removed in the clinic on ___. She presents to the ED for right flank pain and temperature at home to 100.6. Labs were significant for a leukocytosis of of 17.4, with left shift of 82.1, no renal insufficiency Cr 1.0, grossly negative UA for infection. A renal US was obtained, and was significant for no hydronephrosis, but a right possible subscapular hematoma. In this context, urology was consulted. Patient began feeling right sided abdominal pain for several days prior to presentation to the ED. Thought associated with menstruation, but persisted. Pain not associated with food. Endorses nausea, but no vomiting. Poor oral intake. Noted fevers starting 6 days ago, that was controlled with tylenol. The patient denied difficulty with urination, hematuria. Denies sob, dizziness, lightheadedness, cp. Past Medical History: PAST MEDICAL HISTORY: LOW BACK PAIN MIGRAINE HEADACHES OBESITY OVERWEIGHT TOBACCO ABUSE Medications: None Allergies: NKDA PAST SURGICAL HISTORY: Cystoscopy with bilateral stent placement ___ Ureteroscopy with laser lithotripsy stent placement ___ Social History: ___ Family History: Non-contributory Physical Exam: AVSS Wdwn F in NAD. MMM Unlabored breathing. Abdomen obese, soft. TTP in RUQ, right flank. No flank hematoma. Positive mild CVAT right. Ext WWP Pertinent Results: ___ 06:30AM BLOOD WBC-13.8* RBC-3.85* Hgb-10.7* Hct-33.7* MCV-88 MCH-27.8 MCHC-31.7 RDW-14.1 Plt ___ ___ 11:45AM BLOOD WBC-17.4*# RBC-4.49 Hgb-12.6 Hct-39.3 MCV-88 MCH-28.1 MCHC-32.1 RDW-12.6 Plt ___ ___ 11:45AM BLOOD Neuts-82.1* Lymphs-11.9* Monos-5.4 Eos-0.2 Baso-0.5 ___ 11:45AM BLOOD Glucose-83 UreaN-8 Creat-0.7 Na-138 K-4.2 Cl-102 HCO3-23 AnGap-17 ___ 03:00PM URINE Color-Yellow Appear-Clear Sp ___ ___ 03:00PM URINE Blood-NEG Nitrite-NEG Protein-NEG Glucose-NEG Ketone-NEG Bilirub-NEG Urobiln-NEG pH-6.0 Leuks-MOD ___ 11:35AM URINE Blood-SM Nitrite-NEG Protein-TR Glucose-NEG Ketone-40 Bilirub-NEG Urobiln-NEG pH-6.5 Leuks-MOD ___ 03:00PM URINE RBC-1 WBC-9* Bacteri-FEW Yeast-NONE Epi-4 ___ 11:35AM URINE RBC-<1 WBC-4 Bacteri-FEW Yeast-NONE Epi-7 TransE-<1 ___ 03:00PM URINE Mucous-OCC ___ 11:35AM URINE Mucous-RARE ___ 11:35 am URINE **FINAL REPORT ___ URINE CULTURE (Final ___: MIXED BACTERIAL FLORA ( >= 3 COLONY TYPES), CONSISTENT WITH SKIN AND/OR GENITAL CONTAMINATION. Blood cultures x 2 pending ___ ___ 1:00 ___ COMPLETE GU U.S. (BLADDER & RE Clip # ___ Reason: Presence of hydroureter/hydronephrosis UNDERLYING MEDICAL CONDITION: ___ year old woman sp ureteral stent removal, c/o right flank pain + fevers REASON FOR THIS EXAMINATION: Presence of hydroureter/hydronephrosis Wet Read: ___ TUE ___ 1:36 ___ Hypoechoic subcapsular collection adjacent to the right kidney with septations exerting mass effect on the right kidney. Appearance is suggestive of a subacute subcapsular hematoma, but it is not completely specific. Lack of clear anechoic components suggests this collection is not very liquified. No hydronephrosis of the right kidney. Mild hydronephrosis of the left kidney. Wet Read Audit # 1 Final Report HISTORY: Right flank pain and fevers after right kidney lithotripsy and stent removal. TECHNIQUE: Grayscale and Doppler ultrasound images of both kidneys and bladder were obtained. COMPARISON: Renal ultrasound ___, CT abdomen and pelvis ___. FINDINGS: There is a subcapsular hypodense collection with internal septations which is exerting significant mass effect on the right kidney. The collection measures 2 cm in maximum transverse dimension. There is no hydronephrosis of the right kidney. The left kidney has mild hydronephrosis but is otherwise unremarkable. Limited views of the bladder are unremarkable. IMPRESSION: 1. Subcapsular hypoechoic fluid collection in the right kidney with internal septations, which is suggestive of a subacute course. This most likely represents a subcapsular hematoma, but these findings are not entirely specific. 2. Mild hydronephrosis of the left kidney. ___ ___ 2:58 ___ CTU (ABD/PEL) W/&W/O CONTRAST Clip # ___ Reason: Evaluation of potential subcapsular hematoma on US (Split bo Contrast: OMNIPAQUE Amt: 130 UNDERLYING MEDICAL CONDITION: ___ year old woman sp removal right ureteral stent, pw right flank pain REASON FOR THIS EXAMINATION: Evaluation of potential subcapsular hematoma on US (Split bolus protocol; noncon then combo delayed/portal venous 10 min later) CONTRAINDICATIONS FOR IV CONTRAST: None. Wet Read: PRib TUE ___ 5:21 ___ Subcapsular collection along the right posterior kidney most consistent with hematoma measuring 12.1 x 3.9 x 5.0 cm. No stones or hydronephrosis. Wet Read Audit # 1 Final Report INDICATION: Status post right ureteral stent removal with flank pain, evaluation of potential subcapsular hematoma seen on ultrasound. COMPARISON: Ultrasound on ___bdomen and pelvis on ___. Renal and bladder ultrasound on ___. TECHNIQUE: MDCT images were obtained through the abdomen and pelvis without contrast and after administration of IV contrast. Two-minute delayed images were obtained as well. Coronal and sagittal reformations were performed. FINDINGS: The imaged lung bases are clear. The visualized heart and pericardium are unremarkable. The liver enhances homogeneously and there are no focal liver lesions. The gallbladder is normal. The pancreas is normal. The spleen is normal. The stomach, small bowel, and colon are normal. The appendix is normal. There are scattered mildly prominent retroperitoneal lymph nodes. The left kidney is normal. In the right kidney, there is a low-density subcapsular collection measuring 3.9 AP x 12.1 CC x 5.0 laterally along the posterior portion of the kidney, and is consistent with a subacute to chronic hematoma noting rim enhancement and low density, not consistent with acute hematoma. Some fat stranding is present about the lower pole of the right kidney. No stones are identified. There is no hydronephrosis. PELVIS: The bladder is normal. The uterus and adnexa are unremarkable. The rectum is normal. There is no free fluid in the pelvis. There are no hernias identified. There is no pelvic or inguinal lymphadenopathy. The intra-abdominal vasculature is patent. The bones are unremarkable. IMPRESSION: Low-density subcapsular collection with rim enhancement in the posterior right kidney suggestive of subacute to chronic evolving hematoma based on location and relatively recent instrumentation. No stones are identified. No hydronephrosis or stones identified. Brief Hospital Course: ___ was admitted to the urology service for pain control and IV antibiotics with ceftriaxone. On HD #2, it was determined that she was stable for discharge. Her pain was well controlled on oral medications and she was tolerating a regular diet without nausea. urine culture was negative. Antibiotics were stopped. She was afebrile with stable vital signs, and no leukocytosis. She was ambulating independently. Medications on Admission: None Discharge Medications: 1. Acetaminophen 500 mg PO Q6H:PRN pain or fever 2. Docusate Sodium 100 mg PO BID 3. OxycoDONE (Immediate Release) 5 mg PO Q6H:PRN pain greater than 4 RX *oxycodone 5 mg ONE tablet(s) by mouth Q6hrs Disp #*25 Tablet Refills:*0 4. Ibuprofen 600 mg PO Q8H:PRN pain RX *ibuprofen 600 mg ONE tablet(s) by mouth Q8hrs Disp #*40 Tablet Refills:*0 Discharge Disposition: Home Discharge Diagnosis: RIGHT FLANK PAIN likely due to ___ hematoma/fluid collection Discharge Condition: Mental Status: Clear and coherent. Level of Consciousness: Alert and interactive. Activity Status: Ambulatory - Independent. Discharge Instructions: -You can expect to see occasional blood in your urine and to possibly experience some urgency and frequency over the next month; this may be related to the passage of stone fragments or the indwelling ureteral stent (if there is one). -The kidney stone may or may not have been removed AND/or there may fragments/others still in the process of passing. -You may experience some pain associated with spasm of your ureter.; This is normal. Take the narcotic pain medication as prescribed if additional pain relief is needed. -Do not lift anything heavier than a phone book (10 pounds) and refrain from aggressive sports/activities until further advised. -You may continue to periodically see small amounts of blood in your urine--this is normal and will gradually improve -Resume all of your pre-admission medications, except HOLD aspirin until you see your urologist in follow-up -You can expect to see occasional blood in your urine and to possibly experience some urgency and frequency over the next month; this may be related to the passage of stone fragments or the indwelling ureteral stent. -The kidney stone may or may not have been removed AND/or there may fragments/others still in the process of passing. -You may experience some pain associated with spasm of your ureter.; This is normal. Take the narcotic pain medication as prescribed if additional pain relief is needed. -Ureteral stents MUST be removed or exchanged and therefore it is IMPERATIVE that you follow-up as directed. -Do not lift anything heavier than a phone book (10 pounds) -You may continue to periodically see small amounts of blood in your urine--this is normal and will gradually improve -Resume all of your pre-admission medications, except HOLD aspirin until you see your urologist in follow-up -IBUPROFEN (the ingredient of Advil, Motrin, etc.) may be taken even though you may also be taking Tylenol/Acetaminophen. You may alternate these medications for pain control. For pain control, try TYLENOL FIRST, then ibuprofen, and then take the narcotic pain medication as prescribed if additional pain relief is needed. -Ibuprofen should always be taken with food. Please discontinue taking and notify your doctor should you develop blood in your stool (dark, tarry stools) -You MAY be discharged home with a medication called PYRIDIUM that will help with the "burning" pain you may experience when voiding. This medication may turn your urine bright orange. -Colace has been prescribed to avoid post surgical constipation and constipation related to narcotic pain medication. Discontinue if loose stool or diarrhea develops. Colace is a stool softener, NOT a laxative, and available over the counter. The generic name is DOCUSATE SODIUM. It is recommended that you use this medication. -Do not eat constipating foods for ___ weeks, drink plenty of fluids to keep hydrated -No vigorous physical activity or sports for 4 weeks Followup Instructions: ___
19709131-DS-4
19,709,131
23,581,316
DS
4
2174-06-01 00:00:00
2174-06-01 15:34:00
Name: ___ Unit No: ___ Admission Date: ___ Discharge Date: ___ Date of Birth: ___ Sex: M Service: ORTHOPAEDICS Allergies: No Known Allergies / Adverse Drug Reactions Attending: ___. Chief Complaint: Right Ankle Pain Major Surgical or Invasive Procedure: 1. Open reduction, internal fixation of right bimalleolar ankle fracture. 2. Chondroplasty, anterolateral talar surface. History of Present Illness: Mr. ___ is a pleasant ___ year old ___ who presents today after sustaining a twisting injury to his right ankle earlier this evening. Patient reports that he had just finished dinner and was taking his plate to the sink when he tripped on a small trash can in his living room and twisted his right ankle. He felt an immediate crack and noticed a swollen and deformed right ankle. He reports he was in immediate excruciating pain and thought he had dislocated the ankle. He states that he "quickly put it back [into position?]". He was unable to bear any weight through the right lower extremity. He went to ___ where preliminary x-rays of the right ankle were obtained and revealed a bimalleolar right ankle fracture. The patient was placed into a temporizing splint and transferred to ___ for further evaluation and management. Currently patient endorses some numbness and paresthesias over the dorsum of his foot. He endorses some pain/discomfort, but overall states that his pain is minimal. He denies injuring any other extremity. He denies frankly falling, or striking his head. Denies loss of consciousness. Past Medical History: None Social History: ___ Family History: Non-Contributory Physical Exam: On Admission: In general, the patient is a pleasant middle aged gentleman, resting comfortably on the emergency department stretcher in no apparent distress. Vitals: Tc 99.2, HR 81, BP 138/89, RR 18, SpO2 100% Right lower extremity: Skin intact There is notable swelling about the right ankle. There is tenderness to palpation along the medial and lateral malleoli. There are no overlying skin changes. No tederness about the lower leg or proximal tibiofibular joint. Full, painless AROM/PROM of hip, knee ___ fire, although APF and ADF is expectedly painful +SILT SPN/DPN/TN/saphenous/sural distributions. Patient endorses some numbness in the DPN distribution. ___ pulses, foot warm and well-perfused On Discharge: AFVSS General - Awake and alert. Lying down in bed. NAD. Right Lower Extremity - Splint in place, intact, no soiling - Able to wiggle toes - Toes are warm and well perfused with brisk capillary refill. - Sensation intact to light touch at tips of toes. Pertinent Results: ___ 06:50AM BLOOD WBC-8.8 RBC-4.34* Hgb-13.4* Hct-40.5 MCV-93 MCH-30.9 MCHC-33.2 RDW-12.3 Plt ___ ___ 06:50AM BLOOD Glucose-108* UreaN-18 Creat-0.9 Na-140 K-3.9 Cl-105 HCO3-25 AnGap-14 Brief Hospital Course: The patient presented to the emergency department and was evaluated by the orthopedic surgery team. The patient was found to have a right bimalleolar ankle fracture and was admitted to the orthopedic surgery service. The patient was taken to the operating room on ___ for open reduction and internal fixation of his right ankle fracture and chondroplasty of the anterior talar surface, which the patient tolerated well (for full details please see the separately dictated operative report). The patient was taken from the OR to the PACU in stable condition and after recovery from anesthesia was transferred to the floor. The patient was initially given IV fluids and IV pain medications, and progressed to a regular diet and oral medications by POD#1. The patient was given perioperative antibiotics and anticoagulation per routine. The patient's home medications were continued throughout this hospitalization. The patient worked with ___ who determined that discharge to home with home ___ was appropriate. The ___ hospital course was otherwise unremarkable. At the time of discharge the patient was afebrile with stable vital signs that were within normal limits, pain was well controlled with oral medications, splint was clean/dry/intact, and the patient was voiding/moving bowels spontaneously. The patient is non weight bearing in the right lower extremity, and will be discharged on enoxaparin for DVT prophylaxis. The patient will follow up in two weeks per routine. A thorough discussion was had with the patient regarding the diagnosis and expected post-discharge course, and all questions were answered prior to discharge. Medications on Admission: None Discharge Medications: 1. Acetaminophen 650 mg PO Q6H Never exceed 4000 mg in 24 hours. 2. Docusate Sodium 100 mg PO BID Do not take if having loose bowel movements. RX *docusate sodium 100 mg 1 tablet(s) by mouth twice a day Disp #*60 Tablet Refills:*0 3. Enoxaparin Sodium 40 mg SC QHS Duration: 2 Weeks Start: Today - ___, First Dose: Next Routine Administration Time RX *enoxaparin 40 mg/0.4 mL 40 mg sc at bedtime Disp #*14 Syringe Refills:*0 4. OxycoDONE (Immediate Release) ___ mg PO Q4H:PRN Pain RX *oxycodone 5 mg 1 tablet(s) by mouth every four (4) hours Disp #*100 Tablet Refills:*0 Discharge Disposition: Home With Service Facility: ___ Discharge Diagnosis: Right bimalleolar ankle fracture Discharge Condition: Mental Status: Clear and coherent. Level of Consciousness: Alert and interactive. Activity Status: Ambulatory - Independent. Discharge Instructions: MEDICATIONS: - Please take all medications as prescribed by your physicians at discharge. - Continue all home medications unless specifically instructed to stop by your surgeon. - Do not drink alcohol, drive a motor vehicle, or operate machinery while taking narcotic pain relievers. - Narcotic pain relievers can cause constipation, so you should drink eight 8oz glasses of water daily and take a stool softener (colace) to prevent this side effect. ANTICOAGULATION: - Please take enoxaparin (Lovenox) 40mg daily for 2 weeks WOUND CARE: - You may shower. No baths or swimming for at least 4 weeks. - Any stitches or staples that need to be removed will be taken out at your 2-week follow up appointment. - No dressing is needed if wound continues to be non-draining. - Splint must be left on until follow up appointment unless otherwise instructed - Do NOT get splint wet ACTIVITY AND WEIGHT BEARING: - You may *NOT* bear weight with the right leg. Keep the splint on until follow up appointment. Followup Instructions: ___
19709184-DS-8
19,709,184
27,239,374
DS
8
2133-07-20 00:00:00
2133-07-20 10:13:00
Name: ___ Unit No: ___ Admission Date: ___ Discharge Date: ___ Date of Birth: ___ Sex: F Service: OBSTETRICS/GYNECOLOGY Allergies: cyclobenzaprine Attending: ___. Chief Complaint: pelvic pain Major Surgical or Invasive Procedure: none Past Medical History: HISTORY of Abnormal pap smears: denies HISTORY of STIs: h/o chlamydia, s/p treatment; recent test neg as outpatient ISSUES: pelvic pain, endometriosis (previously followed by Dr. ___ at ___ and seen in consultation by Dr. ___ OB HISTORY: G: 0 PAST MEDICAL HISTORY: 1. Endometriosis (diagnosed in ___ 2. Fractured left hip(Dx ___ 3. Left rotator cuff ___ 4. Migraines with Aura(Dx ___, previously on topomax) 5. Rheumatoid arthritis 6. Fibromyalgia PAST SURGICAL HISTORY: 1. Laparoscopic Cystectomy (___) 2. Diagnostic laparoscopy for endometriosis Physical Exam: Discharge physical exam Vitals: VSS Gen: NAD, A&O x 3 CV: RRR Resp: no acute respiratory distress Abd: soft, appropriately tender, no rebound/guarding Ext: no TTP Pertinent Results: ___ 12:50PM POTASSIUM-3.9 ___ 12:29PM COMMENTS-GREEN TOP ___ 12:29PM K+-6.3* ___ 10:00AM URINE HOURS-RANDOM ___ 10:00AM URINE HOURS-RANDOM ___ 10:00AM URINE UHOLD-HOLD ___ 09:05AM GLUCOSE-87 UREA N-9 CREAT-0.8 SODIUM-134 POTASSIUM-7.0* CHLORIDE-100 TOTAL CO2-24 ANION GAP-17 ___ 09:05AM WBC-7.1 RBC-4.08 HGB-12.6 HCT-37.2 MCV-91 MCH-30.9 MCHC-33.9 RDW-11.8 RDWSD-39.3 ___ 09:05AM NEUTS-73.9* LYMPHS-15.8* MONOS-9.5 EOS-0.1* BASOS-0.4 IM ___ AbsNeut-5.27 AbsLymp-1.13* AbsMono-0.68 AbsEos-0.01* AbsBaso-0.03 ___ 09:05AM PLT COUNT-187 ___ 09:05AM ___ PTT-32.0 ___ Brief Hospital Course: On ___, Ms. ___ was admitted from the Emergency Department for management of pelvic pain thought to be due to endometriosis flare. In the ED she was given morphine and toradol for pain control. Plvic ultrasound showed no concerning causes for her pain (normal uterus and endometrium, 1.4 x 1.2 x 1.0 cm cyst or follicle along the peripheral edge of the right ovary is similar to ___, no free fluid). Urine pregnancy test and gonorrhea and chlamydia were also negative. During her hospitalization she received IV toradol, oral dilaudid, gabapentin, ibuprofen, acetaminophen, benadryl and vaginal valium suppository. By hospital day 2, her pain was controlled with oral medications, she was tolerating a regular diet and ambulating independently. She was then discharged home in stable condition with outpatient follow-up scheduled. Medications on Admission: Diazepam 5mg per vagina TID PRN pain folic acid methotrexate sodium 20mg PO weekly norethindrone acetate 5mg PO daily Discharge Medications: 1. Docusate Sodium 100 mg PO BID RX *docusate sodium [Colace] 100 mg 1 capsule(s) by mouth twice daily Disp #*50 Capsule Refills:*0 2. Gabapentin 200 mg PO TID RX *gabapentin 100 mg 2 capsule(s) by mouth three times a day Disp #*180 Capsule Refills:*1 3. HYDROmorphone (Dilaudid) 4 mg PO Q4H:PRN Pain - Moderate Do not drink alcohol or drive while taking this medication. RX *hydromorphone [Dilaudid] 4 mg 1 tablet(s) by mouth every 4 hours Disp #*20 Tablet Refills:*0 4. Ibuprofen 600 mg PO Q6H:PRN Pain - Moderate take with food. RX *ibuprofen 600 mg 1 tablet(s) by mouth every 6 hours Disp #*50 Tablet Refills:*1 Discharge Disposition: Home Discharge Diagnosis: pelvic pain, endometriosis flare Discharge Condition: Mental Status: Clear and coherent. Level of Consciousness: Alert and interactive. Activity Status: Ambulatory - Independent. Discharge Instructions: Dear Ms. ___, You were admitted to the gynecology service from the Emergency Department for pelvic pain, thought to be due to a flare of your endometriosis. You have recovered well and the team believes you are ready to be discharged home. Please call Dr. ___ office with any questions or concerns. Please follow the instructions below. General instructions: * Take your medications as prescribed. * Do not drive while taking narcotics. * Take a stool softener such as colace while taking narcotics to prevent constipation. * Do not combine narcotic and sedative medications or alcohol. * Do not take more than 4000mg acetaminophen (APAP) in 24 hrs. * No strenuous activity until your post-op appointment. * You may eat a regular diet. * You may walk up and down stairs. Call your doctor for: * fever > 100.4F * severe abdominal pain * difficulty urinating * vaginal bleeding requiring >1 pad/hr * abnormal vaginal discharge * nausea/vomiting where you are unable to keep down fluids/food or your medication To reach medical records to get the records from this hospitalization sent to your doctor at home, call ___. Followup Instructions: ___
19709220-DS-3
19,709,220
26,529,662
DS
3
2134-04-19 00:00:00
2134-05-07 16:03:00
Name: ___ Unit No: ___ Admission Date: ___ Discharge Date: ___ Date of Birth: ___ Sex: F Service: MEDICINE Allergies: tramadol Attending: ___. Chief Complaint: unable to care for herself and chronic abdominal pain Major Surgical or Invasive Procedure: None History of Present Illness: ___ year old ___ speaking female with a PMH of nephrectomy, chronic abdominal pain, HTN, multiple ED visits for chronic pain and inability to take care of herself at home who presents again unable to care for herself alone at home. Patient originally from ___ and ___ been living with family members in ___. Up until last month, she was living with her son and daughter in law who have been in ___ for the past month and was doing well with them, able to make food for herself. Patient concerned she can no longer take care of herself at home, no longer has money and has been trying to get ahold of her daughter in ___ but has no cellphone. Denies fevers, chills, nausea, vomiting. Patient with multiple vague complaints. Has had chronic abdominal pain and constipation. Abd pain is intermittent, cramping. Also complaining of b/l knee pain. She has been getting steroid injections in b/l knees, last injection on ___. Reports occasional blood mixed with her stool, but not recently. Wears diapers as she has been incontinent of urine for the past few years. Reports eating well and is able to go to an ___ restaurant near home for free food at times, but recently has run out of money. Reports coughing chronically. Family dynamics per chart review are complex but currently, patient seems to be in best contact with her daughter ___ who is in ___. She does not get along with her daughter ___ and ___ daughter ___ keeps in touch with her mother intermittently but isn't her primary guardian. She was living previously in ___ with her Son and daughter in law ___ (same name) but they have been in ___ for the past month and it is unclear when they are coming back. Phone Numbers: **SEE SW NOTE ___: ___ ___: ___ ___ (daughter: ___ Daughter In Law ___: ___ In the ED, patient HD stable. Patient referred to Elder Protective Services. ROS: Pertinent positives and negatives as noted in the HPI. All other systems were reviewed and are negative. Past Medical History: HTN Nephrectomy DMII Social History: ___ ___ History: FAMILY HISTORY: Mother with asthma, denies DMII history Physical Exam: ADMISSON EXAM: VITALS: Afebrile and vital signs stable (see eFlowsheet) GENERAL: Alert and in no apparent distress, occasionally tearing up EYES: Anicteric, pupils equally round ENT: Ears and nose without visible erythema, masses, or trauma. Oropharynx without visible lesion, erythema or exudate CV: Heart regular, no murmur, no S3, no S4. No JVD. RESP: Lungs clear to auscultation with good air movement bilaterally. Breathing is non-labored GI: Abdomen soft, non-distended, non-tender to palpation. Bowel sounds present. No HSM GU: some ttp, particularly in LLQ MSK: Neck supple, moves all extremities, strength grossly full and symmetric bilaterally in all limbs SKIN: No rashes or ulcerations noted NEURO: Alert, oriented, face symmetric, gaze conjugate with EOMI, speech fluent, moves all limbs, sensation to light touch grossly intact throughout PSYCH: pleasant, appropriate affect DISCHARGE EXAM VITALS: Afebrile and vital signs stable (see eFlowsheet) GENERAL: Alert and in no apparent distress EYES: Anicteric, pupils equally round CV: Heart regular, no murmur, no S3, no S4. No JVD. RESP: Lungs clear to auscultation with good air movement bilaterally. Breathing is non-labored GI: Abdomen soft, non-distended, mild TTP at right side. Bowel sounds present. GU: No suprapubic fullness or tenderness to palpation MSK: Moves all extremities, strength grossly full and symmetric bilaterally in all limbs NEURO: Alert, oriented, face symmetric, gaze conjugate with PSYCH: pleasant, appropriate affect Pertinent Results: ___ 01:22PM BLOOD WBC-6.7 RBC-4.33 Hgb-11.0* Hct-36.8 MCV-85 MCH-25.4* MCHC-29.9* RDW-15.5 RDWSD-47.9* Plt ___ ___ 07:30AM BLOOD WBC-3.4* RBC-3.98 Hgb-10.3* Hct-33.8* MCV-85 MCH-25.9* MCHC-30.5* RDW-15.6* RDWSD-47.7* Plt ___ ___ 06:20AM BLOOD WBC-4.8 RBC-4.02 Hgb-10.2* Hct-33.7* MCV-84 MCH-25.4* MCHC-30.3* RDW-15.4 RDWSD-46.5* Plt ___ ___ 01:22PM BLOOD Glucose-102* UreaN-9 Creat-0.7 Na-141 K-4.7 Cl-102 HCO3-25 AnGap-14 ___ 07:30AM BLOOD Glucose-103* UreaN-13 Creat-0.6 Na-144 K-4.7 Cl-103 HCO3-27 AnGap-15 ___ 06:20AM BLOOD Glucose-93 UreaN-15 Creat-0.7 Na-145 K-4.2 Cl-103 HCO3-26 AnGap-16 ___ 01:22PM BLOOD ALT-16 AST-24 AlkPhos-68 TotBili-0.4 ___ 01:22PM BLOOD Lipase-49 ___ 01:22PM BLOOD cTropnT-<0.01 ___ 06:20AM BLOOD Calcium-9.1 Phos-4.1 Mg-1.9 ___ 07:30AM BLOOD calTIBC-367 VitB12-293 Folate-13 Ferritn-41 TRF-282 ABCT: 1. Patient is status post right nephrectomy with subcentimeter soft tissue density in the surgical bed likely postsurgical but prior imaging should be used for comparison to confirm and exclude tumor recurrence. 2. 5.6 cm cystic left adnexal mass is noted, and should be compared with prior imaging when available. Otherwise, pelvic ultrasound should be obtained. 3. 1.5 cm enlarged epicardial lymph node of unclear clinical significance. This should be compared with prior but if prior imaging cannot be obtained, follow-up imaging should be performed in 3 months given history of malignancy. RECOMMENDATION(S): Compared with prior imaging. If not available, consider pelvic ultrasound for left adnexal mass and repeat CT abdomen pelvis imaging for epicardial lymph node in 3 months. NOTIFICATION: The updated recommendations were discussed with Dr. ___, M.D. by ___, M.D. on the telephone on ___ at 9:14 am, 10 minutes after discovery of the findings. Pelvic US: 1. 5.5 cm left adnexal cyst. 2. Right ovary not visualized. RECOMMENDATION(S): Pelvic ultrasound in ___ year. Brief Hospital Course: ___ year old ___ speaking female with a PMH of nephrectomy, chronic abdominal pain, HTN, multiple ED visits for chronic pain and inability to take care of herself at home who presents again unable to care for herself alone at home incidentally found to have a left adnexal cyst. #Abdominal pain The etiology of her abdominal pain is not immediately clear. She tolerates a diet without pain. She does note some constipation, which could contribute. Pelvic US shows left adnexal cyst, but not convinced this is contributing to her pain. Otherwise, patient is tolerating regular diet. LFT normal. Lipase normal. UCX negative. Exam benign. By discharge, her abdominal pain was improved and she was tolerating a diet. She was continued on omeprazole. #Elder neglect As noted in HPI, complex social history. Patient has been trouble with housing. Her daughter ___ does not seem to be able to take care of her. ___ is in ___. Her son does not return until ___ or so. She was evaluated by SW, EPS and we contacted her daughter ___. She was discharged with plan for outpatient services and to the home of her daughter ___. Medications on Admission: The Preadmission Medication list is accurate and complete. 1. Levothyroxine Sodium 100 mcg PO DAILY 2. Senna 17.2 mg PO DAILY 3. Omeprazole 20 mg PO DAILY 4. MetFORMIN XR (Glucophage XR) 500 mg PO BID 5. Lisinopril 40 mg PO DAILY 6. Metoprolol Succinate XL 50 mg PO DAILY 7. Artificial Tears Preserv. Free ___ DROP BOTH EYES PRN dry eyes 8. Acetaminophen 500 mg PO Q6H:PRN Pain - Mild 9. Multivitamins 1 TAB PO DAILY Discharge Medications: 1. Polyethylene Glycol 17 g PO DAILY RX *polyethylene glycol 3350 [Miralax] 17 gram/dose 1 powder(s) by mouth once a day Refills:*0 2. Acetaminophen 500 mg PO Q6H:PRN Pain - Mild 3. Artificial Tears Preserv. Free ___ DROP BOTH EYES PRN dry eyes 4. Levothyroxine Sodium 100 mcg PO DAILY 5. Lisinopril 40 mg PO DAILY RX *lisinopril 40 mg 1 tablet(s) by mouth once a day Disp #*30 Tablet Refills:*0 6. MetFORMIN XR (Glucophage XR) 500 mg PO BID RX *metformin 500 mg 1 tablet(s) by mouth twice a day Disp #*60 Tablet Refills:*0 7. Metoprolol Succinate XL 50 mg PO DAILY RX *metoprolol succinate 50 mg 1 tablet(s) by mouth once a day Disp #*30 Tablet Refills:*0 8. Multivitamins 1 TAB PO DAILY 9. Omeprazole 20 mg PO DAILY RX *omeprazole 20 mg 2 capsule(s) by mouth once a day Disp #*30 Capsule Refills:*0 10. Senna 17.2 mg PO DAILY Discharge Disposition: Home With Service Facility: ___ Discharge Diagnosis: Abdominal pain Discharge Condition: Mental Status: Clear and coherent. Level of Consciousness: Alert and interactive. Activity Status: Ambulatory - Independent. Discharge Instructions: Ms. ___, it was a pleasure taking care of you during your stay at ___. You were admitted for abdominal pain. Your pain improved and you tolerated a diet. You were seen by our social work team and elder services. They will help you with services at home. We wish your the best, ___ Followup Instructions: ___
19709635-DS-8
19,709,635
28,613,375
DS
8
2156-04-14 00:00:00
2156-04-15 10:36:00
Name: ___ Unit No: ___ Admission Date: ___ Discharge Date: ___ Date of Birth: ___ Sex: F Service: MEDICINE Allergies: Cipro Attending: ___. Chief Complaint: Nausea/vomiting/diarrhea Major Surgical or Invasive Procedure: None History of Present Illness: ___ presents with nausea, vomiting and diarrhea. Patient reports a week long history of vomiting and diarrhea which has worsened over past 3 days. Has noted some associated abdominal pain, predominantly across left side of abdomen. Has not noted fever. No blood in BMs or stool. Is on oxycodone ___ and OxyContin at home for her lower extremity pain secondary to her reflex sympathetic dystrophy, has not had recent changes in her medication dosing however has had difficulty keeping down her narcotics secondary to vomiting. No recent travel or exotic food intake. She notes that she recently had change in her narcotic regimen - 2 weeks ago was on 60 BID of oxycontin and 25mg q4prn of oxycodone, now on 80 bid of oxycontin and 15 q4prn of oxycodone. Patient reports that she has had 6 surgeries on her left foot starting in ___, thought to be secondary to playing basketball and injuries sustained during that. Since ___ she has had pain in the left foot which is chronic despite multiple surgeries. She was diagnosed with reflex sympathetic dystrophy in ___, thought ___ to the multiple surgeries at the left foot. She says she has chronic left foot pain at baseline, described as sharp, burning. She gets exacerbations about once a month, lasting ___ days, which prevents her from her daily activities and is immobilizing. She says her foot gets red/discolored during these episodes with warmth, and the pain can travel up her leg. She had spine stimulators placed in ___ which she says has helped reduce the frequency of exacerbations of her chronic pain. Initial ED vitals were 98.2 116 131/80 16 99%. Initial UA w/ mod leuks, many bacteria and 22 WBC, repeat was completely negative. Labs in ED notable for: lactate 2.4, ALT 106, AST 76, normal CBC, Bun/Cr ___. CT Abd/Pelvis: Normal colon without evidence of diverticulitis, no free pelvic fluid, no abdominal hernia, no free intraperitoneal air. Per ED nurses note - patient stated she vomited in ED but no one has witnessed pt. vomiting or diarrhea. In ED patient was trialed with zofran, ativan IV, phenergan and compazine in ED. She stated it was not working and was still unable to tolerate POs. Also was given oxycodone, oxycontin, gabapentin and ketorolac in ED. Pt was given 4 L NS total for hydration and was A&Ox3. On the floor, vs were: T98.2 P65 BP161/84 R18 O2 sat 99% RA. Patient was sitting in bed, in NAD. Past Medical History: Reflex sympathetic dystophy - dx in ___, thought ___ to multiple left foot surgeries/injuries Spinal cord stimulator - placed in ___ Depression - was hospitalized at ___ in early ___, had suicidal ideation without formed plan, has never attempted suicide Social History: ___ Family History: MS (___), uterine cancer (mom), no family h/o CAD/MI, DM, or mental health issues/substance abuse. Physical Exam: ADMISSION PHYSICAL EXAM: Vitals: T:98.2 BP:161/84 P:65 R:18 O2:99% RA General: Alert, oriented, no acute distress HEENT: Sclera anicteric, MMM, oropharynx clear Neck: supple, JVP not elevated, no LAD Lungs: Clear to auscultation bilaterally, no wheezes, rales, rhonchi CV: Regular rate and rhythm, normal S1 + S2, no murmurs, rubs, gallops Abdomen: soft, mild diffuse tenderness to palpation, non-distended, bowel sounds present, no rebound tenderness or guarding Ext: Warm, well perfused, 2+ pulses, no clubbing, cyanosis or edema; left foot with well-healed surgical scar on plantar surface, no swelling or erythema noted, ROM normal at left ankle. Skin: No rashes noted Neuro: No focal neuro deficits, speech fluent, moving all extremities. DISCHARGE PHYSICAL EXAM: Vitals: T:97.7 ___ R:18 O2:97-99% RA General: Alert, oriented, no acute distress HEENT: Sclera anicteric, MMM, oropharynx clear Neck: supple, JVP not elevated, no LAD Lungs: Clear to auscultation bilaterally, no wheezes, rales, rhonchi CV: Regular rate and rhythm, normal S1 + S2, no murmurs, rubs, gallops Abdomen: soft, mild diffuse tenderness to palpation, non-distended, bowel sounds present, no rebound tenderness or guarding Ext: Warm, well perfused, 2+ pulses, no clubbing, cyanosis or edema; left foot with well-healed surgical scar on plantar surface, no swelling or erythema noted, ROM normal at left ankle; tenderness to palpation along plantar aspect Skin: No rashes noted Neuro: No focal neuro deficits, speech fluent, moving all extremities. Pertinent Results: ADMISSION LABS: ___ 10:15AM BLOOD WBC-7.5 RBC-4.53 Hgb-12.9 Hct-39.1 MCV-86 MCH-28.6 MCHC-33.1 RDW-13.0 Plt ___ ___ 10:15AM BLOOD Neuts-67.3 ___ Monos-3.9 Eos-1.1 Baso-0.4 ___ 10:15AM BLOOD ___ PTT-40.0* ___ ___ 10:15AM BLOOD Glucose-111* UreaN-13 Creat-0.7 Na-136 K-4.3 Cl-100 HCO3-23 AnGap-17 ___ 10:15AM BLOOD ALT-106* AST-76* AlkPhos-89 TotBili-0.2 ___ 10:15AM BLOOD Albumin-4.5 ___ 10:19AM BLOOD Lactate-2.4* ___ 10:05AM URINE RBC-4* WBC-22* Bacteri-MANY Yeast-NONE Epi-12 TransE-1 ___ 10:05AM URINE Blood-SM Nitrite-NEG Protein-30 Glucose-NEG Ketone-TR Bilirub-NEG Urobiln-NEG pH-6.0 Leuks-MOD ___ 12:15PM URINE Blood-NEG Nitrite-NEG Protein-NEG Glucose-NEG Ketone-NEG Bilirub-NEG Urobiln-NEG pH-7.0 Leuks-NEG ___ 10:05AM URINE Color-Yellow Appear-Hazy Sp ___ ___ 12:15PM URINE Color-Straw Appear-Clear Sp ___ DISCHARGE LABS: ___ 07:35AM BLOOD WBC-8.7 RBC-4.23 Hgb-12.3 Hct-36.2 MCV-86 MCH-29.0 MCHC-33.9 RDW-13.1 Plt ___ ___ 07:35AM BLOOD Glucose-85 UreaN-9 Creat-0.6 Na-137 K-3.9 Cl-103 HCO3-19* AnGap-19 ___ 07:35AM BLOOD ALT-63* AST-36 AlkPhos-69 TotBili-0.2 ___ 07:35AM BLOOD Calcium-8.8 Phos-2.8 Mg-1.9 MICRO: ___ 10:05 am URINE **FINAL REPORT ___ URINE CULTURE (Final ___: MIXED BACTERIAL FLORA ( >= 3 COLONY TYPES), CONSISTENT WITH SKIN AND/OR GENITAL CONTAMINATION. BLOOD CULTURE (___): Negative to date as of discharge IMAGING: CT ABD/PELVIS (___): IMPRESSION: 1. No evidence of acute diverticulitis. 2. Neural spinal stimulator is limited in its evaluation; however, no overt evidence of surrounding inflammation. 3. Mild hepatosteatosis. ECG ___: Sinus rhythm. Within normal limits. No previous tracing available for comparison. Brief Hospital Course: ASSESSMENT AND PLAN: ___ with PMHx notable for depression, reflex sympathetic dystrophy, chronic left foot pain, presents with 1 week h/o nausea, vomiting and diarrhea. # Nausea/vomiting/diarrhea: DDx includes viral gastroenteritis versus possible opioid withdrawal. She may have initially had viral syndrome but when unable to take PO meds, may have precipitated withdrawal. Patient did have recent change in narcotic dosing - may have also contributed to withdrawal symptoms. CT abdomen and pelvis in the ED was without acute process. The diarrhea resolved in the ED - while stool studies were ordered she did not have loose bowel movement during hospitalization. She was able to tolerate liquids and jello on the day of discharge without emesis. She was given short-term prescription for PO zofran to help alleviate any further nausea/vomiting she may experience. # Left foot pain/reflex sympathetic dystrophy: Patient has a history of chronic foot pain, is s/p 6 surgeries to her left foot, ___ one in mid ___. In addition, patient had spinal stimulator placed in ___. She reports daily pain ___ at her left foot, and exacerbations ___ per month, where pain can be up to ___. Her narcotic regimen on admission was 80 mg BID oxycontin and 15mg q4hrs prn oxycodone. Her prescription was last filled on ___ (this was confirmed with the pharmacy). However, there was an error in her oxycontin prescription - stated that she should take two 80mg oxycontins BID (script was for 14 days). It was confirmed with the pharmacy that she received 56 80mg oxycontins. Patient reported she did not realize they were 80 mg tablets and that she had been taking 2 tablets BID as prescribed, thus she was taking 160mg BID. On the medical wards she was continued on 80mg BID oxycontin and 15mg q4prn oxycodone. She expressed concern that she did not have any more oxycontin or oxycodone at home to last her through the weekend and to her next PCP ___. After discussing with her PCP, and noting that her prescription was filled on ___, and her next appointment was ___, and she had not used any of her home narcotics while hospitalized, the decision was made, at the recommendation of her PCP, that she not be discharged with new prescriptions for oxycodone or oxycontin. This was communicated to the patient. In addition, patient was advised that should she have further concerns regarding her narcotic regimen, that she discuss it with her PCP or pain clinic at ___ where she has been seen in the past. # Hepatosteatosis: CT abd/pelvis showed mild hepatosteatosis. Patient with mild elevation in LFTs on admission. Trended down the following morning. Hepatitis serologies were pending at discharge but returned negative. These findings and pending tests were discussed with her PCP. # Depression: patient was admitted to ___ for 2 weeks earlier last year for depression. Patient had suicidal ideation at the time, but denies ever having a formed plan or an attempt. Per PCP, patient has had intermittent SI, but never formed plan nor attempt to his knowledge. Patient denied suicidal ideation or thoughts of harming herself during her admission. She was continued on her home Prozac and Klonipin. TRANSITIONAL ISSUES: [ ]PCP follow up for recheck of LFT [ ]PCP follow up regarding further pharmacological management of chronic pain - Discussed narcotic medications with patient's PCP, ___ (phone ___. He recommended not prescribing patient more narcotics as he has follow-up with the patient on ___. Medications on Admission: The Preadmission Medication list is accurate and complete. 1. OxyCODONE SR (OxyconTIN) 80 mg PO Q12H 2. OxycoDONE (Immediate Release) 15 mg PO Q4H:PRN Pain 3. Gabapentin 600 mg PO HS 4. Gabapentin 400 mg PO TID 5. ClonazePAM 2 mg PO QHS 6. Naproxen 500 mg PO Q8H:PRN Pain 7. Fluoxetine 60 mg PO DAILY Discharge Medications: 1. ClonazePAM 2 mg PO QHS 2. Fluoxetine 60 mg PO DAILY 3. Gabapentin 600 mg PO HS 4. Gabapentin 400 mg PO TID 5. OxycoDONE (Immediate Release) 15 mg PO Q4H:PRN Pain 6. OxyCODONE SR (OxyconTIN) 80 mg PO Q12H 7. Naproxen 500 mg PO Q8H:PRN Pain 8. Ondansetron 8 mg PO Q8H:PRN nausea RX *ondansetron 8 mg 1 tablet,disintegrating(s) by mouth every eight (8) hours Disp #*15 Tablet Refills:*0 Discharge Disposition: Home Discharge Diagnosis: Nausea/vomiting Chronic left foot pain Mild Hepatosteatosis Discharge Condition: Mental Status: Clear and coherent. Level of Consciousness: Alert and interactive. Activity Status: Ambulatory - Independent. Discharge Instructions: Ms. ___, It was a pleasure caring for you during your admission to ___ ___. You were admitted for evaluation of 1 week history of nausea, vomiting, diarrhea and left foot pain. You were given medicine to help with the nausea and vomiting and given pain medication. In addition, imaging was done of your abdomen/pelvis which showed some evidence of mild hepatosteatosis (fat in the liver) but was otherwise normal. In addition a few of your liver enzymes were elevated but trended down during your stay. These were discussed with your PCP and ___ follow-up on them. Your diarrhea resolved, and you improved clinically and it was determined you were safe to be discharged to home. Should you develop worsening abdominal pain, bloody in your stool or urine, or develop high fevers, you should seek evaluation at a medical facility or your nearest emergency department. Followup Instructions: ___
19710506-DS-10
19,710,506
26,502,700
DS
10
2123-06-19 00:00:00
2123-06-19 22:54:00
Name: ___ Unit No: ___ Admission Date: ___ Discharge Date: ___ Date of Birth: ___ Sex: M Service: MEDICINE Allergies: No Known Allergies / Adverse Drug Reactions Attending: ___. Chief Complaint: Syncope Major Surgical or Invasive Procedure: Cardiac Catheterization ___ History of Present Illness: Patient is a ___ male with history of hyponatremia, IDDM, TIA, dementia, metastatic prostate cancer, carotid stenosis s/p CEA, and critical aortic stenosis presenting with syncope. Per ED records, patient had syncope at ___ AM this morning. Patient is a very poor historian and cannot describe the details of his fainting episode in detail; however, he does state that he was getting up from a chair and believes that he fell. He denies any pain. He states that he quickly regained consciousness. Patient is actively being worked up for an aortic valve replacement with ___. Per cardiology notes, over the last month, the patient has been increasingly fatigued and short of breath. He has required approximately 160 mg of Lasix daily over the last month which is an increase from a stable dose of 80 mg for many years. Chest x-ray normal at ___. Patient's wife provided more details; reportedly the patient got up from a seated position and could not move, he slowly dropped to his knees, his wife supported him and he did not hit his head. He was unconscious for no more than a minutes per his wife. No loss of bowel or bladder. Additionally, the patient's PCP called to report lesion on L-spine MRI, patient denies any symptoms c/f cauda equina/cord syndrome and do not feel this merits an emergent workup In the ED, initial VS were: 96.5 70 159/67 18 100% RA Exam notable for: systolic murmur best heard in apex Labs showed: Trop 0.02 x 2, MB 2, Hgb 12.4, BNP 609. Imaging showed: CT Head w/ No acute intracranial process. Consults: Cardiology Patient received: 4U insulin, Dipyridamole-Aspirin, galantamine *NF* 4 mg, Memantine 5 mg, Phosphorus 500 mg, Insulin 8 Units, Insulin 9 Units Transfer VS were: 0 98.1 60 144/53 18 97% On arrival to the floor, patient reports that he came in for his heart valve and maybe a pacemaker. He states that he fainted getting out of his chair this morning and next thing he knew he was being taken to the hospital. Currently, he denies F/C, N/V, chest pain/dizziness, abdominal pain, constipation/diarrhea, numbness or weakness. He does have chronic SOB at baseline. He has lower back pain that sometimes radiates down his R leg but is currently OK. REVIEW OF SYSTEMS: 10 point ROS reviewed and negative except as per HPI Past Medical History: 1. Hyponatremia. 2. Diabetes. 3. History of TIA. 4. Squamous cell carcinoma. 5. Dementia. 6. Glaucoma. 7. Hypogonadism. 8. Sciatica. 9. Carotid stenosis status post CEA. 10. Hyperlipidemia. 11. Metastatic prostate cancer Social History: ___ Family History: Mother ___ ___ ATHEROSCLEROTIC CARDIOVASCULAR DISEASE Father ___ ___ CANCER Brother ___ ___ DIABETES MELLITUS CHRONIC RENAL FAILURE Brother Unknown ___ HEART DISEASE CHRONIC RENAL FAILURE DIABETES TYPE II Physical Exam: ADMISSION PHYSCIAL EXAM ======================= VS: 98.5 PO 96 / 51 L Sitting 75 16 96 RA GENERAL: Pleasant, NAD HEENT: AT/NC, anicteric sclera, pink conjunctiva, MMM NECK: supple, no JVD HEART: RRR, S1/S2, + murmur, no gallops, or rubs LUNGS: CTAB, no wheezes, rales, rhonchi, breathing comfortably without use of accessory muscles ABDOMEN: nondistended, nontender in all quadrants, no rebound/guarding EXTREMITIES: no cyanosis, clubbing, or edema NEURO: A&Ox3, moving all 4 extremities with purpose DISCHARGE PHYSICAL EXAM ======================= Vital signs stable GENERAL: Older appearing man, NAD, comfortable. HEENT: NCAT. EOMI. MMM. CARDIAC: RRR. ___ systolic murmur over LUSB with radiation to carotids. PULMONARY: CTAB. Breathing comfortably on room air. ABDOMEN: SNTND, +BS, no rebound/guarding EXTREMITIES: WWP, no ___ edema. Tense, warm R forearm w/ intact radial pulse, decreased wrist flexion. NEURO: AOx3. Motor function grossly intact in ___ SKIN: Hematoma over right forearm as above. Pertinent Results: ADMISSION LABS ============= ___ 02:50PM BLOOD WBC-8.2 RBC-3.99* Hgb-12.4* Hct-37.0* MCV-93 MCH-31.1 MCHC-33.5 RDW-14.8 RDWSD-51.3* Plt ___ ___ 02:50PM BLOOD Neuts-45.8 ___ Monos-6.6 Eos-1.0 Baso-0.2 Im ___ AbsNeut-3.76 AbsLymp-3.79* AbsMono-0.54 AbsEos-0.08 AbsBaso-0.02 ___ 02:50PM BLOOD ___ PTT-24.5* ___ ___ 02:50PM BLOOD Glucose-257* UreaN-35* Creat-1.2 Na-140 K-3.7 Cl-97 HCO3-26 AnGap-17 ___ 02:50PM BLOOD CK(CPK)-60 ___ 02:50PM BLOOD CK-MB-2 proBNP-609 ___ 02:50PM BLOOD Calcium-9.4 Phos-2.6* Mg-2.2 IMAGES ====== CT Head (___): No acute intracranial process. Cath (___): 1. No significant CAD. Bone scan (___): The images show no evidence of abnormal radiotracer uptake. There is mild irregularity of the thoracic spine, likely representing degenerative changes. A decrease in uptake within the L4-L5 region is noted, partially artifactual. The kidneys and urinary bladder are visualized, the normal route of tracer excretion. IMPRESSION: No evidence of focal osteoblastic abnormalities. RUE US (___): No evidence of deep vein thrombosis in the right upper extremity. Subcutaneous edema. CT Torso (___): Panorex (___): MICRO ===== None DISCHARGE LABS ============= ___ 04:53AM BLOOD WBC-6.4 RBC-2.92* Hgb-9.2* Hct-28.3* MCV-97 MCH-31.5 MCHC-32.5 RDW-15.2 RDWSD-54.1* Plt ___ ___ 04:53AM BLOOD ___ PTT-27.1 ___ ___ 04:53AM BLOOD Glucose-230* UreaN-36* Creat-1.0 Na-142 K-4.4 Cl-98 HCO3-31 AnGap-13 PERTINENT LABS ============= ___ 04:53AM BLOOD WBC-6.4 RBC-2.92* Hgb-9.2* Hct-28.3* MCV-97 MCH-31.5 MCHC-32.5 RDW-15.2 RDWSD-54.1* Plt ___ ___ 04:53AM BLOOD Glucose-230* UreaN-36* Creat-1.0 Na-142 K-4.4 Cl-98 HCO3-31 AnGap-13 ___ 02:50PM BLOOD CK-MB-2 proBNP-609 ___ 02:50PM BLOOD cTropnT-0.02* ___ 05:30AM BLOOD CK-MB-1 cTropnT-0.03* ___ 06:50PM BLOOD CK-MB-2 cTropnT-0.04* Brief Hospital Course: ___ man with history of diabetes, TIA, dementia, metastatic prostate cancer, carotid stenosis s/p CEA, and severe aortic stenosis presented for syncopal episode most likely due to combination of symptomatic AS, dysautonomia, and mild hypovolemia. ACUTE ISSUES: ============= # SYNCOPE # SEVERE AORTIC STENOSIS Presented for single episode syncope upon standing from chair. Most likely combination of severe aortic stenosis, hypovolemia, and dysautonomia. Was currently undergoing TAVR evaluation prior to admission and was expedited while in house. s/p cath ___ without significant coronary disease and c/p CT torso on ___. Per cardiac surgery, is high risk for procedure. Patient received compression stockings. Home Lasix dose was decreased to 60 mg daily. Underwent CT Torso and panorex in preparation for TAVR with plan to continue workup as outpatient. Symptoms resolved during hospitalization with plan to discharge home with ___. Will be called to return to hospital to undergo TAVR in the near future. # CHRONIC DIASTOLIC HEART FAILURE Recent admission to ___ for CHF exacerbation in early ___ with subsequent up-titration of Lasix. Dry on admission confirmed with right heart cath. Patient underwent diuresis holiday, restarted on Lasix 60 mg daily prior to discharge. # RIGHT ARM HEMATOMA Due to radial access during cath. Pain on exam and decreased ROM, though with intact radial pulse with good distal sensation. Evaluated by hand surgery without concern for compartment syndrome. US without DVT. ROM improving at time of discharge. # L5 BONE LESION In setting of history of prostate cancer. No signs concerning for cord compression. Recent MRI without central stenosis but did have concerning lesion. Bone scan ___ without evidence of osteoblastic lesions. # TYPE 2 NSTEMI Mild troponin elevation most likely from cardiac demand in setting of severe AS. CKMB normal. Pt continued on aspirin-dipyridamole ___ mg oral QD and atorvastatin 40 mg PO QPM CHRONIC ISSUES: =============== # DEMENTIA Pt continued on home galantamine 4 mg oral BID and memantine 5 mg PO/NG BID # METASTATIC PROSTATE CANCER Unclear exactly what prognosis is at this time. Bone scan without evidence of lesions. Will follow up as outpatient. # HYPOTHYROIDISM Continue Levothyroxine Sodium 88 mcg PO QD # DIABETES Continue Lantus 8U w/ breakfast (home 6U). Insulin sliding scale # GERD Continued home Omeprazole 20 mg PO DAILY # GLAUCOMA Continued home Brimonidine Tartrate 0.15% Ophth. 1 DROP BOTH EYES Q8H. Latanoprost 0.005% Ophth. Soln. 1 DROP BOTH EYES QHS # ANXIETY Continued Sertraline 25 mg PO QD. Alprazolam restarted on discharge. TRANSITIONAL ISSUES: ==================== Discharge weight: 60.7 kg Discharge Cr: 1.0 [ ] Recheck chem-10, weight, and volume status at follow up and titrate Lasix appropriately. Would aim for slightly wet given recent syncope with increased diuretic dose. [ ] Long-acting insulin was increased to 8 units with breakfast. [ ] Underwent expedited TAVR workup while in house. Will plan to return to hospital for TAVR procedure in the near future. [ ] Keep right arm elevated above heart-level until right arm swelling has resolevd #CODE STATUS: DNR/DNI (confirmed) #CONTACT: ___ (wife: ___ Medications on Admission: The Preadmission Medication list is accurate and complete. 1. Brimonidine Tartrate 0.15% Ophth. 1 DROP RIGHT EYE Q8H 2. ALPRAZolam 0.25 mg PO QHS:PRN anxiety 3. Memantine 5 mg PO BID 4. Atorvastatin 40 mg PO QPM 5. Levemir 6 Units Breakfast Insulin SC Sliding Scale using Novolog Insulin 6. Furosemide 80 mg PO BID 7. galantamine 4 mg oral BID 8. Omeprazole 20 mg PO DAILY 9. Levothyroxine Sodium 88 mcg PO DAILY 10. aspirin-dipyridamole ___ mg oral BID 11. oxyCODONE-acetaminophen ___ mg oral Q6H:PRN 12. mometasone 0.1 % topical ASDIR 13. Mupirocin Ointment 2% 1 Appl TP BID 14. Latanoprost 0.005% Ophth. Soln. 1 DROP BOTH EYES QHS 15. Sertraline 25 mg PO DAILY 16. Ferrous GLUCONATE 324 mg PO DAILY 17. Ramelteon 8 mg PO QHS:PRN insomnia Discharge Medications: 1. Furosemide 60 mg PO DAILY RX *furosemide 20 mg 3 tablet(s) by mouth daily Disp #*90 Tablet Refills:*0 2. Levemir 8 Units Breakfast Insulin SC Sliding Scale using HUM Insulin 3. ALPRAZolam 0.25 mg PO QHS:PRN anxiety 4. aspirin-dipyridamole ___ mg oral BID 5. Atorvastatin 40 mg PO QPM 6. Brimonidine Tartrate 0.15% Ophth. 1 DROP RIGHT EYE Q8H 7. Ferrous GLUCONATE 324 mg PO DAILY 8. galantamine 4 mg oral BID 9. Latanoprost 0.005% Ophth. Soln. 1 DROP BOTH EYES QHS 10. Levothyroxine Sodium 88 mcg PO DAILY 11. Memantine 5 mg PO BID 12. mometasone 0.1 % topical ASDIR 13. Mupirocin Ointment 2% 1 Appl TP BID 14. Omeprazole 20 mg PO DAILY 15. oxyCODONE-acetaminophen ___ mg oral Q6H:PRN severe pain 16. Ramelteon 8 mg PO QHS:PRN insomnia 17. Sertraline 25 mg PO DAILY 18.durable equipment Equipment: rolling walker Dx: Muscle weakness (generalized) M62.81 Px: good ___: 13 months Discharge Disposition: Home With Service Facility: ___ Discharge Diagnosis: PRIMARY DIAGNOSIS =========================== # SEVERE AORTIC STENOSIS SECONDARY DIAGNOSES =========================== # SYNCOPE # CHRONIC DIASTOLIC HEART FAILURE # RIGHT ARM HEMATOMA # L5 BONE LESION # TYPE 2 NSTEMI # DEMENTIA # METASTATIC PROSTATE CANCER # HYPOTHYROIDISM # DIABETES # GERD # GLAUCOMA # ANXIETY Discharge Condition: Mental Status: Confused - sometimes. Level of Consciousness: Alert and interactive. Activity Status: Ambulatory - requires assistance or aid (walker or cane). Discharge Instructions: Dear Mr. ___, It was a pleasure to be part of your care. You were admitted to the hospital because you fainted. This was most likely due to your aortic stenosis (the aortic valve in your heart is narrow and it is hard for blood to flow through). You started undergoing evaluation by the team that can replace your aortic valve. You got many studies completed that you need prior to this procedure. You also underwent a bone scan to look at the lesion in your spine, which based on the appearance does not look like metastatic prostate cancer. You will need to follow up in the heart valve clinic to schedule the appointment to have your valve replaced. This clinic will call you. Weight yourself daily. If you gain more than 3 lbs then call your cardiologists office. If you experience any dizziness, lightheadedness, unsteadiness then please seek medical care. We wish you the best, Your ___ Team Followup Instructions: ___
19710506-DS-12
19,710,506
28,489,223
DS
12
2123-07-28 00:00:00
2123-07-28 17:51:00
Name: ___ Unit No: ___ Admission Date: ___ Discharge Date: ___ Date of Birth: ___ Sex: M Service: MEDICINE Allergies: No Known Allergies / Adverse Drug Reactions Attending: ___. Chief Complaint: Syncope Major Surgical or Invasive Procedure: 24 hour Holter Monitor Echocardiogram Exercise Treadmill Test XR Lower Back/Sacrum History of Present Illness: ___ with recent TAVR on ___ admitted for further evaluation after a syncopal episode at home on ___. He had been seen the day prior ___ in the ___ by Dr. ___ with complaints of new onset shortness of breath, shuffling gait, and dizziness with standing. Of note, he reportedly had one low blood pressure at home about a week prior to that visit at 94/57. He also had some bradycardia down to the ___ and occasional ___ while in the hospital which had improved prior to discharge. During this cdac visit, he was hypertensive to 188/65 and 195/80. He was started on 5mg of Lisinopril daily and his Lasix dose was decreased from 60mg BID to 40mg BID. He was sent home with a holter monitor. On ___, he had a syncopal episode at home, witnessed by his wife, in which he sustained a fall. He was brought to ___ ___ where trauma imaging was negative, and ultimately was transferred here for further workup to determine the cause of syncope including EP eval. EKG showed Sinus bradycardia with ventricular ectopy. Past Medical History: Pertinent PMH: 1. Hyponatremia. 2. Diabetes. 3. History of TIA 4. Squamous cell carcinoma. 5. Dementia. 6. Glaucoma. 7. Hypogonadism. 8. Sciatica. 9. Carotid stenosis status post CEA. 10. Hyperlipidemia. 11. Severe aortic stenosis 12. Heart Failure with preserved EF Social History: ___ Family History: Mother ___ ___ ATHEROSCLEROTIC CARDIOVASCULAR DISEASE Father ___ ___ CANCER Brother ___ ___ DIABETES MELLITUS CHRONIC RENAL FAILURE Brother Unknown ___ HEART DISEASE CHRONIC RENAL FAILURE DIABETES TYPE II Physical Exam: Admission VITALS: ___ 1820 Temp: 98.0 PO BP: 181/77 L Sitting HR: 64 RR: 18 O2 sat: 97% O2 delivery: Ra GENERAL: Well-developed, well-nourished. NAD. Mood, affect appropriate. HEENT: PERRL, EOMI. Conjunctiva pink. NECK: Supple with JVP of 8 cm. CARDIAC: RRR, normal S1, S2. No murmurs/rubs/gallops. No thrills, lifts. LUNGS: Resp were unlabored, no accessory muscle use. No crackles, wheezes or rhonchi. ABDOMEN: Soft, NTND. EXTREMITIES: No c/c/e. SKIN: No stasis dermatitis,. PULSES: Distal pulses palpable and symmetric Discharge: VS: T 97.5 BP 165/66 HR 68 RR 18 SpO2 96%RA PE: Gen: Patient comfortably lying in bed in no acute distress. HEENT: Face symmetrical, trachea midline Neuro: A/Ox3. Speaking in complete, coherent sentences. No face, arm, or leg weakness. No tongue deviation. No sensory deficits. Pulm: Breathing unlabored. Breath sounds clear bilaterally. Cardiac: No JVD. No thrills or bruits heard on carotids bilaterally. S1, S2 RRR. I/VI systolic murmur heard best at base. Vasc: No edema noted in bilateral upper or lower extremities. No pigmentation changes noted in bilateral upper or lower extremities. Skin dry, warm. Bilateral radial pulses palpable 2+, ___ palpable 1+. Abd: Rounded, soft, non-tender. BS+ Pertinent Results: ===== LABS ===== CBC ___ 02:16PM BLOOD WBC-5.3 RBC-3.43* Hgb-10.9* Hct-33.3* MCV-97 MCH-31.8 MCHC-32.7 RDW-13.6 RDWSD-49.0* Plt ___ ___ 06:35AM BLOOD WBC-6.9 RBC-3.14* Hgb-10.0* Hct-30.2* MCV-96 MCH-31.8 MCHC-33.1 RDW-13.9 RDWSD-48.9* Plt ___ ___ 07:40AM BLOOD WBC-5.2 RBC-3.06* Hgb-9.4* Hct-29.7* MCV-97 MCH-30.7 MCHC-31.6* RDW-13.8 RDWSD-48.9* Plt ___ ___ 07:04AM BLOOD Hgb-9.4* Hct-28.5* Plt ___ CHEM ___ 02:16PM BLOOD UreaN-28* Creat-1.1 Na-137 K-4.7 Cl-96 HCO3-31 AnGap-10 ___ 06:35AM BLOOD Glucose-253* UreaN-29* Creat-1.1 Na-140 K-4.6 Cl-100 HCO3-27 AnGap-13 Calcium-9.4 Phos-3.5 Mg-2.2 ___ 07:40AM BLOOD Glucose-193* UreaN-29* Creat-1.0 Na-141 K-4.3 Cl-100 HCO3-30 AnGap-11 Mg-2.3 ___ 07:04AM BLOOD UreaN-27* Creat-0.9 Na-138 K-4.3 Cl-99 HCO3-28 AnGap-11 Mg-2.1 TROP ___ 06:35AM BLOOD cTropnT-0.02* ___ 01:30PM BLOOD cTropnT-0.04* ___ 07:40AM BLOOD cTropnT-0.03* BNP ___ 02:16PM BLOOD proBNP-699 ___ 06:35AM BLOOD proBNP-994* ========================= XR LUMBAR-SACRAL SPINE ========================= ___ FINDINGS: There is no spondylolisthesis. Patient is status post L4 laminectomy. Aside from moderate narrowing of the L5-S1 interspace, vertebral body heights and interspaces appear preserved in height. Moderate anterior osteophytes are present throughout the lumbar spine. Degenerative changes are suspected at L4-L5 and L5-S1 facet joints. There is no evidence of fracture, dislocation or lysis. Bones appear demineralized. Vascular calcification is moderate. Surgical clips project over the lower mid pelvis. There are also cholecystectomy clips in the right upper quadrant. IMPRESSION: Similar moderate degenerative changes of the lumbar spine. ========================= EXERCISE TREADMILL TEST ========================= ETT ___: IMPRESSION: Poor exercise tolerance. No anginal symptoms or pre-syncope with no ischemic ST segment changes. Resting systolic hypertension with flat blood pressure response to exercise. In the absence of beta blocker therapy, the heart rate response was blunted but did increase with exercise. No sustained tachy- or bradyarrhythmias. ==================== TRANSTHORACIC ECHO ==================== TTE ___: IMPRESSION: 1) No structural cardiac cause of syncope identified. 2) Normal left ventricular regional/global systolic function with grade I LV diastolic dysfunction (severe ___ in absence of significant mitral regurgitation and low e' velocities). 3) Well seated ___ 3 aortic valve TAVR with normal gradients and no regurgitation. ================ HOLTER RESULTS ================ ___: Sinus, rates 40-99, average HR 58. 17-beat run of atrial fibrillation, atrial bigeminy, frequent PACs, bradycardia to ___. Brief Hospital Course: ASSESSMENT AND PLAN: ___ with history of AS s/p TAVR ___, h/o TIA, diabetes, ___ transferred to ___ from ___ after syncopal episode at home ___. Negative trauma workup at ___. Referred here for cardiology admission with EP consult to evaluate cause of syncope. #Syncope: Holter, TTE and ETT results above. While his symptoms of unheralded syncope are suggestive of a bradyarrhythmic etiology, none was noticed on Holter worn during time of syncope. Additionally TTE does not demonstrate TAVR or structural HD etiologies for syncope. ETT consistent with failure of BP to rise, suggesting vasoplegia exacerbated by vasodilation from exercise. -No structural or EP intervention required at this time. -Continue telemetry -Continue to hold Lasix -Lisinopril to 2.5 mg nightly -Compression stockings #HTN: BPs labile with SBP ranging 130s-190s overnight. - Continue Lisinopril. #Aortic stenosis: s/p TAVR with 26 ___ valve done ___ - Continue ASA/Plavix - Hold Lasix for now #Back pain in setting of hitting chair during syncopal episode ___. Improved with scheduled Tylenol, not requiring prn oxycodone since yesterday morning. ___ cleared pt for home with services as long as pain is controlled. - Optimize pain management for better mobility. - Continue around the clock Tylenol ___ Q6hrs x 7 days and Oxycodone 5mg Q6hrs prn. - Encouraged ambulation today with nursing staff to ensure optimized pain control. #Constipation: Pt states he has not had BM in 3 days, and usually goes daily. He denies abdominal pain, cramping, bloating, urge to go. ___ be exacerbated by oxycodone and decreased ambulation. Abdomen soft, non-distended, BS+. - Senna daily, Miralax daily prn - Encouraged ambulation #HFpEF: Weight is up from admission weight, but fluid status down almost 1.5L, euvolemic on exam. - Hold Lasix as above and re-evaluate as outpatient - Daily weights, I/O #TIA: - Continue plavix and aspirin #DM: On insulin at home, ISS and Lantus 6units QHS - Continue home insulin regimen #Anxiety/Dementia: Well controlled patient exhibits no signs of either anxiety or dementia during his hospitalization - Continue home alprazolam and sertraline - Continue memantine and galantamine #Hyperlipidemia -continue atorvastatin -cardiac diet DISPO: Home ___ with ___ and ___ services. Discharge time: 35 min Medications on Admission: The Preadmission Medication list is accurate and complete. 1. Acetaminophen 650 mg PO Q6H:PRN Pain - Mild 2. ALPRAZolam 0.25 mg PO DAILY PRN anxiety 3. Atorvastatin 40 mg PO QPM 4. Brimonidine Tartrate 0.15% Ophth. 1 DROP RIGHT EYE BID 5. Ferrous Sulfate 325 mg PO DAILY 6. galantamine 4 mg oral BID 7. Latanoprost 0.005% Ophth. Soln. 1 DROP BOTH EYES QHS 8. Levothyroxine Sodium 88 mcg PO DAILY 9. Memantine 5 mg PO BID 10. Polyethylene Glycol 17 g PO DAILY:PRN Constipation - First Line 11. Sertraline 25 mg PO DAILY 12. Vitamin D 1000 UNIT PO DAILY 13. Clopidogrel 75 mg PO DAILY 14. Multivitamins 1 TAB PO DAILY 15. Aspirin 81 mg PO DAILY 16. Furosemide 40 mg PO BID 17. Lisinopril 5 mg PO DAILY 18. Levemir 6 Units Bedtime Insulin SC Sliding Scale using novolog Insulin 19. Pantoprazole 40 mg PO Q24H Discharge Medications: 1. OxyCODONE (Immediate Release) 5 mg PO Q6H:PRN pain Take only as needed for pain. 2. Senna 8.6 mg PO DAILY 3. Acetaminophen 650 mg PO Q6H 4. Levemir 6 Units Bedtime Insulin SC Sliding Scale using novolog Insulin 5. Lisinopril 2.5 mg PO QPM Take this medication at night 6. ALPRAZolam 0.25 mg PO DAILY PRN anxiety 7. Aspirin 81 mg PO DAILY 8. Atorvastatin 40 mg PO QPM 9. Brimonidine Tartrate 0.15% Ophth. 1 DROP RIGHT EYE BID 10. Clopidogrel 75 mg PO DAILY 11. Ferrous Sulfate 325 mg PO DAILY 12. galantamine 4 mg oral BID 13. Latanoprost 0.005% Ophth. Soln. 1 DROP BOTH EYES QHS 14. Levothyroxine Sodium 88 mcg PO DAILY 15. Memantine 5 mg PO BID 16. Multivitamins 1 TAB PO DAILY 17. Pantoprazole 40 mg PO Q24H 18. Polyethylene Glycol 17 g PO DAILY:PRN Constipation - First Line 19. Sertraline 25 mg PO DAILY 20. Vitamin D 1000 UNIT PO DAILY Discharge Disposition: Home With Service Facility: ___ Discharge Diagnosis: Syncope Aortic stenosis s/p TAVR ___ Chronic diastolic heart failure Discharge Condition: Mental Status: Clear and coherent. Level of Consciousness: Alert and interactive. Activity Status: Ambulatory - requires assistance or aid (walker or cane). VS: T 97.5 BP 165/66 HR 68 RR 18 SpO2 96%RA PE: Gen: Patient comfortably lying in bed in no acute distress. HEENT: Face symmetrical, trachea midline Neuro: A/Ox3. Speaking in complete, coherent sentences. No face, arm, or leg weakness. No tongue deviation. No sensory deficits. Pulm: Breathing unlabored. Breath sounds clear bilaterally. Cardiac: No JVD. No thrills or bruits heard on carotids bilaterally. S1, S2 RRR. I/VI systolic murmur heard best at base. Vasc: No edema noted in bilateral upper or lower extremities. No pigmentation changes noted in bilateral upper or lower extremities. Skin dry, warm. Bilateral radial pulses palpable 2+, ___ palpable 1+. Abd: Rounded, soft, non-tender. BS+ Discharge Instructions: You were admitted for further evaluation after your episode of passing out at home. You had a holter monitor, echocardiogram, and exercise stress test, which were reviewed by the doctors. You were also seen by the heart rhythm doctors (___). Your holter monitor did not show any slow rhythms or pauses that could explain you passing out. Your echocardiogram showed your valve is in a good place with no structural abnormalities that could explain you passing out. The exercise stress test showed that your blood pressure did not rise with exercise, which suggests that your vessels do not constrict with exertion but stay open. This is why your blood pressure did not rise appropriately, and may explain why you passed out at home. Because of this, we have made changes to your home medications. Please continue your home medications with the following changes: -Stop Lasix -Decrease Lisinopril to 2.5mg nightly. Take this medication at night, not in the morning. You had an X-Ray of your lower back, which did not show any fracture or dislocation. For your lower back pain, you may continue take Tylenol ___ every 6 hours. You were taking it scheduled while you were in the hospital, and your pain improved. If you need additional relief from pain, you may take oxycodone 5mg as needed twice a day. A written prescription has been given to you. You must get this filled at your pharmacy. Take Senna and Miralax daily to help with constipation. Please stop these medications once you have a bowel movement. You may also try drinking prune juice. Call your primary care doctor if you do not have a bowel movement by ___. Please weigh yourself every day in the morning after you go to the bathroom and before you get dressed. If your weight goes up by more than 3 lbs in 1 day or more than 5 lbs in 3 days, please call your heart doctor or your primary care doctor and alert them to this change. You are also being given a prescription for a rolling walker. Please use this when you walk, especially at night. You may take this prescription to your local medical supply store. A visiting nurse and physical therapist ___ start seeing you at home. They will call you to schedule a time to visit once you are discharged. If you have any urgent questions that are related to your hospitalization or are experiencing any symptoms that are concerning to you and you think you may need to return to the hospital, please call the ___ HeartLine at ___ to speak to a cardiologist or cardiac nurse practitioner. If you are followed at ___, please call ___ or your Doctor's office. It has been a pleasure to have participated in your care and we wish you the best with your health! Your ___ Cardiac Care Team Followup Instructions: ___
19710521-DS-29
19,710,521
26,463,510
DS
29
2193-02-01 00:00:00
2193-02-03 06:27:00
Name: ___ Unit No: ___ Admission Date: ___ Discharge Date: ___ Date of Birth: ___ Sex: F Service: MEDICINE Allergies: Bactrim Attending: ___ ___ Complaint: Hypoxia, cough Major Surgical or Invasive Procedure: none. History of Present Illness: ___ is a ___ yo female with a h/o COPD on ___, CHF, Afib on coumadin, CKD, a 40+ pack year history with a recent admission for LUL treated with levofloxacin p/w SOB, productive cough, and O2 sat of 87% at home (per ___ on 3L NC. Of note, admission on ___ for LUQ pneumonia/COPD exacerbation based on CXR and clinical picture, treated with levofloxacin and steroids. Patient just left rehab facility on ___, has been staying with daughter since. Daughter reports patient was delerious with sundowing during SNF stay, and noted slurring of speech and confusion since release from rehab. No facial droop. Patient has had cough, non-productive. Complains of generalized weakness/not feeling well since discharge. ___ noted that patient was hypoxic to 87% on home ___, and so patient was sent to hospital. Patient had previously been living by herself with periodic nurse visitation in the evenings. Prior to episode of pneumonia, patient had been feeling well, no weight loss or cough. In the ED, initial vital signs were T98 HR86 BP147/79 RR18 O2 96% 4L. At one point patient was febrile to 101 and tachypneic to 33. Patient was given tylenol, a dose of IV vanc and azythromycin and inhalers, and .5 L NS. She had a ___, CT Chest (PE protocol), CXR and ___ Dopplers. Review of Systems: (+) fever, chills, cough, shortness of breath, diarrhea (one episode yesterday), confusion (-) night sweats, headache, weight loss, vision changes, rhinorrhea, congestion, sore throat, sick contacts, chest pain, abdominal pain, nausea, vomiting, constipation, BRBPR, melena, hematochezia, dysuria, hematuria. Past Medical History: -Hypertension -Diastolic CHF (preserved EF of 60% in ___ -GERD -Osteoporosis -Depression -Atrial fibrillation on Coumadin -Sick sinus syndrome s/p PPM ___ EnRhythm dual-chamber placed in ___ -Coronary artery disease status post MI ___ -COPD on 3L home oxygen -Squamous cell carcinoma s/p MOHS surgery -Anemia -Chronic renal insufficiency (baseline sCr 1.8) Social History: ___ Family History: Notable for father who died age ___ from MI. Uncle with colon cancer at age ___. Physical Exam: ADMISSION EXAM: . T96.4 HR86 BP137/75 RR18 O2 97% 4L. General- Alert, oriented, no acute distress HEENT- Sclera anicteric, pupils fixed (cataract surgery ___, arcus senilus, with pigmentation on sclera, slightly dry mucous membranes, oropharynx clear Neck- supple, JVP not elevated, no LAD or enlarged thryoid Lungs- crackles in left upper lung field, dimminished sounds at bases CV- Regular rate and rhythm, normal S1/S2 Abdomen- soft, non-tender, non-distended, bowel sounds present, no rebound tenderness or guarding, no organomegaly GU- no foley Ext- warm, well perfused, 2+ pulses, no clubbing, cyanosis or edema Neuro- CNs2-12 intact, motor function grossly normal, AOx3, has some word finding difficulties, somewhat distractable, and occasionally confused as to recent events/history . DISCHARGE EXAM: . T97.3 HR85 BP156/64 RR20 O2 94% 4L following nebs General- Alert, not-oriented to time or place, oriented, no acute distress HEENT- Sclera anicteric, pupils fixed (cataract surgery ___, arcus senilus, with pigmentation on sclera, slightly dry mucous membranes, oropharynx clear Neck- supple, JVP not elevated, no LAD or enlarged thryoid Lungs- crackles in left upper lung field, dimminished sounds at bases, some wheeze in b/l upper fields CV- Regular rate and rhythm, normal S1/S2 Abdomen- soft, non-tender, non-distended, bowel sounds present, no rebound tenderness or guarding, no organomegaly GU- no foley Ext- warm, well perfused, 2+ pulses, no clubbing, cyanosis or edema Neuro- CNs2-12 intact, motor function grossly normal, AOx3, has some word finding difficulties, somewhat distractable, and occasionally confused as to recent events/history Pertinent Results: ADMISSION LABS: . ___ 03:34PM ___ PO2-30* PCO2-46* PH-7.39 TOTAL CO2-29 BASE XS-0 INTUBATED-NOT INTUBA ___ 03:34PM O2 SAT-48 ___ 02:50PM URINE COLOR-Yellow APPEAR-Clear SP ___ ___ 02:50PM URINE BLOOD-NEG NITRITE-NEG PROTEIN-NEG GLUCOSE-NEG KETONE-NEG BILIRUBIN-NEG UROBILNGN-NEG PH-7.5 LEUK-NEG ___ 01:38PM ___ COMMENTS-GREEN TOP ___ 01:38PM LACTATE-0.9 ___ 01:35PM GLUCOSE-78 UREA N-20 CREAT-1.0 SODIUM-141 POTASSIUM-4.3 CHLORIDE-107 TOTAL CO2-25 ANION GAP-13 ___ 01:35PM estGFR-Using this ___ 01:35PM WBC-4.4# RBC-3.95* HGB-11.2* HCT-35.0* MCV-88 MCH-28.2 MCHC-31.9 RDW-16.4* ___ 01:35PM NEUTS-75.1* LYMPHS-15.7* MONOS-6.8 EOS-2.0 BASOS-0.4 ___ 01:35PM PLT COUNT-243 ___ 01:35PM ___ PTT-40.9* ___ . ADMISSION IMAGING: . ___ CTA CHEST W&W/O C&RECON: 1. Left upper lobe mass-like consolidation (4.7 x 2.6 x 5.3 cm) with surrounding septal thickening and possible accompanying left hilar lymphadenopathy. Given recurrence or persistence since ___ despite treatment, the possibility of neoplasm should be considered. Consider pulmonary consultation to determine the role of bronchoscopy. 2. Right upper lobe peribronchovascular consolidative opacities could reflect a second site of infection with accompanying bibasilar pleural effusions. 3. Unchanged mid thoracic spine compression fractures. ___ BILAT LOWER EXT VEINS: No lower extremity DVT. ___ CHEST (PA & LAT): Left upper lobe consolidative opacities worsened from ___ suggesting recurrent or residual pneumonia; however given recurrence/persistence neoplasm must also be considered. See subsequent CT for further details. ___ CT HEAD W/O CONTRAST:No acute intracranial process. ___ ECG:Atrial fibrillation. Poor R wave progression. Consider prior anteroseptal myocardial infarction of indeterminate age. Non-specific inferior ST-T wave changes. Compared to the previous tracing of ___ ventricular premature beats are not seen on the current tracing. The findings are otherwise similar . DISCHARGE LABS: . ___ 08:00AM BLOOD WBC-4.2 RBC-3.72* Hgb-10.6* Hct-32.4* MCV-87 MCH-28.4 MCHC-32.6 RDW-16.3* Plt ___ ___ 01:35PM BLOOD Neuts-75.1* Lymphs-15.7* Monos-6.8 Eos-2.0 Baso-0.4 ___ 08:00AM BLOOD Plt ___ ___ 08:00AM BLOOD Glucose-81 UreaN-19 Creat-1.1 Na-143 K-4.2 Cl-107 HCO3-28 AnGap-12 ___ 08:00AM BLOOD Vanco-9.7* Brief Hospital Course: ___ is a ___ yo female with a h/o COPD on ___, CHF, Afib on coumadin, CKD, a 40+ pack year history with a recent admission for LUL treated with levofloxacin p/w SOB, productive cough, fever and hypoxia found here to have a persistent LUL consolidation on Chest CT. . ACUTE ISSUES: . # Sepsis/Pneumonia: Given IV vanc, cefepime and azithro in the ED. Febrile, tachypneic and hypoxic on admission, but improved with increase in NC 02, remained stable on the floor throughout stay. Chest CT showed persistent LUL consolidation, suspicious for underlying malignancy. A discussion was had with patient and daughter and decision was made to not further work up, but simply to treat possible HCAP. Given IV zosyn and vanc while inpatient, transitioned to PO linezolid on discharge (initially on linezolid/cefpodoxime, but geriatric fellow asked to stop cefpodoxime at discharge), will complete a 6 day course on ___. HOLD PATIENT'S MIRTAZAPINE WHILE ON LINEZOLID, out of concern for serotonin syndrome. . CHRONIC ISSUES: #COPD: Continued home inhalers, with additional duonebs prn # Paroxysmal atrial fibrillation: INR on admission 2.3. continue home coumadin (4mg daily), metoprolol tartrate and diltiazem. # CAD, HTN, Diastolic CHF: continue home diltiazem, metoprolol, pravastatin. Patient had been on lasix in past, held on last admission, continue to hold. #Anemia: seems to be a chronic issue, normocytic with wide RDW suggesting iron deficiency or anemia of chronic disease. #Diarrhea: per daughter, patient has always taken 3 immodium at bedtime to prevent fecal incontience, but she became constipated at ___ ans this was stopped. Will continue to hold, as it may be contributing to delerium. # GERD: patient continued omeprazole. # HLD: patient continued pravastatin. # Depression: patient continued home mirtazapine. # Osteoporosis: patient continued vitamin D and calcium. . FOLLOW UP: . Department: GERONTOLOGY When: ___ at 2:00 ___ With: ___ Building: ___ Campus: ___ Best Parking: ___ Medications on Admission: The Preadmission Medication list is accurate and complete. 1. Warfarin 4 mg PO DAILY16 2. Tiotropium Bromide 1 CAP IH DAILY 3. LOPERamide 2 mg PO QID:PRN diarrhea 4. Vitamin D 1000 UNIT PO DAILY 5. Diltiazem 90 mg PO BID 6. Lorazepam 0.5 mg PO HS 7. Metoprolol Tartrate 25 mg PO BID 8. Mirtazapine 22.5 mg PO HS 9. Pravastatin 20 mg PO DAILY 10. Fluticasone-Salmeterol Diskus (250/50) 1 INH IH BID Discharge Medications: 1. Diltiazem 90 mg PO BID 2. Fluticasone-Salmeterol Diskus (250/50) 1 INH IH BID 3. Metoprolol Tartrate 25 mg PO BID 4. Mirtazapine 22.5 mg PO HS 5. Pravastatin 20 mg PO DAILY 6. Tiotropium Bromide 1 CAP IH DAILY 7. Vitamin D 1000 UNIT PO DAILY 8. Warfarin 4 mg PO DAILY16 9. Linezolid ___ mg PO Q12H Duration: 6 Days Discharge Disposition: Extended Care Facility: ___ Discharge Diagnosis: # Primary: - Pneumonia # Secondary: -Hypertension -Atrial fibrillation on Coumadin -COPD on 3L home oxygen Discharge Condition: Activity Status: Ambulatory - requires assistance or aid (walker or cane). Mental Status: Confused - always (able to reorient patient, does occasionally become agitated at night). Level of Consciousness: Alert and interactive. Discharge Instructions: Dr ___, It was a pleasure to take care of you at ___ ___. You were admitted because you were having difficulty breathing and you were found to have pneumonia. We were concerned because chest imaging showed that there might also be a mass in your lung. We had a discussion with you and your daughter and decided not to pursue further work-up of the mass, but rather just to treat the pneumonia. We started you on IV antibiotics, but we are sending you home on oral medications. Your new medications are: - linezolid ___ twice daily for 6 day course (complete on: ___ WHILE ON THIS ANTIBIOTIC SHE SHOULD NOT TAKE HER MIRTAZAPINE. She can restart her mirtazapine once this antibiotic course is completed. You are being discharged to a rehab facility because we still feel that you need nursing care while you recover from your pneumonia. You should follow up with Dr ___ in Geriatrics on ___ at 2:00 ___. She will make sure you are getting better on the antibiotics. Weigh yourself every morning, call MD if weight goes up more than 3 lbs. Followup Instructions: ___
19710962-DS-21
19,710,962
29,109,522
DS
21
2145-12-24 00:00:00
2145-12-25 19:57:00
Name: ___ Unit No: ___ Admission Date: ___ Discharge Date: ___ Date of Birth: ___ Sex: F Service: MEDICINE Allergies: cephalexin / codeine / Penicillins / Sulfa (Sulfonamide Antibiotics) Attending: ___ Chief Complaint: Left periprosthetic hip fracture Major Surgical or Invasive Procedure: ORIF Left Hip (___) History of Present Illness: ___ female hx dementia, ___ resident, DNR/DNI/DNH, other comorbidities as outlined below presents with a left periprosthetic fracture s/p mechanical fall. Yesterday at an unknown time, the patient fell from standing in an unwitnessed fall. Per ___ records, +HS, -LOC, +instant hip pain. Transferred to ___, where NCCT head cspine were negative. XR of L hip demonstrated L periprosthetic hip fx, and transferred to ___ for orthopedics evaluation. On admission, patient was confused and cannot comment on physical symptoms. Past Medical History: DNR/DNI/___ dementia/___ resident HTN CHF (unknown if systolic or diastolic) CAD hearing loss COPD GERD Osteoarthritis Social History: ___ Family History: Non-contributory Physical Exam: ADMISSION PHYSICAL EXAM: ======================= Vitals: 97.7 72 129/53 21 100% 2L NC General: Well-appearing female in no acute distress. Left lower extremity: - Skin intact - LLE is shortened and externally rotated. Thigh is slightly swollen but soft. Otherwise, no deformity, edema, ecchymosis, erythema, induration - TTP L anterior inguinal crease. Otherwise Soft, non-tender thigh and leg - Full, painless ROM at hip, knee, and ankle - Fires ___ - SILT S/S/SP/DP/T distributions - 1+ ___ pulses, WWP DISHCHARE PHYSICAL EXAM: ======================= Vitals: Temp 97.9F BP 122/76 HR 98 RR 20 97% on 2L NC General: Elderly female in NAD. Appears younger than stated age. Confused, alert. HEENT: NC/AT. Sclera anicteric, MMM. Neck: supple Lungs: Normal respiratory effort. Faint crackles over bases. No wheezes or rhonchi. CV: Irregularly irregular rhythm, normal rate. Normal S1 and S2. No murmurs, rubs or gallops appreciated. Abdomen: soft, non-tender, non-distended, bowel sounds present, no guarding or masses appreciated. Ext: warm, well perfused, no ___ edema or erythema. Left hip with large incision with stables, healing well without surrounding erythema. Neuro: Alert, oriented to name. Unable to do other CN ___ inability to follow commands. 4+/5 strength in BUE. Moves all extremities. Skin: Warm, dry. No rashes. Pertinent Results: ADMISSION LABS: ============== ___ 05:35AM BLOOD WBC-11.6* RBC-3.20* Hgb-10.1* Hct-31.7* MCV-99* MCH-31.6 MCHC-31.9* RDW-12.9 RDWSD-46.8* Plt ___ ___ 05:35AM BLOOD Neuts-85.3* Lymphs-7.0* Monos-6.6 Eos-0.2* Baso-0.3 Im ___ AbsNeut-9.86* AbsLymp-0.81* AbsMono-0.76 AbsEos-0.02* AbsBaso-0.03 ___ 05:35AM BLOOD Glucose-148* UreaN-25* Creat-1.0 Na-138 K-5.2 Cl-100 HCO3-25 AnGap-13 ___ 09:50PM BLOOD Calcium-8.1* Phos-4.5 Mg-2.1 PERTINENT LABS/MICRO: ==================== ___ 05:43AM BLOOD WBC-5.3 RBC-2.16* Hgb-6.7* Hct-21.7* MCV-101* MCH-31.0 MCHC-30.9* RDW-13.2 RDWSD-48.3* Plt ___ ___ 05:06AM BLOOD CK-MB-2 cTropnT-0.12* ___ 12:21AM BLOOD CK-MB-2 cTropnT-0.12* ___ 06:40AM BLOOD proBNP-9294* ___ 06:40AM BLOOD TSH-1.3 ___ 12:27AM BLOOD Lactate-2.0 ___ Urine culture: ESCHERICHIA COLI | AMPICILLIN------------ =>32 R AMPICILLIN/SULBACTAM-- 8 S CEFAZOLIN------------- <=4 S CEFEPIME-------------- <=1 S CEFTAZIDIME----------- <=1 S CEFTRIAXONE----------- <=1 S CIPROFLOXACIN---------<=0.25 S GENTAMICIN------------ <=1 S MEROPENEM-------------<=0.25 S NITROFURANTOIN-------- <=16 S PIPERACILLIN/TAZO----- <=4 S TOBRAMYCIN------------ <=1 S TRIMETHOPRIM/SULFA---- <=1 S DISCHARGE LABS: ============== ___ 08:10AM BLOOD WBC-10.7* RBC-2.96* Hgb-9.0* Hct-29.9* MCV-101* MCH-30.4 MCHC-30.1* RDW-14.3 RDWSD-51.8* Plt ___ ___ 08:10AM BLOOD Glucose-96 UreaN-31* Creat-0.9 Na-142 K-4.6 Cl-100 HCO3-30 AnGap-12 ___ 08:10AM BLOOD Phos-3.1 Mg-2.1 PERTINENT IMAGING: ================ ___ Left Femur Xray: Mildly displaced periprosthetic fracture of the proximal left femur. No dislocation. ___ CXR: New near complete opacification of the right upper lobe may reflect the sequelae of an aspiration event or near complete upper lobe collapse secondary to mucous plugging. ___ CXR: Resolution of right upper lobe collapse which likely reflected sequela of mucous plugging. ___ CXR: Interstitial abnormality is stable. Cardiomediastinal silhouette is stable. There is atherosclerotic calcification involving the aorta. No pneumothorax is seen. There are small bilateral effusions. ___ TTE: The left atrial volume index is normal. The inferior vena cava diateter is normal. There is mild symmetric left ventricular hypertrophy with a normal cavity size. There is normal regional and global left ventricular systolic function. Quantitative biplane left ventricular ejection fraction is 68 %. Left ventricular cardiac index is normal (>2.5 L/min/m2). There is no resting left ventricular outflow tract gradient. No ventricular septal defect is seen. Tissue Doppler suggests an increased left ventricular filling pressure (PCWP greater than 18mmHg). Mildly dilated right ventricular cavity with normal free wall motion. The aortic sinus diameter is normal for gender with normal ascending aorta diameter for gender. The aortic arch diameter is normal. The aortic valve leaflets (3) are mildly thickened. There is no aortic valve stenosis. There is trace aortic regurgitation. The mitral valve leaflets are mildly thickened with no mitral valve prolapse. There is moderate mitral annular calcification. There is mild [1+] mitral regurgitation. Due to acoustic shadowing, the severity of mitral regurgitation could be UNDERestimated. The tricuspid valve leaflets appear structurally normal. There is mild [1+] tricuspid regurgitation. There is moderate pulmonary artery systolic hypertension. There is no pericardial effusion. IMPRESSION: Normal regional and lobal left ventricular function with mild symmetric LVH. Moderate pulmonary artery systolic hypertension. ___ DVT BLE Ultrasound: No evidence of deep venous thrombosis in the right or left lower extremity veins. Brief Hospital Course: Ms. ___ is a ___ female with a hx of dementia (___ resident, DNR/DNI/DNH), HFpEF, CAD, COPD with reportedly no baseline oxygen requirement, GERD, and OA who presented following a mechanical fall and subsequently underwent operative repair (___). Her post operative course was complicated by acute desaturation, followed by acute hypoxic respiratory failure and afib with RVR. She was treated with diuresis and increasing doses of metoprolol with improvement in symptoms. #S/p fall #ORIF The patient presented following an unwitnessed fall while at ___ resulting in left periprosthetic hip fracture. Etiology of the fall was unclear though felt likely mechanical. She was initially admitted to the orthopedic surgery service and underwent ORIF on ___ without issues. Her wound was healing well and her pain was well controlled with acetaminophen and low dose oxycodone as needed. She worked with physical therapy and occupational therapy. She should continue acetaminophen for pain, enoxaparin for 4 weeks (end date ___, and regular physical therapy as tolerated. #Acute hypoxic respiratory failure She was noted to be desatting during surgery and in the PACU. CXR consistent with mucus plug, which resolved. She then developed a new persistent O2 requirement several days following the surgery. CXR showed mild pulmonary edema and BNP was elevated, concerning for a heart failure exacerbation. DVT ultrasound was negative and CTA was not pursed given GOC, family interest in avoiding procedures/anticoagulation. She was diuresed with IV Lasix with improvement in her oxygenation. Additionally, she as given duonebs for any component of underlying COPD. She should continue home O2 with goal of weaning as tolerated. Goal O2 sat >90%. #Afib w/ RVR Developed atrial fibrillation with RVR early on ___, which was reportedly a new diagnosis for the patient. Etiology remained unknown though she has many risk factors, including recent surgery, HFpEF, anemia, and COPD. There was also consideration of cardiac ischemia vs infection vs PE. TSH was normal. She had several episodes of RVR with rates to the 130-150s, treated with IV metoprolol and increasing doses of po metoprolol. Additionally, she remained on enoxaparin for anticoagulation given her recent fracture. Further systemic anticoagulation was held given GOC, frailty/age, and concern for falls despite a CHADSVASC of 6. Her heart rate stabilized and she was discharged on metoprolol 37.5 mg QID. #___ Carried a diagnosis of CHF without known EF. TTE done on ___ in the setting of atrial fibrillation. There was concern for heart failure exacerbation given new hypoxia, mild pulmonary edema on CXR, and elevated BNP to 10,000. She was given IV Lasix with good response and then transitioned to torsemide 40 mg daily. She will need slight further diuresis over the next few days. #S/p STEMI Following an episode of afib w/ RVR, an EKG showed ST elevations in V2 with borderline elevation in V1-V3. Troponin peaked at 0.12 and there was difficulty assessing symptoms. Cardiology was consulted, felt to be type II. Recommended medical management. She was continued on aspirin and metoprolol was uptitrated. Atorvastatin was not felt to be within her GOC given age and other comorbidities. #Asymptomatic bacteruria UA on admission showed inflammation and culture growing E.coli. Unable to assess symptoms given the patient's baseline mental status. Given lack of symptoms, fever, HD instable, and lack of progression without antibiotics, it was felt that urine was more likely due to asymptomatic bacteruria. #Normocytic anemia #Acute blood loss anemia Hgb 10 on admission, down to 6.7 after surgery following acute blood loss. She received 2u pRBC with appropriate response and blood counts remains stable thereafter. #Urinary retention She developed urinary retention during this hospitalization. She had no history of urinary retention at home and the trigger was felt to be recent surgery. The issue later resolved. #GOC The patient's daughter and healthcare proxy, ___, described several times that the goal was to return the patient to the nursing home with minimal interventions. This shaped several decisions as described above. We discussed the possibility of keeping the patient here for ongoing rate control and diuresis. She wished for the patient to go home, which was felt to be reasonable given her stable clinical condition and overall goals of care. TRANSITIONAL ISSUES: ==================== [ ] Needs follow up with her primary care physician ___ ___ days and orthopedic surgery on ___ [ ] Monitor blood pressure and heart rate, titrate metoprolol as necessary (Goal SBP 100-110s, HR <100) [ ] Discharged on torsemide 40 mg daily. Monitor weight and breathing, titrate dose as necessary. [ ] Repeat BMP/CBC in 1 week to evaluate electrolytes, Cr, and Hgb [ ] Discharged on supplemental oxygen, wean as able. Goal O2>90-92% [ ] Anticoagulation held for atrial fibrillation given GOC. Will remain on Enoxaparin for fracture until ___ [ ] Urine culture with E.coli, felt to be asymptomatic bacteruria. Follow up as outpatient to monitor for symptoms, consider repeat UA if concerned for true infection # Emergency contact: ___ (___) # Code: DNR/DNI/DNH Medications on Admission: The Preadmission Medication list is accurate and complete. 1. Acetaminophen 1000 mg PO Q8H:PRN Pain - Mild 2. Furosemide 40 mg PO DAILY 3. Aspirin 81 mg PO DAILY 4. Ranitidine 150 mg PO DAILY 5. Cyanocobalamin 500 mcg PO DAILY 6. Atenolol 50 mg PO DAILY 7. LOPERamide 4 mg PO QID:PRN diarrhea 8. Nitroglycerin SL 0.4 mg SL Q5MIN:PRN chest pain 9. Albuterol Inhaler 2 PUFF IH Q6H:PRN SOB/wheezing 10. Milk of Magnesia 30 mL PO Q4H:PRN Constipation - First Line Discharge Medications: 1. Enoxaparin Sodium 30 mg SC Q24H 2. Metoprolol Tartrate 37.5 mg PO Q6H 3. Torsemide 40 mg PO DAILY 4. Vitamin D 800 UNIT PO DAILY 5. Acetaminophen 1000 mg PO Q8H:PRN Pain - Mild 6. Albuterol Inhaler 2 PUFF IH Q6H:PRN SOB/wheezing 7. Aspirin 81 mg PO DAILY 8. Cyanocobalamin 500 mcg PO DAILY 9. LOPERamide 4 mg PO QID:PRN diarrhea 10. Milk of Magnesia 30 mL PO Q4H:PRN Constipation - First Line 11. Nitroglycerin SL 0.4 mg SL Q5MIN:PRN chest pain 12. Ranitidine 150 mg PO DAILY Discharge Disposition: Extended Care Facility: ___ ___ Diagnosis: #Primary: Fall Left periprosthetic hip fracture #Secondary: Atrial fibrillation with rapid ventricular rate Heart failure with preserved ejection fraction Acute hypoxic respiratory failure STEMI Asymptomatic bacteruria Urinary retention Normocytic anemia Discharge Condition: Mental Status: Confused - always. Level of Consciousness: Alert and interactive. Activity Status: Out of Bed with assistance to chair or wheelchair. Discharge Instructions: Dear Ms. ___, It was a pleasure caring for you at ___ ___! Why you were admitted to the hospital: - You had a fall and fractured the large bone in your leg What happened while you were here: - You had surgery to correct the fracture - Following surgery, you had issues with oxygen levels requiring supplemental oxygen and fluid removal - You had an irregular heart rhythm called atrial fibrillation, which was slowed down with medications What you should do once you return home: - Continue taking your medications as prescribed - Follow up at the appointments outlined below. You should see your primary care provider ___ ___ days and follow up in the orthopedic surgery clinic on ___ at 2pm INSTRUCTIONS AFTER ORTHOPAEDIC SURGERY: - You were in the hospital for orthopedic surgery. It is normal to feel tired or "washed out" after surgery, and this feeling should improve over the first few days to week. - Resume your regular activities as tolerated, but please follow your weight bearing precautions strictly at all times. ACTIVITY AND WEIGHT BEARING: - Touchdown weight bearing in left lower extremity ANTICOAGULATION: - Please take lovenox 30 mg daily for 4 weeks WOUND CARE: - You may shower. No baths or swimming for at least 4 weeks. - Any stitches or staples that need to be removed will be taken out at your 2-week follow up appointment. - Incision may be left open to air unless actively draining. If draining, you may apply a gauze dressing secured with paper tape. - Splint must be left on until follow up appointment unless otherwise instructed. - Do NOT get splint wet. DANGER SIGNS: Please call your PCP or surgeon's office and/or return to the emergency department if you experience any of the following: - Increasing pain that is not controlled with pain medications - Increasing redness, swelling, drainage, or other concerning changes in your incision - Persistent or increasing numbness, tingling, or loss of sensation - Fever > 101.4 - Shaking chills - Chest pain - Shortness of breath - Nausea or vomiting with an inability to keep food, liquid, medications down - Any other medical concerns Followup Instructions: ___
19711017-DS-4
19,711,017
29,307,519
DS
4
2149-09-05 00:00:00
2149-09-09 20:19:00
Name: ___ Unit No: ___ Admission Date: ___ Discharge Date: ___ Date of Birth: ___ Sex: F Service: MEDICINE Allergies: latex gloves Attending: ___. Chief Complaint: Bilateral Lower extremity edema Major Surgical or Invasive Procedure: None History of Present Illness: ___ year-old woman with PMH dementia (lives at ___ in her assisted living apartment), anxiety, hypertension, Diabetes Mellitus, CKD presenting with subacute lower extremity edema and worsening dyspnea. Patient was referred to ED for increasing bilateral lower extremity edema and SOB from an assisted living memory unit. Of note referral to ED comments that she has anxiety, can be emotionally labile and is usually redirectable. She had some increasing erythema over RLE for which she was treated with a course of Keflex on ___ (end date unknown). Due to worsening ___ edema she was started on lasix 20 mg PO on ___ (per outpatient notes). ACE wraps and elevation were also advised for component of chronic venous stasis, patient describes history of itchy, dry skin and has been itching her legs often. Pt denies f/c, headache, changes in vision, chest pain, abd pain, n/v/d, urinary symptoms (although does report increasing urination since starting lasix). She has no known history of arrhythmia, no history of ischemic heart disease, no history of PE/clots. She has no recent TTEs (most recent Echo ___: LVEF >55%). In the ED, initial VS were: T: 96.9 HR: 73 BP: 161/71 RR: 16 SO2: 96% RA Exam notable for: No acute distress, no murmurs rubs gallops or audible s3 noted; mild crackles to the bases bilaterally, 2+ pitting edema to the knees bilaterally with well demarcated erythema extending from the ankles to the knee ECG: rate 74 irregular rhythm, like sinus with premature beats, stable q waves in anterior leads, no acute ischemic changes. normal axis Labs showed: trop 0.05, bnp 2869, Cr 1.7. Imaging showed: CXR: Mild cardiomegaly with mild interstitial pulmonary edema and small bilateral pleural effusions. Mild bibasilar atelectasis. Past Medical History: Diabetes Mellitus Type 2 Hypertension Dementia anxiety chronic fatigue depression situational eczema edema hernia, unilateral inguinal w/ ___ hyperparathyroidism hypokalemia insomnia polyarthralgia thyromegaly urinary incontinence vitamin d deficiency h/o breast cancer Social History: ___ Family History: Non-contibutory Physical Exam: Admission Physical Examination ============================== VS: ___ 0011 Temp: 97.7 BP: 146/72 L Lying HR: 80 RR: 18 O2 sat: 95% O2 delivery: RA GENERAL: NAD HEENT: AT/NC, anicteric sclera, MMM, JVP to mandible +hepatojuglar reflux NECK: supple, no LAD CV: irregular, S1/S2 +s3, no murmurs, gallops, or rubs PULM: CTAB, bilateral lower lobe rales, no wheezes nor rhonchi, breathing comfortably without use of accessory muscles GI: abdomen soft, nondistended, nontender in all quadrants, no rebound/guarding, no hepatosplenomegaly EXTREMITIES: erythema bilateral lower extremities, 2+ edema to kneesm no cyanosis, clubbing PULSES: 2+ radial pulses bilaterally NEURO: Alert, oriented to self, moving all 4 extremities with purpose, face symmetric DERM: warm and well perfused, no excoriations or lesions, no rashes Discharge Physical Examination ============================== VS: ___ 1122 Temp: 97.3 PO BP: 146/77 HR: 58 RR: 16 O2 sat: 96% O2 delivery: Ra GENERAL: Elderly woman, appears anxious and startled when woken CV: Regular rate, irregular rhythm, normal s1/s2, no MRG RESP: CTAB, no wheezes/crackles/rhonchi. No accessory muscle usage. ABD: Bowel sounds normoactive, soft and NTND, no HSM. Ext: Erythema to 2 inches below the knees bilaterally, blanching. Trace pitting edema to the knee bilaterally. SKIN: No rashes/lesions. No jaundice. Warm. Dry, flaky skin on shins bilaterally. Pertinent Results: ADMISSION LABS ============== ___ 05:15PM WBC-6.9 RBC-3.43* HGB-11.2 HCT-34.2 MCV-100* MCH-32.7* MCHC-32.7 RDW-14.0 RDWSD-51.1* ___ 05:15PM NEUTS-64.7 LYMPHS-13.3* MONOS-13.7* EOS-7.2* BASOS-0.4 IM ___ AbsNeut-4.47 AbsLymp-0.92* AbsMono-0.95* AbsEos-0.50 AbsBaso-0.03 ___ 05:15PM PLT COUNT-216 ___ 05:15PM GLUCOSE-135* UREA N-53* CREAT-1.6* SODIUM-139 POTASSIUM-4.6 CHLORIDE-101 TOTAL CO2-25 ANION GAP-13 ___ 05:15PM CALCIUM-8.7 PHOSPHATE-5.0* MAGNESIUM-2.3 ___ 05:15PM CK-MB-5 cTropnT-0.05* proBNP-2869* ___ 07:50PM URINE BLOOD-NEG NITRITE-NEG PROTEIN-100* GLUCOSE-NEG KETONE-NEG BILIRUBIN-NEG UROBILNGN-NEG PH-6.5 LEUK-NEG DISCHARGE LABS ============== ___ 05:50AM BLOOD WBC-8.9 RBC-3.39* Hgb-10.9* Hct-33.2* MCV-98 MCH-32.2* MCHC-32.8 RDW-13.4 RDWSD-47.8* Plt ___ ___ 05:50AM BLOOD ___ PTT-29.2 ___ ___ 05:50AM BLOOD Glucose-119* UreaN-63* Creat-1.8* Na-143 K-4.9 Cl-102 HCO3-26 AnGap-15 ___ 05:50AM BLOOD Calcium-8.7 Phos-4.1 Mg-2.3 IMAGING: ======= Chest X ray (___) Final Report EXAMINATION: CHEST (PA AND LAT) INDICATION: History: ___ without formal diagnosis of heart failure presenting with exertional dyspnea and lower extremity edema.// Evaluate for pulmonary vascular congestion, pulmonary edema, cardiomegaly. TECHNIQUE: Chest PA and lateral COMPARISON: Chest radiograph ___ FINDINGS: Heart size is mildly enlarged, increased from the prior exam. Mild central mediastinal venous distension is noted with mild interstitial pulmonary edema. Mediastinal and hilar contours are otherwise similar. There are small bilateral pleural effusions. Patchy atelectasis is noted in the lung bases. No pneumothorax. No acute osseous abnormality. 2 clips are seen within the anterior left chest wall. IMPRESSION: Mild cardiomegaly with mild interstitial pulmonary edema and small bilateral pleural effusions. Mild bibasilar atelectasis. Echocardiogram (___) ======================== IMPRESSION: Mild symmetric left ventricular hypertrophy with normal cavity size, and regional/ global systolic function. Mild mitral regur gitation. Mild tricuspid regur gitation. Mild pulmonary artery systolic hypertension. Bilateral pleural ef fusions. Compared with the prior TTE ___, the findings are similar. Brief Hospital Course: ___ yo F PMHx dementia, anxiety, hypertension, DM2, and CKD presenting with worsening bilateral lower extremity edema and dyspnea, which resolved with IV furosemide. Subsequently developed atrial tachycardia which improved with metoprolol. Transitioned to PO diuretics and was stable for discharge to rehab. ACTIVE ISSUES: =============== #Acute on Chronic Heart Failure with Preserved Ejection Fraction: -The patient was sent from the ___ after it was noted that she had increased bilateral lower extremity swelling, shortness of breath, and increased weakness. She was recently started on furosemide 20 mg PO daily by her PCP, however her edema continued to worsen. On admission, we began IV Lasix, and transitioned to PO when euvolemic. On ___ we performed an echocardiogram which showed left ventricular hypertrophy. This was unchanged from the TTE performed in ___. Her creatinine then stabilized at 1.8 on day of discharge and discharge weight was 139 lbs. She was discharged on Lasix 20mg PO daily. #Atrial tachycardia –The patient triggered on ___ for supraventricular tachycardia. Patient was asymptomatic with rates in the 150s-170s. She did not have any subjective dyspnea or associated chest pain. She was hemodynamically stable. Lopressor 5 mg IV was pushed, which normalized her heart rate. Cardiology confirmed this as atrial tachycardia, and there was no indication for anticoagulation. We then began the patient on metoprolol tartrate, and eventually consolidated to metoprolol succinate. #Acute on Chronic kidney disease –The last known baseline of this patient's creatinine was 1.3 in ___. The patient had a mild ___ during her stay, likely from cardiorenal syndrome. Her Cr improved with diuresis and at discharge, was 1.8. CHRONIC ISSUES: =============== #Dementia –Per ___, the patient is prone to labile moods but is easily redirectable. During this hospitalization, we continued her home memantine and donepezil, and also continued her risperidone 0.5 mg p.o. nightly and 0.25 mg p.o. twice daily as needed for severe agitation. #Depression –In the setting of chronic kidney disease with an acutely elevated creatinine, we decreased the patient's venlafaxine dose to 75 mg p.o. nightly. #Diabetes mellitus –We discontinued the patient's glyburide while in the hospital, given the risk of hypoglycemia with this medication. We checked the patient's sugars qACHS and found that she was relatively normoglycemic in the mornings, but hyperglycemic in the 240s at night. We did not supply her with any exogenous insulin. We would suggest that she be transitioned to glimepiride or linagliptin as an outpatient. We held her glyburide at discharge. TRANSITIONAL ISSUES =================== [ ]Recheck chem10 in one week. Discharge Cr 1.8 [ ]Discharge weight is 139 lbs. Continue daily weights [ ]Continued home Lasix 20mg PO daily. Consider titrating dose as Qdaily or QOD depending weights and volume exam [ ]Due to mild ___ and hypotension, held lisinopril. Please consider restarting as outpatient as appropriate [ ]Metoprolol Succinate may need to be titrated up if she becomes symptomatic [ ]Held glyburide as she was normoglycemic off of it. Consider transitioning to glimepiride or linagliptin as an outpatient [ ]Patient was constipated during her stay. Please consider uptitrating bowel regimen as indicated [ ]FYI: patient has LVH and mild pulmonary artery systolic hypertension on TTE. continue to monitor [ ]Continue nutritional supplements with ensure enlive and magic cups [ ]Consider glimepiride or linagliptin instead of glyburide Medications on Admission: The Preadmission Medication list is accurate and complete. 1. Risamine (menthol-zinc oxide) 0.44-20.6 % topical DAILY:PRN 2. Sarna Lotion 1 Appl TP DAILY:PRN rash 3. Ascorbic Acid ___ mg PO DAILY 4. Calcitriol 0.25 mcg PO DAILY 5. Cyanocobalamin 100 mcg PO DAILY 6. Donepezil 10 mg PO QHS 7. Furosemide 20 mg PO DAILY 8. gelatin 600 mg oral DAILY 9. GlyBURIDE 2.5 mg PO DAILY 10. Lisinopril 2.5 mg PO DAILY 11. Memantine 10 mg PO DAILY 12. Multivitamins 1 TAB PO DAILY 13. Venlafaxine 112.5 mg PO DAILY 14. RisperiDONE 0.5 mg PO QHS 15. RisperiDONE 0.25 mg PO BID:PRN severe agitation Discharge Medications: 1. Metoprolol Succinate XL 50 mg PO DAILY 2. Miconazole Nitrate Vag Cream 2% 1 Appl VG QHS Duration: 7 Days Continue through ___. Polyethylene Glycol 17 g PO DAILY 4. Senna 8.6 mg PO BID 5. RisperiDONE 0.25 mg PO BID:PRN severe agitation 6. Venlafaxine XR 75 mg PO DAILY 7. Ascorbic Acid ___ mg PO DAILY 8. Calcitriol 0.25 mcg PO DAILY 9. Cyanocobalamin 100 mcg PO DAILY 10. Donepezil 10 mg PO QHS 11. Furosemide 20 mg PO DAILY 12. gelatin 600 mg oral DAILY 13. Memantine 10 mg PO DAILY 14. Multivitamins 1 TAB PO DAILY 15. Risamine (menthol-zinc oxide) 0.44-20.6 % topical DAILY:PRN 16. RisperiDONE 0.5 mg PO QHS 17. RisperiDONE 0.25 mg PO BID:PRN severe agitation 18. Sarna Lotion 1 Appl TP DAILY:PRN rash 19. HELD- Lisinopril 2.5 mg PO DAILY This medication was held. Do not restart Lisinopril until you see your PCP ___: Extended Care Facility: ___ Discharge Diagnosis: Primary Diagnosis ================= 1. Acute on Chronic Heart Failure with Preserved Ejection Fraction 2. Atrial Tachycardia Secondary Diagnosis =================== 1. Acute Kidney Injury on Chronic Kidney Disease 2. Candidal Vaginitis 3. Diabetes Mellitus 4. Depression 5. Dementia Discharge Condition: Mental Status: Clear and coherent. Level of Consciousness: Alert and interactive. Activity Status: Ambulatory - requires assistance or aid (walker or cane). Discharge Instructions: Dear ___, ___ was a pleasure caring for you at ___ ___! WHY WERE YOU ADMITTED? -You were admitted to the hospital because your legs were getting swollen, you were having trouble breathing, and you were feeling weaker than normal. WHAT HAPPENED IN THE HOSPITAL? -This was felt to be due to a condition called heart failure, where your heart does not pump hard enough and fluid backs up into your lungs. -You were given a diuretic medication through the IV to help get the fluid out. You improved considerably and were ready to leave the hospital. -You developed a really fast heart rate so we gave you medications to slow it down (metoprolol) -We did an ultrasound of your heart which was normal WHAT SHOULD YOU DO AT HOME? -Please take all of your medications as prescribed, especially your furosemide and metoprolol -Please follow up with your primary care provider ___ 1 week after discharge from rehab -Continue walking several times a day - Your weight at discharge is 139 lbs. Please weigh yourself today at home and use this as your new baseline - Please weigh yourself every day in the morning. Call your doctor if your weight goes up by more than 3 lbs. - Seek medical attention if you have new or concerning symptoms or you develop swelling in your legs, abdominal distention, or shortness of breath at night. Thank you for allowing us be involved in your care, we wish you all the best! Your ___ Team Followup Instructions: ___
19711333-DS-17
19,711,333
27,784,816
DS
17
2186-07-13 00:00:00
2186-07-13 13:01:00
Name: ___ Unit No: ___ Admission Date: ___ Discharge Date: ___ Date of Birth: ___ Sex: M Service: MEDICINE Allergies: No Known Allergies / Adverse Drug Reactions Attending: ___. Chief Complaint: fall Major Surgical or Invasive Procedure: ERCP ___ History of Present Illness: Patient is a ___ with history of dementia, NPH s/p shunt, and prostate cancer transferred for outside hospital with concern for bile duct obstruction. History is limited due to patient's dementia and inability to get in touch with family members. Per ___ report and chart review, patient presented to ___ yesterday after slipping and falling at home. There, work-up was negative including head CT, CXR, labs. However he was found to have direct bilirubinemia and transaminitis (Tbili 5 Dbili 3.3 Indirect 1.7, AST 122 ALT 142 ALP 277)) Normal WBC. He denies any sxs including abdominal pain, though interview limited by dementia. Patient denies changes in bowel habits, nausea, vomiting. He was transferred for consideration for ERCP In the ___ ___, initial VS were: 98.4 51 136/58 16 94% RA ___ physical exam was recorded as: Icteric sclerae Abd: soft, NDNT, no rebound or guarding ___ labs were notable for: Cr 1.3, BUN 22 AST 108, ALT 124, ALK phos 281, Tbili 3.8, Dbili 2.5, Alb 3.2 Hb 12.8 WBC 7.8 INR 1.2 Lactate 1.2 CT abd showed: Small left pleural effusion bronchial thickening and atelectasis in the posterior lung bases, mild intrahepatic biliary ductal dilation normal caliber CBD. No definite pancreatic mass identified. Given reported painless jaundice, and mild intrahepatic biliary ductal dilation, consider MRCP to further assess. VP shunt tubing terminates in the right lateral mid abdomen. Urinary bladder is decompressed around a Foley catheter though the wall appears thickened, correlate for cystitis. Patient was given NS Transfer VS were: HR 49 BP 126/81 sats 96% REVIEW OF SYSTEMS: A ten point ROS was conducted and was negative except as above in the HPI. Past Medical History: Dementia NPH s/p shunt Prostate cancer Social History: ___ Family History: Unable to obtain Physical Exam: Admission exam: Gen: NAD, A&Ox0, slow to respond to questions, lying in bed Eyes: EOMI, sclerae icteric ENT: MMM, OP clear Cardiovasc: RRR, no MRG, full pulses, no edema Resp: normal effort, no accessory muscle use, lungs CTA ___. GI: soft, NT, ND, BS+ MSK: No significant kyphosis. No palpable synovitis. Skin: No visible rash. No jaundice. Neuro: AAOx0. No facial droop. GU: Foley catheter in place draining clear urine Discharge exam: VS: Reviewed. AF. HRs mostly ___ on tele GEN: lying in bed, just waking up, no distress HEENT/Neck: PER, MMMs, OP clear HEART: bradycardia, regular LUNGS: poor effort on exam. mild lower L side crackles, improved with cough ABD: soft NT/ND +BS no rebound or guarding EXT: warm well perfused, no pitting edema, distal pulses intact NEURO: not oriented to location or year although able to pick year from multiple choice; mostly responds to questions/commands appropriately; speech somewhat slowed; ___ forwards ok but not backwards; strength symmetric in UEs and LEs, tongue midline, trace L nasolabial flattening but smile symmetric Psych: pleasant affect Pertinent Results: ============================================ Pertinent data from admission: ALT gradually from 124 -> 48 AST gradually from 108 -> 32 Alk Phos gradually from 296 ->196 Tbili gradually from 3.8 -> 1.9 K mildly low, 3.2 day of discharge Mild anemia, HGB 11.8 day of discharge TSH 2.6 CT A/P: 1. Intrahepatic biliary ductal dilation, mild, mild prominence of the pancreatic duct without definite signs of pancreatic head lesion. Given history of painless jaundice, MRCP is advised to exclude underlying lesion. Small hypodensity in the midbody pancreas can also be further assessed at the time of MRCP. 2. Tiny pleural effusions at the lung bases with bronchial wall thickening likely the sequelae of chronic aspiration. Emphysema noted. 3. Thickening of the urinary bladder, correlate for infection. ERCP ___ Impression: •Limited exam of the esophagus was normal •Limited exam of the stomach was normal •Limited exam of the duodenum was normal •The scout film was normal. •The major papilla was slightly prominent and appeared stenosed. •The overlying mucosa however, was normal. •The CBD was successfully cannulated with the CleverCut 3V sphincterotome preloaded with a 0.025in guidewire. •The guidewire was advanced into the intrahepatic biliary tree. •Contrast injection revealed severely dilated CBD to approximately 12mm in diameter to the level of the ampullay with a possible area of narrowing at the level of the ampulla. •The intrahepatic biliary tree appeared normal. No filling defects were noted. •A sphincterotomy was successfully performed at the 12 o'clock position. No post sphicnterotomy bleeding was noted. •A polypoid, soft tissue-like mass was noted to be protuding at the sphincterotomy site. •Brushings and cold forceps biopsies were successfully obtained at the major papilla. •A ___ x 6 cm ___ plastic stent was successfully placed across the ampulla. •There was excellent drainage of bile and contrast at the end of the procedure. •The PD was not injected or cannulated. Recommendations: •Return to ward for on going care. •NPO overnight with aggressive IV hydration with LR at 200 cc/hr •If no abdominal pain in the morning, advance diet to clear liquids and then advance as tolerated •No aspirin, Plavix, NSAIDS, Coumadin for 5 days. •Continue with antibiotics - Ciprofloxacin 500mg BID x 5 days. •Repeat ERCP in ___ weeks for stent pull and re-evaluation. •Follow up with cytology reports. Please call Dr. ___ ___ ___ in 7 days for the pathology results •Follow for response and complications. If any abdominal pain, fever, jaundice, gastrointestinal bleeding please call Advanced Endoscopy Fellow on call ___ Headt CT ___. Findings could suggest hydrocephalus. Prior imaging for comparison would be helpful. 2. Right posterior approach ventriculoperitoneal shunt terminates in the occipital horn of the right lateral ventricle. 3. No intracranial hemorrhage or large vascular territory infarct. ============================================ Brief Hospital Course: A/P: Patient is a ___ with history of dementia, NPH s/p shunt, and prostate cancer transferred for outside hospital with concern for bile duct obstruction. ERCP with sphincterotomy performed ___, found to have ampullary mass. Stent placed and pathology pending. #Biliary obstruction likely due to ampullary mass: Painless jaundice incidentally found on eval for mechanical fall at OSH. Patient was asymptomatic. LFTs were trending down prior to ERCP with stent placement and continued to trend down afterward as well. Will need to call for pathology results and follow-up for repeat ERCP in ___ weeks for stent pull. ERCP team contact info below. #Metabolic encephalopathy #NPH with VP shunt #Dementia Patient had agitated delirium early during hospitalization which improved. However he remained disoriented beyond his baseline throughout the hospitalization. No new focal neurologic findings. CT head was obtained on ___ due to his persistent encephalopathy. There was initial concern for ventriculomegaly and ?VP shunt malfunction but neurosurgery consulted and felt this was unlikely. However this assessment was difficult to make with certainty due to lack of prior imaging. Per discussion with his wife his current encephalopathy seems similar to prior hospital-acquired encephalopathy episodes. Overall feel that shunt malfunction highly unlikely at this time. Head CT will be provided on CD so that can be uploaded at ___ when he follows up with neurosurgery. #Sinus bradycardia: HR ___ on presentation, asymptomatic, BP normal. EKGs variable but overall suggest sinus brady with premature beats/ectopy. Cardiology consulted. HRs increased to ___ with activity, so felt to be benign. Metoprolol held and HRs overall increased, remaining in ___ during the 24 hours prior to discharge. Will require ongoing monitoring but suspect that beta blockers should be avoided unless has critical indication in the past. TTE may be considered in the future. #HTN: Nifedipine continued but hydralazine and lisinopril held. Lisinopril restarted at discharge since BPs mildly elevated. Will require ongoing monitoring and considering whether to restart hydralazine. Metoprolol held due to bradycardia. #Hypokalemia: Mild, started on repletion and discharged on repletion with plan to continue following and wean if possible. Mag low-normal. ___, Wife Phone number: ___ ======================================================= #Transitional issues: (1) obtain repeat LFTs and BMP twice weekly (2) if potassium stable can wean potassium supplementation (3) monitor BP; consider restarting hydralazine if BPs elevated. consider holding lisinopril if BPs low (4) please ensure follow-up with neurosurgery at ___, and please ensure CD of head CT is brought with him for upload; should his encephalopathy worsen or fail to improve then he should be evaluated there to address the question of VP shunt malfunction (5) consider TTE in the future as further workup for his bradycardia and ectopy (6) should likely remain off beta blockers for life, but can consider low dose if critical infication in future (7) ERCP/GI follow-up: - pathology results available in 1 week - Dr. ___ ___ - ERCP in ___ weeks for stent removal - based on pathology results will need further plan determined moving forward (8) augmentin should be continued through ___ (post-procedure prophylaxis) ======================================================= >30 minutes in patient care/coordination of discharge Medications on Admission: The Preadmission Medication list is accurate and complete. 1. Allopurinol ___ mg PO DAILY 2. Donepezil 10 mg PO DAILY 3. Citalopram 20 mg PO DAILY 4. Metoprolol Succinate XL 50 mg PO DAILY 5. Losartan Potassium 100 mg PO DAILY 6. Cyanocobalamin 250 mcg PO DAILY 7. Vitamin D 800 UNIT PO DAILY 8. HydrALAZINE 12.5 mg PO TID Discharge Medications: 1. Acetaminophen 500 mg PO Q6H:PRN Pain - Mild/Fever 2. Amoxicillin-Clavulanic Acid ___ mg PO Q12H Continue through ___. Potassium Chloride 40 mEq PO DAILY for 1 week unless ongoing hypokalemia 4. Allopurinol ___ mg PO DAILY 5. Citalopram 20 mg PO DAILY 6. Cyanocobalamin 250 mcg PO DAILY 7. Donepezil 10 mg PO DAILY 8. Losartan Potassium 100 mg PO DAILY 9. Vitamin D 800 UNIT PO DAILY 10. HELD- HydrALAZINE 12.5 mg PO TID This medication was held. Do not restart HydrALAZINE until instructed by your doctor Discharge Disposition: Extended Care Facility: ___ Discharge Diagnosis: Bile Obstruction due to ampullary mass Severe Sinus Bradycardia Acute encephalopathy Dementia NPH HTN Hypokalemia Discharge Condition: Mental Status: Confused - sometimes. Level of Consciousness: Alert and interactive. Activity Status: Out of Bed with assistance to chair or wheelchair. Discharge Instructions: Mr. ___ was hospitalized for evaluation of bile obstruction and jaundice found incidentally after a mechanical fall at home. During his hospitalization, he was found to have a very low heart rate that our cardiologists ultimately determined was sinus rhythm. He ultimately underwent ERCP, which showed that there may have been a mass causing the obstruction, although the nature of this mass remains unclear. Dr. ___ can be contacted in 1 week to find out the results of the pathology from this mass. He will also need a follow-up procedure in ___ weeks to remove the plastic stent that was placed into his bile duct. While here Mr. ___ also experienced confusion, similar to prior hospitalizations. We expect this will improve with time. We have included a CT scan of the brain that was performed while he was here. We recommend that this be brought to ___ ___ and that he follow-up with his neurosurgeon there. Should his mental status fail to improve then this evaluation should occur sooner in case there is a problem with his stent, although at this time we do not suspect that. We also started potassium pills due to low potassium, but we anticipate the need for these will be short term. He will need to have his potassium checked again in ___ weeks. Summary of gastroenterology plan: -Repeat ERCP in ___ weeks for stent pull and re-evaluation (you should be contacted to schedule this and if not please call the number below) -Follow up with cytology reports. Please call Dr. ___ ___ ___ in 7 days for the pathology results -If any abdominal pain, fever, jaundice, gastrointestinal bleeding please call ___ and ask the operator for the Advanced Endoscopy Fellow on call Followup Instructions: ___
19711702-DS-22
19,711,702
27,352,944
DS
22
2147-10-24 00:00:00
2147-10-28 01:20:00
Name: ___ Unit No: ___ Admission Date: ___ Discharge Date: ___ Date of Birth: ___ Sex: F Service: MEDICINE Allergies: adhesive bandage / cefepime Attending: ___ Chief Complaint: left femoral neck fracture Major Surgical or Invasive Procedure: Open reduction and internal fixation of femoral neck fracture. History of Present Illness: Ms. ___ is a ___ year old female with intravascular lymphoma currently in remission, day ___ s/p autoSCT, presenting after a fall with a left femoral neck fracture. Ms. ___ has been doing particularly well recently, walking up to 2 miles per day. Last evening, she was in the bathroom preparing for bed and was putting on her pajamas. She then fell over and landed on her left shoulder and her left hip. She developed pain immediately and was taken to the ED. The patient does not remember the fall. She denied chest pain, palpitations or shortness of breath preceeding the event. Her husband does not think she hit her head, but the ED was told she hit her head and had a brief period of loss of consciousness. She has had a low grade temperature since this event and is feeling flushed. She was not given pain medication in the ED and denies pain presently. She was given valium 5 mg po once in the ED. In the ED, imaging demonstrated a left femoral neck fracture. She was admitted with a plan for ORIF tomorrow. Past Medical History: ONCOLOGIC HISTORY: 1) Mrs. ___ had her first event in ___ when she was diagnosed with small left inferior cerebellar embolic infarcts in the subacute stage found on a regularly scheduled MRI for follow-up of her meningiomas. At that time, she was asymptomatic and on aspirin. CTA of the head/neck and ECHO were unremarkable. She was discharged on simvastatin, fish oil and aspirin 325mg daily. 2) ___: She developed new gait unsteadiness and "wooziness". MR spectroscopy on ___ revealed multiple stable areas of patchy FLAIR signal hyperintensity within the left frontal centrum semiovale and periventricular white matter without evidence of enhancement or increased perfusion. An LP was performed and all CSF studies were negative. 3) ___: She had worsening dizziness, unsteadiness and fatigue. Repeat MRI on ___ showed new tiny foci of slow diffusion in the right inferomedial cerebellum and left middle cerebellar peduncle, possibly representing subacute infarcts. Repeat TTE was normal. Aspirin was discontinued and she started on clopidogrel 75mg PO daily. A hypercoaguability work-up was unremarkable. TEE was normal. PET was negative. 4) ___: She developed dysarthria and re-presented to the ER. MRI/A of the head revealed multiple small acute and subacute infarctions in the right cerebellar hemisphere and in the superior vermis bilaterally. Neck MRA was normal. CT torso on ___ was without any evidence of malignancy. Additional testing for antiphospholipid antibody syndrome was negative. Factor VIII was slightly elevated at 175% and b2 microglobulin was elevated at 2.7 mg/L (0.8-2.2). She was treated with both aspirin and clopidogrel. 5) ___: She presented with new acute and subacute infarcts in the cerebellar hemispheres, right greater than left, the right parasagittal pons, multiple foci in the vermis, the right genu of the internal capsule, the right splenium of the corpus callosum, and the right centrum semiovale. She was continued on aspirin and clopidogrel. 6) ___: Angiogram suggested vasospasm, but she did not tolerate Verapamil and Cilostazol, both of which caused her to feel dizzy. Autonomic testing showed exaggerated postural tachycardia. 7) ___: She suffered a fall and was found to have new memory problems and weakness on neurologic exam. MRI showed new acute infarction in the anterior right cerebellar hemisphere and right cerebellar peduncle, as well as smaller new early subacute infarctions in the right splenium of the corpus callosum and right frontal white matter. A REVEAL device was implanted on ___ to determine if she was having arrhythmias leading to embolic strokes. 8) ___: She presented with dysarthria and gait instability. MRI ___ showed multiple subacute infarcts in the right frontal, splenium of corpus callosum, right cerebellum, and cerebellar peduncle with interim tiny new infarcts in the right cerebellum. REVEAL device did not show any arrhythmias. Repeat LP was unremarkable. She was discharged with a plan to undergo a cerebral biopsy to r/o intravascular lymphoma or CNS vasculitis. 9) ___: Readmitted for worsening fatigue and somnolence. MRI on ___ showed numerous acute infarcts in a variety of vascular territories, superimposed on the evolving small infarcts. 10) ___: She underwent a brain biopsy on ___ which showedintravascular lymphoma. 11) ___: Bone marrow biopsy on ___ was negative for any evidence of lymphoma. Repeat CT torso on ___ was negative for any evidence of malignancy. 12) ___: Received C1 HD MTX (7040mg/m2). 13) ___: Received C1 R-CHOP (with dexamethasone instead of prednisone) 14) ___: Received C2 R-CHOP 15) ___: Received C2 HD-MTX (dose reduced to 3.5g/m2) 16) ___: Received C3 R-CHOP 17) ___: Received C3 HD-MTX 18) ___: Received C4 R-CHOP 19) ___: Received C4 HD-MTX 20) ___: Received C5D1 R-CHOP 21) Admitted from ___ due to pain from pubic rami, sacral ala and L4 compression fractures. Chemotherapy was held. Repeat MRIs, LP, and CT scans did not show any evidence of recurrent lymphoma. She was managed conservatively and discharged to rehab for ongoing physical therapy. 22) PET scan ___ was without any evidence of lymphoma. 23) ___: Received HD-MTX (3.5gm/m2) and ifosfamide as last cycle of chemotherapy . OTHER PAST MEDICAL HISTORY: DEPRESSION MIGRAINE HEADACHE RECURRENT CVA (CEREBELLAR) MENINGIOMA Presented ___ with focal seizures. Two meningiomas: high right frontal vertex adjacent to interhemispheric falx with mass effect on superior sagittal sinus; s/p resection ___ with mild residual left leg weakness. Second smaller lesion in right parietal extra-axial space, unchanged on serial imaging. SEIZURES Focal seizures: left leg paresthesias occasionally progressing to left leg clonus and once with abdominal twitching; no LOC or confusion. In past, occurred multiple times per day, but now well controlled since ___. Secondary to parasagittal meningioma, resected ___. Last event in ___. HYPOTHYROIDISM OSTEOPOROSIS s/p TONSILLECTOMY s/p APPENDECTOMY s/p CHOLECYSTECTOMY s/p C-SECTION X2 Reveal device implanted, ___ Social History: ___ Family History: Her mother had breast CA. Her father died in his ___. Physical Exam: Physical Exam on Admission: VS: 99.3 140/80 81 18 97% RA Gen: fatigued, falls asleep easily, no pain/distress HEENT: oral thrush noted, mucus membranes moist Car: regular rhythm, tachycardic Chest: port c/d/i, accessed Resp: clear to auscultation bilaterally--but anterior/lateral exam only with poor inspiratory effort Abd: soft, not tender, not distended Ext: left leg externally rotated, pulses palpable Physical Exam on Discharge: VS: T98.5, BP132/70, HR:84, RR16, O2sat:100%2LNC Gen: NAD, A+Ox3 HEENT: no oral thrush appreciated Car: RRR, no M/R/G Ext: left leg with full ROM, non-tender Exam otherwise unchanged from admission Pertinent Results: Lab Results on Admission: ___ 08:25AM BLOOD WBC-3.8* RBC-3.58* Hgb-12.0 Hct-35.0* MCV-98 MCH-33.4* MCHC-34.2 RDW-13.0 Plt ___ ___ 12:00AM BLOOD WBC-3.4* RBC-3.34* Hgb-11.7* Hct-32.8* MCV-98 MCH-34.9* MCHC-35.6* RDW-13.1 Plt ___ ___ 12:00AM BLOOD Neuts-46* Bands-0 ___ Monos-13* Eos-2 Baso-0 ___ Myelos-0 ___ 08:25AM BLOOD Glucose-115* UreaN-7 Creat-0.5 Na-142 K-3.4 Cl-102 HCO3-31 AnGap-12 ___ 12:00AM BLOOD Glucose-108* UreaN-7 Creat-0.6 Na-141 K-3.3 Cl-106 HCO3-29 AnGap-9 ___ 08:25AM BLOOD ALT-13 AST-17 AlkPhos-88 TotBili-0.2 ___ 12:00AM BLOOD ALT-13 AST-15 AlkPhos-80 TotBili-0.3 ___ 08:25AM BLOOD Albumin-4.4 Calcium-9.0 Phos-2.8 Mg-1.8 ___ 12:00AM BLOOD Calcium-8.4 Phos-3.0 Mg-1.7 Imaging: -Noncontrast CT head: no acute process. stable post-operative changes. minimally decreased right parietal meningioma (prelim read) . -CT C-spine: no acute process (prelim) . -CT Pelvis: bones are demineralized. no acute fracture evident. deformity of left inferior and superior pubic ramus related to prior trauma evident. djd (prelim . Pathology Examination Name ___ Age ___ # ___ MRN# ___ ___ ___ ___ Report to: ___. ___ by: ___. ___ SPECIMEN SUBMITTED: Femoral Head Reaming. Procedure date Tissue received Report Date Diagnosed by ___. ___. ___ Previous biopsies: ___ immunophenotyping - PB ___ BONE MARROW (1 JAR) ___ immunophenotyping - BM ___ immunophenotyping - RT occipital lobe BX (and more) DIAGNOSIS: Femoral head (left), reamings: Scant fragments of tendoligamentous tissue, bone, and admixed fibrin. Clinical: Left hip fracture. ___: The specimen is received fresh labeled with the patient's name ___, the medical record number, and additionally labeled "left femoral head reaming". It consists of multiple fragments of red soft tissue measuring 0.3 x 0.2 x 0.2 cm in aggregate. The specimen is entirely submitted in cassette A. . Radiology ReportLOWER EXTREMITY FLUORO WITHOUT RADIOLOGIST IN O.R. LEFTStudy Date of ___ 3:13 ___ Fluoroscopic assistance provided to the surgeon in the OR without the radiologist present. Two spot views obtained. These demonstrate the left hip, with screw placement along the femoral neck. Assessment of fine bony detail is limited by RF technique. Correlation with real-time findings and when appropriate conventional radiographs is recommended for full assessment. Fluoro time recorded as 60.4 seconds on the electronic requisition. . Lab Results on Discharge: ___ 05:56AM BLOOD WBC-4.1 RBC-3.37* Hgb-10.9* Hct-34.2* MCV-102* MCH-32.3* MCHC-31.9 RDW-12.5 Plt ___ ___ 05:56AM BLOOD Neuts-64.6 ___ Monos-8.9 Eos-1.5 Baso-0.4 ___ 05:56AM BLOOD ___ PTT-34.1 ___ ___ 05:56AM BLOOD Glucose-113* UreaN-4* Creat-0.6 Na-138 K-3.6 Cl-102 HCO3-31 AnGap-9 ___ 12:00AM BLOOD ALT-13 AST-15 AlkPhos-80 TotBili-0.3 ___ 05:56AM BLOOD Calcium-8.5 Phos-3.1 Mg-1.6 Brief Hospital Course: Primary Reason for Hospitalization: Ms. ___ is a ___ year old female with a history of intravascular lymphoma in remission, on admission day ___ s/p autologous stem cell transplant, presenting after a fall with a left hip fracture. . ACUTE CARE: 1. Hip fracture/Fall: The patient has known autonomic neuropathy and is on fludrocortisone. She also has a history of cerebellar infarcts and at baseline depends on a walker for mobility. The description of patient's fall that results in femoral neck fracture suggests a mechanical event, without preceding or subsequent symptoms. She was at the bathroom sink and bent down to pick something up on the ground and lost her balance and fell. She underwent surgical fixation of the fracture without major complication. She will receive Lovenox 40 mg subcutaneous for 4 weeks to prevent DVT, and pain control with oxycodone. She will also continue vitamin D. . CHRONIC CARE 1. Intravascular lymphoma/s/p autologous SCT: Patient's counts are currently stable on this admission. Patient was found to be neutropenic two weeks ago for unclear reason, but WBC improved today. Remains on Bactrim and acyclovir for prophylaxis after transplant. Has cognitive changes that have been attributed to her prior strokes and are not anticipated to improve. She has been making improvements in her status since her transplant. Prophylactic antimicrobials were continued for this admission. . 2. History of seizures: Patient was continued with her outpatient regimen of Keppra and lamotrigine. . 3. Hypothyroidism: continued outpatient levothyroxine . 4. Depression/Anxiety: continued outpatient fluoxetine . TRANSITIONS IN CARE: 1. CONTACT/ HCP: ___ (HUSBAND) ___ 2. MEDICATION CHANGES: Please START Enoxaparin 40 mg/0.4 mL Syringes, 1 injection daily for the next 4 weeks to prevent a lower extremity blood clot. Please START Oxycodone 2.5 mg every 4 hours as needed for pain. This medication may cause constipation and sedation. 3. FOLLOW-UP: Please follow up in the Orthopaedic Trauma Clinic in ___ days post-operation for evaluation and any suture/staple removal. Call ___ to schedule appointment upon discharge. . Please follow up with your PCP regarding this admission and any new medications/refills. . Department: HEMATOLOGY/___ When: ___ at 10:00 AM With: ___ Building: ___ Campus: ___ Best Parking: ___ . Department: HEMATOLOGY/ONCOLOGY When: ___ at 10:00 AM With: ___ Building: ___ Campus: ___ Best Parking: ___ . Department: HEMATOLOGY/___ When: ___ at 9:00 AM With: ___ Building: ___ Campus: ___ Best Parking: ___ 4. OUTSTANDING CLINICAL ISSUES: -follow-up appointments, slowly re-introducing weight-bearing Medications on Admission: Acyclovir 400 mg tid Fludrocortisone 0.2 mg daily Fluoxetine 20 mg daily Folate 1 mg daily Lamotrigine 50 mg bid Keppra 1500 mg bid Levothyroxine 1000 mcg daily Ondansetrone 8 mg tid Protonix 40 mg daily Bactrim SS daily Vitamin D3 ___ mg daily Thiamine 100 mg daily Nephrocaps daily Discharge Medications: 1. enoxaparin 40 mg/0.4 mL Syringe Sig: One (1) Subcutaneous DAILY (Daily) for 4 weeks. Disp:*28 syringes* Refills:*0* 2. acyclovir 400 mg Tablet Sig: One (1) Tablet PO Q8H (every 8 hours). 3. fludrocortisone 0.1 mg Tablet Sig: Two (2) Tablet PO DAILY (Daily). 4. fluoxetine 20 mg Capsule Sig: One (1) Capsule PO DAILY (Daily). 5. folic acid 1 mg Tablet Sig: One (1) Tablet PO DAILY (Daily). 6. lamotrigine 25 mg Tablet Sig: Two (2) Tablet PO BID (2 times a day). 7. levothyroxine 100 mcg Tablet Sig: One (1) Tablet PO DAILY (Daily). 8. sulfamethoxazole-trimethoprim 400-80 mg Tablet Sig: One (1) Tablet PO DAILY (Daily). 9. cholecalciferol (vitamin D3) 1,000 unit Tablet Sig: Two (2) Tablet PO DAILY (Daily). 10. thiamine HCl 100 mg Tablet Sig: One (1) Tablet PO DAILY (Daily). 11. B complex-vitamin C-folic acid 1 mg Capsule Sig: One (1) Cap PO DAILY (Daily). 12. oxycodone 5 mg Tablet Sig: 0.5 Tablet PO Q4H (every 4 hours) as needed for pain not responding to Tylenol. Disp:*24 Tablet(s)* Refills:*0* 13. levetiracetam 750 mg Tablet Sig: Two (2) Tablet PO twice a day. 14. ondansetron 8 mg Tablet, Rapid Dissolve Sig: One (1) Tablet, Rapid Dissolve PO three times a day as needed for nausea. 15. Protonix 40 mg Tablet, Delayed Release (E.C.) Sig: One (1) Tablet, Delayed Release (E.C.) PO once a day. Discharge Disposition: Home With Service Facility: ___ Discharge Diagnosis: Primary: Femoral Neck Fracture . Secondary: Intravascular Lymphoma Depression Hypothyrodisim Osteoporosis Seizure Disorder Discharge Condition: Mental Status: Confused - sometimes. Level of Consciousness: Alert and interactive. Activity Status: Out of Bed with assistance to chair or wheelchair with touchdown weightbearing. Discharge Instructions: Ms. ___, You came to the hospital after suffering a femur fracture from a fall. You had fixation of the fracture, and will need further outpatient follow up from ___ orthopedic department. You and your husband requested home physical therapy, not in patient phyiscal therapy, and will be receiving home physical therapy. Please do not weightbear on your affected leg until further instructed by your orthopedic surgeon. . Please note the following changes in your medications: Please START Enoxaparin 40 mg/0.4 mL Syringes, 1 injection daily for the next 4 weeks to prevent a lower extremity blood clot. Please START Oxycodone 2.5 mg every 4 hours as needed for pain. This medication may cause constipation and sedation. . No further changes have been made in your medications. Please continue to take them as usually prescribed. . It has been a pleasure taking care of you! We wish you a speedy recovery. Followup Instructions: ___
19711702-DS-26
19,711,702
20,287,392
DS
26
2149-02-26 00:00:00
2149-02-27 13:26:00
Name: ___ Unit No: ___ Admission Date: ___ Discharge Date: ___ Date of Birth: ___ Sex: F Service: MEDICINE Allergies: adhesive bandage / cefepime / chlorhexidine Attending: ___. Chief Complaint: Aspiration, Synchope Major Surgical or Invasive Procedure: None History of Present Illness: Patient is a ___ with history of autologous stem cell transplant for NH lymphoma complicated by stroke, seizures, chronic UTIs presented from outside ED choked on raisin bread today. Her husband reports that the patient lost consciousness for ___ minutes. He performed chest compressions for ___ minutes, but was not noted to have lost pulses. EMS noted that patient vomited once upon transport. She initially presented to OSH where she was found to have UTI. She was given levofloxacin 500mg and transported to ___. In the ED, initial vital signs were 98.0 113 104/68 24 96%. A CXR here demonstrated heterogeneous opacities through much of the right lung fields predominantly in the right middle lobe, apparently slightly improved from earlier same day examination, noted preliminarily to be compatible with aspiration. Labs demonstrated UA suspicious for infection, mild leukocytosis to 11.6k (N90%, L5%), and negative troponin. Blood cultures were drawn and were pending upon admission. Prior to admission, she received additional 250mg levofloxacin and clindamycin. Upon arrival to the floor, her vitals were stable (with tachycardia) and patient is resting comfortably. Review of Systems: (+) Per HPI (-) fever, chills, night sweats, headache, vision changes, rhinorrhea, congestion, sore throat, cough, shortness of breath, chest pain, abdominal pain, nausea, vomiting, diarrhea, constipation, BRBPR, melena, hematochezia, dysuria, hematuria. Past Medical History: Lymphoma s/p autoSCT ___ Lymphomatous cerebral vasculitis Left hip fracture s/p repair ___ Depression Migraine headaches Meningioma Seizure disorder Hypothyroidism Osteoporosis S/p tonsillectomy S/p appendectomy S/p cholecystectomy S/p c-section x 1 Reveal device implanted, ___ Social History: ___ Family History: Her mother had breast CA. Her father died in his ___. Physical Exam: Admission Physical Exam: Vitals- 98.5, 108/72, 118, 18, 94% 1 L NC General: awake, baseline neurological deficit, no acute distress HEENT: Moist mucus membranes, EOMI, anicteric sclera Neck: supple, no JVD CV: RRR, normal S1 and S2, no M/G/R Lungs: clear to ascultation, no wheezes or crackles Abdomen: soft, non-tender, non-distended GU: no CVA tenderness Ext: pulses equal and symmetric throughout, no edema Neuro: able to follow commands, ambulates normally Skin: warm, dry, no rashes Discharge Physical Exam: Vitals- 98.4, 97/64, 89, 18, 99% RA General: awake, baseline neurological deficit (she is not verbalizing well but is able to follow commands), no acute distress HEENT: Moist mucus membranes, EOMI, anicteric sclera Neck: supple, no JVD CV: RRR, normal S1 and S2, no M/G/R Lungs: clear to ascultation, no wheezes or crackles Abdomen: soft, non-tender, non-distended GU: no CVA tenderness Ext: pulses equal and symmetric throughout, no edema Neuro: able to follow commands, ambulates normally Skin: warm, dry, no rashes Pertinent Results: Admission Labs: ___ 11:45AM ___ PTT-28.7 ___ ___ 11:45AM NEUTS-89.5* LYMPHS-5.4* MONOS-4.4 EOS-0.5 BASOS-0.3 ___:45AM WBC-11.6*# RBC-3.99* HGB-13.2 HCT-37.7 MCV-95 MCH-33.2* MCHC-35.1* RDW-12.7 ___ 11:45AM cTropnT-<0.01 ___ 11:45AM estGFR-Using this ___ 11:45AM GLUCOSE-108* UREA N-16 CREAT-0.7 SODIUM-142 POTASSIUM-3.7 CHLORIDE-105 TOTAL CO2-28 ANION GAP-13 ___ 11:56AM LACTATE-1.2 ___ 11:56AM ___ COMMENTS-GREEN TOP ___ 02:45PM URINE MUCOUS-FEW ___ 02:45PM URINE HYALINE-2* ___ 02:45PM URINE RBC-154* WBC->182* BACTERIA-FEW YEAST-NONE EPI-0 ___ 02:45PM URINE BLOOD-LG NITRITE-NEG PROTEIN-100 GLUCOSE-NEG KETONE-NEG BILIRUBIN-NEG UROBILNGN-NEG PH-5.5 LEUK-LG ___ 02:45PM URINE COLOR-Yellow APPEAR-Hazy SP ___ . Discharge Labs: ___ 04:05PM BLOOD WBC-9.8 RBC-3.61* Hgb-12.1 Hct-34.5* MCV-96 MCH-33.4* MCHC-34.9 RDW-12.3 Plt ___ ___ 05:20AM BLOOD Glucose-101* UreaN-15 Creat-0.8 Na-141 K-3.8 Cl-104 HCO3-32 AnGap-9 . Microbiology: Blood Cultures x2 (___): Pending Urine Cultures (___): No growth . Pathology: None. . Imaging/Studies: CXR (___): IMPRESSION:Heterogeneous opacities through much of the right lung slightly improved from earlier same day examination compatible with aspiration. Brief Hospital Course: Patient is a ___ with history of autologous stem cell transplant for NH lymphoma complicated by stroke, seizures, chronic UTIs presented from outside ED choked on raisin bread today. Active Diagnoses: # Aspiration: Patient was found to be choking on a piece of raisin bread this morning. She lost conscioussness for 1 minute and was rescussitated by her husband. Her CXR on ___ showed a likely aspiration. On admission, she was requiring NC to keep her sats in the ___. She was started on IV clindamycin. On ___ she no longer requied the nasal canula. Speech and swallow evaluated her on ___. She passed her swallow evaluation. She was tolerating her oral medications without any difficuly. The IV clindamycin was discontinued on ___. She was then discharged home on ___. She will follow up with her PCP ___ 5 days. . # UTI: She finished a course of oral ciprofloxacin in late ___ ___ for a UTI but she states that she gets UTIs frequently. WBC count was 11.6 on admission. Afebrile. Foley in place. She was given 500mg Levofloxacin upon transfer to ___. On ___ the levofloxacin was discontinued and IV ceftriaxone was started. The foley catheter was discontinued on ___ because she felt like she had the strength to go to the bathroom. She was discharged with a prescription for oral ciprofloxacin which she will continue until ___. Chronic Diagnoses: # Seizure disorder: Stable. Has a history of lymphomatous cerebral vasculitis. She continued all home seizure medicines during this hospitalization. # Lymphoma: s/p BM transplant in ___. Oncology was made aware of her admission. She will follow up with oncology as an outpatient. Transitional Issues: # She will follow up with her PCP ___ 5 days and keep all of her regularly scheduled oncology appointments. Medications on Admission: 1. Acyclovir 400 mg PO Q8H 2. Fludrocortisone Acetate 0.2 mg PO DAILY 3. Fluoxetine 20 mg PO DAILY 4. FoLIC Acid 2 mg PO DAILY 5. LaMOTrigine 50 mg PO BID 6. LeVETiracetam 1500 mg PO BID 7. Levothyroxine Sodium 100 mcg PO DAILY 8. methenamine hippurate *NF* 1 gram Oral BID UTI prophylaxis 9. modafinil *NF* 50 mg Oral daily 10. Nystatin Cream 1 Appl TP Q12H:PRN fungal infection 11. Pantoprazole 40 mg PO Q24H 12. Potassium Chloride 20 mEq PO BID Hold for K > 4.9 13. Ascorbic Acid ___ mg PO Q6H 14. calcium carbonate-vitamin D3 *NF* 500 mg clacium (1250mg) 125 unit tablet Oral daily 15. Vitamin B Complex With C *NF* (B-complex with vitamin C) 1mg 1,750 unit tablet Oral Daily Discharge Medications: 1. Acyclovir 400 mg PO Q8H 2. Ascorbic Acid ___ mg PO Q6H 3. Fludrocortisone Acetate 0.2 mg PO DAILY 4. Fluoxetine 20 mg PO DAILY 5. FoLIC Acid 2 mg PO DAILY 6. LaMOTrigine 50 mg PO BID 7. LeVETiracetam 1500 mg PO BID 8. Levothyroxine Sodium 100 mcg PO DAILY 9. Pantoprazole 40 mg PO Q24H 10. Ciprofloxacin HCl 500 mg PO Q12H Duration: 5 Days RX *ciprofloxacin 500 mg 1 tablet(s) by mouth twice a day Disp #*10 Tablet Refills:*0 11. calcium carbonate-vitamin D3 *NF* 500 mg clacium (1250mg) 125 unit tablet Oral daily 12. methenamine hippurate *NF* 1 gram Oral BID UTI prophylaxis 13. modafinil *NF* 50 mg Oral daily 14. Nystatin Cream 1 Appl TP Q12H:PRN fungal infection 15. Potassium Chloride 20 mEq PO BID 16. Vitamin B Complex With C *NF* (B-complex with vitamin C) 1mg 1,750 unit tablet Oral Daily Discharge Disposition: Home Discharge Diagnosis: UTI and Aspiration Discharge Condition: Mental Status: Clear and coherent. Level of Consciousness: Alert and interactive. Activity Status: Ambulatory - requires assistance or aid (walker or cane). Discharge Instructions: Dear ___, ___ your hospital stay, you were found to have likely aspiration after chocking on raisin bread on ___. You were also found to have a UTI. On the morning of ___ you were able to breath well with supplemental oxygen and you passed your swallow evaluation. Your IV antibiotics were discontinued and you were placed on oral Ciprofloxacin. You were then discharged. Please continue the Ciprofloxacin until ___ for a total of five days. Please follow up with your PCP ___ 2 days and keep all of your regularly scheduled oncology appointments. Followup Instructions: ___
19711702-DS-28
19,711,702
25,118,271
DS
28
2151-03-14 00:00:00
2151-03-21 14:48:00
Name: ___ Unit No: ___ Admission Date: ___ Discharge Date: ___ Date of Birth: ___ Sex: F Service: MEDICINE Allergies: adhesive bandage / cefepime / chlorhexidine / Chloraprep Attending: ___. Chief Complaint: Somnolence Major Surgical or Invasive Procedure: None History of Present Illness: Ms. ___ is a ___ y/o woman with a PMH of seizure disorder (cerebral lymphomatous vasculitis), migraine headaches, stroke, Non Hodgkin's Lymphoma s/p R-CHOP, autologous stem cell transplant with monthly IVIG infusions, and recurrent UTI who presented with increasing somnolence over the last three months, most notably over the past few weeks. Keppra dosages have recently been titrated down in the setting of this increased somnollence. She saw PCP today, who was concerned about her mental status and fatigue. Recently had a tooth extraction on ___, with no antibiotics required. No fevers at home (temperatures between ___. In the past, has had urinary color change, malodor, and fatigue along with increased urinary frequency associated with UTIs. At baseline, alert, makes eye contact, oriented to person and place, conversant only in phrases, able to feed herself, has a commode by the bed, but has not been able to do these for the past few weeks. In the ED, initial vitals were: T 98.1F P ___ BP 104/63 RR 19 O2 97% RA Labs were notable for normal serum chemistries (with K of 4.3 and Cr of 0.6) and normal CBC (with WBC of 5.6, H/H of 12.4/36.2 and PLT of 196) with 64.7% neutrophils. UA notable for cloudy appearance, large leukocytes, moderate blood, positive nitrites, 300 protein and >182 RBCs, >182 WBCs and many bacteria. Lactate 1.0. Patient was given: ___ 14:33 IVF 1000 mL NS 500 mL ___ 15:43 IV CeftriaXONE 1 gm On the floor, No fevers or chills. No cough, no nausea, vomiting, no diarrhea. No chest pain, or shortness, endorses increasing frequency and darkened urine. Has had some hematuria; no dysuria. Past Medical History: -Non-Hodgkins Lymphoma s/p autoSCT ___ -Lymphomatous cerebral vasculitis -Left hip fracture s/p repair ___ -Reveal device implanted, ___ -Depression -Migraine headaches -nephrolithiasis -Meningioma (___) s/p resection -recurrent UTIs -Seizure disorder -Hypothyroidism -Osteoporosis -S/p tonsillectomy -S/p appendectomy -S/p cholecystectomy -S/p c-section x 1 Social History: ___ Family History: Her mother had breast CA. Her father died in his ___. Physical Exam: ======================= ADMISSION PHYSICAL EXAM ======================= Vitals: T 98.3F BP 119/67 P 86 RR 20 O2 96% RA General: Somnolet, but arousable, in NAD. Answering yes/no questions. HEENT: Sclera anicteric, MMM, OP clear. No evidence of dental abscess. EOMs intact; PERRL. CV: RRR, no MRGs; normal S1/S2. Pulm: CTA b/l; no wheezes, rhonchi, or rales. Chest: Port in place. Abd: Soft, non-tender, non-distended. NABS. GU: No foley Ext: Warm, well perfused, 2+ pulses, no clubbing, cyanosis or edema Neuro: CNII-XII intact, ___ strength upper/lower extremities, grossly normal sensation, gait deferred. Oriented to person and place as per baseline. ====================== DISCHARGE PHYSICAL EXAM ======================= Vitals: 97.8 115/68 69 18 97% RA General: Somnolent, but arousable, in NAD. Answering yes/no questions. HEENT: Sclera anicteric, MMM. EOMs intact CV: RRR, no MRGs; normal S1/S2. Pulm: CTA b/l; no wheezes, rhonchi, or rales. Abd: Soft, non-tender, non-distended. NABS. GU: No foley Ext: Warm, well perfused, 2+ pulses, no clubbing, cyanosis or edema Neuro: Difficult to perform CN exam due to poor cooperation. ___ strength upper/lower extremities, gait deferred. Pertinent Results: ============== ADMISSION LABS ============== ___ 02:34PM BLOOD WBC-5.6 RBC-3.83* Hgb-12.4 Hct-36.2 MCV-95 MCH-32.4* MCHC-34.3 RDW-11.9 RDWSD-40.9 Plt ___ ___ 02:34PM BLOOD Neuts-64.7 ___ Monos-11.2 Eos-2.3 Baso-0.5 Im ___ AbsNeut-3.63 AbsLymp-1.17* AbsMono-0.63 AbsEos-0.13 AbsBaso-0.03 ___ 02:34PM BLOOD Glucose-99 UreaN-12 Creat-0.6 Na-138 K-4.3 Cl-101 HCO3-29 AnGap-12 ___ 02:46PM BLOOD Lactate-1.0 ============== DISCHARGE LABS ============== ___ 05:57AM BLOOD Glucose-92 UreaN-16 Creat-0.6 Na-142 K-3.9 Cl-104 HCO3-27 AnGap-15 ___ 05:57AM BLOOD WBC-3.9* RBC-3.33* Hgb-10.8* Hct-32.0* MCV-96 MCH-32.4* MCHC-33.8 RDW-11.9 RDWSD-40.9 Plt ___ ======= IMAGING ======= CHEST (PA & LAT) (___) IMPRESSION: Streaky basilar opacity, best seen on the lateral view, most likely represents atelectasis and vascular structures rather than focal consolidation. ============ MICROBIOLOGY ============ ___ 2:34 pm BLOOD CULTURE **FINAL REPORT ___ Blood Culture, Routine (Final ___: NO GROWTH. Brief Hospital Course: Ms. ___ is a ___ y.o. woman with hx of seizure disorder (cerebral lymphomatous vasculitis), migraine headaches, CVA, Non Hodgkin's Lymophoma s/p R-CHOP and autologous stem cell transplant with monthly IVIG infusions, and recurrent UTI who presented with increasing lethargy over several weeks. ============ ACUTE ISSUES ============ # Failure to thrive Mrs. ___ has a poor cognitive substrate at baseline, in the setting of stroke, seizure disorder, and lymphomatous cerebral vasculitis, with a known history of decreased responsiveness in the setting of infections. The tempo of her present symptoms was thought to be an acute on chronic deterioration of her overall functional status. There was no evidence of cerebral hypoperfusion (no focal neurologic signs) or meningitis. There were also no signs of seizure at this time. She responded appropriately with fluids and antibiotics, and was continued on maintenance fluids. She returned to her baseline and was discharged on an outpatient course of antibiotics. # UTI The patient had a history of recurrent UTIs, with pansensitive E. coli in the past. Per husband, she had dark, malodorous urine, and increasing frequency. She also has a history of recurrent vaginitis, but had not endorsed any symptoms of foul-smelling or malodorous vaginal discharge. There was no leukocytosis or fever. She was initially started on ceftriaxone, which was switched to ciprofloxacin 500 mg q12h, to be completed after discharge on ___. Her home methenamine and ascorbic acid were continued. # Seizure disorder Ms. ___ has a seizure history in the setting of parafalcine meningioma s/p resection. Her Keppra dose had been recently down-titrated in the setting of increasing somnolence. There were no focal neurologic findings. She was continued on Keppra 500 mg QAM and 750 QHS per home dosing as well as lamotrigine 50 mg bid. ============== CHRONIC ISSUES ============== # Autologous stem cell transplant. Ms. ___ has a history of Hodgkin's lymphoma s/p R-CHOP and ASCT in ___ with monthly IVIG infusions. She was continued on home acyclovir 400 mg PO q8h and home fludrocortisone 0.2 mg PO daily # Depression. She was continued on home fluoxetine 20 mg PO daily. # Osteoporosis. She was continued on calcium 500 mg and vitamin D 1000 units PO daily # GERD. Home pantoprazole 40 mg was continued. # Hypothyroidism. Continued home levothyroxine 125 mcg daily. =================== TRANSITIONAL ISSUES =================== # UTI treatment. The patient will complete her course of ciprofloxacin on ___. # CODE: Full. # CONTACT: Husband, ___. ___ cell: ___ Medications on Admission: The Preadmission Medication list is accurate and complete. 1. Acyclovir 400 mg PO Q8H 2. Ascorbic Acid ___ mg PO Q6H 3. Fludrocortisone Acetate 0.2 mg PO DAILY 4. Fluoxetine 20 mg PO DAILY 5. LaMOTrigine 50 mg PO BID 6. LeVETiracetam 500 mg PO QAM 7. Levothyroxine Sodium 125 mcg PO DAILY 8. Pantoprazole 40 mg PO Q24H 9. methenamine hippurate 1 gram oral BID 10. Potassium Chloride 20 mEq PO BID 11. LeVETiracetam 750 mg PO QPM 12. cromolyn 4 % ophthalmic Q4H:PRN itchiness 13. Calcium Carbonate 500 mg PO DAILY 14. Vitamin D 1000 UNIT PO DAILY Discharge Medications: 1. Acyclovir 400 mg PO Q8H 2. Ascorbic Acid ___ mg PO Q6H 3. Calcium Carbonate 500 mg PO DAILY 4. Fludrocortisone Acetate 0.2 mg PO DAILY 5. Fluoxetine 20 mg PO DAILY 6. LaMOTrigine 50 mg PO BID 7. LeVETiracetam 500 mg PO QAM 8. LeVETiracetam 750 mg PO QPM 9. Levothyroxine Sodium 125 mcg PO DAILY 10. Pantoprazole 40 mg PO Q24H 11. Vitamin D 1000 UNIT PO DAILY 12. cromolyn 4 % ophthalmic Q4H:PRN itchiness 13. methenamine hippurate 1 gram oral BID 14. Ciprofloxacin HCl 500 mg PO Q12H Duration: 4 Days RX *ciprofloxacin HCl 500 mg 1 tablet(s) by mouth every twelve hours Disp #*8 Tablet Refills:*0 15. Potassium Chloride 20 mEq PO BID Discharge Disposition: Home Discharge Diagnosis: ================= PRIMARY DIAGNOSES ================= - failure to thrive - urinary tract infection =================== SECONDARY DIAGNOSES =================== - Non-Hodgkin's lymphoma - lymphomatous cerebral vasculitis - seizure disorder - depression - osteoporosis Discharge Condition: Mental Status: Confused - always. Level of Consciousness: Lethargic but arousable. Activity Status: Out of Bed with assistance to chair or wheelchair. Discharge Instructions: Dear Ms. ___, It was a pleasure caring for you at ___ ___. You were admitted for weakness and a urinary tract infection. We treated your urinary tract infection with antibiotics. We are prescribing you a course of ciprofloxacin for this that you can finish as an outpatient. For your weakness, we informed your regular physicians, Dr. ___, and ___, and we recommend making close follow-up with them, especially Dr. ___ ___ continue to take all medications as prescribed. Your discharge appointments are outlined below. We wish you the very best! Warmly, Your ___ Team Followup Instructions: ___
19711968-DS-14
19,711,968
21,018,022
DS
14
2152-12-02 00:00:00
2152-12-03 08:21:00
Name: ___ Unit No: ___ Admission Date: ___ Discharge Date: ___ Date of Birth: ___ Sex: M Service: MEDICINE Allergies: No Known Allergies / Adverse Drug Reactions Attending: ___. Chief Complaint: Shortness of breath. Major Surgical or Invasive Procedure: None. History of Present Illness: Mr. ___ is a ___ year old man with past medical history of OSA, HTN, HLD, NIDDM, depression s/p ECT in ___, alcohol abuse (last drink >1 week ago), recently discharged from ___. ___ for detox, who presented with SOB for the past 4 days. The shortness of breath started 4 days ago, is not positional, and is mainly exacerbated with ambulation. He says it started after discharge from ___. He was seen at the day of presentation at his PCP office in ___ as part of his follow up after his recent hospital discharge. He was found to be hypoxic and with new ECG changes (flipped T waves in anterior leads, has RBBB at baseline), so he was given 325mg aspirin due to concern for possible ischemia and was sent to ___ ED. He denies chest pain, fever, chills. He reports a minor cough. Has chronic left lower extremity swelling, which is at its baseline. He denies recent travel and history of blood clots. In the ED, initial vitals were: 97.2 74 189/118 26 93% 4L NC -Labs notable for: D-Dimer: 4095, proBNP: 980, Trop-T: <0.01 Na 139 K 3.7 Cr 0.9 WBC 7.8 H/H 12.7/36.3 platelets 230 Lactate:1.1 -Imaging notable for: CXR showed mild pulmonary vascular congestion and small left pleural effusion. CT showed extensive bilateral segmental and subsegmental pulmonary emboli, with central extension into the left main pulmonary artery. -Patient was given: Enoxaparin Sodium 135 mg Vitals prior to transfer: 98.0 74 165/94 24 94% RA On the floor, BP 178 / 102, patient was feeling anxious about having pulmonary embolism. Denied chest pain, SOB, headache, lightheadedness, dizziness. He reports that he had a TIA a couple of weeks ago. He had presented to a detox center, and when he stood up to walk to the counter, he had difficulty walking. He was taken to the ER, evaluated by neurology, and MRI was attempted, but he was too large to fit in the machine. He therefore did not get an MRI and was told to follow up as an outpatient. He has not had an MRI. All neurologic sequela of TIA have resolved. Has not drank since 1 week ago prior to detox. For hypertension, patient give 100mg labetalol, with repeat BP 106/53. ROS: (+) Per HPI (-) Denies fever, chills, night sweats, recent weight loss or gain. Denies headache, sinus tenderness, rhinorrhea or congestion. Denies cough. Denies palpitations. Denies nausea, vomiting, diarrhea, constipation or abdominal pain. No recent change in bowel or bladder habits. No bloody bowel movements. No dysuria. Denies arthralgias or myalgias. Past Medical History: OSA HTN HLD NIDDM ?COPD Depression s/p ECT in ___ Alcohol abuse Social History: ___ Family History: Grandparent had 2 strokes. Grandfather had DM 1. Physical Exam: Admission Exam: Vital Signs: 98.2 PO, 178 / 102, 72, 21, 95 RA General: Alert, oriented, visibly anxious, no acute distress, obese HEENT: Sclera anicteric, MMM, oropharynx clear, EOMI, PERRL, neck supple, JVP not elevated, no LAD CV: Regular rate and rhythm, normal S1 + S2, no murmurs, rubs, gallops Lungs: Decreased breath sounds throughout entire left lung. Clear to auscultation on right, No wheezes, rales, rhonchi Abdomen: Obese, Soft, non-tender, non-distended, bowel sounds present, no organomegaly, no rebound or guarding GU: No foley Ext: Warm, well perfused, 2+ pulses, no clubbing, cyanosis or edema. Left calf larger than right calf. Deformity of right foot. Neuro: CNII-XII intact, ___ strength upper/lower extremities, grossly normal sensation, 2+ reflexes bilaterally. Slight limp with walking, which is baseline. Discharge Exam: VITALS: 98.1, 114 / 64, 64, 22, 94 CPAP General: Alert, oriented, no acute distress, obese HEENT: Sclera anicteric, MMM, oropharynx clear, EOMI, PERRL, neck supple, JVP not elevated, no LAD CV: Regular rate and rhythm, normal S1 + S2, no murmurs, rubs, gallops Lungs: Clear to auscultation bilaterally (previously decreased breath sounds on left); No wheezes, rales, rhonchi Abdomen: Obese, Soft, non-tender, non-distended, bowel sounds present, no organomegaly, no rebound or guarding GU: No foley Ext: Warm, well perfused, 2+ pulses, no clubbing, cyanosis or edema. Left calf larger than right calf (baseline). Deformity of R foot. Neuro: CNII-XII intact, ___ strength upper/lower extremities, grossly normal sensation, 2+ reflexes bilaterally. Gait not assessed. Pertinent Results: Admission Labs: ___ 05:41PM BLOOD WBC-7.8 RBC-4.09* Hgb-12.7* Hct-36.3* MCV-89 MCH-31.1 MCHC-35.0 RDW-14.8 RDWSD-47.4* Plt ___ ___ 05:41PM BLOOD Neuts-67.2 Lymphs-13.4* Monos-16.2* Eos-2.3 Baso-0.5 Im ___ AbsNeut-5.22 AbsLymp-1.04* AbsMono-1.26* AbsEos-0.18 AbsBaso-0.04 ___ 05:41PM BLOOD ___ PTT-25.9 ___ ___ 05:41PM BLOOD Glucose-114* UreaN-11 Creat-0.9 Na-139 K-3.7 Cl-103 HCO3-25 AnGap-15 ___ 05:41PM BLOOD cTropnT-<0.01 ___ 12:30PM BLOOD CK-MB-2 cTropnT-<0.01 ___ 05:41PM BLOOD proBNP-980* ___ 12:30PM BLOOD Calcium-8.9 Phos-3.7 Mg-2.1 Iron-PND ___ 05:41PM BLOOD D-Dimer-4095* ___ 05:41PM BLOOD VitB12-335 ___ 05:41PM BLOOD TSH-1.0 ___ 05:49PM BLOOD Lactate-1.1 Discharge Labs: ___ 07:54AM BLOOD WBC-5.6 RBC-3.89* Hgb-12.0* Hct-35.0* MCV-90 MCH-30.8 MCHC-34.3 RDW-14.6 RDWSD-46.8* Plt ___ ___ 07:54AM BLOOD ___ PTT-31.7 ___ ___ 07:54AM BLOOD Glucose-101* UreaN-10 Creat-0.9 Na-140 K-3.9 Cl-103 HCO3-23 AnGap-18 ___ 07:54AM BLOOD Calcium-8.6 Phos-4.5 Mg-2.2 Imaging: CXR: IMPRESSION: Mild pulmonary vascular congestion and small left pleural effusion. Patchy opacities in lung bases may reflect areas of atelectasis, though infection cannot be completely excluded in the correct clinical setting. CTA Chest: FINDINGS: Included portions of the thyroid gland enhance homogeneously. No supraclavicular, axillary or mediastinal lymphadenopathy by size criteria. Scattered mediastinal lymph nodes measure up to 7 mm in the left prevascular station. There is a 14 mm hilar lymph node on the right(3:99), likely reactive. Heart is normal in size, without a pericardial effusion. Left ventricular myocardium appears thickened. Coronary calcifications are noted. Thoracic aorta is normal in course and caliber with no evidence for dissection or intramural hematoma. Main pulmonary trunk is dilated, measuring up to 3.9 cm in diameter (3:78), suggestive of pulmonary arterial hypertension. There are extensive segmental and subsegmental pulmonary emboli involving all pulmonary arterial branches. On the left, there is central extension of clot burden into the left main pulmonary artery (3:80). There is no evidence of right heart strain. Airways are patent to the segmental bronchi bilaterally. Scattered parenchymal abnormalities are noted. Several wedge-shaped peripheral opacities in the right lower lobe and left lower lobe likely represent small pulmonary infarcts (02:59, 74, 79). There is a 5 mm mixed attenuation nodule in the right middle lobe (3:88). Several additional opacities are nonspecific and may represent an underlying inflammatory process ; for instance, there is a lobulated 1.1 x 0.8 cm perifissural opacity in the inferior right upper lobe (3:99) and an additional 0.7 cm nodular opacity in the posterior segment of the right upper lobe (3:67). Small pleural effusion on the left. No pleural effusion on the right. No pneumothorax. Limited images of the upper abdomen reveals a diffusely hypoattenuating liver, suggestive of hepatic steatosis. No fractures are identified. Degenerative changes throughout the thoracic spine. There is a 1.4 cm skin lesion extending into the subcutaneous fat along the central upper back (3:61), which may represent a sebaceous cyst. IMPRESSION: 1. Extensive bilateral segmental and subsegmental pulmonary emboli, with central extension into the left main pulmonary artery. 2. Dilatation of the main pulmonary artery however no evidence of right heart strain. 3. Bilateral scattered wedge-shaped peripheral parenchymal opacities, suspicious for pulmonary infarcts. Additional parenchymal opacities in the right upper lobe are of unclear etiology and may represent nonspecific inflammation. A follow-up chest CT in 3 months is recommended to evaluate resolution. 4. 5 mm mixed attenuation nodule in the right middle lobe, which could also be re-evaluated at time of follow-up. 5. Prominent right hilar lymph node is likely reactive. 6. Small left pleural effusion. 7. Hepatic steatosis. 8. 1.4 cm superficial skin/subcutaneous lesion along the central upper back, may represent a sebaceous cyst. RECOMMENDATION(S): Chest CT in 3 months. Cardiac Echo: The left atrial volume index is mildly increased. No atrial septal defect or patent foramen ovale is seen by 2D, color Doppler or saline contrast with maneuvers. There is mild symmetric left ventricular hypertrophy. The left ventricular cavity size is top normal/borderline dilated. Overall left ventricular systolic function is normal (LVEF>55%). Tissue Doppler imaging suggests a normal left ventricular filling pressure (PCWP<12mmHg). The right ventricular cavity is mildly dilated with moderate global free wall hypokinesis. The aortic valve leaflets (3) are mildly thickened but aortic stenosis is not present. No aortic regurgitation is seen. The mitral valve leaflets are structurally normal. Trivial mitral regurgitation is seen. The pulmonary artery systolic pressure could not be determined. There is no pericardial effusion. IMPRESSION: Suboptimal image quality. Mild right ventricular cavity dilatation with moderate global hypokinesis. Mild symmetric left ventricular hypertrophy with borderline dilated cavity size and preserved systolic function. No cardiac source of embolism identified. ___: IMPRESSION: No evidence of deep venous thrombosis in the right or left lower extremity veins. Carotid U/S: IMPRESSION: Mild atherosclerotic plaque with bilateral ___ ICA stenosis. Antegrade vertebral flow. Brief Hospital Course: ___ yo man with h/o OSA, HTN, HLD, NIDDM, depression s/p ECT in ___, alcohol abuse (last drink >1 week ago), recently discharged from ___ for detox, who presented with SOB for the past 4 days. #Pulmonary embolism: patient had CTA chest notable for submassive PE (extensive bilateral segmental and subsegmental pulmonary emboli, with central extension into the left main pulmonary artery). He was normotensive to hypertensive in the ED. Troponins and CKMB negative x2. BNP 980 although no prior. EKG showed flipped T-waves in anterior leads; RBBB at baseline (seen since ___. He had ___ dopplers that were negative for DVT bilaterally. He had a TTE with bubble study which was limited due to body habitus but showed mild right ventricular cavity dilatation with moderate global hypokinesis. PA was unable to be adequately visualized. Given this RV finding, his case was reviewed with ___ (PE/thrombolysis team) and he will follow up as an outpatient. He remained normotensive, minimally symptomatic with mild DOE, and was satting well on RA. With exertion, he was noted to desat to 91% intermittently but improved spontaneously. He was initially treated with therapeutic lovenox before being transitioned to Xarelto for a planned ___t minimum. The etiology of his PE is unclear. He was noted to have a 5 mm pulmonary nodule on CT chest which will require follow up in 3 months to rule out malignancy. Patient was made aware and results of this CT communicated to PCP. He has no prior colonoscopy to r/o GI malignancy. No family history of coagulopathy. No recent immobilization. He has multiple comorbidities, including obesity, OSA, HTN, HLD, DM which may have contributed to PE. #HTN: was hypertensive to 170s-180s multiple times this admission; he was maintained on his home lisinopril (30 mg) and PO labetalol PRN; he is being discharged on lisinopril 40 mg. #Anemia: found to have normocytic anemia with lab studies notable for normal RDW, low iron, low TIBC, normal ferritin (although in setting of PE), normal B12, normal TSH. Labs more consistent with anemia of chronic disease, although difficult to interpret ferritin in setting of acute illness. Transferrin saturation is low at ~13% which can be seen with iron deficiency and/or ACD. Patient should have further work up including colonoscopy as above. #?TIA Hx: he had a recent admission at ___ for a TIA (left AMA). Given this, he had carotid U/S done that showed mild atherosclerotic plaque with bilateral ___ ICA stenosis. Bubble study was done with TTE but study was too limited by body habitus to definitively rule out PFO. He is planned for follow up with neurology per prior admission at ___. CHRONIC ISSUES: #Depression: continued on his home regimen. #DM: home metformin was held; managed on sliding scale without issue. #?COPD: continued on his home regimen. #OSA: continued with home CPAP machine. #HLD: increased from 20 to 40 mg QD given concern for comorbidities such as HLD contributing to PE TRANSITIONAL ISSUES - Please repeat CT chest in 3 months (approx. ___ to evaluate 5 mm lung nodule to rule out malignancy - Please do screening colonoscopy given concern for malignancy provoking PE - Please continue rivaroxaban for at least 6 months for unprovoked PE (patient discharged on 15 mg BID x21 days to be followed by 20 mg daily x6 months at least) - Patient will follow up with ___ (PE team) as an outpatient - Please consider heme/onc consult as outpatient for other etiology of PE if other work up unrevealing - Please ensure follow up with neurology given recent history of TIA (pt seen at ___); was planned for MRI but was unable to fit in scanner due to body habitus. If possible to obtain open MRI, please arrange given h/o ?TIA. - Patient's home atorvastatin increased to 40 mg qHS - Patient's home lisinopril increased to 40 mg QD given persistently hypertensive to 150s systolic - Full code - CONTACT: Saw (wife) ___ Medications on Admission: The Preadmission Medication list is accurate and complete. 1. MetFORMIN (Glucophage) 1000 mg PO DAILY 2. Dulera (mometasone-formoterol) 100-5 mcg/actuation inhalation DAILY 3. OXcarbazepine 2400 mg PO QHS 4. Escitalopram Oxalate 30 mg PO DAILY 5. TraZODone 50-200 mg PO QHS:PRN insomnia 6. Atorvastatin 20 mg PO QAM 7. Lisinopril 30 mg PO DAILY 8. TEGretol XR (carBAMazepine) 100 mg oral DAILY Discharge Medications: 1. Atorvastatin 40 mg PO QPM RX *atorvastatin 40 mg 1 tablet(s) by mouth qPM Disp #*30 Tablet Refills:*0 2. Rivaroxaban 15 mg PO BID PE Duration: 21 Days with food RX *rivaroxaban [___] 15 mg (42)- 20 mg (9) 1 tablets(s) by mouth BID for 21 days then daily Disp #*1 Dose Pack Refills:*0 3. Lisinopril 40 mg PO DAILY RX *lisinopril 40 mg 1 tablet(s) by mouth daily Disp #*30 Tablet Refills:*0 4. Dulera (mometasone-formoterol) 100-5 mcg/actuation inhalation DAILY 5. Escitalopram Oxalate 30 mg PO DAILY 6. MetFORMIN (Glucophage) 1000 mg PO DAILY 7. OXcarbazepine 2400 mg PO QHS 8. TEGretol XR (carBAMazepine) 100 mg ORAL DAILY 9. TraZODone 50-200 mg PO QHS:PRN insomnia Discharge Disposition: Home Discharge Diagnosis: Primary: Pulmonary embolism: Extensive bilateral segmental and subsegmental pulmonary emboli, with central extension into the left main pulmonary artery. Secondary: OSA HTN HLD NIDDM depression s/p ECT etOH abuse Discharge Condition: Mental Status: Clear and coherent. Level of Consciousness: Alert and interactive. Activity Status: Ambulatory - Independent. Discharge Instructions: Dear Mr. ___, We have cared for you in the hospital for the blood clots in your lungs. Fortunately, your clinical status is stable and we have started you on a blood thinner for the blood clots. It is unclear at this point why you had the blood clots, but we have arranged for a number of tests to be done in conjunction with your PCP as an outpatient. You will need to have a colonoscopy as soon as possible. Please also have a CT scan of your chest to evaluate for a lung nodule in 3months (approx. ___. Your medication changes are as follows: rivaroxaban 15 mg twice a day with meals (for the first 21 days and this will be changed to 20 mg once a day afterwards); atorvastatin from 20 to 40 mg, and lisinopril from 30 to 40 mg. The length of your rivaroxaban treatment will depend on your improvement but will most likely be at least 6 months. Please return to be evaluated immediately if you develop worsening shortness of breath, chest pain, increasing warmth, redness or pain in your legs, or any other severely concerning symptoms. We have greatly appreciated taking part in your care. Best wishes, ___ Care Team Followup Instructions: ___
19711968-DS-15
19,711,968
29,512,884
DS
15
2154-03-13 00:00:00
2154-03-13 18:43:00
Name: ___ Unit No: ___ Admission Date: ___ Discharge Date: ___ Date of Birth: ___ Sex: M Service: MEDICINE Allergies: No Known Allergies / Adverse Drug Reactions Attending: ___. Chief Complaint: Alcohol withdrawal Major Surgical or Invasive Procedure: None History of Present Illness: ___ yo M pt w/ hx of ETOH abuse presenting to the emergency department for evaluation of alcohol intoxication. The patient reported going through hard social situations and job problems leading to increase drinking. He can drink up to 2 bottles. His last drink was on morning of the day of presentation. He complained of symptoms of headache, blurry vision, ataxia and inability to coordinate his hand. He has had prior episodes of alcohol withdrawal, but mentioned that none are this severe. The patient was brought by EMS. He was found very unsteady on his feet. The patient gave history of frequent falls but no head strike. He has multiple bruises on them. He has a history of PE in the past but is no longer on anticoagulation. He was previously on Xarelto. The patient also mentioned that he presented to an OSH ED for detox. However, there were no beds available and hence he returned back home to drink. In the ED ============= Initial vitals: 98.6 151 134/74 24 97% RA The patient triggered on arrival for tachycardia to 150's. Was given 2 L NS bolus and started on dilt IV and PO. Due to uncontrolled HR, he was started on dilt ggt with slight improvement especially when dilt was given with ___. On exam he is very slurred speech and has multiple bruising on all of his extremities but has now midline C-spine or L or T-spine tenderness palpation. He also has no bony pain/ttp in the extremities. Labs were significant for 14.3 MCV= 88 11.4>------<141 41.2 143 96 14 AGap=27** ------------< 166 4.4 20 1.0 Ca: 8.7 Mg: 1.5 P: 2.3 ALT: 59 AP: 90 Tbili: 0.9 Alb: 4.3 AST: 98 Lip: 71 Serum EtOH 402 Serum ASA, Acetmnphn, ___, Tricyc Negative UA: positive for protein, Bact, prot. Imaging showed CT head: No acute intracranial process. CXR: No acute cardiopulmonary process. The patient received: a total of 180 mg IV dilt a total of 60 mg PO dilt started on a dilt ggt given 2+1 L of IVF Diazepam ___ hours apart to control his symptoms. The patient was shifted to the ICU. In the ICU, the patient was anxious and tremulous and unable to fit stabily. He also is thirsty. He is alert to place and time and person. smells of EtOH. Past Medical History: OSA HTN HLD NIDDM ?COPD Depression s/p ECT in ___ Alcohol abuse Bipolar History of PE with completion of 7 month of anticoagulation with rivaroxiban Social History: ___ Family History: Grandparent had 2 strokes. Grandfather had DM 1. Physical Exam: Admission physical exam VS: Reviewed in MetaVision and notable for tachycardia from Aflutter with 2:1 conduction GEN: Alert, lying in bed, no acute distress HEENT: Moist MM, crusty blood around the edge of the mouth. Anicteric sclerae, no conjunctival pallor. PERRLA, EOMI. NECK: Supple without LAD PULM: full air entry bilaterally, no crackle. no wheeze. no rhonchi HEART: RRR (+)S1/S2 no m/r/g ABD: Soft, distended with fat, tender in the right lower quad on deep palpatoin. No rebound/guarding. BS+ EXTREM: Warm, well-perfused, no edema NEURO: CN II-XII intact, strength ___ in b/l ___, SLIT Discharge physical exam Vitals: 97.7 124/82 93 20 95 RA GEN: Sleeping with CPAP machine, lying in bed, no acute distress HEENT: Moist. Anicteric sclerae, no conjunctival pallor. PERRLA, EOMI. NECK: Supple without LAD PULM: CTAB without increased WOB HEART: RRR (+)S1/S2 no m/r/g ABD: Soft, obese. No rebound/guarding. BS+ EXTREM: Warm, well-perfused, no edema NEURO: Grossly moving all extremities Pertinent Results: Admission labs: =================== ___ 06:27PM URINE HOURS-RANDOM ___ 06:27PM URINE UHOLD-HOLD ___ 06:27PM URINE COLOR-Straw APPEAR-Clear SP ___ ___ 06:27PM URINE BLOOD-SM* NITRITE-NEG PROTEIN-TR* GLUCOSE-NEG KETONE-NEG BILIRUBIN-NEG UROBILNGN-NEG PH-6.0 LEUK-NEG ___ 06:27PM URINE RBC-<1 WBC-<1 BACTERIA-FEW* YEAST-NONE EPI-0 ___ 03:27PM GLUCOSE-166* UREA N-14 CREAT-1.0 SODIUM-143 POTASSIUM-4.4 CHLORIDE-96 TOTAL CO2-20* ANION GAP-27* ___ 03:27PM estGFR-Using this ___ 03:27PM ALT(SGPT)-59* AST(SGOT)-98* ALK PHOS-90 TOT BILI-0.9 ___ 03:27PM LIPASE-71* ___ 03:27PM ALBUMIN-4.3 CALCIUM-8.7 PHOSPHATE-2.3* MAGNESIUM-1.5* ___ 03:27PM ASA-NEG ___ ACETMNPHN-NEG bnzodzpn-NEG barbitrt-NEG tricyclic-NEG ___ 03:27PM WBC-11.4* RBC-4.68 HGB-14.3 HCT-41.2 MCV-88 MCH-30.6 MCHC-34.7 RDW-15.2 RDWSD-48.3* ___ 03:27PM NEUTS-79.8* LYMPHS-11.6* MONOS-6.4 EOS-0.7* BASOS-1.1* IM ___ AbsNeut-9.07* AbsLymp-1.32 AbsMono-0.73 AbsEos-0.08 AbsBaso-0.12* ___ 03:27PM PLT COUNT-141* Imaging tests: ======================================= ___: CT head: No acute intracranial process. ___: CXR: No acute cardiopulmonary process. ___: Echo: The left atrium is mildly dilated. No atrial septal defect is seen by 2D or color Doppler. There is moderate symmetric left ventricular hypertrophy. The left ventricular cavity size is normal. Regional left ventricular wall motion is normal. Overall left ventricular systolic function is normal (LVEF>55%). There is considerable beat-to-beat variability of the left ventricular ejection fraction due to an irregular rhythm/premature beats. Tissue Doppler imaging suggests a normal left ventricular filling pressure (PCWP<12mmHg). The right ventricular cavity is mildly dilated with normal free wall contractility. The aortic root is mildly dilated at the sinus level. The ascending aorta is mildly dilated. The aortic valve leaflets (3) appear structurally normal with good leaflet excursion and no aortic stenosis or aortic regurgitation. The mitral valve leaflets are structurally normal. Mild (1+) mitral regurgitation is seen. The estimated pulmonary artery systolic pressure is normal. There is no pericardial effusion. IMPRESSION: Suboptimal image quality. Moderate symmetric left ventricular hypertrophy with preserved left ventricular systolic function in the setting of beat-to-beat variability. Mildly dilated, normally functioning right ventricle. Mildly dilated aortic root and ascending aorta. Mild mitral regurgitation. ___: RUQUS: 1. Markedly echogenic liver consistent with severe steatosis. Other forms of liver disease including steatohepatitis, hepatic fibrosis, or cirrhosis cannot be excluded on the basis of this examination. No focal liver lesions are identified. 2. No ascites or splenomegaly. 3. Views of the kidneys show bilateral pelvocaliectasis, which is most likely related to the markedly distended urinary bladder. Microbiology: =============== ___ URINE CULTURE (Final ___: < 10,000 CFU/mL. Discharge labs: =============== ___ 07:45AM BLOOD WBC-6.2 RBC-4.00* Hgb-12.3* Hct-35.3* MCV-88 MCH-30.8 MCHC-34.8 RDW-15.9* RDWSD-49.5* Plt Ct-88* ___ 06:18AM BLOOD Glucose-84 UreaN-12 Creat-0.8 Na-140 K-3.4 Cl-101 HCO3-26 AnGap-13 ___ 05:20AM BLOOD ALT-34 AST-26 AlkPhos-86 TotBili-0.8 ___ 06:18AM BLOOD Mg-2.0 ___ 07:03PM BLOOD Hapto-89 ___ 05:20AM BLOOD VitB12-419 Folate-9 ___ 07:03PM BLOOD HBsAg-NEG HBsAb-NEG HBcAb-NEG ___ 07:03PM BLOOD HIV Ab-NEG Brief Hospital Course: Summary ___ with history of DM, HTN, bipolar II, h/o PE (not on anticoagulation), EtOH abuse who presented with symptoms of alcohol withdrawal, found to be in Aflutter with RVR. He was treated with phenobarbital taper and his withdrawal improved. He spontaneously converted to sinus rhythm with diltiazem rate control and was discharged with a holter monitor. # ATRIAL FLUTTER Improved with diltiazem and he converted to NSR on ___. Suspect a provoked event iso withdrawal. He was initiated on anticoagulation however discontinued due to low plt count and low chads-vasc score (1). TTE was without evidence of significant structural heart disease. He was discharged on diltiazem ER 120mg daily. Anticoagulation was held for now and he was discharged with a 48 hour holter monitor. He will follow with his PCP this week. # ALCOHOL WITHDRAWAL # ALCOHOL USE DISORDER Was drinking 2 litres of vodka per day. Symptoms markedly improved with phenobarbital taper. He was counseled extensively abstaining from alcohol in the future. # ___ TEAR I/s/o retching and vomiting. Did not require any transfusion and improved with supportive care. # THROMBOCYTOPENIA Suspect secondary to alcohol and underlying liver disease. 4T score was low, and there was no concern for HIT. Heme onc was consulted and felt this was likely due to etoh and liver disease. Plt on discharge were 88,000. He will followup with heme as outpatient. # BIPOLAR II DISORDER Continued home divalproex. # DEPRESSION Continued home vortioxetene. # HTN. Continued home Lisinopril, amlodipine. Home HCTZ was held iso starting diltiazem and can be restarted if he is hypertensive as an outpatient. # T2DM Continued home metformin. # OSA Continue home CPAP. # HLD Continue home Atorvastatin 40mg qhs. Transitional issues - Started on diltiazem ER 120mg for rate control in case patient goes back into afib or flutter. Would titrate as outpatient pending heart rates. - HCTZ was held in setting of well controlled BPs on diltiazem and other home regimen. - Was sent with 48H Holter monitor and off anticoagulation. Will see PCP this week and consider AC if he has other episodes of flutter or fib. - Will follow in clinic with PCP and hematology (for thrombocytopenia). Next of Kin: ___ Relationship: SISTER Phone: ___ # CODE STATUS: full (presumed) Medications on Admission: The Preadmission Medication list is accurate and complete. 1. Lisinopril 40 mg PO DAILY 2. MetFORMIN (Glucophage) 1000 mg PO DAILY 3. Atorvastatin 40 mg PO QPM 4. BusPIRone 20 mg PO BID 5. amLODIPine 10 mg PO DAILY 6. Trintellix (vortioxetine) 20 mg oral DAILY 7. Pantoprazole 40 mg PO Q24H 8. Hydrochlorothiazide 25 mg PO DAILY 9. Divalproex (EXTended Release) 1500 mg PO DAILY Discharge Medications: 1. Diltiazem Extended-Release 120 mg PO DAILY RX *diltiazem HCl 120 mg 1 capsule(s) by mouth daily Disp #*30 Capsule Refills:*0 2. amLODIPine 10 mg PO DAILY 3. Atorvastatin 40 mg PO QPM 4. BusPIRone 20 mg PO BID 5. Divalproex (EXTended Release) 1500 mg PO DAILY 6. Lisinopril 40 mg PO DAILY 7. MetFORMIN (Glucophage) 1000 mg PO DAILY 8. Pantoprazole 40 mg PO Q24H 9. Trintellix (vortioxetine) 20 mg oral DAILY Discharge Disposition: Home Discharge Diagnosis: Primary: Etoh withdrawal Atrial flutter Secondary: Thrombocytopenia Bipolar disorder HTN T2DM Discharge Condition: Mental Status: Clear and coherent. Level of Consciousness: Alert and interactive. Activity Status: Ambulatory - Independent. Discharge Instructions: Dear Mr. ___, You came to ___ due to alcohol withdrawal and we found you to have an abnormal heart rate. This improved with medication, however it is essential to avoid alcohol in the future. Please take the medication we have prescribed and follow with your outpatient doctors. It was a pleasure taking care of you, Your ___ medical team Followup Instructions: ___
19711968-DS-17
19,711,968
24,032,758
DS
17
2155-10-03 00:00:00
2155-10-02 15:39:00
Name: ___ Unit No: ___ Admission Date: ___ Discharge Date: ___ Date of Birth: ___ Sex: M Service: MEDICINE Allergies: No Known Allergies / Adverse Drug Reactions Attending: ___. Chief Complaint: Alcohol Withdrawal Major Surgical or Invasive Procedure: none History of Present Illness: Patient reports he has been drinking heavily this week. Last drink ___ at 11a. Reports he was suicidal today, planning to cut himself with a kitchen knife. Reports he last thought about killing himself in ___, when he walking up to a roof and thought about jumping while sober. Reports history of alcohol withdrawal seizure. Suicidal thoughts in setting of his girlfriend breaking up with him 2 days ago. Denies violent thoughts or hallucinations. Vomiting earlier today. Intermittent diarrhea. Denies fever, chills, chest pain, shortness of breath, change in bladder function, change in vision or hearing, bruising, adenopathy, new rash or lesion. Per initial psych note, was brought to the ED by EMS after he called ___ reporting SI in the setting of alcohol intoxication. Psychiatry is consulted for safety assessment. On approach, patient is laying down in bed in NAD. When asked he states that he feels "still drunk". BAL 3 hours prior to interview was 329. Patient was notably slurring some words during encounter. He stated that he called ___ tonight because he was having SI with thoughts of cutting himself. "I was holding the knife up like this" to his wrist. He reports that he feels his depression is "out of control" and would like to seek more treatment for it. He denies HI. He reports feeling tremulous and like he is entering alcohol withdrawal. In the ED, - Initial Vitals: 98.4, HR 70, BP 151/66, 95% RA, RR 16 - Exam: AOx3, smells of alcohol, NAD, suicidal ideation with plan - Labs: Na 146, K 3.6, Cr 0.9, BUN 13, HCO3 24, serum EtOH 329, serum ASA, tylenol, TCA negative; WBC 6.6, Hgb 15.6, Plt 169, - Imaging: None - Consults: None - Interventions: CIWA protocol (diazepam 20mgx2, 10mgx6; lorazepam 2mgx2) phenobarbital 650mg, Zofran 4mg, 1L NS, diltiazem 10mg x2 ROS: Positives as per HPI; otherwise negative. Past Medical History: 1. CARDIAC RISK FACTORS - Diabetes - Hypertension - Dyslipidemia -TIA in ___ ___ ___ (left AMA) 2. CARDIAC HISTORY - Atrial flutter 3. OTHER PAST MEDICAL HISTORY - bipolar disorder type 2 - Unprovoked PE in ___ (extensive bilateral segmental and subsegmental pulmonary emboli, with central extension into the left main pulmonary artery) previously on anticoagulation with Xarelto for 7 months - Obesity - OSA - Depression requiring ECT in the past - EtOH abuse Social History: ___ Family History: Father CABG in his ___. Physical Exam: ADMISSION PHYSICAL EXAM ======================== VS: reviewed in metavision GENERAL: somnolent but arousable, clear thought and logic HEENT: short neck, MMM CARDIAC: RR, tachycardic, no MRG LUNGS: CTAB, no wheezes, rales or ronchi ABDOMEN: soft, nt, BS+ EXTREMITIES: no lower extremity edema, pulses ___ 2+ NEUROLOGIC: no clonus, moves all 4 extremities with purpose, face symmetric, CN II-XII grossly intact, insightful DISCHARGE PHYSICAL EXAM =========================== ___ ___ Temp: 97.6 PO BP: 117/77 R Lying HR: 59 RR: 18 O2 sat: 99% O2 delivery: Cpap FSBG: 95 General: obese, lying in bed, CPAP in place but easily arousable. HEENT: OP moist, no LAD appreciated, face symmetric Resp CTA B, no rales, wheezes anteriorly. Normal respiratory effort CV RRR without murmurs, distant heart sounds GI soft, NT, ND, NABS MS: no edema Back with tenderness in area of right upper buttock. Neuro: alert/oriented X3, moves comfortably in bed. No tremor Psych: Appropriate Pertinent Results: ADMISSION LABS ================= ___ 08:12PM BLOOD WBC-6.6 RBC-5.10 Hgb-15.6 Hct-44.0 MCV-86 MCH-30.6 MCHC-35.5 RDW-15.3 RDWSD-46.0 Plt ___ ___ 08:12PM BLOOD Neuts-51.2 ___ Monos-9.7 Eos-1.8 Baso-1.4* Im ___ AbsNeut-3.39 AbsLymp-2.35 AbsMono-0.64 AbsEos-0.12 AbsBaso-0.09* ___ 08:00PM BLOOD ___ PTT-25.8 ___ ___ 08:12PM BLOOD Glucose-146* UreaN-13 Creat-0.9 Na-146 K-3.6 Cl-101 HCO3-24 AnGap-21* ___ 08:12PM BLOOD ASA-NEG ___ Acetmnp-NEG Tricycl-NEG ___ 11:40PM URINE bnzodzp-POS* barbitr-NEG opiates-NEG cocaine-NEG amphetm-NEG oxycodn-NEG mthdone-NEG INTERVAL LABS ================ ___ 02:58PM BLOOD D-Dimer-1427* ___ 02:58PM BLOOD ALT-28 AST-29 LD(LDH)-259* AlkPhos-76 TotBili-1.7* ___ 08:00PM BLOOD ALT-26 AST-24 LD(LDH)-235 AlkPhos-78 TotBili-1.8* ___ 04:04AM BLOOD ALT-22 AST-19 LD(LDH)-206 AlkPhos-73 TotBili-1.3 ___ 04:04AM BLOOD Albumin-3.6 Calcium-8.3* Phos-3.7 Mg-2.3 ___ 01:08AM BLOOD %HbA1c-5.9 eAG-123 ___ 04:04AM BLOOD TSH-5.2* ___ 04:04AM BLOOD Free T4-1.3 DISCHARGE LABS ================ ___ 05:38AM BLOOD WBC-5.5 RBC-4.48* Hgb-13.8 Hct-39.8* MCV-89 MCH-30.8 MCHC-34.7 RDW-16.1* RDWSD-50.8* Plt ___ ___ 05:38AM BLOOD Glucose-104* UreaN-12 Creat-0.9 Na-139 K-3.5 Cl-101 HCO3-23 ___ MICRO ======= N/A PERTINENT IMAGING/STUDIES =========================== ___ CTA CHEST FINDINGS: CHEST PERIMETER: No thyroid findings require any further imaging evaluation. Supraclavicular and axillary lymph nodes are not enlarged. No soft tissue abnormalities in the chest wall. This study is not appropriate for subdiaphragmatic diagnosis but shows no adrenal mass or subphrenic collection. Steatosis of the liver is severe. CARDIO-MEDIASTINUM: Esophagus is unremarkable. Atherosclerotic calcification is not apparent head neck vessels, but is scattered in at least left anterior descending coronary artery. Aorta is normal size and the lumen is intact. Dilatation of the main pulmonary artery, 35 mm, has improved since ___, previously 39 mm, when the patient had multiple pulmonary emboli. Left atrium is newly enlarged, 51 mm in transverse diameter, previously 38 mm. Right ventricle is not enlarged. Cardiac evaluation would require echocardiography. PULMONARY ARTERIES: Main, right, left, and lobar pulmonary arteries are normal. Right and left descending pulmonary arteries are normal. Because of severe respiratory motion, small filling defects are impossible to separate from motion artifacts in the lower lobes. Even if present one would not expect these to have much clinical impact. THORACIC LYMPH NODES: No lymph nodes in the chest are pathologically enlarged. LUNGS, AIRWAYS, PLEURAE: Lungs are grossly clear. Tracheobronchial tree is normal to subsegmental levels and there is no pleural effusion or other pleural abnormality. CHEST CAGE: No evidence of malignancy or infection. No compression fracture. IMPRESSION: No pulmonary emboli in major pulmonary vessels. Subsegmental emboli not excluded in the lower lobes because of motion artifact. Previous pulmonary artery dilatation has improved. New left atrial enlargement. No pulmonary edema. Echocardiography recommended. Upper extremity ultrasound ___: 1. No evidence of deep vein thrombosis in the right upper extremity. 2. Short segment thrombosed superficial vein in the area of patient reported swelling is compatible with superficial thrombophlebitis. Brief Hospital Course: Brief ICU course: ___ y.o w/ EtOH use disorder c/b withdrawal/hallucinations, bipolar disorder type 2, prior PE in ___ s/p 7mo AC with xarelto, atrial flutter, HTN/dyslipidemia, T2DM, depression, and OSA who presents with alcohol intoxication and suicidal ideation, now with alcoholwithdrawal, admitted to ___ for high-risk withdrawal, then transferred to floor on 1:1 sitter to await psychiatry placement. ACUTE ISSUES ======================= #Alcohol withdrawal #Alcohol use disorder At ED, received multiple doses of Diazepam per CIWA protocol, and was escalated to ICU withdrawal protocol, receiving 650mg phenobarbital (10mg/kg) loading dose prior to transfer to ICU. He developed atrial flutter (HR 140-150s) in setting of withdrawal, although HDS, and started and titrated to diltiazem 45mg TID with reversion to normal sinus rhythm while at the ICU. Withdrawal symptoms were minimal after phenobarbital loading dose, so he did not receive additional dosage. He received clonidine for adrenergic hyperactivity. Transferred to floor as patient was >24h post-phenobarbital, and stable. Last drink on ___ at 11am. Has prior history of seizures and atrial fibrillation in ___ i/s/o withdrawal. Initially, BAL 329 and tremulous. Received diazepam per CIWA protocol, and transitioned to ICU withdrawal protocol for high-risk withdrawal. Phenobarb loaded in the ED and transferred to the ICU, where he received clonidine for adrenergic hyperactivity. No evidence of acute alcoholic hepatitis. He also received thiamine 500mg IV TID for 3 days during phenobarbital, followed by 200mg IV daily. His clonidine was tapered to 1 patch on ___, and should be stopped completely on ___. #Suicidal ideation Active SI with plan to use knife to cut wrists. Reports past suicide attempt in ___ where he overdosed on lorazepam with alcohol, waking up 3d later. Initially on ___, however as he became sober he had no more SI. Psychiatry was consulted and recommended inpatient psychiatry. #Atrial fibrillation with RVR Has known history of aflutter. He was tachycardic to 150 BMP, but hemodynamically stable. Per medication filling history, is written for diltiazem 120mg ER. At ED, he received diltiazem 10mg x2, but patient remained in afib. He eventually broke his tachycardia with 45 mg diltiazem TID. ___ 2 (T2DM, HTN), currently not on AC. Had previously been on Xarelto for 7 months for unprovoked PE in ___. At last hospitalization at ___, ___, AC was held given high-risk EtOH use (risk of falls). D-dimer 1427 at ED and CTA negative ruling out PE. He was stable on diltiazem 120 mg po daily. Anticoagulation was discussed, but he declined and will discuss with his pcp. #Superficial thrombophlebitis He noted some erythema and tenderness posterior to his right arm and the location of prior IV. Ultrasound confirmed a superficial thrombosis in this area. He had no air fever at this point. Despite prior history of DVT this is likely a provoked small superficial clot. He was started on ibuprofen for pain management and inflammation and cold packs. This should be continued at discharge. If he develops fevers or chills or tracking erythema, would start antibiotics for MRSA coverage given hospital-associated development - either Bactrim or clindamycin. CHRONIC ISSUES ======================= #HTN Initially held home lisinopril 40mg QD and amlodipine 10mg given afib+RVR. Restarted lisinopril 20 mg po daily, but still hypertensive. Because of the clonidine for alcohol withdrawal, he did not require amlodipine 10 mg po daily. Lisinopril 40 was started at discharge, and amlodipine should be restarted on ___, and clonidine stopped on ___. #DM Placed on ISS #CAD Continued home ASA 81mg and atorvastatin 40mg QPM # Type II diabetes mellitus Resumed home metformin at discharge. TRANSITIONAL ISSUES ==================== Anticoagulation for atrial fibrillation, balancing fall risk and kickboxing, should be discussed with pcp. Hypertension: amlodipine held at dc. Should be restarted on ___, prior to dc of clonidine on ___. Left atrial enlargement: consider outpatient echo. Medications on Admission: The Preadmission Medication list is accurate and complete. 1. Aspirin 81 mg PO DAILY 2. FoLIC Acid 1 mg PO DAILY 3. Multivitamins W/minerals 1 TAB PO DAILY 4. Thiamine 100 mg PO DAILY 5. Atorvastatin 40 mg PO QPM 6. Lisinopril 40 mg PO DAILY 7. MetFORMIN (Glucophage) 1000 mg PO DAILY 8. amLODIPine 10 mg PO DAILY 9. QUEtiapine Fumarate 100 mg PO QHS:PRN insomnia 10. Venlafaxine XR 150 mg PO DAILY 11. Mirtazapine 7.5 mg PO QHS 12. HydrOXYzine 25 mg PO Q4H:PRN anxiety 13. Gabapentin 300 mg PO TID Discharge Medications: 1. Acetaminophen 650 mg PO Q6H:PRN Pain - Mild/Fever 2. Clonidine Patch 0.1 mg/24 hr 1 PTCH TD QTUES Duration: 3 Days Remove on ___. Diltiazem Extended-Release 120 mg PO DAILY 4. Ibuprofen 400 mg PO Q8H Duration: 5 Days 5. Aspirin 81 mg PO DAILY 6. Atorvastatin 40 mg PO QPM 7. FoLIC Acid 1 mg PO DAILY 8. HydrOXYzine 25 mg PO Q4H:PRN anxiety 9. Lisinopril 40 mg PO DAILY 10. MetFORMIN (Glucophage) 1000 mg PO DAILY 11. Mirtazapine 7.5 mg PO QHS 12. Multivitamins W/minerals 1 TAB PO DAILY 13. QUEtiapine Fumarate 100 mg PO QHS:PRN insomnia 14. Thiamine 100 mg PO DAILY 15. HELD- amLODIPine 10 mg PO DAILY This medication was held. Do not restart amLODIPine until advised by your pcp ___: Extended Care Discharge Diagnosis: PRIMARY DIAGNOSIS =================== Alcohol use disorder SECONDARY DIAGNOSES ==================== Bipolar disorder with suicidal ideation Atrial fibrillation Obstructive sleep apnea Diabetes mellitus, type II Hypertension Discharge Condition: tolerating diet. Discharge Instructions: Dear Mr ___, It was a pleasure taking care of you at the ___ ___. Why did you come to the hospital? -You came to the hospital because you were withdrawing from alcohol, and you are having thoughts of killing yourself. What happened while you were in the hospital? -You were given medications to prevent side effects from withdrawing from alcohol, like seizures. -You met with the psychiatry team, and they recommended inpatient psychiatry treatment. - You developed a superficial clot in your right arm, where there was an IV. What should you do once you leave the hospital? - You should not drink alcohol anymore. -If you are having thoughts of hurting herself or killing yourself, he should reach out to your doctor, ___, or friends. There are also numbers that you can call, likely a suicide prevention hotline (___). - Please take your medications as prescribed and go to your future appointments which are listed below. - take ibuprofen for 5 days for the thrombophlebitis - remove the clonidine patch in 3 days We wish you all the best! - Your ___ Care Team Followup Instructions: ___
19712053-DS-10
19,712,053
26,290,291
DS
10
2114-08-04 00:00:00
2114-08-04 17:42:00
Name: ___ Unit No: ___ Admission Date: ___ Discharge Date: ___ Date of Birth: ___ Sex: M Service: MEDICINE Allergies: ___ Attending: ___ Chief Complaint: BRBPR Major Surgical or Invasive Procedure: ___ EGD with Small Bowel Enteroscopy ___ Colonoscopy History of Present Illness: Mr. ___ is a ___ year old man with a past medical history of hypertension, DM2, recent admission with GI bleed secondary to duodenal ulcer vs. small bowel diverticular bleed who presents with bright red blood per rectum. The patient was admitted to ___ from ___ after transfer from ___ for GI bleed. He reported ___ weeks of melenic stools. He then stopped eating for a week and presented to the ED with lightheadedness. He was transferred from ___ for consideration of ___ procedure after EGD at ___ on ___ did not show a clear etiology for bleed. His Hb remained 7.2-8.7 at ___. Creatinine was 1.9 on admission. Lactate 3.9. He had a tagged RBC scan with active GI bleed in the region of small bowel diverticula of the left portion of the abdomen. At ___, a CTA was performed that showed small bowel diverticulosis without active extravasation. GI was consulted and underwent endoscopy that showed a 1 cm duodenal ulcer with active arterial bleed in the bulb which was treated with 4 clips and epinephrine. He was placed on BID IV PPI for 72 hours post-proceure and discharged with PO PPI. Discharge Hb 7.4 His course was complicated by RUE DVT after PICC line placement. He was placed on heparin IV for 48 hours with stable Hb in the ___ range and was discharged on apixaban (10mg BID for 7 days to complete ___ then 5mg BID on ___. The patient was discharge to rehab on ___. At rehab he developed multiple episodes of bright red stool beginning the morning of ___. He was given 500cc NS before arrival. In the ED he denied chest pain, nausea, vomiting, shortness of breath. he had mild abdominal discomfort. In ED initial VS: T 98.7 HR 81 BP 101/57 RR 16 SaO2 98% RA Labs significant for: Hb 5 Lactate 2 Cr 1.8 INR 2.6 Patient was given: 40mg IV pantoprazole Consults: GI VS prior to transfer: T 97.7 HR 68 BP ___ RR 16 SaO2 100% RA On arrival to the MICU, the patient confirms the above. He is not having lightheadedness, shortness of breath, chest pain, abdominal pain, nausea, vomiting. REVIEW OF SYSTEMS: 10 point review of systems negative except as noted above. Past Medical History: RUE ___ associated DVT ___ Upper GI Bleed with Duodenal ulcer ___ Hypertension Diverticulosis with small bowel diverticula Diabetes Obesity Social History: ___ Family History: Mother with lung cancer. Physical Exam: ADMISSION PHYSICAL EXAM ======================= VITALS: Reviewed in metavision GENERAL: Alert and in no apparent distress EYES: Anicteric, pupils equally round ENT: Ears and nose without visible erythema, masses, or trauma. Oropharynx without visible lesion, erythema or exudate CV: Heart regular, no murmur RESP: Lungs clear to auscultation with good air movement bilaterally. Breathing is non-labored GI: Abdomen soft, non-distended, non-tender to palpation. Bowel sounds present. No HSM GU: No suprapubic fullness or tenderness to palpation MSK: Neck supple, moves all extremities. RUE swelling. PSYCH: pleasant, appropriate affect NEUROLOGIC: Moves all extremities. MENTATION: alert and cooperative. Oriented to person and place and time. DISCHARGE PHYSICAL EXAM ========================= ___ 0811 Temp: 98.1 PO BP: 120/66 L Sitting HR: 66 RR: 18 O2 sat: 92% O2 delivery: Ra FSBG: 142 GENERAL: NAD HEENT: AT/NC, PERRL, anicteric sclera, pink conjunctiva NECK: supple, difficult to appreciate JVP due to habitus HEART: RRR, nl S1/S2, no murmurs LUNGS: CTAB no wheezing rales or ronchi ABDOMEN: Obese, soft, nontender, nondistended, no rebound or guarding EXTREMITIES: WWP, trace edema bilaterally to thighs, wrinkles present at ankles. No edema in b/l UE. Pertinent Results: ADMISSION LABS =============== ___ 12:45PM BLOOD WBC-6.1 RBC-1.62* Hgb-5.1* Hct-16.1* MCV-99* MCH-31.5 MCHC-31.7* RDW-18.8* RDWSD-68.7* Plt ___ ___ 12:45PM BLOOD Neuts-76.2* Lymphs-10.1* Monos-10.1 Eos-1.3 Baso-0.2 NRBC-0.3* Im ___ AbsNeut-4.61 AbsLymp-0.61* AbsMono-0.61 AbsEos-0.08 AbsBaso-0.01 ___ 12:59PM BLOOD ___ PTT-31.7 ___ ___ 12:59PM BLOOD ___ 12:59PM BLOOD Glucose-171* UreaN-50* Creat-1.8* Na-131* K-5.7* Cl-103 HCO3-20* AnGap-8* ___ 04:50PM BLOOD ALT-11 AST-25 AlkPhos-87 TotBili-0.5 ___ 12:59PM BLOOD cTropnT-<0.01 ___ 12:59PM BLOOD Calcium-7.7* Phos-3.7 Mg-1.7 ___ 05:04PM BLOOD ___ pO2-32* pCO2-38 pH-7.34* calTCO2-21 Base XS--5 ___ 01:23PM BLOOD Lactate-2.0 Na-130* K-3.9 DISCHARGE LABS =================== ___ 06:05AM BLOOD WBC-3.6* RBC-2.64* Hgb-8.1* Hct-25.4* MCV-96 MCH-30.7 MCHC-31.9* RDW-17.1* RDWSD-59.6* Plt ___ ___ 06:05AM BLOOD Glucose-107* UreaN-12 Creat-1.2 Na-140 K-4.5 Cl-103 HCO3-24 AnGap-13 ___ 06:05AM BLOOD Calcium-8.3* Phos-3.5 Mg-1.7 NOTABLE LABS ============= ___ 03:00AM BLOOD WBC-4.7 RBC-2.26* Hgb-6.8* Hct-20.9* MCV-93 MCH-30.1 MCHC-32.5 RDW-17.8* RDWSD-59.8* Plt ___ ___ 04:19AM BLOOD ___ PTT-29.0 ___ ___ 04:19AM BLOOD Ret Aut-3.1* Abs Ret-0.07 ___ 04:19AM BLOOD Glucose-159* UreaN-20 Creat-0.8 Na-140 K-3.7 Cl-104 HCO3-21* AnGap-15 MICROBIOLOGY =================== __________________________________________________________ ___ 9:30 am BLOOD CULTURE Source: Venipuncture. **FINAL REPORT ___ Blood Culture, Routine (Final ___: NO GROWTH. __________________________________________________________ ___ 1:11 pm BLOOD CULTURE Source: Line-tlcl. **FINAL REPORT ___ Blood Culture, Routine (Final ___: NO GROWTH. __________________________________________________________ ___ 9:42 am BLOOD CULTURE Source: Line-tlcl #2. **FINAL REPORT ___ Blood Culture, Routine (Final ___: NO GROWTH. IMAGING ======== ___ CXR The tip of an endotracheal tube projects 3.7 cm from the carina. The right internal jugular central venous catheter tip projects over the mid SVC. There is moderate pulmonary edema. Bibasilar opacities, left greater than right likely reflect atelectasis. The small to moderate left pleural effusion is also suspected. No pneumothorax. The size of the cardiac silhouette is enlarged but unchanged. ___ EGD with Small Bowel Enteroscopy Normal esophagus. Normal stomach. Previous ulcer with 2 clips in place noted in the duodenum with no evidence of active bleeding. 2mm Polyp in ___ part of duodenum just opposite the ampulla. Multiple diverticula of various sizes (small and large) were noted in the examined portion of the jejunum. There was no evidence of bleeding. ___ (PORTABLE AP) IMPRESSION: ET tube tip is 5 cm above the carinal. NG tube is in the proximal stomach and might be further advanced. Assessment is slightly limited due to motion artifact but there is impression of minimal improvement in vascular congestion and still present left pleural effusion. There is also most likely new left lower lobe atelectasis with left mediastinal shift. ___ (PORTABLE AP) IMPRESSION: Right internal jugular line tip is at the level of superior SVC. Heart size and mediastinum are stable. Right perihilar opacity and right basal consolidation are unchanged, concerning for infection. No appreciable pneumothorax is seen. Left basal consolidation has improved. ___ Report CONCLUSION: The left atrium is mildly dilated. The right atrium is moderately enlarged. There is mild symmetric left ventricular hypertrophy with a mildly increased/dilated cavity. There is suboptimal image quality to assess regional left ventricular function. Global left ventricular systolic function is at least mildly depressed. The visually estimated left ventricular ejection fraction is 45%. There is no resting left ventricular outflow tract gradient. Moderately dilated right ventricular cavity with depressed free wall motion. There is abnormal interventricular septal motion c/w right ventricular pressure and volume overload. The aortic sinus is mildly dilated with mildly dilated ascending aorta. There is a mildly dilated descending aorta. The aortic valve leaflets (3) are mildly thickened. There is no aortic valve stenosis. There is no aortic regurgitation. The mitral leaflets are mildly thickened. There is no mitral valve stenosis. There is trivial mitral regurgitation. There is no pericardial effusion. Moderate pulmonary hypertension IMPRESSION: Suboptimal image quality. At least mild biventricular contractile dysfunction. Tricuspid regurgitation is present but could not be quantified with certainty and may be significant. At least moderate pulmonary hypertension. ___ UP EXT VEINS US IMPRESSION: No evidence of deep vein thrombosis in the bilateral upper extremities. Previously seen DVT and superficial thrombophlebitis have resolved. ___ Colonoscopy Normal mucosa in the whole colon and 10cm into the terminal ileum. Mild diverticulosis of the ascending colon and sigmoid colon. There were two small polyps <5mm in the transverse colon and at the tattoo site. These were not removed given this colonoscopy was done for evaluation of obscure overt GIB. Tattoo next to the 1cm submucosal lesion was noted. Submucosal lesion had normal ovelrying mucosa with no ulceration or stigmata of bleeding. Internal hemorrhoids. External hemorrjoids. Brief Hospital Course: ___ w/ PMHx of HTN, DM2, recent admission with GI bleed ___ duodenal ulcer vs small bowel diverticuli course c/b PICC-associated RUE DVT who p/w BRBPR found to have hypotension likely caused by acute blood loss anemia also found to have volume overload in setting of new diastolic heart failure. # New Diagnosis Diastolic Heart Failure: Pt presented with symptoms of orthopnea, ___ edema, BNP >14K c/f CHF. TTE showed EF 45% with mild biventricular systolic dysfunction, moderate pulmonary HTN. Patient received IV Lasix diuresis with good urine output response and significant symptom improvement. Patient discharged on 40mg PO furosemide BID. # GIB: Recent upper GI bleed secondary to duodenal ulcer that was visualized on EGD and treated with clips and epi on ___. Presented this admission with anemia (Hb 5) in setting of starting anticoagulation for precipitated RUE DVT. Patient received total of 6U pRBC and 2 U FFP for admission HgB 5 and hypotension thought secondary to acute blood loss. S/p EGD ___ and colonoscopy ___ without evidence of bleeding source. Likely bleeding was due to jejunal diverticulosis. No further episodes of BRBPR and Hb stable during admission. Patient was started on BID PPI, to continue for ___ weeks. Afterwards, he will need daily PPI as he is also on ASA daily. CHRONIC/RESOLVED ISSUES ====================== # Pneumonia: Pt presented with cough. CXR w/ RLL infiltrate and leukopenia concerning for PNA. S/p levofloxacin (___). No further cough. # Right upper extremity DVT: Provoked partially occlusive R brachial vein thrombus and occlusive right cephalic vein thrombus diagnosed at OSH in setting of PICC line placement. Pt was started on apixiban at that time; likely contributed GIB. Given distal location in UE, improving R arm swelling and GIB withholding further anticoagulation. Repeat UE US (___) shows no evidence of deep vein thrombosis in the bilateral upper extremities. # T2DM: Last Hgb A1c 4.0% on ___. On metformin, glipizide, pioglitazone at home. Received insulin sliding scale during hospitalization with good blood sugar control. Home glipizide and pioglitazone held on discharge # HTN: On losartan, amlodipine, metoprolol at home. Was on HCTZ and recently stopped. Home metoprolol succinate 100 mg QD was restarted and home dose of losartan was decreased from 100mg QD to 50 mg QD in setting of soft BP. Home amlodipine 10 mg QD was held in setting of soft BP. # ___, resolved Creatinine 1.8 admission with discharge creatinine 0.9. Etiology likely pre-renal in the setting of acute blood loss and hypotension. Improved w/ blood transfusion. TRANSITIONAL ISSUES: =================== [] Please continue to monitor blood pressure. Restart amlodipine and/or increase losartan back to 100 mg QD pending BP [] Will need BID PPI for ___ weeks, then if taking ASA will need daily PPI for life after initial ___ weeks of bid [] Needs outpatient sleep study [] Nighttime O2 at rehab [] Discharge on Lasix 40 mg PO BID. If weight increases or decreases by 3 lbs call notify MD immediately. ___ need adjustment of PO Lasix regimen. [] Please obtain daily standing weight and daily monitor fluid status [] Repeat CBC and serum chemistries ___. [] Discharge weight 153.9kg/ 339.29 lbs [] Discharge creatinine 1.2 [] Dischage Hemoglobin 8.1 Hematocrit 25.4. [] Metformin restarted at d/c. Home glipizide and pioglitazoe given low insulin requirements and HbA1c 4% in ___. f/u with managing physician for ongoing diabetes management [] Repeat CXR in 6 weeks to ensure resolution of pneumonia [] If ongoing or recurrent overt GI bleeding, could consider capsule endoscopy as next step for evaluation (patient has signficant jejunal diverticulosis and capsule endoscopy could suggest if these are the source of his overt bleeding) [] If general health allows, outpatient colonoscopy for removal of polyps could be considered. Polyps are small and non-worrisome Medications on Admission: The Preadmission Medication list is accurate and complete. 1. amLODIPine 10 mg PO DAILY 2. Losartan Potassium 100 mg PO DAILY 3. Metoprolol Succinate XL 100 mg PO DAILY 4. Bisacodyl 10 mg PO/PR DAILY:PRN constipation 5. Docusate Sodium 100 mg PO BID 6. Milk of Magnesia 30 mL PO Q6H:PRN constipation 7. Pantoprazole 40 mg PO Q12H 8. Senna 8.6 mg PO BID 9. Apixaban 5 mg PO BID 10. Aspirin 81 mg PO DAILY 11. GlipiZIDE XL 5 mg PO DAILY 12. MetFORMIN (Glucophage) 1000 mg PO BID 13. Pioglitazone 45 mg PO DAILY Discharge Medications: 1. Furosemide 40 mg PO BID 2. Losartan Potassium 50 mg PO DAILY 3. Aspirin 81 mg PO DAILY 4. Bisacodyl 10 mg PO/PR DAILY:PRN constipation 5. Docusate Sodium 100 mg PO BID 6. MetFORMIN (Glucophage) 1000 mg PO BID 7. Metoprolol Succinate XL 100 mg PO DAILY 8. Milk of Magnesia 30 mL PO Q6H:PRN constipation 9. Pantoprazole 40 mg PO Q12H 10. Senna 8.6 mg PO BID 11. HELD- amLODIPine 10 mg PO DAILY This medication was held. Do not restart amLODIPine until OK by your PCP 12. HELD- GlipiZIDE XL 5 mg PO DAILY This medication was held. Do not restart GlipiZIDE XL until OK by your PCP 13. HELD- Pioglitazone 45 mg PO DAILY This medication was held. Do not restart Pioglitazone until OK by your PCP ___: Extended Care Facility: ___ Discharge Diagnosis: Diastolic heart failure Acute GI bleed Community acquired pneumonia Discharge Condition: Mental Status: Clear and coherent. Level of Consciousness: Alert and interactive. Activity Status: Ambulatory - requires assistance or aid (walker or cane). Discharge Instructions: Dear Mr. ___, It was a pleasure caring for you at ___. WHY WAS I IN THE HOSPITAL? - You were here because you were bleeding and your blood pressure was dangerously low. WHAT HAPPENED TO ME IN THE HOSPITAL? - You received medications to treat a pneumonia. - You underwent endoscopy to look for active sites of bleeding, and we found none. - You received blood transfusions. - You received medications to decrease extra fluid build-up in your body. WHAT SHOULD I DO AFTER I LEAVE THE HOSPITAL? - Continue to take all your medicines and keep your appointments. - Please check your weight daily and call MD if your weight increases or decreases by 3 lbs. - New medication: furosemide 40mg twice daily. - New medication: pantoprazole 40mg twice daily. Take this twice daily for the next ___ weeks then once daily afterwards. - Changed medication: Losartan 50mg daily (decreased from your home dose of 100mg daily). We wish you the best! Sincerely, Your ___ Team Followup Instructions: ___
19712371-DS-4
19,712,371
25,686,052
DS
4
2116-05-16 00:00:00
2116-05-17 13:56:00
Name: ___ Unit No: ___ Admission Date: ___ Discharge Date: ___ Date of Birth: ___ Sex: F Service: NEUROLOGY Allergies: hydrochlorothiazide / Milk of Magnesia Attending: ___. Chief Complaint: ___ weakness Major Surgical or Invasive Procedure: None History of Present Illness: Ms. ___ is a ___ year old right-handed woman with PMH of obesity, OSA on CPAP, HTN, hypercalcemia, breast cancer (treated ___, cervical cancer (remote, treated at ___, anemia, schizophrenia presents with 4 months of worsening lower extremity weakness. She was sent to ED for evaluation for MRI and evaluation for possible myelopathy. She had worsening left shoulder pain in ___ when she was admitted to ___ for evaluation. She was discharged in ___ to ___. Patient says that when she left the hospital she was no longer able to walk. She had been using rollator/ walker for about a year. In rehab, she could not walk even with a walker and felt generalized fatigue. Now she lives at ___. She feels that her arms are weak as well and was weak before the legs. She attributes upper extremity weakness to a previous fall which caused pain/soreness. Pain is especially bad in her left shoulder and she does not move her left arm much as a result. The weakness gradually worsened and two weeks ago she could not move her legs at all. Previously, she couldn't walk but could still lift them up. Now she cannot even turn in bed. She also complains about numbness in both hands described has "like one big blister" on her hands and fingers. This has made it more difficult for her to open a bag of chips or a box of cookies. Denies parathesias. Patient has had long standing urinary incontinence since ___. She wears diapers for this. No bowel incontince. She complains of constipation and says it is difficult to have bowel movements. She also has a longstanding history of chronic back pain and spinal disease on imaging. She reports dysuria. Past Medical History: ANEMIA OBSTRUCTIVE SLEEP APNEA HYPERTENSION SCHIZOPHRENIA HYPERCALCEMIA OSTEOARTHRITIS BACK PAIN H/O BREAST CANCER - treated at ___ ___ - s/p AI therapy completed ___ H/O CERVICAL CANCER - per report remote - treated at ___ Social History: Country of Origin: U.___. Marital status: Widowed Children: Yes: 1 daughter, ___ Lives with: Other: ___ Lives in: Group Setting Tobacco use: Never smoker Alcohol use: Denies Recreational drugs Denies Comments: Her daughter ___, ___. - ___ Rankin Scale: [] 0: No symptoms [] 1: No significant disability - able to carry out all usual activities despite some symptoms [] 2: Slight disability: able to look after own affairs without assistance but unable to carry out all previous activities [] 3: Moderate disability: requires some help but able to walk unassisted [] 4: Moderately severe disability: unable to attend to own bodily needs without assistance and unable to walk unassisted [x] 5: Severe disability: requires constant nursing care and attention, bedridden, incontinent [] 6: Dead Family History: Sister - ___ Sister - breast cancer Brother - stroke, heart attack Brother - stroke Physical ___: Vitals: T:98 HR:83 BP:148/83 RR:16 SaO2:100% RA General: Awake, cooperative, obese elderly woman, NAD. HEENT: NC/AT, no scleral icterus noted, MMM, no lesions noted in oropharynx. Neck: Supple. No nuchal rigidity. Pulmonary: Normal work of breathing. Cardiac: RRR, warm, well-perfused. Abdomen: Soft, non-distended. Extremities: No ___ edema. Skin: No rashes or lesions noted. Neurologic: -Mental Status: Alert, oriented to self, ___, ___. Able to relate history though not clearly. Attentive, can do DOWb. Language is fluent with intact repetition and comprehension. Normal prosody. There were no paraphasic errors. Able to name both high and low frequency objects. Mild dysarthria/hoarseness. Able to follow both midline and appendicular commands. There was no evidence of apraxia or neglect. -Cranial Nerves: II, III, IV, VI: PERRL 1.5 to 1mm and brisk. EOMI without nystagmus. Normal saccades. VFF to confrontation. V: Facial sensation intact to light touch. VII: No facial droop, facial musculature symmetric. VIII: Hearing intact to finger-rub bilaterally. IX, X: Palate elevates symmetrically. XI: ___ strength in trapezii bilaterally. XII: Tongue protrudes in midline with good excursions. -Motor: Flaccid at the knees and hips. Rest and intention tremor in b/l UE and RLE. [Delt][Bi] Tri ECR FE [___] L 4* 5-* 5 4+* 4* ___ 0 0 4 5 4* 4 R 4+ 5 5 4* 4* ___ 0 1 4 5 4* 4 *pain limited **+Hoover's sign when testing R IP, but negative on L IP. -Sensory: No deficits to light touch, pinprick, temperature throughout. No paraspinal numbness to pinprick along back. Decreased vibration in both great toes, present but decreased. Joint position sense intact in b/l toes. -Reflexes: Negative jaw jerk. Negative ___. [Bic] [Tri] [___] [Pat] [Ach] L 2 2 2 0 0 R 2 2 2 0 0 Plantar response was withdrawal bilaterally. -Coordination: rest tremor intention tremor. No dysmetria on FNF on RUE -Gait: unable to ambulate DISCHARGE General examination: General: Comfortable and in no distress Head: No irritation/exudate from eyes, nose, throat Cardio: Regular rate and rhythm, warm Lungs: Unlabored breathing Abdomen: Soft, non tender, non distended Neurologic examination: Mental status: Ms. ___ is awake and pleasant. She can hold a normal conversation. No errors in speech. Cranial nerves: EOMI. Face symmetric. No dysarthria. Shoulders sit symmetrically. Motor: Ms. ___ has frequent involuntary movement of her tongue, fingers, and toes. There is atrophy of the intrinsic muscles of the hands. Ms. ___ has no pronator drift of the right arm, but cannot perform testing of the left arm because of pain limited proximal weakness. There is evidence of muscle activation at the hip flexor muscles on both sides with some subtle movement within plan of bed. This is also true for her hip abduction muscles. Her hip adduction muscles are strong and her legs cannot be spread. Her quadriceps, tibialis anterior, and gastrocnemius strength are symmetric and in the ___ range. Pertinent Results: ___ 03:12PM BLOOD WBC-5.8 RBC-3.64* Hgb-11.1* Hct-34.3 MCV-94 MCH-30.5 MCHC-32.4 RDW-14.2 RDWSD-48.7* Plt ___ ___ 03:12PM BLOOD Neuts-52.6 ___ Monos-8.1 Eos-1.2 Baso-0.3 Im ___ AbsNeut-3.05 AbsLymp-2.18 AbsMono-0.47 AbsEos-0.07 AbsBaso-0.02 ___ 03:12PM BLOOD ___ PTT-30.8 ___ ___ 03:12PM BLOOD Glucose-92 UreaN-12 Creat-0.6 Na-140 K-4.1 Cl-102 HCO3-29 AnGap-9* ___ 07:11AM BLOOD Calcium-10.4* Phos-3.2 Mg-1.6 Cholest-166 ___ 07:11AM BLOOD VitB12-454 ___ 07:11AM BLOOD %HbA1c-4.5 eAG-82 ___ 07:11AM BLOOD Triglyc-49 HDL-77 CHOL/HD-2.2 LDLcalc-79 ___ 07:11AM BLOOD TSH-2.3 ___ 07:11AM BLOOD CRP-6.8* ___ 12:55PM URINE RBC-<1 WBC-10* Bacteri-MOD* Yeast-NONE Epi-<1 TransE-<1 ___ 12:55PM URINE Blood-NEG Nitrite-NEG Protein-NEG Glucose-NEG Ketone-NEG Bilirub-NEG Urobiln-NEG pH-6.5 Leuks-SM* ___ 12:55PM URINE Color-Yellow Appear-Hazy* Sp ___ ___ 12:55 pm URINE **FINAL REPORT ___ URINE CULTURE (Final ___: MIXED BACTERIAL FLORA ( >= 3 COLONY TYPES), CONSISTENT WITH SKIN AND/OR GENITAL CONTAMINATION. ___ Imaging MRI CERVICAL, THORACIC, 1. Multilevel cervical degenerative disease, as detailed above, with complete fusion of C4 and C5 vertebral bodies and kyphotic angulation centered at C4-C5. Spinal canal stenosis is moderate at C3-C4 with spinal cord remodeling, mild-to-moderate at C4-C5, and mild at C5-C6 and C6-C7. Evaluation of cervical cord signal is limited by artifact; mild cord edema or myelomalacia at C3-C4 cannot be excluded. 2. Chronic T9 vertebral body fracture. Mild multilevel thoracic degenerative disease without significant spinal canal narrowing. No thoracic spinal cord signal abnormalities. 3. Extensive multilevel lumbar degenerative disease, as detailed above. Mild narrowing of the thecal sac without significant intrathecal nerve root crowding. Mass effect on multiple exiting and traversing nerve roots, as detailed above. 4. No evidence for pathologic contrast enhancement. Brief Hospital Course: Ms. ___ is a ___ year old right handed woman with PMH most pertinent for cervical spondylosis, schizophrenia, tardive dyskinesia secondary to long standing antipsychotic use, obstructive sleep apnea, and chronic pain who we are assessing for bilateral lower extremity weakness with no ability to walk. Neurologic examination is pertinent for frequent, involuntary movements of tongue, fingers, toes consistent with known history of tardive dyskinesia. Pain limited weakness of the left arm. She has bilateral leg weakness with the hip flexors and hip abductors being most prominently affected. She can provide resistance but is symmetrically weak at hamstrings, quadriceps, tibialis anterior, and gastrocnemius. She has proprioceptive loss in the toes. Ms. ___ has hyporeflexia in the ankles, patella, and brachioradialis, but normal reflexes in biceps and triceps. MRI CTL spine showed cervical spine disease that is most pronounced where there is narrowing of the canal at C3/C4 and C5/6 with possible cord tightening. Her lumbar spine does not look to have narrowing of the canal, but there is extensive disease throughout as the nerve roots exit the spinal canal. Additionally there is moderate thoracic and lumbar degenerative change with diffuse neuroforaminal narrowing. Her inability to walk is multifactorial, with possible contributions from obesity, deconditioning, pain, effort, cervical spine disease, lumbar spine disease and likely peripheral neuropathy. Based on her neurologic examination and imaging, I favor that her leg weakness neurologically is most driven from peripheral neuropathy (lumbar root disease and length dependent neuropathy). We have low suspicion for a chronic inflammatory demyelinating process, but this could be evaluated with an outpatient EMG. Additionally, the patient complains of chronic left shoulder pain and paresthesias. She did not find any relief with the lidocaine patch. We continued her home regimen of gabapentin 300 mg 3 times daily. We will send her for referral with chronic pain management in the outpatient setting. For her obstructive sleep apnea, she was continued on her home CPAP at bedtime. TRANSITIONAL ISSUES -Suspicion for an inflammatory demyelinating polyneuropathy is low. However, this can be evaluated with an outpatient EMG. Her symptoms are chronic and do not appear to be rapidly progressing. -Referred to chronic pain management for left shoulder pain. -Follow-up with ___. Medications on Admission: The Preadmission Medication list is accurate and complete. 1. amLODIPine 10 mg PO DAILY 2. Atorvastatin 10 mg PO QPM 3. Enalapril Maleate 10 mg PO QHS 4. Meclizine 25 mg PO Q8H:PRN vertigo 5. Pantoprazole 40 mg PO Q24H 6. RisperiDONE 4 mg PO QHS 7. TraMADol 25 mg PO Q6H:PRN Pain - Moderate 8. TraZODone 50 mg PO QHS:PRN insomnia 9. Acetaminophen 500 mg PO BID:PRN Pain - Mild/Fever 10. Aspirin 81 mg PO DAILY 11. Vitamin D 1000 UNIT PO DAILY 12. Docusate Sodium 100 mg PO BID 13. Senna 8.6 mg PO BID:PRN Constipation - First Line 14. Gabapentin 300 mg PO TID 15. Perphenazine 4 mg PO TID 16. Venlafaxine XR 75 mg PO DAILY Discharge Medications: 1. Acetaminophen 500 mg PO BID:PRN Pain - Mild/Fever 2. amLODIPine 10 mg PO DAILY 3. Aspirin 81 mg PO DAILY 4. Atorvastatin 10 mg PO QPM 5. Docusate Sodium 100 mg PO BID 6. Enalapril Maleate 10 mg PO QHS 7. Gabapentin 300 mg PO TID 8. Meclizine 25 mg PO Q8H:PRN vertigo 9. Pantoprazole 40 mg PO Q24H 10. Perphenazine 4 mg PO TID 11. RisperiDONE 4 mg PO QHS 12. Senna 8.6 mg PO BID:PRN Constipation - First Line 13. TraMADol 25 mg PO Q6H:PRN Pain - Moderate 14. TraZODone 50 mg PO QHS:PRN insomnia 15. Venlafaxine XR 75 mg PO DAILY 16. Vitamin D 1000 UNIT PO DAILY Discharge Disposition: Extended Care Facility: ___ ___ Diagnosis: Cervical, thoracic, and lumbar degenerative spine disease Polyneuropathy Chronic pain of the left shoulder Discharge Condition: Mental Status: Clear and coherent. Level of Consciousness: Alert and interactive. Activity Status: Out of Bed with assistance to chair or wheelchair. Discharge Instructions: Dear Ms. ___, You came into the hospital because you were having trouble walking. We did imaging of your back that did not show any sudden change that would require urgent treatment. When you leave the hospital you should: - Take all of your medications as prescribed. - Attend all scheduled clinic appointments. - Follow-up with a spine doctor to see if there is any role for surgery. - Follow-up with pain clinic for your shoulder. It was a pleasure taking care of you, Your ___ Care Team Followup Instructions: ___
19712454-DS-24
19,712,454
21,996,141
DS
24
2157-05-06 00:00:00
2157-05-07 16:04:00
Name: ___ Unit No: ___ Admission Date: ___ Discharge Date: ___ Date of Birth: ___ Sex: M Service: MEDICINE Allergies: Penicillins Attending: ___. Chief Complaint: Syncope and fall Major Surgical or Invasive Procedure: None History of Present Illness: ___ with h/o afib on Warfarin, T2DM, HLD, HTN, and prostate cancer presents to the ED s/p fall. He reports that he was in the kitchen on his way to the bathroom when he fell suddenly, without prodrome. When he came to, he found that he had been incontinent of his bowels. It took him a long time to get up, and when he tried to, he hit his head on the stove. He does not remember falling, and this has never happened to him before. He denies any headache, vision changes, chest pain, SOB, palpitations, abdominal pain, N&V, or changes in bowel habits. He denies any extremity weakness or numbness/tingling. Past Medical History: ATRIAL FIBRILLATION COLONIC POLYPS DIABETES TYPE II HYPERCHOLESTEROLEMIA HYPERTENSION OSTEOARTHRITIS h/o prostate cancer s/p seed implant ___ (pt unable to confirm) h/o thigh hematoma while on anti-coagulation Past Surgical History appendectomy umbilical hernia repar and R hemicolectomy for 6 cm cecal adenoma (no invasion); ___ Dr. ___ ___ incisional hernia repair bilateral component, separation panniculectomy and lysis of adhesions; ___. ___ repair by component separation; panniculectomy. Social History: ___ Family History: (per chart, confirmed with pt): Son with heart problem, specifics unknown Physical Exam: ADMISSION PHYSICAL: =================== VS: T 98.5 HR 60 BP 145 / 72 RR 18 SAT 95% O2 on RA GENERAL: Pleasant, lying in bed comfortably HEENT: large ecchymosis on back of head. CARDIAC: RRR, III/VI SEM with radiation to the carotids. LUNG: Mild respiratory distress, lungs clear to auscultation bilaterally, no crackles, wheezes, or rhonchi ABD: Normal bowel sounds, soft, nontender, nondistended, no hepatomegaly, no splenomegaly EXT: Warm, well perfused, trace lower extremity edema PULSES: 2+ radial pulses, 2+ ___ pulses, 2+ DP pulses NEURO: Alert, oriented x3, CN II-XII intact, motor and sensory function grossly intact. No dysmmetria, no dysdiadochokinesia. SKIN: No rashes DISCHARGE PHYSICAL: =================== VS: 24 HR Data (last updated ___ @ 1218) Temp: 97.3 (Tm 98.5), BP: 102/65 (102-136/65-74), HR: 64 (61-65), RR: 18 (___), O2 sat: 97% (93-97), O2 delivery: Ra, Wt: 213.8 lb/96.98 kg GENERAL: Pleasant, sitting in bed, in no acute distress. CARDIAC: Regular rate and rhythm. Grade ___ harsh systolic murmur heard loudest at right second intercostal space, radiates to the carotids. LUNG: Clear to auscultation bilaterally. No crackles, wheezes, or rhonchi. ABD: Soft, nontender, nondistended. No hepatomegaly, no splenomegaly EXT: Warm, well perfused. 2+ pitting edema bilaterally to shins. PULSES: 2+ pedal and radial pulses bilaterally NEURO: AAOx3. Motor and sensory function grossly intact. Pertinent Results: ADMISSION LABS: =============== ___ 06:43AM cTropnT-0.02* ___ 02:45AM GLUCOSE-202* UREA N-32* CREAT-1.2 SODIUM-140 POTASSIUM-5.1 CHLORIDE-99 TOTAL CO2-23 ANION GAP-18 ___ 02:45AM estGFR-Using this ___ 02:45AM ALT(SGPT)-27 AST(SGOT)-35 CK(CPK)-252 ALK PHOS-51 TOT BILI-0.5 ___ 02:45AM LIPASE-60 ___ 02:45AM cTropnT-0.03* ___ 02:45AM ALBUMIN-4.2 CALCIUM-9.7 PHOSPHATE-2.8 MAGNESIUM-1.8 ___ 02:45AM DIGOXIN-1.2 ___ 02:45AM ASA-NEG ETHANOL-NEG ACETMNPHN-NEG tricyclic-NEG ___ 02:45AM WBC-10.1* RBC-4.27* HGB-13.0* HCT-38.5* MCV-90 MCH-30.4 MCHC-33.8 RDW-13.9 RDWSD-44.7 ___ 02:45AM NEUTS-74.6* LYMPHS-10.8* MONOS-12.7 EOS-0.1* BASOS-0.1 IM ___ AbsNeut-7.51* AbsLymp-1.09* AbsMono-1.28* AbsEos-0.01* AbsBaso-0.01 ___ 02:45AM PLT COUNT-118* ___ 02:45AM ___ PTT-30.7 ___ PERTINENT LABS: =============== ___ 05:29AM BLOOD ___ PTT-28.1 ___ DISCHARGE LABS: =============== ___ 06:18AM BLOOD WBC-6.7 RBC-4.04* Hgb-12.3* Hct-37.0* MCV-92 MCH-30.4 MCHC-33.2 RDW-14.0 RDWSD-46.5* Plt ___ ___ 06:18AM BLOOD Glucose-167* UreaN-25* Creat-1.0 Na-141 K-3.9 Cl-99 HCO3-27 AnGap-15 IMAGING/DIAGNOSTICS: ==================== ___ EXAMINATION: CT C-SPINE W/O CONTRAST Q311 CT SPINE IMPRESSION: 1. No acute fractures or traumatic malalignment. 2. Moderate cervical spondylosis with multilevel mild-to-moderate vertebral canal narrowing and severe neural foraminal stenosis, particularly at the left C3-C4 and C5-C6 levels. 3. 1 cm nodule in the right lobe of the thyroid is unchanged from prior exam. ___ EXAMINATION: CT HEAD W/O CONTRAST Q111 CT HEAD IMPRESSION: 1. No acute intracranial abnormalities on noncontrast head CT. Specifically no intracranial hemorrhage or large territory infarct. 2. Bilateral chronic lacunar infarcts. 3. 6 mm thick left occipital scalp hematoma without acute displaced calvarial fracture. ___ EXAMINATION: TRANSTHORACIC ECHO CONCLUSION: The left atrial volume index is SEVERELY increased. The right atrium is mildly enlarged. There is mild symmetric left ventricular hypertrophy with a normal cavity size. There is normal regional and global left ventricular systolic function. Quantitative biplane left ventricular ejection fraction is 72 %. There is no resting left ventricular outflow tract gradient. Tissue Doppler suggests a normal left ventricular filling pressure (PCWP less than 12mmHg). Normal right ventricular cavity size with normal free wall motion. The aortic sinus diameter is normal for gender with normal ascending aorta diameter for gender. The aortic arch diameter is normal. There is no evidence for an aortic arch coarctation. The aortic valve leaflets are moderately thickened. There is moderate aortic valve stenosis (valve area 1.0-1.5 cm2). There is no aortic regurgitation. The mitral valve leaflets appear structurally normal with no mitral valve prolapse. There is mild [1+] mitral regurgitation. The tricuspid valve leaflets appear structurally normal. There is physiologic tricuspid regurgitation. There is mild pulmonary artery systolic hypertension. There is no pericardial effusion. IMPRESSION: Suboptimal image quality. Moderate aortic valve stenosis. Mild symmetric left ventricular hypertrophy with normal cavity size and regional/global biventricular systolic function. Mild mitral regurgitation. Mild pulmonary artery systolic hypertension. Compared with the prior TTE (images reviewed) of ___, the severity of aortic stenosis is now increased. MICROBIOLOGY: None Brief Hospital Course: ___ M with PMH of atrial fibrillation on Coumadin admitted for syncope and fall, of uncertain etiology but suspected due to moderate aortic stenosis vs orthostatic hypotension vs arrhythmia. ACUTE ISSUES: ============= #Syncope Pt was monitored on telemetry for ~48 hours which did not reveal any arrhythmia. For further evaluation of any arrhythmias, he was fitted with ___ Hearts cardiac monitor. A transthoracic echo was performed, and showed moderate aortic stenosis. Pt had mild orthostatic hypotension upon evaluation by physical therapy. Digoxin was discontinued given possibility of contributing to arrhythmia. #Atrial fibrillation Pt had subtherapeutic INR during hospitalization. Warfarin dose was increased while inpatient for goal INR ___. Pt to continue regular home dose at discharge. Digoxin was discontinued and patient was rate-controlled with metoprolol without any evidence of atrial fibrillation. CHRONIC ISSUES: =============== #T2DM: Held home metformin while inpatient. Pt to resume home metformin on discharge. #Depression: Continued home citalopram #HLD: Continued home statin #HTN: Continued home lisinopril TRANSITIONAL ISSUES: ==================== # Aortic Stenosis: - Moderate by TTE criteria. Follow up with cardiologist. #Syncope: -Patient is being sent home with ___ of Hearts cardiac event monitor. He should follow up with his PCP and his new cardiologist for evaluation of any arrhythmias. #Atrial Fibrillation: -Discontinued digoxin. Pt was rate controlled on metoprolol. Pt should follow up with cardiologist for further management of atrial fibrillation. -Pt had subtherapeutic INR during admission. He should follow up with his PCP to manage his warfarin doses. # Code: full (limited trial of life-saving measures) # Contact: Son Phone number: ___ Cell phone: ___ Medications on Admission: The Preadmission Medication list may be inaccurate and requires futher investigation. 1. Citalopram 20 mg PO DAILY 2. Digoxin 0.375 mg PO DAILY 3. Lisinopril 10 mg PO DAILY 4. MetFORMIN (Glucophage) 500 mg PO BID 5. Metoprolol Tartrate 50 mg PO DAILY 6. Simvastatin 20 mg PO QPM 7. Warfarin 5 mg PO DAILY16 8. Aspirin 81 mg PO DAILY 9. Cyanocobalamin ___ mcg PO DAILY 10. Docusate Sodium 100 mg PO BID 11. Multivitamins 1 TAB PO DAILY Discharge Medications: 1. Aspirin 81 mg PO DAILY 2. Citalopram 20 mg PO DAILY 3. Cyanocobalamin ___ mcg PO DAILY 4. Docusate Sodium 100 mg PO BID 5. Lisinopril 10 mg PO DAILY 6. MetFORMIN (Glucophage) 500 mg PO BID 7. Metoprolol Tartrate 50 mg PO DAILY 8. Multivitamins 1 TAB PO DAILY 9. Simvastatin 20 mg PO QPM 10. Warfarin 5 mg PO DAILY16 Discharge Disposition: Home With Service Facility: ___ Discharge Diagnosis: PRIMARY DIAGNOSES: -Syncope -Moderate aortic stenosis -Atrial fibrillation Discharge Condition: Mental Status: Clear and coherent. Level of Consciousness: Alert and interactive. Activity Status: Ambulatory - requires assistance or aid (walker or cane). Discharge Instructions: Dear Mr. ___, It was a pleasure taking part in your care here at ___! Why was I admitted to the hospital? - You were admitted for loss of consciousness and a fall. What was done for me while I was in the hospital? - An ultrasound of your heart was performed to look at the narrowing of one of your heart valves. You will follow up with your new cardiologist when you leave the hospital. - You were monitored for an abnormal heart rhythm. We did not see any dangerous rhythm, but we are sending you home with a device to monitor your heart rhythm for several weeks. What should I do when I leave the hospital? - You should continue to take your medications as prescribed. - You should follow up with a new cardiologist. - You should use your ___ of Hearts cardiac monitor if you feel symptomatic. Sincerely, Your ___ Care Team Followup Instructions: ___
19712454-DS-25
19,712,454
27,092,151
DS
25
2158-08-25 00:00:00
2158-08-25 17:00:00
Name: ___ Unit No: ___ Admission Date: ___ Discharge Date: ___ Date of Birth: ___ Sex: M Service: MEDICINE Allergies: Penicillins Attending: ___. Major Surgical or Invasive Procedure: Cardioversion (___) attach Pertinent Results: INITIAL LABS: ------------- CBC/COAGS ___ 02:25PM BLOOD WBC-6.8 RBC-3.55* Hgb-10.4* Hct-33.7* MCV-95 MCH-29.3 MCHC-30.9* RDW-14.9 RDWSD-51.7* Plt ___ ___ 02:25PM BLOOD Neuts-52.6 ___ Monos-18.2* Eos-0.7* Baso-0.3 Im ___ AbsNeut-3.56 AbsLymp-1.85 AbsMono-1.23* AbsEos-0.05 AbsBaso-0.02 ___ 02:25PM BLOOD ___ PTT-40.5* ___ CMP ___ 02:25PM BLOOD Glucose-127* UreaN-33* Creat-1.2 Na-137 K-5.0 Cl-99 HCO3-23 AnGap-15 ___ 02:25PM BLOOD ALT-17 AST-23 AlkPhos-71 TotBili-0.4 ___ 02:25PM BLOOD Albumin-4.3 Calcium-9.3 Phos-3.8 Mg-2.0 CARDIAC ___ 02:25PM BLOOD cTropnT-0.01 ___ 02:25PM BLOOD proBNP-1207* IRON ___ 02:25PM BLOOD Ferritn-32 OTHER ___ 02:25PM BLOOD TSH-1.2 ___ 02:38PM BLOOD Lactate-0.6 STUDIES: ___ ECG Atrial fibrillation Right bundle branch block Anterolateral infarct, age indeterminate ___ Imaging CHEST (PORTABLE AP) Moderate cardiomegaly and bibasilar atelectasis is unchanged. No pulmonary edema or definite focal consolidation to suggest pneumonia. TTE ___: IMPRESSION: Suboptimal image quality. Mild symmetric left ventricular hypertrophy with mild to moderate global hypokinesis c/w non-ischemic cardiomyopathy or other diffuse process. Mildly dilated right ventricle with moderate free wall hypokinesis. Mildly dilated thoracic aorta. Moderate calcific aortic stenosis. Mild aortic regurgitaiton. At least mild to moderate eccentric mitral regurgitation. Mild pulmonary hypertension. Compared with the prior TTE (images reviewed) of ___ , biventricular systolic function is now reduced. There is severe aortic stenosis Duplex b/l lower extremities ___: IMPRESSION: Patent bilateral iliofemoral vessels with diameters as noted. DISCHARGE LABS: --------------- CBC: ___ 07:53AM BLOOD WBC-6.9 RBC-3.22* Hgb-9.4* Hct-30.5* MCV-95 MCH-29.2 MCHC-30.8* RDW-14.5 RDWSD-50.0* Plt ___ COAGS: ___ 07:53AM BLOOD ___ BMP: ___ 07:53AM BLOOD Glucose-126* UreaN-44* Creat-1.5* Na-140 K-4.6 Cl-99 HCO3-26 AnGap-15 ___ 07:53AM BLOOD Calcium-9.3 Phos-4.0 Mg-2.0 Brief Hospital Course: PATIENT SUMMARY: ___ year old man with paroxysmal atrial fibrillation on warfarin, moderate aortic stenosis, and type II diabetes, who presented to his ___ office with several months of worsening lower extremity edema, found to be hypotensive with systolics to the ___, which normalized without intervention. He was found to be in atrial fibrillation with heart rates in the 100-120s and moderately volume overloaded. ECHO showed worsening EF (35-45%) and severe AS. Cardioverted back into sinus rhythm twice, tweaked metoprolol dosing and started amiodarone loading (which will transition to maintenance in ___. Rates were better controlled but still had persistent ectopy. He was diuresed to euvolemia and started on daily PO lasix. TAVR workup started and will continue planning as outpt. TRANSITIONAL ISSUES: ==================== PCP: [] INR re-check on ___ - INR on d/c 4.1, reduced warfarin dose to 2 mg daily given now on amiodarone, but should adjust as needed for INR goal of ___ [] STOPPED aspirin - confirm no longer taking [] Lisinopril 10mg QD held d/t lower BPs - consider whether d/c or restart for TIIDM protection [] For prostate cancer, recommend repeat MRI L spine in 3 months (ie ___ - hemangiomas vs metastatic disease. CARDS [] TAVR outpt f/u - discussion with Dr. ___ outpt visit with structural team [] For AC for afib, consider DOAC instead of warfarin [] Started amiodarone 200mg BID load (until ___, then 200mg QD ongoing from then ACTIVE ISSUES: =============== # Bilateral lower extremity swelling: # Aortic stenosis Pt reports months of bilateral lower extremity swelling that appears to be worsening; uses ___ stockings at home. On admission, JVP ~ 10cm, mild weight gain (104.6 kg up from 102.3 kg); otherwise, denied dyspnea, orthopnea, PND or increased abdominal girth. His proBNP was elevated at 1200, no priors in system. No known heart failure. TTE showed worsening EF (35-45% down from 72% in ___ and severe AS. Leg swelling due to volume overload from atrial fibrillation in the setting of aortic stenosis/pre-load dependent state. Underwent IV diuresis bolus until euvolemic and discharged on lasix 40mg QD. Underwent TAVR workup with US which showed good access. Will see structural team as outpt for planning. # Atrial fibrillation with mean ventricular rates of 100-120s: Patient with paroxysmal atrial fibrillation on warfarin, presenting in afib with HRs in the 110-120s. It is likely that his tachycardia and known AS led to volume overload, though it is also possible that volume overload led to uncontrolled atrial fibrillation. Of note, he was on digoxin in the past (unclear when stopped); it is unknown whether he has undergone cardioversion. He was cardioverted back into sinus rhythm twice, BB was tweaked and he was loaded on amiodarone (200mg BID with plan to go to maintenance). TSH WNL, discharged on metoprolol tartrate 100mg QD. At discharge, INR supratherapeutic (4.1) after restarting home dosing (6mg QD). Decreased dose to 2mg a day given also started on amiodarone. Will need INR follow up in ___ days. # Episodic nausea with diaphoresis: Pt describes episodes without clear trigger, often at rest, resolves with lying flat for 20 minutes. No associated chest pain, pressure, palpitations, shortness of breath or light headedness. Etiology unclear, may be vasovagal or gastritis given mild anemia on warfarin/aspirin. Did not have any symptoms throughout rest of hospitalization. # Hypotension, transient: Presented to outpatient clinic where pressures were noted to be in the ___ upon arrival to the ED, SBP again in the ___ though ultimately maintained in the ___. Lactate 0.6. Baseline (outpatient) pressures appear to be about 100-120/60-70s. On the floor, pts BPs at baseline. He is asymptomatic and has not felt symptoms of hypotension at home. He remained warm on exam. Held lisinopril given presentation and normal/lower pressures during admission - can decide as outpt if need to restart. #Coag Neg Staph - 1+ BCx Was found to grow GPCs and was started on IV antibiotics for 1 day, speciated to Coag Neg Staph so abx were d/c'ed. BCx remained negative, only 1 bottle was found to be positive. CHRONIC ISSUES: ================ # Anemia, normocytic: Hb ___, down from recent ___. Iron studies wnl. # Thrombocytopenia: Mild, at baseline. # Diabetes, type II: Held metformin and placed on ISS. # Depression: Continued citalopram 20 mg daily # Hyperlipidemia: Continued simvastatin while inpatient # Health maintenance: Discontinued aspirin 81 mg while inpatient; he is on warfarin and the combination increases his risk of bleed. Discussed with patient who was in agreement. # Prostate cancer: Unknown history in terms of past treatments. He does report some difficulty urinating as of late. Of note, MRI of L spine from ___ shows a 1.6 cm L5 anterior body lesion demonstrating hypointensity; also additional lesions along L2 and T12; this may represent hemangiomas though cannot rule out metastatic disease given known history. Recommended repeat MRI L spine in 3 months (ie ___ ================== # LANGUAGE: ___ # CODE STATUS: Full code, limited trial of life sustaining measures # CONTACT: 1. ___ (son) ___ home: ___ 2. ___ (son) ___ Medications on Admission: The Preadmission Medication list is accurate and complete. 1. Warfarin 6 mg PO QHS 2. Metoprolol Tartrate 50 mg PO DAILY 3. Citalopram 20 mg PO DAILY 4. Simvastatin 20 mg PO QPM 5. MetFORMIN (Glucophage) 500 mg PO BID 6. Lisinopril 10 mg PO DAILY 7. Cyanocobalamin ___ mcg PO DAILY 8. Aspirin 81 mg PO DAILY Discharge Medications: 1. Amiodarone 200 mg PO BID Take this 2x a day for 3 weeks (finish ___ you will start taking it 1x a day RX *amiodarone 200 mg 1 tablet(s) by mouth twice a day Disp #*60 Tablet Refills:*0 2. Furosemide 20 mg PO DAILY RX *furosemide 20 mg 1 tablet(s) by mouth once a day Disp #*30 Tablet Refills:*0 3. Metoprolol Succinate XL 100 mg PO DAILY RX *metoprolol succinate 100 mg 1 tablet(s) by mouth once a day Disp #*30 Tablet Refills:*0 4. Warfarin 2 mg PO QHS RX *warfarin [Coumadin] 1 mg 2 tablet(s) by mouth once a day Disp #*60 Tablet Refills:*0 5. Citalopram 20 mg PO DAILY 6. Cyanocobalamin ___ mcg PO DAILY 7. MetFORMIN (Glucophage) 500 mg PO BID 8. Simvastatin 20 mg PO QPM Discharge Disposition: Home With Service Facility: ___ Discharge Diagnosis: PRIMARY DIAGNOSIS: Heart failure paroxysmal atrial fibrillation moderate aortic stenosis Hypotension SECONDARY DIAGNOSIS: Type 2 diabetes mellitus Discharge Condition: Mental Status: Clear and coherent. Level of Consciousness: Alert and interactive. Activity Status: Ambulatory - requires assistance or aid (walker or cane). Discharge Instructions: Dear Mr. ___, It was a pleasure taking care of you at the ___ ___! WHY WAS I IN THE HOSPITAL? ========================== - You were admitted because you had swelling in your legs. WHAT HAPPENED IN THE HOSPITAL? ============================== - This was felt to be due to a condition called heart failure, where your heart does not pump hard enough and fluid backs up into your lungs. You were given a diuretic medication through the IV to help get the fluid out. You improved considerably and were ready to leave the hospital. WHAT SHOULD I DO WHEN I GO HOME? ================================ - Be sure to take all your medications and attend all of your appointments listed below. - Your new medications include a medication for your heart rhythm (amiodarone) and a water pill (lasix). Your heart rate medication dosing was tweaked (metoprolol) - Your weight at discharge is 224lbs. Please weigh yourself today at home and use this as your new baseline, as all scales are different - Please weigh yourself every day in the morning. Call your doctor if your weight goes up by more than 3 lbs. Thank you for allowing us to be involved in your care, we wish you all the best! Your ___ Healthcare Team Followup Instructions: ___
19712479-DS-18
19,712,479
29,916,269
DS
18
2113-04-18 00:00:00
2113-04-18 14:15:00
Name: ___ Unit No: ___ Admission Date: ___ Discharge Date: ___ Date of Birth: ___ Sex: M Service: NEUROSURGERY Allergies: No Known Allergies / Adverse Drug Reactions Attending: ___ Chief Complaint: Bilateral SDH, right greater than left Major Surgical or Invasive Procedure: ___ right burr hole for subdural hematoma evacuation History of Present Illness: ___ y/o male with PMH on Coumadin for Afib s/p multiple falls transferred from ___ with bilateral SDH, right greater than left. He woke overnight and was disoriented. He fell and struck the posterior aspect of the left side of his head. He is unsure if he lost consciousness. He was taken to ___ and underwent a ___ which showed a subacute on chronic right SDH measuring 2.4cm with 8.5cm MLS and an acute left occipital SDH measuring 6.9mm. His INR was noted to be 1.9 and he was given FFP and one dose of Vitamin K. He also received 1g Keppra and was transferred to ___ for further evaluation. Upon arrival, his repeat INR was 1.6 and he received another unit of FFP. The patient states that he fell several times over the past few weeks with headstrike. He reports presenting to ___ ___ after one of these falls he presented to ___ and underwent a CT of the head which he reports was negative and he was discharged to home. He reports posterior left head pain at site of the laceration. He denies nausea, vomiting, fever, chills, dizziness, confusion, diplopia, blurred vision, speech difficulties or weakness, pain or paresthesias of the upper and lower extremities bilaterally. Past Medical History: -Afib on Coumadin -Hypertension -Hyperlipidemia -h/p prostate CA s/p prostatectomy in ___ Social History: Denies the use of etoh or illicit drugs. Remote history of tobacco use, but quit ___ years ago. Retired ___. Resides with his wife and daughter. Son is his health care proxy. Physical Exam: PHYSICAL EXAMINATION ON ADMISSION: T: 99.4 BP: 140/81 HR: 117 RR: 20 O2Sats 95% RA Gen: WD/WN, comfortable, NAD. HEENT: Pupils: 3-2mm bilaterally. EOMs intact throughout. Extrem: Warm and well-perfused. Neuro: Mental status: Awake and alert, cooperative with exam, normal affect. Orientation: Oriented to person, place, and date. Language: Speech fluent with good comprehension and repetition. Naming intact. No dysarthria or paraphasic errors. Cranial Nerves: I: Not tested. II: Pupils equally round and reactive to light, 3mm to 2mm bilaterally. III, IV, VI: Extraocular movements intact bilaterally without nystagmus. V, VII: Facial strength and sensation intact and symmetric. VIII: Hearing intact to voice. IX, X: Palatal elevation symmetrical. XI: Sternocleidomastoid and trapezius normal bilaterally. XII: Tongue midline without fasciculations. Motor: Normal bulk and tone bilaterally. No abnormal movements, tremors. Strength full power ___ throughout. No pronator drift. Sensation: Intact to light touch bilaterally. PHYSICAL EXAMINATION ON DISCHARGE: Awake, alert, oriented x3. Nonfocal on exam. MAE full except L ham 4+/5 secondary to pain. Incision C/D/I with staples Pertinent Results: Please see OMR for pertinent lab or imaging results. Brief Hospital Course: ___ M admitted to neurosurgery service s/p fall with right subacute SDH and smaller left acute SDH #Bilateral SDH, right greater than left The patient was transferred to the ED at ___ on ___ from ___ after the CT of the head demonstrated bilateral SDHs. His INR was 1.9 at OSH and he received FFP and Vitamin K prior to transfer. His repeat INR upon arrival was 1.6 and he received another unit of FFP. He was admitted to the ___ for close neurologic monitoring. He was started on Keppra for seizure prophylaxis. Repeat CT ___ showed improved MLS but small increased in acute left SDH. This was stable on repeat CT ___. He was closely monitored and taken to the OR on ___ for right burr hole evacuation of ___ with Dr. ___ ___ was well tolerated. Post operative CT showed expected evaluation of R SDH and stable L SDH. Subdural drain was in place to thumbprint suction. Repeat CT ___ showed re-expansion of brain and stable L SDH. Subdural drain was removed on ___ without complication. A CT head on ___ was stable with interval reaccumulation of CSF, no new hemorrhage. Patient was cleared for rehab dispo. #Afib Coumadin was held and reversed with 2units FFP and Vit K x 3 doses. Coumadin continued to be held to prevent further bleeding into the subdural space. #Pannus Imaging revealed c1/2 stenosis secondary to degenerative pannus formation, without signal change in the cord. This is chronic and no surgical intervention was indicated. #L thigh spasm He was started on lidocaine patch and flexeril from chronic L thigh spasms. #Dispo He was evaluated by ___, who recommended acute rehab. Medications on Admission: Vitamin C 500mg PO daily; Lisinopril 10mg PO daily; Loratadine 10mg PO daily; Metoprolol Succinate ER 12.5mg PO daily; Omeprazole 20mg PO daily; Simvastatin 10mg PO QPM; Timolol 0.25% 1 drop ___ Warfarin 5mg frequency unknown Discharge Medications: 1. Acetaminophen 325-650 mg PO Q6H:PRN Pain - Moderate Do not exceed 4g/day. 2. Bisacodyl 10 mg PO/PR DAILY:PRN constipation 3. Cyclobenzaprine 5 mg PO TID:PRN muscle spasm 4. Docusate Sodium 100 mg PO BID 5. LevETIRAcetam 500 mg PO BID 6. Multivitamins 1 TAB PO DAILY 7. Ramelteon 8 mg PO QHS:PRN insomnia 8. Senna 8.6 mg PO BID:PRN constipation 9. TraMADol 25 mg PO Q6H:PRN pain ___ request partial fill. 10. Lisinopril 10 mg PO DAILY 11. Loratadine 10 mg PO DAILY 12. Metoprolol Succinate XL 12.5 mg PO DAILY 13. Omeprazole 20 mg PO DAILY 14. Simvastatin 10 mg PO QPM 15. Timolol Maleate 0.25% 1 DROP BOTH EYES DAILY Discharge Disposition: Extended Care Facility: ___ Discharge Diagnosis: Subdural hematoma with brain compression Discharge Condition: Mental Status: Clear and coherent. Level of Consciousness: Alert and interactive. Activity Status: Ambulatory - requires assistance or aid (walker or cane). Discharge Instructions: Discharge Instructions Brain Hemorrhage with Surgery Surgery · You underwent a surgery called a burr hole evacuation to have blood removed from your brain. · Please keep your staples along your incision dry until they are removed. · It is best to keep your incision open to air but it is ok to cover it when outside. · Call your surgeon if there are any signs of infection like redness, fever, or drainage. Activity · We recommend that you avoid heavy lifting, running, climbing, or other strenuous exercise until your follow-up appointment. · You make take leisurely walks and slowly increase your activity at your own pace once you are symptom free at rest. ___ try to do too much all at once. · No driving while taking any narcotic or sedating medication. · If you experienced a seizure while admitted, you are NOT allowed to drive by law. · No contact sports until cleared by your neurosurgeon. You should avoid contact sports for 6 months. Medications · Please do NOT take any blood thinning medication (Aspirin, Ibuprofen, Plavix, Coumadin) until cleared by the neurosurgeon. · You have been discharged on Keppra (Levetiracetam). This medication helps to prevent seizures. Please continue this medication for 7 days from ___. It is important that you take this medication consistently and on time. · You may use Acetaminophen (Tylenol) for minor discomfort if you are not otherwise restricted from taking this medication. What You ___ Experience: · You may have difficulty paying attention, concentrating, and remembering new information. · Emotional and/or behavioral difficulties are common. · Feeling more tired, restlessness, irritability, and mood swings are also common. · You may also experience some post-operative swelling around your face and eyes. This is normal after surgery and most noticeable on the second and third day of surgery. You apply ice or a cool or warm washcloth to your eyes to help with the swelling. The swelling will be its worse in the morning after laying flat from sleeping but decrease when up. · You may experience soreness with chewing. This is normal from the surgery and will improve with time. Softer foods may be easier during this time. · Constipation is common. Be sure to drink plenty of fluids and eat a high-fiber diet. If you are taking narcotics (prescription pain medications), try an over-the-counter stool softener. Headaches: · Headache is one of the most common symptoms after a brain bleed. · Most headaches are not dangerous but you should call your doctor if the headache gets worse, develop arm or leg weakness, increased sleepiness, and/or have nausea or vomiting with a headache. · Mild pain medications may be helpful with these headaches but avoid taking pain medications on a daily basis unless prescribed by your doctor. · There are other things that can be done to help with your headaches: avoid caffeine, get enough sleep, daily exercise, relaxation/ meditation, massage, acupuncture, heat or ice packs. When to Call Your Doctor at ___ for: · Severe pain, swelling, redness or drainage from the incision site. · Fever greater than 101.5 degrees Fahrenheit · Nausea and/or vomiting · Extreme sleepiness and not being able to stay awake · Severe headaches not relieved by pain relievers · Seizures · Any new problems with your vision or ability to speak · Weakness or changes in sensation in your face, arms, or leg Call ___ and go to the nearest Emergency Room if you experience any of the following: · Sudden numbness or weakness in the face, arm, or leg · Sudden confusion or trouble speaking or understanding · Sudden trouble walking, dizziness, or loss of balance or coordination · Sudden severe headaches with no known reason Followup Instructions: ___
19712479-DS-19
19,712,479
23,796,590
DS
19
2113-06-11 00:00:00
2113-06-11 18:32:00
Name: ___ Unit No: ___ Admission Date: ___ Discharge Date: ___ Date of Birth: ___ Sex: M Service: NEUROSURGERY Allergies: No Known Allergies / Adverse Drug Reactions Attending: ___ Chief Complaint: Unsteady gait and confusion Major Surgical or Invasive Procedure: ___ - Left Craniotomy for Subdural hematoma evacuation History of Present Illness: ___ yo M hx Afib known to Neurosurgery for bilat SDH Right > Left and s/p right burr hole evacuation of ___ on ___ presented with worsening unsteady gait over the past week and fall, no headstrike, 4 days prior. Coumadin was stopped at his last hospitalization. He complains also of general weakness. He denies numbness, vision changes, nausea, vomiting. Past Medical History: -Afib on Coumadin -Hypertension -Hyperlipidemia -h/p prostate CA s/p prostatectomy in ___ Social History: ___ Family History: NC Physical Exam: ON ADMISSION: O: T:98.3 BP: 126/95 HR:88 R20 O2Sats97% Gen: WD/WN, comfortable, NAD. HEENT: right burr hole incision well healed Neck: Supple. Extrem: Warm and well-perfused. Neuro: Mental status: Awake and alert, cooperative with exam, normal affect. Orientation: Oriented to person, place, and date, difficulty with month. Language: Speech fluent with good comprehension and repetition. Naming intact. No dysarthria or paraphasic errors. Cranial Nerves: I: Not tested II: Pupils equally round and reactive to light, 3 to 2 mm bilaterally. Visual fields are full to confrontation. III, IV, VI: Extraocular movements intact bilaterally without nystagmus. V, VII: Facial strength and sensation intact and symmetric. VIII: Hearing intact to voice. IX, X: Palatal elevation symmetrical. XI: Sternocleidomastoid and trapezius normal bilaterally. XII: Tongue midline without fasciculations. Motor: Normal bulk and tone bilaterally. No abnormal movements, tremors. Strength full power ___ throughout with the exception of right tricep 4+/5 Bilateral upward drift Sensation: Intact to light touch bilaterally. Toes downgoing bilaterally Coordination: normal on finger-nose-finger ======================================== ON DISCHARGE: Pertinent Results: Please refer to ___ for pertinent imaging and lab results. Brief Hospital Course: Mr. ___ is an ___ year old male known to the neurosurgery service s/p right burr hole evacuation on ___ for chronic bilateral subdural hematoma. Patient was readmitted on ___ from OSH with worsening gait and confusion, found to have worsening bilateral SDH Left > right. #Chronic bilateral Subdural hematoma Mr. ___ was admitted to neurosurgery service on ___ with worsening chronic bilateral SDH, Left>right. Consent was obtained from health care proxy, and patient was taken to the OR on ___ for Left burr holes for subdural hematoma evacuation with placement of left subdural drain. The procedure went accordingly with no intraoperative compilations. Please refer to op note in OMR for further intraoperative details. Patient was taken to Post operative area for further monitoring, where he remained intact on exam, and was then transferred to the step down unit for continued care. Post op head CT demonstrated a an area of hyperdenisty at the drain terminus concerning for new hemorrhage. The patient remained intact and a repeat CT on ___ remained stable. Subdural drain was pulled on ___. The patient was evaluated by ___ and OT on ___ who recommended discharge home with inhome ___ services. Patient remained stable and was cleared to be discharged home on ___. Medications on Admission: The Preadmission Medication list is accurate and complete. 1. Metoprolol Succinate XL 25 mg PO DAILY 2. Omeprazole 20 mg PO DAILY 3. Simvastatin 10 mg PO QPM 4. Timolol Maleate 0.25% 1 DROP BOTH EYES BID 5. Loratadine 10 mg PO DAILY 6. TraZODone 25 mg PO QHS:PRN sleep Discharge Medications: 1. Acetaminophen 325-650 mg PO Q6H:PRN mild pain 2. LevETIRAcetam 500 mg PO BID RX *levetiracetam [Keppra] 500 mg 1 tablet(s) by mouth twice a day Disp #*10 Tablet Refills:*0 3. Loratadine 10 mg PO DAILY 4. Metoprolol Succinate XL 25 mg PO DAILY 5. Omeprazole 20 mg PO DAILY 6. Simvastatin 10 mg PO QPM 7. Timolol Maleate 0.25% 1 DROP BOTH EYES BID 8. TraZODone 25 mg PO QHS:PRN sleep Discharge Disposition: Home With Service Facility: ___ Discharge Diagnosis: Bilateral subdural hematomas Discharge Condition: Mental Status: Clear and coherent. Level of Consciousness: Alert and interactive. Activity Status: Ambulatory - Independent. Discharge Instructions: Surgery - You underwent a surgery called burr holes to have blood removed from your brain. - Please keep your staples along your incision dry until they are removed. - It is best to keep your incision open to air but it is ok to cover it when outside. - Call your surgeon if there are any signs of infection like redness, fever, or drainage. Activity - We recommend that you avoid heavy lifting, running, climbing, or other strenuous exercise until your follow-up appointment. - You make take leisurely walks and slowly increase your activity at your own pace once you are symptom free at rest. ___ try to do too much all at once. - No driving while taking any narcotic or sedating medication. - If you experienced a seizure while admitted, you are NOT allowed to drive by law. - No contact sports until cleared by your neurosurgeon. You should avoid contact sports for 6 months. Medications - Please do NOT take any blood thinning medication (Aspirin, Ibuprofen, Plavix, Coumadin) until cleared by the neurosurgeon. - You have been discharged on Keppra (Levetiracetam). This medication helps to prevent seizures. Please continue this medication as indicated on your discharge instruction. It is important that you take this medication consistently and on time. - You may use Acetaminophen (Tylenol) for minor discomfort if you are not otherwise restricted from taking this medication. What You ___ Experience: - You may have difficulty paying attention, concentrating, and remembering new information. - Emotional and/or behavioral difficulties are common. - Feeling more tired, restlessness, irritability, and mood swings are also common. - You may also experience some post-operative swelling around your face and eyes. This is normal after surgery and most noticeable on the second and third day of surgery. You apply ice or a cool or warm washcloth to your eyes to help with the swelling. The swelling will be its worse in the morning after laying flat from sleeping but decrease when up. - You may experience soreness with chewing. This is normal from the surgery and will improve with time. Softer foods may be easier during this time. - Constipation is common. Be sure to drink plenty of fluids and eat a high-fiber diet. If you are taking narcotics (prescription pain medications), try an over-the-counter stool softener. Headaches: - Headache is one of the most common symptoms after a brain bleed. - Most headaches are not dangerous but you should call your doctor if the headache gets worse, develop arm or leg weakness, increased sleepiness, and/or have nausea or vomiting with a headache. - Mild pain medications may be helpful with these headaches but avoid taking pain medications on a daily basis unless prescribed by your doctor. - There are other things that can be done to help with your headaches: avoid caffeine, get enough sleep, daily exercise, relaxation/ meditation, massage, acupuncture, heat or ice packs. When to Call Your Doctor at ___ for: - Severe pain, swelling, redness or drainage from the incision site. - Fever greater than 101.5 degrees Fahrenheit - Nausea and/or vomiting - Extreme sleepiness and not being able to stay awake - Severe headaches not relieved by pain relievers - Seizures - Any new problems with your vision or ability to speak - Weakness or changes in sensation in your face, arms, or leg Call ___ and go to the nearest Emergency Room if you experience any of the following: - Sudden numbness or weakness in the face, arm, or leg - Sudden confusion or trouble speaking or understanding - Sudden trouble walking, dizziness, or loss of balance or coordination - Sudden severe headaches with no known reason Followup Instructions: ___
19712781-DS-9
19,712,781
28,904,191
DS
9
2171-06-06 00:00:00
2171-06-06 23:20:00
Name: ___ Unit No: ___ Admission Date: ___ Discharge Date: ___ Date of Birth: ___ Sex: F Service: MEDICINE Allergies: No Known Allergies / Adverse Drug Reactions Attending: ___ ___ Complaint: Hand pain and swelling Major Surgical or Invasive Procedure: None History of Present Illness: Ms. ___ is a ___ WF with a PMH of drug abuse, venous stasis ulcer who presents with c/o right hand swelling after sustaining a laceration from putting her right hand through a glass window 2 days ago that was further complicated by a dog bite to the same site. She put her hand through a window trying to get into her boyfriends home and on the same day she was also bitten by her dog whom is not UTD with its shots. She has pain and swelling in the hand and says her thumb feels stiff. She has no fevers/chills or night sweats. She also incidentally has bilateral chronic venous stasis ulcers that she believes are infected. Of note, she was in police custody until bail was posted to be tranferred to ___. In the ED, initial vs were T:98.6 P:78 BP: 148/70 RR:18 Pox:98%. Received dilaudid, vancomycin, rabies vaccine, Rabies Ig x2, and methadone 15mg, in addition to her home meds. On arrival to the floor, patient reports continued pain in her right hand and pain in her legs from her venous stasis ulcers. REVIEW OF SYSTEMS: + hand pain, bilateral leg pain. -fever, chills, night sweats, headache, vision changes, rhinorrhea, congestion, sore throat, cough, shortness of breath, chest pain, abdominal pain, nausea, vomiting, diarrhea, constipation, BRBPR, melena, hematochezia, dysuria, hematuria. Past Medical History: Anxiety Depression bilateral Venous stasis ulcers h/o opiod abuse on methadone Social History: ___ Family History: DM- maternal grandmother HTN- mother ___- father Physical ___: ADMISSION PHYSICAL EXAM: VS:98.2 BP:145/85 P:82 RR:18 Pox:99% on RA GEN: Alert, oriented, no acute distress HEENT: NCAT MMM EOMI sclera anicteric, OP clear NECK: supple, no JVD, no LAD PULM: Good aeration, CTAB no wheezes, rales, ronchi CV: RRR normal S1/S2, no mrg ABD: obese, soft NT ND normoactive bowel sounds, no rebound or guarding NEURO: CNII-XII intact, motor function grossly normal SKIN: venous stasis ulcers on both legs. Right leg: 2 ulcers, RUE: hand swollen around thenar eminence/radial aspect, closed "dog bite" over proximal phalange of thumb, and 2 puncture marks in 1 web space dorsally. The "glass laceration" is tranverse ~3cm and is over the ___ CMC joint. This wound is open and draining non-purulent fluid. She has numbness over the dorsal aspect of the ___ distal to this laceration.. She can flex and extend all digits but has limited range of motion of the thumb ___ swelling. She has significant pain along the course of the EPL with passive flexion. Good cap refill in all digits Right leg: 2 ulcers 3-4 cm in diameter Left leg: multiple ulcers largest 5cm in diameter. Bilateral edema to knees Discharge Physical Exam: Vitals: T: 97.9 BP 110/61 P:74 RR:18 Pox: 98% on RA GEN: Alert, oriented, no acute distress HEENT: NCAT MMM EOMI sclera anicteric NECK: supple, no JVD, no LAD PULM: CTAB no wheezes, rales, ronchi CV: RRR normal S1/S2 ABD: obese, soft NT ND normoactive bowel sounds, no rebound or guarding ___: Hand swollen but erythema improving compared to admission exam, still with some numbness Right leg: 2 ulcers 3-4 cm in diameter, Left leg multiple ulcers largest 5cm in diameter. Bilateral edema to knees SKIN: venous stasis ulcers on both legs. Right leg: 2 ulcers Pertinent Results: ___ 06:15AM PLT COUNT-232 ___ 06:15AM NEUTS-67.8 ___ MONOS-3.1 EOS-0.4 BASOS-0.6 ___ 06:15AM WBC-8.3 RBC-3.64* HGB-11.1* HCT-33.0* MCV-91 MCH-30.5 MCHC-33.7 RDW-14.5 ___ 06:15AM estGFR-Using this ___ 06:15AM GLUCOSE-86 UREA N-10 CREAT-0.6 SODIUM-138 POTASSIUM-4.0 CHLORIDE-100 TOTAL CO2-23 ANION GAP-19 ___ 06:25AM LACTATE-2.0 ___ Hand x-ray: No radiopaque foreign body or fracture. Brief Hospital Course: Ms. ___ is a ___ WF with a PMH of drug abuse, venous stasis ulcer who presents with right hand swelling after sustaining a laceration further complicated by a dog bite to the same hand. #Hand laceration: Pt apparently punched her right hand through a glass window 1 day PTA. She was subsequently bitten by her non-immunized dog at a different site on the same hand. She then noticed increased pain and swelling which brought her to medical attention. An x-ray of her hand showed no fracture or retained foreign body. Due to concern for possible infection due to increased pain, erythema, and swelling she was put on unasyn 3g Q6H for polymicrobial coverage from bite wound and was transitioned to Augmentin. Hand wound was managed by plastic surgery who recommend OT consult for a custom orthoplast thumb SPICA splint which the patient received. She was instructed on TID hand soaks with ___ strength betadine and warm water for 20min daily. Dressing changes daily with non-adherant dressing, vasoline gauze, and kerlix. She was also instructed keep arm held above head to minimize bleeding. #Dog Bite Wound: Please see above. Pt has received 2 dose of rabies vaccine in the hospital as well as rabies Ig. She will need rabies vaccine (___ or PCECV) 1mL IM tomorrow then again on ___ and ___ as an outpatient. Pt was referred to ___ and if can't make it there to go to local ED to get rabies vaccine. #Venous stasis ulcers: Chronic medical problem that is active due to significant wounds present on both shins. Pt states that she has had MRSA in the past and thought the uclers were infected. However ulcer don't appear to be infected. Wound care nurse for ulcer care and pt was instructed to elevate ___ while sitting. #Anxiety and Depression: Chronic problem that is stable on buspar, paxil, and klonopin. #H/O Opiod abuse. She was given methadone 35mg PO Daily. #Alcohol Abuse: Pt has a history of significant alcohol abuse. She was placed on withdrawal precautions (CIWA protcol, given diazepam if CIWA>10) but did not show signs of withdrawal. Transitional Issues: - Blood cultures pending - Needs to complete rabies vaccine series - Plastic surgery f/u for hand laceration Medications on Admission: Preadmission medications listed are correct and complete. Information was obtained from Patient. 1. BusPIRone 60 mg PO DAILY 2. Paroxetine 40 mg PO DAILY 3. Methadone 35 mg PO DAILY 4. Furosemide 40 mg PO DAILY 5. Clonazepam 1 mg PO TID Discharge Medications: 1. BusPIRone 60 mg PO DAILY 2. Clonazepam 1 mg PO TID 3. Furosemide 40 mg PO DAILY 4. Methadone 35 mg PO DAILY 5. Paroxetine 40 mg PO DAILY 6. Amoxicillin-Clavulanic Acid ___ mg PO Q12H Wound Infection RX *amoxicillin-pot clavulanate 875 mg-125 mg 1 tablet by mouth every twelve (12) hours Disp #*9 Tablet Refills:*0 7. Wound Care Supplies Moisture barrier ointment Apply moisture barrier ointment to the periwound tissue with each dressing change. Dispense quantity sufficient for 1 month supply 8. Wound Care Supplies Dispense Spiral Ace Wraps Apply Spiral Ace Wraps to B/L ___ from just above toes to just below knees before getting out of bed. Remove Ace Wraps at bedtime. Please provide qauntity sufficient for 1 month 9. Wound Care Supplies Please dispense dry gauze, sofsorb sponge, and kling wrap. Change dressing daily Dispense quantity sufficient for 1 month of supplies 10. Povidone Iodine ___ Strength 1 Appl TP TID hand soaks Please dilute with warm water and soak hand wound three times per day RX *Betadine 10 % Dilute in warm water to ___ strength three times a day Disp #*1 Bottle Refills:*3 Discharge Disposition: Home Discharge Diagnosis: Hand Laceration Dog Bite wound Venous stasis ulcers Discharge Condition: Mental Status: Clear and coherent. Level of Consciousness: Alert and interactive. Activity Status: Ambulatory - Independent. Discharge Instructions: Dear Ms. ___, It was a pleasure caring for you on your recent admission to ___. You were admitted to the hospital because you had pain and swelling in your right hand after having injured and cut your hand on a glass window. In addition you were also bitten in the hand by a dog that had not been vaccinated. An x-ray of your hand showed that there were no broken bones. While you were hospitalized you received antibiotics to prevent an infection in your hand and you also received a vaccine and immunoglobulin to try to prevent rabies. You were also instructed on how to soak your wounds 3 times per day. You were given a thumb splint and should wear it until your appointment with the hand clinic next week. We also treated the ulcers on your legs. Continue to take your furosemide (water pill) to help prevent fluid accumulation in your legs. Please follow up with your wound care clinic for continued management of these ulcers. Dear Ms. ___, It was a pleasure caring for you on your recent admission to ___. You were admitted to the hospital because you had pain and swelling in your right hand after having injured and cut your hand on a glass window. In addition you were also bitten in the hand by a dog that had not been vaccinated. An x-ray of your hand showed that there were no broken bones. While you were hospitalized you received antibiotics to prevent an infection in your hand and you also received a vaccine and immunoglobulin to try to prevent rabies. You were also instructed on how to clean and care for your wounds. You were given a thumb splint and should wear it until your appointment with the hand clinic next week. We also treated the ulcers on your legs. Continue to take your furosemide (water pill) to help prevent fluid accumulation in your legs. Please follow up with your wound care clinic for continued management of these ulcers. You should also receive 2 more Rabies vaccines, one on ___ and a second one on ___. Please call the ___ clinic to schedule these appointments ___. Otherwise, you can go to your local emergency department. You may also schedule an appointment with Vascular @ ___ for evaluation of your varicose veins. Your medications changes include: Augmentin 825mg Q12H for 4 days to prevent wound infection Oxycodone 5mg Q6H PRN for pain Please see wound care recommendations below: For your leg ulcers: Apply Commercial wound cleanser to irrigate/cleanse all open wounds. Pat the tissue dry with dry gauze. Apply moisture barrier ointment to the periwound tissue with each dressing change. Apply Aquacel AG to all open wounds (silver ion dressing). Cover with dry gauze, Sofsorb sponge, Kling wrap. Change dressing daily. Wound Care for your hands: Please soak your hand wound in betadine and warm water soaks three times per day. Apply Spiral Ace Wraps to B/L ___ from just above toes to just below knees before patient gets OOB or after elevating ___ for 30 minutes. Remove Ace Wraps at bedtime. Followup Instructions: ___
19713049-DS-15
19,713,049
25,204,183
DS
15
2183-07-06 00:00:00
2183-07-09 10:09:00
Name: ___ Unit No: ___ Admission Date: ___ Discharge Date: ___ Date of Birth: ___ Sex: F Service: SURGERY Allergies: No Known Allergies / Adverse Drug Reactions Attending: ___. Chief Complaint: Abdominal pain, N/V, bloody diarrhea Major Surgical or Invasive Procedure: ___ VAC dressing removed ___ ___ pigtail for ant abd collection ___ botox injection, incisional debridement, VAC dressing ___ skin flaps, skin closure (fascia not closed) ___ AbThera change, loss of domain measuring 34x34cm ___ colostomy creation, partial fascial closure, ABThera ___ abdominal washout, placement of RP drain, abthera ___ ex-lap, abdominal washout, colon resection, open abdomen ___ ___ drain History of Present Illness: Ms. ___ is a ___ old woman with history of colonic resection for diverticulitis, who now presents as a transfer from an OSH with concerns for bowel perforation. She states that she started having abdominal pain ___, ___ the middle of the night, without any inciting event. Over the next few days, she also had some intermittent nausea, a few episodes of vomiting, and some bloody diarrhea, which she describes not as real bowel movements but bursts of flatus with blood splattering ___ toilet. She does continue to pass flatus. She has been unable to tolerate much PO ___ the past few days, has kept down a small amount of fluid. She endorses some sweating and subjective fevers. At the OSH she was given zosyn and flagyl. She underwent a CT A/P with IV contrast, which showed concern for perforation near the prior anastomosis. She was therefore transferred here for further care. Of note, prior to transfer, she had a transient desaturation to 89% which improved with placement on 2L nasal cannula. A chest xray showed some haziness at the left base which could represent a developing pneumonia. Upon evaluation ___ the ED now, she continues to have lower abdominal/pelvic pain. She is, however, able to move around freely ___ the bed without too much discomfort. Past Medical History: MI ___ ___ s/p stent, HTN, asthma Past Surgical History: umbilical hernia repair (___), colonic resection for diverticulitis with concomitant TAH/BSO (___), resiting of colostomy, colostomy reversal ___ or ___ Social History: ___ Family History: father w/CABGx5, diverticulosis, pancreatitis, Alzheimer's; mother with lung CA Physical Exam: V/S: T98.3, HR90, BP107/54, RR18, Sat94% 2L NC GEN: A&O, NAD HEENT: No scleral icterus, mucus membranes dry CV: RRR, No M/G/R PULM: normal effort, scattered expiratory wheezing bilaterally ABD: Soft, nondistended, tender to palpation diffusely, but more concentrated ___ central pelvis, no rebound or guarding Ext: No ___ edema, ___ warm and well perfused Physical examination upon discharge: ___: General: NAD CV: ns1, s2, no murmurs LUNGS: Course throughout, no wheezing ABDOMEN: Ostomy left side abdomen with retracted stoma, pigtail left side abdomen, right side abdomen healing abdominal wound with wet to dry dressing, cauterized for bleeding sites x 2, prior to dressing replaced EXT: no pedal edema bil, no calf tenderness bil NEURO: alert and oriented x 3, speech clear Pertinent Results: ___ 07:09AM BLOOD WBC-8.9 RBC-3.27* Hgb-9.4* Hct-31.2* MCV-95 MCH-28.7 MCHC-30.1* RDW-15.7* RDWSD-53.3* Plt ___ ___ 06:35AM BLOOD WBC-9.6 RBC-3.11* Hgb-9.0* Hct-29.9* MCV-96 MCH-28.9 MCHC-30.1* RDW-15.9* RDWSD-53.8* Plt ___ ___ 02:00AM BLOOD WBC-12.6* RBC-4.90 Hgb-14.5 Hct-45.1* MCV-92 MCH-29.6 MCHC-32.2 RDW-13.5 RDWSD-46.2 Plt ___ ___ 02:00AM BLOOD Neuts-86* Bands-10* Lymphs-2* Monos-2* Eos-0 Baso-0 ___ Myelos-0 AbsNeut-12.10* AbsLymp-0.25* AbsMono-0.25 AbsEos-0.00* AbsBaso-0.00* ___ 07:09AM BLOOD Plt ___ ___ 09:15AM BLOOD Plt ___ ___ 05:28AM BLOOD ___ ___ 07:09AM BLOOD Glucose-91 UreaN-7 Creat-0.5 Na-143 K-4.3 Cl-103 HCO3-27 AnGap-13 ___ 09:15AM BLOOD Glucose-107* UreaN-8 Creat-0.6 Na-142 K-4.1 Cl-101 HCO3-27 AnGap-14 ___ 06:35AM BLOOD Glucose-87 UreaN-10 Creat-0.4 Na-141 K-4.1 Cl-101 HCO3-29 AnGap-11 ___ 09:40PM BLOOD ALT-6 AST-11 AlkPhos-79 TotBili-0.3 ___ 01:39AM BLOOD ALT-8 AST-10 LD(LDH)-127 AlkPhos-63 TotBili-0.3 ___ 02:00AM BLOOD Lipase-40 ___ 07:09AM BLOOD Calcium-8.7 Phos-4.5 Mg-2.2 ___ 04:33AM BLOOD calTIBC-170* Ferritn-520* TRF-131* ___ 04:33AM BLOOD Triglyc-232* ___ 02:50AM BLOOD Type-ART pO2-49* pCO2-42 pH-7.50* calTCO2-34* Base XS-7 ___ 02:50AM BLOOD Lactate-1.7 ___: CT abdomen/pelvis: 1. A segment of sigmoid colon along the anastomosis appears perforated with extensive extra-luminal locules of gas, surrounding fat stranding, and bowel contents, possibly secondary to diverticulitis. Rectal contrast is noted within this collection and extends into the proximal colon. 2. Retroperitoneal air is seen to extend along the left flank to the spleen ___: CT abd. and pelvis: 1. Extensive extra-luminal locule of gas and stranding appears increased since the prior study compatible with colonic perforation. No focal fluid collections are seen. 2. A tiny focus of extra-luminal contrast ___ the pelvis and contrast within the descending colon likely reflects prior rectal contrast administration. ___: ___ drainage: Successful CT-guided placement of ___ pigtail catheter into the lower abdominal collection predominantly containing gas. Sample of aspirated necrotic fluid ___ this region was sent for microbiology evaluation. ___: CT abdomen and pelvis: - . Mild interval increase ___ extensive extra-luminal gas and fluid since ___, with some of these areas for example inferior to the right kidney becoming more organized when compared to the prior examination from ___. 2. Tiny focus of extra-luminal oral contrast just distal to the large bowel anastomosis (601, 49) ___ a similar location to prior which likely reflects the site of perforation. ___: ECHO: he left atrial volume index is normal. No atrial septal defect is seen by 2D or color Doppler. The estimated right atrial pressure is at least 15 mmHg. Left ventricular wall thickness, cavity size and regional/global systolic function are normal (LVEF >55%). Right ventricular chamber size and free wall motion are normal. The diameters of aorta at the sinus, ascending and arch levels are normal. The mitral valve appears structurally normal with trivial mitral regurgitation. There is no mitral valve prolapse. The pulmonary artery systolic pressure could not be determined. There is no pericardial effusion. IMPRESSION: Normal left ventricular wall thickness, cavity size, and regional/global systolic function. No definite pathologic valvular flow identified. ___: CXR: IMPRESSION: ET tube tip is 4 cm above the carina. NG tube tip is ___ the stomach. Right internal jugular line tip is at the level of lower SVC. Right PICC line tip is at the level of mid SVC. There is interval progression of ___ lower lobe opacities concerning for aspiration or pneumonia. Vascular congestion is new but no overt pulmonary edema is present ___ particular on the right. No pneumothorax. ___: CXR: Interstitial edema has worsened. Support lines and tubes unchanged. Bilateral effusions right greater than left are stable. Cardio-mediastinal silhouette is unchanged. No pneumothorax is seen. ___: CXR Lungs are low volume with improving pulmonary edema. Small bilateral effusions are stable. Cardio-mediastinal silhouette is unchanged. The ETT has been removed. The NG tube and right-sided central lines are unchanged ___ position. No pneumothorax is seen. ___: CTA chest: 1. No pulmonary embolism or acute aortic abnormality. 2. There is a small to moderate amount of low-attenuation fluid and stranding ___ the abdomen and pelvis. This fluid appears more organized ___ the right lower quadrant (series 2:154) and the left lower quadrant extending into the pelvis (series 2:164). ___ addition, there is a small organized pocket of fluid measuring 2 x 2 cm (series 2:166), non drainable given its size and location. 3. Adjacent to the end colostomy site, there is a subcutaneous fluid collection measuring 5.2 x 2.0 cm ___ the left mid abdomen (series 2:154). 4. Status post and colostomy without evidence of obstruction. 5. 2 drains terminate ___ the anterior abdominal wall. 1 inferior approach drain terminates ___ the pelvis. 6. Small bilateral pleural effusions with associated compressive atelectasis. ___: CT abdomen and pelvis: 1. New rim enhancing gas and fluid containing collection within the pelvis adjacent to the proximal jejunum at site of prior drains, with several loculations insinuating deeper into the pelvis. Associated inflammatory changes of the adjacent small bowel. 2. Interval increase size of left anterior abdominal rim enhancing collection. 3. No evidence of mechanical bowel obstruction. 4. Centri-lobular nodular opacities within the right lower lobe, likely infectious/inflammatory. Aspiration is a differential consideration. 5. Stable postsurgical changes of a left hemi-colectomy with left lower quadrant colostomy. Large ventral wall hernia containing non-obstructed large and small bowel appears unchanged. ___: ___ drainage: Successful CT-guided placement of ___ pigtail catheters into the left upper abdominal and lower abdominal/pelvic collections. Samples were sent for microbiology evaluation. ___: CT abdomen and pelvis: 1. Near complete resolution of previously seen fluid collections ___ the pelvis and left lower abdomen. Small amount of residual fluid persists just anterior to the rectal stump. 2. No new collection seen ___ the abdomen and pelvis. 3. Interval decrease ___ size of the fluid collection ___ the anterior abdominal wall. 4. Persistent centri-lobular opacities ___ the right lower lobe which have slightly increased ___ extent, likely secondary to aspiration. ___: CT abd and pelvis: 1. Since ___, there has been interval removal of the superior left abdominal abscess drain. Along the tract of the removed drainage catheter is a 4.3 x 1.6 cm fluid collection with peripheral enhancement which is not significantly changed from the prior study. 2. The lower drainage catheter is unchanged ___ position with near complete resolution of the collection. 3. No new abscess is identified. 4. There is increased gas and skin ulceration along the midline anterior abdominal wall scar spanning greater than 10 cm. Findings are concerning for dehiscence. No abscess is identified. However, underlying infection cannot be excluded. Clinical correlation is requested. 5. Subcutaneous fluid collection along the inferior margin of the scar measuring 2.7 cm, decreased ___ size since prior. 6. 3.3 x 2.3 x 4.2 cm fat soft tissue density with a hyperattenuating rim suggestive of an omental infarct. ___: CT abd. and pelvis: . Irregular 11 cm anterior intra-abdominal collection surrounding the transverse colon and adjacent to the colostomy. This is technically amenable for CT-guided drainage. 2. Extensive postsurgical changes as detailed above. 3. No significant amount of fluid surrounding the left pelvic drain. This can be potentially removed. ___ CXR: previously seen right PICC has been removed. There is elevation of the right hemi-diaphragm with overlying sub-segmental atelectasis, similar to previous. There is minimal sub-segmental atelectasis at the left lung base. The heart is not enlarged. There may be a trace left effusion. ___: ___ drainage: Successful CT-guided placement of a ___ pigtail catheter into the anterior abdominal collection. Samples were sent for microbiology evaluation. ___: Abd and pelvis: 1. No residual fluid collection/abscess is identified within the subcutaneous tissues or pelvis. 2 percutaneous pigtail drainage catheters remain ___ stable position, without significant surrounding fluid. 2. Persistent centri-lobular nodules within the right lower lobe, suspicious for aspiration pneumonitis/pneumonia. 3. Postsurgical changes from left hemi-colectomy and left lower quadrant colostomy. ___: Abscess: ___ 5:30 pm ABSCESS RETROPERITONEAL ABSCESS. **FINAL REPORT ___ GRAM STAIN (Final ___: NO POLYMORPHONUCLEAR LEUKOCYTES SEEN. 4+ (>10 per 1000X FIELD): GRAM NEGATIVE ROD(S). 3+ ___ per 1000X FIELD): GRAM POSITIVE ROD(S). 2+ ___ per 1000X FIELD): GRAM POSITIVE COCCI. ___ PAIRS AND SINGLY. SMEAR REVIEWED; RESULTS CONFIRMED. WOUND CULTURE (Final ___: MIXED BACTERIAL FLORA. This culture contains mixed bacterial types (>=3) so an abbreviated workup is performed. Any growth of P.aeruginosa, S.aureus and beta hemolytic streptococci will be reported. IF THESE BACTERIA ARE NOT REPORTED, THEY ARE NOT PRESENT ___ this culture. ANAEROBIC CULTURE (Final ___: MIXED BACTERIAL FLORA. Mixed bacteria are present, which may include anaerobes and/or facultative anaerobes. The presence of B.fragilis, C.perfringens, and C.septicum is being ruled out. BACTEROIDES FRAGILIS GROUP. HEAVY GROWTH. BETA LACTAMASE POSITIVE. ___ 11:00 am ABSCESS Source: ___ ant abd. **FINAL REPORT ___ GRAM STAIN (Final ___: NO POLYMORPHONUCLEAR LEUKOCYTES SEEN. NO MICROORGANISMS SEEN. FLUID CULTURE (Final ___: NO GROWTH. ANAEROBIC CULTURE (Final ___: NO GROWTH. FUNGAL CULTURE (Final ___: NO FUNGUS ISOLATED. ___ 11:20 pm STOOL CONSISTENCY: NOT APPLICABLE **FINAL REPORT ___ C. difficile DNA amplification assay (Final ___: Reported to and read back by ___ @ ___ ON ___ - ___. CLOSTRIDIUM DIFFICILE. Positive for toxigenic C difficile by the Cepheid nucleic amplification assay. (Reference Range-Negative). ___ 6:21 pm URINE Source: ___. **FINAL REPORT ___ URINE CULTURE (Final ___: YEAST. >100,000 CFU/mL. ENTEROCOCCUS FAECIUM. 10,000-100,000 CFU/mL. SENSITIVITIES: MIC expressed ___ MCG/ML _________________________________________________________ ENTEROCOCCUS FAECIUM | AMPICILLIN------------ =>32 R LINEZOLID------------- 2 S NITROFURANTOIN-------- 64 I TETRACYCLINE---------- =>16 R VANCOMYCIN------------ =>32 R ___ 5:00 pm ABSCESS Source: abdominal abscess. **FINAL REPORT ___ GRAM STAIN (Final ___: NO POLYMORPHONUCLEAR LEUKOCYTES SEEN. 4+ (>10 per 1000X FIELD): GRAM POSITIVE COCCI. ___ PAIRS AND CLUSTERS. 4+ (>10 per 1000X FIELD): GRAM NEGATIVE ROD(S). 3+ ___ per 1000X FIELD): GRAM POSITIVE ROD(S). FLUID CULTURE (Final ___: STREPTOCOCCUS ANGINOSUS (___) GROUP. SPARSE GROWTH. SENSITIVITIES: MIC expressed ___ MCG/ML _________________________________________________________ STREPTOCOCCUS ANGINOSUS (___) GROUP | CEFTRIAXONE----------- 0.5 S CLINDAMYCIN-----------<=0.25 S ERYTHROMYCIN----------<=0.12 S PENICILLIN G----------<=0.06 S VANCOMYCIN------------ 1 S ANAEROBIC CULTURE (Final ___: MIXED BACTERIAL FLORA. Mixed bacteria are present, which may include anaerobes and/or facultative anaerobes. The presence of B.fragilis, C.perfringens, and C.septicum is being ruled out. BACTEROIDES FRAGILIS GROUP. SPARSE GROWTH. BETA LACTAMASE POSITIVE. Brief Hospital Course: ___ old woman with history of CAD c/b recent MI s/p stent (___), perforated diverticulitis s/p sigmoid resection (___) with colostomy s/p reversal who initially presented as a transfer from an OSH with concerns for bowel perforation. She reported onset of lower abdominal pain that progressively worsened with associated nausea, vomiting, and bloody diarrhea. She initially presented to an OSH where she underwent CT A/P with concern for ___ perforation Ms. ___ was admitted to the ICU with the diagnosis of perforated sigmoid diverticulitis on ___. She was started on Ceftazidime/Flagyl. ___ considered that there was no drainable collection. Vital signs and abdominal exam remained stable. She was transferred to the floor later ___ the day. hospital course ___ On ___, she was taken to the operating room for exploratory laparotomy, colonic resection, open abdomen, and temporary abdominal closure with Abthera vac. Briefly, it appeared that she had a ___ anastomosis perforation with chronic interloop abscess that tracked into the pelvis and laterally and up into the paracolic gutters. For full details of the operation, please refer to the separately dictated operative report. Because of her open abdomen and bowel discontinuity, she was taken to the ICU post-operatively, intubated, for monitoring, with plans for serial takeback ___ the next few days. Over the next few days from ___ to ___, she underwent 4 subsequent operations for washout including placement of an ___ for continuous irrigation of the retroperitoneum where the abscess had been, culminating on ___ with an abdominal closure via skin flaps over visceral with open fascia. She tolerated this procedures were and while on a small amount of levophed for pressure support, she was able to wean off of this and extubate before her last operation. She thereafter went back to the ICU, extubated, for monitoring. On ___, given her stability, she was transferred to the floor. On the floor, she was doing well initially then had increasing respiratory support requirement and was desaturating. She was placed on a nonrebreather and maintained a saturation ___ the high ___. She was also using her accessory muscles at this point. An ABG showed low PO2. She underwent an emergent CTA chest/CT abdomen which showed no evidence of PE. She was thereafter transferred to the ICU for further monitoring. She received 20mg IV Lasix, and had put out >700cc of urine, and subsequently had improved respiratory status. On ___, patient underwent a CT scan of the abdomen pelvis which demonstrated improved fluid collections. On ___ the drain ___ the right upper quadrant was removed and psychiatry was consulted. Psychiatry recommended adding Remeron for sleep nightly. On ___ patient's white blood cell count was 17,000 with increased left shift, and a UA and chest x-ray was obtained. On ___, patient's white blood cell count was noted to be downtrending to 15.1 from 17. The patient's stool culture demonstrated c. difficile so she was started on a 14 day course of oral vancomycin. On ___ the patient was taken to the operating room for Botox injection and skin closure revision followed by wound VAC placement. For details of the surgical procedure please see surgeon's operative note. Postoperatively bleeding from the skin was noted and was cauterized. On ___, the patient was restarted on Plavix and white blood cell counts continue to down trend 13.7. On ___, patient was transfused 1 unit of packed red blood cells for hematocrit of 21.6. On ___, the wound VAC was changed. And based on infectious disease recommendations the patient was started on cefepime and Flagyl. CK level was obtained and and the patient was started on daptomycin. Based on sensitivities, the patient was started on Unasyn on 0 ___. On ___, CT of the abdomen pelvis was obtained which did not demonstrate any drainable collection by interventional radiology. On ___ left-sided drain under bulb suction was removed. On ___, the wound VAC was changed. Stoma was noted to be retracted. On ___, the patient completed the course of oral vancomycin. Unasyn was also discontinued. The VAC dressing was removed on ___ and the patient transitioned to wet to dry daily dressing changes. On ___, following completion of stoma training with the family and the patient, the patient was deemed appropriate for discharge home with services. On the day of discharge, the patient was noted to have bleeding from the wound right abdomen associated with removal of fragments of the VAC black sponge. Silver nitrate was applied to the sites and a wet to dry dressing was applied. There was no further evidence of bleeding. The left drain was left ___ place to a gravity bag. All appropriate follow-up instructions were given to the patient and all questions were answered. Prior to discharge the patient was tolerating a diet, pain was controlled on oral regimen alone, and patient was ambulate independently. ___ services were provided to assist with drain and ostomy care. A follow-up appointment was made ___ the acute care clinic. The patient requested a new primary care provider ___. An appointment was made for her to follow-up ___ 1 week ___ Health Care Associates with her new primary care provider. Medications on Admission: Had lapse ___ insurance and has not taken any medications ___ the past 2months, but previously had been on metoprolol, atorvastatin, ASA, and plavixThe Preadmission Medication list. 1. Metoprolol Tartrate 12.5 mg PO BID 2. Clopidogrel 75 mg PO DAILY 3. Atorvastatin 40 mg PO QPM 4. Aspirin 81 mg PO DAILY Discharge Medications: 1. Docusate Sodium 100 mg PO BID:PRN constipation RX *docusate sodium 100 mg 1 tablet(s) by mouth twice a day Disp #*28 Tablet Refills:*0 2. Furosemide 20 mg PO DAILY please follow-up with your PCP for continuation of this medication RX *furosemide 20 mg 1 tablet(s) by mouth once a day Disp #*14 Tablet Refills:*0 3. Mirtazapine 7.5 mg PO QHS RX *mirtazapine 7.5 mg 1 tablet(s) by mouth at bedtime Disp #*10 Tablet Refills:*0 4. OxyCODONE (Immediate Release) ___ mg PO Q4H:PRN Pain - Moderate RX *oxycodone 5 mg ___ tablet(s) by mouth every four (4) hours Disp #*20 Tablet Refills:*0 5. Pantoprazole 40 mg PO Q24H RX *pantoprazole 40 mg 1 tablet(s) by mouth once a day Disp #*14 Tablet Refills:*0 6. Polyethylene Glycol 17 g PO DAILY:PRN constipation RX *polyethylene glycol 3350 17 gram/dose 17 gm powder(s) by mouth once a day Disp #*6 Packet Refills:*1 7. ProAir HFA (albuterol sulfate) 90 mcg/actuation inhalation Q6H:PRN wheezing, shortness of breath RX *albuterol sulfate [ProAir HFA] 90 mcg 1 spray every six (6) hours Disp #*1 Inhaler Refills:*0 8. Senna 8.6 mg PO BID:PRN decreased ostomy o/p RX *sennosides [senna] 8.6 mg 1 tab by mouth once a day Disp #*14 Tablet Refills:*0 9. Simethicone 40-80 mg PO QID:PRN gas 10. Aspirin 81 mg PO DAILY RX *aspirin 81 mg 1 tablet(s) by mouth once a day Disp #*14 Tablet Refills:*0 11. Atorvastatin 40 mg PO QPM RX *atorvastatin 40 mg 1 tablet(s) by mouth at bedtime Disp #*14 Tablet Refills:*0 12. Clopidogrel 75 mg PO DAILY RX *clopidogrel 75 mg 1 tablet(s) by mouth once a day Disp #*14 Tablet Refills:*0 13. Metoprolol Tartrate 12.5 mg PO BID RX *metoprolol tartrate 25 mg 0.5 (One half) tablet(s) by mouth twice a day Disp #*28 Tablet Refills:*0 Discharge Disposition: Home With Service Facility: ___ Discharge Diagnosis: perforated diverticulitis abdominal wall abscesses colostomy respiratory failure pneumonia c.diff Discharge Condition: Mental Status: Clear and coherent. Level of Consciousness: Alert and interactive. Activity Status: Ambulatory - Independent. Discharge Instructions: ___ were admitted to the hospital with abdominal pain. There was concern for bowel perforation near the previous anastomosis site. Your abdominal pain worsened, and ___ were taken to the operating room for an exploratory laparotomy and lysis of adhesions. ___ underwent creation of a colostomy. ___ subsequently returned to the operating room for additional wound debridements and closure of the abdominal wound. A vac dressing was placed and removed. ___ now have a small dressing over the wound. ___ have received colostomy teaching. A drain was placed ___ the left abdominal abscess which was left ___ place at discharge. Your vital signs have been stable. ___ are being discharged with the following instructions: ___ have an appointment scheduled with the Acute care clinic and your new PCP ___ experience new chest pain, pressure, squeezing or tightness. *New or worsening cough, shortness of breath, or wheeze. *If ___ are vomiting and cannot keep down fluids or your medications. ___ are getting dehydrated due to continued vomiting, diarrhea, or other reasons. Signs of dehydration include dry mouth, rapid heartbeat, or feeling dizzy or faint when standing. ___ see blood or dark/black material when ___ vomit or have a bowel movement. ___ experience burning when ___ urinate, have blood ___ your urine, or experience a discharge. ___ have shaking chills, or fever greater than 101.5 degrees Fahrenheit or 38 degrees Celsius. *Any change ___ your symptoms, or any new symptoms that concern ___. Please resume all regular home medications , unless specifically advised not to take a particular medication. Also, please take any new medications as prescribed. ___ are being discharged with the abdominal drain ___ place, please follow these instructions: ___ Drain Care: -Please look at the site every day for signs of infection (increased redness or pain, swelling, odor, yellow or bloody discharge, warm to touch, fever). -Note color, consistency, and amount of fluid ___ the drain. Call the doctor, ___, or ___ nurse if the amount increases significantly or changes ___ character. -Be sure to empty the drain bag or bulb frequently. Record the output daily. ___ should have a nurse doing this for ___ may shower; wash the area gently with warm, soapy water. -Keep the insertion site clean and dry otherwise. -Avoid swimming, baths, hot tubs; do not submerge yourself ___ water. - If ___ develop worsening abdominal pain, fevers or chills please call Interventional Radiology at ___ at ___ and page ___. -When the drainage total is LESS THAN 10cc/ml for 2 days ___ a row, please have the ___ call Interventional Radiology at ___ at ___ and page ___. This is the Radiology fellow on call who can assist ___. Followup Instructions: ___
19713049-DS-19
19,713,049
26,993,648
DS
19
2183-12-13 00:00:00
2183-12-28 15:16:00
Name: ___ Unit No: ___ Admission Date: ___ Discharge Date: ___ Date of Birth: ___ Sex: F Service: SURGERY Allergies: No Known Allergies / Adverse Drug Reactions Attending: ___. Chief Complaint: Foul smelling wound drainage Major Surgical or Invasive Procedure: None History of Present Illness: ___ with an extensive past surgical history including exlap, LOA, resection of prior colorectal anastomosis with end-colostomy, prolonged open abdomen ___ pelvis sepsis due to perforated diverticulitis and subsequent abdominal closure with skin flaps c/b flap necrosis most recently s/p ___ revision and incisional hernia repair w/ ___ component separation now seen in consultation for midline wound evaluation. Pt was recently admitted to surgical service for management of this midline wound which appeared slightly open. Pt was discharged on ___ with a wound vac in place which she has continued until today. Pt reports that ___ took down her vac earlier today and noted a foul smell without any notable drainage; given the foul smell which is an acute change, she was sent to ___ ED for further workup and management. Aside from foul smell, pt denies any issues with her wound such as increasing pain, change in size, fevers, chills, nausea, or vomiting. She does report decreased ostomy output during the day today but no obstipation. Past Medical History: PSHx: - CAD c/b MI in ___ s/p drug-eluting stent x1, on Aspirin 81mg indefinitely and ticagrelor 90mg PO BID for at least ___ year - Morbid obesity - HTN - HLD - Asthma - Adjustment disorder PSHx: s/p exlap, LOA, resection of prior colorectal anastomosis w/ end colostomy, prolonged open abdomen ___ pelvic sepsis due to perforated diverticulitis and subsequent abdominal closure with skin flaps c/b flap necrosis requiring wound debridement and injection of botox into the abdominal wall musculature to assist with regaining abdominal domain s/p revision of ___ and repair of giant incisional hernia using bilateral component separation technique with mesh in Social History: ___ Family History: father w/CABGx5, diverticulosis, pancreatitis, Alzheimer's; mother with lung CA Physical Exam: Admission Physical Exam: 98.9 68 92/56 16 95%RA Gen: NAD, comfortable CV: RRR R: clear ___ Abd: soft, NT/ND, stoma is patent but with a small amt of hard stool palpated, there is an approximate 6cm x4cm midline wound which is foul smelling. the base appears clean. there is no purulent drainage. there are no fistulae. Ext: no c/c/e Discharge Physical Exam: VS: 98.4, 106/70, 65, 18, 91 Ra Gen: A&O. lying comfortably in bed. CV: HRR Pulm: LS ctab Abd: soft, NT/ND. Midline abdominal wound beefy red with healthy granulating tissue. VAC replaced prior to discharge. Ext: WWP no edema Pertinent Results: ___ 06:42AM BLOOD WBC-7.8 RBC-3.50* Hgb-9.8* Hct-31.8* MCV-91 MCH-28.0 MCHC-30.8* RDW-16.0* RDWSD-52.8* Plt ___ ___ 04:44PM BLOOD WBC-12.8* RBC-3.99 Hgb-11.1* Hct-36.0 MCV-90 MCH-27.8 MCHC-30.8* RDW-15.9* RDWSD-52.4* Plt ___ ___ 06:42AM BLOOD Glucose-76 UreaN-10 Creat-0.7 Na-143 K-4.4 Cl-104 HCO3-26 AnGap-13 ___ 04:44PM BLOOD Glucose-85 UreaN-15 Creat-0.9 Na-138 K-4.5 Cl-98 HCO3-26 AnGap-14 ___ 06:42AM BLOOD Calcium-8.5 Phos-4.0 Mg-1.9 IMAGING: CT Abd / Pelvis: 1. Interval decrease in rim enhancing fluid collection in the pelvis located between the vaginal stump, rectal stump and the urinary bladder. 2. Wide open midline pelvic wall with extensive subcutaneous fat stranding and inflammatory stranding between the subcutaneous fat and the peritoneal lining in the right lower pelvis. 2 small rim enhancing fluid collections enclosing tiny locules of free air are seen within this inflammatory soft tissue stranding. 3. There is no extravasation/leak of orally ingested contrast from the small bowel loops into either of the above described collections or into the peritoneal cavity. 4. Right lower quadrant colostomy is intact Brief Hospital Course: ___ w/ extensive surgical history admitted for wound evaluation. Pt is currently stable and afebrile, but with a foul smelling wound which does not demonstrate any evidence purulent discharge. The wound VAC was taken down and dakins dressing applied. On HD2, the patient was seen by Dr ___ was pleased with how the wound looked and was not concerned about any foul odor or infection. The VAC was replaced and the patient was discharged home to resume ___ with q3d vac changes. During this hospitalization, the patient ambulated early and frequently, was adherent with respiratory toilet and incentive spirometry, and actively participated in the plan of care. The patient received subcutaneous heparin and venodyne boots were used during this stay. At the time of discharge, the patient was doing well, afebrile with stable vital signs. The patient was tolerating a regular diet, ambulating, voiding without assistance, and pain was well controlled. The patient was discharged home with ___ services for wound care. The patient received discharge teaching and follow-up instructions with understanding verbalized and agreement with the discharge plan. Medications on Admission: The Preadmission Medication list may be inaccurate and requires futher investigation. 1. Albuterol Inhaler 1 PUFF IH Q6H:PRN shortness of breath 2. Furosemide 20 mg PO DAILY 3. Atorvastatin 40 mg PO QPM 4. FLUoxetine 40 mg PO DAILY 5. Mirtazapine 7.5 mg PO QHS 6. Pantoprazole 40 mg PO Q24H 7. Aspirin 81 mg PO DAILY 8. Metoprolol Tartrate 12.5 mg PO BID 9. Polyethylene Glycol 17 g PO DAILY 10. Docusate Sodium 100 mg PO BID 11. OxyCODONE (Immediate Release) 10 mg PO 3X/WEEK (___) Discharge Medications: 1. Docusate Sodium 100 mg PO BID 2. Albuterol Inhaler 1 PUFF IH Q6H:PRN shortness of breath 3. Aspirin 81 mg PO DAILY 4. Atorvastatin 40 mg PO QPM 5. FLUoxetine 40 mg PO DAILY 6. Furosemide 20 mg PO DAILY 7. Metoprolol Tartrate 12.5 mg PO BID 8. Mirtazapine 7.5 mg PO QHS 9. OxyCODONE (Immediate Release) 10 mg PO 3X/WEEK (___) RX *oxycodone 5 mg ___ tablet(s) by mouth Q3D Disp #*20 Tablet Refills:*0 10. Pantoprazole 40 mg PO Q24H 11. Polyethylene Glycol 17 g PO DAILY Discharge Disposition: Home With Service Facility: ___ Discharge Diagnosis: Draining abdominal wound Discharge Condition: Mental Status: Clear and coherent. Level of Consciousness: Alert and interactive. Activity Status: Ambulatory - Independent. Discharge Instructions: You were admitted to ___ with concerns about your abdominal wound. The wound was evaluated and did not seem to be infected. You are ready to be discharged home to continue your recovery. The ___ should resume changing the VAC dressing every 3 days. We will see you in clinic for follow-up. Please call your doctor or nurse practitioner or return to the Emergency Department for any of the following: *You experience new chest pain, pressure, squeezing or tightness. *New or worsening cough, shortness of breath, or wheeze. *If you are vomiting and cannot keep down fluids or your medications. *You are getting dehydrated due to continued vomiting, diarrhea, or other reasons. Signs of dehydration include dry mouth, rapid heartbeat, or feeling dizzy or faint when standing. *You see blood or dark/black material when you vomit or have a bowel movement. *You experience burning when you urinate, have blood in your urine, or experience a discharge. *Your pain in not improving within ___ hours or is not gone within 24 hours. Call or return immediately if your pain is getting worse or changes location or moving to your chest or back. *You have shaking chills, or fever greater than 101.5 degrees Fahrenheit or 38 degrees Celsius. *Any change in your symptoms, or any new symptoms that concern you. Please resume all regular home medications, unless specifically advised not to take a particular medication. Also, please take any new medications as prescribed. Please get plenty of rest, continue to ambulate several times per day, and drink adequate amounts of fluids Followup Instructions: ___
19713100-DS-62
19,713,100
28,902,046
DS
62
2177-08-28 00:00:00
2177-08-28 17:12:00
Name: ___ Unit No: ___ Admission Date: ___ Discharge Date: ___ Date of Birth: ___ Sex: M Service: NEUROLOGY Allergies: Amitiza / Oxybutynin / Bactrim Attending: ___. Chief Complaint: Abnormal movements Major Surgical or Invasive Procedure: None History of Present Illness: Mr. ___ is an ___ man with hypotonic bladder with chronic foley c/b multiple drug-resistant UTIs (MRSA and ESBL E. Coli), CAD s/p CABG, s/p bovine AVR, DM, and HTN who was discharged from ___ on ___ after treatment for Cipro-sensitive Acinetobacter and Enterobacter UTI. Had been doing well until yesterday when he began experiencing uncontrollable tremors of his face and neck. No fevers documented at rehab. + chills. Also noted to be hypoxic to 90% on room air-> 94% on 3L at rehab. ___ WNL. Of note, he had a witnessed fall onto his left face on ___. Sent to ED for tremors and hypoxemia. He is able to answer questions and follow commands but has difficulty with articulating words due to facial tremors. He denies ever having these symptoms before. Also denies focal weakness, paresthesias, or confusion. Only other complaint at this time is left groin pain. 10-point ROS reviewed and was otherwise negative. . Vitals in ED: 98.0 60 92/61 20 94% 4L. Given Levofloxacin IV 750mg x1. Past Medical History: 1. Hypotonic bladder with incomplete emptying, s/p indwelling foley since ___ c/b frequent Multidrug resistent UTIs, incl MRSA and ESBL E Coli 2. BPH 3. CAD s/p CABG x 3 in ___ - CABG anatomy: LIMA to LAD, SVG to OM, and SVG to RCA - s/p stenting ___ of mid RCA, PTCA of proximal RCA and PDA - redo single vessel CABG in ___ with Dr. ___. 4. Bovine AVR in ___. Type 2 Diabetes Mellitus: diet controlled 6. Hypertension 7. Hx of Chronic constipation 8. Hyperlipidemia 9. Depression /Anxiety 10. Asbestosis 11. Spinal stenosis 12. R kidney mass - Followed by urology w/ serial imaging, likely RCC 13. Osteoarthritis 14. Carotid stenosis - chronic occlusion of ___, ___ with 40% stenosis Social History: ___ Family History: Daughter- died at ___,breast cancer. Father- died from ___ in his ___. No family history of early MI, arrhythmia, cardiomyopathies, or sudden cardiac death. Physical Exam: Admission Exam: Vitals: 98.2 122/70 84 20 93% 2L Gen: uncontrollable facial twitching, can only articulate few words, A&Ox3, appears uncomfortable HEENT: OP clear, MMM Neck: supple, no LAD CV: RRR, S1/S2 nl, no MRG Lungs: CTAB except decreased breath sounds at bases Abd: soft, NT, ND, NABS Ext: 2+ bilat pitting edema to knees Neuro: tremors of head, neck, and upper extremities, further exam limited ___ tremors Skin: abrasions on face from fall Psych: appropriate Discharge Exam: General: Elderly Caucasian M, sitting up at bedside, cooperative, NAD HEENT: NCAT, MMM, OP clear Neck: Supple. decreased ROM Pulmonary: CTAB without R/R/W Cardiac: RRR, Abdomen: soft, obese, NT, mildly distended with normoactive bowel sounds, no masses appreciated (difficult to assess ___ body habitus) Extremities: Warm, well-perfused bilaterally Skin: No rashes or lesions, Neurologic Exam: -Mental Status: A&O x 2 stated it was ___. Able to relate history with moderate difficulty and dysarthria. Language is fluent with intact repetition and comprehension. Normal prosody. dysarthria and difficulty forming words secondary to tremor, -Cranial Nerves: I: Olfaction not tested. II: PERRL 4-->2.5mm brisk bilaterally. VF. III, IV, VI: EOMI without nystagmus. Normal saccades. V: Facial sensation intact to light touch. VIII: Hearing intact to finger-rub bilaterally. IX, X: Palate elevates symmetrically. XI: ___ strength in trapezii and SCM bilaterally. XII: Tongue protrudes midline. -Motor: Normal bulk and tone. able to maintain arms and legs antigravity. No tremors or abnormal movements noted. -Sensation: Intact to light touch -DTRs: Plantar response was extensor bilaterally. -Coordination: no dysmetria on FNF Pertinent Results: ___ 02:44AM BLOOD WBC-7.1 RBC-4.49* Hgb-13.4* Hct-38.6* MCV-86 MCH-29.9 MCHC-34.8 RDW-16.4* Plt ___ ___ 02:44AM BLOOD Neuts-67.0 ___ Monos-5.7 Eos-4.4* Baso-1.0 ___ 02:44AM BLOOD Glucose-122* UreaN-20 Creat-1.0 Na-136 K-4.2 Cl-99 HCO3-28 AnGap-13 ___ 02:44AM BLOOD Lactate-1.1 K-4.4 . BCx, UCx (___): pending, NGTD . CXR (___): 1. Persistent left basilar atelectasis and pleural effusion, new pneumonia and/or increase in pleural effusion may well be present. Conventional radiographs recommended, when feasible. 2. Probable subsegmental atelectasis in the right lung base. 3. No overt pulmonary edema. CT head ___: IMPRESSION: No acute intracranial process. EEG ___: Preliminary read shows right frontocentral slowing without any epileptiform features. Brief Hospital Course: Mr. ___ is an ___ man with hypotonic bladder with chronic foley c/b multiple drug-resistant UTIs (MRSA and ESBL E. Coli), CAD s/p CABG, s/p bovine AVR, DM, and HTN, recent discharge for Acinetobacter and Enterobacter UTI admitted for work-up and mgmt of hypoxemia and increased tremors likely ___ new pneumonia. . ## Tremors: likely ___ PNA vs. recent fall vs. Ciprofloxacin. Electrolytes ok. Neurology consulted, who recommended starting Clonazepam, which improved the tremors significantly. Statin was held but can probably be restarted. CT head was negative for intracranial bleed. Patient was transferred to the Neurology service for EEG monitoring to rule out seizure activity. Clonazepam was held and his EEG showed right frontocentral slowing without any epileptiform features. By ___ his abnormal movements had completely resolved. Of note pt has previously been evaluated by Dr. ___ in movement disorders clinic for "tremors" (last seen in ___. We will have him follow up with Drs. ___ within 2 months. . ## Acinetobacter/Enterobacter UTI: Ciprofloxacin was stopped on admission and he was treated with Zosyn instead through ___. Needs outpatient Urology follow-up. . ## HCAP: He was treated with Zosyn during his admission for aspiration pneumonitis vs. pneumonia. He was transitioned to Clindamycin 300mg PO QID upon discharge to complete a total 10 day course. . ## Hypoxemia: Likely due to aspiration. See above for management of pneumonia. There was no sign of volume overload on CXR. He was maintained on supplemental O2 via NC which was gradually weaned down. ## CAD s/p CABG, s/p AVR, HTN, HL: Continued on home cardiac meds. . ## Carotid artery stenosis: Continued on home ASA. . ## Depression: Celexa dose was decreased due to tremors. . ## h/o Renal mass: Needs outpt Urology follow-up. . ## Code status: DNR/DNI. . ## Dispo: He was discharged back to his rehab facility in good condition on ___. He was instructed to follow up with Drs. ___ within 2 months in neurology clinic. Medications on Admission: Ciprofloxacin 500mg BID (until ___ Lasix 20mg daily (started ___ Atorvastatin 80mg QHS Tolterodine 4mg QHS Celexa 40mg daily Toprol XL 25mg daily Isosorbide mononitrate 60mg daily ASA 81mg daily Omeprazole 20mg daily Calcium carbonate 1300mg QPM Vit D3 1000U daily Colace 100mg BID Miralax daily PRN Trazodone 75mg QHS PRN Lotrisone cream BID Dulcolax 10mg daily PRN Discharge Medications: 1. metoprolol succinate 25 mg Tablet Extended Release 24 hr Sig: One (1) Tablet Extended Release 24 hr PO DAILY (Daily). 2. isosorbide mononitrate 60 mg Tablet Extended Release 24 hr Sig: One (1) Tablet Extended Release 24 hr PO DAILY (Daily). 3. aspirin 81 mg Tablet, Chewable Sig: One (1) Tablet, Chewable PO DAILY (Daily). 4. cholecalciferol (vitamin D3) 1,000 unit Tablet Sig: One (1) Tablet PO DAILY (Daily). 5. docusate sodium 100 mg Capsule Sig: One (1) Capsule PO BID (2 times a day). 6. polyethylene glycol 3350 17 gram Powder in Packet Sig: One (1) Powder in Packet PO DAILY (Daily) as needed for constipation. 7. trazodone 50 mg Tablet Sig: 1.5 Tablets PO HS (at bedtime) as needed for insomnia. 8. clotrimazole 1 % Cream Sig: One (1) Appl Topical BID (2 times a day). 9. bisacodyl 10 mg Suppository Sig: One (1) Suppository Rectal HS (at bedtime) as needed for constipation. 10. tolterodine 2 mg Tablet Sig: One (1) Tablet PO BID (2 times a day). 11. calcium carbonate 500 mg calcium (1,250 mg) Tablet Sig: One (1) Tablet PO QPM (once a day (in the evening)). 12. omeprazole 20 mg Capsule, Delayed Release(E.C.) Sig: One (1) Capsule, Delayed Release(E.C.) PO DAILY (Daily). 13. citalopram 40 mg Tablet Sig: One (1) Tablet PO once a day. 14. clindamycin HCl 300 mg Capsule Sig: One (1) Capsule PO four times a day for 7 days. Discharge Disposition: Extended Care Facility: ___ Discharge Diagnosis: Abnormal movements - likely related to infection/medication Pneumonia Discharge Condition: Mental Status: Clear and coherent. Level of Consciousness: Alert and interactive. Activity Status: Ambulatory - requires assistance or aid (walker or cane). Discharge Instructions: Dear Mr. ___, You were admitted to ___ on ___ for abnormal movements and low oxygen saturation. The abnormal movements you were having seem to have been due to the antibiotic you were on to treat your UTI. For that reason, that medication was stopped and changed to a new antibiotic called Zosyn. Your low oxygen level was also found to be due to a new pneumonia and the Zosyn will also treat this. You will be changed to a different antibiotic called Clindamycin upon discharge which can be taken orally for the next 7 days to complete your treatment. After stopping the other antibiotic (Cipro), the abnormal movements stopped as well and you have been doing well. An EEG showed no evidence of seizure activity. We made the following changes to your medications: Discontinued Ciprofloxacin Started Clindamycin 300mg four times per day If you experience any of the below listed danger signs, please call your doctor or go to the nearest Emergency Department. Weigh yourself every morning, call MD if weight goes up more than 3 lbs. It was a pleasure taking care of you during your hospital stay. Followup Instructions: ___
19713100-DS-63
19,713,100
25,149,963
DS
63
2177-09-24 00:00:00
2177-09-24 23:30:00
Name: ___ Unit No: ___ Admission Date: ___ Discharge Date: ___ Date of Birth: ___ Sex: M Service: MEDICINE Allergies: ___ / Oxybutynin / Bactrim Attending: ___. Chief Complaint: Chest pain Major Surgical or Invasive Procedure: PICC line placement Foley catheter exchange History of Present Illness: ___ w/hx CAD s/p CABG, chronic foley for hypotonic bladder c/b recurrent MDR UTIs, DM & HTN recently admitted for a UTI and pneumonia now re-presents from home where he was awakened from sleep by substernal non-radiating chest pain. Describes pain as both dull and sharp, lasting a few hours. Took full strength aspirin at home prior to admission. We note that he had been discharged to ___ on ___ sent home only 3 days prior to admission. Review of OMR demonstrates that cardiac catheterization showing 3 vessel disease was performed ___ yr ago, no subsequent stress testing. . In the ED, initial VS: 98.2 77 90/55 20 98% 4LxNC. He recieved Ciprofloxacin IV for positive UA. Serial troponins were 0.05 and 0.06 with Cr 1.0. ED EKG NSR w/RBBB, rate 78 bpm, no ST segment changes. Admitted to the cardiology service for ___. On arrival to the floor he describes pain as above, said it is "very mild" and "better." Denies dyspnea, cough, syncope, dizziness, palpitations, abdominal pain, fevers, chills. Past Medical History: 1. Hypotonic bladder with incomplete emptying, s/p indwelling foley since ___ c/b frequent MDR UTIs including MRSA and ESBL E Coli 2. BPH 3. CAD s/p CABG x ___ - CABG anatomy: LIMA to LAD, SVG to OM, and SVG to RCA - s/p stenting ___ of mid RCA, PTCA of proximal RCA and PDA - redo single vessel CABG in ___ with Dr. ___. 4. Bovine AVR in ___. Type 2 Diabetes Mellitus: diet controlled 6. Hypertension 7. Hx of Chronic constipation 8. Hyperlipidemia 9. Depression /Anxiety 10. Asbestosis 11. Spinal stenosis 12. R kidney mass - Followed by urology w/ serial imaging, likely RCC 13. Osteoarthritis 14. Carotid stenosis - chronic occlusion of ___, ___ with 40% stenosis Social History: ___ Family History: Daughter- died at ___ from breast cancer. Father- died from MI in his ___. Physical Exam: ADMISSION EXAM: VS - 76, RR: 22, BP: 120/80, O2Sat: 95, 3L NC GENERAL - Alert, interactive, well-appearing in NAD HEENT - PERRLA, EOMI, sclerae anicteric, MMM, OP clear NECK - Supple, no thyromegaly, no JVD, no carotid bruits HEART - PMI non-displaced, RRR, nl S1-S2, no MRG LUNGS - CTAB, no r/rh/wh, good air movement, resp unlabored, no accessory muscle use ABDOMEN - NABS, soft/NT/ND, no masses or HSM EXTREMITIES - WWP, no c/c/e, 2+ peripheral pulses . Healing right heel ulcer, no signs of infection. SKIN - no rashes or lesions LYMPH - no cervical, axillary, or inguinal LAD NEURO - awake, A&Ox3, CNs II-XII grossly intact, muscle strength ___ throughout, sensation grossly intact throughout, DTRs 2+ and symmetric, cerebellar exam intact, steady gait . CARDIOLOGY TO MEDICINE TRANSFER EXAM: T 96, BP 144/94, HR 96, RR 20, O2 93% RA General: AOx3, sometimes slightly tangential but redirectable Mouth: Dry MM Neck: No elevated JVD Heart: RRR, normal S1, S2, no extra heart sounds, no MRG Lungs: CTAB Abd: slight TTP Extremeties: Legs wrapped and in multipodus boots, edema improved GU: Foley with clear, yellow urine Skin: Seborrhea on face . DISCHARGE EXAM VS Tm 98.1 Tc 98.1 146/80 (120-140s/70-90s) 86 20 92/RA GEN elderly man lying down in bed w/1 pillow, NAD, breathing comfortably and speaking in full sentences HEENT NCAT MMM EOMI, conjunctiva non-injected, OP clear NECK supple, JVP flat, no LAD PULM CTAB, min bibasilar rales, no rhonchi or wheeze; no cough CV RRR normal S1/S2, no mrg ABD obese NT ND normoactive bowel sounds, no suprapubic tenderness, R groin tender to deep palpation, no r/g, no CVAT FOLEY in place, no tenderness or discharge from urethral meatus, clear yellow urine, no sediment EXT WWP 2+ pulses palpable bilaterally, waffle boots and ACE-wraps in place, symmetric bilateral nonpitting pedal edema, R heel eschar well-healing NEURO AOX3, speech fluent but perseverating and anxious-seeming, thought process non-linear, CN intact, strength ___ throughout, gait not assessed Pertinent Results: ADMISSION LABS ___ 04:10AM BLOOD WBC-6.5 RBC-4.68 Hgb-13.4* Hct-41.9 MCV-90 MCH-28.7 MCHC-32.0 RDW-16.4* Plt ___ ___ 04:10AM BLOOD Neuts-65.6 ___ Monos-4.8 Eos-5.6* Baso-0.9 ___ 04:10AM BLOOD ___ PTT-28.7 ___ ___ 04:10AM BLOOD Glucose-122* UreaN-28* Creat-1.0 Na-136 K-4.9 Cl-100 HCO3-28 AnGap-13 ___ 04:10AM BLOOD CK-MB-7 ___ 04:10AM BLOOD cTropnT-0.05* ___ 01:04PM BLOOD CK-MB-7 cTropnT-0.06* ___ 04:10AM BLOOD Calcium-9.2 Phos-3.7 Mg-2.0 . PERTINENT LABS ___ 04:10AM BLOOD cTropnT-0.05* ___ 01:04PM BLOOD CK-MB-7 cTropnT-0.06* ___ 06:55PM BLOOD CK-MB-5 cTropnT-0.09* . DISCHARGE LABS ___ 06:45AM BLOOD WBC-5.3 RBC-5.45 Hgb-15.0 Hct-48.4 MCV-89 MCH-27.6 MCHC-31.1 RDW-16.8* Plt ___ ___ 06:45AM BLOOD Neuts-69.5 ___ Monos-5.6 Eos-6.1* Baso-0.7 ___ 06:45AM BLOOD Glucose-108* UreaN-16 Creat-0.9 Na-137 K-3.8 Cl-100 HCO3-28 AnGap-13 ___ 06:45AM BLOOD Calcium-9.2 Phos-2.9 Mg-1.6 . MICROBIOLOGY . URINALYSIS ___ 04:10AM URINE Color-Yellow Appear-Cloudy Sp ___ ___ 04:10AM URINE Blood-MOD Nitrite-POS Protein-TR Glucose-NEG Ketone-NEG Bilirub-NEG Urobiln-NEG pH-7.0 Leuks-LG ___ 04:10AM URINE RBC-11* WBC->182* Bacteri-MANY Yeast-NONE Epi-0 TransE-<1 ___ 04:10AM URINE WBC Clm-FEW . ___ URINE CULTURE (Final ___: ESCHERICHIA COLI. >100,000 ORGANISMS/ML.. STAPHYLOCOCCUS, COAGULASE NEGATIVE >100,000 ORGANISMS/ML. _________________________________________________________ ESCHERICHIA COLI | STAPHYLOCOCCUS, COAGULASE NEGATIVE | | AMPICILLIN------------ 8 S AMPICILLIN/SULBACTAM-- 4 S CEFAZOLIN------------- <=4 S CEFEPIME-------------- <=1 S CEFTAZIDIME----------- <=1 S CEFTRIAXONE----------- <=1 S CIPROFLOXACIN--------- =>4 R GENTAMICIN------------ <=1 S =>16 R LEVOFLOXACIN---------- =>8 R MEROPENEM-------------<=0.25 S NITROFURANTOIN-------- <=16 S <=16 S OXACILLIN------------- =>4 R TETRACYCLINE---------- 4 S TOBRAMYCIN------------ <=1 S TRIMETHOPRIM/SULFA---- <=1 S VANCOMYCIN------------ 2 S . ___ URINE CULTURE (Final ___: GRAM NEGATIVE ROD(S). ~1000/ML. . ___ BLOOD CULTURE X2 - NEGATIVE (FINAL) ___ BLOOD CULTURE (Preliminary): STAPHYLOCOCCUS, COAGULASE NEGATIVE. Isolated from only one set in the previous five days. Susceptibility testing requested by ___. ___ ___ (___). ___ BLOOD CULTURE . IMAGING . ___ CXR Chest, PA and lateral radiographs demonstrate stable elevation of left hemidiaphragm and adjacent left lower lobe atelectasis obscuring left heart border. Left pleural effusion. Stable right lower lung opacifications, likely representing atelectasis. No overt pulmonary edema evident. Stable small left pleural effusion. No pneumothorax identified. Mediastinal and hilar contours are unchanged. IMPRESSION: 1. Stable left lower lung atelectasis and pleural effusion. 2. No overt pulmonary edema. . ___ CXR Moderate-to-large left pleural effusion has improved. Right lower lobe opacity consistent with atelectasis has worsened. The left hemidiaphragm is elevated as before. Mild vascular congestion is probably unchanged. There is no evidence of pneumothorax. Sternal wires are aligned. Cardiac size cannot be evaluated, it is obscured by pleural or parenchymal abnormality. . ___ RIGHT GROIN ULTRASOUND Ultrasound of the right groin focused in the inguinal region demonstrates no evidence for hernia. IMPRESSION: No hernia in right groin. . ___ RENAL ULTRASOUND MPRESSION: 1. Please note that ultrasound is insensitive technique for evaluating pyelonephritis. The patient has a known solid mass in the upper pole of the right kidney, but no evidence for hydronephrosis or stones. 2. No perinephric abscess is identified. . ___ CXR (PICC PLACEMENT) IMPRESSION: Left PICC line terminates in the left brachiocephalic vein. . OTHER STUDIES . ___ EKG Sinus rhythm. HR 78. Right bundle-branch block. Compared to the previous tracing of ___ no diagnostic interim change . ___ TTE The left atrium and right atrium are normal in cavity size. There is mild symmetric left ventricular hypertrophy with normal cavity size and regional/global systolic function (LVEF>55%). Right ventricular chamber size and free wall motion are normal. The aortic valve is not well seen. There is mild aortic valve stenosis (valve area 1.2-1.9cm2). No aortic regurgitation is seen. The mitral valve leaflets are mildly thickened. Trivial mitral regurgitation is seen. IMPRESSION: Very limited study. Normal global and regional biventricular systolic function. Probable mild aortic stenosis. If more detailed evaluation of cardiac structures is desired, recommend a transesophageal examination or a cardiac MRI. Compared with the prior study (images reviewed) of ___, the findings are similar. . ___ TTE The left ventricle is not well seen. There is mild symmetric left ventricular hypertrophy. The left ventricular cavity size is normal. Due to suboptimal technical quality, a focal wall motion abnormality cannot be fully excluded. Overall left ventricular systolic function is normal (LVEF>55%). The right ventricular free wall is hypertrophied. Right ventricular chamber size is normal. The aortic valve is not well seen. No masses or vegetations are seen on the aortic valve, but cannot be fully excluded due to suboptimal image quality. No aortic regurgitation is seen. The mitral valve leaflets are not well seen. No masses or vegetations are seen on the mitral valve, but cannot be fully excluded due to suboptimal image quality. No masses or vegetations are seen on the tricuspid valve, but cannot be fully excluded due to suboptimal image quality. The pulmonary artery systolic pressure could not be determined. There is no pericardial effusion. IMPRESSION: Suboptimal image quality. Unable to adequately assess for the absence/presenceof valvular vegetations or abscesses. . PENDING STUDIES AT DISCHARGE ___ & ___ BLOOD CULTURES ___ will call rehab with results) Brief Hospital Course: ___ w/ hx of hypotonic bladder requiring chronic foley c/b multiple MDR urinary tract infections, coronary artery disease s/p CABG, type 2 diabetes mellitus and hypertension who was initially admitted to the Cardiology service with chest pain and then transferred to the General Medicine service for management of E.coli and coagulase negative urinary tract infections. Hospital course was notable for coagulase negative staph septicemia. . # ATYPICAL CHEST PAIN Patient presented with chest pain with non-ischemic EKG, minimally-elevated troponin and negative CK-MD. ___ echocardiogram was performed and was not significantly changed from prior with preserved EF and no regional hypokinesis. Chest pain was treated with tylenol; pain recurred frequently during this admission, whenever the patient was anxious or agitated and improved with low dose benzodiazpines and pain medications. It was also noted to be transient and migratory, appearing variably in his chest, abdomen and right groin. He was transferred from cardiology to medicine because pain was felt to be non-cardiogenic. . #CAD s/p CABG No evidence of active ischemia. Pt previously on a statin which was held during a prior admission because of myoclonic jerking. Not restarted on the cardiology service - deferred for scheduled neurology follow-up. Patient continued on home aspirin with addition of lisinopril and metoprolol for hypertension and managment of peripheral edema. . #Urinary tract infections/Coagulase negative staph septicemia: Patient has history of frequent multidrug resistant UTIs likely complicated by his chronic foley which he has for chronic bladder hypotonia. He had a grossly positive UA on admission and was initially treated with ciprofloxacin based upon prior culture data. Antibiotics were switched to macrobid when speciation/sensitivities showed Cipro-R E coli and coag negative staph. Vancomycin was added when blood cultures drawn subsequently (during episode of transient hypotension, fluid responsive) grew coag negative staph. Infectious Disease was consulted and a repeat TTE showed no vegetation, but was not of good quality. After consultation with ID, pt was discharged with plan for 12-day additional course both vancomycin & macrobid, for 14-day course of both (PICC placed before discharge). Note: foley exchanged on admission on ___. . #VENOUS INSUFFICIENCY Bilateral symmetric leg edema was noted on admission. Cardiology felt it likely ___ venous insufficiency rather than heart failure as patient was not grossly volume overloaded. Patient's legs were wrapped with ace bandages. #Acute on chronic diastolic heart failure: Patient experienced volume overload after fluid resuscitation for hypotension which was likely related to receiving isosorbide. He improved substantially after he was diuresed 3+ liters with PO lasix. Will continue 20mg PO lasix QD on discharge. . # DEPRESSION/ANXIETY Patient endorsed and manifested both depression and anxiety during this admission. Considered a possible contributor to his migratory aches and pains. Home celexa was decreased to 20 mg QD to comply w/recent DFA warning. Trazodone continued qHS (daughter requests this prescription *not* be PRN, pt takes trazodone nightly at home and has hx of sundowning in hospitals/rehab when he does not take trazodone). Seen by social work during this admission, for counseling and support surrounding his difficulty with current medical situation and ongoing grief over loss of his wife. . # MIGRATORY ACHES AND PAIN Patient has chronic migratory aches and pains, especially noted to correlate with anxiety and agitated in the hospital. Daughter reports similar symptoms at home whenever she leaves him with a caregiver, however briefly. He does have known R renal cell carcinoma (not being treated by urology, following radiographically) which could cause discomfort). Treated in-hospital with 1x doses pRN 5 mg PO oxycodone and/or 1 mg PO ativan with good effect. Also prescribed standing tylenol ___ TID. ___ rehab MD prescribe oxycodone/ativan on a PRN basis; no scripts provided at discharge. . # CHRONIC CONSTIPATION Continued home laxatives. . # HX BLADDER SPASM Continued home Tolterodine 2 mg PO BID . # HX GERD Continued omeprazole 20 mg Capsule PO DAILY . # HX ___ INTERTRIGO Previously on clotrimazole 1 % Cream Sig: One (1) Appl Topical BID, no e/o ___ intertrigo on exam during this admission - held. . TRANSITIONAL ISSUES *Needs physical therapy *Needs ongoing social work/counseling surrounding depression/anxiety/grief *Consider starting oxycodone and/or ativan as-needed for migratory pain and anxiety *Needs follow-up electrolyte check (Na, K, Mg, Phos, Cr) - patient started on lisinopril and lasix during this admission *Needs follow-up UA/UCx, BCx in 12 days when antibiotics completed. *Needs PICC pulled after antibiotic course completed (minimum 14 days vancomycin) *Consider restarting Imdur (60 mg QD) if SBP >110 for at least 2 days off antibiotics. *Needs daily wound care to R heel eschar (wound care recs for nursing on page 1) NOTE: We will call with results of pending blood cultures. Medications on Admission: 1. metoprolol succinate 25 mg Tablet Extended Release 24 hr Sig: One (1) Tablet Extended Release 24 hr PO DAILY (Daily). 2. isosorbide mononitrate 60 mg Tablet Extended Release 24 hr Sig: One (1) Tablet Extended Release 24 hr PO DAILY (Daily). 3. aspirin 81 mg Tablet, Chewable Sig: One (1) Tablet, Chewable PO DAILY (Daily). 4. cholecalciferol (vitamin D3) 1,000 unit Tablet Sig: One (1) Tablet PO DAILY (Daily). 5. docusate sodium 100 mg Capsule Sig: One (1) Capsule PO BID (2 times a day). 6. polyethylene glycol 3350 17 gram Powder in Packet Sig: One (1) Powder in Packet PO DAILY (Daily) as needed for constipation. 7. trazodone 50 mg Tablet Sig: 1.5 Tablets PO HS (at bedtime) as needed for insomnia. 8. clotrimazole 1 % Cream Sig: One (1) Appl Topical BID (2 times a day). 9. bisacodyl 10 mg Suppository Sig: One (1) Suppository Rectal HS (at bedtime) as needed for constipation. 10. tolterodine 2 mg Tablet Sig: One (1) Tablet PO BID (2 times a day). 11. calcium carbonate 500 mg calcium (1,250 mg) Tablet Sig: One (1) Tablet PO QPM (once a day (in the evening)). 12. omeprazole 20 mg Capsule, Delayed Release(E.C.) Sig: One (1) Capsule, Delayed Release(E.C.) PO DAILY (Daily). 13. citalopram 40 mg Tablet Sig: One (1) Tablet PO once a day. 14. clindamycin HCl 300 mg Capsule Sig: One (1) Capsule PO four times a day for 7 days. Discharge Medications: 1. metoprolol succinate 25 mg Tablet Extended Release 24 hr Sig: One (1) Tablet Extended Release 24 hr PO DAILY (Daily). Disp:*30 Tablet Extended Release 24 hr(s)* Refills:*2* 2. aspirin 81 mg Tablet, Chewable Sig: One (1) Tablet, Chewable PO DAILY (Daily). 3. docusate sodium 100 mg Capsule Sig: One (1) Capsule PO BID (2 times a day). 4. citalopram 20 mg Tablet Sig: One (1) Tablet PO DAILY (Daily). 5. lisinopril 5 mg Tablet Sig: 0.5 Tablet PO DAILY (Daily). Disp:*30 Tablet(s)* Refills:*2* 6. nitrofurantoin monohyd/m-cryst 100 mg Capsule Sig: One (1) Capsule PO Q12H (every 12 hours) for 9 days. Disp:*18 Capsule(s)* Refills:*0* 7. furosemide 20 mg Tablet Sig: One (1) Tablet PO DAILY (Daily). 8. polyethylene glycol 3350 17 gram Powder in Packet Sig: One (1) packet PO once a day as needed for constipation. 9. trazodone 50 mg Tablet Sig: 1.5 Tablets PO HS (at bedtime): please give at 9 pm. 10. tolterodine 2 mg Tablet Sig: One (1) Tablet PO BID (2 times a day). 11. bisacodyl 10 mg Suppository Sig: One (1) suppository Rectal at bedtime as needed for constipation. 12. omeprazole 20 mg Capsule, Delayed Release(E.C.) Sig: One (1) Capsule, Delayed Release(E.C.) PO DAILY (Daily). 13. cholecalciferol (vitamin D3) 1,000 unit Tablet Sig: One (1) Tablet PO DAILY (Daily). 14. calcium carbonate 500 mg calcium (1,250 mg) Tablet Sig: One (1) Tablet PO at bedtime. 15. vancomycin in D5W 1 gram/200 mL Piggyback Sig: One (1) piggyback Intravenous Q 12H (Every 12 Hours) for 14 days. Disp:*24 piggyback * Refills:*0* 16. acetaminophen 325 mg Tablet Sig: Two (2) Tablet PO TID (3 times a day): maximum 6 tabs per day. 17. vancomycin 750 mg Recon Soln Sig: One (1) piggyback Intravenous every twelve (12) hours for 14 days. Disp:*28 piggybacks* Refills:*0* Discharge Disposition: Extended Care Facility: ___ ___ Diagnosis: PRIMARY DIAGNOSES Complicated urinary tract infection Septicemia from urinary source Atypical chest pain Heart failure with preserved ejection fraction (55%) . SECONDARY DIAGNOSES Coronary artery disease Hypertension Bladder dystonia Spinal stenosis Hyperlipidemia Diabetes mellitus Discharge Condition: Mental Status: Clear and coherent. Level of Consciousness: Alert and interactive. Activity Status: Out of Bed with assistance to chair or wheelchair. Discharge Instructions: Dear Mr. ___, It was a pleasure taking care of ___ at ___. ___ were admitted for evaluation of your chest pain. Labs and studies suggested your pain was not related to your heart. . ___ were found to have accumulated fluid in your legs (edema), so a heart ultrasound (ECHO) was performed to check for heart failure. ___ edema improved with a new medication called lasix. . ___ were also found to have another urinary tract infection. ___ were treated with macrobid and vancomycin - ___ will receive ___ additional 14 days of antibiotics at rehab. Your PICC line will be removed after the antibiotics finish and your infection clears. The following changes were made to your medications: STOP IMDUR (ISOSORBIDE MONONITRATE) STOP CLOTRIMAZOLE STOP CLINDAMYCIN START LISINOPRIL, TAKE 2.5 MG ___ OF A 5 MG TABLET) DAILY START LASIX (FUROSEMIDE), ONE 20 MG TABLET DAILY START MACROBID (ANTIBIOTIC), 1 TAB EVERY 12 HOURS FOR 9 DAYS START VANCOMYCIN (ANTIBIOTIC), 1 750 mg INFUSION EVERY 12 HOURS FOR 14 DAYS DECREASED CELEXA (CITALOPRAM) TO ONE 20 MG TABLET DAILY . NOTE: ___ received some oxycodone and ativan here in the hospital to treat aches and anxiety. We did not prescribe these medications, but recommend the rehab MD consider doing so if ___ suffer similar symptoms there. PLEASE REVIEW THIS LIST OF MEDICATIONS WITH THE REHAB MD ON ARRIVAL, AND WITH YOUR PRIMARY CARE DOCTOR AT YOUR NEXT APPOINTMENT. . While at rehab, ___ should be weighed every morning, & rehab staff should call MD if your weight goes up more than 3 lbs. ___ should continue to do this at home after ___ leave rehab, too. Followup Instructions: ___
19713100-DS-64
19,713,100
26,503,964
DS
64
2177-11-02 00:00:00
2177-11-02 17:24:00
Name: ___ Unit No: ___ Admission Date: ___ Discharge Date: ___ Date of Birth: ___ Sex: M Service: MEDICINE Allergies: ___ / Oxybutynin / Bactrim Attending: ___. Chief Complaint: groin pain Major Surgical or Invasive Procedure: NONE History of Present Illness: ___ yo man with pmhx of hypotonic bladder with chronic foley c/b multiple drug-resistant UTIs (MRSA and ESBL E. Coli), CAD s/p CABG, s/p bovine AVR, DM, and HTN who initially presented to the emergency department because he noticed his foley bag was empty this morning. He was concerned when he awoke this mornign and didn't see any urine the the bag. He also had groin pressure at that time. After he sat up, he noted that urine went into the bag and his groin pain resolved. He currently denies groin pain, hematuria. No chest pain or shortness of breath. In the emergency department, initial vitals were 97.4 99 147/100 18 97% on RA. Patinet was incidentally noted to have left leg redness and swelling on examination. He had a left lower extremity ultrasound, which did not show a DVT. He had blood and urine cultures taken. He received a dose of vancomycin for cellulitis and was admitted to medicine service for treatment of cellulitis. Vitals on transfer were 97.7, 86, 20, 100/64, 100%. On the floor, patinet complains that he is very tired and would like to sleep. He has not been sleeping well at home. He thinks his left leg redness and swelling are somewhat worse than normal. He had subjective fevers at home but did not take his temperature. His groin pain is resolved. REVIEW OF SYSTEMS: Denies chills, night sweats, headache, vision changes, rhinorrhea, congestion, sore throat, cough, shortness of breath, abdominal pain, nausea, vomiting, diarrhea, constipation, BRBPR, melena, hematochezia, hematuria. Past Medical History: 1. Hypotonic bladder with incomplete emptying, s/p indwelling foley since ___ c/b frequent Multidrug resistent UTIs, incl MRSA and ESBL E Coli 2. BPH 3. CAD s/p CABG x 3 in ___ - CABG anatomy: LIMA to LAD, SVG to OM, and SVG to RCA - s/p stenting ___ of mid RCA, PTCA of proximal RCA and PDA - redo single vessel CABG in ___ with Dr. ___. 4. Bovine AVR in ___. Type 2 Diabetes Mellitus: diet controlled 6. Hypertension 7. Hx of Chronic constipation 8. Hyperlipidemia 9. Depression /Anxiety 10. Asbestosis 11. Spinal stenosis 12. R kidney mass - Followed by urology w/ serial imaging, likely RCC 13. Osteoarthritis 14. Carotid stenosis - chronic occlusion of LICA, ___ with 40% Social History: ___ Family History: Daughter- died at ___,breast cancer. Father- died from MI in his ___. Physical Exam: ADMISSION PHYSICAL EXAM: ======================== VS - 98.1, 90/58, 90, 20, 94% on RA GENERAL - Alert and interactive, but keeping eyes closes most of visit, appears tired HEENT - PERRL, EOMI, sclerae anicteric, MMM, OP clear NECK - Supple, no thyromegaly, no carotid bruits HEART - RRR, nl S1-S2, no MRG LUNGS - Clear to auscultation b/l, no wheezes/rales/rhonchi ABDOMEN - NABS, soft/NT/ND, no masses or HSM EXTREMITIES - LLE edema > RLE, Healing right heel ulcer with minimial surrounding erythema, LLE with erythema extending from foot to mid calf, blister on anterior right ankle/shin SKIN - LLE erythema LYMPH - no cervical, axillary, or inguinal LAD NEURO - awake, ___, CNs II-XII grossly intact DISCHARGE PHYSICAL EXAM: ======================== VS - 98.0; 97-140/58-78; 80-96; 18; 95RA EXTREMITIES - LLE edema > RLE, LLE with mild erythema extending from foot to mid calf, non-tender, no fluctuance onychomycosis of all 10 toe nails 3 cm ulcer with mild fibrinous exudate on right posterior heel c/w pressure ulcer, no surrounding erythema, non-tender, no drainage, does not probe to bone GU- foley in place, draining clear urine Exam otherwise unchanged since admission Pertinent Results: ADMISSION LABS: ___ 08:05PM BLOOD WBC-9.6# RBC-4.79 Hgb-13.5* Hct-41.0 MCV-86 MCH-28.1 MCHC-32.8 RDW-18.0* Plt ___ ___ 08:05PM BLOOD Neuts-74.1* Lymphs-17.1* Monos-4.4 Eos-4.0 Baso-0.4 ___ 08:05PM BLOOD Glucose-132* UreaN-26* Creat-1.0 Na-137 K-4.5 Cl-99 HCO3-29 AnGap-14 ___ 06:25AM BLOOD Calcium-8.6 Phos-3.1 Mg-1.7 ___ 06:25AM BLOOD %HbA1c-6.5* eAG-140* DISCHARGE LABS: ___ 06:45AM BLOOD WBC-4.9 RBC-4.54* Hgb-12.7* Hct-40.1 MCV-88 MCH-28.0 MCHC-31.7 RDW-18.9* Plt ___ ___ 06:45AM BLOOD Glucose-111* UreaN-18 Creat-0.8 Na-140 K-4.2 Cl-105 HCO3-27 AnGap-12 ___ 06:45AM BLOOD Calcium-8.7 Phos-3.5 Mg-1.8 MICRO/PATH: Urine culture ___: MIXED BACTERIAL FLORA ( >= 3 COLONY TYPES), CONSISTENT WITH FECAL CONTAMINATION. Blood cultures ___: no growth to date at the time of discharge IMAGING/STUDIES: ___ LLE U/S: The left common femoral, superficial femoral, and popliteal veins demonstrate normal compressibility, flow, and augmentation. The left posterior tibial veins demonstrate flow. The left peroneal veins are not seen. IMPRESSION: No evidence for left lower extremity deep vein thrombosis. ___ CXR: There is no focal consolidation or pleural effusion. Elevation of the left hemidiaphragm is stable. Linear opacities at the right base are either atelectasis or scarring. The upper lung zones are clear. There is mild enlargement of the cardiac silhouette. Median sternotomy wires are present and intact. Again seen are calcified pleural plaques in the periphery of the left hemithorax. IMPRESSION: Atelectasis or scarring at the right base. No focal consolidation. Brief Hospital Course: ___ with PMHx of hypotonic bladder with chronic foley c/b multiple drug-resistant UTIs (MRSA and ESBL E. Coli), CAD s/p CABG, s/p bovine AVR, known Right upper pole kidney mass concerning for RCC, DM, and HTN presenting initially because his foley catheter was not draining. # Positive UA: Patient has extensive history of urinary tract infections and multi-drug resistant organisms in the setting of a chronic indwelling foley catheter. Initial UA with many WBC, positive nitrate and positive leuks. Exam without CVA or suprapubic tenderness. No fever, leukocytosis, tachycardia, hematuria, suprapubic pain. Urine Cx growing mixed bacterial flora. Repeat UA with small leuks, no nitrate, 12 WBC and few bacateria. Likely colonization due to chronic indwelling catheter instead of true infection. Catheter was replaced and draining appropriately throughout hospitalization. Antibiotics not initiated given the lack of evidence suggesting infection. # Left lower extremity redness: Patient with dependent erythema of both lower extremities, left greater than right. No tenderness to palpation or warmth although he has pain of the left foot related to prior closed trauma while riding in a scooter. LLE U/S negative for DVT. Likely stasis dermatitis. # Right heel ulcer: Patient with healing ulcer on right heel. On exam, ulcer mostly covered with eschar, with small area of soft tissue ulceration, without drainage or surrounding erythema or tenderness. Ulcer does not probe to bone. No fevers or leukocytosis concerning for soft tissue infection or osteomyelitis. Wound care per wound care nurse, and instruction given to his daycare nurse to continue wound care. # Coronary artery disease: Continued aspirin 81 mg daily, atorvastatin 80 mg daily. # Hypotonic bladder: Continued tolterodine 2 mg BID. # GERD: Continued omeprazole 20 mg daily. # Hypertension: Continued lisinopril, furosemide, and metoprolol. # Depression/Anxiety: Continued Celexa and Cymbalta. # Chronic constipation: Continued colace 100 mg BID, polyethylene glycol PRN, senna. TRANSITIONAL ISSUES: ==================== - code status: DNR/DNI - Blood culture NGTD at the time of discharge, will follow by primary team Medications on Admission: Metoprolol succinate 25 mg daily aspirin 81 mg dialy colace 100 mg bid citalopram 20 mg daily cymbalta 20 mg daily lisinopril 2.5 mg daily furosemide 20 mg daily polyethylene glycol 17 gram daily PRN constipation trazodine 50 mg qHS tolterodine 2 mg BID bisacodyl ___aily PRN omeprazole 20 mg daily cholecalciferol 1000 units daily calcium carbonate 500 mg qHS acetaminophen 650 mg TID PRN atorvastatin 80 mg daily Discharge Medications: 1. metoprolol succinate 25 mg Tablet Extended Release 24 hr Sig: One (1) Tablet Extended Release 24 hr PO once a day. 2. aspirin 81 mg Tablet, Chewable Sig: One (1) Tablet, Chewable PO DAILY (Daily). 3. docusate sodium 100 mg Capsule Sig: One (1) Capsule PO BID (2 times a day). 4. citalopram 20 mg Tablet Sig: One (1) Tablet PO DAILY (Daily). 5. lisinopril 5 mg Tablet Sig: 0.5 Tablet PO DAILY (Daily). 6. furosemide 20 mg Tablet Sig: One (1) Tablet PO DAILY (Daily). 7. polyethylene glycol 3350 17 gram Powder in Packet Sig: One (1) Powder in Packet PO DAILY (Daily) as needed for constipation. 8. trazodone 50 mg Tablet Sig: One (1) Tablet PO HS (at bedtime) as needed for insomnia. 9. tolterodine 2 mg Tablet Sig: One (1) Tablet PO BID (2 times a day). 10. bisacodyl 5 mg Tablet, Delayed Release (E.C.) Sig: Two (2) Tablet, Delayed Release (E.C.) PO DAILY (Daily) as needed for constipation. 11. omeprazole 20 mg Capsule, Delayed Release(E.C.) Sig: One (1) Capsule, Delayed Release(E.C.) PO DAILY (Daily). 12. cholecalciferol (vitamin D3) 1,000 unit Tablet Sig: One (1) Tablet PO once a day. 13. calcium carbonate 200 mg calcium (500 mg) Tablet, Chewable Sig: One (1) Tablet, Chewable PO DAILY (Daily). 14. acetaminophen 325 mg Tablet Sig: Two (2) Tablet PO every eight (8) hours as needed for fever, pain. 15. atorvastatin 80 mg Tablet Sig: One (1) Tablet PO DAILY (Daily). 16. Cymbalta 20 mg Capsule, Delayed Release(E.C.) Sig: One (1) Capsule, Delayed Release(E.C.) PO once a day. Discharge Disposition: Home With Service Facility: ___ Discharge Diagnosis: Primary: - Foley dysfunction and suprapubic pain - ___ edema and dependent erythema Secondary: -Hypotonic bladder requiring chronic foley -CHF Discharge Condition: Mental Status: Clear and coherent. Level of Consciousness: Alert and interactive. Activity Status: Out of Bed with assistance to chair or wheelchair. Discharge Instructions: Dear Mr. ___, It was a pleasure taking care of you! You were admitted to ___ ___ for concern of urinary tract infection and left leg cellulitis. It turns out you experienced bladder discomfort related to your foley tubing being clamped and you were determined not to have had a urinary tract infection. You were further determined to not have an infection in your left leg. Your foley was changed after initial doses of antibiotics and you were monitored clinically off antibiotics and you demonstrated no evidence of infection. You are being discharged home. It is important to note that you do not need to come to the hospital for occasional ordinary discomfort related to your foley catheter. Reasons to come to the hospital with relation to the catheter include fevers, blood in the foley, or severe discomfort. The following changes have been made to your medications: - No changes were made to your home medications - Please continued taking your other home medications as previously instructed Please follow-up as advised below. Followup Instructions: ___
19713100-DS-65
19,713,100
24,884,495
DS
65
2177-11-13 00:00:00
2177-11-13 23:48:00
Name: ___ Unit No: ___ Admission Date: ___ Discharge Date: ___ Date of Birth: ___ Sex: M Service: MEDICINE Allergies: ___ / Oxybutynin / Bactrim Attending: ___. Chief Complaint: tremors, confusion Major Surgical or Invasive Procedure: None History of Present Illness: ___ yo M w/ hypotonic bladder with incomplete emptying necessitating chronic indwelling foley since ___ c/b frequent multidrug resistent UTIs (MRSA and ESBL E Coli) brought to the ER by his daughter for concern of altered mental status and tremors. Patient recently admitted, received a brief course of antibiotics for concern of UTI and cellulitis. DC'd home without antibiotics as there was low concern for infection. Per his daughter, on the evening of discharge on ___, patient was his usual self, ate dinner, and was interacting well with his family. After dinner, she noticed that he has tremors that started in his hands, then eventually spread to his entire body, associated with feeling hot. He was oriented to person and place, but kept grasping at the air, thinking he is falling while in bed. The daughter does not believe he has hallucinations. ED COURSE: In the ED, 103; 147/112; 24; 96%3LNC. Patient was given cipro, ceftriaxone for dirty UA. Also given home meds and clonazepam. CXR showed atelectasis. CT head without acute intracranial process; 1.8 posterior fossa meningioma unchanged. CT abd/pelvis with unchange right renal mass, and fecal loading. CBC, chem 10 wnl. VS on transfer: 103, RR: 24, BP: 147/112, O2Sat: 96%, O2Flow: 3L (Nasal Cannula). On arrival to the medical floor, the patient drowsy but arousable. AAOx2.5. Moving all extremities. Cannot answer questions appropriately. Past Medical History: 1. Hypotonic bladder with incomplete emptying, s/p indwelling foley since ___ c/b frequent Multidrug resistent UTIs, incl MRSA and ESBL E Coli 2. BPH 3. CAD s/p CABG x 3 in ___ - CABG anatomy: LIMA to LAD, SVG to OM, and SVG to RCA - s/p stenting ___ of mid RCA, PTCA of proximal RCA and PDA - redo single vessel CABG in ___ with Dr. ___. 4. Bovine AVR in ___. Type 2 Diabetes Mellitus: diet controlled 6. Hypertension 7. Hx of Chronic constipation 8. Hyperlipidemia 9. Depression /Anxiety 10. Asbestosis 11. Spinal stenosis 12. R kidney mass - Followed by urology w/ serial imaging, likely RCC 13. Osteoarthritis 14. Carotid stenosis - chronic occlusion of LICA, ___ with 40% Social History: ___ Family History: Daughter- died at ___,breast cancer. Father- died from MI in his ___. Physical Exam: ADMISSION EXAM: VS - 98.4; 85; 126/74; 18; 99%RA GENERAL - Drowsy but arousable. appears tired. oriented to person, place, year, answers mostly yes/no questions HEENT - PERRL, sclerae anicteric, MMM, OP clear NECK - Supple, no thyromegaly HEART - RRR, nl S1-S2, no MRG LUNGS - Clear to auscultation from anterior fields (cannot sit up) ABDOMEN - NABS, soft/NT/ND, no masses or HSM EXTREMITIES - Healing right heel ulcer with minimial surrounding erythema, LLE with erythema extending from foot to mid calf, nontender, not warm LYMPH - no cervical, axillary, or inguinal LAD NEURO - CNs II-XII grossly intact, able to lift bilateral arms, cannot follow commands to lift legs DISCHARGE EXAM: VS - 97.7; 103-142/67-87; 74-82; 18; 93%RA GENERAL - Awake, alert, oriented to time, place, person. answers appropriately. HEENT - PERRL, sclerae anicteric, MMM, OP clear, b/l eyes with crusting over eyelids, minimal drainage, no conjuctival injection, b/l ears with cerumen. NECK - Supple, no thyromegaly HEART - RRR, nl S1-S2, no MRG LUNGS - CTAB ABDOMEN - NABS, soft/NT/ND, no masses or HSM EXTREMITIES - Healing right heel ulcer with minimial surrounding erythema, ulcer covered with eschar, non-draining, nontender, not warm NEURO - CNs II-XII grossly intact SKIN - facial erythematous patches with crusting and peeling markedly improved Pertinent Results: ADMISSION LABS: ___ 06:45AM BLOOD WBC-4.9 RBC-4.54* Hgb-12.7* Hct-40.1 MCV-88 MCH-28.0 MCHC-31.7 RDW-18.9* Plt ___ ___ 11:15PM BLOOD Neuts-68.3 ___ Monos-5.6 Eos-4.7* Baso-0.6 ___ 06:45AM BLOOD Glucose-111* UreaN-18 Creat-0.8 Na-140 K-4.2 Cl-105 HCO3-27 AnGap-12 ___ 06:45AM BLOOD Calcium-8.7 Phos-3.5 Mg-1.8 ___ 11:17PM BLOOD Lactate-2.0 DISCHARGE LABS: ___ 09:00AM BLOOD WBC-5.9 RBC-5.63 Hgb-15.7 Hct-50.6 MCV-90 MCH-27.9 MCHC-31.0 RDW-18.6* Plt ___ ___ 09:00AM BLOOD Glucose-124* UreaN-21* Creat-1.0 Na-141 K-4.5 Cl-101 HCO3-34* AnGap-11 MICROBIOLOGY: ___ Urine culture **FINAL REPORT ___ MIXED BACTERIAL FLORA ( >= 3 COLONY TYPES), CONSISTENT WITH FECAL CONTAMINATION. IMAGING: CT Head W/O Contrast ___: There is no evidence of intracranial hemorrhage, edema, masses or mass effect. The gray-white matter differentiation is normal. The ventricles and sulci are moderately enlarged, consistent with moderate involutional changes. The basal cisterns are normal. Again seen is a partially calcified extraaxial lesion along the left lateral aspect of the posterior cranial fossa overlying the mastoid portion of the temporal bone (4:9), now measuring 1.7 x 1.0 cm, stable since the prior study 1.6 x 0.8 cm. No significant mass effect is seen in the adjacent parenchyma. Moderate calcifications are seen in the cavernous portion of both internal carotid arteries. The imaged paranasal sinuses and mastoid air cells are clear. Bilateral intraocular lens implants are noted. IMPRESSION: No acute intracranial pathology. CT Abd & Pelvis With Contrast ___. The appendix is not definitely visualized. No secondary signs of appendicitis are seen. The presence of motion at this level limits further evaluation. 2. Enhancing right upper pole renal mass, concerning for renal cell carcinoma, stable since the recent prior study of ___. 3. Cholelithiasis. 4. Moderate fecal loading throughout the entire colon. 5. Stable mild compression of L1 vertebral body, unchanged. 6. Extensive coronary arterial calcification and aortic annular calcification. CXR ___: In comparison with the study of ___, there is little interval change. Continued elevation of the left hemidiaphragmatic contour with mild atelectatic changes at the bases and calcified pleural plaques at the periphery of the left hemithorax. Upper zones remain clear and there is no evidence of vascular congestion. No change in the intact median sternotomy wires. Brief Hospital Course: ___ with PMHx of hypotonic bladder with chronic foley c/b multiple drug-resistant UTIs (MRSA and ESBL E. Coli), CAD s/p CABG, s/p bovine AVR, DM, and HTN presented with altered mental status and tremors. # Altered Mental Status - Per patient's daugher, patient was confused the evening he returned home (thinking he is falling), but otherwise oriented to time, person and place. Evening symptoms could be from sun-downing in an elderly gentleman. For his tremors, patient is followed by outpatient neurology for secondary myoclonus of unknown etiology. Patient received clonazepam in the ED for agitation and became difficult to arouse once on arrival to the floor. Infectious workup negative no change on CXR and no infectious etiology on CT abdomen. U/A chronically with bacteria, likely colonization from chronic indwelling foley, culture with mixed flora. No history of trauma, and CT head negative for bleed. No electrolyte abnormalities or hypoglycemia. By the second morning of admission, patient awake, alert, AAOx3, back to his baseline. Geriatrics consulted to help managed his psychopharmacology. Recommended stopping celexa and tolterodine, increasing cymbalta to 30mg daily, and uptitrate trazodone as needed for sleep (but do not exceed 100mg qHS) which was done. # Positive UA: Patient has extensive history of urinary tract infections and multi-drug resistant organisms in the setting of a chronic indwelling foley catheter. UA with WBC, + nitrate, + leuks and bacteria, but culture showed mixed flora/contamination. Exam without CVA or suprapubic tenderness. No fever, leukocytosis, tachycardia, hematuria, suprapubic pain. Likely colonization due to chronic indwelling catheter instead of true infection. Catheter was replaced a few days ago on previous hospitalization. Catheter usually replaced in Dr. ___ every ___ week. Discontinued tolterodine in the setting of anti-cholingeric contributing to his delirium. # Depression/Anxiety: Tapered off Celexa. Increased cymbalta to 30mg daily. # Conjunctivitis: Significant thick drainage from bilateral eyes. patient with poor eye hygiene. Symptoms improved with 5-day course of erythromycin eye gel. # Seborrheic dermatitis: Improved with topical triamcinolone cream. # Hypertension: Patient with SBP 90-110s. Continued metoprolol but stopped furosemide and lisinopril. CHRONIC ISSUES: # Left lower extremity redness: Stasis dermatitis. LLE U/S negative for DVT on ___. # Right heel pressure ulcer: Patient with healing ulcer on right heel. Low concern for soft tissue infection or osteomyelitis. # Coronary artery disease: Continued aspirin 81 mg daily, atorvastatin 80 mg daily. # Hypotonic bladder: Stopped tolterodine (see above). Continued chronic indwelling foley, last changed on ___. # GERD: Continued omeprazole 20 mg daily. # Chronic constipation: Continued colace 100 mg BID, polyethylene glycol PRN, senna. # Transitional issues: - code status: DNR/DNI - Patient will transition from Dr. ___ to new PCP in ___ - Neurology and urology f/u Medications on Admission: 1. metoprolol succinate 25 mg Tablet Extended Release 24 hr Sig: One (1) Tablet Extended Release 24 hr PO once a day. 2. aspirin 81 mg Tablet, Chewable Sig: One (1) Tablet, Chewable PO DAILY (Daily). 3. docusate sodium 100 mg Capsule Sig: One (1) Capsule PO BID (2 times a day). 4. citalopram 20 mg Tablet Sig: One (1) Tablet PO DAILY (Daily). 5. lisinopril 5 mg Tablet Sig: 0.5 Tablet PO DAILY (Daily). 6. furosemide 20 mg Tablet Sig: One (1) Tablet PO DAILY (Daily). 7. polyethylene glycol 3350 17 gram Powder in Packet Sig: One (1) Powder in Packet PO DAILY (Daily) as needed for constipation. 8. trazodone 50 mg Tablet Sig: One (1) Tablet PO HS (at bedtime) as needed for insomnia. 9. tolterodine 2 mg Tablet Sig: One (1) Tablet PO BID (2 times a day). 10. bisacodyl 5 mg Tablet, Delayed Release (E.C.) Sig: Two (2) Tablet, Delayed Release (E.C.) PO DAILY (Daily) as needed for constipation. 11. omeprazole 20 mg Capsule, Delayed Release(E.C.) Sig: One (1) Capsule, Delayed Release(E.C.) PO DAILY (Daily). 12. cholecalciferol (vitamin D3) 1,000 unit Tablet Sig: One (1) Tablet PO once a day. 13. calcium carbonate 200 mg calcium (500 mg) Tablet, Chewable Sig: One (1) Tablet, Chewable PO DAILY (Daily). 14. acetaminophen 325 mg Tablet Sig: Two (2) Tablet PO every eight (8) hours as needed for fever, pain. 15. atorvastatin 80 mg Tablet Sig: One (1) Tablet PO DAILY (Daily). 16. Cymbalta 20 mg Capsule, Delayed Release(E.C.) Sig: One (1) Capsule, Delayed Release(E.C.) PO once a day. Discharge Medications: 1. metoprolol succinate 25 mg Tablet Extended Release 24 hr Sig: One (1) Tablet Extended Release 24 hr PO DAILY (Daily). 2. aspirin 81 mg Tablet, Chewable Sig: One (1) Tablet, Chewable PO DAILY (Daily). 3. docusate sodium 100 mg Capsule Sig: One (1) Capsule PO BID (2 times a day) as needed for constipation. 4. polyethylene glycol 3350 17 gram Powder in Packet Sig: One (1) Powder in Packet PO DAILY (Daily) as needed for constipation. 5. bisacodyl 5 mg Tablet, Delayed Release (E.C.) Sig: Two (2) Tablet, Delayed Release (E.C.) PO DAILY (Daily) as needed for constipation. 6. omeprazole 20 mg Capsule, Delayed Release(E.C.) Sig: One (1) Capsule, Delayed Release(E.C.) PO DAILY (Daily). 7. cholecalciferol (vitamin D3) 1,000 unit Tablet Sig: One (1) Tablet PO DAILY (Daily). 8. calcium carbonate 200 mg calcium (500 mg) Tablet, Chewable Sig: One (1) Tablet, Chewable PO DAILY (Daily). 9. acetaminophen 325 mg Tablet Sig: ___ Tablets PO every six (6) hours as needed for pain. 10. atorvastatin 80 mg Tablet Sig: One (1) Tablet PO DAILY (Daily). 11. senna 8.6 mg Tablet Sig: One (1) Tablet PO BID (2 times a day) as needed for constipation. 12. duloxetine 30 mg Capsule, Delayed Release(E.C.) Sig: One (1) Capsule, Delayed Release(E.C.) PO DAILY (Daily). Disp:*30 Capsule, Delayed Release(E.C.)(s)* Refills:*2* 13. trazodone 100 mg Tablet Sig: One (1) Tablet PO at bedtime as needed for insomnia. 14. Triamcinolone cream for facial lesions Discharge Disposition: Extended Care Facility: ___ Discharge Diagnosis: Delirium Myoclonic tremors Hypotonic Bladder Discharge Condition: Mental Status: Clear and coherent. Level of Consciousness: Alert and interactive. Activity Status: Out of Bed with assistance to chair or wheelchair. Discharge Instructions: Mr. ___, It was a pleasure participating in your care at ___. You were admitted for tremors. There was a infectious workup which was negative and your symptoms improved. We made the following changes to your medications: STOPPED Celexa STOPPED Tolterodine INCREASED Cymbalta to 30mg daily STARTED triamcinolone cream for facial lesions STOPPED Lisinopril STOPPED Lasix Followup Instructions: ___
19713100-DS-66
19,713,100
23,578,711
DS
66
2178-01-13 00:00:00
2178-01-14 10:52:00
Name: ___ Unit No: ___ Admission Date: ___ Discharge Date: ___ Date of Birth: ___ Sex: M Service: MEDICINE Allergies: ___ / Oxybutynin / Bactrim Attending: ___. Chief Complaint: Constipation and low O2 sat Major Surgical or Invasive Procedure: None History of Present Illness: Mr. ___ is an ___ man with a history of CAD, T2DM, HLD, chronic urinary colonization with chronic indwelling Foley, and chronic constipation who presents with constipation and abdominal pain. He states that his last bowel movement was 1 day ago but was small and pellet-like. He does not remember the last time he had a softer bowel movement. He frequently has the urge to go and strains to have bowel movements but only gets small pellets if anything at all. He also has associated crampy abdominal/groin pain for the past 3 weeks. He denies any N/V, bloody stools, melena, changes in diet or unusual foods, fever, chills, or night sweats. His daughter later called the ___ and said that his inital complaint at home had been CP and SOB, but when EMS arrived, he denied these symptoms and was only reported abdominal pain. He continues to deny that he has any CP or SOB. He also denies and palpitations, orthopnea, PND, leg swelling, cough, or increased fatigue. In the ___, his initial VS were T 96.9, HR 88, BP 122/80, RR 18, sat 93% RA, pain ___ lower abdomen. His exam was notable for a soft abdomen with mild tenderness to palpation in the lower quadrants and guaiac negative rectal exam. His labs were notable for Trop-T 0.08, lytes and CBC wnl, and UA positive for moderate leuks and bacteria, nitrites, and 15 WBCs. A KUB showed moderate fecal loading in the ascending colon, rectum and sigmoid colon, and an abdominal CT showed no signs of an acute process, moderate fecal loading, and a stable right renal mass concerned for RCC. He was given 1L NS, 1g ceftriaxone, and 650mg acetaminophen and admitted for constipation. His VS prior to transfer were T 98.0, BP 119/87, HR 83, RR 18, sat 95% on 3L NC. On the floor, he continues to complain of lower abdominal pain and constipation, and denies any CP or SOB. He is also complaining of a longstanding ulcer on his penis near the meatus around the Foley. Past Medical History: 1. Hypotonic bladder with incomplete emptying, s/p indwelling foley since ___ c/b frequent Multidrug resistent UTIs, incl MRSA and ESBL E Coli 2. BPH 3. CAD s/p CABG x 3 in ___ - CABG anatomy: LIMA to LAD, SVG to OM, and SVG to RCA - s/p stenting ___ of mid RCA, PTCA of proximal RCA and PDA - redo single vessel CABG in ___ with Dr. ___. 4. Bovine AVR in ___. Type 2 Diabetes Mellitus: diet controlled 6. Hypertension 7. Hx of Chronic constipation 8. Hyperlipidemia 9. Depression /Anxiety 10. Asbestosis 11. Spinal stenosis 12. R kidney mass - Followed by urology w/ serial imaging, likely RCC 13. Osteoarthritis 14. Carotid stenosis - chronic occlusion of LICA, ___ with 40% Social History: ___ Family History: Daughter- died at ___,breast cancer. Father- died from MI in his ___. Physical Exam: ADMISSION EXAM: Vitals: T 98.1, BP 142/59, HR 88, RR 22, sat 95% on 3L NC General: Alert, oriented, distressed when left alone, drifts off to sleep but easily awakened and refocused HEENT: Sclera anicteric, MMM, oropharynx clear Neck: supple, JVP not elevated, no LAD Lungs: CTAB, no wheezes, rales, ronchi CV: RRR, normal S1/S2, ___ systolic ejection murmur heard best at the RUSB with no radiation to carotids Abdomen: obese, non-distended, NABS, soft, mildly tender to deep palpation in RLQ and suprapubic area, no rebound tenderness or guarding, no organomegaly Ext: Warm, well perfused, 2+ pulses; no clubbing or cyanosis; 1+ pitting edema to the knee bilaterally (chronic per patient); some erythema of the medial compartment of the L lower limb (chronic per patient) DISCHARGE VS: Tc 97.6, Tm 98.1, BP 153/60 (140s-150s/50s-60s), HR 86 (80s-100s), RR 24, sat 99% on RA Abdomen: obese, non-distended, NABS, soft, nontender GU: Mild suprapubic tenderness, 1cm stage 2 ulcer at meatus without erythema, purulence, or evidence of recent bleeding Ext: Warm, well perfused, 2+ pulses; no clubbing or cyanosis; 1+ pitting edema to the knee bilaterally (chronic, unchanged); some erythema of the medial compartment of the L lower limb (chronic, unchanged) Neuro: CNII-XII intact, strength and sensation intact and symmetric bilaterally Exam otherwise unchanged since admission Pertinent Results: ADMISSION LABS ___ 06:50AM BLOOD WBC-7.0 RBC-4.55* Hgb-13.2* Hct-40.4# MCV-89 MCH-29.1 MCHC-32.7 RDW-17.5* Plt ___ ___ 06:50AM BLOOD Neuts-65.7 ___ Monos-6.3 Eos-3.8 Baso-0.3 ___ 06:50AM BLOOD ___ PTT-29.3 ___ ___ 06:50AM BLOOD Glucose-119* UreaN-20 Creat-0.9 Na-135 K-4.3 Cl-100 HCO3-28 AnGap-11 ___ 06:57AM BLOOD Lactate-0.8 CARDIAC ENZYMES ___ 06:50AM BLOOD CK-MB-6 ___ 06:50AM BLOOD cTropnT-0.08* ___ 01:10PM BLOOD cTropnT-0.07* UA ___ 06:50AM URINE Color-Yellow Appear-Hazy Sp ___ ___ 06:50AM URINE Blood-NEG Nitrite-POS Protein-TR Glucose-NEG Ketone-NEG Bilirub-NEG Urobiln-2* pH-6.5 Leuks-MOD ___ 06:50AM URINE RBC-2 WBC-15* Bacteri-MOD Yeast-NONE Epi-<1 ___ 06:50AM URINE Mucous-RARE MICRO Urine and blood cultures from ___: pending IMAGING ABDOMEN (SUPINE & ERECT) Study Date of ___ 3:06 AM IMPRESSION: Moderate fecal loading in the ascending colon, rectum and sigmoid colon. CHEST (PA & LAT) Study Date of ___ 5:10 AM IMPRESSION: New right lower lobe plate-like atelectasis. Unchanged calcified pleural plaques. CT ABD & PELVIS WITH CONTRAST Study Date of ___ 8:17 AM IMPRESSION: 1. No evidence of acute intra-abdominal process. 2. Stable right renal mass concerning for RCC. 3. Cholelithiasis without any evidence of cholecystitis. 4. Moderate fecal loading. Brief Hospital Course: This is an ___ man with a history of CAD, T2DM, HLD, chronic urinary colonization with chronic indwelling Foley, and chronic constipation who presents with constipation and suprapubic pain but no signs of acute infection. # Constipation: He has had a chronic problem with constipation. His last bowel movement was 1 day prior to admission and was small and pellet-like, as his stools typically are. He takes Senna and Colace regularly at home and said he usually responds well to Dulcolax but hadn't taken it recently. His constipation is likely a combination of poor hydration and immobility. He does not take narcotics or other constipating medications. His diet consists of lots of fruit and fish, and he avoids pasta and junk foods that might be constipating. He was given an agressive bowel regimen of standing senna, colace, miralax, bisacodyl, and fleets enema. He also underwent manual disimpaction and had milk of magnesia x1, all of which resulted in a very large bowel movements prior to dischargen. He felt significant relief of his abdominal pain and suprapubic discomfort after the bowel movement. # Suprapubic pain w/ positive UA: He has a known hypotonic bladder with incomplete emptying and has had an indwelling Foley since ___ for this issue. His UA in the ___ was positive for moderate leuks and bacteria, nitrites, and 15 WBCs. He was given in 1g ceftriaxone in the ___, but antibiotics were not continued on the floor as he was afebrile, mentating normally, and did not have an elevated WBC count to suggest infection. Urine and blood cultures were sent and were still pending at the time of discharge. His pain became much more severe on the night of admission and he was frequently calling out in pain. He was started on tolterodine 1g BID. After his large bowel movement the morning after admission (see above), his suprapubic pain was greatly improved, so the tolterodine was stopped given prior episodes of altered mental status while taking this medication. Ultimately it was thought that his suprapubic pain was caused by his known bladder spasm and made worse by his constipation. Will follow up with Dr. ___ in late ___. # Hypoxia: He denied SOB on this admission, but per his daughter, he was reporting increasing SOB at home prior to EMS arrival. He reported that his O2 sat goes to 89% on RA at home, but he remains asymptomatic. His CXR showed plate-like in the right middle lobe, but no signs of infiltrate or infection. His lung exam was clear. There was some concern for PE given his risk factors of immobility and likely RCC but given that he was not complaining of chest pain and his EKG did not show sinus tach or new right heart strain, a CTA was deferred. A D-dimer also was not sent given the high likelihood of a false positive in the setting of RCC and chronic urinary colonization. He was encouraged to use incentive spirometry and had O2 sats of 99% on room air the morning after admission. # Chest pain: Per his daughter, he was complaining of CP and SOB prior to EMS arrival, but he consistently denied CP during admission. There was some concern for PE (see above "hypoxia"). His EKG showed no changes from prior and no signs of acute ischemia. His CK-MB was not elevated, and his TropT was mildly elevated (0.07, 0.08) but at his baseline of 0.04-0.09. # Penile ulcer: He has had four recent ___ visits on ___ and ___ for a penile ulcer around the meatus that is being irritated by his Foley catheter. On exam, he had a 1-cm stage 2 ulcer near the meatus that was tender to palpation but had minimal erythema, no purulent discharge, and no signs of bleeding. Per his outpatient urologist, a suprapubic catheter has been offered on multiple occasions, and the patient has always refused. A wound care consult was called to dress the wound. # Depression/Anxiety: He is a frequent visitor to the ___ with many somatic complaints. He frequently expressed fear on this admission that he was going to die and did not like to be left alone for very long. He still struggles with death ___ years ago of his wife of ___ years. He was continued on his home duloxetine and trazodone QHS for insomnia. # Hypertension: His BPs were 140s-160s/60s-80s on the floor. He was first started on metoprolol tartrate 12.5 mg BID and then increased to 25 mg BID. Plans were made to discharge him on metoprolol succinate 50 mg QD. Starting an ACE inhibitor instead of increasing his metoprolol was considered given his known DM and CAD, but his ACE inhibitor had previously been discontinued due to hypokalemia. It was elected to leave the decision about starting an ACE inhibitor to the discretion of his PCP in ongoing ___. BP checks were planned for his ___ sessions at daycare at home. # Left lower extremity erythema: He reports that this has been a chronic problem since a prior trauma to the leg. The erythema extended along the medial aspect of his L lower extremity from ankle to knee. There was no warmth or tenderness to palpation to suggest acute cellulitis, and the compartment was soft. Given the chronicity of the problem and his benign exam, LENIS were not done. # Coronary artery disease: He is s/p CABG LIMA->LAD, SVG->ramus->PDA; catheterization in ___nd DOE -> Stents to PDA, mRCAx2, pRCA. ___ P-MIBI WNL; and a single redo CABG with AVR and a porcine valve in ___. He is followed by Dr. ___. He denies any chest pain on this admission, although his daughter says he was complaining of some chest pain at home (see above "chest pain"). He EKG and cardiac enzymes were negative for any signs of acute ischemia. # GERD: He was continued on his home omeprazole. # T2DM: His blood sugars are controlled by diet alone at home. His glucose was followed with his daily lytes, and was not elevated above 150. # Limited mobility: He reports a maximum of ___ steps of ambulation at home and uses a wheelchair to get around. He receives home ___ at daycare. ___ was consulted to assess his ___ needs following discharge. Transitional issues -Code status: DNR/DNI, confirmed with patient -Pending studies: blood and urine cultures from ___ -Medication changes: daily miralax, dulcolax if he hasn't had a bowel movement in more than one day, increase dose of metoprolol succinate from 25mg to 50mg QD. -Plan to check BP with new PCP ___ ___ -Plan for BP ___ and consideration of restarting an ACE inhibitor with his PCP ___ on ___: Preadmission medications listed are correct and complete. Information was obtained from webOMR. 1. Metoprolol Succinate XL 25 mg PO DAILY 2. Aspirin 81 mg PO DAILY 3. Docusate Sodium 100 mg PO BID:PRN constipation 4. Polyethylene Glycol 17 g PO DAILY:PRN constipation 5. Bisacodyl 10 mg PO DAILY:PRN constipation 6. Omeprazole 20 mg PO DAILY 7. Vitamin D 1000 UNIT PO DAILY 8. Calcium Carbonate 500 mg PO DAILY 9. Acetaminophen 325-650 mg PO Q6H:PRN pain 10. Atorvastatin 80 mg PO DAILY 11. Senna 1 TAB PO BID:PRN constipation 12. Duloxetine 30 mg PO DAILY 13. traZODONE 100 mg PO HS:PRN insomnia Discharge Medications: 1. Acetaminophen 325-650 mg PO Q6H:PRN pain 2. Aspirin 81 mg PO DAILY 3. Atorvastatin 80 mg PO DAILY 4. Bisacodyl 10 mg PO DAILY:PRN constipation RX *bisacodyl 5 mg 2 tablet(s) by mouth once a day Disp #*30 Tablet Refills:*0 5. Calcium Carbonate 500 mg PO DAILY 6. Docusate Sodium 100 mg PO BID:PRN constipation RX *docusate sodium 100 mg 1 tablet(s) by mouth twice a day Disp #*30 Tablet Refills:*0 7. Duloxetine 30 mg PO DAILY 8. Omeprazole 20 mg PO DAILY 9. Polyethylene Glycol 17 g PO DAILY Hold for loose stools. RX *polyethylene glycol 3350 17 gram/dose 1 packet by mouth daily Disp #*30 Packet Refills:*0 10. Senna 2 TAB PO BID Hold if patient has loose stools. RX *senna 8.6 mg 2 tablets by mouth twice a day Disp #*60 Tablet Refills:*0 11. traZODONE 100 mg PO HS:PRN insomnia 12. Vitamin D 1000 UNIT PO DAILY 13. Metoprolol Succinate XL 50 mg PO DAILY RX *metoprolol succinate 50 mg 1 tablet(s) by mouth daily Disp #*30 Tablet Refills:*0 Discharge Disposition: Home Discharge Diagnosis: Constipation Hypoxia Hypotonic bladder Urinary colonization Discharge Condition: Mental Status: Clear and coherent. Level of Consciousness: Alert and interactive. Activity Status: Out of Bed with assistance to chair or wheelchair. Discharge Instructions: Dear Mr. ___, It was a pleasure to take care of you during your hospital stay. You were admitted to ___ for constipation and low oxygen saturation. You also had some worsening of your chronic groin pain. You were given a number of laxatives and had a large bowel movement, after which you felt much better. Your oxygen saturation came back to normal without any supplemental oxygen. The following changes were made to your medications: - Please CONTINUE taking Senna and Colace on a daily basis along with at least 2 liters of fluids daily. - Please START taking Miralax on a daily basis - Please START taking Dulcolax if it has been more than 1 day since your last bowel movement. - Please INCREASE your dose of metoprolol from 25mg daily to 50mg daily. No other changes were made to your medications. You should continue all of your other medications as you were before you were admitted to the hospital. Followup Instructions: ___
19713100-DS-70
19,713,100
26,972,142
DS
70
2178-05-18 00:00:00
2178-05-18 16:01:00
Name: ___ Unit No: ___ Admission Date: ___ Discharge Date: ___ Date of Birth: ___ Sex: M Service: MEDICINE Allergies: Amitiza / Oxybutynin / Bactrim Attending: ___. Chief Complaint: multidrug resistant uti treatment Major Surgical or Invasive Procedure: none History of Present Illness: Mr. ___ is an ___ year old man with a hypotonic bladder, BPH, chronic indwelling foley and multiple recent multidrug resistant urinary tract infections who was sent to the ED by his PCP for admission and iv antibiotics for a UTI. He has multiple other chronic medical problems (see below). He was last admitted to ___ from ___ to ___ for treatment of a UTI. He was treated with meropenem initially then narrowed to po ciprofloxacin on which he was discharged home. Patient denies fevers or chills, but he complains of a dull suprapubic ache which has worsened over the course of the last three days. He does not have back pain. In the ED, initial VS were:97.6, hr 88, bp 86/47, rr 20, sat 95%. His subsequent blood pressures ranged from 108-118/71-76, even before he recieved fluid. He was given NS x 1 Liter and cefepime 2g iv once.A #20 right EJ was inserted. Transfer vitals were 97.2 oral, HR 79, BP 108/74, RR ___, O2 sat 2L NC. On arrival to the floor, he had mild suprapubic discomfort. Past Medical History: 1. Hypotonic bladder with incomplete emptying, s/p indwelling foley since ___ c/b frequent Multidrug resistent UTIs, incl MRSA and ESBL E Coli 2. BPH 3. CAD s/p CABG x 3 in ___ - CABG anatomy: LIMA to LAD, SVG to OM, and SVG to RCA - s/p stenting ___ of mid RCA, PTCA of proximal RCA and PDA - redo single vessel CABG in ___ with Dr. ___. 4. Bovine AVR in ___. Type 2 Diabetes Mellitus: diet controlled 6. Hypertension 7. Hx of Chronic constipation 8. Hyperlipidemia 9. Depression /Anxiety 10. Asbestosis 11. Spinal stenosis 12. R kidney mass - Followed by urology w/ serial imaging, likely RCC 13. Osteoarthritis 14. Carotid stenosis - chronic occlusion of ___, ___ with 40% Social History: ___ Family History: Daughter- died at ___,breast cancer. Father- died from MI in his ___. Physical Exam: Admission exam: VS - Temp 97.9 F, BP 105/76, HR 76, R 20, O2-sat 97% 3LNC GENERAL - NAD, comfortable HEENT - NC/AT, PERRLA, EOMI, sclerae anicteric, MM dry, OP clear NECK - supple, no thyromegaly, no JVD, no carotid bruits LUNGS - CTA bilat except for fine crackles in the bases bilaterally, no r/rh/wh, good air movement, resp unlabored, no accessory muscle use HEART - RRR, no MRG, nl S1-S2 ABDOMEN - NABS, soft/ND, no masses or HSM, no rebound/guarding. There is mild ttp in the suprapubic area. BACK: no cva tenderness EXTREMITIES - There is moderate edema in both lower extremities with discoloration and erythema especially in the left leg--it is not warm nor tender, 2+ peripheral pulses (radials, DPs) SKIN - no rashes or lesions LYMPH - no cervical, axillary, or inguinal LAD NEURO - awake, A&Ox3, CNs II-XII grossly intact, muscle strength ___ on flexion of r hip, 4- on flextion of left hip, upper extremity strength is ___ bilaterally, sensation grossly intact throughout, gait was not assessed. Discharge exam: VS - Temp 97.7 F, BP 110-130/60-64, HR 78-86, R 20, O2-sat 92-94%/RA GENERAL - NAD, comfortable HEENT - NC/AT, PERRLA, EOMI, sclerae anicteric, MMM, OP clear NECK - supple, no thyromegaly, no JVD, no carotid bruits LUNGS - CTA bilat except for fine crackles in the bases bilaterally, no r/rh/wh, good air movement, resp unlabored, no accessory muscle use HEART - RRR, no MRG, nl S1-S2 ABDOMEN - NABS, soft/ND, no masses or HSM, no rebound/guarding. Non-tender. BACK: no cva tenderness EXTREMITIES - There is moderate edema in both lower extremities with discoloration and erythema especially in the left leg--it is not warm nor tender, 2+ peripheral pulses (radials, DPs) SKIN - no rashes or lesions LYMPH - no cervical, axillary, or inguinal LAD NEURO - awake, A&Ox3, CNs II-XII grossly intact, muscle strength ___ on flexion of r hip, 4- on flextion of left hip, upper extremity strength is ___ bilaterally, sensation grossly intact throughout, gait was not assessed. Discharge exam: T 97.9 112-142/61-70 ___ 94%/RA 20 GENERAL - elderly man, lying in bed in no apparent distress LUNGS - CTA bilat HEART - RRR, no MRG, nl S1-S2 ABDOMEN - soft, non-tender, non-distended BACK: no cva tenderness EXTREMITIES - trace edema in both lower extremities with discoloration and erythema especially in the left leg--it is not warm nor tender Skin: Rash on right check with crusted blood, erythematous rash on face. NEURO - A&Ox3. Pertinent Results: Admission labs: ___ 11:30PM BLOOD WBC-6.6 RBC-4.15* Hgb-12.3* Hct-36.0* MCV-87 MCH-29.7 MCHC-34.2 RDW-17.6* Plt ___ ___ 11:30PM BLOOD Neuts-66.0 ___ Monos-6.8 Eos-5.8* Baso-0.4 ___ 05:32AM BLOOD ___ PTT-31.5 ___ ___ 10:15PM BLOOD Glucose-126* UreaN-25* Creat-1.0 Na-138 K-4.3 Cl-101 HCO3-28 AnGap-13 ___ 08:00PM BLOOD CK-MB-6 cTropnT-0.09* ___ 05:25AM BLOOD CK-MB-6 cTropnT-0.08* ___ 10:15PM BLOOD Calcium-9.2 Phos-4.5 Mg-2.2 Microbiology: ___ 7:25 pm URINE **FINAL REPORT ___ URINE CULTURE (Final ___: PSEUDOMONAS AERUGINOSA. >100,000 ORGANISMS/ML.. Piperacillin/Tazobactam sensitivity testing performed by ___ ___. FOSOMYCIN Susceptibility testing requested by ___. ___ PAGER ___. . ZONE SIZE FOR FOSOMYCIN IS 27 MM. Zone size determined using a method that has not been standardized for this drug-. organism combination and for which no CLSI or FDA-approved interpretative standards exist. Interpret results with caution. SENSITIVITIES: MIC expressed in MCG/ML _________________________________________________________ PSEUDOMONAS AERUGINOSA | AMIKACIN-------------- 4 S CEFEPIME-------------- 8 S CEFTAZIDIME----------- 2 S CIPROFLOXACIN--------- =>4 R GENTAMICIN------------ =>16 R MEROPENEM------------- =>16 R PIPERACILLIN/TAZO----- S TOBRAMYCIN------------ =>16 R ___ 11:05 pm URINE **FINAL REPORT ___ URINE CULTURE (Final ___: PSEUDOMONAS AERUGINOSA. >100,000 ORGANISMS/ML.. SENSITIVITIES PERFORMED ON CULTURE # ___-___ ___. ___ 9:01 am URINE Source: Catheter. **FINAL REPORT ___ URINE CULTURE (Final ___: ___ PARAPSILOSIS. >100,000 ORGANISMS/ML.. IDENTIFICATION REQUESTED BY ___ ___ ___ ___. ___ 5:19 pm DIRECT ANTIGEN TEST FOR VARICELLA-ZOSTER VIRUS **FINAL REPORT ___ DIRECT ANTIGEN TEST FOR VARICELLA-ZOSTER VIRUS (Final ___: Negative for Varicella zoster by immunofluorescence. Refer to culture results for further information. ___ 5:19 pm Direct Antigen Test for Herpes Simplex Virus Types 1 & 2 **FINAL REPORT ___ Direct Antigen Test for Herpes Simplex Virus Types 1 & 2 (Final ___: Negative for Herpes simplex by immunofluorescence. Refer to culture results for further information. Imaging: ___ CXR: As compared to the previous radiograph, there is unchanged evidence of elevation of the left hemidiaphragm and subpleural partly calcified scars. Status post CABG. Minimal atelectasis at the right lung base but no evidence of current pneumonia or fluid overload. Unchanged appearance of the cardiac silhouette. ___ Abdominal X-ray: There is moderate colonic fecal load with minimally dilated cecum. Air is seen in scant loops of nondilated small bowel. This is a nonobstructive bowel gas pattern. Remnant contrast material is seen in the large bowel. There is no supine radiographic evidence of pneumoperitoneum or pneumatosis. IMPRESSION: Moderate colonic fecal load. Nonobstructive bowel gas pattern. CXR ___ Cardiac size is top normal. The main pulmonary arteries are larger as before. Elevation of the left hemidiaphragm is longstanding. There are low lung volumes. Bibasilar atelectases have increased. Bilateral calcified pleural plaques are again noted. There are probably small bilateral pleural effusions. There is no pneumothorax. Kidney ultrasound ___: The right kidney measures 10.2 cm. The left kidney measures 10.4 cm. Bilateral kidneys are without evidence of hydronephrosis or stones. The vascular right upper pole tumor is again noted measuring 3.3 x 3.6 x 2.9 cm. The bladder is decompressed and not evaluated. There is no evidence of distinct collections. IMPRESSION: No evidence of distinct collections. Right upper pole solid tumor is again identified measuring 3.3 x 3.6 x 2.9 cm. Abdominal X-ray ___ There is a nonobstructing bowel gas pattern. There is air in the ascending and transverse colon. There is fecal material in the descending colon. There is no air in the rectum. There are few air fluid levels in the small bowel loops that are nondistended. There are severe degenerative changes in the lumbar spine. There are vascular calcifications. CXR ___ Elevated left hemidiaphragm is redemonstrated. No definitive opacity except for minimal bibasilar atelectasis is demonstrated. Pulmonary nodules seen in the left mid lower lung are demonstrated and might represent at least in part pleural calcifications. No pneumothorax is seen. Brief Hospital Course: Acute issues: # Urinary tract infection: Patient with BPH and hypotonic bladder with incomplete emptying, s/p indwelling foley since ___ c/b frequent multidrug resistent UTIs, including MRSA, ESBL E Coli, Pseudomonas, and Klebsiella. Had multiple ED visits the week of admission, initially treated with Cipro then switched to Keflex when culture grew Klebsiella resistant to Cipro. Repeat culture grew Pseudomonas, so patient admitted to the hospital for IV antibiotics and was started on cefepime. He was trialed on fosfomycin, but deteriorated clinically so cefepime was resumed. Patient continued to complain of suprapubic pain, repeat UA suggestive of infection and culture grew yeast ___ PARAPSILOSIS) and patient was started on fluconazole to complete a ___onstipation: Patient with significant abdominal pain and distension, abdominal X-ray on ___ showed large amount of dense stool. Patient disimpacted without significant success, given MoviPrep with good result. Bowel regimen up-titrated, but patient with no bowel movements for next 3 days. MoviPrep given again, again with good success. # Tremors: Patient with intermittant somnolence and tremor of chin and hands in the context of possibly worsening UTI. Patient had similar tremors on hospitalization in ___, which were thought to be myoclonus secondary to infection. Neurology consulted, recommended discontinuing duloxetine, trazodone, oxycodone and starting clonazepam, as that seemed to help previuosly. However, clonazepam then held due to patient lethargy. # Depression: Patient's duloxetine held due to tremors. Patient with decreased appetite, tearfulness, hopelessness. Started on low dose ___ likely need uptitration on an outpatient basis. # Delirium/acute encephalopathy: patient with waxing and waning mental status throughout hospitalization. UTI and constipation thought to be main contributing factors, treated as above. EKG repeatedly unchanged from baseline, electrolytes and LFTs normal, CXR normal. # Hypoxia: patient with intermittant desats into the high ___ on room air. No signs of acute pulmonary process on multiple chest x-rays, improved with deep breathing/incentive spirometry. # Facial rash: patient with crusted rash on right side of face, DFA negative for zoster or HSV. Also with erythematous rash on forehead. Chronic issues: # Penile ulcer: Few small areas of penile irritation, but no frank ulcer noted. The ulcer on his penis was swabbed and purulent discharge cultured on previous admission. RPR, GC/Chlamydia, and HSV had been negative in outpatient setting. The ulcer was thought to result from irritation due to his indwelling foley. # Hypotonic bladder/BPH - chronic issue, patient with indwelling foley. To follow up with urology as an outpatient. # normocytic normochromic Anemia: Likely anemia of chronic disease. Stable # Right Kidney Mass - concerning for rcc and stable on recent ct scan; patient has not wished to pursue further workup of this mass. # HTN: stable on metoprolol succinate 50mg daily # CAD s/p CABG: stable on ASA, metoprolol. Atorvastatin decreased to 40mg daily while patient is on fluconazole #Chronic Diastolic Congestive Heart Failure: stable on lasix and beta blockade; lisinopril had been stopped due to hypotension # DM2 - Hgb A1c 6.5 ___. Not on outpatient treatment at present, sugars well controlled in house. Transitional issues: - titrate ___ dose to effect - recheck LFTs after course of fluconazole completed, increase atorvastatin dose back to 80mg daily - titrate bowel regimen to acheive daily bowel movements if possible - increase furosemide back to 40mg daily if patient appears to be retaining fluid on 20mg daily Medications on Admission: The Preadmission Medication list may be inaccurate and requires futher investigation. 1. Aspirin 81 mg PO DAILY 2. Atorvastatin 80 mg PO DAILY 3. Bisacodyl 10 mg PO DAILY:PRN constipation 4. Calcium Carbonate 500 mg PO DAILY 5. Docusate Sodium 100 mg PO BID 6. Duloxetine 30 mg PO DAILY 7. Furosemide 40 mg PO DAILY 8. Lactulose 30 mL PO DAILY 9. Metoprolol Succinate XL 50 mg PO DAILY hold for HR<55, bp<95 10. Multivitamins 1 TAB PO DAILY 11. Omeprazole 20 mg PO DAILY 12. Polyethylene Glycol 17 g PO DAILY 13. Senna 1 TAB PO BID 14. traZODONE 100 mg PO HS:PRN insomnia 15. Vitamin D 800 UNIT PO DAILY 16. Milk of Magnesia 30 mL PO Q6H:PRN constipation 17. Naproxen 500 mg PO Q8H:PRN pain 18. Lidocaine Jelly 2% 1 Appl TP DAILY: PRN penile pain/foley pain Discharge Medications: 1. Aspirin 81 mg PO DAILY 2. Calcium Carbonate 500 mg PO DAILY 3. Docusate Sodium 100 mg PO BID 4. Furosemide 20 mg PO DAILY 5. Metoprolol Succinate XL 50 mg PO DAILY hold for HR<55, bp<95 6. Milk of Magnesia 30 mL PO Q6H:PRN constipation 7. Multivitamins 1 TAB PO DAILY 8. Omeprazole 20 mg PO DAILY 9. Polyethylene Glycol 17 g PO DAILY 10. Senna 1 TAB PO BID 11. Vitamin D 800 UNIT PO DAILY 12. Acetaminophen 650 mg PO Q6H:PRN pain 13. Lidocaine Jelly 2% 1 Appl TP DAILY: PRN penile pain/foley pain 14. Bisacodyl 10 mg PR HS constipation 15. Bisacodyl 10 mg PO DAILY constipation 16. Atorvastatin 40 mg PO DAILY 17. CefePIME 2 g IV Q12H 18. Fluconazole 200 mg PO Q24H Duration: 5 Days 19. Mirtazapine 7.5 mg PO HS 20. Lactulose 30 mL PO BID Discharge Disposition: Extended Care Facility: ___ Discharge Diagnosis: Complicated urinary tract infection Hypotonic bladder Constipation Discharge Condition: Mental Status: Confused - sometimes. Level of Consciousness: Alert and interactive. Activity Status: Out of Bed with assistance to chair or wheelchair. Discharge Instructions: Dear Mr. ___, You were admitted to the hospital with a urinary tract infection. You were treated with intravenous antibiotics and will be discharged on an additional 7 days of antibiotics. You were also found to have yeast in your urine and were started on an antifungal medication which you will continue for an additional 5 days. You had shaking tremors, so we changed your antidepressant and stopped some of your sedating medications. You were also found to be very constipated and were treated with aggressive laxatives which improved your pain. Weigh yourself every morning, call your MD if your weight goes up more than 3 lbs. It was a pleasure taking care of you during your hospitalization and we wish you the best going forward. Followup Instructions: ___
19713100-DS-71
19,713,100
22,677,918
DS
71
2178-06-10 00:00:00
2178-06-10 17:56:00
Name: ___ Unit No: ___ Admission Date: ___ Discharge Date: ___ Date of Birth: ___ Sex: M Service: MEDICINE Allergies: ___ / Oxybutynin / Bactrim Attending: ___. Chief Complaint: UTI, delirium Major Surgical or Invasive Procedure: foley catheter exchange ___ History of Present Illness: ___ year old man with a hypotonic bladder, BPH, chronic indwelling foley and multiple recent multidrug resistant urinary tract infections and h/o CHF (EF >55%), who was brought in from ___ for facial twitching, found to have evidence of a UTI. Patient notes lower central abdominal pain x 1 week; this has been intermittent. No urinary frequency. No fevers, chills, nausea, vomiting, diarrhea, hematuria, hematochezia. "Twitching" was noted by facility at 10 am, but patient thinks it may have been going on for months. In the ED, initial vital signs were 96.4 80 100/60 16 98%. Labs were notable for potassium 5.9, BUN/cr ___, wbc 8.2, hct 45.2, plt 263, bnp 2232, AST 51. Potassium on recheck was 5.2. UA was floridly positive w/ >182 WBCs and many bacteria. Lactate was 1.8. Blood and urine cx were sent. CXR was done which was read as no acute process, mild CHF. Patient was given a 500 cc bolus for boderline blood pressures with response and 2 grams of cefepime. He was admitted to medicine for further evaluation and management. VS on transfer were: 97 97/62 24 94%. On arrival to the floor, the patient is comfortable. He denies any current abdominal pain. He was not hungry. He was not bothered by mild shaking that he had. VS on arrival were: 98.0 150/96 86 22 95%2L 93.4 kg. Review of Systems: (+) As noted above. (-) fever, chills, night sweats, headache, vision changes, rhinorrhea, congestion, sore throat, cough, shortness of breath, chest pain, nausea, vomiting, diarrhea, constipation, melena, hematochezia, dysuria, hematuria. Past Medical History: 1. Hypotonic bladder with incomplete emptying, s/p indwelling foley since ___ c/b frequent Multidrug resistent UTIs, including MRSA and ESBL E Coli 2. BPH 3. CAD s/p CABG x 3 in ___ - CABG anatomy: LIMA to LAD, SVG to OM, and SVG to RCA - s/p stenting ___ of mid RCA, PTCA of proximal RCA and PDA - redo single vessel CABG in ___ with Dr. ___. 4. CHF was preserved EF 55% in ___ 5. Bovine AVR in ___. Type 2 Diabetes Mellitus: diet controlled 7. Hypertension 8. Hx of Chronic constipation 9. Hyperlipidemia 10. Depression/Anxiety 11. Asbestosis 12. Spinal stenosis 13. R kidney mass - Followed by urology w/ serial imaging, likely RCC 14. Osteoarthritis 15. Carotid stenosis - chronic occlusion of LICA, ___ with 40% Social History: ___ Family History: Daughter- died at ___,breast cancer. Father- died from MI in his ___. Physical Exam: Admission Exam: Vitals- 98.0 150/96 86 22 95%2L 93.4 kg. General- Alert, oriented, no acute distress HEENT- Sclera anicteric, MMM, oropharynx clear Neck- supple, JVP not elevated, no LAD Lungs- Clear to auscultation bilaterally, no wheezes, rales, ronchi CV- Regular rate and rhythm, mechanical S1 + normal S2, no murmurs, rubs, gallops Abdomen- soft, mild TTP in lower central abdomen, non-distended, bowel sounds present, no rebound tenderness or guarding, no organomegaly GU- + foley Ext- warm, well perfused, 2+ pulses. 1+ nonpitting BLE. No clubbing or cyanosis Neuro- CNs2-12 intact, motor function grossly normal Discharge Exam: Alert and oriented x 3 groin rash appreciated, erythematous c/w candidiasis Pertinent Results: Admission Labs: ___ 06:55PM SODIUM-140 POTASSIUM-5.2* CHLORIDE-105 ___ 02:48PM LACTATE-1.8 ___ 02:40PM URINE COLOR-Yellow APPEAR-Hazy SP ___ ___ 02:40PM URINE BLOOD-TR NITRITE-POS PROTEIN-30 GLUCOSE-NEG KETONE-NEG BILIRUBIN-NEG UROBILNGN-NEG PH-5.5 LEUK-LG ___ 02:40PM URINE RBC-11* WBC->182* BACTERIA-MANY YEAST-NONE EPI-0 ___ 02:40PM URINE MUCOUS-FEW ___ 02:30PM GLUCOSE-121* UREA N-22* CREAT-1.0 SODIUM-139 POTASSIUM-5.9* CHLORIDE-101 TOTAL CO2-25 ANION GAP-19 ___ 02:30PM estGFR-Using this ___ 02:30PM ALT(SGPT)-19 AST(SGOT)-51* ALK PHOS-66 TOT BILI-0.5 ___ 02:30PM LIPASE-35 ___ 02:30PM proBNP-2232* ___ 02:30PM ALBUMIN-4.0 CALCIUM-9.4 PHOSPHATE-4.0 MAGNESIUM-2.2 ___ 02:30PM WBC-8.2# RBC-5.21 HGB-15.0 HCT-45.2 MCV-87 MCH-28.8 MCHC-33.2 RDW-16.8* ___ 02:30PM NEUTS-73.2* ___ MONOS-5.1 EOS-2.6 BASOS-0.6 ___ 02:30PM PLT COUNT-263 ___ 02:30PM ___ PTT-30.1 ___ Discharge labs: ___ 06:30AM BLOOD WBC-5.3 RBC-4.39* Hgb-12.6* Hct-37.8* MCV-86 MCH-28.8 MCHC-33.4 RDW-16.8* Plt ___ ___ 06:30AM BLOOD Plt ___ ___ 06:30AM BLOOD Glucose-103* UreaN-17 Creat-0.7 Na-141 K-3.8 Cl-102 HCO3-30 AnGap-13 ___ 06:30AM BLOOD Calcium-8.7 Phos-3.1 Mg-1.9 ___ 10:41AM BLOOD ___ pO2-55* pCO2-52* pH-7.38 calTCO2-32* Base XS-3 ___ 2:40 pm URINE **FINAL REPORT ___ URINE CULTURE (Final ___: KLEBSIELLA PNEUMONIAE. >100,000 ORGANISMS/ML.. Ertapenem AND Tigecycline Susceptibility testing requested by S. ___ ___ ___. Piperacillin/Tazobactam sensitivity testing performed by ___ ___. Ertapenem SENSITIVE sensitivity testing performed by ___. Tigecycline 1.0 MG/ML SENSITIVE Sensitivity testing performed by Etest. MIC interpretations are based on manufacturer's guidelines that are FDA approved. SENSITIVITIES: MIC expressed in MCG/ML _________________________________________________________ KLEBSIELLA PNEUMONIAE | AMPICILLIN/SULBACTAM-- =>32 R CEFAZOLIN------------- =>64 R CEFEPIME-------------- 16 I CEFTAZIDIME----------- =>64 R CEFTRIAXONE----------- =>64 R CIPROFLOXACIN--------- =>4 R GENTAMICIN------------ <=1 S MEROPENEM-------------<=0.25 S NITROFURANTOIN-------- 256 R PIPERACILLIN/TAZO----- S TOBRAMYCIN------------ <=1 S TRIMETHOPRIM/SULFA---- 4 R Blood culture ___ and ___ all pending CXR ___: Low lung volumes without acute findings. CT HEAD NONCON ___: There is no evidence of hemorrhage, edema, or acute infarct. Hypodense foci in the left basal ganglia is unchanged compared to ___ and likely represents a prior lacunar infarct. There is re- demonstration of the partially calcified extra-axial lesion on the mastoid portion of the left temporal bone relatively unchanged compared to prior study measuring 1.8 x 1.0 cm and without mass effect on the adjacent parenchyma. Mastoid air cells, middle ear cavities and visualized paranasal sinuses are clear. No softtissue swelling. IMPRESSION: No acute process. Stable posterior fossa partially calcified meningioma. CXR ___: In comparison with study of ___, there are continued low lung volumes with elevation of the left hemidiaphragmatic contour. A thick band of atelectasis is seen at the right base with mild streaks of atelectasis above the elevated left hemidiaphragm. Midline sternal wires remain intact and calcified pleural plaques are again seen. Brief Hospital Course: ___ year old man with a hypotonic bladder, BPH, chronic indwelling foley and multiple recent multidrug resistant urinary tract infections here with symptomatic UTI with an multidrug resistant klebsiella complicated by acute delirium. ACTIVE ISSUES: 1. URINARY TRACT INFECTION: patient prone to repeat infections due to his chronic indwelling foley. While he presented with a grossly positive urinalysis, his chronic and colonized foley obscures the interpretation of this finding- we initially suspected asymptomatic bacteriuria due to a complaint of only minimal suprapubic tenderness which would not necessitate treatment (and which would only foster resistance) however he became densely encephalopathic with tremors which prompted us to treat. He started cefepime which was changed to imipenem/cilastin on ___ when a MDR klebsiella grew out. His mental status quickly improved, as did his suprapubic pain within 24hr. He will be discharged to complete 10d of ertapenem daily IM injections ending on ___. His foley was changed on ___. It must be changed every ___ weeks to prevent infection. Per his urology team, he has refused suprapubic catheters in the past. ID was consulted to help direct antibiotic selection and the need for treatment of frequently positive UA- it is suggested that urinalyses only be done and treated if the patient has symptoms of UTI, such as fevers, severe delirium, upper-urinary tract symptoms. 2. TOXIC METABOLIC ENCEPHALOPATHY: Patient showed waxing and waning mental status on HD1 and 2, which fluctuated several times over the course of the day. It was probably due to his klebsiella UTI, as he cleared after receiving appropriate carbapenem treatment. CT head, electrolytes, and other infectious workup was negative. He does tend to sundown at his baseline, however. 3. MYOCLONIC JERKS: Had brief and sudden jerking movements while delirious- Was seen by neuro in the past suggesting it was due to encephalopathy. It improves has his mental status clears. 4. GROIN CANDIDIASIS: his groin pain was likely due to candidiasis. Prescribed BID ketoconazole cream and recommend drying agents as tolerated. INACTIVE PROBLEMS: # HTN: Stable on metoprolol succinate 50mg daily as outpatient. # CAD s/p CABG: Stable on ASA, metoprolol. # Chronic Diastolic Congestive Heart Failure: not exacerbated # Right Kidney Mass: concerning for RCC and stable on recent CT scan; he had declined tx in the past # DM2 - Hgb A1c 6.5 ___. Not on outpatient treatment at present, sugars well controlled in house. # Prophylaxis: Subcutaneous heparin, bowel regimen, pain control with # Access: peripherals # Code: DNR/DNI (confirmed with patient) # Communication: Patient, HCP is daughter ___ (Phone number: ___, Cell phone: ___ PENDING TESTS AT DISCHARGE: -blood cultures pending ___ TRANSITIONAL CARE ISSUES: - check UA only in context of clinical infection - finishing ertapenem for MDR klebsiella Medications on Admission: The Preadmission Medication list is accurate and complete. 1. Aspirin 81 mg PO DAILY 2. Calcium Carbonate 500 mg PO DAILY 3. Docusate Sodium 100 mg PO BID 4. Furosemide 20 mg PO DAILY 5. Metoprolol Succinate XL 50 mg PO DAILY hold for HR<55, bp<95 6. Milk of Magnesia 30 mL PO Q6H:PRN constipation 7. Multivitamins 1 TAB PO DAILY 8. Omeprazole 20 mg PO DAILY 9. Polyethylene Glycol 17 g PO DAILY 10. Senna 1 TAB PO BID 11. Vitamin D 800 UNIT PO DAILY 12. Acetaminophen 650 mg PO Q6H:PRN pain 13. Lidocaine Jelly 2% 1 Appl TP DAILY: PRN penile pain/foley pain 14. Bisacodyl 10 mg PR HS constipation 15. Bisacodyl 10 mg PO DAILY constipation 16. Atorvastatin 40 mg PO DAILY 17. Mirtazapine 7.5 mg PO HS 18. Lactulose 30 mL PO BID Discharge Medications: 1. Aspirin 81 mg PO DAILY 2. Bisacodyl 10 mg PO DAILY constipation 3. Calcium Carbonate 500 mg PO DAILY 4. Furosemide 20 mg PO DAILY 5. Metoprolol Succinate XL 50 mg PO DAILY hold for HR<55, bp<95 6. Multivitamins 1 TAB PO DAILY 7. Omeprazole 20 mg PO DAILY 8. Vitamin D 800 UNIT PO DAILY 9. Atorvastatin 40 mg PO DAILY 10. Docusate Sodium 100 mg PO BID 11. Senna 1 TAB PO BID 12. Mirtazapine 7.5 mg PO HS 13. Bisacodyl 10 mg PR HS constipation 14. Milk of Magnesia 30 mL PO Q6H:PRN constipation 15. Acetaminophen 650 mg PO Q6H:PRN pain 16. Polyethylene Glycol 17 g PO DAILY 17. Lidocaine Jelly 2% 1 Appl TP DAILY: PRN penile pain/foley pain 18. ertapenem *NF* 1 gram Injection DAILY LAST DOSE ON ___ RX *ertapenem [Invanz] 1 gram 1 gram injected daily Disp #*9 Gram Refills:*0 19. Ketoconazole 2% 1 Appl TP BID apply to groin Discharge Disposition: Extended Care Facility: ___ Discharge Diagnosis: Urinary tract infection, complicated by chronic foley acute toxic metabolic encephalopathy Discharge Condition: Mental Status: Confused - sometimes. Level of Consciousness: Alert and interactive. Activity Status: Out of Bed with assistance to chair or wheelchair. Discharge Instructions: Dear Mr. ___, You were admitted with a urinary tract infection. You are prone to these infections because you need to have a foley catheter in place chronically. We treated you with antibiotics and you improved. You will need to continue getting a daily shot of antibiotics ending on ___. You were also very delirious while hospitalized due to your infection, you improved with antibiotics. You also have a groin rash that we are treating with antifungal medicine The following changes have been made to your medications 1. START ERTAPENEM daily through ___ 2. START KETACONAZOLE CREAM BID until your groin rash improves No other changes were made to your medications Followup Instructions: ___
19713100-DS-72
19,713,100
29,718,045
DS
72
2178-07-06 00:00:00
2178-07-06 19:52:00
Name: ___ Unit No: ___ Admission Date: ___ Discharge Date: ___ Date of Birth: ___ Sex: M Service: MEDICINE Allergies: ___ / Oxybutynin / Bactrim Attending: ___. Chief Complaint: altered mental status Major Surgical or Invasive Procedure: foley removal and placement History of Present Illness: Mr ___ is an ___ male with history of hypotonic bladder, BPH, chronic indwelling foley and multiple recent multidrug resistant UTIs and h/o CHF (EF >55%) presenting from rehab with altered mental status and dysuria. Per daughter, the patient has been progressively more disoriented and confused for the past 4 days. He was describing general malaise and burning with urination for the past ___ days. He denies fevers or chills. No n/v/d. Importantly, he has been admitted twice in the past 2 months for UTIs complicated by AMS. First UTI was imipenem resistant pseudomonas treated ultimately with cefepime. Second UTI, he was treated with cefepime which was switched to imipenem/cilastin given MDR klebsiella. Last foley change on ___. In the ED, 97.7 92 137/78 20 93. Grossly positive UA. CXR without infiltrate. Labs WNL. Patient received zosyn 4.5gm IV x2, Imipenem x1, Morphine 4mgIV x1, Acetaminophen 1000mg po x1, phenazopyridine 100mg x1. VS prior to transfer: 97.7 73 143/56 20 99% At time of transfer patient A+Ox2, slurred speech which is consistent with recent pt's baseline. On arrival to the floor initial vital signs: 98.1 121/75 73 16 99 2L. He continued to describe lethargy with burning on urination. ROS: per HPI, denies fever, chills, night sweats, headache, vision changes, rhinorrhea, congestion, sore throat, cough, shortness of breath, chest pain, abdominal pain, nausea, vomiting, diarrhea, constipation, BRBPR, melena, hematochezia, hematuria. Past Medical History: 1. Hypotonic bladder with incomplete emptying, s/p indwelling foley since ___ c/b frequent Multidrug resistent UTIs, including MRSA and ESBL E Coli 2. BPH 3. CAD s/p CABG x 3 in ___ - CABG anatomy: LIMA to LAD, SVG to OM, and SVG to RCA - s/p stenting ___ of mid RCA, PTCA of proximal RCA and PDA - redo single vessel CABG in ___ with Dr. ___. 4. CHF was preserved EF 55% in ___ 5. Bovine AVR in ___. Type 2 Diabetes Mellitus: diet controlled 7. Hypertension 8. Hx of Chronic constipation 9. Hyperlipidemia 10. Depression/Anxiety 11. Asbestosis 12. Spinal stenosis 13. R kidney mass - Followed by urology w/ serial imaging, likely RCC 14. Osteoarthritis 15. Carotid stenosis - chronic occlusion of LICA, ___ with 40% Social History: ___ Family History: Daughter- died at ___,breast cancer. Father- died from MI in his ___. Physical Exam: ADMISSION PHYSICAL EXAM: VS 98.1 121/75 73 16 99 2LNC GEN Alert, oriented to person, partially to place, not oriented to time, no acute distress HEENT NCAT MMM EOMI sclera anicteric, OP clear NECK supple, no JVD, no LAD PULM Good aeration, CTAB no wheezes, rales, ronchi CV RRR normal S1/S2, no mrg ABD soft + suprapubic tenderness, ND normoactive bowel sounds EXT trace lower leg edema L>R. WWP 2+ pulses palpable bilaterally, no c/c/e NEURO CNs2-12 intact, motor function grossly normal SKIN: Stage ___ sacral decub ulcer, 2cm area of tenderness/erythema along penile shaft. PHYSICAL EXAM: VS - 97.6 134/85 83 20 95RA GENERAL - alert, oriented x3NAD, comfortable, appropriate HEENT - NC/AT, PERRLA, EOMI, sclerae anicteric, MMM, OP clear NECK - supple, no JVD HEART - PMI non-displaced, RRR, nl S1-S2, no MRG LUNGS - CTAB, no r/rh/wh, good air movement, resp unlabored, no accessory muscle use ABDOMEN - NABS, soft/NT/ND, no masses or HSM, no rebound/guarding SKIN: Stage ___ sacral pressure ulcer, 2cm area of tenderness/erythema along penile shaft. NEURO - awake, A&Ox3, CNs II-XII grossly intact, muscle strength ___ throughout, sensation grossly intact throughout, DTRs 2+ and symmetric, cerebellar exam intact, steady gait Pertinent Results: ADMISSION LABS ___ 10:05PM BLOOD WBC-5.5 RBC-4.86 Hgb-13.7* Hct-42.3 MCV-87 MCH-28.3 MCHC-32.5 RDW-17.2* Plt ___ ___ 10:05PM BLOOD Neuts-64.7 ___ Monos-7.2 Eos-3.2 Baso-0.9 ___ 10:05PM BLOOD Glucose-131* UreaN-19 Creat-0.9 Na-142 K-4.1 Cl-102 HCO3-29 AnGap-15 ___ 10:27PM BLOOD ___ pO2-74* pCO2-50* pH-7.40 calTCO2-32* Base XS-4 ___ 10:27PM BLOOD Lactate-1.2 DISCHARGE LABS: ___ 06:00AM BLOOD WBC-7.2 RBC-4.67 Hgb-13.2* Hct-40.7 MCV-87 MCH-28.3 MCHC-32.5 RDW-17.1* Plt ___ ___ 06:00AM BLOOD Glucose-139* UreaN-11 Creat-0.8 Na-141 K-3.3 Cl-102 HCO3-30 AnGap-12 ___ 06:00AM BLOOD Calcium-8.1* Phos-2.4*# Mg-1.5* MICROBIOLOGY: ___ | AMIKACIN-------------- <=2 S CEFEPIME-------------- <=1 S CEFTAZIDIME----------- <=1 S CEFTRIAXONE----------- <=1 S CIPROFLOXACIN--------- 1 S MEROPENEM-------------<=0.25 S NITROFURANTOIN-------- 256 R PIPERACILLIN/TAZO----- <=4 S TRIMETHOPRIM/SULFA---- <=1 S IMAGING: EKG: Normal sinus rhythm. Right bundle-branch block. Since the previous tracing of ___ right bundle-branch block has appeared. Rate PR QRS QT/QTc P QRS T 81 ___ 41 0 41 CXR: Frontal and lateral views of the chest were obtained. There is no focal consolidation, pleural effusion or pneumothorax. Right basilar atelectasis is seen. Elevation of left hemidiaphragm is unchanged. Cardiac and mediastinal silhouettes are stable. Median sternotomy wires are intact status post CABG. IMPRESSION: No acute intrathoracic process. ___: Grayscale and color Doppler sonographic evaluation was performed of the left lower extremity. Normal compressibility, flow and response to augmentation is seen in the common femoral, superficial femoral and popliteal veins. Normal compressibility and flow is seen in the posterior tibial and peroneal veins. IMPRESSION: No left lower extrmemity DVT. PICC LINE PLACEMENT ___: PROCEDURE DETAILS: The patient was brought to the angiographic suite and placed supine on the table. A preprocedure timeout was performed using three patient identifiers. The skin of the right upper extremity was prepped and draped in the usual sterile fashion including the indwelling single-lumen PICC catheter. An initial scout image demonstrated the PICC to be in the mid axillary line. A nitinol wire was advanced through the PICC; however, this would not pass more centrally in the mid axillary line. The PICC was withdrawn and a 4.5 ___ peel-away sheath was advanced over the wire. A 5 ___ Kumpe catheter was advanced over the wire and we attempted to inject contrast; however, contrast could not be injected via the catheter. The catheter was gradually withdrawn until there was opacification of an axillary vein; however, clearly a false tract had been created. So, this catheter was removed and firm manual compression was applied for 5 minutes. Following this, we attempted to place a new PICC. A second right upper extremity vein was selected; this appeared to be the right basilic vein. 1 cc of lidocaine was infiltrated into the skin and subcutaneous tissues for local anesthesia. Using direct ultrasound visualization, a micropuncture needle was advanced into the vein. Ultrasound images were saved prior to and after venopuncture, confirming patency of the vein. A nitinol wire advanced through the micropuncture needle without difficulty. A small skin incision was made and the micropuncture needle was exchanged for a 4.5 ___ peel-away sheath. The nitinol wire was advanced readily into the IVC confirming venous positioning. The wire was withdrawn into the SVC to estimate the length of required tubing. A new single-lumen Power PICC was selected, flushed and cut to 42 cm. This advanced over the nitinol wire without difficulty. The peel-away sheath was gradually removed as the catheter was advanced. The nitinol wire was removed. Following completion of this maneuver, the tip of the catheter was in the distal SVC. The catheter was secured to the skin with a StatLock device. The catheter was aspirating and flushing without difficulty. There were no immediate post-procedure complications. IMPRESSION: Unsuccessful repositioning of a PICC, a new single-lumen Power PICC has been placed with the tip in the distal SVC. The catheter has been flushed and is ready for use. Brief Hospital Course: ASSESSMENT & PLAN: Mr ___ is an ___ male with history of hypotonic bladder, BPH, chronic indwelling foley and multiple recent multidrug resistant UTIs who presented with altered mental status, general malaise and was found to have UTI. ACTIVE ISSUES: #URINARY TRACT INFECTION: He presented with altered mental status in the setting of chronic indwelling foley and a recent history of UTI pseudomonas (resistant to imipenem) and MDR Klebsiella. Urinalysis positive and it was decided to treat for UTI (rather than just colonization) because of AMS and malaise. His indwelling foley catheter was replaced on ___. He initially received imipenem and Zosyn in the ED, but was tapered to Zosyn based on prior urine culture sensitivities. Urine culture resulted (___) however Zosyn kept on board because of likelihood of inadequate urine culture and clinical presentation. He received an ___ guided PICC line and will continue Zosyn for total of 10days. His mental status improved with IV abx treatment. #ACUTE DELERIUM: He initially presented with confusion and altered mental status in the setting of UTI. He was refusing oral medications and was not oriented to place or time, however this resolved by ___. On discharge, he was alert, oriented x3. # Left lower extremity swelling: His left leg was asymetrically edematous (1+)on presentation however was not warm to touch or erythematous. LENIS negative. Edema resolved. On discharge, there was bilateral trace edema. Notable asymmety in exam. CHRONIC ISSUES: # Wound care: He has chronic Stage ___ sacral pressure ulcers on left ischium. This was treated according to ulcer protocol with Mepilex. No dressing to coccyx was necessary on patchy skin overlying coccyx. Also there is 2cm area of tenderness/erythema along penile shaft that will need excellent skin care along the penile shaft as the drainage from the urethra will be chronic. # HTN: stable. # CAD s/p CABG: Stable, continued statin ASA, metoprolol. He was transitioned from metoprolol tartrate to metoprolol succinate prior to discharge. # DM2 - Hgb A1c 6.5 ___. FSG was monitored closely and she was kept on humalog ISS. # History of right Kidney Mass: concerning for RCC and stable on recent CT scan; he had declined tx in the past. Has appointment with Dr. ___. TRANSITIONAL: -DNR/DNI -Will follow-up with Dr. ___ right kidney mass. -Patient should be told that he can leave Rehab only after his anitbiotic infusions are completed and he can stand and transfer by himself. Medications on Admission: The Preadmission Medication list is accurate and complete. 1. Aspirin 81 mg PO DAILY 2. Bisacodyl 10 mg PO DAILY constipation 3. Calcium Carbonate 500 mg PO DAILY 4. Furosemide 20 mg PO DAILY 5. Metoprolol Succinate XL 50 mg PO DAILY hold for HR<55, bp<95 6. Multivitamins 1 TAB PO DAILY 7. Omeprazole 20 mg PO DAILY 8. Vitamin D 800 UNIT PO DAILY 9. Atorvastatin 40 mg PO DAILY 10. Docusate Sodium 100 mg PO BID 11. Senna 1 TAB PO BID 12. Mirtazapine 7.5 mg PO HS 13. Milk of Magnesia 30 mL PO Q6H:PRN constipation 14. Acetaminophen 650 mg PO Q6H:PRN pain 15. Polyethylene Glycol 17 g PO DAILY 16. Lidocaine Jelly 2% 1 Appl TP DAILY: PRN penile pain/foley pain 17. Ketoconazole 2% 1 Appl TP BID apply to groin Discharge Medications: 1. Acetaminophen 650 mg PO Q6H:PRN pain 2. Aspirin 81 mg PO DAILY 3. Atorvastatin 40 mg PO DAILY 4. Bisacodyl 10 mg PO DAILY constipation 5. Calcium Carbonate 500 mg PO DAILY 6. Docusate Sodium 100 mg PO BID 7. Furosemide 20 mg PO DAILY 8. Ketoconazole 2% 1 Appl TP BID apply to groin 9. Lidocaine Jelly 2% 1 Appl TP DAILY: PRN penile pain/foley pain 10. Milk of Magnesia 30 mL PO Q6H:PRN constipation 11. Mirtazapine 7.5 mg PO HS 12. Multivitamins 1 TAB PO DAILY 13. Omeprazole 20 mg PO DAILY 14. Polyethylene Glycol 17 g PO DAILY 15. Senna 1 TAB PO BID 16. Vitamin D 800 UNIT PO DAILY 17. Metoprolol Succinate XL 50 mg PO DAILY hold for HR<55, bp<95 18. Piperacillin-Tazobactam 4.5 g IV Q8H RX *piperacillin-tazobactam 4.5 gram Infuse 4.5gm IV every 8 hours Disp #*21 Unit Refills:*0 Discharge Disposition: Extended Care Facility: ___ Discharge Diagnosis: Complicated Urinary Tract Infection Acute Delerium Dehydration Pressure Ulcer Urethral shaft inflammation Discharge Condition: Mental Status: Confused - sometimes. Level of Consciousness: Alert and interactive. Activity Status: Ambulatory - requires assistance or aid (walker or cane). Discharge Instructions: Dear Mr. ___, It was a pleasure taking care of you while you were admitted to ___. You were admitted with confusion and a urinary tract infection. You were treated with IV fluids and antibiotics which you tolerated well. You had a PICC line placed so that you can continue antibiotic infusion over the next 7 days when you return to your skilled nursing facility. You were also seen by wound care regarding pressure ulcers on your sacrum and inflamed tissue on your penis. This wound care will continue at rehab. You will continue your treatment at rehab until your anitbiotic infusions are completed and you can stand and transfer by yourself. Followup Instructions: ___
19713100-DS-73
19,713,100
22,138,619
DS
73
2178-07-13 00:00:00
2178-07-14 10:46:00
Name: ___ Unit No: ___ Admission Date: ___ Discharge Date: ___ Date of Birth: ___ Sex: M Service: MEDICINE Allergies: ___ / Oxybutynin / Bactrim Attending: ___ ___ Complaint: Groin pain Major Surgical or Invasive Procedure: none History of Present Illness: ___ male with history of hypotonic bladder, BPH, chronic indwelling foley and multiple recent multidrug resistant UTIs (3x in the last two months), CAD s/p CABG, CHF EF55%, and likely RCC on imaging now presenting with mild pelvic and severe groin pain after recent discharge on ___ for multidrug resistant UTI on pip/tazo. Patient states he has had this pain since his last bladder infection, it initially improved but seems to have gotten worse over the last several days. He denies any fevers or chills or back pain. He denies any abdominal pain. He denies any chest pain, shortness of breath, cough, sore throat, runny nose. On exam in the ED, patient had no abdominal pain. He does have some mild suprapubic tenderness, which he says is the same pain he had during his last urinary tract infection. He denies any back pain has no CVA tenderness and he is afebrile. UA showed 61 WBCs, 28 RBCs, No bacteria, and many yeast. Other labs were unremarkable. Pt had foley catheter changed in ED, with urine and blood cultures sent, and was started on cefepime. Pt was also started on fluconazole IV and admitted to medicine. Currently, Pt reports feeling "lousy." When asked to point to where his pain is, he points to his groin. This groin pain, R > L, has been worsening since his discharge. Pt denies any fever, or chills. Reports chronic cough but denies rhinorrhea, sore throat, myalgias. No nausea or vomiting. Reports constipation. No focal numbness or weakness. Pt does not feel confused and is appropriately alert and interactive. He is very distressed about the frequency of his UTIs and hospitalizations. Of note, he has been admitted 3x in the past 3 months for UTIs and altered mental status. First UTI in ___ was sensitive Klebsiella and imipenem resistant pseudomonas treated ultimately with cefepime. He also had a urine culture w/ > 100k colonies of ___ parapsilosis, which was treated with fluconazole 200mg po daily for 1 week. Second UTI, he was treated with cefepime which was switched to imipenem/cilastin given MDR klebsiella. During most recent admission in early ___, Pt's UCx showed PROVIDENCIA STUARTII, but this was felt to be due to an inadequate urine culture, and Pt was discharged on ___ on 10 day course of pip/tazo. Past Medical History: 1. Hypotonic bladder with incomplete emptying, s/p indwelling foley since ___ c/b frequent Multidrug resistent UTIs, including MRSA and ESBL E Coli 2. BPH 3. CAD s/p CABG x 3 in ___ - CABG anatomy: LIMA to LAD, SVG to OM, and SVG to RCA - s/p stenting ___ of mid RCA, PTCA of proximal RCA and PDA - redo single vessel CABG in ___ with Dr. ___. 4. CHF was preserved EF 55% in ___ 5. Bovine AVR in ___. Type 2 Diabetes Mellitus: diet controlled 7. Hypertension 8. Hx of Chronic constipation 9. Hyperlipidemia 10. Depression/Anxiety 11. Asbestosis 12. Spinal stenosis 13. R kidney mass - Followed by urology w/ serial imaging, likely RCC 14. Osteoarthritis 15. Carotid stenosis - chronic occlusion of LICA, ___ with 40% Social History: ___ Family History: Daughter- died at ___,breast cancer. Father- died from MI in his ___. Physical Exam: ADMISSION PHYSICAL EXAM: 97.5, 122/71, 73, 90% RA. GENERAL - well-appearing man in NAD, appropriate HEENT - NC/AT, PERRLA, EOMI, sclerae anicteric, MMM, OP clear NECK - supple, no thyromegaly, no JVD, no carotid bruits LUNGS - minor inspiratory crackles in bases, mild expiratory wheezes, no accessory muscle use HEART - RRR, no MRG, nl S1-S2 ABDOMEN - NABS, soft, mild tenderness to suprapubic palpation, otherwise non-tender, no rebound/guarding Pelvic - several sacral decub ulcers in various stages w/ large dressing in place. Small scrotal ulcer. Bilateral erythema and edema in inguinal skin folds R > L. Skin is warm and very tender to palpation. Brown stool-like substance and creamy white substance in bilateral inguinal folds. Foley in place, mild excoriation of head of penis. EXTREMITIES - WWP, lower extremities in bilateral compression stockings, trace edema bilaterally, 2+ peripheral pulses (radials, DPs) NEURO - awake, A&Ox3, CNs II-XII grossly intact, muscle strength ___ throughout, sensation grossly intact throughout DISCHARGE PHYSICAL EXAM: 97.7 147/84 75 18 94%ra GENERAL - well-appearing man in NAD, appropriate HEENT - NC/AT, MMM, OP clear LUNGS - CTAB HEART - RRR, no MRG, nl S1-S2 ABDOMEN - NABS, soft, NT/ND, no rebound/guarding, no HSM Pelvic - several sacral decub ulcers in various stages w/ large dressing in place. Bilateral erythema in inguinal skin folds significantly improved from prior examination. Inguinal skin only mildly tender to palpation. No obvious breakes in the skin. Foley in place, mild excoriation of head of penis. EXTREMITIES - WWP, lower extremities in bilateral compression stockings, trace edema bilaterally, 2+ peripheral pulses (radials, DPs) NEURO - awake, A&Ox3. no focal deficits Pertinent Results: LABS: ___ 07:58PM BLOOD WBC-8.9 RBC-4.83 Hgb-13.4* Hct-41.5 MCV-86 MCH-27.8 MCHC-32.4 RDW-17.4* Plt ___ ___ 05:42AM BLOOD WBC-9.4 RBC-4.66 Hgb-13.1* Hct-40.4 MCV-87 MCH-28.2 MCHC-32.5 RDW-17.6* Plt ___ ___ 05:20AM BLOOD WBC-6.0 RBC-4.76 Hgb-13.0* Hct-40.9 MCV-86 MCH-27.4 MCHC-31.9 RDW-17.5* Plt ___ ___ 07:58PM BLOOD Glucose-113* UreaN-15 Creat-1.0 Na-139 K-4.4 Cl-102 HCO3-29 AnGap-12 ___ 05:42AM BLOOD Glucose-114* UreaN-13 Creat-0.8 Na-142 K-3.8 Cl-104 HCO3-29 AnGap-13 ___ 05:20AM BLOOD Glucose-109* UreaN-12 Creat-0.8 Na-143 K-3.8 Cl-105 HCO3-31 AnGap-11 ___ 07:58PM BLOOD ALT-12 AST-28 AlkPhos-57 TotBili-0.3 ___ 05:42AM BLOOD ALT-11 AST-17 LD(LDH)-211 AlkPhos-57 TotBili-0.4 ___ 05:42AM BLOOD Calcium-8.4 Phos-2.7 Mg-1.7 ___ 08:01PM BLOOD Lactate-1.3 MICROBIOLOGY: ___ 4:15 pm STOOL CONSISTENCY: NOT APPLICABLE Source: Stool. **FINAL REPORT ___ C. difficile DNA amplification assay (Final ___: Negative for toxigenic C. difficile by the Illumigene DNA amplification assay. (Reference Range-Negative). __________________________________________________________ ___ 8:05 pm BLOOD CULTURE Blood Culture, Routine (Pending): __________________________________________________________ Time Taken Not Noted Log-In Date/Time: ___ 8:11 pm BLOOD CULTURE Blood Culture, Routine (Pending): __________________________________________________________ ___ 7:40 pm URINE **FINAL REPORT ___ URINE CULTURE (Final ___: YEAST. >100,000 ORGANISMS/ML.. __________________________________________________________ ___ 10:05 pm BLOOD CULTURE **FINAL REPORT ___ Blood Culture, Routine (Final ___: NO GROWTH. __________________________________________________________ ___ 3:30 am BLOOD CULTURE **FINAL REPORT ___ Blood Culture, Routine (Final ___: NO GROWTH. __________________________________________________________ ___ 10:05 pm URINE Site: NOT SPECIFIED **FINAL REPORT ___ URINE CULTURE (Final ___: Culture workup discontinued. Further incubation showed contamination with mixed fecal flora. Clinical significance of isolate(s) uncertain. Interpret with caution. PROVIDENCIA ___. >100,000 ORGANISMS/ML.. GENTAMICIN & TOBRAMYCIN sensitivity testing performed by ___ ___. SENSITIVITIES: MIC expressed in MCG/ML _________________________________________________________ ___ ___ | AMIKACIN-------------- <=2 S CEFEPIME-------------- <=1 S CEFTAZIDIME----------- <=1 S CEFTRIAXONE----------- <=1 S CIPROFLOXACIN--------- 1 S GENTAMICIN------------ S MEROPENEM-------------<=0.25 S NITROFURANTOIN-------- 256 R PIPERACILLIN/TAZO----- <=4 S TOBRAMYCIN------------ R TRIMETHOPRIM/SULFA---- <=1 S = = = = = = = = ================================================================ Brief Hospital Course: ___ male with history of hypotonic bladder, BPH, chronic indwelling foley and multiple recent multidrug resistant UTIs (3x in the last two months), CAD s/p CABG, CHF EF55%, and likely RCC on imaging now presenting with groin pain after recent discharge on ___ for multidrug resistant UTI on pip/tazo. # Inguinal intertrigo: Initial exam showed significant b/l inguinal erythema with tenderness to palpation. Patient stated his groin pain has been relatively constant since his last hospitalization. Pt was noted to have intertrigo during his admission in ___ and was prescribed ketoconazole cream bid, which has stayed on his medication list per our paperwork but was actually not given upon speaking with his SNF. He was instead treated with topical zinc oxide for his intertrigo. Intertrigo was treated with miconazole powder with significant improvement of erythema and pain. He should be continued on miconazole topical powder upon discharge to SNF. # candiduria: Pt had many yeast on admission UA. He previously grew > 100k colonies of ___ parapsilosis on urine Cx from ___ and was treated for 1 week with fluconazole 200mg po daily. Pt had a renal ultrasound in ___, which did not show any evidence of fungus balls. Per IDSA guidelines from ___ [Clin Infect Dis. ___ most appropriate treatment for symptomatic candiduria is with fluconazole 200mg po daily x 2 weeks. Pt's indwelling foley was switched out in ED. Patient treated with 14-day course of PO fluconazole 200mg daily (end date ___. Baseline LFTs were wnl. Patient should have repeat LFTs after completing course of fluconazole. # Bacterial UTI: With regards to continuing treatment for recent bacterial UTI, his admission UA shows no bacteria, and it is unlikely that Pt failed bacterial UTI therapy on pip/tazo. Treatment with pip/tazo was resumed and he is scheduled to finish his 10-day course for complicated bacterial UTI on ___. # known right kidney mass: concerning for RCC and stable on recent CT scan and renal ultrasound. Will f/u with Dr. ___ urology. # HTN: continued home metoprolol, furosemide # CAD s/p CABG: stable, continued home atorvastatin, ASA, metoprolol. # DM2 - Hgb A1c 6.5 ___. Sliding scale while inpatient. # depression: continued home duloxetine. Added mirtazapine given poor appetite. # insomnia: continued home trazodone qhs prn = = = = = = = = = = = = = = = = = = = ================================================================ TRANSITIONAL ISSUES #Intertrigo: continue treatment with topical miconazole powder until clinically resolved #UTI: f/u final urine cultures. continue fluconazole 200mg daily until ___. Re-check LFTs at end of fluconazole course to assess for azole-induced hepatic injury. Zosyn for bacterial UTI from previous admission to end ___. After final dose of Zosyn, right PICC line can be discontinued Medications on Admission: The Preadmission Medication list is accurate and complete. 1. Aspirin 81 mg PO DAILY Start: In am 2. Calcium Carbonate 500 mg PO DAILY Start: In am 3. Furosemide 20 mg PO DAILY Start: In am hold for sbp < 90 4. Loratadine *NF* 10 mg Oral daily 5. Metoprolol Succinate XL 50 mg PO DAILY Start: In am hold for sbp < 90 or HR < 55 6. Multivitamins 1 TAB PO DAILY Start: In am 7. zinc oxide *NF* unknown Topical tid to groins and buttocks 8. Omeprazole 20 mg PO DAILY Start: In am 9. Vitamin D 800 UNIT PO DAILY Start: In am 10. Atorvastatin 40 mg PO DAILY Start: In am 11. Docusate Sodium 100 mg PO BID Start: In am hold for diarrhea 12. Acetaminophen 650 mg PO TID 3 gm max daily 13. Senna 2 TAB PO HS hold for loose stool 14. traZODONE 25 mg PO HS:PRN insomnia 15. Acetaminophen 650 mg PO Q4H:PRN pain, fever Do not exceed 4gm per day. 16. Bisacodyl 10 mg PR HS:PRN constipation 17. Fleet Enema ___AILY:PRN constipation 18. Lidocaine Jelly 2% 1 Appl TP ASDIR as needed for penile / foley pain 19. Milk of Magnesia 30 mL PO Q6H:PRN constipation 20. Polyethylene Glycol 17 g PO DAILY:PRN constipation 21. Polyethylene Glycol 17 g PO DAILY ordered ___ 22. Duloxetine 30 mg PO QHS 23. Piperacillin-Tazobactam 4.5 g IV Q8H Discharge Medications: 1. Acetaminophen 650 mg PO TID 3 gm max daily 2. Aspirin 81 mg PO DAILY 3. Atorvastatin 40 mg PO DAILY 4. Bisacodyl 10 mg PR HS:PRN constipation 5. Calcium Carbonate 500 mg PO DAILY 6. Docusate Sodium 100 mg PO BID hold for diarrhea 7. Duloxetine 30 mg PO QHS 8. Furosemide 20 mg PO DAILY hold for sbp < 90 9. Lidocaine Jelly 2% 1 Appl TP ASDIR as needed for penile / foley pain 10. Metoprolol Succinate XL 50 mg PO DAILY hold for sbp < 90 or HR < 55 11. Milk of Magnesia 30 mL PO Q6H:PRN constipation 12. Multivitamins 1 TAB PO DAILY 13. Piperacillin-Tazobactam 4.5 g IV Q8H 14. Polyethylene Glycol 17 g PO DAILY:PRN constipation 15. Senna 2 TAB PO HS hold for loose stool 16. traZODONE 25 mg PO HS:PRN insomnia 17. Vitamin D 800 UNIT PO DAILY 18. Fluconazole 200 mg PO Q24H Duration: 14 Days 19. Miconazole Powder 2% 1 Appl TP TID 20. Mirtazapine 7.5 mg PO HS 21. OxycoDONE (Immediate Release) 2.5 mg PO Q4H:PRN pain 22. Acetaminophen 650 mg PO Q4H:PRN pain, fever Do not exceed 4gm per day. 23. Fleet Enema ___AILY:PRN constipation 24. Loratadine *NF* 10 mg Oral daily 25. Omeprazole 20 mg PO DAILY 26. Polyethylene Glycol 17 g PO DAILY ordered ___ Discharge Disposition: Extended Care Facility: ___ Discharge Diagnosis: Intertrigo ___ urinary tract infection Discharge Condition: Mental Status: Clear and coherent. Level of Consciousness: Alert and interactive. Activity Status: Out of Bed with assistance to chair or wheelchair. Discharge Instructions: Dear Mr. ___, It was a pleasure taking part in your care here at ___. You were admitted for a fungal infection in your groin called intertrigo. This was treated with antifungal powder and improved. You were also found to have a fungal bladder infection. This will be treated with 2 weeks of an antifungal pill. I wish you a speedy recovery! Followup Instructions: ___
19713100-DS-76
19,713,100
24,017,443
DS
76
2178-09-10 00:00:00
2178-09-14 09:03:00
Name: ___ Unit No: ___ Admission Date: ___ Discharge Date: ___ Date of Birth: ___ Sex: M Service: MEDICINE Allergies: ___ / Oxybutynin / Bactrim Attending: ___. Chief Complaint: Altered mental status Major Surgical or Invasive Procedure: None History of Present Illness: The pt is a ___ from ___ Short Term Rehabilitation Facility. History of chronic indwelling foley and multiple recent multidrug resistant UTIs (Klebsiella, ___), CAD s/p CABG, CHF EF55%, and likely Renal Cell Carcinoma. Multiple admission for UTI in the past year, 3 over several weeks. Most recent discharge on ___. Last night the pt presented from ___ with AMS and shaking chills. Per report, the patient was doing well, until last night around 11PM, when he began complaining that he didn't feel well. He was noted to have generalized twitching, most prominent in the facial muscles. His mental status began to decline and he was not answering questions appropriately, prompting transport to the ___. Per the ___ nursing staff, this is very similar to how he has presented with his multiple prior UTIs. His baseline mental status is normally very coherent and generally oriented x2 and answers questions appropriately. Past Medical History: 1. Hypotonic bladder with incomplete emptying, s/p indwelling foley since ___ c/b frequent Multidrug resistent UTIs, including MRSA and ESBL E Coli 2. BPH 3. CAD s/p CABG x 3 in ___ - CABG anatomy: LIMA to LAD, SVG to OM, and SVG to RCA - s/p stenting ___ of mid RCA, PTCA of proximal RCA and PDA - redo single vessel CABG in ___ with Dr. ___. 4. CHF was preserved EF 55% in ___ 5. Bovine AVR in ___. Type 2 Diabetes Mellitus: diet controlled 7. Hypertension 8. Hx of Chronic constipation 9. Hyperlipidemia 10. Depression/Anxiety 11. Asbestosis 12. Spinal stenosis 13. R kidney mass - Followed by urology w/ serial imaging, likely RCC 14. Osteoarthritis 15. Carotid stenosis - chronic occlusion of ___, ___ with 40% Social History: ___ Family History: Daughter- died at ___,breast cancer. Father- died from MI in his ___ Physical Exam: ADMISSION EXAM: Vital Signs: Temp 98.2, BP 111/95, HR 51, RR 22, O2sat 96% on RA GENERAL: Elderly male, sitting on the bed, intermittent myoclonus HEENT: NC/AT, PERRLA, EOMI, conjectiva erythematous, dry mucus membranes NECK: supple, no LAD, no JVP elevation. LUNGS: Fine crackles at bases, no wheezing HEART: RRR, no MRG, nl S1-S2 ABDOMEN: normal bowel sounds, soft, non-tender, non-distended EXTREMITIES: no edema, 2+ pulses radial and dp. Right heel w/ stage II pressure ulcer, mild blanchable erythema in LLE . NEURO: awake, oriented x 2 (self and hospital), muscle strength ___ in UE and less in LEs. DISCHARGE EXAM: Vital Signs: 97.5 149/91 68 22 98%/2L nc GENERAL: NAD. Much more alert and interactive than yesterday. Fluently conversant. NECK: supple, no LAD, no JVP elevation. LUNGS: CTA bilat, no r/rh/wh, good air movement, resp unlabored, no accessory muscle use HEART/Chest: RRR, no MRG, nl S1-S2. Reproducible tenderness to palpation over anterior left chest wall. ABDOMEN: normal bowel sounds, soft, non-tender, non-distended, no rebound or guarding, no masses EXTREMITIES: no edema, 2+ pulses radial and dp. Right heel w/ stage II pressure ulcer. Neuro: Alert and oriented x2. no focal deficits Pertinent Results: LABS: ___ 02:20AM BLOOD WBC-9.8 RBC-4.81 Hgb-13.7* Hct-41.9 MCV-87 MCH-28.6 MCHC-32.8 RDW-18.0* Plt ___ ___ 10:45AM BLOOD WBC-6.0 RBC-4.73 Hgb-13.6* Hct-41.7 MCV-88 MCH-28.7 MCHC-32.5 RDW-18.0* Plt ___ ___ 07:30AM BLOOD WBC-4.7 RBC-4.85 Hgb-13.8* Hct-43.1 MCV-89 MCH-28.5 MCHC-32.0 RDW-18.0* Plt ___ ___ 02:20AM BLOOD Glucose-135* UreaN-24* Creat-0.8 Na-139 K-3.9 Cl-102 HCO3-25 AnGap-16 ___ 09:15AM BLOOD Glucose-98 UreaN-25* Creat-1.0 Na-142 K-4.5 Cl-102 HCO3-32 AnGap-13 ___ 07:40AM BLOOD Glucose-107* UreaN-17 Creat-0.8 Na-143 K-4.3 Cl-103 HCO3-36* AnGap-8 ___ 05:20PM BLOOD Glucose-90 UreaN-16 Creat-0.8 Na-141 K-4.1 Cl-102 HCO3-30 AnGap-13 ___ 07:30AM BLOOD Glucose-108* UreaN-14 Creat-0.7 Na-142 K-4.0 Cl-106 HCO3-28 AnGap-12 ___ 07:40PM BLOOD CK-MB-4 cTropnT-0.15* ___ 11:57PM BLOOD CK-MB-4 cTropnT-0.18* ___ 07:00AM BLOOD CK-MB-5 cTropnT-0.20* ___ 06:00PM BLOOD CK-MB-5 cTropnT-0.16* ___ 10:45AM BLOOD CK-MB-5 cTropnT-0.14* ___ 07:30AM BLOOD CK-MB-5 cTropnT-0.10* ___ 02:36AM BLOOD Lactate-2.3* ___ 08:08PM BLOOD Lactate-1.0 ========================================================= MICROBIOLOGY __________________________________________________________ ___ 2:30 pm BLOOD CULTURE Blood Culture, Routine (Pending): __________________________________________________________ ___ 2:30 am URINE **FINAL REPORT ___ URINE CULTURE (Final ___: PSEUDOMONAS AERUGINOSA. >100,000 ORGANISMS/ML.. SENSITIVITIES: MIC expressed in MCG/ML _________________________________________________________ PSEUDOMONAS AERUGINOSA | CEFEPIME-------------- 2 S CEFTAZIDIME----------- <=1 S CIPROFLOXACIN--------- 1 S GENTAMICIN------------ 2 S MEROPENEM------------- 0.5 S PIPERACILLIN/TAZO----- <=4 S TOBRAMYCIN------------ <=1 S __________________________________________________________ ___ 2:20 am BLOOD CULTURE Blood Culture, Routine (Pending): ================================================================ IMAGING/OTHER STUDIES: CXR ___: IMPRESSION: 1. No acute cardiac or pulmonary findings. 2. Marked elevation of the left hemidiaphragm, not significantly changed compared to CT from ___. GU U/S ___: 1. Fluid/debris level within the bladder, likely related to the known infections. 2. Prostate volume of 51 mL. 3. Stable 3.1 x 2.8 x 2.9 cm right upper pole solid mass likely represents a renal cell carcinoma. CXR ___: FINDINGS: As compared to the previous radiograph, there is persistent elevation of the left hemidiaphragm. A lucency projecting over the right upper abdomen is slightly more conspicuous than on the prior image, to exclude potential small pneumothorax. Close clinical and radiographic followup is recommended. The findings were discussed at the time of the initial image evaluation. Unchanged appearance of the cardiac silhouette and of the lung parenchyma EKG ___: Sinus rhythm with borderline prolongation of the P-R interval. Right bundle-branch block. Indeterminate QRS axis in the frontal plane. Borderline P-R interval prolongation of the Q-T interval. Compared to the previous tracing of ___ the rate has decreased. The other findings are similar CHEST CTA ___: IMPRESSION: 1. No pulmonary embolism. 2. Bibasilar atelectasis or consolidations, which may be consistent with pneumonia in the correct clinical setting. 3. Calcified pleural plaques, consistent with prior asbestos exposure. Brief Hospital Course: Patient is an ___ male with PMH of hypotonic bladder w/ chronic indwelling foley since ___ complicated by numerous UTI's (some of which were MDR) who presents to the hospital from REHAB with myoclonus and AMS, similar symptoms to previous UTI's. He was found to have positive UA and admitted to medicine for treatment of UTI and AMS. #Pseudomonas UTI: Patient had a chronic indwelling foley catheter for hypotonic bladder since ___ and has had numerous UTI's with various organisms. The latest organisms that have grown include Pseudomonas, Providencia, and Klebsiella, all of which have been sensitive to zosyn. His current presentation of AMS, myoclonus, and positive UA is nearly identical to previous UTI presentations. His Foley was last changed at ___ on ___. Foley was changed on day of admission after first dose of Zosyn was administered. Treated UTI with Zosyn x 2 days. Sensitivities showed ciprofloxacin susceptibility, so switched to PO ciprofloxacin 500mg BID on ___. He was discharged on this medication to finish a total of 7 days of antibiotics for complicated UTI. #Metabolic encephalopathy: On presentation, patient was lethargic and oriented x 0, with myoclonus. He could follow some simple commands, was moving all 4 extremities equally, and could answer some yes/no questions with head nod/shake. His baseline MS according to ___ nursing staff is alert and oriented x2, fluentally conversant and appropriate. Given patient's myoclonic jerks and evidence of UTI on UA along with his history, AMS was attributed to metabolic encephalopathy ___ UTI. Per ___ staff, he has had nearly identical symptomatology/mental status changes during his numerous previous UTIs. By time of discharge, mental status had improved back to baseline, with patient alert, oriented to self, place, and situation. He was fluently conversant and appropriate. #NSTEMI - On the evening of ___, patient experienced mid-sternal chest pain. Although reproduciblity of chest pain with palpation was suggestive of costochondritis; given his extensive coronary history and elevation in troponins (peak of 0.20), pt. was treated medically as NSTEMI. Unclear if this was related to clot (type I) or demand ischemia (type II), but given patient's history of severe CAD, treated as type I NSTEMI. Patient received ASA 325mg, metoprolol, atorvastatin 80mg, supplemental O2, and heparin gtt x 48 hours. At discharge, troponins had downtrended to 0.10 and patient was chest pain free. He will be scheduled for close followup with his cardiologist. #Right heel stage II pressure ulcer: No evidence of infection. Wound care consult was obtained. They recommended cleanse with commercial cleanserpat dry aloe vesta cream aound woundadaptic and dry gauzewrap with kling. Change dressing daily. #Multiple admissions for recurrent UTIs: Patient has been admitted to ___ 54 times for UTIs since placement of Foley catheter in ___. Per urology notes, the reason for Foley placement was "hypotonic bladder"; however, patient's daughter states that Foley was placed because of incontinence and resultant skin-breakdown/infections. A primary goal of this admission was to take measures to prevent future UTIs and re-admissions for Mr. ___. To this end, his Foley catheter was removed on ___ for a voiding trial. Patient voided spontaneously without any evidence of urinary retention for remainder of admission. Patient was incontinent. Groin area was kept dry and clean with BID cleansing of the area, as well as by keeping a towel above and below the genitals and changing the towel BID. Ketoconazole cream also was applied to genitals, inguinal folds, and pannus fold BID. Foley catheter should remain OUT at rehab to decrease risk of recurrent UTI. If patient demonstrates AMS, complains of suprapubic pain, or does not void for 8 hours, he should be straight cathed. Under no circumstance should Foley catheter be replaced without discussion with Mr. ___ PCP, ___ MD Phone: ___ #Depression/Anxiety- severe per prior notes and geriatrics note: Held mirtazapine and duloxetine in setting of AMS. Restarted upon discharge. # Known right kidney mass: concerning for RCC and stable on recent CT scan and renal ultrasound. Being followed by urology = = = = = ================================================================ TRANSITIONAL ISSUES: #RECURRENT ADMISSIONS FOR UTIs: See above section #Multiple re-admissions for recurrent UTIs. Again, If patient demonstrates AMS, complains of suprapubic pain, or does not void for 8 hours, he should be straight cathed. Under no circumstance should Foley catheter be replaced without discussion with Mr. ___ PCP, ___ MD Phone: ___ Medications on Admission: The Preadmission Medication list is accurate and complete. 1. Acetaminophen 650 mg PO Q8H:PRN pain 2. Aspirin 81 mg PO DAILY 3. Atorvastatin 40 mg PO DAILY 4. Bisacodyl 10 mg PO DAILY:PRN constipation 5. Calcium Carbonate 500 mg PO DAILY 6. Duloxetine 30 mg PO QHS 7. Furosemide 20 mg PO DAILY hold for SBP<100 8. Metoprolol Succinate XL 50 mg PO DAILY hold for SBP<100 or HR<50 9. Milk of Magnesia 30 mL PO Q6H:PRN constipation 10. Mirtazapine 15 mg PO HS 11. Multivitamins 1 TAB PO DAILY 12. Omeprazole 20 mg PO DAILY 13. Polyethylene Glycol 17 g PO DAILY 14. Senna 2 TAB PO HS 15. traZODONE 50 mg PO HS 16. Vitamin D 800 UNIT PO DAILY 17. Lidocaine Jelly 2% 1 Appl TP ASDIR 18. Loratadine *NF* 10 mg Oral daily 19. Docusate Sodium 100 mg PO BID 20. OxycoDONE (Immediate Release) 2.5 mg PO Q4H:PRN pain hold for sedation or RR<10 21. Fleet Enema ___AILY:PRN constipation 22. Vigamox *NF* (moxifloxacin) 0.5 % ___ 1 gtt TID Discharge Medications: 1. Acetaminophen 650 mg PO Q8H:PRN pain 2. Aspirin 81 mg PO DAILY 3. Atorvastatin 80 mg PO DAILY 4. Bisacodyl 10 mg PO DAILY:PRN constipation 5. Calcium Carbonate 500 mg PO DAILY 6. Docusate Sodium 100 mg PO BID 7. Milk of Magnesia 30 mL PO Q6H:PRN constipation 8. Multivitamins 1 TAB PO DAILY 9. Polyethylene Glycol 17 g PO DAILY 10. Senna 2 TAB PO HS 11. Vitamin D 800 UNIT PO DAILY 12. Ciprofloxacin HCl 500 mg PO Q12H RX *ciprofloxacin [Cipro] 500 mg 1 tablet(s) by mouth twice a day Disp #*7 Tablet Refills:*0 13. Ketoconazole 2% 1 Appl TP BID RX *ketoconazole 2 % Apply to affected areas BID:PRN Disp #*1 Tube Refills:*3 14. Duloxetine 30 mg PO QHS 15. Fleet Enema ___AILY:PRN constipation 16. Furosemide 20 mg PO DAILY 17. Loratadine *NF* 10 mg Oral daily 18. Metoprolol Succinate XL 50 mg PO DAILY 19. Mirtazapine 15 mg PO HS 20. Omeprazole 20 mg PO DAILY 21. traZODONE 50 mg PO HS 22. Vigamox *NF* (moxifloxacin) 0.5 % ___ 1 gtt TID Discharge Disposition: Extended Care Facility: ___ Discharge Diagnosis: Primary: Metabolic encephalopathy Urinary tract infection Non ST segment elevation myocardial infarction Secondary: Hypertension Pressure Ulcer Discharge Condition: Mental Status: Clear and coherent. Level of Consciousness: Alert and interactive. Activity Status: Out of Bed with assistance to chair or wheelchair. Discharge Instructions: Dear Mr. ___, You were admitted to ___ for altered mental status and a bladder infection. You were treated with antibiotics and your mental status returned to baseline and your bladder infection cleared. We removed your Foley catheter because this is likely causing your recurrent bladder infections. You were able to urinate without the catheter. We will provide detailed instructions to the staff at your rehab facility about how to properly care for your hygiene. Also, during this admission, you had chest pain and were found to have a very small heart attack. You were treated with blood thinners and your chest pain improved. Followup Instructions: ___
19713100-DS-78
19,713,100
27,606,339
DS
78
2178-12-21 00:00:00
2178-12-25 13:25:00
Name: ___ Unit No: ___ Admission Date: ___ Discharge Date: ___ Date of Birth: ___ Sex: M Service: MEDICINE Allergies: ___ / Oxybutynin / Bactrim Attending: ___. Chief Complaint: Tremors, Weakness Major Surgical or Invasive Procedure: None History of Present Illness: ___ male presents with facial and b/l upper extremity tremor/myoclonus x ___ days, possibly chronic, unclear at this time. Seen by ___ in setting of these tremors who contacted on call physician of PCP group. Family had contacted her because patient was having twitching of his hands and face. This has been a recurrent issue in the setting of UTIs for which the patient has been evaluated multiple times. With the goal of avoiding an ED visit, patient was treated empirically with a course of Bactrim for one day. Patient did not improve and patient brought to ED this afternoon. There was a report of desat of 89-90% with somnolence per EMS, mental status improved significantly with 4L N/C by EMS. Patient has no complaints at this time other than the tremor. Previously has been treated with meropenem for ESBL klebsiella in the past. In the ED, initial vitals were: 97.2 80 152/103 16 100% 4L NP. Labs were notable for a normal white count and normal lactate. UA showed evidence of infection and pt has history of ESBL klebsiella, which previous ID recommendations list meropenem as a potential herapeutic option on prior visits. Pt was given 500mg meropenem IV x 1. CXR was obtained, which showed no focal infiltrates. On the floor, patient continues to have tremors in face. Patient afebrile, with good urine output. Past Medical History: PAST MEDICAL & SURGICAL HISTORY: 1. Hypotonic bladder with incomplete emptying, s/p indwelling foley since ___ c/b frequent Multidrug resistent UTIs, including MRSA and ESBL E Coli 2. BPH 3. CAD s/p CABG x 3 in ___ - CABG anatomy: LIMA to LAD, SVG to OM, and SVG to RCA - s/p stenting ___ of mid RCA, PTCA of proximal RCA and PDA - redo single vessel CABG in ___ with Dr. ___. 4. CHF was preserved EF 55% in ___ 5. Bovine AVR in ___. Type 2 Diabetes Mellitus: diet controlled 7. Hypertension 8. Hx of Chronic constipation 9. Hyperlipidemia 10. Depression/Anxiety 11. Asbestosis 12. Spinal stenosis 13. R kidney mass - Followed by urology w/ serial imaging, likely RCC 14. Osteoarthritis 15. Carotid stenosis - chronic occlusion of LICA, ___ with 40% Social History: ___ Family History: Denies significant family history of early MI, arrhythmia or sudden cardiac death. Daughter died at ___, breast cancer. Father died from MI in his ___. Physical Exam: ADMISSION PHYSICAL EXAM: Vitals: 97.7, 79, 144/103, 18, 100% 2L GENERAL: Facial twitching present. Appears in no acute distress. Alert and interactive. HEENT: Normocephalic, atraumatic. ___: Regular rate and rhythm, without murmurs, rubs or gallops. S1 and S2 normal. RESP: CTAB in all lung fields. No wheezing, rhonchi or crackles. NO labored breathing. ABD: soft, NT, ND GU: skin around groin and scrotum no erythema or ulcers. EXTREM: no c,c,e, RLE pressure ulcer, 1cm x 1cm, stage 3, with fibrinous debris without purulence. NEURO: Alert and oriented x person, place, and year. Speech slurred. DISCHARGE PHYSICAL EXAM: VS: 97.9/98.4, 118/76 (116-132/76-82), 89 (76-89), 20, 100%2L (on RA at discharge) GENERAL: NAD, alert, interactive. HEENT: NC/AT, sclerae anicteric, MMM LUNGS: Clear to auscultation except minor crackles at b/l bases, otherwise no w/r/r HEART: Regular rate and rhythm, without murmurs, rubs or gallops. S1 and S2 normal. ABDOMEN: NABS, soft/NT/ND. EXTREMITIES: WWP NEURO: awake, A&Ox3. Pertinent Results: Labs on Admission ================== ___ 12:15PM BLOOD WBC-5.6 RBC-4.73 Hgb-12.8* Hct-39.7* MCV-84 MCH-27.2 MCHC-32.3 RDW-17.5* Plt ___ ___ 12:15PM BLOOD Neuts-64.6 ___ Monos-5.9 Eos-2.5 Baso-0.8 ___ 12:15PM BLOOD Plt ___ ___ 12:15PM BLOOD Glucose-108* UreaN-26* Creat-0.9 Na-140 K-4.6 Cl-103 HCO3-27 AnGap-15 ___ 12:29PM BLOOD Lactate-1.7 Imaging ======== CXR ___: 1. Findings suggest minimal interstitial edema. 2. Stable elevated hemidiaphragm and bibasilar atelectasis. Possible small/trace left pleural effusion. Micro ====== Urine culture (___): ENTEROCOCCUS SP. Blood culture 1 (___): pending Blood culture 2 (___): pending Labs on Discharge ================== ___ 06:30AM BLOOD WBC-5.4 RBC-4.84 Hgb-12.9* Hct-40.3 MCV-83 MCH-26.6* MCHC-32.0 RDW-17.6* Plt ___ ___ 06:30AM BLOOD Glucose-117* UreaN-18 Creat-0.6 Na-144 K-4.2 Cl-104 HCO3-28 AnGap-16 ___ 06:30AM BLOOD Calcium-8.9 Phos-2.9 Mg-1.9 Brief Hospital Course: This patient is an ___ yo M with PMH of hypotonic bladder with multidrug resistant UTIs, BPH, CAD, CHF (LVEF 55%), AS s/p AVR, diet-controlled DM, HTN, and HLD who presented with tremors and weakness and was found to have enterococcus UTI. Active Problems ============== #Urinary tract infection: Pt was initially started on Meropenem for treatment of his UTI before culture grew, as Meropenem had been recommended for his previous UTIs. After one day of meropenam, pt had minimal improvement in his symptoms and SBP decreased to ___, so one dose of daptomycin was given in addition. Pt clinically improved after 36 hours of antibiotics. Urine culture sensitivities grew enterococcus sensitive to ampicillin, so ampicillin 2g q6h IV was started, and transitioned to Ampicillin 500mg q6h PO upon discharge, which the pt should continue for a total of 2 weeks (end on ___. Blood cultures pending, NGTD. #Pain: Pt complained of pelvic pain and groin pain (apparently chronic). Improved with acetaminophen. #Delirium: Pt had been occasionally confused on first day of admission, much improved after day 1. Likely related to the UTI, which is now being appropriately treated with ampicillin. #Nutrition: There was a concern for aspiration while eating and drinking. Speech and swallow was consulted for concern for aspiration. Pt refused bedside swallow study ___, and the speech team was not able to return before patient was discharged. Nutrition was consulted and Vitamin C 500 mg x 14 days was started per nutrition recs. Chronic Problems =============== #Coronary artery disease: Continued aspirin, beta-blocker and statin throughout hospital course. #Hypertension: Continued home Metoprolol throughout hospital course. #Hyperlipidemia: Continued statin throughout hospital course. #Chronic CHF: Questionable diagnosis of ischemic cardiomyopathy with preserved EF 55% in ___. Home regimen includes beta-blocker and furosemide. Continued home dose metoprolol XL throughout hospital course and held furosemide during acute illness. Restarted furosemide upon discharge. #Diabetes mellitus: Diet controlled, last HbA1c 6.5% in ___. Pt was put on insulin sliding scale during his hospital course and blood sugars remained < 150, but this was discontinued upon discharge. #Right heel stage III pressure ulcer: no evidence of acute infection, managed by nursing with mepilex. #Depression and anxiety: Severe per prior notes and geriatrics. Continued mirtazapine and duloxetine throughout hospital course and upon discharge. Discontinued his previously prescribed Trazadone for concern of polypharmacy and oversedation. #Known right kidney mass: Concerning for RCC and stable on recent CT scan and renal ultrasound. Being followed by Urology as outpatient Transitional Issues ============== - Pt going home with services that he already has in place. - Pt has follow-up appointment with his PCP ___ nurse (___) on ___ at 2pm - Blood cultures x 2 (___) pending - Pt could benefit from re-evaluation of his statin as an outpatient - Pt may benefit from a swallow evaluation in the future given the concern for aspiration while eating. - Urology should f/u known right kidney mass - renal US scheduled for ___. - Confirmed with pt that he is DNR Medications on Admission: The Preadmission Medication list is accurate and complete. 1. Acetaminophen 650 mg PO Q8H:PRN pain 2. Aspirin 81 mg PO DAILY 3. Atorvastatin 80 mg PO DAILY 4. Bisacodyl 5 mg PO DAILY:PRN constipation 5. Calcium Carbonate 500 mg PO DAILY 6. Duloxetine 30 mg PO DAILY 7. Fleet Enema ___AILY:PRN constipation 8. Docusate Sodium 100 mg PO BID 9. Furosemide 20 mg PO DAILY do not give if SBP<100 10. Milk of Magnesia 30 mL PO Q6H:PRN constipation 11. Mirtazapine 15 mg PO HS 12. Multivitamins 1 TAB PO DAILY 13. Omeprazole 20 mg PO DAILY 14. Polyethylene Glycol 17 g PO DAILY 15. Senna 2 TAB PO BID 16. TraZODone 50 mg PO HS 17. Vitamin D 1000 UNIT PO DAILY 18. Metoprolol Succinate XL 25 mg PO DAILY Discharge Medications: 1. Acetaminophen 650 mg PO Q8H:PRN pain 2. Aspirin 81 mg PO DAILY 3. Atorvastatin 80 mg PO DAILY 4. Bisacodyl 5 mg PO DAILY:PRN constipation 5. Calcium Carbonate 500 mg PO DAILY 6. Docusate Sodium 100 mg PO BID 7. Duloxetine 30 mg PO DAILY 8. Fleet Enema ___AILY:PRN constipation 9. Metoprolol Succinate XL 25 mg PO DAILY 10. Milk of Magnesia 30 mL PO Q6H:PRN constipation 11. Mirtazapine 15 mg PO HS 12. Multivitamins 1 TAB PO DAILY 13. Omeprazole 20 mg PO DAILY 14. Polyethylene Glycol 17 g PO DAILY 15. Senna 2 TAB PO BID 16. Vitamin D 1000 UNIT PO DAILY 17. Ampicillin 500 mg PO Q6H Take this medication one pill (500mg) every 6 hours. RX *ampicillin 500 mg 1 (One) capsule(s) by mouth Every 6 hours Disp #*50 Capsule Refills:*0 18. Ascorbic Acid ___ mg PO DAILY Duration: 14 Days RX *ascorbic acid ___ mg 1 (One) tablet(s) by mouth daily Disp #*12 Tablet Refills:*0 19. Furosemide 20 mg PO DAILY Discharge Disposition: Home With Service Facility: ___ Discharge Diagnosis: Primary Diagnosis Enterococcus urinary tract infection Discharge Condition: Level of Consciousness: Alert and interactive. Activity Status: Bedbound. Mental Status: Confused - sometimes. Discharge Instructions: Dear Mr. ___, It was a pleasure taking care of you. You were admitted to the hospital because you were feeling weak. You were found to have a urinary tract infection, which is being treated with the antibiotic Ampicillin. You should continue taking this antibiotic for 12 more days (for a total of 2 weeks), through ___. You have a follow up appointment at Dr. ___ office with his nurse (___) on ___ at 2pm. Followup Instructions: ___
19713100-DS-79
19,713,100
26,548,607
DS
79
2179-01-31 00:00:00
2179-02-14 21:42:00
Name: ___ Unit No: ___ Admission Date: ___ Discharge Date: ___ Date of Birth: ___ Sex: M Service: MEDICINE Allergies: Amitiza / Oxybutynin / Bactrim Attending: ___. Chief Complaint: CC: UTI and malaise Major Surgical or Invasive Procedure: None History of Present Illness: The patient is a ___ year old community dwelling male with MMP including CAD s/p CABG, hypotonic bladder with incomplete emptying, c/b frequent Multidrug resistent UTIs, including MRSA and ESBL E Coli who now presents from home with malaise- per ED dash altered MS, tachycardia, hypoxia but per EMS run pt was not altered,tachycardia nor hypoxic but did have wheezing on exam and referred in by home ___. In ED UA c/w infection, leukocytosis on labs, CXR with mild congestive heart failure. Discussed with ID who advised administering cipro following the cultures. If patient gets sick, suggest to administer meropenem to cover previous resistent bugs. Recent organisms are sensitive. The patient tells me that he was feeling badly starting today. No n/v/cp/sob/no constipation or diarrhea. No HA, slurred speech/neuro sx, no clear weight loss or weight gain. + shivers but no clear fevers, penile pain this morning but has since resolved. no dysuria. No URI sx. No new MSK, no rashes. . Of note he was recently admitted in ___ with tremors and found to have a UTI. Urine cultures grew ampicillin sensitive enteroccocus sensitive to ampicillin. There is no culture in our system but per Dr ___ urine culture on ___ was negative. . In ER: (Triage Vitals:0 97.8 88 121/85 22 94% Nasal Cannula ) Meds Given:cipro Fluids given:none Radiology Studies: CxR and renal US consults called: ID and geriatrics . PAIN SCALE: ___ ________________________________________________________________ [+ ]Medication allergies [ ] Seasonal allergies [X]all other systems negative except as noted above Past Medical History: PAST MEDICAL & SURGICAL HISTORY: 1. Hypotonic bladder with incomplete emptying, s/p indwelling foley since ___- Indwelling foley removed ___ including MRSA and ESBL E Coli 2. BPH 3. CAD s/p CABG x 3 in ___ - CABG anatomy: LIMA to LAD, SVG to OM, and SVG to RCA - s/p stenting ___ of mid RCA, PTCA of proximal RCA and PDA - redo single vessel CABG in ___ with Dr. ___. 4. CHF was preserved EF 55% in ___ 5. Bovine AVR in ___. Type 2 Diabetes Mellitus: diet controlled 7. Hypertension 8. Hx of Chronic constipation 9. Hyperlipidemia 10. Depression/Anxiety 11. Asbestosis 12. Spinal stenosis 13. R kidney mass - Followed by urology w/ serial imaging, likely RCC 14. Osteoarthritis 15. Carotid stenosis - chronic occlusion of LICA, ___ with 40% Social History: FROM ___ and ___ d/c summmary Was at rehab and recently moved home, lives with his daughter. He has had at least 20 ED visits this year. He worked in ___ (in the ___) and was also in the Navy (Phillipines in the 1960s). His wife died ___ years ago. He has a 100 pack year history of smoking, quit in the 1980s, no etoh, no illicits. He is able to walk about 5 steps with a walker and climb 4 or 5 stairs with the support of a railing. ============== His daughter ___ puts all of his pills in a pill box. He can dress himself but he needs assistance to bathe. He lives with his daughter. Dtr does bills and cooks. He quit smoking many years ago. He used to drink heavily when he was in the service in ___ ___ but not since then. He is a retired ___. He uses a wheelchair at home. He has an aide who comes morning and night 7 days per week. His aide takes him out to the store. He is a widower. He confirms that he does not use oxygen at home. Family History: His father died of an MI in his mid ___. His mother died of an MI in her mid ___ as well. Physical Exam: PHYSICAL EXAM: I3 - PE >8 1. VS: T = 97.5 P 85 BP = 137/52 RR = 16 O2Sat on __93%% on 2L __ liters O2 Wt, ht, BMI GENERAL: Elderly male laying in bed. He is extremely hard of hearing. Nourishment: OK Grooming: good Mentation: alert,speaks in full sentences 2. Eyes: [X] WNL EOMI without nystagmus, Conjunctiva: clear 3. ENT [] WNL Dry MM 4. Cardiovascular [] WNL Irregular, S1, S2, no m/r/g [X] Edema RLE 1+ - 2+ [X] Edema LLE 1+ 2+ DPP pulses not appreciated but dopplered by RN [] Vascular access [x] Peripheral [] Central site: 5. Respiratory [ ] RLL crackles Decreased BS on the L side. 6. Gastrointestinal [ X] WNL Soft,nt, obesely disteded, 7. Musculoskeletal-Extremities [] WNL [ ] Tone WNL [ X]Upper extremity strength ___ and symmetrical [ ]Other: [ ] Bulk WNL [X] Lower extremity strength ___ and symmetrica [ ] Other: [] Normal gait []No cyanosis [ ] No clubbing [] No joint swelling 8. Neurological [] WNL [ X] Alert and Oriented x 3 CN II-XII intact [ X] Normal attention but unable to DOMYB 9. Integument [] WNL Erythema at L ankle c/w venstatsis. 10. Psychiatric [x] WNL [X] Appropriate [] Flat affect [] Anxious [] Manic [] Intoxicated [x] Pleasant with a good sense of humor [] Depressed [] Agitated [] Psychotic Discharge physical exam: VS: 96.7 BP: 134/76 HR: 83 R: 18 O2: 92% RA Sitting in chair in NAD. HOH. HEENT: MMM, Oropharynx clear Lungs: Clear B/L on ausculatation ___: RRR S1, S2 present no m/r/g Abd: Soft, NT, ND GU: No foley Ext: No edema Neuro: Awake, alert and oriented x ___. Mental status fluctuates from awake and alert to intermittently agitated. Pertinent Results: ___ 02:34PM LACTATE-1.7 ___ 02:25PM GLUCOSE-119* UREA N-16 CREAT-0.7 SODIUM-143 POTASSIUM-4.5 CHLORIDE-102 TOTAL CO2-32 ANION GAP-14 ___ 02:25PM estGFR-Using this ___ 02:25PM CK(CPK)-54 ___ 02:25PM cTropnT-0.01 ___ 02:25PM CK-MB-4 ___ 02:25PM WBC-6.0 RBC-4.72 HGB-12.6* HCT-38.0* MCV-81* MCH-26.7* MCHC-33.1 RDW-18.8* ___ 02:25PM NEUTS-70.1* ___ MONOS-7.1 EOS-2.3 BASOS-0.5 ___ 02:25PM PLT COUNT-270 ___ 01:05PM URINE COLOR-Straw APPEAR-Cloudy SP ___ ___ 01:05PM URINE BLOOD-SM NITRITE-NEG PROTEIN-TR GLUCOSE-NEG KETONE-NEG BILIRUBIN-NEG UROBILNGN-NEG PH-6.5 LEUK-LG ___ 01:05PM URINE RBC-7* WBC->182* BACTERIA-FEW YEAST-NONE EPI-1 ___ 01:05PM URINE WBCCLUMP-MANY ================== EKG: SR with PACs, RBB, no acute changes at 89 bpm. . LAST ___ There is mild symmetric left ventricular hypertrophy. The left ventricular cavity size is normal. Due to suboptimal technical quality, a focal wall motion abnormality cannot be fully excluded. Overall left ventricular systolic function is normal (LVEF>55%). The right ventricular free wall is hypertrophied. Right ventricular chamber size is normal. The aortic valve is not well seen. No masses or vegetations are seen on the aortic valve, but cannot be fully excluded due to suboptimal image quality. No aortic regurgitation is seen. The mitral valve leaflets are not well seen. No masses or vegetations are seen on the mitral valve, but cannot be fully excluded due to suboptimal image quality. No masses or vegetations are seen on the tricuspid valve, but cannot be fully excluded due to suboptimal image quality. The pulmonary artery systolic pressure could not be determined. There is no pericardial effusion. IMPRESSION: Suboptimal image quality. Unable to adequately assess for the absence/presenceof valvular vegetations or abscesses. . CXR: Mild congestive heart failure, slightly progressed compared to the previous exam, with small left pleural effusion. Mild bibasilar atelectasis. . Abdominal US: ReportNo hydronephrosis. Unchanged right upper pole mass likely represents a renal Preliminary Reportcell carcinoma. . Urine Culture: ___ 1:05 pm URINE Site: CATHETER **FINAL REPORT ___ URINE CULTURE (Final ___: KLEBSIELLA PNEUMONIAE. >100,000 ORGANISMS/ML.. Piperacillin/tazobactam sensitivity testing available on request. KLEBSIELLA PNEUMONIAE. >100,000 ORGANISMS/ML.. ___ MORPHOLOGY. SENSITIVITIES: MIC expressed in MCG/ML _________________________________________________________ KLEBSIELLA PNEUMONIAE | KLEBSIELLA PNEUMONIAE | | AMPICILLIN/SULBACTAM-- =>32 R =>32 R CEFAZOLIN------------- =>64 R =>64 R CEFEPIME-------------- =>64 R 16 I CEFTAZIDIME----------- =>64 R =>64 R CEFTRIAXONE----------- =>64 R =>64 R CIPROFLOXACIN---------<=0.25 S <=0.25 S GENTAMICIN------------ <=1 S <=1 S MEROPENEM-------------<=0.25 S <=0.25 S NITROFURANTOIN-------- <=16 S 64 I PIPERACILLIN/TAZO----- 16 S TOBRAMYCIN------------ <=1 S <=1 S TRIMETHOPRIM/SULFA---- 2 S 2 S Brief Hospital Course: The patient is a complicated ___ year old male with multiple medical problems including CAD s/p CABG x 2, s/p bioprosthetic AVR, incomplete bladder emptying who presented with malaise, leukocytosis and UTI and also new oxygen requirement concerning for acute diastolic heart failure, confirmed on CXR. Given IV lasix and Cipro-> to Meropenem empirically due to myoclonic jerking previously described. Transitioned back to Ciprofloxacin with improvement in myoclonus. Also with troponin leak and stable EKG consistent with demand ischemia from CHF. Also concerns for dementia and night terrors. Followed by geriatrics and started on low dose olanzipine for agitation. #Acute encephalopathy/Malaise: Likely related to recurrent bacterial UTI, hypernatremia and diastolic CHF (see below). Also with report of months of insomnia and shouting at night. Daughter concerned for underlying dementia, psych condition, or ? PTSD. Consulted Geriatrics. Geriatric depression screen was negative. His mental status began to improve begining ___ as his tremors resolved and his Na improved to the 130s. The patient would benefit from futher evaulation and work up of his subacute change in mental status once his urinary tract infection has been treated. He remains oriented x2-3 with intermittent periods of agitation and confusion. #Klebsiella UTI: Positive UA and similar presentation to prior. Was started on Cipro at first given recent sensitive urine cultures. However, has h/o ESBL organisms. Per previous neuro note, cipro increased myoclonic jerking, so changed to Meropenem pending urine culture. Also monitoring PVR given known retention, currently in the 200s. The culture was later Cipro sensitive and was switched back (following discussion with the patients daughter that stated she believes it was the UTI and not the cipro that makes him jerking more pronounced). The patient has no further episodes of myoclonic jerking. He was discharged on oral Cipro to complete a ___cute diastolic CHF: CXR with pulmonary edema and troponin leak. Continued on BB and statin. Given IV lasix with good results. The patient was resumed on his home dose of Lasix 20mg daily on discharge. Weight is 185. # Hypernatremia: In the setting of diruresis and poor water intake the pts Na went up to 147. He became increasingly lethargic. He was given 2L of free water and his Na and mental status appeared to improve over the same time course. Sodium on discharge is 141. # Myoclonic jerking: Of hands, neck, and face. Discussed with daughter and this increases with UTI. Has been seen by neuro in the past for this. Although prior notes have recommended avoiding Fluoroquinolones the patients jerking appeared to improve in the setting of UTI tx and free water correction. No further episodes of myoclnic jerking on discharge. # Urinary Retention: The pt was noted to have cloudy urine. A foley was attempted by nursing but unsuccesful. Urology was consulted on ___ and a foley was placed for acute urinary retention. The patient has a history of increased urinary tract infections when he had a chronic foley catheter therefore the decision had been made in ___ to discontinue the ___. The patient had his foley removed this admission and had post void residuals checked which were less than 200cc. He was discharged home WITHOUT a foley in place. #Depression and anxiety: Severe per prior notes and geriatrics. The patient continued to express depressive symptoms while hospitalized. He continued mirtazapine and duloxetine and may benefit from further psychiatric evaulation as an outpatient. Chronic issues: # CAD/CABG: Troponin increase with stable EKG consistent with demand ischemia in setting of CHF and UTI. trending. Continued ASA, BB, statin # Hypertension: Continued home Metoprolol #Hyperlipidemia: Continued statin # Diabetes mellitus: Diet controlled on SSI while hospitalized. - Diabetic diet. Transitional issues: ***Known right kidney mass: Concerning for RCC and stable on recent CT scan and renal ultrasound. Being followed by Urology as outpatient - Patient was discharged without a foley catheter- this should only be placed for urinary retention with PVR >500cc per urology. - Should have continued follow up with PCP for ___ of agitation and depression Medications on Admission: The Preadmission Medication list may be inaccurate and requires futher investigation. 1. Acetaminophen 650 mg PO Q8H:PRN pain 2. Aspirin 81 mg PO DAILY 3. Atorvastatin 80 mg PO DAILY 4. Bisacodyl 5 mg PO DAILY constipation 5. Calcium Carbonate 500 mg PO DAILY 6. Docusate Sodium 100 mg PO BID 7. Duloxetine 30 mg PO DAILY 8. Fleet Enema ___AILY:PRN constipation 9. Metoprolol Succinate XL 25 mg PO DAILY 10. Milk of Magnesia 30 mL PO Q6H:PRN constipation 11. Mirtazapine 15 mg PO HS 12. Multivitamins 1 TAB PO DAILY 13. Omeprazole 20 mg PO DAILY 14. Polyethylene Glycol 17 g PO DAILY 15. Senna 2 TAB PO BID 16. Vitamin D 1000 UNIT PO DAILY 17. Ampicillin 500 mg PO Q6H Take this medication one pill (500mg) every 6 hours. 18. Ascorbic Acid ___ mg PO DAILY 19. Furosemide 20 mg PO DAILY Taken from OMR- the patient does not know his medications. Discharge Medications: 1. Acetaminophen 650 mg PO Q8H:PRN pain 2. Ascorbic Acid ___ mg PO DAILY 3. Aspirin 81 mg PO DAILY 4. Atorvastatin 80 mg PO DAILY 5. Bisacodyl 5 mg PO DAILY constipation 6. Calcium Carbonate 500 mg PO DAILY 7. Docusate Sodium 100 mg PO BID 8. Duloxetine 30 mg PO DAILY 9. Fleet Enema ___AILY:PRN constipation 10. Furosemide 20 mg PO DAILY 11. Metoprolol Succinate XL 25 mg PO DAILY 12. Milk of Magnesia 30 mL PO Q6H:PRN constipation 13. Mirtazapine 30 mg PO HS 14. Multivitamins 1 TAB PO DAILY 15. Omeprazole 20 mg PO DAILY 16. Polyethylene Glycol 17 g PO DAILY 17. Senna 2 TAB PO BID 18. Vitamin D 1000 UNIT PO DAILY 19. OLANZapine (Disintegrating Tablet) 2.5-5 mg PO BID:PRN agitation RX *olanzapine [Zyprexa Zydis] 5 mg ___ tablet,disintegrating(s) by mouth BID PRN Disp #*14 Tablet Refills:*0 20. Ciprofloxacin HCl 500 mg PO Q12H Duration: 2 Days RX *ciprofloxacin 500 mg 1 tablet(s) by mouth twice a day Disp #*4 Tablet Refills:*0 Discharge Disposition: Home With Service Facility: ___ Discharge Diagnosis: Klebsiella UTI Urinary Retention Acute encephalopathy Acute on chronic diastolic CHF CAD/CABG Hypotonic bladder BPH Discharge Condition: Mental Status: Confused - sometimes. Level of Consciousness: Lethargic but arousable. Activity Status: Out of Bed with assistance to chair or wheelchair. Discharge Instructions: It was a pleasure taking care of you during your recent admission to ___. You were admitted with confusion and weakness and found to have a recurrent urinary tract infection and heart failure. You were treated with antibiotics and improved. You also had a bladder catheter for a short time. This was removed prior to discharge. For your heart failure, you were treated with IV furosemide. You no longer need oxygen and you should take the same dose of furosemide you were taking prior to admission. You will need to take 2 additional days of antibiotics after discharge. Followup Instructions: ___
19713162-DS-11
19,713,162
24,044,018
DS
11
2142-01-26 00:00:00
2142-01-26 11:14:00
Name: ___ Unit No: ___ Admission Date: ___ Discharge Date: ___ Date of Birth: ___ Sex: M Service: ORTHOPAEDICS Allergies: Codeine Attending: ___ Chief Complaint: cellulitis to right leg (s/p R TKA on ___ Major Surgical or Invasive Procedure: None during this admission History of Present Illness: ___ year old male Past Medical History: hyperlipidemia Social History: ___ Family History: Mother died of MI at age ___. Brother died age ___ of MI. Brother had bypass ___ years ago. Physical Exam: Well appearing in no acute distress Afebrile with stable vital signs Pain well-controlled Respiratory: CTAB Cardiovascular: RRR Gastrointestinal: NT/ND Genitourinary: Voiding independently Neurologic: Intact with no focal deficits Psychiatric: Pleasant, A&O x3 Musculoskeletal Lower Extremity: * Cellulitis right lower extremity, improving within marked borders * Aquacel dressing C/D/I * Thigh full but soft * No calf tenderness * ___ strength * SILT, NVI distally * Toes warm Pertinent Results: ___ 06:45AM BLOOD WBC-9.6 RBC-3.15* Hgb-10.0* Hct-29.9* MCV-95 MCH-31.7 MCHC-33.4 RDW-12.2 RDWSD-42.5 Plt ___ ___ 06:40AM BLOOD WBC-9.7 RBC-3.06* Hgb-9.7* Hct-29.1* MCV-95 MCH-31.7 MCHC-33.3 RDW-12.3 RDWSD-42.6 Plt ___ ___ 06:10AM BLOOD WBC-8.9 RBC-3.17* Hgb-10.2* Hct-30.8* MCV-97 MCH-32.2* MCHC-33.1 RDW-12.1 RDWSD-43.0 Plt ___ ___ 08:00PM BLOOD WBC-10.0 RBC-3.18* Hgb-10.5* Hct-31.0* MCV-98 MCH-33.0* MCHC-33.9 RDW-12.0 RDWSD-42.4 Plt ___ ___ 08:00PM BLOOD Neuts-75.3* Lymphs-10.8* Monos-12.4 Eos-0.3* Baso-0.4 Im ___ AbsNeut-7.51* AbsLymp-1.08* AbsMono-1.24* AbsEos-0.03* AbsBaso-0.04 ___ 08:00PM BLOOD ___ PTT-31.5 ___ ___ 06:45AM BLOOD Creat-0.6 ___ 06:10AM BLOOD Glucose-224* UreaN-9 Creat-0.6 Na-137 K-4.9 Cl-103 HCO3-23 AnGap-11 ___ 07:40PM BLOOD Glucose-182* UreaN-10 Creat-0.8 Na-137 K-4.4 Cl-98 HCO3-23 AnGap-16 ___ 06:10AM BLOOD Calcium-8.5 Phos-3.8 Mg-2.0 ___ 06:10AM BLOOD CRP-187.2* ___ 07:40PM BLOOD CRP-267.7* ___ 01:25PM BLOOD Vanco-4.7* ___ 10:13PM BLOOD Lactate-1.2 ___ 07:46PM BLOOD Lactate-3.5* Brief Hospital Course: The patient was admitted to the Orthopaedic surgery service for cellulitis of the right leg (had his right knee replaced on ___. Patient was started on IV antibiotics - Ancef & Vancomycin. Postoperative course was remarkable for the following: HD#2, the patient was started on Gabapentin for complaints of sharp, burning pain. He was also given a steroid cream for a rash on his back (not correlated to the antibiotics). HD#3, vanco trough was 4.7 and dose was increased to 1500mg Q12. Cellulitis was improving and patient continued IV Antibiotics for additional 24 hours. HD#4, cellulitis continued to improve. Patient was transitioned to oral antibiotics upon discharge (Keflex ___ QID x 2 weeks). Otherwise, pain was controlled with oral pain medications. The patient received Lovenox daily for DVT prophylaxis. The surgical dressing will remain in place until ___. The patient was seen daily by physical therapy. Labs were checked throughout the hospital course and repleted accordingly. At the time of discharge the patient was afebrile with stable vital signs. The patient's hematocrit was acceptable and pain was adequately controlled on an oral regimen. The patient's weight-bearing status is weight bearing as tolerated on the operative extremity with no range of motion restrictions. Please use walker or 2 crutches, wean as able. Mr. ___ is discharged to home with services in stable condition. Medications on Admission: 1. Lisinopril 5 mg PO DAILY 2. Nitroglycerin SL 0.4 mg SL Q5MIN:PRN chest pain 3. Rosuvastatin Calcium 40 mg PO QPM 4. Vitamin D 1000 UNIT PO DAILY 5. Acetaminophen 1000 mg PO Q8H 6. Docusate Sodium 100 mg PO BID:PRN Constipation - First Line 7. Senna 8.6 mg PO BID:PRN Constipation - First Line 8. Metoprolol Succinate XL 150 mg PO DAILY 9. Enoxaparin Sodium 40 mg SC Q24H 10. Aspirin 81 mg PO DAILY 11. OxyCODONE (Immediate Release) ___ mg PO Q4H:PRN Pain Discharge Medications: 1. Cephalexin 500 mg PO Q6H 2. Gabapentin 100 mg PO TID 3. Acetaminophen 1000 mg PO Q8H 4. Docusate Sodium 100 mg PO BID:PRN Constipation - First Line 5. Enoxaparin Sodium 40 mg SC Q24H 6. Lisinopril 5 mg PO DAILY 7. Metoprolol Succinate XL 150 mg PO DAILY 8. Nitroglycerin SL 0.4 mg SL Q5MIN:PRN chest pain 9. OxyCODONE (Immediate Release) ___ mg PO Q4H:PRN Pain 10. Rosuvastatin Calcium 40 mg PO QPM 11. Senna 8.6 mg PO BID:PRN Constipation - First Line 12. Vitamin D 1000 UNIT PO DAILY 13. HELD- Aspirin 81 mg PO DAILY This medication was held. Do not restart Aspirin until Lovenox course completed. Discharge Disposition: Home With Service Facility: ___ Discharge Diagnosis: cellulitis to right leg (s/p R TKA on ___ Discharge Condition: Mental Status: Clear and coherent. Level of Consciousness: Alert and interactive. Activity Status: Ambulatory - requires assistance or aid (walker or cane). Discharge Instructions: Weigh yourself every morning, call MD if weight goes up more than 3 lbs. 1. Please return to the emergency department or notify your physician if you experience any of the following: severe pain not relieved by medication, increased swelling, decreased sensation, difficulty with movement, fevers greater than 101.5, shaking chills, increasing redness or drainage from the incision site, chest pain, shortness of breath or any other concerns. 2. Please follow up with your primary physician regarding this admission and any new medications and refills. 3. Resume your home medications unless otherwise instructed. 4. You have been given medications for pain control. Please do not drive, operate heavy machinery, or drink alcohol while taking these medications. As your pain decreases, take fewer tablets and increase the time between doses. This medication can cause constipation, so you should drink plenty of water daily and take a stool softener (such as Colace) as needed to prevent this side effect. Call your surgeons office 3 days before you are out of medication so that it can be refilled. These medications cannot be called into your pharmacy and must be picked up in the clinic or mailed to your house. Please allow an extra 2 days if you would like your medication mailed to your home. 5. You may not drive a car until cleared to do so by your surgeon. 6. Please call your surgeon's office to schedule or confirm your follow-up appointment. 7. SWELLING: Ice the operative joint 20 minutes at a time, especially after activity or physical therapy. Do not place ice directly on the skin. You may wrap the knee with an ace bandage for added compression. Please DO NOT take any non-steroidal anti-inflammatory medications (NSAIDs such as Celebrex, ibuprofen, Advil, Aleve, Motrin, naproxen etc) until cleared by your physician. 8. ANTICOAGULATION: Please continue your Lovenox for four (4) weeks to help prevent deep vein thrombosis (blood clots). If you were taking Aspirin prior to your surgery, you should hold this medication while on the one-month course of anticoagulation medication. 9. WOUND CARE: Remove Aquacel dressing on ___. Dry sterile dressing changes daily as needed for drainage after Aquacel is removed. Check wound regularly for signs of infection such as redness or thick yellow drainage. Staples will be removed by your doctor at follow-up appointment approximately 2 weeks after surgery. 10. ___ (once at home): Home ___, dressing changes as instructed, and wound checks. 11. ACTIVITY: Weight bearing as tolerated on the operative extremity. Two crutches or walker. Wean assistive device as able. Mobilize. ROM as tolerated. No strenuous exercise or heavy lifting until follow up appointment. Physical Therapy: WBAT RLE ROMAT Wean assistive device as able (i.e. 2 crutches or walker) Mobilize frequently Treatments Frequency: remove Aquacel dressing on ___ wound checks daily dry sterile dressing changes daily as needed after aquacel removed ice and elevation Followup Instructions: ___
19713183-DS-13
19,713,183
25,629,356
DS
13
2195-07-06 00:00:00
2195-07-06 17:05:00
Name: ___ Unit No: ___ Admission Date: ___ Discharge Date: ___ Date of Birth: ___ Sex: F Service: MEDICINE Allergies: Penicillins / Keflex Attending: ___. Chief Complaint: Chest Pain Major Surgical or Invasive Procedure: cardiac catheterization with 2 drug eluting stents to the proximal left anterior descending artery History of Present Illness: This patient is a ___ year old female who presented with CC of CP. The patient was in her usual state of health when at 1240 she got up to answer the doorbell and on getting back developed non-radiating ___ CP with diaphoresis. She called the ambulance and presented to the ED. En-route she got a 12-lead EKG which revealed ST-elevations in V1-3, 1, AVL, AVR and reciprocal changes in 2, 3, AVF and V4-6. In the ED she got ASA and fentanyl which helped the pain. She denied any shortness of breath or back pain or any preivous hx of CP/angina. She went to the cath lab for primary PCI. . On review of systems, s/he denies any prior history of stroke, TIA, deep venous thrombosis, pulmonary embolism, bleeding at the time of surgery, cough, hemoptysis, black stools or red stools. S/he denies recent fevers, chills or rigors. S/he denies exertional buttock or calf pain. All of the other review of systems were negative. . Cardiac review of systems is notable for absence of chest pain, paroxysmal nocturnal dyspnea, orthopnea, ankle edema, palpitations, syncope or presyncope. Past Medical History: 1. CARDIAC RISK FACTORS: + Diabetes, + Dyslipidemia, + Hypertension 2. OTHER PAST MEDICAL HISTORY: - s/p hysterectomy - severe degenerative arthritis - s/p hip replacements X 2, knee replacements X 2 - Rt ankle underwent cutdown in ___ - recurrent venous stasis ulcerations of her right medial ankle - Hx of colitis and pseudopolyps Social History: ___ Family History: Father died of CAD at ___ Physical Exam: On Admission: GENERAL: NAD. Oriented x3. Mood, affect appropriate. HEENT: NCAT. Sclera anicteric. PERRL, EOMI. Conjunctiva were pink, no pallor or cyanosis of the oral mucosa. No xanthalesma. NECK: Supple with JVP not visualised. CARDIAC: PMI located in ___ intercostal space, midclavicular line. RR, normal S1, S2. No m/r/g. No thrills, lifts. No S3 or S4. LUNGS: No chest wall deformities, scoliosis or kyphosis. Resp were unlabored, no accessory muscle use. CTAB, no crackles, wheezes or rhonchi. ABDOMEN: Soft, NTND. No HSM or tenderness. Abd aorta not enlarged by palpation. No abdominial bruits. EXTREMITIES: No c/c/e. No femoral bruits. SKIN: No stasis dermatitis, ulcers, scars, or xanthomas. NEURO: AAOx3, CNII-XII intact, ___ strength biceps, triceps, wrist, knee/hip flexors/extensors, 2+ reflexes biceps, brachioradialis, patellar, ankle. PULSES: Right: Carotid 2+ Femoral 2+ Popliteal 2+ DP 2+ ___ 2+ Left: Carotid 2+ Femoral 2+ Popliteal 2+ DP 2+ ___ 2+ On Discharge: GENERAL: ___ yo F in no acute distress, sitting up in chair HEENT: mucous membs moist, no lymphadenopathy, JVP 2 cm above clavicle CHEST: ctab CV: S1 S2, ? S3 ABD: soft, non-tender, non-distended, BS normoactive. EXT: wwp, no edema. DPs, PTs 1+. NEURO: CNs II-XII intact. ___ strength in U/L extremities. SKIN: no rash PSYCH: alert, anxious Pertinent Results: ___ 01:40PM BLOOD WBC-7.9 RBC-4.18* Hgb-12.6 Hct-36.1 MCV-86 MCH-30.1 MCHC-34.8 RDW-13.4 Plt ___ ___ 10:35PM BLOOD Hct-31.1* Plt ___ ___ 05:25AM BLOOD WBC-8.1 RBC-4.07* Hgb-12.2 Hct-34.5* MCV-85 MCH-30.1 MCHC-35.5* RDW-13.0 Plt ___ ___ 03:28AM BLOOD WBC-10.2 RBC-4.09* Hgb-12.1 Hct-35.0* MCV-86 MCH-29.7 MCHC-34.6 RDW-13.4 Plt ___ ___ 07:05AM BLOOD WBC-8.4 RBC-3.91* Hgb-11.8* Hct-34.3* MCV-88 MCH-30.2 MCHC-34.4 RDW-13.5 Plt ___ ___ 07:29AM BLOOD WBC-5.7 RBC-3.60* Hgb-10.6* Hct-32.9* MCV-92 MCH-29.6 MCHC-32.3 RDW-13.7 Plt ___ ___ 01:40PM BLOOD ___ PTT-28.9 ___ ___ 03:28AM BLOOD ___ PTT-33.6 ___ ___ 07:05AM BLOOD ___ ___ 07:29AM BLOOD ___ ___ 05:25AM BLOOD Glucose-140* UreaN-16 Creat-0.4 Na-136 K-3.5 Cl-99 HCO3-22 AnGap-19 ___ 07:29AM BLOOD Glucose-130* UreaN-20 Creat-0.5 Na-139 K-3.8 Cl-108 HCO3-23 AnGap-12 ___ 10:35PM BLOOD CK(CPK)-541* ___ 03:28AM BLOOD CK(CPK)-298* ___ 01:40PM BLOOD cTropnT-0.02* ___ 05:25AM BLOOD CK-MB-39* MB Indx-7.2* cTropnT-1.42* ___ 03:28AM BLOOD CK-MB-14* MB Indx-4.7 cTropnT-0.77* . Imaging ___ Cardiac Catheterization 1. Anterior STEMI with thrombotic occlusion of the proximal LAD. 2. Severe LCX (distal OM) disease and totally occluded RCA. 3. Severe proximal right common iliac calcific stenosis. 4. Dual antiplatelet therapy for at least 12 months. 5. Successful treatment of the culprit lesion (90% in proximal LAD and a hazy 60% tandem stenosis) with deployment of a 3.0 x 12 mm and 2.5 x 8 mm Resolute stents in overlapped fashion leaving no residual satenoses in the treated segment. . ___ Echocardiogram The left atrium is mildly dilated. The estimated right atrial pressure is ___ mmHg. Left ventricular wall thicknesses are normal. The left ventricular cavity size is normal. Overall left ventricular systolic function is severely depressed (LVEF= ___ %) secondary to akinesis of the apex, and distal segments of all LV walls, and hypokinesis of the mid segments. The basal segments are hyperdynamic. No masses or thrombi are seen in the left ventricle. Right ventricular chamber size is normal. with focal hypokinesis of the apical free wall. The ascending aorta is mildly dilated. The aortic arch is mildly dilated. The aortic valve leaflets (3) are mildly thickened but aortic stenosis is not present. Trace aortic regurgitation is seen. The mitral valve appears structurally normal with trivial-mild mitral regurgitation. There is moderate pulmonary artery systolic hypertension. There is no pericardial effusion. IMPRESSION: Severe focal and global left ventricular function involving predominantly the mid-distal LV segments c/w Takotsubo or ischemic cardiomyopathy (multivessel CAD). Moderate pulmonary artery systolic hypertension. . ___ ECG Artifact is present. Sinus rhythm. The P-R interval is 200 milliseconds. There is ST segment elevation in the anterior leads consistent with acute myocardial infarction. There are reciprocal changes in the inferior and anterolateral leads ___ US: FINDINGS: Targeted sonogram was performed to the right groin in the region of recent cardiac catheterization, demonstrating a 4 x 3.6 x 1.8 cm hematoma. Just medial to this, there is apparent contiguity between the common femoral vein and proximal superficial femoral artery, with arterialized venous flow in this region, consistent with an arteriovenous fistula. No pseudoaneurysm is demonstrated. IMPRESSION: 1. Findings concerning for arteriovenous fistula between proximal superficial femoral artery and common femoral vein. 2. Large right groin hematoma. On Discharge: Brief Hospital Course: Ms. ___ is a ___ year old woman with diabetes, hypertension, and hyperlipidemia who presented with a STEMI. She received two drug eluting stents to the proximal LAD. . # Anterior STEMI s/p DES to pLAD: ___ year old female with diabetes, but no cardiac history who was in her usual state of health until around 12 ___ on the day of admission when she developed the acute onset of subseternal chest pain EMS was called, and a 12 lead ECG demonstrated ST elevations in I, avL, V1-V3, with ST depressions in II, III, aVF, V5-V6. The patient was taken emergently to the cath lab where there was a thrombotic appearing lesion in the proximal LAD prior to the first diagonal, as well as a lesion in the distal LCx that was not thought to be the culprit, and a totally occluded proximal RCA with left to right collaterals. The patient's LAD lesion was stented with good result, and resolution of her ECG changes. The patient was hemodynamically stable post-procedure and without chest pain, shortness of breath, palpitations or orthopnea. Her ECG revealed resolution of anterior STE but there were residual 1 mm STD in inferior and lateral precordial leads. An echo demonstrated severely depressed left ventricular systolic function with EF ___ % from akinesis of the apex, and distal segments of all LV walls, and hypokinesis of the mid segments. She will remain on plavix for at least ___ year, aspirin indefinitely although the dose can be decreased from 325 to 81mg at one month post stenting, lisinopril that can be increased to 10 mg as tolerated, metoprolol XL that can be increased as tolerated, atorvastatin, SL nitro prn, and warfarin. Of note, after intervention, pt did have right groin bleeding with an enlargening ecchymosis necessitating epi injection which stopped bleeding temporarily. There has been some oozing, but this has stabilized. . # Apical Akinesis: After echo results discussed above, it was decided to start patient on lovenox and warfarin to prevent left ventricular thrombus from apical and distal akinesis. Pt initially started on warfarin 5 mg, but due to brisk INR response, this was decreased to 2.5 mg. The patient was not discharged on Lovenox, given a therapuetic INR. Decision to continue anticoagulation will be left to primary cardiologist after repeat echo to see if there is apical recovery. . # Acute Systolic Heart Failure: Post MI, her echocardigram showed an ejection fraction of ___ with complete akinesis of the apex and distal segments, and hypokinesis of the mid segments . She was given IV lasix that was transitioned to PO lasix 20 mg. She was given heart failure teaching. She was initiated on lisinopril and metoprolol. . # Hypertension: She was placed on an ace inhibitor and metoprolol. . # HLD: high dose atorvastatin as above . # Diabetes mellitus: Pt was switched to ISS in house. Discharged on home metformin. . # CODE: Ms. ___ code status was DNR/DNI during this admission. . Transitional Issues - One month of aspirin 325 mg for 1 month and then reduce to aspirin 81 mg at follow-up. - Can increase metoprolol and lisinopril for HR, blood pressure, and MI/CHF as tolerated. Good HR control takes precedence. - Repeat echo in ___ months to evaluate for recovery of LV function and specifically apical function to assess need for continued anticoagulation Medications on Admission: - atenolol 25mg one daily - simvastatin 20 mg HS - percocet ___ one tab QID - metformin 500 BID - neopolydex eye drops one gtt right eye BID for 30 days - lidoderm patch 5% one patch daily for 12 hours - ofloxacin 0.3% one gtt BID daily for 30 days (filled one month ago) - trazadone 100mg one tab at bedtime - trizmterene HCTZ ___ one daily - triamcinalone cream 0.25% top BID for rash on hand Discharge Medications: 1. aspirin 325 mg Tablet, Delayed Release (E.C.) Sig: One (1) Tablet, Delayed Release (E.C.) PO DAILY (Daily). 2. clopidogrel 75 mg Tablet Sig: One (1) Tablet PO DAILY (Daily). 3. oxycodone-acetaminophen ___ mg Tablet Sig: One (1) Tablet PO four times a day as needed for pain. 4. atorvastatin 80 mg Tablet Sig: One (1) Tablet PO DAILY (Daily). 5. docusate sodium 100 mg Capsule Sig: One (1) Capsule PO BID (2 times a day). 6. lidocaine 5 %(700 mg/patch) Adhesive Patch, Medicated Sig: One (1) Adhesive Patch, Medicated Topical DAILY (Daily). 7. nitroglycerin 0.4 mg Tablet, Sublingual Sig: One (1) Tablet, Sublingual Sublingual ASDIR (AS DIRECTED) as needed for chest pain. 8. lisinopril 5 mg Tablet Sig: One (1) Tablet PO DAILY (Daily): HOld SBP < 100. 9. trazodone 100 mg Tablet Sig: One (1) Tablet PO HS (at bedtime) as needed for insomnia. 10. metformin 500 mg Tablet Sig: One (1) Tablet PO twice a day. 11. furosemide 20 mg Tablet Sig: One (1) Tablet PO once a day. 12. warfarin 2.5 mg Tablet Sig: One (1) Tablet PO once a day. 13. metoprolol succinate 50 mg Tablet Extended Release 24 hr Sig: One (1) Tablet Extended Release 24 hr PO once a day. Discharge Disposition: Extended Care Facility: ___ Discharge Diagnosis: ST Elevation myocardial infarction New Acute systolic congestive heart failure Hypertension Dyslipidemia Diabetes Mellitus Discharge Condition: Mental Status: Clear and coherent. Level of Consciousness: Alert and interactive. Activity Status: Ambulatory - requires assistance or aid (walker or cane). Discharge Instructions: It was a pleasure taking care of you at ___. You had chest pain and an ECG showed that you were having a heart attack. You were brought to ___ and taken to the catheterization lab and a blockage was found in one of your large heart arteries. The blockage was cleared and two drug eluting stents were placed to keep the artery open. It is extrememely important that you take aspirin and clopidogrel (Plavix) every day without fail to prevent the stents from clotting off and causing another heart attack. Do not stop taking aspirin and clopidogrel (Plavix) or miss any doses unless Dr. ___ you it is OK. Your right groin area will be bruised and sore for a few weeks. You should call the Heartline if you notice that it has started bleeding again or the soreness and swelling worsens. You heart is weaker after the heart attack and you needed some medicine to remove extra fluid in the hospital. You will need to watch your weight carefully every day to make sure that you are not retaining fluid again. Weigh yourself every morning before breakfast and call Dr. ___ you notice that your weight is increasing more than 3 pounds in 1 day or 5 pounds in 3 days. You also need to follow a low sodium diet. Information about this was given to you. . We made the following changes to your medicines: 1. START taking aspirin (325 mg) and Clopidogrel every day to prevent the stents from clotting off 2. STOP taking simvastatin, take atorvastatin instead to lower your cholesterol for now. 3. Take nitroglycerin as needed for chest pain 4. Take colace as needed for constipation 5. STOP taking Atenolol, take metoprolol instead to lower your heart rate and help your heart pump better 6. STOP taking triamterene/HCTZ for your blood pressure 7. START taking warfarin to prevent a blood clot long term, you will need to get your warfarin level )INR) checked frequently to make sure it is more than 2.0 and less than 3.0. 8. START taking lisinopril to help your heart recover from the heart attack. Followup Instructions: ___
19713183-DS-15
19,713,183
25,072,624
DS
15
2197-04-11 00:00:00
2197-04-11 22:44:00
Name: ___ Unit No: ___ Admission Date: ___ Discharge Date: ___ Date of Birth: ___ Sex: F Service: MEDICINE Allergies: Penicillins / Keflex Attending: ___. Chief Complaint: chest pressure Major Surgical or Invasive Procedure: cardiac catheterization History of Present Illness: ___ yo F with h/o CAD s/p ant STEMI in ___ s/p 2 DES to LAD, HTN, HLD, CHF (EF ___, DM presenting with chest pressure. Recent URI (bad cough) 3 days ago, now with DOE and chest pressure. Trops elevated to 0.14, EKG notable for new TWIs V2-V6, 1, aVL, and inferiorly. Patient currently CP free and HD stable. Of note, pt recalls having "massive explosion in my chest" during her STEMI in ___, unlike her current symptoms. In the ED, initial vitals were Pain 0 T97.5 P73 BP106/54 RR10 O2 sat 95%. Labs were significant for TnT 0.14, AG 17 with a Lactate of 3.3. CXR showed. EKG showed NSR, borderline ___ AVB (PR 202), diffuse TWI I/aVL, V2-V6, II/III/aVF. Patient was dx with NSTEMI given recommend ASA 325, heparin gtt and admitted to ___. Denies any recent fevers/chills, rigors, myalgias. Past Medical History: 1. CARDIAC RISK FACTORS: +Diabetes, +Dyslipidemia, +Hypertension 2. CARDIAC HISTORY: - CABG: - PERCUTANEOUS CORONARY INTERVENTIONS: ___ 2 to LAD - PACING/ICD: 3. OTHER PAST MEDICAL HISTORY: CHF (EF ___ 1. Cardiac disease as above. 2. AV fistula in the right groin, followed by Dr. ___, ___ status ___ open ligation of AV fistula ___. 3. Hypertension. 4. Hyperlipidemia. 5. Hysterectomy. 6. Left hip replacement. 7. Bilateral knee replacements. 8. Laminectomy. 9. Cataract surgery Social History: ___ Family History: Father died of CAD at ___. No family history of early MI, arrhythmia, cardiomyopathies, or sudden cardiac death; otherwise non-contributory. Physical Exam: admission exam VS: Wt=71.2kg (156.64lb) T= 98 BP=119/60 HR=81 RR=20 O2 sat= 96% RA General: no acute distress, lying comfortably in bed, speaking full sentences HEENT: NCAT, EOMI, PERRL Neck: no JVP elevation CV: rrr, normal S1 and S2, no m/r/g Lungs: ctab, good respiratory effort Abdomen: soft, nd, nt, +bs GU: no foley Ext: wwp, trace edema in L ankle (c/w baseline), no edema in R ankle Neuro: mentating well Skin: intact PULSES: 2+ distal pulses discharge exam VS: 98.9 122/61 (92/51-123/81) 70s 19 98% RA weight 75.7kg I/O - 1080/2275 (24H), ___ (8H) General: no acute distress, sitting comfortably in bed HEENT: NCAT, EOMI, PERRL Neck: JVP does not appear elevated CV: rrr, normal S1 and S2, no m/r/g Lungs: ctab, good respiratory effort Abdomen: soft, nd, nt, +bs GU: no foley Ext: wwp, no edema. left groin site with no hematoma or bruit. dressing c/d/i. PULSES: 2+ distal pulses Pertinent Results: admission labs ___ 10:55AM BLOOD WBC-10.2# RBC-3.94*# Hgb-12.0# Hct-37.1# MCV-94 MCH-30.4 MCHC-32.3 RDW-13.3 Plt ___ ___ 10:55AM BLOOD Neuts-72.2* ___ Monos-5.5 Eos-2.9 Baso-0.6 ___:44PM BLOOD ___ PTT-40.5* ___ ___ 10:55AM BLOOD Glucose-160* UreaN-22* Creat-0.7 Na-139 K-3.7 Cl-102 HCO3-20* AnGap-21* ___ 10:55AM BLOOD proBNP-5737* ___ 04:00AM BLOOD Albumin-3.5 Calcium-8.5 Phos-3.2# Mg-1.5* ___ 11:03AM BLOOD Lactate-3.3* ___ 10:55AM BLOOD cTropnT-0.14* ___ 07:44PM BLOOD cTropnT-0.11* ___ 05:50AM BLOOD cTropnT-0.14* discharge labs ___ 05:50AM BLOOD Hct-35.1* Plt ___ ___ 05:50AM BLOOD Glucose-130* UreaN-11 Creat-0.6 Na-138 K-4.0 Cl-103 HCO3-25 AnGap-14 ___ 05:50AM BLOOD Calcium-8.9 Phos-4.2 Mg-1.9 micro: URINE CULTURE (Final ___: ESCHERICHIA COLI. >100,000 ORGANISMS/ML.. _________________________________________________________ ESCHERICHIA COLI | AMPICILLIN------------ <=2 S AMPICILLIN/SULBACTAM-- <=2 S CEFAZOLIN------------- <=4 S CEFEPIME-------------- <=1 S CEFTAZIDIME----------- <=1 S CEFTRIAXONE----------- <=1 S CIPROFLOXACIN---------<=0.25 S GENTAMICIN------------ <=1 S MEROPENEM-------------<=0.25 S NITROFURANTOIN-------- <=16 S PIPERACILLIN/TAZO----- <=4 S TOBRAMYCIN------------ <=1 S TRIMETHOPRIM/SULFA---- <=1 S admission ECG: EKG showed NSR, borderline ___ AVB (PR 202), diffuse TWI I/aVL, V2-V6, II/III/aVF CXR: Trace bilateral pleural effusions. Mild bibasilar atelectasis ECHO: ___ The left atrium is mildly dilated. Left ventricular wall thicknesses and cavity size are normal. There is mild to moderate regional left ventricular systolic dysfunction with mild hypokinesis of the distal half of the inferolateral and inferoseptal walls, and apex. The remaining segments contract well (LVEF 45-50%). No mass/thrombus is seen in the left ventricle. A small perimembranous ventricular septal defect is suggested (clips 34, 43, 62). No muscular VSD is suggested. Right ventricular chamber size and free wall motion are normal. The ascending aorta and aortic arch are mildly dilated. The aortic valve leaflets (3) are mildly thickened but aortic stenosis is not present. Trace aortic regurgitation is seen. The mitral valve leaflets are structurally normal. No mitral regurgitation is seen. The estimated pulmonary artery systolic pressure is high normal. There is a trivial/physiologic pericardial effusion. IMPRESSION: Normal left ventricular cavity size with regional systolic dysfunction c/w CAD. Dilated thoracic aorta. Possible small perimembranous VSD. Dilated ascending aorta. Compared with the prior study (images reviewed) of ___ overall left ventricular dysfunction is markedly improved and the estimated PA systolic pressure is now much lower. A possible small perimembranous VSD is now suggested (the area was not as well examined on the prior study and is not reported on the ___ of ___. The area was also not examined on the prior OR TEE of ___. If clinically indicated a TEE or TTE with saline contrast may allow for the clarification of the possible perimembranous VSD. If the patient is going for left heart catheterization, a left ventriculogram would also allow for a more definitive diagnosis. If a right heart catheterization is going to be performed, a saturation run is suggested, though the defect/flow is very small. Cardiac catheterization ___ 1.Severe two vessel CAD. 2.Known CTO RCA. Progression of severe diffuse LCX and Om1. 3.Successful PTCA and stenting of the LCX as described above with deployment of 3 overlapping DESs, with excellent result. 4.Successful deployment of ___ AngioSeal to the L CF arteriotomy. 5.ASA 325 mg po daily x1 month then 81 mg daily indefinitely. 6.Clopidogrel 75 mg po daily x12 months minimum. 7.Hydration and ___ renal function. 8.No step-up in O2 saturation. Therefore, if indeed a membranous VSD suspected on TTE is present, it is likely hemodynamically insignificant. Brief Hospital Course: ___ yo F with h/o CAD s/p ant STEMI in ___ s/p 2 DES to LAD, HTN, HLD, CHF (EF ___, DM presenting with NSTEMI. # NSTEMI: Patient presented with shortness of breath and some chest pressure. ECG showed diffuse TWI I/aVL, V2-V6, II/III/aVF. Troponin noted to be 0.14. Patient was treated for ACS with ASA, plavix, atorastatin, beta blocker, and a heparin gtt. ECHO showed normal left ventricular cavity size with regional systolic dysfunction c/w CAD. Systolic dysfunction improved with EF 45-50%. Dilated thoracic aorta. Possible small perimembranous VSD. Dilated ascending aorta. She ultimately underwent a cardiac catheterization on ___ which showed severe 2 vessel disease. She had 3 overlapping DES placed in L. circumflex. She also had a right heart catheterization during this time given concern for possible perimembranous VSD. This did not she any step-up in O2 saturation. therefore, if VSD is present, it is hemodynamically insignificant. Patient tolerated the procedure well. She was instructed to continue aspirin and plavix for at least one year and discharged with plans to follow up with her outpatient cardiologist. # Chronic congestive heart failure with systolic dysfunction: LVEF ___ on previous ECHO, however repeat echo on this admission showed improvement in systolic function to 45-50%. She appeared euvolemic on exam and was continued on her current lasix dosing. She was switched from metoprolol tartrate to metoprolol succinate. She was continued on her low dose lisinopril. # HLD: continued atorvastatin 80mg daily # DM: held oral hypoglycemics. She was treated with insulin sliding scale while in house. # UTI: pt asymptomatic. UA positive. Ucx showing >100K E. coli that is pan sensitive. She completed a 3 day course of ceftriaxone. # Insomnia: Continued home trazodone and gabapentin # chronic pain: continued home percocet # transitional issues: - continue aspirin and plavix for at least ___ year - blood culture pending at time of discharge # CODE: DNR/DNI # CONTACT: Patient, Father ___ (friend): ___ Cell phone: ___ Medications on Admission: The Preadmission Medication list is accurate and complete. 1. Aspirin 81 mg PO DAILY 2. Lisinopril 1.25 mg PO DAILY 3. Furosemide 20 mg PO BID 4. Metoprolol Succinate XL 25 mg PO DAILY 5. Atorvastatin 40 mg PO DAILY 6. MetFORMIN (Glucophage) 500 mg PO BID 7. TraZODone 100 mg PO HS 8. Pantoprazole 40 mg PO Q12H 9. Gabapentin 1000 mg PO HS 10. Nitroglycerin SL 0.4 mg SL PRN chest pain 11. Percocet (oxyCODONE-acetaminophen) 5mg-500mg oral qid prn pain 12. Systane (peg 400-propylene glycol) 0.4-0.3 % ophthalmic QAM 13. Oxycodone-Acetaminophen (5mg-325mg) 1 TAB PO QD:PRN back pain Discharge Medications: 1. Aspirin 81 mg PO DAILY 2. Furosemide 20 mg PO BID 3. Gabapentin 1000 mg PO HS 4. Lisinopril 1.25 mg PO DAILY 5. Nitroglycerin SL 0.4 mg SL PRN chest pain 6. Pantoprazole 40 mg PO Q12H 7. TraZODone 100 mg PO HS 8. MetFORMIN (Glucophage) 500 mg PO BID please do not start this medication until the evening of ___ given recent cardiac catheterization 9. Metoprolol Succinate XL 25 mg PO DAILY 10. Percocet (oxyCODONE-acetaminophen) 5mg-500mg oral qid prn pain 11. Systane (peg 400-propylene glycol) 0.4-0.3 % ophthalmic QAM 12. Atorvastatin 80 mg PO DAILY 13. Clopidogrel 75 mg PO DAILY 14. Oxycodone-Acetaminophen (5mg-325mg) 1 TAB PO QD:PRN back pain Discharge Disposition: Extended Care Facility: ___ Discharge Diagnosis: primary diagnosis: non ST elevation myocardial infarcation secondary diagnosis: diabetes type 2, chronic systolic congestive heart failure Discharge Condition: Mental Status: Clear and coherent. Level of Consciousness: Alert and interactive. Activity Status: Ambulatory - requires assistance or aid (walker or cane). Discharge Instructions: Ms. ___, It was a pleasure taking care of you at the ___ ___. You were admitted here because of the concern that you had another heart attack. You were treated medically for this heart attack with a blood thinner as well as some other heart medications. You remained stable and chest pain-free during your admission. You underwent a catheterization and had 3 new DRUG ELUDING STENTS placed. It is important that you take your aspirin and plavix everyday and do not miss any doses. You were also treated for a urinary tract infection (UTI) during this hospitalization. - It is important that you continue to take your heart medications at home: aspirin, plavix, lisinopril, metoprolol, Lipitor. - For your congestive heart failure, it is important to continue to take your lasix as well as to weigh yourself every morning, call MD if weight goes up more than 3 lbs. ___ MD's Followup Instructions: ___
19713183-DS-16
19,713,183
28,197,786
DS
16
2199-06-10 00:00:00
2199-06-10 16:15:00
Name: ___ Unit No: ___ Admission Date: ___ Discharge Date: ___ Date of Birth: ___ Sex: F Service: MEDICINE Allergies: Penicillins / Keflex Attending: ___. Chief Complaint: Chest pain Major Surgical or Invasive Procedure: Cardiac catheterization with DES to LCX ___ History of Present Illness: ___ with a history of CAD s/p anterior STEMI in ___ w/ 2 DES to LAD, and NSTEMI ___ treated with 3 overlapping ___ of the LCX, mild sCHF (LVEF of 50-55%), diastolic heart failure, HLD, orothostatic hypotension, T2DM, who presents to ED with chest pain. She was watching HG TV at ___ and suddenly, felt ___ pain in chest, radiating to the back and down both shoulders. She felt clammy, had nausea with 3x episodes of vomiting. Was given 2x Sublingual nitro and aspirin with no benefit. Pain was unrelenting and patient asked to be taken to the ED. In the ED, initial vitals were: 6 97.4 87 162/77 18 97% RA and EKG showed ST elevations in the inferior leads. Was Given 324mg of Aspirin, started on heparin gtt and sent to the Cath lab. R radial arm approach was found to be tortuous and was ultimately aborted, TR band placed. L arm groin access worked, ___ sheath, 95% LCx stenosis proximal to prior stent, ballooned, then stented with DES. Sheath was left in. She was started on ticagrelor 180 loading dose. On Arrival to CCU, patient stated chest pain fully resolved after the procedure. Denied any nausea/vomiting, shortness of breath. REVIEW OF SYSTEMS: (+) per HPI Past Medical History: 1. CAD as above. 2. AV fistula in the right groin followed by Dr. ___, at ___, now status ___ ligation of AV fistula ___. 4. Hyperlipidemia. 5. Hysterectomy. 6. Left hip replacement. 7. Bilateral knee replacement. 8. Laminectomy. 9. Cataract surgery. 10. Orthostatic hypotension. 11. T2DM Social History: ___ Family History: No early CAD No family history of early MI, arrhythmia, cardiomyopathies, or sudden cardiac death; otherwise non-contributory. Physical Exam: Admission exam: VS: 97.6 73 127/49 78 14 98% Tele: Sinus GEN: pleasant Elderly female, lying in bed, no acute distress HEENT: PERRL, Moist mucous membranes, posterior oropharynx NECK: JVD not distended CV: RRR, normal S1/S2 no murmurs rubs or gallops LUNGS: Clear throughout, diminished breath sounds ABD: Non-tender, non-distended, +BS EXT: Warm, well perfused, 2+ distally SKIN: clear NEURO: CN III-XII intact Discharge exam: VS: 98.6 HR ___ BP ___ RR 18 99% RA Wt: 71 kg I/O ___ Tele: Sinus GEN: pleasant elderly female, lying in bed, no acute distress HEENT: PERRL, Moist mucous membranes, posterior oropharynx NECK: JVD not distended CV: RRR, normal S1/S2 no murmurs rubs or gallops LUNGS: Clear throughout, diminished breath sounds in bases bilaterally ABD: Non-tender, non-distended, +BS EXT: Warm, well perfused, 2+ distally SKIN: clear NEURO: CN III-XII intact Pertinent Results: Admission exam: ___ 11:12PM WBC-8.9 RBC-3.49* HGB-10.6* HCT-33.4* MCV-96 MCH-30.4 MCHC-31.7* RDW-14.2 RDWSD-49.1* ___ 11:12PM ___ PTT-32.5 ___ ___ 11:12PM ___ ___ 11:12PM LIPASE-47 ___ 11:12PM UREA N-39* CREAT-1.2* ___ 11:19PM GLUCOSE-199* LACTATE-3.6* NA+-138 K+-3.7 CL--104 TCO2-18* ___ 11:19PM HGB-11.1* calcHCT-33 O2 SAT-95 CARBOXYHB-2 MET HGB-0 ___ 02:27AM ALT(SGPT)-11 AST(SGOT)-26 LD(LDH)-210 ALK PHOS-70 TOT BILI-0.1 ___ 02:27AM CALCIUM-8.7 PHOSPHATE-4.3 MAGNESIUM-1.5* ___ 07:51AM CK-MB-26* MB INDX-7.2* cTropnT-1.06* ___ 07:51AM CK(CPK)-363* Discharge labs: ___ 07:10AM BLOOD WBC-7.0 RBC-3.10* Hgb-9.4* Hct-30.0* MCV-97 MCH-30.3 MCHC-31.3* RDW-14.6 RDWSD-51.2* Plt ___ ___ 07:10AM BLOOD Glucose-169* UreaN-16 Creat-0.8 Na-139 K-3.6 Cl-103 HCO3-22 AnGap-18 ___ 07:10AM BLOOD Calcium-8.9 Phos-4.8*# Mg-2.4 IMAGING: TTE ___ The left atrium is elongated. No atrial septal defect is seen by 2D or color Doppler. The estimated right atrial pressure is ___ mmHg. Left ventricular wall thicknesses and cavity size are normal. There is mild regional left ventricular systolic dysfunction with hypokinesis of the basal halves of the inferior and inferolateral walls. The remaining segments contract normally (LVEF = 40-45 %). The estimated cardiac index is normal (>=2.5L/min/m2). There is no ventricular septal defect. Right ventricular chamber size and free wall motion are normal. The diameters of aorta at the sinus, ascending and arch levels are normal. The aortic valve leaflets (3) are mildly thickened but aortic stenosis is not present. Trace aortic regurgitation is seen. The mitral valve leaflets are mildly thickened. There is no mitral valve prolapse. Mild (1+) mitral regurgitation is seen. There is mild pulmonary artery systolic hypertension. There is an anterior space which most likely represents a prominent fat pad. IMPRESSION: Suboptimal image quality. Normal left ventricular cavity size with regional systolic dysfunction c/w CAD (PDA distribution). Mild mitral regurgitation. Mild pulmonary artery systolic hypertension. Cath ___ Interventional Details A ___ Fr XB-3.5 guide provided good support. Heparin given and a therapeutic ACT confirmed. Crossed with moderate difficulty into the distal OM branch using a Prowater wire due to significant proximal angulation of the LCx origin complicated by proximal lesion location. The lesion was serially predilated with 2.0mm and 3.0mm balloons at ___ atm with complete expansion. A 3.0x18mm Resolute Integrity would not cross. Further predilatation was performed with a 3.0mm NC balloon at ___ atm, and a Choice ___ XS wire was placed as a buddy wire, however the stent would still not cross. A 3.0x8mm Xience ___ stent was then attempted without success. The Prowater wire was then removed and with further serial predilatation using a 3.0x8mm NC balloon at 18 atm and the support of a Guideliner passed into the proximal LCx, a 2.5x12mm Xience ___ stent was advanced with difficulty and deployed at 15 atm overlapping the previously placed stents and extending proximally to near the LCx origin. The entire stent and overlap zone were post-dilated with a 3.0mm NC balloon at 18 atm. Final angiography demonstrated no residual, no dissection, and normal flow. The patient had resolving chest pain at procedure end and left the cath lab in hemodynamically stable condition. Intra-procedural Complications: None Impressions: Successful PCI of the LCx with drug-eluting stent Brief Hospital Course: ___ with a history of CAD s/p anterior STEMI in ___ w/ 2 DES to LAD, and NSTEMI ___ treated with 3 overlapping ___ of the LCX, mild sCHF (LVEF of 50-55%), mild systolic congestive heart failure, HLD, T2DM, who presents with STEMI 95% LCx stenosis proximal to prior stent s/p DES. # CORONARIES: CAD s/p multiple STEMI and stents as above # PUMP: LVEF = 40-45 %, 1+ MR # RHYTHM: NSR; on telemetry noted to have second degree block with Mobitz I. #STEMI: Sister ___ presented with acute onset chest pain and was found to have ST elevations in inferior leads. She underwent cardiac catheterization and was found to have 95% left circumflex stenosis proximal to prior LCX stents. Given proximity to prior stent, this is considered in stent thrombosis. She had a DES placed in the LCX and was placed on ticagrelor 90 mg BID for planned 12 month course. Her home atorvastatin was increased to 80 mg qHS and she will continue on aspirin 81 for a lifelong course. She was started on lisinopril 5 mg daily and continued on home metoprolol. #Second degree heart block: During her hospital course, patient was intermittently found to have second degree heart block in ___ I/___ pattern. She was briefly symptomatic during one of these episodes and so was discharged with ___ of Hearts monitor. She may be considered for pacemaker if she continues to be symptomatic. #)Congestive heart failure: Patient with a history of CHF, NYHA class III, on Lasix 40 mg qAM and 20 qPM. Previous LVEF was 55%; repeat TTE this admission showed LVEF 40-45% with inferior/inferolateral hypokinesis. She was started on lisinopril 5 mg this admission and continued on home metoprolol 12.5 XL. #Diarrhea: ___ hospital course complicated by diarrhea, thought to be ___ drug effect. Her CDiff was negative, and she was placed on immodium with symptomatic improvement. CHRONIC ISSUES: ================ #GERD: continued on home omeprazole #Hyperlipidemia: placed on atorvastatin 80 mg qHS, increased from home dose of atorvastatin 40 mg qHS. #Type 2 diabetes mellitus: Patient was maintained on SSI during hospital course, transitioned to home metformin by time of discharge. TRANSITIONAL ISSUES -Patient had DES to LCX placed and should continue on ticagrelor x12 months, ending ___ -Patient noted to have intermittent second degree Mobitz I heart block during admission and was short of breath around the time of one episode of block. As such, she had ___ of Hearts monitor placed at discharge for monitoring. If she continues to be symptomatic and coinciding with heart block, she may be considered for permanent pacemaker. - For ___ providers: patient is in our system with ___ ___: ___ and ___. Medical records office was made aware of the duplication and will merge. In the meantime, please review both ___ records for full patient data. - Full code - Contact: ___ (sister superior) ___ ___ on Admission: The Preadmission Medication list is accurate and complete. 1. Atorvastatin 40 mg PO QPM 2. Furosemide 40 mg PO QAM 3. Gabapentin 1000 mg PO QHS 4. MetFORMIN (Glucophage) 500 mg PO BID 5. Nitroglycerin SL 0.3 mg SL Q5MIN:PRN Chest pain 6. Omeprazole 20 mg PO DAILY 7. TraZODone 100 mg PO QHS:PRN insomnia 8. Acetaminophen 650 mg PO Q6H:PRN pain 9. Vitamin D Dose is Unknown PO DAILY 10. Furosemide 20 mg PO QHS 11. Metoprolol Succinate XL 12.5 mg PO DAILY 12. Potassium Chloride 20 mEq PO DAILY 13. Aspirin 81 mg PO DAILY 14. Systane (peg 400-propylene glycol) 0.4-0.3 % ophthalmic BID Discharge Medications: 1. Potassium Chloride 20 mEq PO DAILY Hold for K > 2. Acetaminophen 650 mg PO Q6H:PRN pain 3. Aspirin 81 mg PO DAILY 4. Atorvastatin 80 mg PO QPM 5. Furosemide 40 mg PO QAM 6. Furosemide 20 mg PO QPM 7. Gabapentin 1000 mg PO QHS 8. Metoprolol Succinate XL 12.5 mg PO DAILY 9. Nitroglycerin SL 0.3 mg SL Q5MIN:PRN Chest pain 10. Omeprazole 20 mg PO DAILY 11. TraZODone 100 mg PO QHS:PRN insomnia 12. Lisinopril 5 mg PO DAILY 13. LOPERamide 2 mg PO QID:PRN diarrhea 14. TiCAGRELOR 90 mg PO BID 15. MetFORMIN (Glucophage) 500 mg PO BID 16. Systane (peg 400-propylene glycol) 0.4-0.3 % ophthalmic BID 17. Vitamin D 400 UNIT PO DAILY **UNKNOWN HOME DOSE** Discharge Disposition: Extended Care Facility: ___ Discharge Diagnosis: Primary diagnosis: ST elevation myocardial infarction with 95% left circumflex stenosis, s/p drug eluding stent x1 Second degree Mobitz I heart block Secondary diagnosis: Coronary artery disease with history of anterior STEMI in ___ with 2 DES to LAD, NSTEMI ___ with 3 overlapping DES to LCX Mild systolic congestive heart failure Hyperlipidemia Type 2 diabetes mellitus GERD Discharge Condition: Mental Status: Clear and coherent. Level of Consciousness: Alert and interactive. Activity Status: Ambulatory - requires assistance or aid (walker or cane). Discharge Instructions: Dear Ms. ___, You were seen at ___ due to chest pain. This was due to a heart attack; you have a blockage in one of the arteries to your heart. You underwent a catheterization of the arteries, and a new stent was placed. You will need to continue on medications due to this stent, specifically ticagrelor (aka Brilinta), for a full year (ending ___. You will need to be on aspirin for a lifelong course. In addition, you had an abnormal heart rhythm. This is not a dangerous rhythm but if you continue to have symptoms from it, you may do well with a pacemaker. To monitor how frequently this rhythm occurs, we are discharging you on a heart monitor called a ___ of Hearts" monitor. Your cardiologist will be able to follow up the information on this monitor and determine if you should have a pacemaker placed. Please take all medications as prescribed and please follow up with the appointments we have arranged. It was a pleasure taking care of you at ___. Sincerely, Your ___ care team Followup Instructions: ___
19713531-DS-4
19,713,531
26,257,129
DS
4
2185-05-19 00:00:00
2185-05-19 16:19:00
Name: ___ Unit No: ___ Admission Date: ___ Discharge Date: ___ Date of Birth: ___ Sex: M Service: MEDICINE Allergies: No Known Allergies / Adverse Drug Reactions Attending: ___ Chief Complaint: Coffee ground emesis, tarry stool, transfer from ___ Major Surgical or Invasive Procedure: Intubation for EGD ___ EGD ___ Extubation ___ History of Present Illness: Mr. ___ is ___ year old M with h/o EtOH cirrhosis (MELD 17) c/b esophageal varices who presents to the ED (___ from ___ same day) with concern for upper GI bleed. On presentation, he endorsed three days of weakness, dark vomiting, and dark tarry stools. He notes that it was "projectile" out of "both ends." He became so significantly weak that he decided to present to ED at ___. He denies any headache, fever, chest pain, SOB, or abdominal pain. He has intermittently had abdominal pain in the past and that he also chronically has poor appetite (he reports not having eaten anything for 3 weeks). He reports that he takes NSAIDs daily. He was seen at ___ where he was found to be hypotensive (101/45), HR 105, INR 2.02, potassium 4.3, creatinine 1.26, total bilirubin 1.6, AST 34, ALT 18, Hgb 5.0, Hct 15.4. He was given Octreotide (25cc/hr), PPI, Ceftriaxone, 1L IVF, and ordered for 1u PRBC. He was transferred to ___ for ICU admission. Of note, he was admitted for similar episode recently in ___ to ___. At the time, he had presented from his sober living house with one day of black tarry stools and hematemesis of black/dark-colored blood. He had a known extensive history of esophageal varices which have required clipping and banding in the past, most recently as of ___. At the time, he had also been taking significant Advil/ibuprofen at home. His Hgb was found to be 7. He was started on protonix and octreotide infusions and admitted to the ICU. He received 1u pRBC, and EGD did not reveal active bleeding, only portal HTN gastropathy; nadolol was started and octreotide was weaned. His course was complicated by hepatic encephalopathy and improved on lactulose. He was continued on antibiotic prophylaxis for SBP (Bactrim). At that discussion, his sister (___) confirmed code status as DNR/DNI. EGD ___ An ___ endoscope was used. With the patient in left lateral decubitus position, esophagus was intubated under direct vision. The scope passed through the esophagus into stomach and duodenum. The duodenal bulb and second portion appeared normal. There was no evidence of bleeding there. The stomach was carefully examined. There was moderately severe portal hypertensive gastropathy with snake skin-like mucosa and multiple petechiae noted, especially in the mid and high fundus. Retroflexion did not demonstrate any definite gastric varices. On withdrawal, a small erosion was seen in the region of the GE junction. The esophagus was carefully examined. A small variceal chain that completely flattens with air insufflation is seen in the thoracic area. Overall, the varices in the esophagus appeared largely obliterated and there are no stigmata of recent hemorrhage. IMPRESSION: 1. Largely obliterated esophageal varices. 2. Moderately severe portal hypertensive gastropathy. 3. Erosion at the gastroesophageal junction. Prior to this, he had also presented to our ___ from ___ - ___ for hematemesis. On arrival to the ED his hemoglobin was 4.7. In the ED he received 4 units of packed red blood cells, 2 units of FFP, and 10 mg of vitamin K. An upper endoscopy was done the same day that showed 3 large esophageal varices with copious amount of blood in the esophagus. He had recurrence of his bleed several times during the hospital stay and had several bands placed. He required pressors for hypotension and was intubated for airway protection. His course was complicated by pseudomonal VAP with 14 day course of meropenem. On this presentation-- Initial Vitals: T 97.2 HR 118 BP 100/58 RR 16 O2 Sat 100% RA Exam: Pale, appears unwell Tachycardic Bilateral breath sounds, no wheezing or crackles Abdomen soft, no focal tenderness, no rebound or guarding Labs: (At ___ CBC: WBC 6.9, Hgb 5.0, Hct 15.4, Plt 62, MCV 93.3 Coags: INR 2.02, ___ 22.8, PTT 37 Chem panel: Na 136 K 4.3 Cl 106 CO2 21 BUN 47 Cr 1.26 Glc 120 AG 9 Ca 8.0 LFTs: AST 34 ALT 18 AP 54 Tbili 1.6 Alb 2.3 Tprot 4.2 Imaging: RUQ US ___ 1. Patent TIPS. 2. Cholelithiasis. Circumferential gallbladder wall edema is likely due to underlying liver disease. Consults: None Interventions: Getting 1U RBC VS Prior to Transfer: T 99.1 HR 100 BP 97/55 RR 13 O2 Sat 99% 2L NC On presentation to ICU, he reports dry mouth and also requests 200mg ambien. He is understandable that since it is 6AM, he will not be getting sleep medications and that he can get sponge/ice cubes for his mouth but otherwise we would like to keep NPO. ROS: Positives as per HPI; otherwise negative. Past Medical History: - EtoH cirrhosis c/b EV s/p banding ___, SBP, & HE - TIPS ___ - Portosystemic shunt embolization ___ - Alcohol use disorder, now sober - Insomnia - Psoriasis - Anti-E antibody - Depression/anxiety - Hx of LUE DVT, provoked in setting of PICC, noted in ___ hospitalization (AC deferred given bleeding risk) Social History: ___ Family History: Mother is alive and healthy, father died in his ___ to "cancer" Physical Exam: ADMISSION EXAM: ============== VS: BP 118/68. HR 103. RR 18. O2 Sat 100% RA. GEN: Well-appearing male, restless, lifting his legs up out of bed HEENT: PERRL, EOMI. Pale conjunctivae. NECK: No lymphadenopathy. No thyroidomegaly CV: Regular rhythm, tachycardic to low 100s. No murmurs appreciated. RESP: Normal work of breathing, decreased inspiratory effort, no wheezes or crackles appreciated. GI: Soft, nontender, slightly distended. No large pocket visualized on US. MSK: Warm, SCDs in place. No lower extremity edema. SKIN: Small spider angioma on chest. Pale skin with decreased capillary refill. NEURO: Alert, oriented, good attention. Can do MOYB and DOWB. Able to recite last two presidents. PSYCH: Odd affect, tangential speech. DISCHARGE EXAM: ============== VITALS: 24 HR Data (last updated ___ @ 2335) Temp: 98.1 (Tm 98.6), BP: 112/63 (95-112/47-64), HR: 76 (76-82), RR: 20 (___), O2 sat: 100% (96-100), O2 delivery: Ra GENERAL: Alert and interactive. In no acute distress. HEENT: Sclera anicteric and without injection. Moist mucous membranes, good dentition. NECK: No JVD. CARDIAC: Regular rhythm, normal rate. Audible S1 and S2. No murmurs/rubs/gallops. LUNGS: Clear to auscultation bilaterally w/appropriate breath sounds appreciated in all fields. No wheezes, rhonchi or rales. No increased work of breathing. ABDOMEN: NBS. Softly distended abdomen. Non-tender to palpation in all quadrants. Unable to appreciate liver edge. Umbilical hernia present. EXTREMITIES: No clubbing, cyanosis, or edema. NEUROLOGIC: A&Ox3. No asterixis. Appropriate mood and affect Pertinent Results: ADMISSION LABS: ============== ___ 05:14AM BLOOD WBC-5.6 RBC-1.64* Hgb-5.0* Hct-15.8* MCV-96 MCH-30.5 MCHC-31.6* RDW-17.6* RDWSD-60.8* Plt Ct-33* ___ 05:14AM BLOOD Neuts-64.9 ___ Monos-9.2 Eos-1.3 Baso-0.2 Im ___ AbsNeut-3.62 AbsLymp-1.33 AbsMono-0.51 AbsEos-0.07 AbsBaso-0.01 ___ 05:14AM BLOOD ___ PTT-23.0* ___ ___ 05:14AM BLOOD ___ ___ 05:14AM BLOOD Glucose-135* UreaN-45* Creat-1.0 Na-140 K-5.9* Cl-112* HCO3-20* AnGap-8* ___ 05:14AM BLOOD ALT-17 AST-44* LD(LDH)-302* AlkPhos-46 TotBili-1.1 ___ 05:14AM BLOOD Albumin-2.3* Calcium-7.9* Phos-4.1 Mg-1.6 ___ 05:14AM BLOOD Hapto-<10* ___ 09:07AM BLOOD ___ pO2-30* pCO2-42 pH-7.38 calTCO2-26 Base XS--1 ___ 06:05AM BLOOD K-5.5* ___ 09:07AM BLOOD Lactate-1.7 K-4.5 ___ 09:07AM BLOOD freeCa-1.18 ___ 08:50AM URINE Color-Straw Appear-Clear Sp ___ ___ 08:50AM URINE Blood-NEG Nitrite-NEG Protein-NEG Glucose-NEG Ketone-NEG Bilirub-NEG Urobiln-NEG pH-6.0 Leuks-NEG INTERVAL LABS: ============= CBC labs: ___ 05:44PM BLOOD WBC-5.6 RBC-2.33* Hgb-6.9* Hct-21.3* MCV-91 MCH-29.6 MCHC-32.4 RDW-18.3* RDWSD-57.8* Plt Ct-39* ___ 11:04PM BLOOD WBC-5.5 RBC-2.66* Hgb-8.0* Hct-24.2* MCV-91 MCH-30.1 MCHC-33.1 RDW-18.0* RDWSD-58.4* Plt Ct-42* ___ 09:47AM BLOOD WBC-5.0 RBC-2.60* Hgb-7.6* Hct-23.1* MCV-89 MCH-29.2 MCHC-32.9 RDW-18.1* RDWSD-55.9* Plt Ct-37* ___ 03:13AM BLOOD WBC-5.0 RBC-2.48* Hgb-7.3* Hct-21.9* MCV-88 MCH-29.4 MCHC-33.3 RDW-18.0* RDWSD-55.1* Plt Ct-44* ___ 02:15PM BLOOD WBC-5.8 RBC-2.64* Hgb-7.8* Hct-23.8* MCV-90 MCH-29.5 MCHC-32.8 RDW-18.3* RDWSD-55.8* Plt Ct-55* DISCHARGE LABS: ============== ___ 04:38AM BLOOD WBC-4.0 RBC-2.52* Hgb-7.6* Hct-22.9* MCV-91 MCH-30.2 MCHC-33.2 RDW-19.1* RDWSD-56.8* Plt Ct-31* ___ 04:38AM BLOOD ___ PTT-30.9 ___ ___ 04:38AM BLOOD Glucose-98 UreaN-6 Creat-0.7 Na-141 K-3.6 Cl-108 HCO3-27 AnGap-6* ___ 04:38AM BLOOD ALT-19 AST-28 AlkPhos-65 TotBili-1.2 ___ 04:38AM BLOOD Calcium-8.2* Phos-3.9 Mg-1.4* NOTE: received IV Mg prior to discharge IMAGING/REPORTS: =============== ___ RUQ U/S WITH DOPPLERS FINDINGS: The liver appears diffusely coarsened and nodular consistent with known cirrhosis. No focal liver lesions are identified. There is no ascites. There is stable splenomegaly, with the spleen measuring 16.0 cm. There is no intrahepatic biliary dilation. The CHD measures 5 mm. Cholelithiasis. Circumferential gallbladder wall edema is likely due to underlying liver disease. The main portal vein is patent with hepatopetal flow. The TIPS is patent and demonstrates wall-to-wall flow. Portal vein and intra-TIPS velocities are as follows: Main portal vein: 41 cm/sec, previously 66 cm/sec Proximal TIPS: 99 cm/sec, previously 117cm/sec Mid TIPS: 84 cm/sec, previously 161 cm/sec Distal TIPS: 95 cm/sec, previously 127 cm/sec Flow within the left portal vein is towards the TIPS shunt. Flow within the right anterior portal vein is towards the TIPS. Appropriate flow is seen in the hepatic veins and IVC. PANCREAS: The imaged portion of the pancreas appears within normal limits, without masses or pancreatic ductal dilation, with portions of the pancreatic tail obscured by overlying bowel gas. KIDNEYS: Limited views of the kidneys demonstrate no hydronephrosis. RETROPERITONEUM: Visualized portions of aorta and IVC are within normal limits. IMPRESSION: 1. Cirrhotic liver, patent TIPS. 2. Cholelithiasis. Circumferential gallbladder wall edema is likely due to underlying liver disease. ___ CXR Low lung volumes, however improved since ___. Minimal retrocardiac atelectasis without focal consolidations. Cardiac size is mildly enlarged. There is no pulmonary edema. Somewhat linear hyperdensities projecting over the lower mediastinum and upper mid abdomen could represent high-density material within known esophageal varices. Heterotopic calcification of the left humerus is again seen. There are old left-sided rib and proximal left humerus fractures. ___ 1. Patent appearing TIPS stent. 2. Cirrhotic liver morphology with sequela of portal hypertension, including moderate splenomegaly and small volume ascites, improved from prior study. 3. Unchanged appearance of a linear hypodensity within hepatic segment VII, likely representing a chronically thrombosed accessory right hepatic vein. 4. Cholelithiasis. 5. Fat-containing umbilical hernia MICRO: ===== URINE CULTURE (Final ___: < 10,000 CFU/mL. ___ 8:51 am BLOOD CULTURE x2 Blood Culture, Routine (Pending): No growth to date. Brief Hospital Course: Mr. ___ is ___ year old M with h/o EtOH cirrhosis (MELD 17) c/b esophageal varices presents to the ED with c/o GIB. ACUTE ISSUES =============== # Acute blood loss anemia # Upper GI bleed Presenting Hgb 5 from a baseline of around ___ in setting of reporting coffee ground emesis and dark tarry stool. He has a history of EV s/p banding in ___ and he is s/p TIPS during previous ___ admission. Last EGD on ___ which did not show any active varices. He has an anti-E antibody pertinent for blood product matching. He was admitted to the MICU on ___ and remained HD stable. No further GI bleeding while in ICU. Initially on octreotide gtt, IV PPI and ceftriaxone. He underwent EGD (requiring temporary intubation) on ___ which was notable for ___ tear requiring clipping. He received 3U PRBCs on ___. He was hemodynamically stable afterward without GI bleeding while here and is called out to the floor ___. He was monitored on the floor and was found to be hemodynamically stable with stable H&H. He was continued on ceftriaxone and transitioned to ___ on discharge with plan to complete a 7 day course. He should continue PPI BID x 8 weeks. He should continue sucralfate 1gm QID x 2 weeks. He should have a repeat EGD in 8 weeks with duodenal biopsies. Hgb on day of discharge: 7.6. # Alcoholic cirrhosis # Severe protein-calorie malnutrition MELD 17. Child class C. RUQ u/s on admission without PVT or biliary dilation. - Volume: held diuretics initially while in ICU, restarted on ___. - Ascites: No tappable pocket on bedside u/s so diagnostic para not performed - Infection: Empirically started on CTX iso GI bleeding; infectious work up otherwise negative. - Bleeding: as above - HE: lactuose/rifixamin - Screening: RUQUS without sign of malignancy - Trend MELD labs daily - Will need nutrition consult once able to tolerate PO intake; on MVI/thiamine/folate # Altered mental status # Hepatic encephalopathy S/p TIPS on ___ and portosystemic shunt embolization on ___. Prior MRI ___ showed hypodensities seen on CT in the right temporal and inferior right frontal lobes which correspond to areas of gliosis from prior chronic infarction. Initially on admission to ICU, no asterixis but had some odd affect and tangential speech. Continued lactulose/ rifixamin with mental status at baseline on day of discharge. # Code Status Per ___ records, DNR/DNI after discussion with his HCP sister ___. Patient was insistent on full code so code status was left as full code and discussed with HCP as being full code on admission to ICU. CHRONIC ISSUES =============== # Hx of LUE DVT: In the setting of ___, noted in ___ hospitalization (Soleal vein) but anticoagulation deferred given risk of variceal bleeding. # Insomnia: Held Seroquel & doxepin in ICU. Restart as clinically indicated. TRANSITIONAL ISSUES: ====================== - ANTI-E antibody, difficult match for blood products - it will take an hour for blood bank to obtain blood for him as long as T&S is active - Odd affect, tangential speech at times, but not encephalopathic, not delirious - Patient this admission elected for full code. ___ sister reported DNR/DNI on admission per ___ report sin the past. HCP states he makes his own medical decisions when he is doing well. - To discharge discussion about hepatology follow-up and potential workup for liver transplantation can be considered - Omeprazole 40mg BID x 8 weeks, sucralfate 1g QQID x 2 weeks - Complete 7 day ceftriaxone course - NO NSAIDs. Patient has been told this on multiple admissions but denies that this was ever discussed. ___. - F/u on tTg IgA and total IgA - Plan for repeat EGD in 8 weeks with duodenal biopsies Medications on Admission: The Preadmission Medication list is accurate and complete. 1. Doxepin HCl 25 mg PO HS insomnia 2. FoLIC Acid 1 mg PO DAILY 3. Furosemide 20 mg PO DAILY 4. QUEtiapine Fumarate 100 mg PO QHS insomnia 5. Spironolactone 50 mg PO DAILY 6. Thiamine 100 mg PO DAILY 7. Lactulose 30 mL PO BID 8. Rifaximin 550 mg PO BID 9. Multivitamins 1 TAB PO DAILY 10. Pantoprazole 40 mg PO Q24H 11. Albuterol Inhaler 2 PUFF IH Q6H:PRN SOB/wheezing 12. Acetaminophen 500 mg PO Q12H:PRN Pain - Mild/Fever Discharge Medications: 1. Sucralfate 1 gm PO QID 2. Lactulose 30 mL PO TID 3. Acetaminophen 500 mg PO Q12H:PRN Pain - Mild/Fever 4. Albuterol Inhaler 2 PUFF IH Q6H:PRN SOB/wheezing 5. FoLIC Acid 1 mg PO DAILY 6. Furosemide 20 mg PO DAILY 7. Multivitamins 1 TAB PO DAILY 8. Pantoprazole 40 mg PO Q24H 9. Rifaximin 550 mg PO BID 10. Spironolactone 50 mg PO DAILY 11. Thiamine 100 mg PO DAILY Discharge Disposition: Home Discharge Diagnosis: PRIMARY DIAGNOSES: ================== - ___ tear - Blood loss anemia - Hepatic encephalopathy SECONDARY DIAGNOSES: ==================== - Cirrhosis - Esophageal varices Discharge Condition: Mental Status: Clear and coherent. Level of Consciousness: Alert and interactive. Activity Status: Ambulatory - Independent. Discharge Instructions: Dear Mr. ___, It was a pleasure caring for you at ___ ___. WHY WERE YOU IN THE HOSPITAL? - You were admitted to the hospital because you were having episodes of forceful vomiting with blood in your vomit. WHAT HAPPENED WHEN YOU WERE IN THE HOSPITAL? - We looked in your esophagus (the tube that runs from your mouth to your stomach) and saw that you had a small tear that was causing the bleeding. We closed this tear and your bleeding resolved. - We provided you with blood products and supportive medications as needed. WHAT SHOULD YOU DO AFTER YOU LEAVE THE HOSPITAL? - Continue to take all your medicines as prescribed below. - Show up to your appointments as listed below. We wish you the best! Sincerely, Your ___ Team Followup Instructions: ___
19713635-DS-19
19,713,635
29,145,813
DS
19
2145-06-15 00:00:00
2145-06-16 19:59:00
Name: ___ Unit No: ___ Admission Date: ___ Discharge Date: ___ Date of Birth: ___ Sex: F Service: MEDICINE Allergies: amoxicillin / Bactrim / ___ Attending: ___ Chief Complaint: Rash Major Surgical or Invasive Procedure: Biopsy of left abdominal wall History of Present Illness: ___ F with PMHx anxiety and depression, recently treated for UTI with ___ and Bactrim, who presents with flu-like symptoms and 1 day of pruritic rash over her upper and lower extremities, chest, and back. Of note, she was recently treated for UTI, initially with ___ x 7 days, then Bactrim. She says she initially had dysuria, and her PCP called in ___ x 7 days. She completed this course with initial improvement, but urgency and dysuria returned. She was seen at urgent care and started on Bactrim. Reports UA and urine cultures have otherwise been negative. She took her last dose of Bactrim yesterday to complete 7 day course. However, over the last 3 days she has had new flu-like symptoms, including fevers/chills, joint pains, nausea. Tmax 100 at home. Reports decreased PO intake due to malaise and decreased appetite. Then on day ___ of Bactrim, she noted onset of erythematous, mildly pruritic rash over her chest and thighs. Since then, it has progressed down her legs and arms, now with "burning" sensation and worsening pruritis. Otherwise, no sensation of throat closing, SOB, wheezing, abdominal pain, vomiting, diarrhea, dizziness/LH. No other new medications. No blistering of rash or mucosal involvement. In the ED, initial VS were: T: 100.5, HR: 119, BP: 134/79, RR: 19, 99% RA Exam notable for: Gen: NAD HEENT: oropharynx without erythema, exudate, or edema CV: RRR; no m/r/g Resp: CTAB Abd: Soft; mild discomfort to palpation in left abdomen; ND; no ___ sign; no CVA tenderness Skin: diffuse, warm, erythematous, coalesced urticarial rash over face, UEs, back, torso, and thighs; no weeping or discharge; no skin sloughing; no involvement at mucocutaneous borders LN: no cervical or axillary LAD Labs showed: - Transaminitis: ALT 136, AST 160 - Thrombocytopenia: Plt 92 - WBC 4.1, HgB 12.0, Hct 35.1 - UA: neg leuks, neg nitrites, mod blood - Chemistry panel within normal limits Imaging showed: None Consults: Dermatology: Favor DRESS/DIHS (drug induced hypersensitivity reaction) most likely to Bactrim, with associated thrombocytopenia related to Bactrim. The differential diagnosis would also include morbilliform drug rash (which can also be associated with fevers) and less likely, infectious mononucleosis. Preformed punch biopsy in ED. Plan to admit for steroids. Patient received: N/A Transfer VS were: T: 98.8, BP: 109/62, HR: 108, RR: 17, 98% Ra On arrival to the floor, patient recounts history as above. She endorses burning and itching of her rash, diffuse across upper and lower extremities, chest, and back. She has no fevers/chills, N/V, abdominal pain. REVIEW OF SYSTEMS: 10 point ROS reviewed and negative except as per HPI Past Medical History: PAST MEDICAL AND SURGICAL HISTORY: - Anxiety, depression - IBS - ADHD Social History: ___ Family History: Paternal grandmother: CABG, CVA, T2DM Maternal grandmother: ___ disease Father: ___ Physical ___: ADMISSION PHYSICAL EXAM: VS: ___ 0042 Temp: 98.8 PO BP: 109/62 R Sitting HR: 108 RR: 17 O2 sat: 98% O2 delivery: Ra GENERAL: NAD HEENT: AT/NC, anicteric sclera, MMM NECK: supple, no LAD CV: RRR, S1/S2, no murmurs, gallops, or rubs PULM: CTAB, no wheezes, rales, rhonchi, breathing comfortably without use of accessory muscles GI: abdomen soft, nondistended, nontender in all quadrants, no rebound/guarding, no hepatosplenomegaly EXTREMITIES: no cyanosis, clubbing, or edema PULSES: 2+ radial pulses bilaterally NEURO: Alert, moving all 4 extremities with purpose, face symmetric DERM: Confluent erythematous, blanching macules and papules coalescing into patches over the chest, back, and bilateral upper and lower extremities. No mucosal involvement. No blistering, sloughing. Otherwise, warm and well perfused. DISCHARGE PHYSICAL EXAM GENERAL: NAD, uncomfortable, HEENT: AT/NC, anicteric sclera, MMM NECK: supple, no LAD CV: RRR, S1/S2, no murmurs, gallops, or rubs PULM: CTAB, no wheezes, rales, rhonchi, painful breathing with deep inspiration GI: abdomen soft, nondistended, tender in all quadrants to light palpation worst in the RUQ, no rebound/guarding, no hepatosplenomegaly EXTREMITIES: no cyanosis, clubbing, or edema PULSES: 2+ radial pulses bilaterally NEURO: Alert, moving all 4 extremities with purpose, face symmetric DERM: Confluent mildly erythematous, blanching macules and papules coalescing into patches over the chest, upper and lower extremities. Right upper extremity has stable petichie. With improvement from prior days. No mucosal involvement. No blistering, sloughing. Otherwise, warm and well perfused. Pertinent Results: Important Results ============= ___ 06:17PM BLOOD WBC-4.1 RBC-4.05 Hgb-12.0 Hct-35.1 MCV-87 MCH-29.6 MCHC-34.2 RDW-13.4 RDWSD-42.5 Plt Ct-92* ___ 06:17PM BLOOD Neuts-52.5 ___ Monos-10.5 Eos-6.6 Baso-0.2 Im ___ AbsNeut-2.16 AbsLymp-1.22 AbsMono-0.43 AbsEos-0.27 AbsBaso-0.01 ___ 06:17PM BLOOD Plt Smr-LOW* Plt Ct-92* ___ 07:22AM BLOOD ___ PTT-29.1 ___ ___ 07:22AM BLOOD Plt ___ ___ 06:17PM BLOOD Glucose-84 UreaN-10 Creat-0.8 Na-139 K-4.3 Cl-103 HCO3-21* AnGap-15 ___ 07:22AM BLOOD Glucose-135* UreaN-9 Creat-0.8 Na-139 K-4.5 Cl-102 HCO3-21* AnGap-16 ___ 06:17PM BLOOD ALT-136* AST-160* AlkPhos-82 TotBili-0.3 ___ 07:22AM BLOOD ALT-253* AST-244* LD(LDH)-477* AlkPhos-86 TotBili-0.4 ___ 07:40AM BLOOD Lipase-12 ___ 06:17PM BLOOD Albumin-4.2 ___ 07:22AM BLOOD Calcium-8.7 Phos-3.2 Mg-1.9 ___ 07:55AM BLOOD WBC-6.3 RBC-3.75* Hgb-11.1* Hct-32.7* MCV-87 MCH-29.6 MCHC-33.9 RDW-13.3 RDWSD-42.4 Plt ___ ___ 07:40AM BLOOD WBC-6.7 RBC-3.84* Hgb-11.1* Hct-32.8* MCV-85 MCH-28.9 MCHC-33.8 RDW-13.2 RDWSD-41.1 Plt ___ ___ 02:27AM BLOOD WBC-7.7 RBC-3.90 Hgb-11.1* Hct-33.2* MCV-85 MCH-28.5 MCHC-33.4 RDW-13.2 RDWSD-41.6 Plt ___ ___ 07:40AM BLOOD Neuts-45.0 ___ Monos-9.0 Eos-4.3 Baso-0.3 Im ___ AbsNeut-3.01 AbsLymp-2.75 AbsMono-0.60 AbsEos-0.29 AbsBaso-0.02 ___ 07:55AM BLOOD Plt ___ ___ 07:55AM BLOOD ___ PTT-25.6 ___ ___ 03:35PM BLOOD Parst S-NEGATIVE FOR INTRACELLULUAR AND EXTRACELLULAR PARASITS ___ 07:55AM BLOOD Glucose-97 UreaN-10 Creat-0.6 Na-142 K-4.0 Cl-104 HCO3-28 AnGap-10 ___ 07:55AM BLOOD ALT-235* AST-99* LD(LDH)-243 AlkPhos-79 TotBili-0.4 ___ 07:55AM BLOOD Calcium-8.6 Phos-3.9 Mg-2.1 RUQ US IMPRESSION: Normal abdominal ultrasound. Brief Hospital Course: ASSESSMENT & PLAN: ================== ___ F with PMHx anxiety and depression, recently treated for UTI with ___ and Bactrim, who presents with flu-like symptoms and 1 day of progressive, diffuse, pruritic rash with thrombocytopenia and Transaminitis initially concerning for DRESS, but less likely after derm evaluation/biopsy. Self-resolving symptoms off steroids, likely related to other causes of acute hepatitis including viral vs parasitic. ACUTE ISSUES: =============== #acute hepatitis #Thrombocytopenia #Anemia Patient presenting with flu-like symptoms and whole-body rash beginning about 1 week after starting Bactrim. Labs notable for transaminitis, thrombocytopenia, and elevated INR. Differential diagnosis included DRESS, morbilliform drug rash (which can also be associated with fevers) infectious mononucleosis, tick ___ illness, acute HIV, acute viral infection and autoimmune hepatitis. Prednisone was started for possible DRESS syndrome however after 2 doses were discontinued as DRESS was deemed less likely due to a risk assessment model, skin biopsy pathology, and per recommendations from dermatology. Topical ointments were used to address patient's pruritus. The patient's LFTs were trended during her hospital course with a peak AST of 244 and ALT of 302 with an LDH of 477 which all down trended prior to discharge. On ___ on the patient developed significant abdominal and chest wall pain that was pleuritic in nature. Chest x-ray and EKG did not demonstrate any signs of acute infection or pericarditis. The patient's abdominal pain was mostly localized to the right upper quadrant and epigastrium and left upper quadrant; there were no peritoneal signs. Right upper quadrant ultrasound was negative for any hepatic cysts or obstructive processes. The patient's pain was treated with oxycodone and her pain subsequently resolved. On ___ the patient's rash improved significantly and her pain decreased. Bactrim was added to allergy list. Heme/onc smear revealed reactive lymphocytes, RBC smear revealed occaisional schistocytes but had low retics, parasite smear x 2 were negative, ferritin was 276, AMA negative, ___ negative, HIV negative, Smooth muscle Ab negative, Heb B immune, HCV negative, monospot negative. CHRONIC ISSUES: =============== #UTI Has completed 7 day course of Bactrim for UTI. UA without evidence of infection on admission. #Depression: Continue home escitalopram #ADHD: Continue home Adderall PRN Transitional Issues ============================= [] Will need punch biopsy stitch removal in 2 weeks [] Recommend checking TSH in 6 weeks for late onset autoimmune hypothyroidism [] Repeat labs on ___, please ensure LFTs downtrending and CBC normalized [] Adderall held at discharge given liver injury, consider re-starting after labs on ___ [] The following laboratory studies will need follow up: - HHV ___ - babesia PCR - anaplasma PCR - CMV - RPR w/ prozone - Parvovirus B19 - The last of 3 parasite smears Medications Added ======================== -Betamethasone Dipro 0.05% Oint 1 Appl TP BID Duration: 2 Weeks -Lidocaine 5% Patch 1 PTCH TD QPM -Sarna Lotion 1 Appl TP QID:PRN itch -Ranitidine 75 mg PO/NG DAILY -OxyCODONE (Immediate Release) 5 mg PO/NG Q8H:PRN Medications Held ======================== -Amphetamine-Dextroamphetamine 5 mg PO BID:PRN inattention Cr: 0.6 Code: FULL Contact: ___ ___ Medications on Admission: The Preadmission Medication list is accurate and complete. 1. Escitalopram Oxalate 5 mg PO DAILY 2. Amphetamine-Dextroamphetamine 5 mg PO BID:PRN inattention Discharge Medications: 1. Betamethasone Dipro 0.05% Oint 1 Appl TP BID Duration: 2 Weeks RX *betamethasone dipropionate 0.05 % Apply TP twice a day Refills:*0 2. OxyCODONE (Immediate Release) 5 mg PO Q8H:PRN Pain - Severe RX *oxycodone 5 mg 1 tablet(s) by mouth QH8:PRN Disp #*6 Tablet Refills:*0 3. Ranitidine 75 mg PO DAILY RX *ranitidine HCl [Heartburn Relief (ranitidine)] 75 mg 1 tablet(s) by mouth daily Disp #*30 Tablet Refills:*0 4. Sarna Lotion 1 Appl TP QID:PRN itch RX *camphor-menthol [Sarna Anti-Itch] 0.5 %-0.5 % 1 Appl TP QID:PRN Refills:*0 5. Escitalopram Oxalate 10 mg PO DAILY 6. HELD- Amphetamine-Dextroamphetamine 5 mg PO BID:PRN inattention This medication was held. Do not restart Amphetamine-Dextroamphetamine until your doctor checks your liver function 7.Outpatient Lab Work 573.3 Hepatitis, unspecified ___, MD CBC with dif, Chem-10, LFTs, Coags Discharge Disposition: Home Discharge Diagnosis: Primary diagnosis ================== Acute hepatitis Discharge Condition: Mental Status: Clear and coherent. Level of Consciousness: Alert and interactive. Activity Status: Ambulatory - Independent. Discharge Instructions: Dear Ms ___, It was a privilege caring for you at ___. WHY WAS I IN THE HOSPITAL? -You were in the hospital due to a rash that covered your body and abdominal pain. WHAT HAPPENED TO ME IN THE HOSPITAL? - You were seen by internal medicine, dermatology and infectious disease who ordered laboratory tests that showed abnormal liver and blood markers. Tests were sent to assess the cause of these abnormalities. - You improved considerably and were felt well enough to leave the hospital WHAT SHOULD I DO AFTER I LEAVE THE HOSPITAL? - Continue to take all your medicines and keep your appointments. - We recommend seeing your primary care physician to discuss your medications within the next 2 weeks. We wish you the best! Sincerely, Your ___ Team Followup Instructions: ___
19713771-DS-6
19,713,771
22,029,535
DS
6
2188-05-21 00:00:00
2188-05-23 11:58:00
Name: ___ Unit No: ___ Admission Date: ___ Discharge Date: ___ Date of Birth: ___ Sex: F Service: OBSTETRICS/GYNECOLOGY Allergies: gluten / egg Attending: ___. Chief Complaint: Nausea and vomiting Major Surgical or Invasive Procedure: Exploratory laparotomy, left salpingo-oophorectomy History of Present Illness: HPI: ___ G0 who presented to ___ ED yesterday after developing persistent n/v/d and abd pain which persisted. Was unable to tolerate any po since ___. Otherwise denies f/c, uri sx, dysuria, joint/muscle pains outside of her usual. Prior to ___, had actually been feeling very well since starting rituximab. Has been walking and much more active than prior. Does report 6 pound weight loss and possibly slightly less than normal apetite but was actively calorie counting and dieting over this past month (eating 1200-1500 calories) per day. AT ___ was found to have ___ with Cr 2.9 and started on IVF. Non-contract CT scan showed a 25cm cystic abdominal mass and she was transferred to ___ for further workup. Here her pain is relatively well controlled with po meds, creatinine is improving with IVF, at 1.9 this am. Continues to deny f/c. N/V/D also currently resolved. ROS otherwise negative Past Medical History: OB/Gyn hx: -G0 -amenorrheic on mirena -denies hx STI, fibroids, ovarian cysts or other gyn issues PMH: -RA on rituximab since ___ -eosinophilic esophagitis -hypothyroid -bipolar PSH: -OMFS surgery to correct jaw alignment Social History: ___ Family History: Father with CAD, possible UC, possible RA Mother with A-fib Grandmother died of melanoma Physical Exam: Admission PE VS: 98 70 118/86 16 100% RA Gen: NAD, resting comfortably in bed HEENT: EOMI, PERRLA, MMM, OP clear CV: RRR nl s1s2 no m/r/g Resp: CTAB no w/r/r Abd: soft, diffuse mild tenderness, no rebound or guarding, ND, +BS Ext: no c/c/e Neuro: CN II-XII intact, ___ strength throughout Skin: warm, dry no rashes On day of discharge: Afebrile, vitals stable No acute distress CV: regular rate and rhythm Pulm: clear to auscultation bilaterally Abd: soft, appropriately tender, nondistended, incision clean/dry/intact, no rebound/guarding ___: nontender, nonedematous Pertinent Results: ___ 07:25PM GLUCOSE-101* UREA N-19 CREAT-2.2*# SODIUM-140 POTASSIUM-3.9 CHLORIDE-105 TOTAL CO2-21* ANION GAP-18 ___ 07:25PM CALCIUM-9.4 PHOSPHATE-4.1 MAGNESIUM-2.7* URIC ACID-8.8* ___ 07:25PM CEA-1.5 CA125-11 ___ 07:25PM LITHIUM-1.7*# Pelvic US ___: IMPRESSION: 1. Normal-sized bilateral ovaries, with normal flow. Only the right ovary was identified by transvaginal ultrasound. The left ovary was seen by transabdominal approach. 2. Large predominantly anechoic cystic structure in the mid to left upper abdomen, correlating with findings on the earlier outside hospital CT. It is unclear if this structure originates from the ovaries, but no direct connection to either ovary was identified on this study. MRI pelvis ___: IMPRESSION: Large simple appearing cystic lesions which appears to be arising from the pelvis extending into the abdomen, likely from the left ovary. Its characteristics are most consistent with an ovarian serous cystadenoma. Given the lack of complex features, a serous cystadenocarcinoma is thought to be less likely. The other differential consideration is a benign mesenteric cyst. Brief Hospital Course: ___ year old female with PMH of rheumatoid arthritis on rituximab, bipolar disorder and hypothyroidism admitted to medicine after presenting with 5 days of nausea, vomiting, diarrhea, poor PO intake and crampy lower abdominal pain found to have large pelvic cystic mass. Patient transferred to Gyn-Onc for exploratory laparotomy and left salpingoo-phorectomy for mesosalpinx inclusion cyst. Please see operative note for details. Pre-operative: *) Pelvic mass/nausea/vomiting: 22 cm abdominopelvic mass. ACS general surgery and Gyn consulted. Abd/Pelvic MRI and PUS - likely peritoneal inclusion cyst or a large left ovarian cyst with plan for removal given patients symptoms. Nausea and pain improved with IVF, pain meds and anti-emetics. *) ___: Pre-renal acute kidney injury due to dehydration. Had very limited PO intake over 4 days prior to presenting with slightly elevated lithium level potentially contributing to ___. No evidence of obstruction on CT. Creatinine 2.9 on admission, improved to 0.9 on day of discharge after IV fluid resuscitation. *) RA: Currently asymptomatic, last received rituximab on ___. Patient discharged with instructions to f/u with rheumatology. Post-operative: Her post-operative course is detailed as follows. Immediately postoperatively, her pain was controlled with IV dilaudid and toradol. Her diet was advanced without difficulty and she was transitioned to oxycodone, acetaminophen, and ibuprofen. On post-operative day #1, her urine output was adequate so her Foley catheter was removed and she voided spontaneously. By post-operative day #1, she was tolerating a regular diet, voiding spontaneously, ambulating independently, and pain was controlled with oral medications. She was then discharged home in stable condition with outpatient follow-up scheduled. Medications on Admission: The Preadmission Medication list is accurate and complete. 1. Levothyroxine Sodium 100 mcg PO DAILY 2. Lithium Carbonate SR (Lithobid) 900 mg PO QHS 3. LaMOTrigine 200 mg PO QHS Discharge Medications: 1. Acetaminophen ___ mg PO Q6H:PRN pain do not exceed 4000 mg in 24 hours RX *acetaminophen [Acetaminophen Extra Strength] 500 mg ___ tablet(s) by mouth every 6 hours Disp #*40 Tablet Refills:*0 2. Docusate Sodium 100 mg PO BID take while using oxycodone for pain RX *docusate sodium [Colace] 100 mg 1 capsule(s) by mouth twice a day Disp #*40 Capsule Refills:*0 3. Ibuprofen 400 mg PO Q8H:PRN Pain RX *ibuprofen 400 mg 1 tablet(s) by mouth every 8 hours Disp #*20 Tablet Refills:*0 4. OxycoDONE (Immediate Release) ___ mg PO Q4H:PRN pain do not drive while taking, use with a stool softener RX *oxycodone [Oxecta] 5 mg ___ tablet(s) by mouth every 4 hours Disp #*35 Tablet Refills:*0 5. LaMOTrigine 200 mg PO QHS 6. Levothyroxine Sodium 100 mcg PO DAILY 7. Lithium Carbonate SR (Lithobid) 900 mg PO QHS Lithobid SR Discharge Disposition: Home Discharge Diagnosis: Mesosalpinx inclusion cyst Final pathology pending Discharge Condition: Mental Status: Clear and coherent. Level of Consciousness: Alert and interactive. Activity Status: Ambulatory - Independent. Discharge Instructions: Dear Ms. ___, . You were admitted to the gynecologic oncology service after undergoing the procedures listed below. You have recovered well after your operation, and the team feels that you are safe to be discharged home. Please follow these instructions: . * Take your medications as prescribed. * Do not drive while taking narcotics. * Do not combine narcotic and sedative medications or alcohol. * Do not take more than 4000mg acetaminophen (APAP) in 24 hrs. * No strenuous activity until your post-op appointment. * Nothing in the vagina (no tampons, no douching, no sex) for 12 weeks. * No heavy lifting of objects >10 lbs for 6 weeks. * You may eat a regular diet. * It is safe to walk up stairs. . Incision care: * You may shower and allow soapy water to run over incision; no scrubbing of incision. No bath tubs for 6 weeks. * If you have steri-strips, leave them on. If they are still on after ___ days from surgery, you may remove them. . To reach medical records to get the records from this hospitalization sent to your doctor at home, call ___. . Call your doctor at ___ for: * fever > 100.4 * severe abdominal pain * difficulty urinating * vaginal bleeding requiring >1 pad/hr * abnormal vaginal discharge * redness or drainage from incision * nausea/vomiting where you are unable to keep down fluids/food or your medication * chest pain or difficulty breathing * onset of any concerning symptoms Followup Instructions: ___
19713924-DS-9
19,713,924
20,665,354
DS
9
2182-08-28 00:00:00
2182-09-04 16:35:00
Name: ___ Unit No: ___ Admission Date: ___ Discharge Date: ___ Date of Birth: ___ Sex: M Service: NEUROLOGY Allergies: No Known Allergies / Adverse Drug Reactions Attending: ___. Chief Complaint: Headache Major Surgical or Invasive Procedure: None History of Present Illness: ___ is a ___ year old right handed man who presented to the ED for evaluation of a headache that has been present for the past 4 days. He says that 4 days ago he started to get a headache that he felt mostly over the right side of his head. It came on gradually and continued to get worse. He described it as being bot pounding and squeezing at times. He also states that he noticed that the headache would get more bearable when he stood up. He says that usually within 1 minute of standing or lying down it would change the severity of the headache (being worse and unbearable when lying down). He tried some aspirin and tylenol but felt that neither was relieving the headache. He has been unable to sleep well over the past few days due to the pain and states that he feels exhausted now because he has slept so little. He has not noticed any other associated symptoms with the headache, no visual changes, no tinitus, no sensory changes, no weakness and no incoordination. He has noted no change in his bowel or bladder habits. No fevers and no stiff neck. He says that he never gets headaches and that is why this makes him particularly concerned. He has had no neck injuries in the past and no car accidents. He has never had a concussion injury. Past Medical History: abdominal hernia Social History: ___ Family History: Father died ___ years ago from a stomach cancer Mother - hypertension 2 children - both healthy Physical Exam: Vitals: 97.2 68 136/77 16 99% RA General: Awake, cooperative, has some head pain, but not in acute distress. HEENT: NC/AT Neck: Supple, no carotid bruits appreciated. No nuchal rigidity Pulmonary: CTABL Cardiac: RRR, no murmurs Abdomen: soft, nontender, nondistended Extremities: no edema, pulses palpated Skin: no rashes or lesions noted. Neurologic: -Mental Status: Alert, oriented x 3. Able to relate history without difficulty. Attentive, digit span to 7. Language is fluent with intact repetition and comprehension. Normal prosody. There were no paraphasic errors. Pt. was able to name both high and low frequency objects. Able to read without difficulty. Speech was not dysarthric. Able to follow both midline and appendicular commands. Pt. was able to register 3 objects and recall ___ at 5 minutes. The pt. had good knowledge of current events. There was no evidence of apraxia or neglect. -Cranial Nerves: I: Olfaction not tested. II: PERRL 3 to 2mm and brisk. VFF to confrontation. Funduscopic exam revealed no papilledema, exudates, or hemorrhages. III, IV, VI: EOMI. ___ beats of end-gaze nystagmus on left lateral gaze. Normal saccades. V: Facial sensation intact to light touch. VII: No facial droop, facial musculature symmetric. VIII: Hearing intact to finger-rub bilaterally. IX, X: Palate elevates symmetrically. XI: ___ strength in trapezii and SCM bilaterally. XII: Tongue protrudes in midline. -Motor: Normal bulk, tone throughout. No pronator drift bilaterally. No adventitious movements, such as tremor, noted. No asterixis noted. Delt Bic Tri WrE FFl FE IO IP Quad Ham TA ___ L 5 ___ ___ 5 5 5 5 5 5 5 R 5 ___ ___ 5 5 5 5 5 5 5 -Sensory: No deficits to light touch, pinprick, cold sensation, vibratory sense, proprioception throughout. No extinction to DSS. -DTRs: Bi Tri ___ Pat Ach L 2 2 2 2 1 R 2 2 2 2 1 Plantar response was flexor bilaterally. -Coordination: No intention tremor, no dysdiadochokinesia noted. No dysmetria on FNF or HKS bilaterally. -Gait: Good initiation. Narrow-based, normal stride and arm swing. Able to walk in tandem without difficulty. Romberg absent. Discharge Physical Exam: Normal, as documented above. Pertinent Results: ___ 05:00PM CEREBROSPINAL FLUID (CSF) PROTEIN-36 GLUCOSE-68 ___ 05:00PM CEREBROSPINAL FLUID (CSF) WBC-1 RBC-1* POLYS-4 ___ ___ 10:00AM GLUCOSE-106* UREA N-13 CREAT-0.9 SODIUM-140 POTASSIUM-5.1 CHLORIDE-106 TOTAL CO2-24 ANION GAP-15 ___ 10:00AM estGFR-Using this ___ 10:00AM CALCIUM-9.0 PHOSPHATE-3.2 MAGNESIUM-2.0 ___ 10:00AM WBC-6.6 RBC-4.92 HGB-15.1 HCT-44.1 MCV-90 MCH-30.7 MCHC-34.3 RDW-13.2 ___ 10:00AM NEUTS-61.1 ___ MONOS-5.4 EOS-2.3 BASOS-1.4 ___ 10:00AM PLT COUNT-291 ___ 10:00AM ___ PTT-36.9* ___ CTA: IMPRESSION: 1. No acute intracranial hemorrhage or mass effect. Mild mucosal thickening in the ethmoid air cells. 2. Patent major intra- and extra-cranial arteries as described above. No abnormal enhancement in the cavernous sinuses during the arterial phase images to suggest an obvious arteriovenous communication. 3. Mild degenerative changes noted in the cervical spine, without significant canal stenosis. Anterior osteophytes are also noted in the upper thoracic spine imaged. Other details as above. Brief Hospital Course: ___ is a ___ year old right handed man who presented to the ED for evaluation of a headache that has been present for the past 4 days. The patient was admitted to Neurology for further work-up and observation. He received a LP that demonstrated high normal pressure. A CT scan was normal without evidence of bleeding or blood clot. His headache improved overnight with IVF and conservative treatments. He was discharged in good condition with Topamax for headache prophylaxis. Medications on Admission: None Discharge Medications: 1. Topiramate (Topamax) 25 mg PO DAILY qhs RX *topiramate 25 mg See Instructions Tablet(s) by mouth at bedtime Disp #*60 Each Refills:*1 2. Acetaminophen-Caff-Butalbital ___ TAB PO Q6H:PRN headache RX *Fioricet 50 mg-325 mg-40 mg ___ Tablet(s) by mouth q6-8 hours Disp #*18 Each Refills:*0 Discharge Disposition: Home Discharge Diagnosis: Headache Discharge Condition: Mental Status: Clear and coherent. Level of Consciousness: Alert and interactive. Activity Status: Ambulatory - Independent. Neuro Exam: Normal neurologic exam. Discharge Instructions: Mr. ___, you were admitted with a headache. You received a spinal tap that demonstrated high normal pressure. A CT scan was normal without evidence of bleeding or blood clot. You did well overnight without further episodes. You are being discharged with a medication that can help prevent headaches, called Topamax. You should start with 25 mg at bedtime and increase to 50 mg at bedtime in 2 weeks. You should get some basic labs done the week following increasing that medication. This medication can cause a tingling feeling in your hands and can decrease your appetite. It also puts you at risk for kidney stones, so it is important to stay hydrated. You should continue taking any of your regular home medications. When you get a headache, you should take Fioricet ___ tabs every ___ hours or ibuprofen 600 mg every 6 hours as needed. Take ibuprofen with food. If you need either of these medications more than 3 days in a row, please call your doctor as this medication can cause stomach problems and give you rebound headaches. Followup Instructions: ___
19714173-DS-11
19,714,173
24,019,764
DS
11
2142-01-17 00:00:00
2142-01-17 17:00:00
Name: ___ Unit No: ___ Admission Date: ___ Discharge Date: ___ Date of Birth: ___ Sex: F Service: MEDICINE Allergies: No Known Allergies / Adverse Drug Reactions Attending: ___ Chief Complaint: hyperglycemia, DKA Major Surgical or Invasive Procedure: None History of Present Illness: Patient is a ___ female history of type 1 diabetes, complicated by recurrent episodes of gastroparesis, DKA, initially transferred from ___ for DKA iso EtOH intoxication and missed doses of insulin. Intially presented to ___ with glucose greater than 500. Initial labs notable for a potassium of 3.3, a bicarbonate of 13->8 with positive ketones and initial blood pH of 7.3. The patient was given 3 L normal saline, insulin drip, and transferred to ___ given lack to ICU beds at ___. On arrival to ED here, initial VS notably only for tachycardia to 120's. Labs again revealed bicarb of 7, glucose of 147, pH of 7.19. Patient was started on an insulin drip and admitted to MICU. Her gap closed and she was transitioned to subQ insulin on ___. However, shortly thereafter, she became hypoglycemic to the 70's for dinner and again to 50's-60's AM of transfer. Pt seen by ___ who recommended dose reducing her Levemir from 18->14->10 BID and decreasing Humalog to 4TID with meals. When seen on the floor, pt appears well and c/o just some mild nausea. She otherwise denies further fevers/chills, SOB, cough, abdominal pain, dysuria, or urinary frequency. FSBG's have been in the low 200's. Past Medical History: 1. Type 1 DM 2. Gastroparesis 3. GERD 4. Generalized anxiety disorder 5. Mitral valve prolapse recently diagnosed due to exertional dyspnea, orthostatic hypotension, and persistent tachycardia 6. Chronic otitis media with right eardrum perforation Social History: ___ Family History: Father with 2 heart attacks in his ___. Mother with breast cancer. Healthy siblings Physical Exam: Admission to the floor: VITALS: PO 149 / 89 96 20 99 RA GENERAL: Alert, oriented, no acute distress HEENT: Sclera anicteric, MMM, oropharynx clear NECK: supple, JVP not elevated, no LAD LUNGS: Clear to auscultation bilaterally, no respiratory distress CV: RRR, normal S1 S2, III/VI systolic murmur heard best in the LUSB ABD: soft, non-tender, non-distended, bowel sounds present, no rebound tenderness or guarding, no organomegaly EXT: Warm, well perfused, 2+ pulses, no clubbing, cyanosis or edema NEURO: AOx3, CNII-XII intact. Strength and sensation grossly intact. Discharge physical exam: VSS: T: 98.3PO 114 / 76L Sitting 93 18 97% RA GENERAL: Alert, oriented, no acute distress HEENT: Sclera anicteric, MMM, oropharynx clear NECK: supple, JVP not elevated, no LAD LUNGS: Clear to auscultation bilaterally, no respiratory distress CV: RRR, normal S1 S2, ___ systolic murmur heard best in the LUSB ABD: soft, non-tender, non-distended, bowel sounds present, no rebound tenderness or guarding, no organomegaly EXT: Warm, well perfused, 2+ pulses, no clubbing, cyanosis or edema NEURO: AOx3, CNII-XII intact. Strength and sensation grossly intact Pertinent Results: ADMISSION LABS: ___ 02:20AM BLOOD Neuts-83.8* Lymphs-8.3* Monos-7.0 Eos-0.0* Baso-0.1 Im ___ AbsNeut-16.86* AbsLymp-1.68 AbsMono-1.40* AbsEos-0.00* AbsBaso-0.02 ___ 02:20AM BLOOD WBC-20.1* RBC-3.62* Hgb-10.3* Hct-34.0 MCV-94 MCH-28.5 MCHC-30.3* RDW-14.8 RDWSD-51.3* Plt ___ ___ 07:22AM BLOOD WBC-13.1* RBC-3.28* Hgb-9.3* Hct-31.7* MCV-97 MCH-28.4 MCHC-29.3* RDW-15.1 RDWSD-53.0* Plt ___ ___ 02:00AM BLOOD WBC-7.6 RBC-3.28* Hgb-9.3* Hct-29.6* MCV-90# MCH-28.4 MCHC-31.4* RDW-15.2 RDWSD-50.1* Plt ___ ___ 03:04AM BLOOD WBC-5.1 RBC-3.35* Hgb-9.5* Hct-29.7* MCV-89 MCH-28.4 MCHC-32.0 RDW-15.1 RDWSD-48.9* Plt ___ ___ 05:28AM BLOOD WBC-5.6 RBC-3.59* Hgb-10.1* Hct-31.7* MCV-88 MCH-28.1 MCHC-31.9* RDW-15.0 RDWSD-48.5* Plt ___ ___ 06:15AM BLOOD WBC-5.2 RBC-3.86* Hgb-10.9* Hct-34.1 MCV-88 MCH-28.2 MCHC-32.0 RDW-14.9 RDWSD-47.4* Plt ___ ___ 05:34AM BLOOD WBC-6.0 RBC-3.95 Hgb-11.1* Hct-35.0 MCV-89 MCH-28.1 MCHC-31.7* RDW-14.9 RDWSD-47.1* Plt ___ ___ 05:47AM BLOOD WBC-6.6 RBC-3.91 Hgb-11.1* Hct-34.6 MCV-89 MCH-28.4 MCHC-32.1 RDW-14.7 RDWSD-46.5* Plt ___ ___ 02:20AM BLOOD ___ PTT-27.2 ___ ___ 02:20AM BLOOD Plt ___ ___ 07:22AM BLOOD Plt ___ ___ 10:35AM BLOOD ___ PTT-25.0 ___ ___ 02:00AM BLOOD ___ PTT-23.6* ___ ___ 02:00AM BLOOD Plt ___ ___ 03:04AM BLOOD ___ PTT-31.2 ___ ___ 03:04AM BLOOD Plt ___ ___ 05:28AM BLOOD Plt ___ ___ 03:04AM BLOOD ___ PTT-31.2 ___ ___ 06:15AM BLOOD Plt ___ ___ 05:34AM BLOOD Plt ___ ___ 05:47AM BLOOD Plt ___ ___ 02:20AM BLOOD Glucose-176* UreaN-10 Creat-0.7 Na-135 K-4.0 Cl-104 HCO3-7* AnGap-28* ___ 07:22AM BLOOD Glucose-124* UreaN-8 Creat-0.6 Na-136 K-4.1 Cl-112* HCO3-12* AnGap-16 ___ 10:30AM BLOOD Glucose-194* UreaN-8 Creat-0.5 Na-136 K-3.7 Cl-112* HCO3-11* AnGap-17 ___ 02:51PM BLOOD Glucose-227* UreaN-5* Creat-0.5 Na-135 K-4.1 Cl-112* HCO3-13* AnGap-14 ___ 08:55PM BLOOD Glucose-77 UreaN-3* Creat-0.4 Na-141 K-3.2* Cl-117* HCO3-16* AnGap-11 ___ 02:00AM BLOOD Glucose-132* UreaN-<3* Creat-0.4 Na-140 K-3.8 Cl-116* HCO3-17* AnGap-11 ___ 05:08PM BLOOD Glucose-79 UreaN-3* Creat-0.4 Na-140 K-3.6 Cl-111* HCO3-19* AnGap-14 ___ 03:04AM BLOOD Glucose-90 UreaN-<3* Creat-0.3* Na-145 K-3.3 Cl-113* HCO3-23 AnGap-12 ___ 05:28AM BLOOD Glucose-211* UreaN-7 Creat-0.4 Na-142 K-3.9 Cl-106 HCO3-26 AnGap-14 ___ 06:15AM BLOOD Glucose-251* UreaN-10 Creat-0.4 Na-134 K-4.0 Cl-99 HCO3-25 AnGap-14 ___ 02:20AM BLOOD ALT-15 AST-25 AlkPhos-86 TotBili-0.2 ___ 02:00AM BLOOD ALT-11 AST-14 LD(LDH)-155 AlkPhos-67 TotBili-0.2 ___ 02:20AM BLOOD Albumin-4.2 Calcium-8.3* Phos-2.3* Mg-2.1 ___ 10:30AM BLOOD Calcium-7.6* Phos-1.4* Mg-2.1 ___ 08:55PM BLOOD Calcium-7.6* Phos-1.6* Mg-2.0 ___ 02:00AM BLOOD Calcium-8.0* Phos-1.3* Mg-2.0 Iron-70 ___ 05:08PM BLOOD Calcium-8.6 Phos-2.9 Mg-1.9 ___ 03:04AM BLOOD Calcium-8.2* Phos-3.2 Mg-1.8 ___ 05:28AM BLOOD Calcium-8.5 Mg-2.1 ___ 06:15AM BLOOD Calcium-9.0 Phos-3.9 Mg-2.0 ___ 05:34AM BLOOD Calcium-9.1 Phos-3.5 Mg-2.0 ___ 05:47AM BLOOD Calcium-9.2 Phos-4.2 Mg-2.1 ___ 02:00AM BLOOD calTIBC-255* Ferritn-66 TRF-196* ___ 01:00PM BLOOD D-Dimer-435 ___ 05:28AM BLOOD TSH-1.8 ___ 01:00PM BLOOD HCG-<5 ___ 02:20AM BLOOD HCG-<5 ___ 02:20AM BLOOD ASA-NEG Ethanol-NEG Acetmnp-9* Bnzodzp-NEG Barbitr-NEG Tricycl-NEG ___ 02:24AM BLOOD ___ pO2-23* pCO2-22* pH-7.19* calTCO2-9* Base XS--19 ___ 02:32AM BLOOD Comment-GREEN ___ 10:44AM BLOOD Type-ART pO2-88 pCO2-27* pH-7.34* calTCO2-15* Base XS--9 ___ 03:11PM BLOOD ___ pO2-41* pCO2-30* pH-7.33* calTCO2-17* Base XS--8 ___ 09:17PM BLOOD ___ pO2-41* pCO2-30* pH-7.37 calTCO2-18* Base XS--6 ___ 02:24AM BLOOD Glucose-169* ___ 02:32AM BLOOD Lactate-2.1* ___ 10:44AM BLOOD Lactate-0.6 Urine culture: **FINAL REPORT ___ URINE CULTURE (Final ___: Culture workup discontinued. Further incubation showed contamination with mixed skin/genital flora. Clinical significance of isolate(s) uncertain. Interpret with caution. ESCHERICHIA COLI. >100,000 CFU/mL. PRESUMPTIVE IDENTIFICATION. Cefazolin interpretative criteria are based on a dosage regimen of 2g every 8h. SENSITIVITIES: MIC expressed in MCG/ML _________________________________________________________ ESCHERICHIA COLI | AMPICILLIN------------ <=2 S AMPICILLIN/SULBACTAM-- <=2 S CEFAZOLIN------------- <=4 S CEFEPIME-------------- <=1 S CEFTAZIDIME----------- <=1 S CEFTRIAXONE----------- <=1 S CIPROFLOXACIN---------<=0.25 S GENTAMICIN------------ <=1 S MEROPENEM-------------<=0.25 S NITROFURANTOIN-------- <=16 S PIPERACILLIN/TAZO----- <=4 S TOBRAMYCIN------------ <=1 S TRIMETHOPRIM/SULFA---- <=1 S CTA chest ___ FINDINGS: The aorta and its major branch vessels are patent, with no evidence of stenosis, occlusion, dissection, or aneurysmal formation. There is no evidence of penetrating atherosclerotic ulcer or aortic arch atheroma present. The pulmonary arteries are well opacified to the subsegmental level, with no evidence of filling defect within the main, right, left, lobar, segmental or subsegmental pulmonary arteries. The main and right pulmonary arteries are normal in caliber, and there is no evidence of right heart strain. A right-sided PICC line terminates within the proximal right atrium. There is no supraclavicular, axillary, mediastinal, or hilar lymphadenopathy. The thyroid gland appears unremarkable. There is no evidence of pericardial effusion. There is no pleural effusion. There is no evidence of pulmonary parenchymal abnormality. The airways are patent to the subsegmental level. Limited images of the upper abdomen are unremarkable. No lytic or blastic osseous lesion suspicious for malignancy is identified. IMPRESSION: No evidence of pulmonary embolism or aortic abnormality.   Chest X-ray ___ No acute cardiopulmonary process DISCHARGE LABS: ___ 05:47AM BLOOD WBC-6.6 RBC-3.91 Hgb-11.1* Hct-34.6 MCV-89 MCH-28.4 MCHC-32.1 RDW-14.7 RDWSD-46.5* Plt ___ ___ 05:47AM BLOOD Glucose-307* UreaN-17 Creat-0.5 Na-134 K-4.1 Cl-98 HCO3-22 AnGap-18 ___ 03:04AM BLOOD ALT-12 AST-16 LD(LDH)-166 AlkPhos-66 TotBili-0.2 ___ 05:47AM BLOOD Calcium-9.2 Phos-4.2 Mg-2.1 Brief Hospital Course: Patient is a ___ female history of type 1 diabetes, complicated by recurrent episodes of gastroparesis, DKA, transferred from ___ for DKA. # DKA: Pt presented with ___ with AGMA with glucose >600, ketones in the urine in the setting of missing doses of home insulin. Pt does not c/o obvious localizing symptoms but UA grossly dirty and culture growing >100,00K Ecoli so UTI may also be possible trigger. Pt noted to have some hypoglycemia s/p restarting SubQ insulin but most recent FSBG's have been in the low 200's range. ___ was following and home levemir changed to to 12 units bid and with 6U TID Humalog and 1:50 ISS for FSBG >150. FSBG's on this regimen were stabilized largely in the 200's. Pt encouraged to f/u closely with her Endocrinologist post-discharge. # Leukocytosis/fever # UTI Pt presented with leukocytosis to 20, recorded low grade fever of 100.4 with positive UA and culture >100K E.coli. She was treated with 7 day course of cipro for complicated UTI given poorly controlled MD # Tachycardia: Pt presented with tachycardia to the 110's-120's. Likely ___ an element of volume depletion form DKA, however, did not seem to respond very well to fluid resuscitation. Patient with baseline supraventricular tachycardia/orthostatic hypotension/dyspnea on exertion w/ recent ECHO showing MVP. Patient undergoing outpatient work-up for this. HR's on transfer to the floor have been in the 90's, however upon standing and ambulating is going to 130s. CT-PE protocol ordered and is negative for PE. Discussed ___ with pt's OP Cardiologist, Dr. ___, ___ she plans on continuing work-up with holter monitor after pt is discharged. CHRONIC ISSUES: ================= # Insomnia: Continued home Mirtazapine # GAD: Continued home Venlafaxine #GERD: Continued omeprazole Billing: greater than 30 minutes spent on discharge counseling and coordination of care. Medications on Admission: The Preadmission Medication list is accurate and complete. 1. Verapamil SR 120 mg PO Q24H 2. Omeprazole 20 mg PO DAILY 3. Mirtazapine 15 mg PO QHS 4. Venlafaxine XR 150 mg PO DAILY 5. Atorvastatin 40 mg PO QPM 6. Levemir 15 Units Breakfast Levemir 25 Units Bedtime Insulin SC Sliding Scale using HUM Insulin Discharge Medications: 1. Ciprofloxacin HCl 500 mg PO Q12H Duration: 3 Days RX *ciprofloxacin HCl [Cipro] 500 mg 1 tablet(s) by mouth every 12 hours Disp #*6 Tablet Refills:*0 2. Docusate Sodium 100 mg PO BID 3. Ferrous Sulfate 325 mg PO DAILY 4. Levemir 15 Units Breakfast Levemir 25 Units Bedtime Insulin SC Sliding Scale using HUM Insulin 5. Omeprazole 20 mg PO BID 6. Atorvastatin 40 mg PO QPM 7. Mirtazapine 15 mg PO QHS 8. Venlafaxine XR 150 mg PO DAILY 9. Verapamil SR 120 mg PO Q24H Discharge Disposition: Home Discharge Diagnosis: Hyperglycemia Tachycardia UTI Discharge Condition: Mental Status: Clear and coherent. Level of Consciousness: Alert and interactive. Activity Status: Ambulatory - Independent. Discharge Instructions: Ms. ___, You were hospitalized for elevated sugars. Your insulin dosage was adjusted while you were hospitalized. You were also treated for a UTI while you were here. You were also evaluated for your elevated heart rate and your shortness of breath. Your CT of your chest did not show evidence of a pulmonary embolism. Please ___ with your Cardiologist for further w/u of this. She will also reschedule your Holter Monitor placement. We wish you all the best in your recovery. Best wishes, Your ___ team Followup Instructions: ___
19714298-DS-14
19,714,298
25,768,961
DS
14
2159-06-07 00:00:00
2159-06-07 21:26:00
Name: ___ Unit No: ___ Admission Date: ___ Discharge Date: ___ Date of Birth: ___ Sex: F Service: MEDICINE Allergies: levofloxacin / Dilaudid / Celexa / Flagyl Attending: ___. Chief Complaint: dizziness and headache Major Surgical or Invasive Procedure: cardiac cath -- endovascular with stent placement in left subclavian artery History of Present Illness: Ms ___ is a ___ female with a history of moderate/severe aortic stenosis, A. fib on warfarin, HTN and previous PE, t/f left vertebral artery dissection who presented from ___ w/ reported chest pain radiating into her right arm, intermittent shortness of breath and neck pain The patient states she has had intermittent dizziness over the course of 1.5 weeks that occurred about ___ times. Each time lasting on the order of ___ seconds. She was able to recall one time in which it occurred while standing up and got better with sitting down. She reports that she has had occasional dizziness over the past year but usually not this frequent. She also reported that dizziness was different from prior episodes. Prior episodes were usually the room spinning. These were described as lightheadedness that affected her vision. She also endorsed intermittent headache. She thinks that she was not drinking enough water during this time. She denies chest pain/pressure during this episodes and stated she did not have any leading up to this admission. The last episode of dizziness occurred about ___ days ago. However, over the past few days she then developed neck pain and arm pain. As the pain built up she then experienced pain her chest and felt short of breath. Additionally, she had numbness in her arm. Denies difficulty walking, numbness/tingling to the lower extremities. She was worried that she was having a heart attack which prompted her to go the the ED. At ___-P, there was concern for a neurologic process for which she was transferred to ___. Of note, she last saw outpt cardiologist Dr. ___ on ___ at that appointment metoprolol was restarted. In the ED, initial vitals: Afeb HR 80, BP 160/90, RR 20, 97% RA - Exam notable for: well appearing elderly female in NAD, AOx3, nystagmus with central stare, CN2-12 grossly intact, Sensation intact to light touch in all extremities, moving all extremities spontaneously, FNF intact, gait normal. - Labs notable for: CBC WNL BMP WNL Trop < 0.01 ___: 30.4 | PTT 39.7 | INR 2.5 - Imaging notable for: ___ MRI & MRA brain: Preliminary Read: IMPRESSION: 1. No acute intracranial abnormality, specifically no evidence of acute infarct, hemorrhage or intracranial mass. 2. No evidence of dissection of the vertebral arteries bilaterally. The right vertebral artery is dominant and the left vertebral artery is diminutive. 3. Patent circle of ___ without evidence of stenosis, occlusion, or aneurysm. 4. Patent bilateral cervical carotid and vertebral arteries without evidence of stenosis, occlusion, or dissection. - Patient was given: ___ 06:15 PO Acetaminophen 1000 mg ___ 10:42 PO Metoprolol Succinate XL 25 mg ___ 10:42 PO/NG Levothyroxine Sodium 75 mcg ___ 13:18 PO/NG Digoxin .125 mg - Consults: Neurology:Overall we do not think that her symptoms are due to cerebral ischemia, most likely musculoskeletal tension, induced by using special pillow. (A treatment for dissection would be anticoagulation, which she is already on) Decision was made to admit for cardiac structural etiology of her dizziness. - Vitals prior to transfer: 85 | 172/98 | 18 | 98% RA On arrival to the floor, she reported that she felt much better an did not have any dizziness. She denied having dizziness in the ED. Past Medical History: PMH: CHF, HTN, afib, HLD, PE, hypothyroidism, anxiety, asthma, back pain, bladder cancer, cervical herniated disc, insomnia, compression fractures, osteoporosis, degenerative joint disease with tendinitis, history of small bowel obstruction, glucose intolerance PSH: - cystectomy w/ ileal conduit - exploratory laparotomy and LOA for SBO - open CCY - TAH/BSO Social History: ___ Family History: Family history was noncontributory to this issue. Physical Exam: ADMISSION PHYSICAL EXAM: =================== VS: ___ 1511 Temp: 97.6 PO BP: 122/67 HR: 60 RR: 16 GENERAL: Pleasant, lying in bed comfortably HEENT: No nystagmus. MMM CARDIAC: Regular rate, irregular rhythm. Systolic III/VI murmur loudest at ___ and ___ with minimal radiation to carotids. No rub or gallop LUNG: CTAB, no crackles, wheezes, or rhonchi ABD: Soft, nontender, nondistended, no hepatomegaly, no splenomegaly EXT: Warm, well perfused, no lower extremity edema PULSES: 2+ radial pulses, 2+ ___ pulses, 2+ DP pulses NEURO: Alert, oriented, CN II-XII intact, motor and sensory function grossly intact SKIN: No significant rashes DISCHARGE PHYSICAL EXAM: ================== ___ ___ Temp: 98.2 PO BP: 112/70 L Lying HR: 84 RR: 18 O2 sat: 99% O2 delivery: Ra GENERAL: Pleasant, laying in bed. CARDIAC: Regular rate, irregularly irregular rhythm. Systolic III/VI murmur loudest at ___ and ___. No rub or gallops. Carotid bruit heard L>R but milder LUNG: CTAB, no crackles, wheezes, or rhonchi ABD: Soft, nontender, nondistended, + ostomy, no erythema or tenderness around bag/site EXT: Warm, well perfused, trace lower extremity edema to mid shin bilaterally PULSES: 2+ radial pulses, 2+ ___ pulses, 2+ DP pulses NEURO: Alert, oriented, CN II-XII intact, motor and sensory function grossly intact Pertinent Results: ADMISSION LABS: =========== ___ 03:59PM BLOOD WBC-9.1 RBC-5.33* Hgb-14.5 Hct-48.7* MCV-91 MCH-27.2 MCHC-29.8* RDW-14.5 RDWSD-48.0* Plt ___ ___ 03:59PM BLOOD Plt ___ ___ 11:03AM BLOOD ___ PTT-39.8* ___ ___ 11:03AM BLOOD Glucose-103* UreaN-14 Creat-0.7 Na-143 K-4.5 Cl-106 HCO3-26 AnGap-11 ___ 11:03AM BLOOD Calcium-9.4 Phos-3.7 Mg-1.9 DISCHARGE LABS: ============ ___ 04:50AM BLOOD WBC-8.5 RBC-4.77 Hgb-12.8 Hct-41.8 MCV-88 MCH-26.8 MCHC-30.6* RDW-14.3 RDWSD-45.8 Plt ___ ___ 04:50AM BLOOD ___ PTT-34.1 ___ ___ 04:50AM BLOOD Plt ___ ___ 04:50AM BLOOD Glucose-105* UreaN-18 Creat-0.7 Na-142 K-4.3 Cl-106 HCO3-27 AnGap-9* ___ 04:50AM BLOOD Calcium-9.1 Phos-3.4 Mg-1.9 IMAGING: ======== ___ MRI/MRA Brain 1. No acute intracranial abnormality. Specifically, no evidence of acute infarct, hemorrhage or intracranial mass. 2. Right temporal lobe encephalomalacia, presumably sequela of prior infarct is identified. 3. There is severe short-segment stenosis, with near occlusion of the left subclavian artery just prior to the takeoff of the left vertebral artery and of the proximal left vertebral artery. There is distal reconstitution of the left subclavian artery. There is retrograde flow through the remainder of the left vertebral artery from the mid V1 segments to the V4 segment. 4. No T1 hyperintense signal of the left vertebral artery to suggest mural thrombus and acute dissection. 5. There is approximately 40% stenosis of the left cervical internal carotid artery by NASCET criteria and 70% stenosis of the right cervical internal carotid artery by NASCET criteria. The remainder of the MRA neck is unremarkable. 6. Unremarkable MRA of the head. 7. Additional findings described above. TTE ___: Moderate to severe aortic valve stenosis with thickened/deformed leaflets and trace aortic regurgitation. Mild symmetric left ventricular hypertrophy with normal cavity size and regional/global biventricular systolic function. Moderate pulmonary artery systolic hypertension. Moderate mitral regurgitation. ___ carotid series complete: Right ICA 40-59% stenosis. Left ICA <40% stenosis. Retrograde flow in the left vertebral artery which can be seen in left subclavian steal. ___ Cardiac cath endovascular Normal left and right heart filling pressures. Aortic valve area of 1.4mm2 with peak-to-peak gradient of ~18mmhg. Normal augmentation with Dobutamine without increase in peak-to-peak gradient. Overall consistent with only moderate aortic stenosis. • Low normal cardiac function. • Moderate non-obstructive coronary artery disease. • Severe left subclavian artery disease just proximal to the take-off of the vertebral artery. S/p BMS 6x20mm Brief Hospital Course: BRIEF HOSPITAL COURSE ================================= Ms. ___ is a ___ yo F with history of moderate/severe aortic stenosis, A Fib on warfarin, HTN, and previous PE who presented to ___ with chest pain radiating to her left arm, intermittent shortness of breath, and neck pain. She also reported multiple episodes of dizziness over the past couple weeks. She had a full neurological workup including MRI/MRA that showed no acute process but did show subclavian stenosis and diminutive left vertebral artery without evidence of dissection, with reversal of flow suggestive of subclavian steal syndrome. Upon admission to ___, she reported that her dizziness has mostly resolved. She had a vascular medicine consult who recommended cardiac catheterization with upper extremity evaluation, to evaluate her aortic valve, coronary arteries, and intervene on subclavian stenosis. The catheterization demonstrated moderate non-obstructive coronary artery disease, moderate aortic stenosis, and severe left subclavian artery disease just proximal to take off of vertebral artery, now s/p stent placement with good anterograde flow. She was started on triple therapy for the stent with aspirin, Plavix, and Eliquis BID. She did well and remained hemodynamically stable. TRANSITIONAL ISSUES: ================================= [] There is approximately 40% stenosis of the left cervical internal carotid artery by NASCET criteria and 70% stenosis of the right cervical internal carotid artery by NASCET criteria. Follow up as outpatient [] plan to continue triple therapy for 1 month and then discontinue aspirin 81 mg --> please ensure patient stops aspirin after 1 month (approximately ___ [] follow up if left arm numbness/tingling symptoms have resolved after stent placement MEDICATIONS: - New Meds: plavix 75 mg daily, aspirin 81 mg daily, Eliquis 5 mg BID - Stopped Meds: warfarin - Changed Meds: simvastatin --> rosuvastatin 20 mg nightly # CODE: Full # CONTACT: ___ ___ ___ ___ ACUTE ISSUES: ========== # Subclavian steal syndrome: MRA with subclavian stenosis and reversal of vertebral artery flow. Her symptoms of intermittent lightheadedness with left arm pain/numbness were consistent with a diagnosis of subclavian steal syndrome. She was evaluated by the vascular medicine team (see below) and underwent a cardiac angiogram with stent placed in left subclavian artery. # Low flow, low gradient mild-moderate aortic stenosis Patient with history of aortic stenosis. She had an echo done inpatient that showed moderate to severe aortic valve stenosis with thickened/deformed leaflets and trace aortic regurgitation. On coronary cath, however, she had normal augmentation with dobutamine, without increase in gradient, suggesting the presence of low flow, low gradient AS, with severity overestimated by echo due to low flow state. Her AS should be classified as mild-moderate based on cath. # Atrial fibrillation Patient with history of A Fib on anticoagulation. She was maintained on daily dose of warfarin with goal INR ___ until cath scheduled. Warfarin was held in the setting of cath and day of INR was 1.9. Her warfarin was restarted for goal INR ___. # Difficult venous access Patient with very difficult venous access with inability to get labs despite multiple attempts by experienced IV nurses. ___ had a PICC placed for lab draws and this resolved the issue. CHRONIC ISSUES: ============ # Hypothyroidism - Continue home levothyroxine 100mg Medications on Admission: The Preadmission Medication list is accurate and complete. 1. Digoxin 0.125 mg PO DAILY 2. Levothyroxine Sodium 75 mcg PO DAILY 3. Simvastatin 20 mg PO QPM 4. Warfarin 4 mg PO DAILY16 5. Vitamin D 400 UNIT PO DAILY 6. flaxseed oil 1,000 mg oral DAILY 7. Metoprolol Succinate XL 25 mg PO DAILY Discharge Medications: 1. Apixaban 5 mg PO/NG BID RX *apixaban [Eliquis] 5 mg 1 tablet(s) by mouth twice a day Disp #*30 Tablet Refills:*1 2. Aspirin 81 mg PO DAILY RX *aspirin 81 mg 1 tablet(s) by mouth once a day Disp #*30 Tablet Refills:*0 3. Clopidogrel 75 mg PO DAILY to prevent stent thrombosis RX *clopidogrel 75 mg 1 tablet(s) by mouth once a day Disp #*30 Tablet Refills:*1 4. Rosuvastatin Calcium 20 mg PO QPM RX *rosuvastatin 20 mg 1 tablet(s) by mouth once a day at night Disp #*30 Tablet Refills:*0 5. Levothyroxine Sodium 100 mcg PO DAILY 6. Digoxin 0.125 mg PO DAILY 7. flaxseed oil 1,000 mg oral DAILY 8. Metoprolol Succinate XL 25 mg PO DAILY 9. Vitamin D 400 UNIT PO DAILY Discharge Disposition: Home Discharge Diagnosis: PRIMARY DIAGNOSIS: ============== Dizziness/lightheadedness Subclavian steal syndrome Moderate/severe aortic stenosis SECONDARY DIAGNOSIS: ================= Atrial fibrillation on anticoagulation Hypothyroidism Discharge Condition: Mental Status: Clear and coherent. Level of Consciousness: Alert and interactive. Activity Status: Ambulatory - Independent. Discharge Instructions: Dear Ms. ___, It was a pleasure taking part in your care here at ___! Why was I admitted to the hospital? - You were admitted for arm pain and dizziness What was done for me while I was in the hospital? - You were monitored closely for further symptoms - You had an ultrasound of your heart - You were seen by the vascular medicine team - You underwent a cardiac angiogram and they put a stent in your left subclavian artery to help with your arm symptoms What should I do when I leave the hospital? Please take all your home medications as prescribed. Please go to all of your follow up appointments and alert your doctor if you have any concerning symptoms (see below). Sincerely, Your ___ Care Team Followup Instructions: ___
19714545-DS-14
19,714,545
28,460,336
DS
14
2175-01-03 00:00:00
2175-01-03 16:12:00
Name: ___ Unit No: ___ Admission Date: ___ Discharge Date: ___ Date of Birth: ___ Sex: M Service: SURGERY Allergies: No Known Allergies / Adverse Drug Reactions Attending: ___. Chief Complaint: s/p MVC Major Surgical or Invasive Procedure: None History of Present Illness: Mr. ___ is a ___ year old male without significant past medical history who has been brought in by EMS status post EMS. The Patient was an unrestrained driver of a Jeep who struck another car and went off the road, striking a stone wall head-on at unknown speeds. There was no airbags in the vehicle, and patient was found unresponsive by a physician first responder outside of his vehicle with a leftward gaze. Patient eventually regained consciousness after approximately 4 minutes but was amnestic and perseverant. EMS arrived on scene, stabilized the patient, and brought him to the ___ ED without further issues. His injuries include left ___ left transverse process fractures, T5-10 spinous process fractures and a left ear laceration. He complained of back pain, neck pain, and left ear pain. He denied, numbness, weakness, tingling, bowel or bladder incontinence. Past Medical History: None Social History: ___ Family History: Non-contributory. Physical Exam: On admission: Temp: 98 HR: 78 BP: 144/111 Resp: 20 O(2)Sat: 100 Normal Constitutional: Boarded and collared HEENT: Pupils equal, round and reactive to light, Extraocular muscles intact Blood in the left naris. C. collar in place. Abrasion to The back of the head Chest: Breast sounds equal bilaterally. Trachea midline. No chest wall tenderness or crepitus Cardiovascular: Regular Rate and Rhythm, Normal first and second heart sounds Abdominal: Soft, Nontender, Nondistended Extr/Back: Multiple abrasions to all extremities Neuro: Speech fluent, strength and sensation grossly normal throughout On discharge: VS: 98.1, 84, 135/87, 14, 99% on room air. Pertinent Results: ___ 06:57PM BLOOD WBC-15.5* RBC-5.48 Hgb-16.4 Hct-48.2 MCV-88 MCH-29.9 MCHC-34.0 RDW-12.3 Plt ___ ___ 06:57PM BLOOD Plt ___ ___ 06:57PM BLOOD ___ PTT-32.4 ___ ___ 06:57PM BLOOD ___ 06:57PM BLOOD UreaN-16 Creat-0.9 ___ 06:57PM BLOOD Lipase-34 ___ 06:57PM BLOOD ASA-NEG Ethanol-NEG Acetmnp-NEG Bnzodzp-NEG Barbitr-NEG Tricycl-NEG ___ 07:04PM BLOOD Glucose-108* Na-143 K-3.6 Cl-106 calHCO3-22 IMAGING: CT Torso: T5-10 Spinous process fractures, L2-4 Left Transverse process fx ___ CT c-spine without contrast No acute fracture or traumatic malalignment. ___ CT chest, abdomen and pelvis with contrast Fracture of the left transverse process of L2 to L4. No other acute abnormality. ___ MRI cervical and thoracic spine 1. Severe spinal canal narrowing at C6-7 with disc protrusion indenting and remodeling of the spinal cord. There is no spinal cord signal abnormality, although artifact somewhat degrades image quality. 2. Left paracentral disc protrusion at T7-T8 resulting in flattening and remodeling of the ventral spinal cord. 3. No evidence of fracture or ligamentous injury. 4. Small bilateral pleural effusions. Brief Hospital Course: Mr. ___ was admitted to the inpatient ward under the Acute Care Surgery service after his involvement in a motor vehicle collision. As previously discussed, his injuries include T5 - 9 spinous process fractures, left 2 - 4 transverse process fractures, left ear laceration and small vertex subgaleal hematoma. The patient arrived in a cervical collar, which remained in place until CT and MR imaging confirmed there were no acute fractures or ligamentous injuries. The Plastic surgery service sutured the patient's left ear using dissolvable sutures. On hospital day 2, the patient was seen by physical and occupational therapy. Based on occupational therapy's evaluation, the patient had no cognitive deficits warranting outpatient follow up. The patient was ambulating independently, although somewhat limited by pain, but was safe to be discharged home without services. During this time, Mr. ___ was eating a regular diet and tolerating it well. He was resumed on his home medication regimen. He had no issues voiding. Mr. ___ was discharged home the afternoon of ___. He was afebrile, hemodynamically stable and in no acute distress. He will be following up with the Neurosurgery team in approximately one month. He was given a prescription for short-term pain medication. He was also instructed to place bacitracin ointment to his ear three times daily for the next week. Medications on Admission: Lisinopril-HCTZ ___, lorazepam 0.5 PRN ___ times daily, wellbutrin XL 300 daily, viagra 100qday, valacyclovir 500'', amlodipine 5mg' Discharge Medications: 1. Acetaminophen ___ mg PO Q6H:PRN pain 2. Amlodipine 5 mg PO DAILY 3. Bacitracin-Polymyxin Ointment 1 Appl TP TID 4. BuPROPion (Sustained Release) 300 mg PO DAILY 5. Hydrochlorothiazide 25 mg PO DAILY 6. Lisinopril 20 mg PO DAILY 7. OxycoDONE (Immediate Release) ___ mg PO Q4H:PRN pain RX *oxycodone 5 mg ___ tablet(s) by mouth every four (4) hours Disp #*45 Tablet Refills:*0 Discharge Disposition: Home Discharge Diagnosis: - T5 - T9 spinous process fractures - L2 - L4 transverse process fractures - Left ear laceration - Small subgaleal hematoma Discharge Condition: Mental Status: Clear and coherent. Level of Consciousness: Alert and interactive. Activity Status: Ambulatory - Independent. Discharge Instructions: You were admitted to ___ on ___ after you were involved in a motor vehicle collision. On further evaluation, you were wound to have the following injuries: - T5 - T9 spinous process fractures - L2 - L4 transverse process fractures - Left ear laceration - Small subgaleal hematoma You were evaluated by the neurosurgery team. Due to concerns of a cervical spine (neck) fracture or injury, you were kept in a cervical collar until your MRI was completed. Those results showed you had no fracture to your cervical spine or ligament injury. Your collar was removed. Your spinous process and transverse process fractures are non-operative. You are being discharged on pain medications to control the pain that they may cause. You were seen by occupational and physical therapy prior to discharge. You are now safe to be discharged home. Please take any medications you were taking prior to admission to the hospital. While taking narcotic pain medications, you should not drive or operate heavy machinery. If you become constipated from the pain medications, you may take Colace (docusate sodium) 100mg twice a day to prevent constipation. A laxative may be utilized to facilitate a bowel movement. Followup Instructions: ___
19714547-DS-8
19,714,547
25,371,645
DS
8
2183-04-04 00:00:00
2183-04-04 23:24:00
Name: ___ Unit No: ___ Admission Date: ___ Discharge Date: ___ Date of Birth: ___ Sex: M Service: MEDICINE Allergies: No Known Allergies / Adverse Drug Reactions Attending: ___. Chief Complaint: back abscess Major Surgical or Invasive Procedure: ___ line placement ___ TEE ___ History of Present Illness: ___ yo M with a history of hypertension, insulin dependent diabetes and stage V CKD not on dialysis, who presented to the emergency room today with back abscess with purulent drainage, found to have significant electrolyte abnormalities concerning for DKA, admitted to ICU on insulin gtt. On arrival to the ER, initial vital signs were 97.6 88 97/51 16 100%. Labs were notable for WBC 32, Na 125, K 3.0, Cr 8.8, bicarb 12, gap 24. He received 1.5L of NS and repeat labs showed persistent hypokalemia, hyponatremia, hypochloremia and low bicarb. ABG 7.26/25/114/12. Lactate was 1.1. He was started on the DKA pathway given low bicarb with insulin gtt at 3 units/h and D5NS + 20mEq of K @ 200cc/h. His abscess was I&D'ed with yellow purulence. There was drainage from the surrounding tissue concerning for deeper infection, thus a CT was performed which showed that the infection was confined to subcutaneous tissue with surrounding edema. Patient received a dose of vancomycin. On transfer, vitals were: 99.0 90 138/68 16 100% RA On arrival to the MICU, VS were T 101.0 BP 129/81 HR 115 RR 18 O2 100% RA. Patient reports that for the last ___ days he has been feeling increasingly lethargic, with vomiting in the morning, poor appetite, and difficult to control blood sugars in the 300-400 range. He also has had episodes of diarrhea. He has not taken his temperature, and denies chills. He denies dysuria or hematuria, nor back pain. The cyst on his back was developing for several days, but worse in the last ___ days. His brother popped it the night prior to presentation to the ER. He denies polydipsia, and has been trying to control his sugar intake. He has been drinking water and diet cranberry juice primarily. He reports increased urinary frequency. Of note, he was hospitalized at ___ on ___ for a planned eye surgery complicated by respiratory failure requiring brief intubation lasting approximately ___ hours. Review of systems: (+) Per HPI (-) Denies chest pain or shortness of breath, but currently feels palpitations. He started feeling lightheaded last night prior to presentation to the ER. He has shortness of breath when taking long walks but otherwise denies dyspnea. He denies abdominal pain, constipaiton. he occasionally has lower extremity swelling which improves with furosemide Past Medical History: Stage V chronic kidney disease DM- insulin dependent Hypertension Diabetic retinopathy h/o imperforate anus s/p repair Sickle cell trait Congenital radial abnormality of left arm s/p multiple surgeries Retinal detachment s/p repair ___ and ___ (bilateral) s/p eye surgery ___ (drain placed) Social History: ___ Family History: Mother: DM, HTN, deceased d/t MI Father: DM, HTN Brother: died at ___ of MI Uncle: lung ca Physical Exam: ADMISSION PHYSICAL EXAM =========================== Vitals- T 101.0 BP 129/81 HR 115 RR 18 O2 100% RA GENERAL: Alert, oriented, no acute distress HEENT: Sclera anicteric, conjunctival injection bilaterally, cataracts bilaterally, blind bilaterally. EOMI intact on left. MMM, oropharynx clear NECK: supple, JVP not elevated, no LAD LUNGS: Clear to auscultation bilaterally, no wheezes, rales, rhonchi CV: Regular rate and rhythm, normal S1S2, grade II/VI systolic murmur best heard at apex ABD: soft, non-tender, non-distended, bowel sounds present, no rebound tenderness or guarding, no organomegaly EXT: Warm, well perfused, 2+ pulses, no clubbing, cyanosis or edema. Patient has a congenital abnormality of his left arm with missing radius. SKIN: on the right side of the upper back there is a 4x4cm skin defect packed with guaze with edema and firm tissue underneath, no surrounding erythema. NEURO: A+Ox3 DISCHARGE PHYSICAL EXAM ========================= General: Awake, alert, appropriate, answering questions appropriately. HEENT: Blind in right eye with bilateral cataracts. CV: S1S2 RRR w/o murmurs. Lungs: CTA bilaterally w/o crackles or wheezing. Ab: Positive BS’s, NT/ND, no HSM. Ext: Congenital absence of the left radius. No lower extremity edema. Back: Abscess site is without drainage or significant erythema. Neuro: Appropriately oriented. No focal motor deficits. Pertinent Results: ADMISSION LABS ================ ___ 02:50AM BLOOD WBC-32.8*# RBC-2.84* Hgb-8.2* Hct-24.1* MCV-85 MCH-28.9 MCHC-34.2 RDW-14.1 Plt ___ ___ 02:50AM BLOOD Neuts-87.6* Lymphs-3.1* Monos-6.3 Eos-2.8 Baso-0.2 ___ 02:50AM BLOOD Plt ___ ___ 02:50AM BLOOD Glucose-186* UreaN-90* Creat-8.8* Na-125* K-3.0* Cl-92* HCO3-12* AnGap-24* ___ 07:30AM BLOOD CK(CPK)-80 ___ 07:30AM BLOOD Albumin-3.2* Calcium-7.5* Phos-4.5 Mg-1.3* ___ 10:00AM BLOOD Vanco-12.1 ___ 07:39AM BLOOD ___ pO2-114* pCO2-25* pH-7.26* calTCO2-12* Base XS--13 Comment-GREEN TOP DISCHARGE LABS =============== ___ 02:43AM BLOOD WBC-9.9 RBC-2.56* Hgb-7.1* Hct-21.7* MCV-85 MCH-27.9 MCHC-32.8 RDW-14.6 Plt ___ ___ 02:43AM BLOOD Neuts-72.3* Lymphs-15.3* Monos-6.6 Eos-5.3* Baso-0.4 ___ 02:43AM BLOOD Plt ___ ___ 02:43AM BLOOD Glucose-135* UreaN-82* Creat-7.8* Na-142 K-2.9* Cl-105 HCO3-25 AnGap-15 ___ 02:43AM BLOOD Calcium-8.0* Phos-5.6* Mg-2.3 ___ 04:00AM BLOOD Vanco-23.0* RADIOLOGY ========== TEE ___ No echocardiographic evidence of endocarditis. Symmetric left ventricular hypertrophy with normal biventricular function. Mild mitral regurgitation. CT CHEST W/O CONTRAST Study Date of ___ 5:15 AM 1. 4.6 x 2.4 cm focal area of subcutaneous stranding and edema with overlying skin defect and packing material. No undrained fluid collection. The muscle plane and deeper structures of the back are not involved. 2. Mild generalized subcutaneous edema throughout the subcutaneous fat of the back. 3. Gynecomastia. CXR ___ Right PICC ends in the proximal right atrium and can be pulled back approximately 2.0 - 2.5 cm. No pneumothorax. MICROBIOLOGY ============= ___ 5:00 am BLOOD CULTURE Blood Culture, Routine (Preliminary): STAPH AUREUS COAG +. Consultations with ID are recommended for all blood cultures positive for Staphylococcus aureus, yeast or other fungi. FINAL SENSITIVITIES. Staphylococcus species may develop resistance during prolonged therapy with quinolones. Therefore, isolates that are initially susceptible may become resistant within three to four days after initiation of therapy. Testing of repeat isolates may be warranted. SENSITIVITIES: MIC expressed in MCG/ML _________________________________________________________ STAPH AUREUS COAG + | CLINDAMYCIN-----------<=0.25 S ERYTHROMYCIN----------<=0.25 S GENTAMICIN------------ <=0.5 S LEVOFLOXACIN---------- 0.25 S OXACILLIN------------- 0.5 S TRIMETHOPRIM/SULFA---- <=0.5 S Anaerobic Bottle Gram Stain (Final ___: GRAM POSITIVE COCCI IN CLUSTERS. Reported to and read back by ___. ___ (___) ___ @ 10:48 AM. ___ 5:00 am SWAB Source: right upper back. **FINAL REPORT ___ WOUND CULTURE (Final ___: STAPH AUREUS COAG +. HEAVY GROWTH. Staphylococcus species may develop resistance during prolonged therapy with quinolones. Therefore, isolates that are initially susceptible may become resistant within three to four days after initiation of therapy. Testing of repeat isolates may be warranted. SENSITIVITIES: MIC expressed in MCG/ML _________________________________________________________ STAPH AUREUS COAG + | CLINDAMYCIN-----------<=0.25 S ERYTHROMYCIN----------<=0.25 S GENTAMICIN------------ <=0.5 S LEVOFLOXACIN---------- 0.25 S OXACILLIN------------- 0.5 S TETRACYCLINE---------- <=1 S TRIMETHOPRIM/SULFA---- <=0.5 S ___ 3:05 am STOOL CONSISTENCY: SOFT Source: Stool. **FINAL REPORT ___ C. difficile DNA amplification assay (Final ___: Negative for toxigenic C. difficile by the Illumigene DNA amplification assay. (Reference Range-Negative). Brief Hospital Course: ___ yo M with a history of DMII, stage V CKD and HTN, presenting with right back abscess and worsening renal function with metabolic acidosis. ACTIVE ISSUES ============== # Sepsis/Back Abscess Patient initially met SIRS criteria with leukocytosis and tachycardia. Sources of infection likely back abscess now s/p drainage in the ED. CT shows no extension into muscular tissue. Area was drained and packed in ER. Initially there was concern for UTI but urine culture grew only skin flora. Cdiff negative. Blood and wound cultures now growing gram positive cocci/staph aureus, now have sensitivities and vanc has been narrowed to nafcillin (day ___- ___. Patient sent home on Nafcillin and will followup with OPAT to determine length of course. # Diarrhea Patient now with perfuse diarrhea. Was Cdiff negative on ___. Restarted home dose lomitil for diarrhea. # Hypertension Home meds were initially held in the setting of sepsis. Home dose metoprolol and minoxidil were restarted. Home dose amlodipine was restarted and uptitrated to 10mg PO daily. Home dose lisinopril was stopped per renal recs. # Anemia No active bleeding, likely has basline anemia due to CKD. # Stage V CKD Progressively worsening kidney disease over the last several years, followed by Dr. ___. It appears that patient has missed many recent outpatient appointments to discuss renal replacement therapy. Worsening creatinine combined with significant electrolyte abnormalities are concerning future need for dialysis, though patient did not meet criteria for needing urgent dialysis during admission. Patient was started on sodium bicarbonate tabs. # Diabetes mellitus Patient was on humalog ___ 20 units BID at home. ___ was consulted and recommended 70/30 insulin 14 units BID with breakfast/dinner. Patient was set up # Metabolic acidosis Patient presented with low bicarbonate, and acidosis of 7.25 consistent with metabolic acidosis with appropriate compensation. He has a delt-delta of slightly less than one (___), indicating an additional non-anion gap metabolic acidosis which could be due to renal disease or patient's report of diarrhea. Blood sugar has been <300, and there is no glucose or ketones in urine so this is not due to ketoacidosis. In addition, lactate is normal. It is odd that his potassium is low and phosphate is normal, but otherwise, picture is most consistent with worsening renal function. Initially upon arrival, received bicarb infusion. Improved and was stable prior to discharge. TRANSITIONAL ISSUES ==================== - wound and blood cultures grew Staph Aureus, patient to remain on Nafcillin 2g q4hrs and will followup outpatient with infectious disease regarding length of course of antibiotics - patient with progressive kidney disease and will require close renal followup for discussions about dialysis initiation - ___ consult obtained to aid in sugar control, recommended Insulin 70/30, 14 units twice a day with breakfast and dinner Medications on Admission: The Preadmission Medication list is accurate and complete. 1. Amlodipine 5 mg PO DAILY 2. Atorvastatin 20 mg PO DAILY 3. Calcitriol 0.25 mcg PO 3X/WEEK (___) 4. Fluticasone Propionate NASAL 2 SPRY NU BID 5. Furosemide 80 mg PO QAM 6. Lisinopril 40 mg PO DAILY 7. Metoprolol Succinate XL 100 mg PO DAILY 8. Minoxidil 2.5 mg PO DAILY 9. Aspirin 81 mg PO DAILY 10. Humalog ___ 32 Units Breakfast Humalog ___ 32 Units Dinner 11. Furosemide 40 mg PO HS 12. PrednisoLONE Acetate 1% Ophth. Susp. 1 DROP LEFT EYE QID 13. Latanoprost 0.005% Ophth. Soln. 1 DROP LEFT EYE BID 14. Brimonidine Tartrate 0.15% Ophth. 1 DROP LEFT EYE BID 15. Dorzolamide 2%/Timolol 0.5% Ophth. 1 DROP LEFT EYE QHS Discharge Medications: 1. Amlodipine 10 mg PO DAILY RX *amlodipine 10 mg 1 tablet(s) by mouth daily Disp #*30 Tablet Refills:*2 2. Aspirin 81 mg PO DAILY 3. Atorvastatin 20 mg PO DAILY 4. Brimonidine Tartrate 0.15% Ophth. 1 DROP LEFT EYE BID 5. Calcitriol 0.25 mcg PO 3X/WEEK (___) 6. Dorzolamide 2%/Timolol 0.5% Ophth. 1 DROP LEFT EYE QHS 7. Furosemide 80 mg PO QAM 8. Minoxidil 2.5 mg PO DAILY 9. PrednisoLONE Acetate 1% Ophth. Susp. 1 DROP LEFT EYE QID 10. Latanoprost 0.005% Ophth. Soln. 1 DROP LEFT EYE HS 11. Metoprolol Succinate XL 100 mg PO DAILY 12. Fluticasone Propionate NASAL 2 SPRY NU BID 13. Nafcillin 2 g IV Q4H RX *nafcillin in dextrose iso-osm 2 gram/100 mL 2 g IV q4hrs Disp #*28 Intravenous Bag Refills:*0 14. Sodium Bicarbonate ___ mg PO TID RX *sodium bicarbonate 650 mg 3 tablet(s) by mouth three times a day Disp #*270 Tablet Refills:*1 15. Outpatient Lab Work Labs: ___ LFTs, CBC, Chem-10, ESR/CRP ICD-9: 790.7 Fax to ___, Attention: OPAT 16. Insulin SC Sliding Scale Insulin SC Sliding Scale using HUM Insulin 17. HumaLOG Mix ___ (insulin lispro protam-lispro) 100 unit/mL (75-25) subcutaneous BID ___ Units BID following sliding scale (Breakfast and Dinner) RX *insulin lispro protam-lispro [Humalog Mix 75-25] 100 unit/mL (75-25) ___ Units SQ twice a day Disp #*1 Vial Refills:*3 Discharge Disposition: Home With Service Facility: ___ Discharge Diagnosis: PRIMARY Abscess Staph Bacteremia Diabetes Chronic Renal Failure Discharge Condition: Mental Status: Clear and coherent. Level of Consciousness: Alert and interactive. Activity Status: Ambulatory - Independent. Discharge Instructions: Dear Mr. ___, It was a pleasure taking care of you at ___. You were admitted due to an infection in your back. You were treated with IV antibiotics and you started to feel better. You will go home with an IV line and receive IV antibiotics at home. It is very important that you continue to take these antibiotics, continue to take insulin for your diabetes and make sure you attend your followup appointments. Followup Instructions: ___
19714547-DS-9
19,714,547
29,658,686
DS
9
2185-08-27 00:00:00
2185-08-28 22:37:00
Name: ___ Unit No: ___ Admission Date: ___ Discharge Date: ___ Date of Birth: ___ Sex: M Service: MEDICINE Allergies: No Known Allergies / Adverse Drug Reactions Attending: ___. Chief Complaint: ESRD Major Surgical or Invasive Procedure: Hemodialysis Multiple pRBC transfusions during this admission (5 units total) History of Present Illness: ___ w/ hx stage V CKD ___ type 1 DM and hypertensive nephrosclerosis, legally blind ___ retinal detachment, and sickle cell trait, admitted to start hemodialysis. Patient was seen in ___ clinic yesterday ___ with cough x1 month (s/p abx?). Patient reports mild itching but otherwise minimal uremic symptoms (no anorexia/nausea/vomiting, no fatigue, no SOP/CP, no muscle weakness, pain or cramping). CXR suggested new cardiomegaly, possible pericardial effusion, and patient was directed to ED for cardiac eval before he starts dialysis. Regarding his ESRD, he has been on kidney transplant list (followed by ___ and found out on ___ that his foster nephew is a match and will be his living donor. In the ED, patients vitals were T 98.4, BP 129/70, HR 66, RR 18, SpO2 90% RA. Initial exam was generally well appearing, notable for 1+ bilateral ___ edema. No effusion on bedside US. Past Medical History: Stage V chronic kidney disease LUE AVFistula since ___ DM- insulin dependent Hypertension Diabetic retinopathy h/o imperforate anus s/p repair Sickle cell trait Congenital radial abnormality of left arm s/p multiple surgeries Retinal detachment s/p repair ___ and ___ (bilateral) Social History: ___ Family History: Mother: DM, HTN, deceased d/t MI Father: DM, HTN Brother: died at ___ of MI Uncle: lung ca Strongly positive family history for diabetes with multiple family members on dialysis. Two paternal cousins with sickle cell. Physical Exam: ======================= ADMISSION PHYSICAL EXAM: ======================= Vitals: T 97.5, BP 127/69, HR 71, RR 18, SpO2 98% RA. General: Alert, oriented, no acute distress HEENT: Sclerae anicteric, MMM, oropharynx clear Neck: supple, JVP not elevated Lungs: CTAB no crackles/wheezes CV: RRR, S1/S2, III/VI crescendo/decrescendo systolic murmur w/o radiation Abdomen: soft, NT/ND, BS+, no rebound tenderness or guarding Ext: Warm, well perfused. No wounds/ulcers on feet, significant lower extremity pitting edema up to knees, no cyanosis. L upper extremity with congenital malformation (no thumb, shortened). AVFistula of LUE with palpable thrill. Neuro: AOx3. No vision in R eye (cannot see light/dark). L eye able to see light/dark but no acuity. Cranial nerves otherwise intact. ======================= DISCHARGE PHYSICAL EXAM: ======================= Vitals: Tm 98.7 122/70, BP 76, RR 18 100% RA General: Alert, oriented, no acute distress HEENT: Sclerae anicteric, MMM, oropharynx clear Neck: supple Lungs: CTAB no crackles/wheezes CV: RRR, S1/S2, III/VI crescendo/decrescendo systolic murmur w/o radiation. No rubs. Abdomen: soft, NT/ND, BS+, no rebound tenderness or guarding Ext: Warm, well perfused. No wounds/ulcers on feet, minimal lower extremity pitting edema up to knees, no cyanosis. L upper extremity with congenital club hand malformation (no thumb, shortened forearm). AVFistula of LUE with palpable thrill. LUE is swollen from upper arm to hand is edematous, with intact sensation and radial pulse. No palpable mass or fluctuance. Neuro: AOx3. No vision in R eye (cannot see light/dark). L eye able to see light/dark but no acuity. Cranial nerves otherwise intact. Pertinent Results: =============== ADMISSION LABS: =============== ___ 11:40AM BLOOD WBC-7.3 RBC-2.33* Hgb-6.8* Hct-21.7* MCV-93 MCH-29.2 MCHC-31.3* RDW-17.3* RDWSD-59.3* Plt ___ ___ 11:40AM BLOOD Neuts-73.5* Lymphs-10.0* Monos-9.1 Eos-5.5 Baso-0.7 Im ___ AbsNeut-5.36 AbsLymp-0.73* AbsMono-0.66 AbsEos-0.40 AbsBaso-0.05 ___ 11:40AM BLOOD Plt ___ ___ 11:40AM BLOOD Glucose-124* UreaN-181* Creat-20.3* Na-141 K-4.7 Cl-89* HCO3-27 AnGap-30* ___ 11:40AM BLOOD Calcium-9.6 Phos-9.3* Mg-2.7* ___ 03:15PM BLOOD HBsAg-Negative HBsAb-Negative HBcAb-Negative ___ 03:15PM BLOOD HCV Ab-Negative ___ 11:53AM BLOOD K-4.5 =============== DISCHARGE LABS: =============== ___ 10:45AM BLOOD WBC-9.8 RBC-2.90* Hgb-8.5* Hct-25.8* MCV-89 MCH-29.3 MCHC-32.9 RDW-15.7* RDWSD-50.5* Plt ___ ___ 10:45AM BLOOD Glucose-150* UreaN-67* Creat-9.7* Na-137 K-4.6 Cl-92* HCO3-29 AnGap-21* ___ 10:45AM BLOOD Calcium-9.7 Phos-4.8* Mg-2.1 ======== IMAGING: ======== CXR ___: Vascular congestion and bilateral small pleural effusions consistent with heart failure. Increasing cardiac silhouette may suggest new cardiomegaly or pericardial effusion given patient's history of end-stage renal disease requiring dialysis. LUE US ___: 1. No evidence of deep vein thrombosis in the left upper extremity. 2. Patent arteriovenous fistula. A 1.0 x 0.5 cm hypoechoic region adjacent to the fistula is of indeterminate age and may represent a hematoma. Fistulogram ___: Conclusions: The patient has a left upper arm straight graft. The central axillary vein is completely occluded. The occlusion could not be recanalized with a wire. The graft outflow drains via large collateral with multiple draining veins to the subclavian vein. Percutaneous angioplasty of the 50% venous anastamosis stenosis with no residual stenosis. The outflow vein does remain smaller in caliber compared to the dilated axillary vein. Mild arterial limb stenosis was not treated at this time and is noncontributory to LUE swelling. Brief Hospital Course: BRIEF SUMMARY ============ Mr. ___ is a ___ year old man with history of stage V CKD ___ type 1 DM and hypertensive nephrosclerosis, legally blind ___ diabetic retinopathy & retinal detachment, chronic anemia, and sickle cell trait, admitted to start hemodialysis. ACTIVE ISSUES =============== #ESRD on HD via LUE AV Fistula: Patient started HD on ___ and AV Fistula functioned well. However, LUE developed edema after first HD session. Ultrasound ruled out DVT, confirmed patent fistula and 1cm hypoechoic region adjacent to the fistula that might represent a hematoma. Fistulogram showed complete occlusion of axillary vein that could not be re-canalized. However, graft drains via large cephalic collateral to subclavian vein. Percutaneous angioplasty was performed for 50% stenosis of venous anastamosis with no residual stenosis. Arrangements and coordination for out-patient hemodialysis included TB screen (PPD was negative) and hepatitis serologies (also negative), and patient was set up to continue hemodialysis in an outpatient basis at ___. His home Lasix, sodium bicarb, and sevelemer were discontinued. # Cardiomegaly: Work-up of the increased cardiac silhouette on CXR included a TTE, which showed normal LVEF, mild RV dilation, mild pulmonary HTN, and very small pericardial effusion, but overall no change from previous TTE in ___. Patient's mild dyspnea and slight oxygen requirement resolved after several session of hemodialysis. Likely related to his hypervolemic state on admission. #C hronic anemia ___ ESRD: Receives Aranesp every other week in outpatient setting. Required multiple pRBC transfusions during the admission as well as epo. Hb on discharge is 8.5. CHRONIC ISSUES: ================ # Type 1 DM: Most recent A1c was 5.7% in ___. # Hyperparathyroidism ___ ESRD: Continued on home calcitriol. TRANSITIONAL ISSUES: ====================== # Patient set up with outpatient HD at ___ # Home Lasix, sevelemer, and bicarb were discontinued in the setting of improved volume status and electrolyte abnormalities. # He has follow-up arranged with transplant team in ___s appointment in ___are to follow up on fistulogram. # Please continue to monitor left upper extremity arm swelling, as it is anticipated to improve over time. # CODE STATUS: Full Code (confirmed) # CONTACT: ___ (brother, ___, ___ ___ on Admission: The Preadmission Medication list is accurate and complete. 1. Aranesp (in polysorbate) (darbepoetin alfa in polysorbat) 200 mcg/mL injection EVERY 2 WEEKS 2. amLODIPine 10 mg PO DAILY 3. Atorvastatin 20 mg PO QPM 4. Calcitriol 0.5 mcg PO DAILY 5. Cephalexin 250 mg PO Q24H 6. Furosemide 160 mg PO QAM 7. Furosemide 80 mg PO QPM 8. LOPERamide 2 mg PO QID:PRN diarrhea 9. Metoprolol Succinate XL 100 mg PO DAILY 10. Minoxidil 2.5 mg PO BID 11. sevelamer CARBONATE 4000 mg PO TID W/MEALS 12. Sodium Bicarbonate 2 tabs PO BID 13. Aspirin 81 mg PO DAILY 14. Artificial Tears ___ DROP BOTH EYES PRN dry eyes 15. Dorzolamide 2%/Timolol 0.5% Ophth. 1 DROP LEFT EYE BID 16. Latanoprost 0.005% Ophth. Soln. 1 DROP LEFT EYE QHS 17. PrednisoLONE Acetate 1% Ophth. Susp. 1 DROP LEFT EYE QID Discharge Medications: 1. amLODIPine 10 mg PO DAILY 2. Aranesp (in polysorbate) (darbepoetin alfa in polysorbat) 200 mcg/mL injection EVERY 2 WEEKS 3. Artificial Tears ___ DROP BOTH EYES PRN dry eyes 4. Aspirin 81 mg PO DAILY 5. Atorvastatin 20 mg PO QPM 6. Calcitriol 0.5 mcg PO DAILY 7. Cephalexin 250 mg PO Q24H 8. Dorzolamide 2%/Timolol 0.5% Ophth. 1 DROP LEFT EYE BID 9. Latanoprost 0.005% Ophth. Soln. 1 DROP LEFT EYE QHS 10. LOPERamide 2 mg PO QID:PRN diarrhea 11. Metoprolol Succinate XL 100 mg PO DAILY 12. Minoxidil 2.5 mg PO BID 13. PrednisoLONE Acetate 1% Ophth. Susp. 1 DROP LEFT EYE QID Discharge Disposition: Home Discharge Diagnosis: PRIMARY DIAGNOSIS: ================== ESRD (starting HD this admission) Type 1 diabetes complicated by diabetic nephropathy Hyperparathyroidism ___ ESRD (and hyperphosphatemia) Anemia SECONDARY DIAGNOSIS: =================== Hypertensive nephrosclerosis Legally blind, s/p retinal detachment and laser therapy Discharge Condition: Mental Status: Clear and coherent. Level of Consciousness: Alert and interactive. Activity Status: Ambulatory - Independent. Discharge Instructions: Dear Mr. ___, We saw you in the hospital to initiate hemodialysis for your kidney disease. You were also more short of breath than previously and required extra oxygen. Echocardiogram imaging of your heart showed some enlargement of your heart, but normal contraction, and minimal extra fluid around your heart. Overall, it looked very similar to your previous one in ___. You had multiple sessions of hemodialysis during your stay at the ___, which helped remove a significant amount of the excess fluid in your body. During these sessions, you received numerous blood transfusions to help with your chronic anemia that is caused by your renal disease. When your left arm swelled up after the first hemodialysis session, we did several tests to rule out a clot in the arm and to check how well your fistula was working. You received a procedure called a fistulogram, which showed that there was a narrowing of the veins, which was then fixed. You will need to continue hemodialysis sessions regularly after leaving the hospital. As part of your work-up to receive hemodialysis in the out-patient setting, we screened you for TB and for hepatitis viruses and your results were negative. We have also stopped some of your home medications. It was a pleasure to take part in your care! Regards, Your ___ Team Followup Instructions: ___
19714853-DS-13
19,714,853
28,487,322
DS
13
2155-09-28 00:00:00
2155-09-28 20:21:00
Name: ___ Unit No: ___ Admission Date: ___ Discharge Date: ___ Date of Birth: ___ Sex: M Service: MEDICINE Allergies: No Known Allergies / Adverse Drug Reactions Attending: ___. Chief Complaint: fever Major Surgical or Invasive Procedure: None History of Present Illness: ___ yo male with history of diverticulitis, CAD s/p CABG, and AVR on aspirin/plavix who was transferred from an OSH with two days of fever, N/V and abdominal pain. He had a cataract repair on ___. On ___, he started to feel unwell. He felt "woozy" and reports poor PO intake with nausea and vomiting. Also noted to have abdominal pain that was worse when driving over bumps in the road. Denies dysuria, frequency, or urgency. He denies foley catheter placement during surgery. He denies prior UTI's. He has not had prior abdominal surgery. He reports a colonoscopy a few years ago and notes normal daily bowel movements. His last BM was on ___. His BP's are typically greater than 100. At the OSH, he was febrile, and persistently hypotensive despite 3L fluid. He was exquisitely tender to palpation abdominal exam with guarding most notably in right lower quadrant. Non-con CT abd did not reveal any acute abdominal issue. There was concern for ischemic bowel, so he was given 1 dose zosyn and transferred. In the ED, initial VS: 5 98.8 114 98/57 20 94% on RA. - Labs were notable for lactate 1.5, trop 0.13, and Cr 2.6 - UA w/ UTI - portable CXR w/o obvious pneumonia; possible mild bibasilar atelectasis/effusion - gen surg consult: no need for OR - noncon CT from OSH: stone, AAA without extravastation, no wall thickening about gall bladder, no free air or fluid - blood pressures dipping into 80-90s systolic with HR around 100, sat 96% on 3L O2, afebrile - Total 5L NS received (3 @OSH, 2 here) - 20g in right AC, 22g in left AC both from OSH - Abdominal exam still with severe tenderness to palpation throughout stay, no rebound or guarding - foley new from OSH Vitals prior to transfer were: ___ 20 95% on 2L. On arrival to the MICU, he is currently nauseated but passing gas. He reports ___ squeezing abdominal pain that was initially over the right side of the abdomen but is now moving to the left side. He is thirsty but denies any lightheadedness or dizziness. Review of systems: (+) Per HPI, cough, weight loss, occaisional exertional chest pain (-) Denies fever, chills, night sweats, recent weight gain. Denies headache, sinus tenderness, rhinorrhea or congestion. Denies shortness of breath, or wheezing. Denies chest pressure, palpitations, or weakness. Denies diarrhea. Denies arthralgias or myalgias. Denies rashes or skin changes. Past Medical History: CAD s/p MI ___ years ago, CABG with AVR in ___iverticulitis Pancreatitis GERD s/p bilateral TKR Glaucoma in right eye s/p cataract repair in left eye Social History: ___ Family History: No family history of heart disease Physical Exam: ADMISSION EXAM: Vitals: 98.4 93 ___ 16 99% on 2L General: Alert, oriented, no acute distress HEENT: Sclera anicteric, MMM, oropharynx clear, EOMI, PERRL Neck: supple, JVP at 8, no LAD CV: Tachycardic, normal S1 + S2, no murmurs, rubs, gallops Lungs: decreased breath sounds throughout but mostly at left base, crackles at right base Abdomen: +BS, soft, exquisitely tender to palpation and percussion, distended, no rebound, mild guarding Back: no CVA tenderness Ext: warm, well perfused, 2+ pulses, 1+ bilateral ___ edema Neuro: CNII-XII intact, ___ strength upper/lower extremities, grossly normal sensation, 2+ reflexes bilaterally, gait deferred, finger-to-nose intact . DISCHARGE EXAM: Vitals: T 98.6 BP 146/68 RR 20 O2 sat 96% Physical Exam Gen: sitting up in bed appears comfortable in NAD HEENT- EOMI, MMM Neck - supple, no JVD, no LAD Chest- nl S1 S2 no M/R/G LUNGS- CTAB NO W/R/R ABDOMEN-soft NTND, no rebound Neuro- AOx3 Pertinent Results: ADMISSION LABS: ___ 09:35PM BLOOD WBC-14.1* RBC-3.28* Hgb-10.3* Hct-32.0* MCV-98 MCH-31.3 MCHC-32.1 RDW-14.0 Plt Ct-67* ___ 09:35PM BLOOD Neuts-91.5* Lymphs-5.1* Monos-3.2 Eos-0.1 Baso-0.1 ___ 06:40AM BLOOD Hypochr-1+ Anisocy-1+ Poiklo-1+ Macrocy-2+ Microcy-NORMAL Polychr-NORMAL Ovalocy-1+ Tear Dr-1+ ___ 09:35PM BLOOD ___ PTT-28.0 ___ ___ 09:35PM BLOOD Glucose-102* UreaN-49* Creat-2.6* Na-139 K-4.1 Cl-106 HCO3-20* AnGap-17 ___ 09:35PM BLOOD ALT-101* AST-132* CK(CPK)-43* AlkPhos-66 TotBili-0.6 ___ 09:35PM BLOOD Lipase-19 ___ 09:35PM BLOOD Albumin-3.0* Calcium-7.7* Phos-3.1 Mg-1.6 OTHER LABS: ___ 06:40AM BLOOD VitB12-1270* ___ 02:30PM BLOOD HBsAg-NEGATIVE HBsAb-NEGATIVE HBcAb-NEGATIVE ___ 06:40AM BLOOD PEP-NO SPECIFI IgG-716 IgA-195 IgM-36* IFE-NO MONOCLO ___ 05:00AM BLOOD Vanco-8.6* ___ 02:30PM BLOOD HCV Ab-NEGATIVE ___ 09:47PM BLOOD Lactate-1.5 ___ 09:35PM BLOOD cTropnT-0.13* ___ 06:40AM BLOOD CK-MB-5 cTropnT-0.15* ___ 03:01PM BLOOD CK-MB-5 cTropnT-0.16* ___ 03:28AM BLOOD CK-MB-4 cTropnT-0.16* ___ 02:30PM BLOOD CK-MB-4 cTropnT-0.16* REPORTS: CXR: 1. Vascular congestion could be due to volume overload (particularly if the patient is receiving volume support). 2. New left base pneumonia or atelectasis. ECHO: The left atrium is mildly dilated. The estimated right atrial pressure is ___ mmHg. There is mild symmetric left ventricular hypertrophy with normal cavity size. There is mild regional left ventricular systolic dysfunction with hypokinesis of the septum and inferior wall. The remaining segments contract normally (LVEF = 40 %). Right ventricular chamber size and free wall motion are normal. A bioprosthetic aortic valve prosthesis is present. The aortic valve prosthesis appears well seated, with normal leaflet motion and transvalvular gradients. No aortic regurgitation is seen. The mitral valve leaflets are mildly thickened. Mild (1+) mitral regurgitation is seen.There is mild pulmonary artery systolic hypertension. There is moderate tricuspid regurgitation. There is no pericardial effusion. IMPRESSION: Suboptimal image quality. Well seated, normal functioning aortic valve bioprosthesis. Mild symmetric left ventricular hypertrophy with regional systolic dysfunction c/w CAD. Puilmonary artery hypertension. Moderate tricuspid regurgitation. . KUB: Nonspecific bowel gas pattern with no evidence of bowel obstruction or perforation. RUQ U/S: 1. Ill-defined hypoechoic area in segment III of the liver is indeterminate. This finding would be better evaluated with cross-sectional imaging such as CT/MRI. 2. Cholelithiasis without sonographic evidence of acute cholecystitis. 3. Echogenic and atrophic kidneys most likely related to chronic renal disease. Bilateral simple renal cysts and non-obstructing left-sided nephrolithiasis. 4. Fusiform infrarenal abdominal aortic aneurysm appears stable to prior exam, however, is better evaluated on prior CT abdomen. CXR: Increase in mild bibasilar atelectasis. The rest of the exam is unchanged Brief Hospital Course: BRIEF CLINICAL HISTORY: ___ year old male with HTN, HLD, CAD s/p CABG who presents with four days of fatigue along with two days of fever and abdominal pain to outside hospital with course complicated by ___ on CKD, hypotension, and acute GIB. ACTIVE ISSUES: #GIB: Patient had moderate volume (~300cc) of coffee ground emesis on the afternoon of ___. Hemodynamically stable with SBPs in 130's, HR in 80's, clinically stable. The patient was bolused a liter of fluid, placed on a PPI, made NPO, had his antibiotics switched to IV, and GI was consulted. They attempted to take the patient for an EGD on ___ to the ___ ___ to have anesthesia oversee his care, but his procedure was postponed until ___. Per the endoscopy report "Esophagitis in the lower third of the esophagus and gastroesophageal junction, Erythema in the antrum consistent with mild gastritis, Otherwise normal EGD to third part of the duodenum." Given this information and a stabilization in the patient's hemoglobin and hematocrit, he was placed on PO pantoprazole 40mg BID, and allowed to resume his diet as tolerated. On ___, we resumed his ASA and the patient remained asymptomatic throughout the evening and morning. His AM labs on ___ revealed a drop in his hemoglobin and hematocrit and we again halted his ASA. He was given 2 units of pRBC on ___ and his hct increased appropriately. It was stable over the next ___ hours and he had no evidence of bleeding at the time of discharge on ___. His ASA and BB were restarted the day prior to discharge. # Hypotension: differential is septic shock with undetermined infectious source vs NSTEMI four days prior to admission. Evidence for sepsis was Fever, leukocytosis, hypotension and tachycardia. Potential sources included positive UA, but patient also reported cough and there was PNA vs atelectasis on CXR. GI source was also considered in setting of abdominal pain but work up for that was negative as below. Unfortunately Zosyn was given at OSH without BC or urine culture drawn so we do not know what to make of our negative UA. He does have toxic granulation which points towards infectious etiology though a major cardiac event could not be excluded. TTE showed inferior and septal wall hypokinesis which is new compared to TTE in ___. Troponin mildly elevated but CK-MB normal and trop remained stable. CT abdomen reviewed with radiology did not show any acute process to explain pain or elucidate source of infection. Treated empirically with Vanc/Zosyn. Blood and urine cx obtained which showed no growth. Medically managed empirically for MI with aspirin/plavix/statin. The patient was normotensive on continued to show no signs of sepsis. Vanc was discontinued and pt remained on Zosyn for 2 additional days. He continued to remain stable and af and antibiotic course was tranistioned to Cipro/Flagyl as it was thought primary SIRS event was most likely of GI etiology. # Abdominal pain: Likely this was due to constipation. CT abdomen only showed fecal loading. KUB showed constipation. RUQ US showed No cholecystis. ACS consulted on admission and said not surgical. No concern for obstruction. LFTs mildly elevated so obtained hepatitis serologies, which were all negative. Recommended serial abd exams. Pt received enema and had several large BM and improvement in symptoms. He did not complain of abdominal pain over the weekend ___ - ___. #Hypoxemia: pt was stable on 2L NC in MICU with some prominent pulm vasculature and atelectasis. Given reduced EF, and slightly elevated JVD hypoxemia was thought to be ___ mild pulm edema, especially in setting of fluid resuscitation and new reduction in EF. No signs of PE. Received small dose of lasix in MICU and SOB improved. There was a concern for aspiration on the floor and speech and swallow evaluated patient. They recommended he remain NPO until strength and mental status improved. He was transitioned to a puree diet after several days. # ___ on CKD: creatinine elevated to 2.6 on admission from baseline creatinine of 1.5. Urine lytes on admission c/w pre renal with fena of 0.59%. Pt ___ had low UOP. Given IVF. Cr trended up throughout hospital course despite fluids so renal was consulted and urine spun, showing muddy brown casts c/w ATN. ATN was thought to be ___ prolonged prerenal state given prerenal findings and hypotension on admission. SPEP and UPEP were also ordered and were negative. Cr peaked at 4.4 and thereafter trended down. #Hypernatremia: Pt's ATN was complicated by hypernatremia. Sodium peaked at 149 on ___ and pt was started on D5W. Renal was consulted and free water replacement was calculated consider free water clearance. The patients hypernatremia improved after ___ Liters of D5W. Sodium has remained stable for the rest of admission. # Thrombocytopenia: Per records, Plt have been in low 100s in PCP's office. Plats below baseline on admission and trended down with no signs of bleeding. No schistocytes on smear so TTP /HUS thought to be less likely. Held SC heparin once plats dropped below 50. We trended platelets and they were in the 200s at the time of discharge. # HTN: held home antihypertensives on admission. His home meds were restarted started with metoprolol once BP stabilized above 140/90, but metoprolol was held in the setting of GIB. Blood pressures remained stable. His BB was restarted the day prior to discharge. His ramipril was also continued at the time of discharge. # Gout: renally dosed allopurinol # Recent cataract surgery: continued prednisolone, ketorlac # Med rec: continued vit D, MVI, timolol, ranitidine.held iron # CAD: Stable angina at home. trended troponins and checked EKG as above. continued aspirin, plavix, pravastatin until GIB. Imdur, metoprolol, ramipril held at first but reintroduced when patient stabilized. . - Medications on Admission: Preadmissions medications listed are incomplete and require futher investigation. Information was obtained from OSH records. 1. Allopurinol ___ mg PO DAILY 2. Doxazosin 8 mg PO HS 3. Isosorbide Mononitrate (Extended Release) 30 mg PO DAILY 4. Pravastatin 40 mg PO DAILY 5. Timolol Maleate 0.5% 1 DROP BOTH EYES BID 6. Vitamin D 1000 UNIT PO DAILY 7. Centrum Silver *NF* (multivitamin-minerals-lutein;<br>mv with min-lycopene-lutein;<br>mv-min-folic acid-lutein) 0.4-300-250 mg-mcg-mcg Oral daily 8. Ferrous Sulfate 325 mg PO DAILY 9. Aspirin 81 mg PO DAILY 10. Metoprolol Succinate XL 50 mg PO DAILY 11. Ranitidine 300 mg PO DAILY 12. Clopidogrel 75 mg PO DAILY 13. Ramipril 5 mg PO DAILY 14. ketorolac *NF* 0.5 % OS qid 15. PrednisoLONE Acetate 1% Ophth. Susp. 1 DROP LEFT EYE QID Discharge Medications: 1. Allopurinol ___ mg PO DAILY renally dosed 2. Isosorbide Mononitrate (Extended Release) 30 mg PO DAILY 3. Pravastatin 40 mg PO DAILY 4. PrednisoLONE Acetate 1% Ophth. Susp. 1 DROP LEFT EYE QID 5. Ramipril 5 mg PO DAILY 6. Timolol Maleate 0.5% 1 DROP BOTH EYES BID 7. Simethicone 40-80 mg PO QID 8. Pantoprazole 40 mg PO Q12H 9. Acetaminophen 325-650 mg PO Q6H:PRN pain do not exceed more than 2 gram per day RX *acetaminophen 325 mg 1 tablet(s) by mouth every 6 hours Disp #*60 Tablet Refills:*0 10. Centrum Silver *NF* (multivitamin-minerals-lutein;<br>mv with min-lycopene-lutein;<br>mv-min-folic acid-lutein) 0.4-300-250 mg-mcg-mcg Oral daily 11. Doxazosin 8 mg PO HS 12. Ferrous Sulfate 325 mg PO DAILY 13. Ranitidine 300 mg PO DAILY 14. Vitamin D 1000 UNIT PO DAILY 15. Metoprolol Succinate XL 50 mg PO DAILY 16. Aspirin 81 mg PO DAILY Discharge Disposition: Extended Care Facility: ___ Discharge Diagnosis: Primary: Hypotension secondary to NSTEMI and SIRS GI bleed esophagitis CAD Discharge Condition: Mental Status: Confused - sometimes. Level of Consciousness: Alert and interactive. Activity Status: Ambulatory - requires assistance or aid (walker or cane). Discharge Instructions: Dear Mr. ___, It was a pleasure taking care of you during your admission to ___. You were transferred here due to low blood pressure and trouble with your kidneys. You were started on antibiotics because we believed there was an infection in your blood. You may have also had a minor heart attack contributing to your low blood pressure as well. Your blood pressure returned to normal and your kidneys improved, but you began to bleed into your gastrointestinal tract. You were given fluids, blood, and placed on medications to protect your stomach. You were seen by the GI doctors and had a procedure done to look for any areas of bleeding. Your procedure revealed some minor tears in your esophagus that were healing. Your blood counts stabilized and you continued to improve until discharge. Followup Instructions: ___
19715664-DS-7
19,715,664
29,713,954
DS
7
2152-09-08 00:00:00
2152-09-08 20:27:00
Name: ___ Unit No: ___ Admission Date: ___ Discharge Date: ___ Date of Birth: ___ Sex: F Service: MEDICINE Allergies: Procardia XL Attending: ___. Chief Complaint: progressive SOB Major Surgical or Invasive Procedure: ___ Cardioversion History of Present Illness: ___ w/ hx of pacemaker placement and CHF, HTN, HLD, p/w generalized weakness and increased SOB. Patient reports progressive SOB over the past week and a half and generalized weakness. She took an extra pill of furosemide 2 days last at the directionof her ___, but bp was low 100s at home so she has been taking only her regular dose for the past few days. She denies any fevers, sick contacts, cough, PND, increased swelling, adding pillows( baseline 3 pillows), CP, SOB, abdominal pain, pain on urination, nausea, vomiting, changed bowel habits. She does endorse a mild headache that has come and gone but denies diziness. No recent plane travel, opperations. At adult daycare today she was feeling weak and the nurse there checked her vitals found her to be tachycardic sent her in to the ED. In the ED, initial vital signs were: T 98.2 P ___ B146/99 R 18 O2 sat 98% RA. Exam notable for tachycardia, clear lungs, b/l edea to b/l legs. Labs were notable for troponin <.01, h/h 11.7/36.4 (at baseline) WBC 7.3 70% neutrophils, UA with moderate leukocytes , negative nitrites, BUN/Cr ___ (at baseline) proBNP 2602 ___ 209) Patient was given CeftriaXONE 1 g IV sent to the floor. On Transfer Vitals were: 98.2 128/91 114 18 98% Past Medical History: Hypertensive heart disease, Chronic diastolic heart failure. S/p dual-chamber pacemaker - implanted at the ___ ___ ___ likely for sick sinus syndrome HTN HLD Glucose intolerance. Status post hernia repair. Status post CCY. Status post shoulder surgery Social History: ___ Family History: non contributory Physical Exam: ADMISSION PHYSICAL EXAM: PHYSICAL EXAM: Vitals: 98.2 128/91 114 18 98% General: well appearing sitting in bed, speaking in full sentances, NAD HEENT: moist mucous membranes, JVP to midneck CV: tachycardic Lungs: CTA b/l with crackes at bases, no wheezes Abdomen: soft, nontender, Ext: WWP, 1+ pulses b/l, 1+ swelling to midcalf. Neuro: CN II-XII grossly intact, no pronator drift, can lift both legs off without much effort, Skin: large hyperpigmented macule on R abdomen clear boarders (this has been there for a long time, per patient) ============================================================== DISCHARGE PHYSICAL EXAM: Vitals: 97.9 131/57 59 18 97% tele: a paced v sensed in ___ General: well appearing sitting in chair breathing comfortably HEENT: moist mucous membranes, JVP 6cm at clavical, Lungs: CTA-B CV: RRR no m/r/g appreciated Abdomen: soft, nontender, no rebound/ guarding. Ext: warm and well perfused 1+ to ankles Neuro: grossly intact Skin: rectangular rash with well defined erythematous boarder on midchest. Pertinent Results: INITIAL LABS: ___ 12:20PM URINE MUCOUS-RARE ___ 12:20PM URINE RBC-0 WBC-8* BACTERIA-NONE YEAST-NONE EPI-1 TRANS EPI-<1 ___ 12:20PM URINE BLOOD-NEG NITRITE-NEG PROTEIN-NEG GLUCOSE-NEG KETONE-NEG BILIRUBIN-NEG UROBILNGN-NEG PH-6.0 LEUK-MOD ___ 12:20PM URINE COLOR-Straw APPEAR-Clear SP ___ ___ 12:20PM PLT COUNT-280 ___ 12:20PM NEUTS-70.0 ___ MONOS-4.5 EOS-4.6* BASOS-0.5 ___ 12:20PM WBC-7.3 RBC-4.69 HGB-11.7* HCT-36.4 MCV-78* MCH-24.9* MCHC-32.0 RDW-14.8 ___ 12:20PM URINE GR HOLD-HOLD ___ 12:20PM URINE UHOLD-HOLD ___ 12:20PM URINE HOURS-RANDOM ___ 12:20PM URINE HOURS-RANDOM ___ 12:20PM CALCIUM-9.4 PHOSPHATE-3.7 MAGNESIUM-2.1 ___ 12:20PM proBNP-2602* ___ 12:20PM cTropnT-<0.01 ___ 12:20PM estGFR-Using this ___ 12:20PM GLUCOSE-119* UREA N-28* CREAT-1.7* SODIUM-138 POTASSIUM-4.4 CHLORIDE-103 TOTAL CO2-22 ANION GAP-17 ___ 12:27PM LACTATE-2.6* ___ 12:27PM ___ COMMENTS-GREEN TOP ___ 09:00PM CK-MB-1 cTropnT-<0.01 ___ 09:47PM LACTATE-2.3* INTERIM LABS: ___ 07:30AM BLOOD WBC-6.4 RBC-4.40 Hgb-11.4* Hct-34.4* MCV-78* MCH-25.9* MCHC-33.2 RDW-14.7 Plt ___ ___ 07:45AM BLOOD WBC-6.7 RBC-4.46 Hgb-11.3* Hct-35.8* MCV-81* MCH-25.3* MCHC-31.4 RDW-14.7 Plt ___ ___ 06:50AM BLOOD WBC-7.4 RBC-4.41 Hgb-11.0* Hct-33.9* MCV-77* MCH-24.9* MCHC-32.4 RDW-15.0 Plt ___ ___ 05:14PM BLOOD WBC-8.1 RBC-4.52 Hgb-11.5* Hct-35.0* MCV-78* MCH-25.5* MCHC-32.9 RDW-14.9 Plt ___ ___ 07:00AM BLOOD WBC-7.9 RBC-4.62 Hgb-11.8* Hct-36.4 MCV-79* MCH-25.5* MCHC-32.5 RDW-14.8 Plt ___ ___ 07:30AM BLOOD Glucose-99 UreaN-28* Creat-1.9* Na-142 K-4.2 Cl-102 HCO3-25 AnGap-19 ___ 07:45AM BLOOD Glucose-97 UreaN-36* Creat-2.1* Na-140 K-5.1 Cl-104 HCO3-18* AnGap-23* ___ 06:50AM BLOOD Glucose-98 UreaN-35* Creat-1.7* Na-138 K-4.1 Cl-102 HCO3-26 AnGap-14 ___ 05:14PM BLOOD Glucose-103* UreaN-35* Creat-1.7* Na-137 K-4.3 Cl-102 HCO3-23 AnGap-16 ___ 07:00AM BLOOD Glucose-103* UreaN-32* Creat-1.7* Na-140 K-4.1 Cl-102 HCO3-24 AnGap-18 ___ 12:20PM BLOOD cTropnT-<0.01 ___ 09:00PM BLOOD CK-MB-1 cTropnT-<0.01 ___ 05:00PM BLOOD CK-MB-1 cTropnT-<0.01 ___ 07:30AM BLOOD Calcium-9.9 Phos-4.6* Mg-2.2 ___ 07:45AM BLOOD Calcium-8.9 Phos-5.0* Mg-2.2 ___ 06:50AM BLOOD Calcium-8.8 Phos-4.2 Mg-2.4 ___ 05:14PM BLOOD Calcium-9.3 Phos-4.4 Mg-2.4 ___ 07:00AM BLOOD Calcium-9.7 Phos-4.2 Mg-2.5 ___ 07:30AM BLOOD TSH-1.2 DISCHARGE LABS: ___ 12:55PM BLOOD WBC-8.1 RBC-4.23 Hgb-11.1* Hct-33.1* MCV-78* MCH-26.3* MCHC-33.6 RDW-14.7 Plt ___ ___ 12:55PM BLOOD Glucose-107* UreaN-38* Creat-1.9* Na-135 K-4.3 Cl-99 HCO3-22 AnGap-18 ___ 12:55PM BLOOD Calcium-9.6 Phos-4.5 Mg-2.6 ___ CXR Left-sided dual-chamber pacemaker device is noted with leads terminating in the right atrium and right ventricle, unchanged. Lung volumes are low which accentuate the size of the cardiac silhouette which appears moderately enlarged. Aorta remains tortuous and calcified. There is crowding of the bronchovascular structures with probable mild pulmonary vascular congestion. Patchy opacities in the lung bases likely reflect areas of atelectasis. A small left pleural effusion may be present. No pneumothorax is demonstrated. Multilevel degenerative changes are seen in the thoracic spine. IMPRESSION: Low lung volumes with patchy bibasilar airspace opacities, likely atelectasis. Possible mild pulmonary vascular congestion and small left pleural effusion. ___ echo The left atrium is moderately dilated. No atrial septal defect is seen by 2D or color Doppler. There is mild symmetric left ventricular hypertrophy with normal cavity size and regional/global systolic function (LVEF>55%). There is no ventricular septal defect. Right ventricular chamber size and free wall motion are normal. The ascending aorta is mildly dilated. The aortic valve leaflets (3) are mildly thickened but aortic stenosis is not present. No aortic regurgitation is seen. The mitral valve leaflets are mildly thickened. Mild to moderate (___) mitral regurgitation is seen. The tricuspid valve leaflets are mildly thickened. There is mild pulmonary artery systolic hypertension. ICAEL Accredited Electronically signed by ___, MD, Interpreting physician ___ ___ 13:47 ___ ECG Probable atrial flutter with a 2:1 conduction. Left axis deviation. Left anterior fascicular block. Non-specific ST-T wave changes. TRACING ___ ECHO No spontaneous echo contrast or thrombus is seen in the body of the left atrium/left atrial appendage or the body of the right atrium/right atrial appendage. No atrial septal defect is seen by 2D or color Doppler. Overall left ventricular systolic function is normal (LVEF>55%). Right ventricular chamber size and free wall motion are normal. There are simple atheroma in the descending thoracic aorta. The aortic valve leaflets (3) appear structurally normal with good leaflet excursion. Mild (1+) aortic regurgitation is seen. The mitral valve leaflets are mildly thickened. Moderate (2+) mitral regurgitation is seen ___ 0.2 cm2, regurgitant volume 32 mL). There is no pericardial effusion. IMPRESSION: No spontaneous echo contrast or thrombus seen in the ___. Normal biventricular systolic function. Moderate mitral regurgitation. Mild aortic regurgitation. Brief Hospital Course: ___ year old female with Chronic diastolic heart failure s/p dual-chamber pacemaker placement presents with progressive SOB and generalized weakness found to be tachycardic in new onset atrial flutter. Patient was cardioverted and started on anticoagulation and rate controlled with metoprolol. At discharge patients SOB was much improved. #atrial flutter: Patient was found to be in new onset aflutter, thought to likely driving symptoms. Labetaolol was discontinued in favor of metoprolol. Given CHADS2 score = 3 patient was started on coumadin with a heparin bridge. Patient had successful DCCV cardioversion on ___. After procedure patient experienced significant symptomatic relief. INR on discharge = 2.2 #CHF exacerbation: Patient appeared volume up on admission with elevated JVP and crackles on exam likely due to new onset aflutter causing CHF exacerbation. Initially diuresed with double home dose of IV lasix with good effect. She resumed her home dose of lasix and remained euvolemic for the remainder of her hospitalization. #HTN: Patient was found to be hypotensive on admission. Home labetalol discontinued in favor of metoprolol. After the procedure her blood pressure improved significantly to 140s systolic. She was sent home on a reduced dose of Valsartan to be uptitrated by outpatient doctors. #GERD: replace home esomeprazole with Omeprazole 40 mg PO DAILY #HLD- Not on statin given age # Code: full (confirmed) # Emergency Contact: daughter ___ (HCP) ___ (cell)/ ___ ***TRANSITIONAL ISSUES*** -Patient will need INR monitoring as an outpatient -INR goal ___ -INR on discharge 2.2 -Patient developed contact dermatitis after cardioversion. She is being treated with hydrocortisone cream. Please ensure resolution. -Labetalol was discontinued. -Patient started on metoprolol. discharged on metoprolol XL 75mg daily. -Valsartan dose reduced to 80mg BID please continue to titrate to outpatient bps. Medications on Admission: The Preadmission Medication list is accurate and complete. 1. Furosemide 20 mg PO DAILY 2. esomeprazole magnesium 40 mg oral daily 3. Labetalol 150 mg PO BID 4. Valsartan 80 mg PO QAM 5. Valsartan 160 mg PO QPM 6. Aspirin 81 mg PO DAILY 7. Cyanocobalamin 1000 mcg IM/SC MONTHLY Discharge Medications: 1. Aspirin 81 mg PO DAILY 2. Furosemide 20 mg PO DAILY 3. Valsartan 80 mg PO BID RX *valsartan [Diovan] 80 mg 1 tablet(s) by mouth twice a day Disp #*56 Tablet Refills:*0 4. Hydrocortisone Cream 1% 1 Appl TP QID RX *hydrocortisone 1 % please apply up to 4 times a day QID: PRN as needed Refills:*0 5. Cyanocobalamin 1000 mcg IM/SC MONTHLY 6. esomeprazole magnesium 40 mg oral daily 7. Metoprolol Succinate XL 75 mg PO DAILY RX *metoprolol succinate 25 mg 3 tablet(s) by mouth daily Disp #*105 Tablet Refills:*0 8. Warfarin 4 mg PO DAILY16 RX *warfarin 1 mg 4 tablet(s) by mouth daily Disp #*112 Tablet Refills:*1 Discharge Disposition: Home With Service Facility: ___ Discharge Diagnosis: Final diagnosis: atrial flutter diastolic CHF exacerbation acute on chronic Secondary Diagnosis: HTN Discharge Condition: Mental Status: Clear and coherent. Level of Consciousness: Alert and interactive. Activity Status: Ambulatory - Independent. Discharge Instructions: Dear Ms. ___, You were admitted to the hospital after you were found to have a fast heart rate and more shortness of breath. You were found to have a fast and irregular heart rate called atrial flutter. To treat you we put you on a medication called metoprolol and you had a procedure called cardioversion to restore a normal rhythm. Because this heart rate puts you at a high risk of stroke you were started on a blood thinner called coumadin. You will need to have your blood tests checked very frequently and monitored by your primary care doctor to make sure you are taking the right amount of medication. -Please stop taking labetalol at home as it is no longer needed -Losartan dose was decreased to 80 mg twice daily. Followup Instructions: ___
19715664-DS-8
19,715,664
28,113,132
DS
8
2154-04-28 00:00:00
2154-04-30 18:29:00
Name: ___ Unit No: ___ Admission Date: ___ Discharge Date: ___ Date of Birth: ___ Sex: F Service: MEDICINE Allergies: Procardia XL Attending: ___. Chief Complaint: Left elbow cellulitis Gout Major Surgical or Invasive Procedure: none History of Present Illness: ___ with PMx atrial fibrillation s/p DCCV on Coumadin, ___, SSS s/p biV pacer, HTN, who presents with L elbow swelling and erythema. Per her daughter this was noted 48 hours ago. There was no witnessed trauma, but she had a bruise earlier last week on the elbow. Since ___, elbow became painful, red, swollen. The pain has resolved. There has been no fever. The patient has not been eating since onset, and also complained of chest discomfort, initially described as discomfort with swallowing. In the ED, initial vitals were: 98.3 66 137/52 16 94% RA Exam notable for: On exam pleasant and not toxic-appearing, erythema and swelling from above L elbow to mid L forearm, no pain with palpation of skin or ROM Labs notable for: WBC 11.9 (increased from baseline), Hgb 10.4, INR 2.0, lactate 1.2, trop <0.01, Cr 1.7 (baseline) Imaging notable for: Left elbow film: IMPRESSION: 1. No fracture or dislocation. 2. No joint effusion. ECG: SR @ 60, borderline LAD, borderline LBBB, TWI III, equivocal STD V4-V6, overall CWP Patient was given: ___ 00:01 IV Vancomycin 1000 mg ___ 00:01 PO Acetaminophen 650 mg On the floor, the patient has no complaints. ROS notable for absence of nausea/emesis, weight gain, orthopnea, ___ edema, dysuria, cough. 'Chest pain' as above. Of note, patient has had nausea/epigastric discomfort as outpatient concerning for angina equivalent. ROS notable also for feeling "off balance" since poor PO intake/L elbow pain started. Past Medical History: Hypertensive heart disease, Chronic diastolic heart failure. S/p dual-chamber pacemaker - implanted at the ___ ___ ___ likely for sick sinus syndrome HTN HLD Glucose intolerance. Status post hernia repair. Status post CCY. Status post shoulder surgery Multinodular toxic goiter Elongated, unfolding aortic arch causing rightward deviation of trachea Social History: ___ Family History: non contributory Physical Exam: ON ADMISSION: VS 98.0 PO 139 / 55 61 18 95% on RA General: Alert, oriented, no acute distress HEENT: Sclera anicteric, MMM, oropharynx clear, EOMI, PERRL, neck supple, JVP not elevated, no LAD CV: Regular rate and rhythm, normal S1 + S2, ___ systolic murmur loudest at LUSB. Lungs: Clear to auscultation bilaterally, no wheezes, rales, rhonchi Abdomen: Soft, non-tender, non-distended, bowel sounds present, no organomegaly, no rebound or guarding GU: No foley Ext: Warm, well perfused, 2+ pulses, no clubbing, cyanosis, trace edema in bilateral lower extremities. MSK: Dorsal aspect of R elbow joint edematous/erythematous/indurated, but non-tender. Surrounding erythema over forearm and upper arm demarcated with marker. No pain with active/passive elbow flexion/extension. Neuro: CNII-XII intact, ___ strength upper/lower extremities, grossly normal sensation, gait deferred. ON DISCHARGE: Vitals: 98.7 122/54 60 17 97% RA General: lying in bed, knows she's at ___, comfortable HEENT: sclera anicteric, moist mucous membranes, CN intact. Neck: unable to visualize JVP Lungs: few rhonchi bilaterally CV: Regular rate and rhythm, normal S1 + S2, ___ systolic murmur loudest at ___. Abdomen: soft, non-tender, non-distended, bowel sounds present, no rebound tenderness or guarding Ext: L elbow with resolution of erythema, mild swelling. Non-tender and full ROM. BLE warm, well perfused, trace edema. No inflamed joints. Bilaterally ankles non-tender. Neuro: motor function grossly normal. Good strength in BUE. Pertinent Results: ADMISSION LABS: ___ 10:30PM BLOOD WBC-11.9*# RBC-4.20 Hgb-10.4* Hct-33.1* MCV-79* MCH-24.8* MCHC-31.4* RDW-15.0 RDWSD-42.8 Plt ___ ___ 10:30PM BLOOD Neuts-77.7* Lymphs-12.2* Monos-7.8 Eos-1.4 Baso-0.4 Im ___ AbsNeut-9.22*# AbsLymp-1.44 AbsMono-0.92* AbsEos-0.16 AbsBaso-0.05 ___ 10:30PM BLOOD ___ PTT-38.4* ___ ___ 10:30PM BLOOD Plt ___ ___ 10:30PM BLOOD Glucose-117* UreaN-20 Creat-1.7* Na-135 K-3.9 Cl-96 HCO3-25 AnGap-18 ___ 10:30PM BLOOD cTropnT-<0.01 ___ 09:16PM BLOOD CK-MB-<1 cTropnT-<0.01 ___ 10:30PM BLOOD Calcium-9.2 Phos-3.6 Mg-2.3 ___ 10:30PM BLOOD TSH-0.47 ___ 10:36PM BLOOD Lactate-1.2 DISCHARGE LABS: ___ 07:50AM BLOOD WBC-6.8 RBC-3.88* Hgb-9.6* Hct-30.3* MCV-78* MCH-24.7* MCHC-31.7* RDW-14.5 RDWSD-40.7 Plt ___ ___ 07:50AM BLOOD ___ ___ 07:50AM BLOOD Glucose-123* UreaN-32* Creat-1.7* Na-137 K-4.4 Cl-98 HCO3-25 AnGap-18 ___ 07:50AM BLOOD Calcium-9.1 Phos-4.2 Mg-2.6 ___ 07:50AM BLOOD TotProt-5.7* Calcium-8.8 Phos-4.1 Mg-2.3 IMAGING: ELBOW (AP, LAT & Oblique) ___: IMPRESSION: 1. No fracture or dislocation. 2. No joint effusion. CHEST (PORTABLE AP) ___: IMPRESSION: Comparison to ___. Improved inspiration. A density in the right lung apex is caused by a calcified costosternal junction of the first right rib. Currently there is no evidence of pneumonia. No pulmonary edema. Minimal atelectasis in the retrocardiac lung areas. Borderline size of the cardiac silhouette. Mild elongation of the descending aorta. ANKLE (AP, MORTISE & LA) ___: IMPRESSION: No acute fracture is seen. CHEST (PORTABLE AP) ___: IMPRESSION: 1. Superior portion of trachea appears shifted to the right side when compared to ___ chest radiograph; this could be secondary to low lung volumes or patient's rotated position when image was taken. However, cannot rule out a comparison mass. Recommend repeat chest x-ray with adequate inspiration for further evaluation. TRANSTHORACIC ECHOCARDIOGRAM ___: Conclusions There is mild symmetric left ventricular hypertrophy with normal cavity size and global systolic function (LVEF>55%). Due to suboptimal technical quality, a focal wall motion abnormality cannot be fully excluded. Right ventricular chamber size is normal There is an anterior space which most likely represents a prominent fat pad. CT CHEST W/O CONTRAST ___: IMPRESSION: Multinodular goiter with mild attenuation of the trachea. The rightward displacement of the trachea at the level of the superior mediastinum is due to an elongated, unfolding aortic arch. No significant attenuation of the trachea at this level. No mediastinal masses. Multiple pulmonary nodules the largest in the left upper lobe measuring 7 mm and the right upper lobe measuring 6 mm. Follow-up should be determined in the clinical context of the patient. MICROBIOLOGY: ___ 10:30 pm BLOOD CULTURE Blood Culture, Routine (Pending): ___ 11:05 pm BLOOD CULTURE Blood Culture, Routine (Pending): Brief Hospital Course: ___ yo F with PMHx atrial fibrillation s/p DCCV on Coumadin, ___, SSS s/p biV pacer, HTN, who presents with L elbow swelling and erythema and occasional chest discomfort; course as below: # Left elbow cellulitis: Non-purulent cellulitis with possible inciting incident mild trauma with possible skin break. She has an elevated white count but no fevers, tachycardia. Low concern for septic joint/hematoma; no pain or joint effusion on XRay. No risk factors or history of MRSA infection. Clinically improved with Keflex, will complete 7 day course. # Polyarthralgias: Per daughter, had shoulder, ankle pain for the last several months. Elevated ESR 106, CRP 211, uric acid 11. Per rheumatology, concerning for gout. Globulin gap normal. RF 18 (mild elevation), ___, ANCA negative. SPEP, UPEP pending. Started on prednisone 20 mg with taper for 8 day course, in addition to allopurinol 50 mg daily, with plan to follow up in ___ clinic in 1 week. She was continued on home vitamin D and started on calcium. # Chest discomfort - EKGs unchanged, troponin negative, no e/o CHF exacerbation. Recently seen as outpatient for fatigue with concern for ?angina/ hypotension/bradycardia contributing. Cardiac medications adjusted (amlodipine increased, diovan decreased, metoprolol decreased) with reported good effect. TSH 0.47. No events on telemetry, pacemaker interrogation with no arrhythmias. She may benefit from outpatient stress test and/or esophageal evaluation. She was continued on ranitidine and esomeprazole for GERD. # L ankle pain: ?unwitnessed injury during hospitalization with strain vs. sprain. Xray with no e/o fracture. Could be related to gout. She was seen by ___ who recommended rehab given acute on chronic ankle pain and weakness. Treatment of gout, as above. CHRONIC ISSUES: # Atrial fib s/p DCCV: CHADS-Vasc 5, on warfarin. Continue metoprolol & warfarin # Chronic diastolic heart failure: Appeared compensated. Continued on home metoprolol, lasix, valsartan. Evening dose Lasix 20 mg was held due to poor PO intake and hypovolemia. # HTN: Continued home amlodipine, metoprolol, valsartan # Sick sinus syndrome s/p s/p dual-chamber pacemaker placement: Pacemaker interrogated, as above. # CKD: Cr at baseline. Medications were renally-dosed. # Iron-deficiency anemia: At baseline hgb. She was continued on ferrous sulfate # Toxic multinodular goiter: Found on CT which was done for tracheal deviation (see below). TSH normal, goiter not impinging on trachea. # FEN: IVF PRN, replete electrolytes, regular diet # PPX: systemic anti-coagulation, Senna/Colace, analgesics prn # ACCESS: PIVs # CODE: Full, confirmed # CONTACT: Daughter ___ ___ # DISPO: Medicine for now -------------- Transitional issues: # L elbow cellulitis: Keflex ___ mg q8H ___ # Chest discomfort: EKGs unchanged, pacemaker with no events. ___ benefit from outpatient stress test. ___ benefit from esophageal eval as outpatient. # Gout: Started on prednisone with following taper: ___ - 20mg ; ___ mg; ___ mg; ___ - 10 mg ___ mg; ___ mg; ___ mg. Started on allopurinol 50 mg daily. ___ benefit from colchicine 0.6 every other day, given CKD, after completion of prednisone taper. Started on calcium, in addition to home medication Vitamin D, for osteoporosis protection. # Evening dose furosemide 20 mg held due to volume depletion secondary to poor PO intake. Can restart if develops dyspnea, volume overload, or weight gain of 3 lbs or more. # CXR showed tracheal deviation with no evidence of pneumothorax. Chest CT was done for further eval and showed anatomical variant elongated aorta causing rightward shift of trachea, toxic multinodular goiter (TSH normal), and pulmonary nodules. No impingement on trachea. Follow up CT in ___ months for monitoring pulmonary nodules. # Will need follow up in ___ clinic (at ___ ___ within 1 week of discharge. # CODE: Full, confirmed # CONTACT: Daughter ___ ___ ___ on Admission: The Preadmission Medication list is accurate and complete. 1. Valsartan 80 mg PO QPM 2. Metoprolol Succinate XL 50 mg PO DAILY 3. Warfarin 4 mg PO DAILY16 4. amLODIPine 5 mg PO DAILY 5. Ranitidine 150 mg PO QHS 6. Ferrous Sulfate 325 mg PO DAILY 7. Furosemide 40 mg PO QAM 8. Furosemide 20 mg PO QPM 9. esomeprazole magnesium 40 mg oral DAILY 10. Aspirin 81 mg PO DAILY 11. Cyanocobalamin 1000 mcg IM/SC QMONTHLY 12. Vitamin D 3000 UNIT PO DAILY Discharge Medications: 1. Acetaminophen 650 mg PO Q6H:PRN Pain - Mild 2. Allopurinol 50 mg PO DAILY 3. Calcium Carbonate 500 mg PO TID 4. Cephalexin 250 mg PO Q8H 5. Ipratropium-Albuterol Neb 1 NEB NEB Q6H:PRN wheezing 6. amLODIPine 5 mg PO DAILY 7. Aspirin 81 mg PO DAILY 8. esomeprazole magnesium 40 mg oral DAILY 9. Ferrous Sulfate 325 mg PO DAILY 10. Metoprolol Succinate XL 50 mg PO DAILY 11. Ranitidine 150 mg PO QHS 12. Valsartan 80 mg PO QPM 13. Vitamin D 3000 UNIT PO DAILY 14. Warfarin 2.5 mg PO 2X/WEEK (MO,FR) 15. Warfarin 2 mg PO 5X/WEEK (___) 16. HELD- Furosemide 40 mg PO QAM This medication was held. Do not restart Furosemide until pending clinical evaluation at rehab, will restart in ___ days or sooner if gain 3 or more pounds Discharge Disposition: Extended Care Facility: ___ Discharge Diagnosis: PRIMARY DIAGNOSES: Left elbow cellulitis Gout SECONDARY DIAGNOSES: Atrial fibrillation Sick sinus syndrome with pacemaker Diastolic heart failure Chronic kidney disease Discharge Condition: Mental Status: Confused - sometimes. Level of Consciousness: Alert and interactive. Activity Status: Out of Bed with assistance to chair or wheelchair. Discharge Instructions: Dear Ms. ___, You were admitted to ___ from ___ for left elbow and forearm infection (cellulitis). We treated you with antibiotics (Keflex). Your last day on this medication will be ___. Your daughter also told us about your history of joint pains. Our rheumatology team evaluated you further and found that you may have gout. You were started on prednisone for an 8 day course (doses outlined below) and allopurinol, which you will need on an ongoing basis. Prednisone can increase risk of osteoporosis so we started you on calcium, in addition, to the Vitamin D you were taking, for bone protection. We scheduled you for a follow up appointment in ___ clinic in ___ weeks. You also had vague chest discomfort a couple times in the hospital. We did not think there was dangerous cause of this. Our cardiology team interrogated your pacemaker and there was no evidence of an abnormal heart rhythm. You should follow up with a cardiologist in ___ weeks, as they might want to do additional testing. While you were in the hospital, we held your evening dose of furosemide 20 mg, because you weren't drinking as much as you normally would. You should check your weight daily and if it goes up by 3 lbs or more, you should restart this medicine. You will also need to follow up within 1 week to check your INR level for Coumadin. Thank you for allowing us to take part in your care! -Your entire ___ team Followup Instructions: ___
19715664-DS-9
19,715,664
21,615,543
DS
9
2155-04-13 00:00:00
2155-04-17 20:54:00
Name: ___ Unit No: ___ Admission Date: ___ Discharge Date: ___ Date of Birth: ___ Sex: F Service: MEDICINE Allergies: Procardia XL Attending: ___. Chief Complaint: Dyspnea Major Surgical or Invasive Procedure: None History of Present Illness: Ms. ___ is a ___ year old woman with a past medical history of atrial fibrillation s/p DCCV on Coumadin, HFpEF, SSS s/p biV pacer, HTN, gout, and dementia who presents with dyspnea. The patient's daughter provides history as the patient is ___ speaking. The patient began having symptoms three days prior to admission. She is having shortness of breath with moving a few steps. At baseline she can walk about 100 feet with a walker. The daughter also noted that the patient's heart rate was elevated to 100 transiently at rest three times over the past three days. This is associated with a mild chest pressure in the substernal region. Overall, she is feeling more weakness, fatigue, and lightheadedness. The patient denies cough, fevers, chills. She has two pillow orthopnea at baseline and this has not changed. No PND. Lower extremity edema is more notable than at baseline. No change in the diet. Denies chest pain and shortness of breath at the time of presentation to the ED. ED Course: Initial vitals 98.5 56 113/61 24 97% RA Exam: Normal heart and lung exam. Mild pitting edema. Bowel sounds present, abdomen soft, no rebound, no guarding. Labs notable for: Na 133 K 5 Cl 95 HCO3 19 BUN 48 Cr 1.9 Glucose 148 AG 19 CK 67 MB 1 Trop <0.01 NT-proBNP 4802 CBC: 10.2>10.6/33.6<270 INR 2.7 UA 2WBC, few ___ Patient was given ___ 17:15 IV Furosemide 40 mg Imaging with: CXR showing Mild interstitial pulmonary edema and mild bibasilar atelectasis. EKG shows paced with rate 60, new TWI in V2, No ischemic ST-T changes, T waves appear slightly more peaked than prior EKG. Vitals at the time of transfer 98.3 69 117/82 18 96% RA Upon arrival to the floor, the patient reports no shortness of breath or chest pain. She is comfortable at rest. She reports ___ edema is mildly improving since furosemide given. The patient's daughter reports that they dry weight is 215 lb. REVIEW OF SYSTEMS: General: no weight loss, fevers, sweats. Eyes: no vision changes. ENT: no odynophagia, dysphagia, neck stiffness. Cardiac: See HPI Resp: See HPI GI: no nausea, vomiting, diarrhea. GU: no dysuria, frequency, urgency. Neuro: no unilateral weakness, numbness, headache. MSK: no myalgia or arthralgia. Heme: no bleeding or easy bruising. Lymph: no swollen lymph nodes. Integumentary: no new skin rashes or lesions. Psych: no mood changes Past Medical History: Chronic diastolic heart failure Atrial fibrillation s/p DCCV in ___ S/p dual-chamber pacemaker - implanted at the ___ ___ ___ likely for sick sinus syndrome HTN HLD chronic recurrent tophaceous gout Glucose intolerance. Status post hernia repair. Status post CCY. Status post shoulder surgery Multinodular toxic goiter Elongated, unfolding aortic arch causing rightward deviation of trachea Social History: ___ Family History: non contributory Physical Exam: ADMISSION PHYSICAL EXAM: VITALS: 98.3 135/74 103 21 91 RA WEIGHT ON ADMISSION: 98.7 kg DRY WEIGHT: 97.5kg (per pt daughter) GEN: Well appearing and appears stated age. No acute distress. HEENT: PERRL, EOMI, Oropharynx clear with moist mucous membranes. NECK: JVP at 12cm PULM: Mild bibasilar crackles. No wheezes, rales, or rhonchi. Good air movement bilaterally CV: RRR normal S1 S2. No murmurs rubs or gallops. Radial pulses 2+ symmetric. ABD: Soft, nontender, nondistended. Bowel sounds present. EXTR: Warm, well perfused. No cyanosis, clubbing. Trace pedal edema. Full ROM in bilateral MTP. No warmth or erythema noted. NEURO: Alert and oriented. Strength ___ in upper and lower extremities. Sensation to light touch intact and symmetric. SKIN: No visible ecchymoses or rash. DISCHARGE PHYSICAL EXAM: 97.6 153 / 78 51 20 95 Ra General: sleeping comfortably, nad, easily awaken HEENT: moist mucus membranes, sclera nonicteric Neck: supple CV: irregular rhythm, no murmurs, 2+ radial pulse Lungs: clear to auscultation bilaterally, no crackles or wheezes, no use of accessory muscles Abdomen: obese abdomen, soft, nontender Ext: 1+ edema in bilateral lower extremities Neuro: oriented to self and place, grossly moving all extremities Pertinent Results: ADMISSION LABS ___ 09:30PM CK-MB-1 cTropnT-<0.01 ___ 02:05PM URINE HOURS-RANDOM ___ 02:05PM URINE HOURS-RANDOM ___ 02:05PM URINE UHOLD-HOLD ___ 02:05PM URINE GR HOLD-HOLD ___ 02:05PM URINE COLOR-Straw APPEAR-Clear SP ___ ___ 02:05PM URINE BLOOD-NEG NITRITE-NEG PROTEIN-NEG GLUCOSE-NEG KETONE-NEG BILIRUBIN-NEG UROBILNGN-NEG PH-6.0 LEUK-SM* ___ 02:05PM URINE RBC-2 WBC-2 BACTERIA-FEW* YEAST-NONE EPI-1 TRANS EPI-<1 ___ 01:10PM GLUCOSE-128* UREA N-48* CREAT-1.9* SODIUM-133 POTASSIUM-5.0 CHLORIDE-95* TOTAL CO2-19* ANION GAP-24* ___ 01:10PM CK(CPK)-67 ___ 01:10PM cTropnT-<0.01 ___ 01:10PM CK-MB-1 proBNP-4802* ___ 01:10PM WBC-10.2* RBC-3.84* HGB-10.6* HCT-33.6* MCV-88 MCH-27.6 MCHC-31.5* RDW-16.6* RDWSD-52.4* ___ 01:10PM NEUTS-81.1* LYMPHS-10.9* MONOS-4.4* EOS-2.2 BASOS-0.5 IM ___ AbsNeut-8.30* AbsLymp-1.11* AbsMono-0.45 AbsEos-0.22 AbsBaso-0.05 ___ 01:10PM PLT COUNT-270 ___ 01:10PM ___ PTT-40.9* ___ DISCHARGE LABS ___ 07:00AM BLOOD WBC-9.1 RBC-3.55* Hgb-9.7* Hct-31.2* MCV-88 MCH-27.3 MCHC-31.1* RDW-16.0* RDWSD-50.5* Plt ___ ___ 07:00AM BLOOD Plt ___ ___ 07:00AM BLOOD ___ PTT-36.2 ___ ___ 07:00AM BLOOD Glucose-98 UreaN-30* Creat-1.6* Na-140 K-3.8 Cl-100 HCO3-25 AnGap-15 ___ 07:00AM BLOOD Calcium-9.2 Phos-3.4 Mg-2.3 PERTINENT IMAGING ECHO ___ The left atrial volume index is moderately increased. No atrial septal defect is seen by 2D or color Doppler. The estimated right atrial pressure is ___ mmHg. Left ventricular wall thicknesses are normal. The left ventricular cavity size is top normal/borderline dilated. Regional left ventricular wall motion is normal. Overall left ventricular systolic function is normal (LVEF>55%). Doppler parameters are indeterminate for left ventricular diastolic function. Right ventricular chamber size and free wall motion are normal. The diameters of aorta at the sinus, ascending and arch levels are normal. The aortic valve leaflets (3) are mildly thickened but aortic stenosis is not present. No aortic regurgitation is seen. The mitral valve leaflets are structurally normal. There is no mitral valve prolapse. Mild (1+) mitral regurgitation is seen. There is moderate pulmonary artery systolic hypertension. There is no pericardial effusion. IMPRESSION: Mild left ventricular dilatation with preserved and regional/global systolic function. Mild mitral regurgitation. Pulmonary artery systolic hypertension. Compared with the prior study (images reviewed) of ___, estimated pulmonary artery pressures are higher; the technically suboptimal nature of the prior study precludes definitive comparison Brief Hospital Course: Ms. ___ is a ___ year old woman with a past medical history of atrial fibrillation s/p DCCV on Coumadin, HFpEF, SSS s/p dual chamber PPM pacer, HTN, chronic tophaceous gout, and dementia who presents with palpitations and reported dyspnea with evidence of mild pulmonary edema and an elevated BNP consistent with heart failure exacerbation. On pacemaker interrogation, patient also noted to have pacer dysfunction with RA lead fracture that likely precipitated diastolic heart failure exacerbation. Pacer was evaluated by EP and changed to VVI 50bpm with no further atrial arrhythmic events. ACTIVE ISSUES # Dyspnea # Acute on chronic diastolic CHF exacerbation - LVEF >55% # Atrial Lead Fracture Patient reported palpitations and dyspnea on exertion without significant change in orthopnea. Admission CXR showed evidence of mild pulmonary edema and NT-proBNP 4802 from baseline of 165 in ___. Patient was diuresed with additional IV Lasix and was subsequently continued on her home dose. She was seen by EP for pacemaker interrogation, which revealed a RA lead fracture which likely resulted in the absence of atrial sensing/pacing function resulting in A-V dysynchrony and high RV pacing burden. Lead fracture was suspected to be ___ which correlated with the onset of reported dyspnea and clinical heart failure. Echo again revealed mild LV dilatation with preserved and regional/global systolic function (LVEF >55%) and mild MR. # Atrial fibrillation # SSS s/p dual chamber pacemaker CHADS2VASC=5. Patient previously underwent successful ___ in ___. Well controlled since that time. Patient was continued on 2mg warfarin daily and metoprolol for rate control. She was monitored on telemetry with pacemaker interrogation as above. Predominant rhythm was recorded as SR with infrequent V pacing. # Acute Renal Failure on CKD CKD with Baseline around 1.6. Patient tolerated diuresis well with Cr downtrending from 1.9 on admission to 1.6 at discharge. Home valsartan was held. CHRONIC ISSUES ============== # HTN Stable. Patient was continued on amlodipine. Valsartan was held in the setting of acute renal failure. # Chronic recurrent tophaceous gout Stable. Patient followed by rheumatology as an outpatient. Continued on prednisone 5mg daily. Allopurinol initially held in the setting of acute renal failure, but restarted with improved renal function. Clinical exam showed no signs of acute flare. # GERD Stable. Patient continued on pantoprazole daily. TRANSITIONAL ISSUES =================== []Patient was noted to have RA lead fracture causing an erratic ventricular pacing that likely precipitated diastolic heart failure exacerbation. Switched to VVI 50bmp with predominately NS rhythm and infrequent V pacing. Patient should have close follow up with cardiology. Please consider further pacing adjustment as needed. []Home valsartan was held in the setting of acute kidney injury. Patient remained normotensive. Consider restarting in the outpatient setting. []Please check her electrolytes within ___ days of discharge Medications on Admission: The Preadmission Medication list may be inaccurate and requires futher investigation. 1. Allopurinol ___ mg PO DAILY 2. amLODIPine 5 mg PO DAILY 3. Cyanocobalamin 1000 mcg IM/SC EVERY 4 WEEKS (___) 4. Esomeprazole 40 mg Other DAILY 5. Furosemide 40 mg PO QAM 6. Furosemide 20 mg PO QPM 7. Metoprolol Succinate XL 50 mg PO DAILY 8. PredniSONE 5 mg PO DAILY 9. Valsartan 80 mg PO BID 10. Warfarin 4 mg PO DAILY16 11. Ferrous Sulfate 325 mg PO DAILY 12. Vitamin D 4000 UNIT PO DAILY Discharge Medications: 1. Metoprolol Succinate XL 50 mg PO DAILY 2. Warfarin 2 mg PO DAILY16 3. Allopurinol ___ mg PO DAILY 4. amLODIPine 5 mg PO DAILY 5. Cyanocobalamin 1000 mcg IM/SC EVERY 4 WEEKS (___) 6. Esomeprazole 40 mg Other DAILY 7. Ferrous Sulfate 325 mg PO DAILY 8. Furosemide 20 mg PO QPM 9. Furosemide 40 mg PO QAM 10. PredniSONE 5 mg PO DAILY 11. Vitamin D 4000 UNIT PO DAILY 12. HELD- Valsartan 80 mg PO BID This medication was held. Do not restart Valsartan until your primary care physician instructs you to do so. Discharge Disposition: Home With Service Facility: ___ Discharge Diagnosis: Diastolic Heart Failure with Acute Exacerbation Atrial Fibrillation RA Lead Fracture Discharge Condition: Mental Status: Clear and coherent. Level of Consciousness: Alert and interactive. Activity Status: Ambulatory - requires assistance or aid (walker or cane). Discharge Instructions: Dear Ms. ___, Why were you admitted to the hospital? -You were feeling short of breath and were experiencing occasional palpitations in your chest What happened while you were here? -You were given IV Lasix to help remove some of the fluid around your lungs that were making it hard to breath -The Electrophysiology Team (cardiology) looked at your pacemaker and found that one of the leads was broken. They changed the setting on your pacemaker to help with this. This reprogramming fixed some of the abnormal heart rhythms you were experiencing. They were likely contributing to your shortness of breath. What should you do when you go home? -Continue to take your home Lasix -You should follow up with your outpatient cardiologist, Dr. ___. It was a pleasure taking care of you, Your ___ Care Team Followup Instructions: ___
19716166-DS-16
19,716,166
21,471,585
DS
16
2153-08-07 00:00:00
2153-08-07 19:44:00
Name: ___ Unit No: ___ Admission Date: ___ Discharge Date: ___ Date of Birth: ___ Sex: M Service: MEDICINE Allergies: No Known Allergies / Adverse Drug Reactions Attending: ___ Chief Complaint: Chest Pressure Major Surgical or Invasive Procedure: Cardiac Catheterization (___) History of Present Illness: Mr. ___ is a ___ year old man with stage 4 lung adenocarcinoma on chemotherapy who presents with 2.5 weeks of progressive, intermittent chest tightness. About 2.5 weeks ago he was working on a ___ and doing some minor manual labor and felt central chest pressure and a tightness in his neck. He subsequently felt very unwell including fevers and fatigue, but his symptoms mostly resolved by the next day. Over the course of the next week he felt intermittent chest pressure and neck tightness with activity. This past ___, he again felt tightness in his chest and throat along with dyspnea. He also felt aching in his arms, legs along with headaches and dry heaves. He spoke to an oncologist on call and eventually was seen in urgent care later that day. At that point, his symptoms had significantly improved. However, over the past two days he had significant chest pressure with exertion and called his oncologist on ___ night. She ordered him for an EKG/CXR which he had early ___ and was read as abnormal. He was sent to the ___ ED. Review of systems in positive for pain in the right calf after walking for 15 minutes that is present for several years. Rare sensation of palpitations. No abdominal pain, bloody stool, diarrhea. EMERGENCY DEPARTMENT COURSE Initial vital signs were notable for: T 97.4, HR 113, BP 131/59, RR 16, O2 98% RA Labs were notable for: - proBNP 740 - Hemoglobin 9.5 - Troponin 1.34 -> 1.48 - MB 4 -> 3 Patient was given: - Heparin gtt - Atorvastatin 80mg - Metoprolol tartrate 6.25mg - Aspirin 324mg Consults: STEMI Consult: - Cancel code STEMI. Patient is chest pain free and comfortable. - Please check serial troponin - Please obtain posterior ECG - Please trend ECG q30 minutes x3 - TTE in AM - Admit to ___ Cardiology - NPO for cath in AM - Atorvastatin 80mg PO daily, metoprolol tartrate 6.25 mg PO Q6H, heparin GTT ACS protocol, ASA 81 mg PO daily (already got 324 today so next dose ___ Vital signs prior to transfer: - T 98.8, HR 103, BP 113/62, RR 21, O2 93%RA Upon arrival to the floor: He reported being chest pain free. Past Medical History: - HTN - HLD - OSA - GERD - hypogonadism Social History: ___ Family History: Father with COPD Physical Exam: ======================= ADMISSION PHYSICAL EXAM ======================= VITALS: T 98.6, BP 139/74, HR 114, RR 16, O2 96RA GENERAL: Comfortable appearing, sitting up in a chair. Accompanied by his wife. ___ equal and reactive, no scleral icterus or injection. Moist mucous membranes. NECK: No JVD CARDIAC: S1/S2 regular with no murmurs, rubs or S3/S4. CHEST: Port-a-cath in R upper chest with mild surrounding erythema. LUNGS: Clear bilaterally with diminished lung sounds. ABDOMEN: Soft, non-tender, non-distended. EXTREMITIES: Warm extremities. Faintly palpable DP pulse on R foot, ___ pulse not palpable. SKIN: Warm and dry NEUROLOGIC: Grossly normal strength in upper and lower extremities ======================= DISCHARGE PHYSICAL EXAM ======================= GENERAL: WDWN adult man sitting in bed in NAD ___: NCAT, sclerae anicteric NECK: Supple, JVP not elevated CARDIAC: RRR, normal S1/S2, no m/r/g CHEST: Port-a-cath in R upper chest with mild surrounding erythema, dressing clean. Lungs CTAB, no increased work of breathing ABDOMEN: Soft, non-tender, non-distended, normoactive BS EXTREMITIES: Warm extremities. Faintly palpable DP pulse on R foot. No edema. Pertinent Results: ADMISSION LABS ============= ___ 03:51PM BLOOD WBC-6.2 RBC-3.39* Hgb-9.5* Hct-28.6* MCV-84 MCH-28.0 MCHC-33.2 RDW-16.8* RDWSD-51.1* Plt ___ ___ 03:51PM BLOOD Neuts-78.9* Lymphs-10.5* Monos-9.8 Eos-0.3* Baso-0.2 Im ___ AbsNeut-4.89 AbsLymp-0.65* AbsMono-0.61 AbsEos-0.02* AbsBaso-0.01 ___ 03:51PM BLOOD Plt ___ ___ 03:51PM BLOOD Glucose-147* UreaN-16 Creat-0.8 Na-137 K-3.5 Cl-96 HCO3-24 AnGap-17 ___ 03:51PM BLOOD CK-MB-4 proBNP-740* ___ 03:51PM BLOOD cTropnT-1.34* PERTINENT LABS ============= ___ 03:51PM BLOOD cTropnT-1.34* ___ 03:51PM BLOOD CK-MB-4 proBNP-740* ___ 06:31PM BLOOD CK-MB-3 ___ 06:31PM BLOOD cTropnT-1.48* ___ 02:31AM BLOOD CK-MB-3 cTropnT-1.27* ___ 06:59AM BLOOD CK-MB-3 cTropnT-1.17* ___ 07:55AM BLOOD %HbA1c-5.8 eAG-120 ___ 06:59AM BLOOD Triglyc-112 HDL-37* CHOL/HD-3.6 LDLcalc-75 ___ 06:59AM BLOOD TSH-6.2* ___ 06:59AM BLOOD Free T4-1.0 DISCHARGE LABS ============= ___ 05:08AM BLOOD WBC-5.3 RBC-3.47* Hgb-9.5* Hct-29.6* MCV-85 MCH-27.4 MCHC-32.1 RDW-17.1* RDWSD-52.2* Plt ___ ___ 05:08AM BLOOD Plt ___ ___ 05:08AM BLOOD ___ PTT-24.2* ___ ___ 05:08AM BLOOD Glucose-110* UreaN-11 Creat-0.7 Na-136 K-4.2 Cl-98 HCO3-25 AnGap-13 ___ 05:08AM BLOOD Calcium-8.8 Phos-3.1 Mg-1.7 IMAGING/PROCEDURES ================== CHEST X RAY (___) FINDINGS: PA and lateral views of the chest provided. Opacity seen in the left lower lobe which may represent atelectasis or developing pneumonia. A Port-A-Cath is seen along the right anterior chest wall with the tip terminating in the right atrium. There is no effusion, or pneumothorax. There are no signs of congestion or edema. The cardiomediastinal silhouette is normal. Imaged osseous structures are intact. Surgical anchors are noted in the right humeral head. IMPRESSION: Left lower lobe opacity, which may represent atelectasis or developing pneumonia. TTE (___) CONCLUSION: The left atrial volume index is normal. There is no evidence for an atrial septal defect by 2D/color Doppler. The estimated right atrial pressure is ___ mmHg. There is normal left ventricular wall thickness with a normal cavity size. There is mild regional left ventricular systolic dysfunction with hypokinesis of the mid-distal inferolateral, anterolateral, and anterior walls (see schematic). The visually estimated left ventricular ejection fraction is 45-50%. There is no resting left ventricular outflow tract gradient. No ventricular septal defect is seen. Diastolic parameters are indeterminate. Normal right ventricular cavity size with normal free wall motion. The aortic sinus diameter is normal for gender with normal ascending aorta diameter for gender. The aortic valve leaflets are moderately thickened. There is no aortic valve stenosis. There is trace aortic regurgitation. The mitral valve leaflets are mildly thickened with no mitral valve prolapse. There is mild [1+] mitral regurgitation. The tricuspid valve leaflets appear structurally normal. There is physiologic tricuspid regurgitation. The estimated pulmonary artery systolic pressure is normal. There is a trivial pericardial effusion. IMPRESSION: Mild regional systolic dysfunction with hypokinesis of the mid-distal inferolateral, anterolateral, and anterior walls consistent with multivessel coronary artery disease. Mild mitral regurgitation. Normal pulmonary pressure. CARDIAC CATHETERIZATION (___) Coronary Description The coronary circulation is right dominant. LM: The Left Main, arising from the left cusp, is a large caliber vessel and is normal. This vessel trifurcates into the Left Anterior Descending, Left Circumflex, and Ramus Intermedius. LAD: The Left Anterior Descending artery, which arises from the LM, is a large caliber vessel. There is a 50% tubular stenosis in the proximal segment. There is a 30% diffuse stenosis in the mid segment. The Septal Perforator, arising from the proximal segment, is a small caliber vessel. Cx: The Circumflex artery, which arises from the LM, is a large caliber vessel with mild luminal irregularities. The ___ Obtuse Marginal, arising from the proximal segment, is a medium caliber vessel. There is a 70% stenosis in the ostium. The ___ Obtuse Marginal, arising from the mid segment, is a medium caliber vessel. RI: The Ramus Intermedius, which arises from the LM, is a medium caliber vessel. There is a 100% stenosis in the proximal segment. There are collaterals from the distal RCA. RCA: The Right Coronary Artery, arising from the right cusp, is a large caliber vessel. There is a 95% stenosis in the proximal and mid segments. There is a 95% stenosis in the mid and distal segments. The Acute Marginal, arising from the proximal segment, is a small caliber vessel. The Right Posterior Descending Artery, arising from the distal segment, is a medium caliber vessel. The Right Posterolateral Artery, arising from the distal segment, is a medium caliber vessel. Interventional Details Percutaneous Coronary Intervention: Percutaneous coronary intervention (PCI) was performed on an ad hoc basis based on the coronary angiographic findings from the diagnostic portion of this procedure. A ___ AL 0.75 guiding catheter provided excellent support. After crossing with a wire all stenoses were dilated using a 2.0 mm NC balloon. Unsuccessful attempt to pass a 2.5mm x 38mm stent, so did further dilations using a 2.5mm NC balloon at high pressure. The balloon at this point became stuck to the wire and pulled wire out of vessel as removed. Tried unsuccessfully to recross all stenoses using a Sion wire and then a Prowater wire but unsuccessful because of passage into dissection flaps.. Since there is only mild stenosis (approx 40%) and normal flow and patient free of chest pain, decided that risks outweigh benefits of more aggressive attempts. Complications: There were no clinically significant complications. Findings • Three vessel coronary artery disease. • PTCA alone (POBA) of RCA. MICROBIOLOGY ============ None Brief Hospital Course: Mr. ___ is a ___ year old man with stage 4 lung adenocarcinoma on chemotherapy who presentsed with 2.5 weeks of progressive, intermittent chest tightness and found to have likely subacute STEMI. Underwent cardiac cath with POBA, deferred stenting given small dissection. ============ ACUTE ISSUES ============ #Subacute STEMI Presented with 2.5 weeks of worsening intermittent chest and neck pressure and found to have ST elevations in aVL, V1 with ST depressions in II, III, aVF, V3-V6, Q waves in I and aVL. Troponins and CK-MB downtrending. Overall given duration of symptoms concern for subacute/missed MI. While admitted, on ASA, heparin, beta blockade, high-intensity statin. Cardiac cath revealed 95% RCA lesion, TIMI 3 flow after POBA. Stenting deferred due to small dissection, plan for PCI in 6 weeks. Post-procedure remaining chest pain-free, no anginal equivalents or symptoms with ambulation. Noted to have sinus tachycardia to low 100s, transitioned to PO metoprolol succinate 50. TTE notable for regional systolic dysfunction with EF 45-50% consistent with multivessel CAD. While admitted no evidence clinical HF on history or exam. Given new systolic dysfunction in setting of ACS started spironolactone, should re-check BMP in 2 weeks. Plan for PCI and repeat TTE in six weeks. #Anemia On admission noted to have Hgb 9.5, decreased from 14.5 in ___. Denied black, bloody stool. Guaiac negative, brown stool. Likely in setting of active malignancy treated with chemotherapy and radiation. Patient remained hemodynamically stable without overt bleeding. Hgb stable while admitted. #Hypertension Held home HCTZ and ACEI. Started spironolactone. Holding HCTZ and ACEI on discharge, can re-assess at follow-up. #Stage IV Lung CA Patient status post radiation/chemo and immunotherapy with further progression of disease. On Carboplatin/Pemetrexed/Pembrolizumab q3w x 4 cycles as first line treatment for stage IV adenocarcinoma of lung. C1 ___, C2 ___, C3 planned for ___. While admitted, continued folic acid 1mg daily, multivitamin 1 tab daily, guaifenesen PRN cough, zofran PRN for nausea (QTc<450). Given subacute STEMI, consider discussion with cardiology prior to initiating C3. #GERD Continued omeprazole 20mg daily. #Peripheral Artery Disease Was planned to have non-invasive vascular studies. Continued ASA, statin as above. TRANSITIONAL ISSUES ======================== [ ] Assess heart rate, consider increasing metoprolol succinate dose [ ] Cath in 6 weeks for stenting [ ] Consider repeat TTE in 3 months [ ] Consider referral to cardiac rehab [ ] Re-check BMP one to two weeks post-discharge (started spironolactone this admission) [ ] Holding lisinopril, HCTZ on discharge [ ] Re-check Hgb, consider need for further work-up, management of anemia [ ] Needs ABI/PVR for PAD New Meds: Aspirin 81 MG daily Clopidogrel 75MG daily Spironolactone 4X per week (MWFS) Changed Meds: Atorvastatin 80MG daily (from 40MG) Held/Stopped Meds: Lisinopril Hydrochlorothiazide Medications on Admission: The Preadmission Medication list is accurate and complete. 1. Lisinopril 30 mg PO DAILY 2. Dexamethasone 4 mg PO PRN FOR NAUSEA Look below for instructions 3. Ondansetron 8 mg PO Q8H:PRN Nausea/Vomiting - Second Line 4. Prochlorperazine 10 mg PO Q6H:PRN Nausea/Vomiting - First Line 5. FoLIC Acid 1 mg PO DAILY 6. LORazepam 0.5-1 mg PO Q6H:PRN anxiety or insomnia 7. Atorvastatin 40 mg PO QPM 8. Hydrochlorothiazide 25 mg PO DAILY 9. Metoprolol Succinate XL 50 mg PO DAILY 10. Omeprazole 20 mg PO DAILY 11. testosterone cypionate 200 mg/mL injection 1X/WEEK 12. GuaiFENesin ER 600 mg PO Q12H 13. Guaifenesin-CODEINE Phosphate ___ mL PO Q6H:PRN cough 14. tadalafil 10 mg oral DAILY:PRN 15. Multivitamins 1 TAB PO DAILY Discharge Medications: 1. Aspirin 81 mg PO DAILY RX *aspirin 81 mg 1 tablet(s) by mouth Daily Disp #*90 Tablet Refills:*0 2. Clopidogrel 75 mg PO DAILY to prevent stent thrombosis RX *clopidogrel 75 mg 1 tablet(s) by mouth Daily Disp #*90 Tablet Refills:*0 3. Spironolactone 25 mg PO 4X/WEEK (___) RX *spironolactone 25 mg 1 tablet(s) by mouth Four days a week Disp #*30 Tablet Refills:*0 4. Atorvastatin 80 mg PO QPM RX *atorvastatin 80 mg 1 tablet(s) by mouth Daily at bedtime Disp #*90 Tablet Refills:*0 5. Dexamethasone 4 mg PO PRN FOR NAUSEA Look below for instructions 6. FoLIC Acid 1 mg PO DAILY 7. GuaiFENesin ER 600 mg PO Q12H 8. Guaifenesin-CODEINE Phosphate ___ mL PO Q6H:PRN cough 9. LORazepam 0.5-1 mg PO Q6H:PRN anxiety or insomnia 10. Metoprolol Succinate XL 50 mg PO DAILY 11. Multivitamins 1 TAB PO DAILY 12. Omeprazole 20 mg PO DAILY 13. Ondansetron 8 mg PO Q8H:PRN Nausea/Vomiting - Second Line 14. Prochlorperazine 10 mg PO Q6H:PRN Nausea/Vomiting - First Line 15. tadalafil 10 mg oral DAILY:PRN 16. testosterone cypionate 200 mg/mL injection 1X/WEEK Discharge Disposition: Home Discharge Diagnosis: ST-Elevation Myocardial Infarction Discharge Condition: Mental Status: Clear and coherent. Level of Consciousness: Alert and interactive. Activity Status: Ambulatory - Independent. Discharge Instructions: Dear Mr. ___, It was a pleasure taking care of you at ___ ___. WHY WAS I ADMITTED TO THE HOSPITAL? - You were admitted to the hospital for a heart attack. WHAT HAPPENED WHILE I WAS IN THE HOSPITAL? - You underwent a procedure (cardiac catheterization) that revealed a blockage in one of the blood vessels of the heart. - The blockage was opened during the procedure and blood flow was restored. A stent was not placed at this time due to a small tear (dissection) in the wall of the blood vessel. You will be scheduled in approximately 6 weeks for a repeat procedure and stent placement at that time. - You were started on new medications for your heart disease and to prevent future heart attacks or heart failure. WHAT SHOULD I DO WHEN I GO HOME? - You should continue to take your medications as prescribed. It is important you take all the medications to reduce further damage to your heart. - You should attend the appointments listed below. We wish you the best! Your ___ Care Team Followup Instructions: ___
19716166-DS-17
19,716,166
20,824,826
DS
17
2153-11-12 00:00:00
2153-11-12 21:23:00
Name: ___ Unit No: ___ Admission Date: ___ Discharge Date: ___ Date of Birth: ___ Sex: M Service: MEDICINE Allergies: No Known Allergies / Adverse Drug Reactions Attending: ___. Chief Complaint: syncope Major Surgical or Invasive Procedure: endotracheal intubation ___ Comprehensive EP evaluation w induction or attempt ___ ICD placement ___ History of Present Illness: ___ is a ___ year old man with recurrent stage IV NSCLC along with CAD on ASA/Plavix who is admitted from the ED with syncope. At approximately 330pm yesterday patient developed acute dizziness while walking; the senstation lasted about one minute before resolving. He had approximately four more similar episodes throughout the afternoon. At dinner that night he got up to get glass of water. He again felt a wave of severe dizziness and he sat down before passing out. His wife caught him and reported he was out for about 3 minutes. He also had generalized shaking, and "turned blue." When he woke up he was incontinent of urine and confused for approximately 5 minutes. He did not bite his tongue. EMS was activated and he was sent to the ___ ED. Patient otherwise denies recent fevers or chills. No headaches. No mucositis. No dysphagia or odynophagia. No CP or palpitation. He has chronic dyspnea with exertion, primarily walking up stairs. No orthopnea. He has a chronic cough, which had gotten better but returned about 3 weeks ago. No N/V. Appetite is fair, but he has lost abou 10 pounds in 6 weeks. No diarrhea. No dysuria. No new leg pain or swelling. In the ED, initial VS were pain 0, T 98.5, HR 106, BP 162/108, RR 12, O2 96%RA. Initial labs notable for Na 140, K 3.7, HCO3 23, Cr 0.7, WBC 9.9, HCT 34.3, PLT 225, Trop <0.01, INR 1.2. CT head showed no acute process. CTA chest showed no evidence of PE, left hilar soft tissue mass and left lung opacities, mild pulmonary edema, and moderate left pleural effusion. Patient was given IV NS and atorvastatin. VS prior to transfer were T 98.3, HR 101, BP 145/89, RR 18, O2 95%RA. REVIEW OF SYSTEMS: A complete 10-point review of systems was performed and was negative unless otherwise noted in the HPI. PAST ONCOLOGIC HISTORY: Please see Dr. ___ note from ___ for full history. Briefly, non-small cell cancer of left lung, poorly differentiated adenocarcinoma, mucin producing, previously stage IIIB (cT1N3M0) s/p concurrent chemo/radiation with Cisplatin and etoposide, completed treatment ___ with partial response, followed by Durvalumab q2w started ___ PET/CT ___ showed progressive disease. Biopsy of pleura based tumor confirmed recurrent adenocarcinoma, stage IV, PD-L1 50%; no actionable gene mutation. PET/CT after 4 cycles of Carboplatin/Pemetrexed/Pembrolizumab q3w showed progressive disease. Started Abraxane/Avastin on ___. Past Medical History: - HTN - HLD - OSA - GERD - hypogonadism Social History: ___ Family History: Father with COPD Physical Exam: ADMISSION EXAM: =============== VS: T 98.3 HR 108 BP 135/96 RR 16 SAT 96% O2 on RA GENERAL: Pleasant and generally well appearing man in no distress EYES: Anicteric sclerea, PERLL, EOMI; ENT: Oropharynx clear without lesion, JVD not elevated CARDIOVASCULAR: Regular rate and rhythm, no murmurs, rubs, or gallops RESPIRATORY: Appears in no respiratory distress, decreased BS left base and halfway up, right lung is clear GASTROINTESTINAL: Normal bowel sounds; nondistended; soft, nontender without rebound or guarding; no hepatomegaly, no splenomegaly MUSKULOSKELATAL: Warm, well perfused extremities without lower extremity edema; Normal bulk NEURO: Alert, oriented, CN II-XII intact, motor and sensory function grossly intact SKIN: No significant rashes DISCHARGE EXAM: =============== VS: 24 HR Data (last updated ___ @ 550) Temp: 97.3 (Tm 98.0), BP: 102/65 (100-102/61-65), HR: 78 (78-81), RR: 16, O2 sat: 97% (93-97), O2 delivery: 2L, Wt: 162.7 lb/73.8 kg Fluid Balance (last updated ___ @ 450) Last 8 hours Total cumulative -185ml IN: Total 240ml, PO Amt 240ml OUT: Total 425ml, Urine Amt 425ml Last 24 hours Total cumulative -185ml IN: Total 240ml, PO Amt 240ml OUT: Total 425ml, Urine Amt 425ml GENERAL: Sitting comfortably in chair in no acute distress HEENT: Oropharynx clear. Sclerae anicteric. CHEST: ICD site mildly nontender, nonerythematous. No area of fluctuance. NECK: Supple. JVP not elevated CARDIAC: Normal rate and rhythm. Normal S1 and S2. No murmurs, rubs, or gallops. LUNGS: Clear to auscultation bilaterally. ABDOMEN: Soft, non-tender, non-distended. No palpable hepatomegaly or splenomegaly. EXTREMITIES: Warm, well perfused. 2+ pedal pulses. Neuro: AAOx3. No focal deficits. Pertinent Results: ADMISSION LABS: =============== ___ 08:28PM BLOOD WBC: 9.9 RBC: 3.82* Hgb: 10.3* Hct: 34.3* MCV: 90 MCH: 27.0 MCHC: 30.0* RDW: 19.2* RDWSD: 63.1* Plt Ct: 335 ___ 08:28PM BLOOD Neuts: 82.7* Lymphs: 5.7* Monos: 9.7 Eos: 1.0 Baso: 0.5 Im ___: 0.4 AbsNeut: 8.21* AbsLymp: 0.57* AbsMono: 0.96* AbsEos: 0.10 AbsBaso: 0.05 ___ 11:19PM BLOOD ___: 12.6* PTT: 25.9 ___: 1.2* ___ 08:28PM BLOOD Glucose: 125* UreaN: 11 Creat: 0.7 Na: 140 K: 3.7 Cl: 104 HCO3: 23 AnGap: 13 ___ 08:28PM BLOOD cTropnT: <0.01 MICROBIOLOGY: ============= None IMAGING/DIAGNOSITICS: ===================== ___ CXR: Stable examination. No pneumothorax identified. ___ CXR: Interval improvement of pulmonary vascular congestion. Lucency in the left apex may suggest a pneumothorax however no definitive pleural line is seen. ___ CXR IMPRESSION: In comparison with the study of ___, the monitoring and support devices are essentially unchanged. Cardiac silhouette remains at the upper limits of normal or mildly enlarged and there is moderate pulmonary edema and substantial volume loss in the left lower lobe. Increased opacification in the perihilar and suprahilar region on the left would suggests superimposed aspiration/pneumonia in the appropriate clinical setting. ___ Cardiac Catheterization Findings • Stable LAD and LCx disease comapred to prior. • Moderate residual RCA disease after prior POBA with normal flow and intact RI collaterals ___ TTE Conclusion: The left atrium is mildly dilated. There is no evidence for an atrial septal defect by 2D/color Doppler. The estimated right atrial pressure is ___ mmHg. There is normal left ventricular wall thickness with a normal cavity size. There is normal regional and global left ventricular systolic function. Quantitative 3D volumetric left ventricular ejection fraction is 67 %. Left ventricular cardiac index is low normal (2.0-2.5 L/min/m2). There is no resting left ventricular outflow tract gradient. Tissue Doppler suggests an increased left ventricular filling pressure (PCWP greater than 18 mmHg). Normal right ventricular cavity size with normal free wall motion. Tricuspid annular plane systolic excursion (TAPSE) is normal. The aortic sinus diameter is normal for gender with normal ascending aorta diameter for gender. The aortic arch diameter is normal. There is no evidence for an aortic arch coarctation. The aortic valve leaflets (?#) are mildly thickened. There is no aortic valve stenosis. There is no aortic regurgitation. The mitral valve leaflets appear structurally normal with no mitral valve prolapse. There is mild [1+] mitral regurgitation. The pulmonic valve leaflets are not well seen. The tricuspid valve leaflets appear structurally normal. There is physiologic tricuspid regurgitation. There is moderate pulmonary artery systolic hypertension. There is a small loculated pericardial effusion primarily anterior to the right atrium and basal right ventricle. IMPRESSION: Normal left ventricular wall thickness and biventricular cavity sizes and regional/global systolic function. Moderate pulmonary artery systolic hypertension. Mild mitral regurgitation with normal valve morphology. ___ CXR IMPRESSION: The endotracheal tube is been advanced now terminates 2.7 cm above the carina. There is slightly increased left lower lobe atelectasis. Otherwise, no significant interval change compared to most recent prior study from earlier today. ___ Imaging CTA CHEST 1. No evidence of pulmonary embolism or aortic abnormality. 2. Left hilar soft tissue has grown from PET-CT in ___ narrowing numerous bronchi. Left lung opacities may represent post obstructive pneumonia or atelectasis. Scattered right lung opacities likely reflect ongoing infectious/inflammatory process. 3. Mild pulmonary edema in the lung apices. 4. Moderate left pleural of effusion has grown from ___. 5. Left-sided soft tissue pleural based masses appear overall similar to prior PET-CT on ___. ___ Imaging CT HEAD W/O CONTRAST There is no evidence of infarction, hemorrhage, edema, or mass. There is prominence of the ventricles and sulci suggestive of involutional changes. There is no evidence of fracture. There is severe calcification of the left V4 artery (2:4). There is mild mucosal thickening of the right maxillary sinus and bilateral anterior and posterior ethmoid air cells. The remainder of the visualized portions of the paranasal sinuses, mastoid air cells, and middle ear cavities are clear. The visualized portion of the orbits are unremarkable. ___ Imaging FDG TUMOR IMAGING (PET- 1. Worsening disease in the left lung base with increased uptake in the left pleural effusion. 2. Interval increase in the size and metabolic activity of the left adrenal gland, compatible with disease progression. 3. Treated left upper lobe mass demonstrate background activity. EK: Sinus tachycardia at 103 with occasional PAC. TWI in AVL, flattening in II. No other ischemic changes. DISCHARGE LABS: =============== ___ 05:30AM BLOOD WBC-8.0 RBC-3.57* Hgb-9.7* Hct-32.5* MCV-91 MCH-27.2 MCHC-29.8* RDW-19.0* RDWSD-62.8* Plt ___ ___ 05:30AM BLOOD Plt ___ ___ 05:30AM BLOOD Glucose-101* UreaN-12 Creat-0.6 Na-139 K-4.7 Cl-103 HCO3-25 AnGap-11 ___ 05:30AM BLOOD Calcium-9.2 Phos-4.1 Mg-1.9 Brief Hospital Course: Outpatient Providers: Mr. ___ is a ___ yo M with PMH significant for recurrent stage IV NSCLC, CAD s/p NSTEMI s/p RCA angioplasty admitted for syncope, subsequently intubated in the setting of VT storm, received 1 shock, transferred to CCU, subsequently stabilized and extubated ACTIVE ISSUES: =============== #Polymorphic Ventricular Tachycardia #Syncope Patient presenting with syncopal event in setting of lightheadedness with frequent NSVT. CT head negative. Two troponins negative. CT chest neg for PE or not suggestive of infection. Patient ultimately progressed to unstable polymorphic VT for which he was shocked and maintained on Lidocaine gtt with repletion of K and Mg. No evidence of acute ischemia on cardiac catheterization. Etiology for polymorphic VT likely ___ R on T phenomenon in setting of known cardiac disease and prolonged QTc. Patient had been taking Zofran and Chlorpromazine in the past for nausea associated with chemo though reportedly had not used in weeks to family's knowledge. Recently started Trazodone which he had been taking the past ___ nights prior to admission and recently prescribed Azithromycin. No evidence of long-QTc syndrome to family's knowledge or sudden cardiac death. He was recently started on Abraxane/Avastin on ___ with Abraxane (paclitaxel) known to cause tachyarrhythmias and bradyarrhythmias, though most commonly associated with sinus bradycardia. Also with tumor burden in lung with encroachment on pulmonary arteries. Patient was started on metoprolol and verapamil with good response and decrease in ectopy burden. He underwent an EP study on ___ which was unable to find a specific focus for ablation. He then underwent ICD placement on ___. Procedure was uncomplicated and device was interrogated prior to discharge. #Elevated Transaminases, improving Patient with uptrending LFTs as outpatient, initially with concern for possible DILI. Recently started on chemotherapeutic regimen as above. LFTs downtrended through admission without intervention. CHRONIC ISSUES: =============== #Stage IV NSCLC #Secondary malignancy of pleura #Secondary malignancy of lung #Pleural Effusion Patient s/p concurrent chemo/radiation with Cisplatin and etoposide, completed treatment ___ with partial response, followed by Durvalumab q2w started ___ PET/CT ___ showed progressive disease. Biopsy of pleura based tumor confirmed recurrent adenocarcinoma, stage IV, PD-L1 50%; no actionable gene mutation. PET/CT after 4 cycles of Carboplatin/Pemetrexed/Pembrolizumab q3w showed progressive disease. Started Abraxane/Avastin on ___. Next cycle was due ___ but held while inpatient. Held Compazine and lorazepam in setting of NSVT. #CAD s/p NSTEMI ___ s/p RCA angioplasty Continued home ASA, Plavix, spironolactone, metoprolol, atorvastatin. #GERD #Hx PUD Continued home omeprazole #Hypoxemic Respiratory Failure, resolved Patient hypoxemic during initial episode of VT for which he was intubated. Most likely precipitated by arrhythmia. No evidence of PE or concern for pneumonia. Patient passed SBT and extubated on ___ #___ Refused hospital-provided CPAP during admission TRANSITIONAL ISSUES: ==================== [ ] Given polymorphic VT, please avoid QTc prolonging medications. Would recommend alternative antiemetics for chemotherapy (e.g. Aloxi, if available, or Ativan to prevent QT prolongation) [ ] No lifting heavy objects greater than gallon of milk in left hand for 10 days [ ] No golf or swimming for 6 months [ ] No driving for 6 months [ ] Care connect with ___ in ___ clinic prior to discharge. Medications on Admission: The Preadmission Medication list may be inaccurate and requires futher investigation. 1. Atorvastatin 80 mg PO QPM 2. FoLIC Acid 1 mg PO DAILY 3. LORazepam 0.5-1 mg PO Q6H:PRN anxiety or insomnia 4. Metoprolol Succinate XL 50 mg PO DAILY 5. Multivitamins 1 TAB PO DAILY 6. Omeprazole 20 mg PO DAILY 7. Ondansetron 8 mg PO Q8H:PRN Nausea/Vomiting - Second Line 8. Aspirin 81 mg PO DAILY 9. Clopidogrel 75 mg PO DAILY to prevent stent thrombosis 10. Spironolactone 25 mg PO 4X/WEEK (___) 11. Prochlorperazine 10 mg PO Q6H:PRN Nausea/Vomiting - First Line 12. Dexamethasone 4 mg PO ASDIR 13. TraZODone 50 mg PO QHS:PRN insomnia 14. Chlorpheniramine-Hydrocodone 5 mL PO Q12H:PRN mouth pain Discharge Medications: 1. Magnesium Oxide 400 mg PO DAILY Duration: 2 Doses RX *magnesium oxide 400 mg 1 (One) capsule(s) by mouth once a day Disp #*30 Capsule Refills:*0 2. Spironolactone 25 mg PO 4X/WEEK (___) RX *spironolactone 25 mg 1 (One) tablet(s) by mouth 4 times per week Disp #*30 Tablet Refills:*0 3. Verapamil SR 480 mg PO Q24H RX *verapamil 240 mg 2 (Two) tablet(s) by mouth once a day Disp #*60 Tablet Refills:*0 4. Metoprolol Succinate XL 25 mg PO QHS RX *metoprolol succinate 25 mg 1 (One) tablet(s) by mouth once a day Disp #*30 Tablet Refills:*0 5. Acetaminophen 325-650 mg PO Q6H:PRN Pain - Mild/Fever 6. Aspirin 81 mg PO DAILY 7. Atorvastatin 80 mg PO QPM 8. Clopidogrel 75 mg PO DAILY to prevent stent thrombosis 9. Dexamethasone 4 mg PO ASDIR 10. Multivitamins 1 TAB PO DAILY 11. Omeprazole 20 mg PO DAILY 12. HELD- Ondansetron 8 mg PO Q8H:PRN Nausea/Vomiting - Second Line This medication was held. Do not restart Ondansetron until talking to your oncologist 13. HELD- Prochlorperazine 10 mg PO Q6H:PRN Nausea/Vomiting - First Line This medication was held. Do not restart Prochlorperazine until talking with your oncologist 14. HELD- TraZODone 50 mg PO QHS:PRN insomnia This medication was held. Do not restart TraZODone until talking with your oncologist Discharge Disposition: Home Discharge Diagnosis: PRIMARY DIAGNOSIS: ================== Polymorphic Ventricular Tachycardia s/p ICD placement SECONDARY DIAGNOSIS: ==================== Stage IV Non-Small Cell Lung Cancer Secondary malignancy of pleura Secondary malignancy of lung Pleural Effusion Coronary artery disease Gastroesophageal Reflux Disease Hypoxemic Respiratory Failure Discharge Condition: Mental Status: Clear and coherent. Level of Consciousness: Alert and interactive. Activity Status: Ambulatory - Independent. Discharge Instructions: Dear. Mr. ___, You were admitted because: - You passed out and were found to have a dangerously abnormal heart rhythm. You received an electric shock. During your stay: - Your breathing was initially supported with a breathing tube. You improved and no longer needed the breathing tube so it was removed. - You underwent cardiac catheterization to examine the arteries around your heart. - You underwent an electrophysiologic study to examine your abnormal heart rhythms. - You had an ICD placed to prevent future dangerous abnormal heart rhythms. - Your chemotherapy was held during this hospital admission in case these drugs made it more likely for your heart to return to the dangerous abnormal rhythm. After you leave: - Please take your medications as prescribed. - Please attend any outpatient follow-up appointments you have - Please weigh yourself every morning, call MD if weight goes up more than 3 lbs in 1 day or 5lb in 1 week. - Please avoid driving for 6 months - Please do not hold anything heavier than a gallon of milk for a month. Please avoid motions (such as golfing) that involve lifting your arm above your head for a month. Please also avoid swimming while the wound from your ICD procedure is healing. It was a pleasure participating in your care! We wish you the very best! Sincerely, Your ___ HealthCare Team Followup Instructions: ___
19716166-DS-18
19,716,166
27,704,745
DS
18
2154-01-25 00:00:00
2154-01-25 20:01:00
Name: ___ Unit No: ___ Admission Date: ___ Discharge Date: ___ Date of Birth: ___ Sex: M Service: MEDICINE Allergies: No Known Allergies / Adverse Drug Reactions Attending: ___. Chief Complaint: Fatigue and Dyspnea Major Surgical or Invasive Procedure: None History of Present Illness: Mr. ___ is a ___ year old male with recurrent metastatic NSCLC, CAD s/p NSTEMI and VT storm s/p ICD who presents with progressive dyspnea. Of note, the patient was recently admitted at ___ from ___ with syncope and was admitted to the oncology service where he developed unstable VT thought to be from R on T phenomenon due to his cardiac disease and QTc prolonging medications. He responded responded to defibrillation and was transferred to the CCU where he underwent ICD placement on ___ and was started on metoprolol and verapamil. Since discharge, the patient had been feeling well until 2 weeks ago when he noticed the onset of cough and dyspnea. He was diagnosed with PNA by his PCP and treated with amoxicillin and doxycycline x7 days. Over the last week, the patient has noted progressive fatigue with dizziness and presyncope upon standing. He has had no fevers or chills. No decreased PO intake and no diarrhea. Then, over the last 2 days, he has had progressive dyspnea on exertion, worse that his baseline, so he presented to the ___ ED for further evaluation. Of note, he has had no chest pain and only occasional palpitations. He has had no shocks from his ICD. He denies abd pain or dysuria. In the ED, the initial vital signs were: T 98.6 HR 81 BP 132/61 R 18 SpO2 97% RA Laboratory data was notable for: Trop <0.01 Normal Chem10 BNP 830 WBC 8.8 Hgb 9.1 Plt 209 INR 1.1 The patient received: ___ 20:26 PO Omeprazole 20 mg ___ 20:26 PO Metoprolol Succinate XL 25 mg Imaging demonstrated: ___ 18:04 Chest (Pa & Lat) IMPRESSION: There is persisting and progressed small to moderate left pleural effusion, with left upper and lower atelectasis/consolidation, presumably due to known small cell lung cancer. ECG: SNR Rate 77. Normal axis and intervals. No Q waves or ST-T wave changes Upon arrival to 11R, the patient feels well and endorses the above history. He is without dyspnea at rest or chest pain. Past Medical History: ONCOLOGIC HISTORY: He had been healthy with hypertension and GERD, has had persistent dry cough since ___ weeks before hospitalization. He did not respond to supportive care and empirical antibiotics. He developed chills, high fevers night sweat and profuse diarrhea ___ after shoveling snow. The symptoms continued the following day. He was referred to the hospital on ___ 8. He vomited a few times on the day of admission. He received empirical antibiotics for possible pneumonia and underwent the following workup. During admission, he was noted to have leukopenia and thrombocytopenia as well as elevated transaminases, alkaline phosphatases and LDH. The cytopenia improved spontaneously but liver function remained abnormal throughout the hospital course. His fever gradually subsided, cough and diarrhea decreased and he was discharged home on ___. ___, CT of chest and abdomen: 1. Ill-defined left hilar mass with associated nodularity and opacification along the left major fissure and extension into the superolateral left aspect of the mediastinum. Mass encases the left main pulmonary artery, as well as the left lingular, lower lobar, and upper lobar pulmonary arteries. 2. Notably, the mass also causes significant narrowing of the left upper lobar bronchus. 3. Associated enlarged left para-aortic, right upper paratracheal, and subcarinal mediastinal lymph nodes. 4. Incidentally noted 3.5 x 3.2 cm hypodense mass involving the appendix, without adjacent fat stranding. This is worrisome for a separate neoplasm. Less likely metastasis, but this possibility is not excluded. ___ brain MRI: no evidence of metastasis. ___ Bronchoscopy and the transbronchial biopsy of the left upper lobe of lung showed: Poorly differentiated adenocarcinoma with mucinous features, predominantly present in submucosal lymphatic spaces. The carcinoma is strongly positive for CK 7, and shows only focal CK 20 positivity. It is negative for TTF-1, Napsin, p40, and CDX-2. Attempt of FOUNDATION ONE CDx was unsuccessful due to inadequate tissue. ___ Colonoscopy: The appendiceal orifice was examined carefully. A pair of large-cap forceps were used to retract the appendix through the AO, and the mucosa appeared normal without any masses. Due to inadequate prep, small to medium sized lesions may have been missed. Colonic biopsy showed normal mucosa. ___: began XRT for stage IIIB NSCLC ___ - ___: cycle 1 cisplatin/etoposide. ___ - ___ - ___: cycle 2 cisplatin/etoposide anticipated. ___: completion of radiation. ___: began Durvalumab q2w ___: port-a-cath placement due to difficulty with venous access. ___: CT guided left pleural mass biopsy - Poorly differentiated adenocarcinoma with focal mucin production and papillary features, similar to the previous left upper lobe tumor. ___: C1 Carboplatin/Pemetrexede/Pembrolizumab ___: C2 Carboplatin/Pemetrexede/Pembrolizumab ___ - ___: admitted to ___ for subacute MI. S/p angioplasty for RCA stenosis. Felt dramatic improvement of symptoms of chest pressure and dyspnea after the procedure. ___ echocardiogram - Mild regional systolic dysfunction with hypokinesis of the mid-distal inferolateral, anterolateral, and anterior walls consistent with multivessel coronary artery disease. Mild mitral regurgitation. Normal pulmonary pressure. Estimated LVEF 45-50% ___: coronary angiogram and angioplasty - • Three vessel coronary artery disease. • PTCA alone (POBA) of RCA. ___: C3 Carboplatin/Pemetrexede/Pembrolizumab ___: C4 Carboplatin/Pemetrexede/Pembrolizumab ___: C1 Abraxane and ___: C2 Abraxane and Avastin anticipated. ___: noted abnormal liver function of unclear reason. ___ - ___: admitted to ___ following a syncopal episode. Was diagnosed unstable polymorphic ventricular tachycardia, r/o secondary to R on T phenomenon in the setting of known cardiac disease and prolonged QTc. PE and CNS metastases were excluded. Endotracheal intubation ___ Comprehensive EP evaluation w induction or attempt ___ ICD placement ___ Liver function worsened at first, felt to be cardiogenic, improved towards the latter part of hospitalization. ___: office follow up visit; worsening of LFT noted; atorvastatin was held. ___: C1W1 gemcitabine, 3 weeks on 1 week off. ___: C2W1 gemcitabine PAST MEDICAL HISTORY: Metastatic Lung Cancer L adrenal Metastasis CAD s/p NSTEMI in ___: Coronary angiogram ___ with normal LMCA; LAD proximal 50% and mid 30% stenoses; LCx with 70% stenosis in the ostium of OM1; ramus with 100% proximal stenosis and collaterals from the distal RCA; RCA large vessel with 95% disease throughout. PCI was attempted to the right coronary but a stent could not be placed. Stenoses could not be crossed and wire passed into dissection flaps. Given normal flow and the absence of chest pain, POBA alone was performed. Disease was noted to be stable on re-look in ___. Polymorphic VT s/p ICD ___ HTN HLD OSA GERD Social History: ___ Family History: Father with COPD Identical twin with HCM Physical Exam: ADMISSION GENERAL: Tired, NAD, sitting comfortably in bed HEENT: Clear OP, no lesions or thrush EYES: PERRL, anicteric NECK: supple RESP: No increased WOB, decreased breath sounds L side with mild crackles. No rhonchi or wheezing ___: Regular, no MRG. ICD over L anterior chest c/d/I without errythema GI: soft, NTND no rebound or guarding EXT: warm, no edema SKIN: dry, no obvious rashes NEURO: CN II-XII intact ACCESS: POC c/d/i DISCHARGE GENERAL: NAD, sitting comfortably in bed HEENT: Clear OP, no lesions or thrush EYES: PERRL, anicteric NECK: supple RESP: No increased WOB, decreased breath sounds on left. No rhonchi or wheezing ___: Regular, no MRG. ICD over L anterior chest c/d/I without errythema GI: soft, NTND no rebound or guarding EXT: warm, no edema SKIN: dry, no obvious rashes NEURO: CN II-XII intact Pertinent Results: ADMISSION ___ 06:30PM BLOOD WBC-8.8 RBC-3.26* Hgb-9.1* Hct-29.3* MCV-90 MCH-27.9 MCHC-31.1* RDW-22.5* RDWSD-68.8* Plt ___ ___ 06:30PM BLOOD Neuts-74.5* Lymphs-9.5* Monos-12.7 Eos-1.1 Baso-0.3 Im ___ AbsNeut-6.52* AbsLymp-0.83* AbsMono-1.11* AbsEos-0.10 AbsBaso-0.03 ___ 06:30PM BLOOD ___ PTT-26.9 ___ ___ 06:30PM BLOOD Glucose-140* UreaN-13 Creat-0.8 Na-137 K-3.9 Cl-98 HCO3-25 AnGap-14 ___ 07:20AM BLOOD ALT-24 AST-20 AlkPhos-109 TotBili-0.3 ___ 06:30PM BLOOD proBNP-830* ___ 06:30PM BLOOD cTropnT-<0.01 ___ 10:40PM BLOOD cTropnT-<0.01 ___ 06:30PM BLOOD Calcium-9.1 Phos-3.4 Mg-1.9 ___ 07:20AM BLOOD Cortsol-12.6 ___ 06:37PM BLOOD Lactate-1.2 DISCHARGE ___ 05:25AM BLOOD WBC-7.9 RBC-3.46* Hgb-9.7* Hct-30.6* MCV-88 MCH-28.0 MCHC-31.7* RDW-22.1* RDWSD-67.8* Plt ___ ___ 05:25AM BLOOD Glucose-96 UreaN-9 Creat-0.7 Na-139 K-4.3 Cl-100 HCO3-25 AnGap-14 REPORTS ___ (PA & LAT) There is persisting and progressed small to moderate left pleural effusion, with left upper and lower atelectasis/consolidation, presumably due to known lung cancer. ___ (PA & LAT) Compared to chest radiographs, DIS since ___ most recently ___ through ___. Marked elevation of the left lung base is due in part to moderate subpulmonic left pleural effusion. Left suprahilar mass is noted. No pneumothorax. Right lung clear. Heart borderline enlarged unchanged. Right transjugular central venous infusion catheter ends close to the superior cavoatrial junction. Transvenous right atrial pacer defibrillator lead in standard position. RECOMMENDATION(S): If there is concern about the specific nature of these radiographic findings, chest CT scan, with intravenous contrast if tolerated, would be helpful to compare with most recent chest CT, performed on ___. Brief Hospital Course: Mr. ___ is a ___ year old man with metastatic lung cancer on gemcitabine, CAD s/p NSTEMI and recent VT storm s/p ICD presents from home with progressive fatigue and dyspnea with progressive left sided pleural effusion found on CXR. #FATIGUE #DYSPNEA: Patient presented with progressive dyspnea, fatigue and lightheadedness with standing. He was recently treated as an outpatient for community acquired pneumonia. He was initially improving, but subsequently developed progressive dyspnea and fatigue. He had one episode of presyncope upon standing, which prompted him to present to the ED. Workup showed progressive left-sided pleural effusion found on CXR. He had no hypoxemia on exam at rest or with ambulation. No evidence of ischemia. He received one liter of IVF in the ED and his symptoms resolved. His pleural effusion was thought to be contributing to his dyspnea though his symptoms improved without intervention. Adrenal insufficiency was considered given his adrenal metastasis and fatigue; however, he was without hypotension or electrolyte abnormalities and AM cortisol WNL. Lastly, it was though his fatigue and pre-syncope could also be exacerbated by his metoprolol and verapamil, which were started during his last hospitalization. His blood pressures remained stable and the doses weren't reduced. IP consult for thoracentesis was deferred to outpatient setting. #LUNG CANCER #SECONDARY MALIGNACY OF PLEURA #SECONDARY MALIGNANCY OF ADRENAL GLAND: C2D1 of Gemcitabine was on ___. #CORONARY ARTERY DISEASE #S/P ICD: No need to interrogate device at this time given other, more likely cause for his symptoms. No chest pain. Negative trop x2. Continued home ASA. Atorvastatin on hold due to elevated LFTs. Continued home verapamil, metoprolol, and spironolactone. #OSA: ordered CPAP while in house #GERD: continued home omeprazole while in house Name of health care proxy: ___ Phone number: ___ #CODE STATUS: full, presumed TRANSITIONAL ISSSUES: [] Repeat CXR within 1 month to monitor resolution of pleural effusion [] consider therapeutic/diagnostic thoracentesis in outpatient setting, IP follow up currently being arranged. [] Consider outpatient echocardiogram to assess for new valvular abnormalities of systolic dysfunction that could explain his symptoms. Medications on Admission: The Preadmission Medication list is accurate and complete. 1. Aspirin 81 mg PO DAILY 2. Metoprolol Succinate XL 25 mg PO QHS 3. Omeprazole 20 mg PO DAILY 4. Magnesium Oxide 400 mg PO DAILY 5. Spironolactone 25 mg PO 4X/WEEK (___) 6. Verapamil SR 480 mg PO Q24H 7. TraZODone 50 mg PO QHS:PRN insomnia 8. Prochlorperazine 10 mg PO Q6H:PRN Nausea/Vomiting - First Line 9. Ondansetron 8 mg PO Q8H:PRN Nausea/Vomiting - Second Line 10. Multivitamins 1 TAB PO DAILY Discharge Medications: 1. Aspirin 81 mg PO DAILY 2. Magnesium Oxide 400 mg PO DAILY 3. Metoprolol Succinate XL 25 mg PO QHS 4. Multivitamins 1 TAB PO DAILY 5. Omeprazole 20 mg PO DAILY 6. Ondansetron 8 mg PO Q8H:PRN Nausea/Vomiting - Second Line 7. Prochlorperazine 10 mg PO Q6H:PRN Nausea/Vomiting - First Line 8. Spironolactone 25 mg PO 4X/WEEK (___) 9. TraZODone 50 mg PO QHS:PRN insomnia 10. Verapamil SR 480 mg PO Q24H Discharge Disposition: Home Discharge Diagnosis: PRIMARY DIAGNOSIS: ================== Dyspnea Orthostatic hypotension SECONDARY DIAGNOSIS: ==================== Polymorphic Ventricular Tachycardia s/p ICD placement Stage IV Non-Small Cell Lung Cancer Secondary malignancy of pleura Secondary malignancy of lung Pleural Effusion Coronary artery disease Gastroesophageal Reflux Disease Hypoxemic Respiratory Failure Discharge Condition: Mental Status: Clear and coherent. Level of Consciousness: Alert and interactive. Activity Status: Ambulatory - Independent. Discharge Instructions: Dear. Mr. ___, You were admitted because: - You were feelings lightheaded and short of breath. During your stay: - You were given fluids through and IV. - You had a chest x ray, which showed fluid around your lung. Your symptoms improved and there was no urgency to remove this fluid during your hospitalization. After you leave: - Please take your medications as prescribed. - Please attend any outpatient follow-up appointments you have. Be sure to follow up with interventional pulmonology to follow up the fluid around your lung. - Please weigh yourself every morning, call your doctor if weight goes up more than 3 lbs in 1 day or 5lb in 1 week. - Please continue to avoid driving until instructed by your doctor. - Please do not hold anything heavier than a gallon of milk for a month. It was a pleasure participating in your care! We wish you the very best! Sincerely, Your ___ HealthCare Team Followup Instructions: ___
19716166-DS-19
19,716,166
20,934,658
DS
19
2154-02-12 00:00:00
2154-02-12 13:33:00
Name: ___ Unit No: ___ Admission Date: ___ Discharge Date: ___ Date of Birth: ___ Sex: M Service: MEDICINE Allergies: No Known Allergies / Adverse Drug Reactions Attending: ___. Chief Complaint: Dizziness, Presyncope Major Surgical or Invasive Procedure: None. History of Present Illness: Mr. ___ is a ___ yo M with PMH significant for CAD s/p RCA POBA ___ (pLAD 50%, mLAD 30%, 70% OM1, 100% RI w/collaterals from distal RCA, stable coronary disease ___, infarct related cardiomyopathy (LVEF previously 40%, most recently 67%) with PVC (likely from anterolateral papillary muscle), PMVT s/p single chamber ___ ICD ___, recurrent Stage IV NSCLC on Gemzar presenting with presyncope found to be in polymorphic VT. Patient was in his normal state of health until earlier on the day of admission when he developed dyspnea and palpitations while ascending a flight of stairs. This occurred after receiving chemotherapy earlier this morning. The episode lasted a few seconds and resolved with rest. At 1715, patient was watching TV and took a deep breath, after which he again developed dizziness and lightheadedness, with symptoms similar to prior VT. He subsequently presented to ___ ED for further work-up. On arrival, patient denied any CP, SOB, hemoptysis, leg swelling, history of blood clots, fevers/chills, URI sx, n/v, abdominal pain. While in the ED, he experienced 3 similar episodes of lightheadedness with "warm sensation" and palpitations lasting ___ seconds found to be in polymorphic VT. During the second episode, patient syncopized while in bed and received a shock by his AICD. Patient reportedly had eyes rolled back and regained consciousness after the shock. EP evaluated the patient and performed ICD interrogation which confirmed polymorphic VT. Patient subsequently experienced another episode of lightheadedness/palpitations lasting ___ seconds with episode of polymorphic VT which subsequently resolved on its own. He received IV Lidocaine and was started on Lidocaine prior to arrival. Of note, patient presented with syncope and lightheadedness on ___ and progressed to unstable polymorphic VT for which he was intubated and shocked. At that time, concern for precipitant of prolonged QTC in setting of Zofran, Chlorpromazine, Trazodone, and Azithromycin. He was started on Metoprolol and Verapamil with decrease in ectopy burden. He ultimately underwent an EP study on ___, though unable to find specific focus for ablation. Patient underwent ICD placement on ___. In the ED, - Initial vitals were: T97.1, HR 105, BP 148/70, RR 16, 96% RA - Exam notable for: no JVD, Lungs CTA b/l - Labs notable for: Hgb 11. BNP 1394. Mg 1.8, K 4.4. Troponin <0.01 - Studies notable for: CXR with left basilar opacity concerning for small left pleural effusion, compressive atelectasis and pleural based mets, though infection difficult to exclude. Grossly similar left suprahilar mass Bedside TTE without pericardial effusion - Patient was given: IV Mg 4gm, Metoprolol succinate 25mg, Verapamil 240mg, Lidocaine 100mg IV bolus followed by Lidocaine 1mg/min IV gtt On arrival to the CCU, patient currently denies any chest pain, palpitations, shortness of breath, dizziness/lightheadedness. He explained that over the past few months, he has noted progressive dyspnea on exertion associated with palpitations, as well as orthopnea requiring him to wake up in the middle of the night and sleep on the cough with multiple pillows. He denies any chest pain at rest or on exertion. In light of these symptoms, he was evaluated by wife's PCP toward end of ___ and was prescribed 7 day course of Augmentin/Doxycycline with mild improvement in his symptoms. Given ongoing fatigue and lightheadedness with standing, he presented again to the ED on ___ with CXR showing progressive left sided pleural effusion and was discharged with outpatient IP f/u for thoracentesis. ICD was not interrogated at that time. As above, patient presented for scheduled chemotherapy earlier on day of presentation. He has not been taking any antiemetics (Chlorpromazine, Zofran) at home, though did receive dose of Chlorpromazine earlier today while receiving treatment. Past Medical History: Cardiac History: - HTN - HLD - CAD s/p POBA RCA ___ (noted 70% stenosis ostium OM1, 100% stenosis proximal segment ramus intermedius, 95% stenosis proximal, mid and distal RCA) - Heart failure with recovered EF - Hx VT storm s/p ICD Other PMH: -NSCLC Regimen: Previously on cisplatin and etoposide, Day 1, 8, 29, 36, etoposide day ___. x 2 Cycles and Imfinzi 10 mg/kg Q 2 weeks x 7 Cycles/ Carboplatin/Pemetrexed/Pembrolizumab q3w x 4 cycles. Abraxane 260 mg/m2 and Avastin 15 mg/m2 Q 3 weeks x 4 cycles. Current Treatment: Gemzar 1000 mg/m2 week ___ week 4 off - OSA - GERD - Hypogonadism Social History: ___ Family History: Mother with CAD s/p CABG (___), HTN; Father with CAD s/p CABG (___), HTN, Diabetes; Brother with HTN, and ?heart condition. Says heart disease runs in maternal aunts/uncles, though could not provide specifics. No history of arrhythmias or sudden unexplained cardiac death at young age. Physical Exam: ADMISSION EXAM ==================== VS: REVIEWED IN METAVISION GENERAL: Well developed, well nourished in NAD. Oriented x3. Mood, affect appropriate. HEENT: Normocephalic, atraumatic. Sclera anicteric. PERRL. EOMI. NECK: Supple. JVP not elevated. CARDIAC: Tachycardic, regular rhythm. No murmurs, rubs, or gallops. LUNGS: No chest wall deformities or tenderness. Respiration is unlabored with no accessory muscle use. Decreased breath sounds LLL. No crackles or rhonchi ABDOMEN: Soft, non-tender, non-distended. No palpable hepatomegaly or splenomegaly. EXTREMITIES: Warm, well perfused. No clubbing, cyanosis, or peripheral edema. SKIN: No significant lesions or rashes. PULSES: Distal pulses palpable and symmetric. NEURO: AAOx3, no focal deficits DISCHARGE EXAM ============== 24 HR Data (last updated ___ @ 749) Temp: 98.2 (Tm 98.8), BP: 132/66 (100-132/58-69), HR: 73 (55-89), RR: 20 (___), O2 sat: 94% (93-97), O2 delivery: RA, Wt: 157.19 lb/71.3 kg GENERAL: Well developed, well nourished in NAD. Oriented x3. Mood, affect appropriate. HEENT: Normocephalic, atraumatic. Sclera anicteric. EOMI. NECK: Supple. JVP not elevated. CARDIAC: Normal rate, regular rhythm. No murmurs, rubs, or gallops. LUNGS: No chest wall deformities or tenderness. Respiration is unlabored with no accessory muscle use. Decreased breath sounds LLL. No crackles or rhonchi. ABDOMEN: Soft, non-tender, non-distended. No palpable hepatomegaly or splenomegaly. EXTREMITIES: Warm, well perfused. No clubbing, cyanosis, or peripheral edema. SKIN: No significant lesions or rashes. PULSES: Distal pulses palpable and symmetric. NEURO: AAOx3, no focal deficits Pertinent Results: ADMISSION LABS =================== ___ 07:51PM BLOOD WBC-6.4 RBC-3.87* Hgb-11.0* Hct-34.1* MCV-88 MCH-28.4 MCHC-32.3 RDW-20.8* RDWSD-63.7* Plt ___ ___ 07:51PM BLOOD Glucose-146* UreaN-10 Creat-0.7 Na-137 K-4.4 Cl-101 HCO3-21* AnGap-15 ___ 07:51PM BLOOD ___ PTT-29.7 ___ ___ 07:51PM BLOOD cTropnT-<0.01 ___ 01:18AM BLOOD cTropnT-<0.01 ___ 07:51PM BLOOD proBNP-139___* RELEVANT STUDIES =================== ___ CXR PORTABLE AP: Left basilar opacification likely reflects a combination of a small left pleural effusion, compressive atelectasis, and known pleural based metastases though infection is difficult to exclude in the correct clinical setting. Grossly similar left suprahilar mass. TTE ___: CONCLUSION: The left atrial volume index is mildly increased. The estimated right atrial pressure is ___ mmHg. There is normal left ventricular wall thickness with a normal cavity size. Overall left ventricular systolic function is moderately depressed secondary to hypokinesis of the anterior septum, anterior free wall, and apex. The visually estimated left ventricular ejection fraction is 35%. There is no resting left ventricular outflow tract gradient. Tissue Doppler suggests an increased left ventricular filling pressure (PCWP greater than 18 mmHg). Normal right ventricular cavity size with normal free wall motion. Tricuspid annular plane systolic excursion (TAPSE) is normal. The aortic sinus diameter is normal for gender with normal ascending aorta diameter for gender. The aortic arch diameter is normal with a normal descending aorta diameter. There is no evidence for an aortic arch coarctation. There is trace aortic regurgitation. The mitral valve leaflets appear structurally normal with no mitral valve prolapse. There is trivial mitral regurgitation. The pulmonic valve leaflets are normal. The tricuspid valve leaflets appear structurally normal. There is tricuspid regurgitation present (could not be qualified). Due to acoustic shadowing, the severity of tricuspid regurgitation may be UNDERestimated. The estimated pulmonary artery systolic pressure is normal. There is a small pericardial effusion subtending the right heart. There are no 2D or Doppler echocardiographic evidence of tamponade. IMPRESSION: extensive anteroapical hypokinesis Compared with the prior TTE (images reviewed) of ___ , the left ventricualr ejection fraction is reduced. PREVIOUS CARDIAC STUDIES ========================= ___ echocardiogram - Mild regional systolic dysfunction with hypokinesis of the mid-distal inferolateral, anterolateral, and anterior walls consistent with multivessel coronary artery disease. Mild mitral regurgitation. Normal pulmonary pressure. Estimated LVEF 45-50% ___: coronary angiogram and angioplasty - • Three vessel coronary artery disease. • PTCA alone (POBA) of RCA. ___ Cardiac Catheterization Findings • Stable LAD and LCx disease comapred to prior. • Moderate residual RCA disease after prior POBA with normal flow and intact RI collaterals ___ TTE Conclusion: The left atrium is mildly dilated. There is no evidence for an atrial septal defect by 2D/color Doppler. The estimated right atrial pressure is ___ mmHg. There is normal left ventricular wall thickness with a normal cavity size. There is normal regional and global left ventricular systolic function. Quantitative 3D volumetric left ventricular ejection fraction is 67 %. Left ventricular cardiac index is low normal (2.0-2.5 L/min/m2). There is no resting left ventricular outflow tract gradient. Tissue Doppler suggests an increased left ventricular filling pressure (PCWP greater than 18 mmHg). Normal right ventricular cavity size with normal free wall motion. Tricuspid annular plane systolic excursion (TAPSE) is normal. The aortic sinus diameter is normal for gender with normal ascending aorta diameter for gender. The aortic arch diameter is normal. There is no evidence for an aortic arch coarctation. The aortic valve leaflets (?#) are mildly thickened. There is no aortic valve stenosis. There is no aortic regurgitation. The mitral valve leaflets appear structurally normal with no mitral valve prolapse. There is mild [1+] mitral regurgitation. The pulmonic valve leaflets are not well seen. The tricuspid valve leaflets appear structurally normal. There is physiologic tricuspid regurgitation. There is moderate pulmonary artery systolic hypertension. There is a small loculated pericardial effusion primarily anterior to the right atrium and basal right ventricle. IMPRESSION: Normal left ventricular wall thickness and biventricular cavity sizes and regional/global systolic function. Moderate pulmonary artery systolic hypertension. Mild mitral regurgitation with normal valve morphology. TTE (___) CONCLUSION: The left atrial volume index is normal. There is no evidence for an atrial septal defect by 2D/color Doppler. The estimated right atrial pressure is ___ mmHg. There is normal left ventricular wall thickness with a normal cavity size. There is mild regional left ventricular systolic dysfunction with hypokinesis of the mid-distal inferolateral, anterolateral, and anterior walls (see schematic). The visually estimated left ventricular ejection fraction is 45-50%. There is no resting left ventricular outflow tract gradient. No ventricular septal defect is seen. Diastolic parameters are indeterminate. Normal right ventricular cavity size with normal free wall motion. The aortic sinus diameter is normal for gender with normal ascending aorta diameter for gender. The aortic valve leaflets are moderately thickened. There is no aortic valve stenosis. There is trace aortic regurgitation. The mitral valve leaflets are mildly thickened with no mitral valve prolapse. There is mild [1+] mitral regurgitation. The tricuspid valve leaflets appear structurally normal. There is physiologic tricuspid regurgitation. The estimated pulmonary artery systolic pressure is normal. There is a trivial pericardial effusion. IMPRESSION: Mild regional systolic dysfunction with hypokinesis of the mid-distal inferolateral, anterolateral, and anterior walls consistent with multivessel coronary artery disease. Mild mitral regurgitation. Normal pulmonary pressure. CARDIAC CATHETERIZATION (___) Coronary Description The coronary circulation is right dominant. LM: The Left Main, arising from the left cusp, is a large caliber vessel and is normal. This vessel trifurcates into the Left Anterior Descending, Left Circumflex, and Ramus Intermedius. LAD: The Left Anterior Descending artery, which arises from the LM, is a large caliber vessel. There is a 50% tubular stenosis in the proximal segment. There is a 30% diffuse stenosis in the mid segment. The Septal Perforator, arising from the proximal segment, is a small caliber vessel. Cx: The Circumflex artery, which arises from the LM, is a large caliber vessel with mild luminal irregularities. The ___ Obtuse Marginal, arising from the proximal segment, is a medium caliber vessel. There is a 70% stenosis in the ostium. The ___ Obtuse Marginal, arising from the mid segment, is a medium caliber vessel. RI: The Ramus Intermedius, which arises from the LM, is a medium caliber vessel. There is a 100% stenosis in the proximal segment. There are collaterals from the distal RCA. RCA: The Right Coronary Artery, arising from the right cusp, is a large caliber vessel. There is a 95% stenosis in the proximal and mid segments. There is a 95% stenosis in the mid and distal segments. The Acute Marginal, arising from the proximal segment, is a small caliber vessel. The Right Posterior Descending Artery, arising from the distal segment, is a medium caliber vessel. The Right Posterolateral Artery, arising from the distal segment, is a medium caliber vessel. Interventional Details Percutaneous Coronary Intervention: Percutaneous coronary intervention (PCI) was performed on an ad hoc basis based on the coronary angiographic findings from the diagnostic portion of this procedure. A ___ AL 0.75 guiding catheter provided excellent support. After crossing with a wire all stenoses were dilated using a 2.0 mm NC balloon. Unsuccessful attempt to pass a 2.5mm x 38mm stent, so did further dilations using a 2.5mm NC balloon at high pressure. The balloon at this point became stuck to the wire and pulled wire out of vessel as removed. Tried unsuccessfully to recross all stenoses using a Sion wire and then a Prowater wire but unsuccessful because of passage into dissection flaps.. Since there is only mild stenosis (approx 40%) and normal flow and patient free of chest pain, decided that risks outweigh benefits of more aggressive attempts. Complications: There were no clinically significant complications. Findings • Three vessel coronary artery disease. • PTCA alone (POBA) of RCA. DISCHARGE LABS ============== ___ 08:33AM BLOOD Glucose-95 UreaN-12 Creat-1.0 Na-138 K-4.5 Cl-99 HCO3-23 AnGap-16 Brief Hospital Course: SUMMARY: ========= ___ yo M with PMH significant for CAD s/p RCA POBA ___ (pLAD 50%, mLAD 30%, 70% OM1, 100% RI w/collaterals from distal RCA, stable coronary disease ___, infarct related cardiomyopathy (LVEF previously 40%, most recently 67%) with PVC (likely from anterolateral papillary muscle), PMVT s/p single chamber ___. ___ ICD ___, recurrent Stage IV NSCLC on Gemzar presenting with presyncope found to be in polymorphic VT. #CORONARIES: LAD with 50% tubular stenosis proximal segment, 30% diffuse stenosis in mid-segment. ___ OM with 70-80% stenosis . Ramus Intermedius 100% stenosis in proximal segment with robust collaterals from distal RCA. RCA with diffuse mild-moderate disease throughout with 50% focal stenosis in distal segment #PUMP: EF 67% (previous 45-50% ___, mild MR, moderate PASP #RHYTHM: Sinus ACUTE ISSUES: ============ #Polymorphic VT Patient with history of PMVT now s/p ICD placement presenting with recurrent symptomatic PMVT. Previous etiology concerning for medication-induced prolonged QTC. Had been controlled on Metoprolol, Verapamil with previous EP study without focus amenable to ablation. ICD interrogation consistent with acute sustained PMVT appropriately shock-terminated by ICD, as well as 8 episodes of NSVT since ___. QTc notably more prolonged than prior in setting of hypomagnesemia with early after depolarizations after receiving Chlorpromazine. Patient with known ischemic cardiomyopathy (EF previously recovered, now reduced), no evidence of acute ischemic event. Possible contribution of scar from prior XRT therapy to the chest. EP was consulted who recommended starting a lidocaine drip and amiodarone drip, which was later changed to PO amiodarone. He continued to have brief episodes of non-sustained VT without receiving shocks. The decision was made to hold off on further ischemic workup given patient's prognosis from a lung cancer perspective, as he would not be a surgical candidate and further ischemic work up would be of limited benefit. Lidocaine gtt was downtitrated, however, patient developed recurrent NSVT and PO mexilitine was started. After initiation of mexilitine, lidocaine gtt was titrated off and patient was maintained on PO regimen of metoprolol succinate 50mg daily, amiodarone 400mg TID and mexiletine 200mg q8h with adequate suppression of VT. Discontinued Verapamil, though given recurrent frequent NSVT, restarted prior to discharge. Patient triggered for junctional escape rhythm on ___, though was asymptomatic and hemodynamically stable. No further medication adjustments were made. Discharge medications: Metoprolol succinate XL 50 mg PO daily, Verapamil 240 mg PO BID, Mexiletine 200 mg PO q8h, amiodarone 400 mg PO TID. # Acute HFrEF Had previous reduced EF with recovery, most recent TTE showing EF reduced again to 35%. Differential includes myocardial stunning from recent ICD shocks vs. ischemic etiology, although EKG and troponins not concerning for this. Patient does have history of CAD, however, due to life expectancy with comorbid stage IV NSCLC, coronary angiography not pursued. - PRELOAD: maintaining euvolemia without diuretics - AFTERLOAD: lisinopril 2.5mg - NHBK: Continued home spironolactone 25mg 4x/week and metoprolol succinate as above CHRONIC ISSUES: =============== #NSCLC #Pleural Effusions Per outpatient oncologist, currently on third line therapy with plan to repeat chest CT as an outpatient to assess disease burden. Will also be considered for clinical trials based on adequate performance status. On Gemzar 1000 mg/m2 week ___ week 4 off. Pleural effusion with malignant cells giving evidence of metastatic adenocarcinoma. #Hypertension Mgmt of hypertension as above (see HFrEF) #CAD Continue ASA and increased Metoprolol as above. Outpatient physician was considering ___, although he had a transaminitis on a statin before. TRANSITIONAL ISSUES: ================== [] Avoid QT prolonging agents [] Repeat TTE in ___ weeks, if EF still low, send further w/u for non-ischemic cardiomyopathy [] Follow-up pleural fluid analysis [] Repeat LFTs at outpatient follow-up. Had mild transaminitis (AST 71, ALT 118) on ___. Thought to possibly be due to amiodarone. ADVANCED CARE PLANNING: ====================== #CODE: Full, confirmed #CONTACT/HCP: ___ (wife) ___ ___ (daughter) ___ Medications on Admission: The Preadmission Medication list is accurate and complete. 1. Aspirin 81 mg PO DAILY 2. Magnesium Oxide 400 mg PO DAILY 3. Metoprolol Succinate XL 25 mg PO QHS 4. Multivitamins 1 TAB PO DAILY 5. Spironolactone 25 mg PO 4X/WEEK (___) 6. Prochlorperazine 10 mg PO Q6H:PRN Nausea/Vomiting - First Line 7. Omeprazole 20 mg PO DAILY 8. Verapamil 240 mg PO Q12H 9. GuaiFENesin-CODEINE Phosphate ___ mL PO QHS:PRN cough Discharge Medications: 1. Amiodarone 400 mg PO TID RX *amiodarone 400 mg 1 tablet(s) by mouth three times a day Disp #*90 Tablet Refills:*0 2. Lisinopril 2.5 mg PO DAILY RX *lisinopril 2.5 mg 1 tablet(s) by mouth once a day Disp #*90 Tablet Refills:*0 3. Mexiletine 200 mg PO Q8H RX *mexiletine 200 mg 1 capsule(s) by mouth every eight (8) hours Disp #*90 Capsule Refills:*0 4. Metoprolol Succinate XL 50 mg PO DAILY RX *metoprolol succinate 50 mg 1 tablet(s) by mouth once a day Disp #*90 Tablet Refills:*0 5. Verapamil 240 mg PO Q12H 6. Aspirin 81 mg PO DAILY 7. GuaiFENesin-CODEINE Phosphate ___ mL PO QHS:PRN cough 8. Magnesium Oxide 400 mg PO DAILY 9. Multivitamins 1 TAB PO DAILY 10. Omeprazole 20 mg PO DAILY 11. Spironolactone 25 mg PO 4X/WEEK (___) 12.Outpatient Lab Work Labs: Chem10, LFTs Date: ___ ICD-9: E942.0 Please fax to ___ S., MD ___ Discharge Disposition: Home Discharge Diagnosis: Polymorphic ventricular tachycardia Heart failure with reduced ejection fraction Non small cell lung cancer Discharge Condition: Mental Status: Clear and coherent. Level of Consciousness: Alert and interactive. Activity Status: Ambulatory - Independent. Discharge Instructions: Dear Mr. ___, WHY WERE YOU ADMITTED TO THE HOSPITAL? - You were admitted to the hospital because you were you were having an abnormal heart rhythm which caused your ICD to shock you. WHAT WAS DONE WHILE YOU WERE IN THE HOSPITAL? - You were given IV medication to normalize your heart rhythm. You were started on new oral medications to control your heart rhythm. WHAT DO YOU NEED TO DO WHEN YOU LEAVE THE HOSPITAL? - Take all of your medications as prescribed (listed below) - Follow up with your doctors as listed below - Weigh yourself every morning, seek medical attention if your weight goes up more than 3 lbs. - Seek medical attention if you have new or concerning symptoms or you develop swelling in your legs, abdominal distention, or shortness of breath at night. Please see below for more information on your hospitalization. It was a pleasure taking part in your care here at ___! We wish you all the best! - Your ___ Care Team Followup Instructions: ___
19716166-DS-20
19,716,166
27,532,827
DS
20
2154-02-21 00:00:00
2154-02-22 11:25:00
Name: ___ Unit No: ___ Admission Date: ___ Discharge Date: ___ Date of Birth: ___ Sex: M Service: MEDICINE Allergies: No Known Allergies / Adverse Drug Reactions Attending: ___. Chief Complaint: syncope Major Surgical or Invasive Procedure: ICD Interrogation Ventricular Tachycardia Ablation History of Present Illness: Mr. ___ is a ___ yo M with PMH significant for CAD s/p RCA POBA ___ (pLAD 50%, mLAD 30%, 70% OM1, 100% RI w/collaterals from distal RCA, stable coronary disease ___, infarct related cardiomyopathy (LVEF previously 40%, most recently 67%) with PVC (likely from anterolateral papillary muscle), PMVT s/p single chamber ___ ICD ___, recurrent Stage IV NSCLC on Gemzar presenting with presenting with syncope found to be in polymorphic VT. Of note, he was admitted to ___ on ___ with syncope and was noted to have recurrent polymorphic VT. He was thought to have PVC triggering polymorphic VT originating from somewhere in the anterolateral LV. EPS was performed without focus amenable to ablation. An ICD was implanted given the fact that his prognosis from his lung cancer may still be at least one year. He was sent home on metoprolol and verapamil He was then readmitted from ___ for presyncope ___ polymorphic VT. He was still on metop/verapamil at that time. ICD interrogation was consistent with acute sustained PMVT appropriately shock-terminated by ICD. He was initially on a Lidocaine drip which was transitioned to mexilitine. PO amio was also started. He was discharged on a regimen of metoprolol succinate 50mg daily, amiodarone 400mg TID and mexiletine 200mg q8h. Discontinued Verapamil, though given recurrent frequent NSVT, restarted prior to discharge. Patient triggered for junctional escape rhythm on ___, though was asymptomatic and hemodynamically stable. No further medication adjustments were made. He was discharged yesterday ___. This morning he woke up feeling dizzy, however was steady on his feet. While watching TV he felt a non-painful sensation arise from his chest to his head prior to losing consciousness. This was similar to prior episodes. He was oriented upon waking, and denies any shock, nausea, vomiting, headache, chest pain, shortness of breath, palpitations, or incontinence. The event lasted several seconds, and resulting in EMS transport to ___. In the ED he was noted to be normotensive with normal RR and oxygen saturation on room air. His labs were notable for a mild leukocytosis and a normal K and Mag. EP was consulted and noted a single episode of VT terminated after ATP with no shock delivered. He was not given any medications in the ED, and was admitted for further monitoring and evaluation. On arrival to the floor he endorses the above HPI and is currently asymptomatic. He notes having taken all of his medications as prescribed. Past Medical History: Cardiac History: - HTN - HLD - CAD s/p POBA RCA ___ (noted 70% stenosis ostium OM1, 100% stenosis proximal segment ramus intermedius, 95% stenosis proximal, mid and distal RCA) - Heart failure with recovered EF - Hx VT storm s/p ICD Other PMH: -NSCLC Regimen: Previously on cisplatin and etoposide, Day 1, 8, 29, 36, etoposide day ___. x 2 Cycles and Imfinzi 10 mg/kg Q 2 weeks x 7 Cycles/ Carboplatin/Pemetrexed/Pembrolizumab q3w x 4 cycles. Abraxane 260 mg/m2 and Avastin 15 mg/m2 Q 3 weeks x 4 cycles. Current Treatment: Gemzar 1000 mg/m2 week ___ week 4 off - OSA - GERD - Hypogonadism Social History: ___ Family History: Mother with CAD s/p CABG (___), HTN; Father with CAD s/p CABG (___), HTN, Diabetes; Brother with HTN, and ?heart condition. Says heart disease runs in maternal aunts/uncles, though could not provide specifics. No history of arrhythmias or sudden unexplained cardiac death at young age. Physical Exam: ADMISSION EXAM: =============== ___ 1158 Temp: 98.0 PO BP: 108/56 R Lying HR: 60 RR: 20 O2 sat: 94% O2 delivery: RA GENERAL: Well developed, well nourished in NAD. Oriented x3. Mood, affect appropriate. HEENT: Normocephalic, atraumatic. Sclera anicteric. EOMI. NECK: Supple. JVP not elevated. CARDIAC: Normal rate, regular rhythm. No murmurs, rubs, or gallops. LUNGS: No chest wall deformities or tenderness. Respiration is unlabored with no accessory muscle use. Decreased breath sounds LLL. No crackles or rhonchi. ABDOMEN: Soft, non-tender, non-distended. No palpable hepatomegaly or splenomegaly. EXTREMITIES: Warm, well perfused. No clubbing, cyanosis, or peripheral edema. SKIN: No significant lesions or rashes. PULSES: Distal pulses palpable and symmetric. NEURO: AAOx3, no focal deficits DISCHARGE EXAM: =============== VS: 24 HR Data (last updated ___ @ ___ Temp: 98.3 (Tm 98.3), BP: 101/58 (90-124/51-71), HR: 58 (54-67), RR: 18 (___), O2 sat: 91% (90-97) GENERAL: Well developed, well nourished in NAD. Oriented x3. Mood, affect appropriate. HEENT: Normocephalic, atraumatic. Sclera anicteric. EOMI. NECK: Supple. JVP not elevated. CARDIAC: Normal rate, regular rhythm. No murmurs, rubs, or gallops. LUNGS: No chest wall deformities or tenderness. Respiration is unlabored with no accessory muscle use. Decreased breath sounds LLL. No crackles or rhonchi. ABDOMEN: Soft, non-tender, non-distended. No palpable hepatomegaly or splenomegaly. EXTREMITIES: Warm, well perfused. No clubbing, cyanosis, or peripheral edema. SKIN: No significant lesions or rashes. PULSES: Distal pulses palpable and symmetric. NEURO: AAOx3, no focal deficits Pertinent Results: ADMISSION LABS: ============== ___ 10:55AM BLOOD WBC-12.1* RBC-3.34* Hgb-9.6* Hct-30.8* MCV-92 MCH-28.7 MCHC-31.2* RDW-22.8* RDWSD-72.8* Plt ___ ___ 10:55AM BLOOD Neuts-79.3* Lymphs-5.6* Monos-11.9 Eos-0.2* Baso-0.4 Im ___ AbsNeut-9.59* AbsLymp-0.68* AbsMono-1.44* AbsEos-0.02* AbsBaso-0.05 ___ 11:25AM BLOOD ___ PTT-28.7 ___ ___ 08:33AM BLOOD Glucose-95 UreaN-12 Creat-1.0 Na-138 K-4.5 Cl-99 HCO3-23 AnGap-16 ___ 10:55AM BLOOD ALT-121* AST-53* AlkPhos-139* TotBili-0.3 ___ 08:33AM BLOOD Calcium-9.4 Phos-3.8 Mg-2.0 PERTINENT LABS: =============== ___ 06:07AM BLOOD ALT-98* AST-36 AlkPhos-140* DISCHARGE LABS: =============== ___ 06:00AM BLOOD WBC-9.1 RBC-3.26* Hgb-9.4* Hct-29.9* MCV-92 MCH-28.8 MCHC-31.4* RDW-21.2* RDWSD-70.4* Plt ___ ___ 06:00AM BLOOD Glucose-106* UreaN-16 Creat-0.9 Na-138 K-4.0 Cl-102 HCO3-21* AnGap-15 ___ 06:00AM BLOOD Calcium-9.3 Phos-3.7 Mg-2.0 IMAGING/STUDIES: ================= ___ CHEST (PORTABLE AP) IMPRESSION: Left-sided pacemaker and right-sided Port-A-Cath are unchanged. Small left pleural effusion unchanged. Cardiomediastinal silhouette is stable. No pneumothorax. There is stable subsegmental atelectasis in the left lower lobe. ___ ICD Interrogation Interrogation: Battery voltage/time to ERI: ___ years, 12uA Charge Time: 7.8 sec Presenting rhythm: VS Underlying rhythm: SR ___ Mode, base and upper track rate: VVI 40 ICD Configuration: VT1 171: monitor only VT2 190: ATPx2, 30Jx1, 36Jx3 VF 250: ATPx1, 30Jx1, 36Jx5 Lead Testing R waves: 11.7 mV RV thresh: 0.75 V @ 0.5 ms RV imp: 460 ohms DF impedance: 61 ohms (RV to can) Diagnostics: VP: 0% Events: ___ 0940: VT-2 ATP (successful per ICD, but there were 7 beats of polymorphic VT before resuming sinus rhythm Summary: 1. 1 episode of sustained monomorphic VT, self-terminated after ATP and no shock delivered 2. ICD function normal with acceptable lead measurements and battery status 3. Programming changes: none 4. Follow-up: Inpatient admission under Dr. ___, EP attending ___ ICD Interrogation Diagnostics: VP: 0% Events: ___ 0940: VT-2 ATP (successful per ICD, but there were 7 beats of polymorphic VT before resuming sinus rhythm Brief Hospital Course: Outpatient Providers: SUMMARY: ___ yo M with PMH significant for CAD s/p RCA POBA ___ (pLAD 50%, mLAD 30%, 70% OM1, 100% RI w/collaterals from distal RCA, stable coronary disease ___, infarct related cardiomyopathy (LVEF previously 40%, most recently 67%) with PVC (likely from anterolateral papillary muscle), PMVT s/p single chamber ___. ___ ICD ___, recurrent Stage IV NSCLC on ___ presenting with presyncope found to be in polymorphic VT now maintained on Amiodarone and Verapamil and s/p VT ablation on ___. ACTIVE ISSUES: # Polymorphic VT Patient has a history of PMVT now s/p ICD placement presenting with recurrent symptomatic PMVT. Previous etiology concerning for medication-induced prolonged QTC (currently 523). Had been controlled on Metoprolol, Verapamil during prior EP study without focus amenable to ablation. ICD interrogation consistent with acute sustained PMVT appropriately self-terminated after ATP and no shock delivered. Patient with known ischemic cardiomyopathy (EF previously recovered, now reduced), though no evidence of acute ischemic event. Possible contribution of scar from prior XRT to the chest. Patient on verapamil, amid, metoprolol and mexiletine with little room for maximizing doses. He complicated an amiodarone load and transitioned to 400mg QD prior to discharge. As he was not a great candidate for surgery given comorbidities, and PVCs appeared predominantly unifocal, decision to VT ablate was made and performed on ___. His mexiletine was also discontinued prior to discharge. He was sent home on amiodarone and verapamil. # HFrEF Had previous reduced EF with recovery, most recent TTE showing EF reduced again to 35%. Differential included myocardial stunning from recent ICD shocks vs. ischemic vs. non-ischemic etiologies. Patient does have history of CAD, however, due to life expectancy with comorbid stage IV NSCLC, coronary angiography was not pursued. There was no role for ischemic work-up for now and can repeat TTE as an outpatient and pursue further workup if EF continues to be depressed, as current decline in systolic function likely ___ episodes of VT and ICD discharges. Patient was continued on metoprolol and spironolactone throughout. #Elevated Transaminases Possibly ___ recent Amiodarone. No RUQ pain. Mildly elevated INR. AST downtrended to WNL. ALT remained mildly elevated at 98 on discharge. CHRONIC ISSUES: =============== #___ #Pleural Effusions Per outpatient oncologist, currently on third line therapy with plan to repeat chest CT as an outpatient to assess disease burden. Will also be considered for clinical trials based on adequate performance status. Cytology with metastatic adenocarcinoma. Patient is on Gemzar 1000 ___ week 4 off. #Hypertension Patient with history of hypertension. Continued on spironolactone, metoprolol and lisinopril during course. #CAD Unikely that patient would have undergone coronary angiogram given comorbidities so was not worked up as possible contributor to dysrrhythmia. TRANSITIONAL ISSUES: DISCHARGE WEIGHT: 72.6kg (160.05 lbs) DISCHARGE Cr/BUN: 0.9 MEDICATION CHANGES: - NEW: None - STOPPED: Mexiletine - CHANGED: Amiodarone 400mg TID to ___ QD Metoprolol succinate 50mg QD to 50mg BID [] QTc was prolonged to 524 prior to discharge. Please avoid QT prolonging meds [] No ischemic evaluation was conducted this admission given that he would not be candidate for CABG and already had complicated PCI in the past [] Please consider repeat TTE as an outpatient [] He did not receive ___ this admission and he will follow-up with outpatient oncologist Dr. ___ ___ status: Full ___ Contact/HCP: ___ (wife) ___ ___ (daughter) ___ Medications on Admission: The Preadmission Medication list is accurate and complete. 1. Aspirin 81 mg PO DAILY 2. Metoprolol Succinate XL 50 mg PO DAILY 3. Multivitamins 1 TAB PO DAILY 4. Omeprazole 20 mg PO DAILY 5. Spironolactone 25 mg PO 4X/WEEK (___) 6. Amiodarone 400 mg PO TID 7. Lisinopril 2.5 mg PO DAILY 8. Mexiletine 200 mg PO Q8H 9. GuaiFENesin-CODEINE Phosphate ___ mL PO QHS:PRN cough 10. Magnesium Oxide 400 mg PO DAILY 11. Verapamil 240 mg PO Q12H Discharge Medications: 1. Metoprolol Succinate XL 50 mg PO Q12H 2. Amiodarone 400 mg PO TID 3. Aspirin 81 mg PO DAILY 4. GuaiFENesin-CODEINE Phosphate ___ mL PO QHS:PRN cough 5. Lisinopril 2.5 mg PO DAILY 6. Magnesium Oxide 400 mg PO DAILY 7. Mexiletine 200 mg PO Q8H 8. Multivitamins 1 TAB PO DAILY 9. Omeprazole 20 mg PO DAILY 10. Spironolactone 25 mg PO 4X/WEEK (___) 11. Verapamil SR 240 mg PO Q12H Discharge Disposition: Home Discharge Diagnosis: PRIMARY: -------------------- Polymorphic Ventricular Tachycardia SECONDARY: -------------------- Heart failure with reduced ejection fraction Non Small Cell Lung Cancer Hypertension Coronary Artery Disease Discharge Condition: Mental Status: Clear and coherent. Level of Consciousness: Alert and interactive. Activity Status: Ambulatory - Independent. Discharge Instructions: Dear Mr. ___, WHY WERE YOU ADMITTED TO THE HOSPITAL? - You were admitted to the hospital because you were having an abnormal heart rhythm which caused you to lose consciousness. WHAT WAS DONE WHILE YOU WERE IN THE HOSPITAL? - Your heart rhythm medications were optimized and you underwent a ventricular tachycardia ablation on ___. WHAT DO YOU NEED TO DO WHEN YOU LEAVE THE HOSPITAL? - Take all of your medications as prescribed (listed below) - Follow up with your doctors as listed below - Weigh yourself every morning, seek medical attention if your weight goes up more than 3 lbs. - Seek medical attention if you have new or concerning symptoms or you develop swelling in your legs, abdominal distention, or shortness of breath at night. - Seek medical attention if you are having worsening ilghtheadedness and dizziness. Please see below for more information on your hospitalization. It was a pleasure taking part in your care here at ___! We wish you all the best! - Your ___ Care Team Followup Instructions: ___
19716166-DS-21
19,716,166
21,255,294
DS
21
2154-02-27 00:00:00
2154-03-04 14:02:00
Name: ___ Unit No: ___ Admission Date: ___ Discharge Date: ___ Date of Birth: ___ Sex: M Service: MEDICINE Allergies: No Known Allergies / Adverse Drug Reactions Attending: ___. Chief Complaint: Chest Pain/ Pre-syncope Major Surgical or Invasive Procedure: cardiac cateterization History of Present Illness: HISTORY OF PRESENTING ILLNESS: Mr. ___ is a ___ yo M with PMH significant for CAD s/p RCA POBA ___ (pLAD 50%, mLAD 30%, 70% OM1, 100% RI w/collaterals from distal RCA, stable coronary disease ___, infarct related cardiomyopathy (LVEF 35 % on ___, VT s/p ICD and VT ablation (___), recurrent Stage IV NSCLC on Gemzar presenting with presenting with progressive DOE and presyncopal episode. Mr. ___ was recently admitted here from ___ for syncope ___ polymorphic VT. He ended up getting a VT ablation during that admission. He states that since discharge he hasn't felt like himself. He states he has had progressive DOE, increasing ___ edema, orthopnea, and nausea without vomiting. The DOE got to the point where he could not make it up one flight of stairs. He did not have SOB with rest. He had a presyncopal episode earlier today which prompted him to seek care at the ED. During this episode he felt SOB, lightheadedness, palpitations, and a brief discomfort in his chest for less than 1 min that he has trouble characterizing. In the ED... - Initial vitals: 24 HR Data (last updated ___ @ 1536) Temp: 99.4 (Tm 99.4), BP: 129/80, HR: 66, RR: 18, O2 sat: 92%, O2 delivery: Ra - EKG: No changes from prior EKG. NSR no ST changes - Labs/studies notable for: troponin elevated to 0.23 proBNP 1351 - Patient was given: Lasix IV 40 mg good response. was able to be weaned of O2. On the floor the patient states SOB is much improved. Denies CP atm. Currently euvolemic and off supplemental O2. Mr. ___ has not had a recent stress test. He had a recent cath which showed CAD (see below for full report). His last TTE showed EF 35%. REVIEW OF SYSTEMS: remainder of 10 point ROS negative. Past Medical History: Cardiac History: - HTN - HLD - CAD s/p POBA RCA ___ (noted 70% stenosis ostium OM1, 100% stenosis proximal segment ramus intermedius, 95% stenosis proximal, mid and distal RCA) - Heart failure with recovered EF - Hx VT storm s/p ICD Other PMH: -NSCLC Regimen: Previously on cisplatin and etoposide, Day 1, 8, 29, 36, etoposide day ___. x 2 Cycles and Imfinzi 10 mg/kg Q 2 weeks x 7 Cycles/ Carboplatin/Pemetrexed/Pembrolizumab q3w x 4 cycles. Abraxane 260 mg/m2 and Avastin 15 mg/m2 Q 3 weeks x 4 cycles. Current Treatment: Gemzar 1000 mg/m2 week ___ week 4 off - OSA - GERD - Hypogonadism Social History: ___ Family History: Mother with CAD s/p CABG (___), HTN; Father with CAD s/p CABG (___), HTN, Diabetes; Brother with HTN, and ?heart condition. Says heart disease runs in maternal aunts/uncles, though could not provide specifics. No history of arrhythmias or sudden unexplained cardiac death at young age. Physical Exam: Admission Physical Exam: ================================ GENERAL: Well-developed, well-nourished. NAD. Mood, affect appropriate. HEENT: NCAT. Sclera anicteric. PERRL, EOMI. Conjunctiva pink, no pallor or cyanosis of the oral mucosa. No xanthelasma. NECK: No JVD CARDIAC: RRR, normal S1, S2. No extra heart sounds. No murmurs/rubs. No thrills, lifts. LUNGS: No chest wall deformities, scoliosis or kyphosis. Resp were unlabored, no accessory muscle use. No crackles, wheezes or rhonchi. ABDOMEN: Soft, NTND. No HSM or tenderness. EXTREMITIES: No c/c/e. No femoral bruits. SKIN: No stasis dermatitis, ulcers, scars, or xanthomas. PULSES: Distal pulses palpable and symmetric Discharge Physical Exam: ============================= GENERAL: Well-developed, well-nourished. NAD. Mood, affect appropriate. HEENT: NCAT. Sclera anicteric. PERRL, EOMI. Conjunctiva pink, no pallor or cyanosis of the oral mucosa. No xanthelasma. NECK: No JVD CARDIAC: RRR, normal S1, S2. No extra heart sounds. No murmurs/rubs. No thrills, lifts. LUNGS: No chest wall deformities, scoliosis or kyphosis. Resp were unlabored, no accessory muscle use. No crackles, wheezes or rhonchi. ABDOMEN: Soft, NTND. No HSM or tenderness. EXTREMITIES: No c/c/e. No femoral bruits. SKIN: No stasis dermatitis, ulcers, scars, or xanthomas. PULSES: Distal pulses palpable and symmetric Pertinent Results: Admission Labs: ======================== ___ 09:01AM BLOOD WBC-10.5* RBC-3.41* Hgb-9.7* Hct-31.1* MCV-91 MCH-28.4 MCHC-31.2* RDW-20.3* RDWSD-67.9* Plt ___ ___ 09:01AM BLOOD Plt ___ ___ 09:01AM BLOOD Glucose-105* UreaN-12 Creat-0.8 Na-134* K-4.7 Cl-97 HCO3-21* AnGap-16 ___ 09:01AM BLOOD ALT-25 AST-26 CK(CPK)-59 AlkPhos-124 TotBili-0.3 ___ 09:01AM BLOOD CK-MB-2 proBNP-1351* ___ 09:01AM BLOOD cTropnT-0.23* ___ 01:30PM BLOOD cTropnT-0.23* ___ 07:46PM BLOOD CK-MB-1 cTropnT-0.20* ___ 02:51AM BLOOD Calcium-9.5 Phos-5.0* Mg-2.2 Discharge Labs: ========================== ___ 04:56AM BLOOD WBC-12.9* RBC-3.37* Hgb-9.7* Hct-31.0* MCV-92 MCH-28.8 MCHC-31.3* RDW-20.1* RDWSD-67.9* Plt ___ ___ 04:56AM BLOOD Glucose-112* UreaN-18 Creat-1.0 Na-137 K-4.5 Cl-98 HCO3-26 AnGap-13 ___ 04:56AM BLOOD Plt ___ ___ 07:46PM BLOOD CK-MB-1 cTropnT-0.20* ___ 04:56AM BLOOD Calcium-9.6 Phos-4.8* Mg-2.0 Imaging: ========================== Cardiac Cath ___ Two vessel CAD. Recommendations: Had extensive discussions with patient and referring cardiologist around findings and options for management. No clear culprit for current presentation, and comparing angiographic images there has been no significant change compared to prior cath ___. Decided maximize medical therapy, and consider MIBI to evaluate for ischemic territory. ICD interrogation report ___ Battery function normal. No episodes of VT or evidence of other malignant arrhythmias. Brief Hospital Course: PATIENT SUMMARY: ==================== Mr. ___ is a ___ yo M with PMHx significant for CAD s/p RCA POBA ___ (pLAD 50%, mLAD 30%, 70% OM1, 100% RI w/collaterals from distal RCA, stable coronary disease ___, infarct related cardiomyopathy (LVEF 35 % on ___, VT s/p ICD and VT ablation (___), recurrent Stage IV NSCLC on Gemzar presenting with progressive DOE and presyncopal episode. He was found to have acute decompensated CHF. He was diuresed with IV Lasix and was euvolemic at discharge. He was also found to have an NSTEMI and underwent cardiac catheterization which revealed stable coronary artery disease. He was medically optimized for CAD and discharged. ==================== ACUTE ISSUES: ==================== #Acute on chronic HFrEF: Patient presented clinically volume overloaded with orthopnea, DOE, and increasing ___ edema. CXR showed pulmonary edema. He has a history of ischemic and nonischemic CM. Most recent EF 35% (___). Patient is NYHA class I at baseline. Patient reports compliance with medidcations, no changes in diet, no alcohol/drugs. s/p cath ___ without any new obstructive disease. Unclear precipitating factor. He was diuresed to euvolemia with IV Lasix and had symptomatic relief. He was dishcharged on his home medications. #NSTEMI: The patient had atypical chest pain briefly before a presyncopal episode prior to admission. He has known stable CAD on medical management. Trops were initially negative and rose to 0.23 on admission. TIMI score of 4. Of note, due to life expectancy with comorbid stage IV NSCLC, coronary angiography was not pursued on previous admission. s/p cardiac cath on ___ which revealed stable 2 vessel coronary artery disease. Possibly type II NSTEMI in the setting of decompensated CHF vs. recent VT ablation, rather than an acute plaque rupture. ==================== CHRONIC ISSUES: ==================== #Stage IV lung cancer: Per outpatient oncologist, currently on third line therapy with plan to repeat chest CT as an outpatient to assess disease burden. Will also be considered for clinical trials based on adequate performance status. Cytology with metastatic adenocarcinoma. The patient did not receive Gemzar during this hospitalization after discussions with his outpatient oncologist, Dr. ___. #HTN The patient was continued on home BP regimen. No changes were made and the patient remained normotensive thorughout admission. ==================== TRANSITIONAL ISSUES: ==================== -Discharge Weight: 154.8 lbs -Discharge Cr: 1.0 [ ]Consider MIBI to evaluate for ischemic territory [ ]Patient is due for next chemotherapy cycle of Gemzar. Please coordinate with patient's oncologist, Dr. ___ [ ]FYI the patient had episodes of junctional bradycardia during his stay. He demonstrated chronotropic competence however and was otherwise asymptomatic. His PPM was interrogated and was working appropriately Medications on Admission: The Preadmission Medication list may be inaccurate and requires futher investigation. 1. Aspirin 81 mg PO DAILY 2. GuaiFENesin-CODEINE Phosphate ___ mL PO QHS:PRN cough 3. Lisinopril 2.5 mg PO DAILY 4. Magnesium Oxide 400 mg PO DAILY 5. Metoprolol Succinate XL 50 mg PO Q12H 6. Multivitamins 1 TAB PO DAILY 7. Omeprazole 20 mg PO DAILY 8. Spironolactone 25 mg PO 4X/WEEK (___) 9. Verapamil SR 240 mg PO Q12H 10. Amiodarone 400 mg PO DAILY Discharge Medications: 1. Atorvastatin 80 mg PO QPM RX *atorvastatin 80 mg 1 tablet(s) by mouth once a day Disp #*30 Tablet Refills:*0 2. Isosorbide Mononitrate (Extended Release) 30 mg PO DAILY RX *isosorbide mononitrate 30 mg 1 tablet(s) by mouth once a day Disp #*30 Tablet Refills:*0 3. Amiodarone 400 mg PO DAILY 4. Aspirin 81 mg PO DAILY 5. GuaiFENesin-CODEINE Phosphate ___ mL PO QHS:PRN cough 6. Lisinopril 2.5 mg PO DAILY 7. Magnesium Oxide 400 mg PO DAILY 8. Multivitamins 1 TAB PO DAILY 9. Omeprazole 20 mg PO DAILY 10. Spironolactone 25 mg PO 4X/WEEK (___) 11. Verapamil SR 240 mg PO Q12H 12. HELD- Metoprolol Succinate XL 50 mg PO Q12H This medication was held. Do not restart Metoprolol Succinate XL until you see your cardiologist Discharge Disposition: Home With Service Facility: ___ Discharge Diagnosis: Primary diagnoses: ================== 1) NSTEMI 2) Acute on chronic heart failure with reduced EF 3) Ventricular Tachycardia SECONDARY DIAGNOSES: =================== 1) Junctional Bradycardia 2) Non small cell lung cancer Discharge Condition: Mental Status: Clear and coherent. Level of Consciousness: Alert and interactive. Activity Status: Ambulatory - Independent. Discharge Instructions: Dear Mr. ___, It was a pleasure taking care of you at ___ ___. WHY WAS I ADMITTED TO THE HOSPITAL? - You were admitted to the hospital because you had chest pain and almost fainted - You were also becoming more short of breath a few days prior to your admission WHAT HAPPENED WHILE I WAS IN THE HOSPITAL? - You were treated with medications called diuretics (Lasix) to remove extra fluid from your lungs. Your shortness of breath improved. - You received a cardiac catheterization which showed that you did not have any worsening blockages in your arteries - You were given medications to protect your heart which you tolerated well - You had episodes where your heart rate became slow, but you were not symptomatic. This slow heart rate is not dangerous. WHAT SHOULD I DO WHEN I GO HOME? - Your discharge weight is 154.8 lbs. Please weigh yourself daily. Call your doctor if you gain more than 3 lbs. - You should continue to take your medications as prescribed. - You should attend the appointments listed below. - Seek medical attention if you have new or concerning symptoms or you develop swelling in your legs, abdominal distention, or shortness of breath at night. We wish you the best! Your ___ Care Team Followup Instructions: ___
19716166-DS-22
19,716,166
29,255,705
DS
22
2154-04-28 00:00:00
2154-04-28 12:12:00
Name: ___ Unit No: ___ Admission Date: ___ Discharge Date: ___ Date of Birth: ___ Sex: M Service: MEDICINE Allergies: No Known Allergies / Adverse Drug Reactions Attending: ___. Major Surgical or Invasive Procedure: Radiation therapy -- ___ attach Pertinent Results: LABORATORY RESULTS: ___ 06:20AM BLOOD WBC-2.8* RBC-3.09* Hgb-9.0* Hct-28.0* MCV-91 MCH-29.1 MCHC-32.1 RDW-18.9* RDWSD-61.1* Plt ___ ___ 05:17AM BLOOD WBC-1.3* RBC-2.97* Hgb-8.6* Hct-26.5* MCV-89 MCH-29.0 MCHC-32.5 RDW-18.8* RDWSD-59.7* Plt ___ ___ 05:14AM BLOOD WBC-1.7* RBC-2.45* Hgb-6.9* Hct-21.9* MCV-89 MCH-28.2 MCHC-31.5* RDW-20.1* RDWSD-64.1* Plt ___ ___ 05:17AM BLOOD Neuts-94* Bands-2 Lymphs-3* Monos-1* Eos-0* Baso-0 AbsNeut-1.25* AbsLymp-0.04* AbsMono-0.01* AbsEos-0.00* AbsBaso-0.00* ___ 04:34PM BLOOD Glucose-113* UreaN-18 Creat-0.6 Na-139 K-3.9 Cl-100 HCO3-25 AnGap-14 ___ 02:33AM BLOOD Glucose-105* UreaN-15 Creat-0.5 Na-138 K-3.7 Cl-98 HCO3-26 AnGap-14 ___ 06:12AM BLOOD Glucose-120* UreaN-15 Creat-0.5 Na-138 K-4.2 Cl-97 HCO3-26 AnGap-15 ___ 05:14AM BLOOD Glucose-114* UreaN-25* Creat-0.6 Na-139 K-3.3* Cl-97 HCO3-28 AnGap-14 ___ 05:17AM BLOOD Glucose-113* UreaN-25* Creat-0.6 Na-136 K-4.3 Cl-93* HCO3-30 AnGap-13 ___ 02:33AM BLOOD cTropnT-0.05* proBNP-3115* ___ 07:15PM BLOOD cTropnT-0.09* proBNP-2908* ___ 06:12AM BLOOD cTropnT-0.03* ___ 02:33AM BLOOD Calcium-8.7 Phos-3.7 Mg-1.7 ___ 04:36PM BLOOD Lactate-1.8 TTE: LVEF 35%. Findings similar to previous. CXR: Single lead left chest wall AICD unchanged. Right chest wall Port-A-Cath tip overlying the SVC. Stable mediastinal contour. Bilateral pulmonary opacifications worse at the left lung base than the right. Stable left pleural effusion. No pneumothorax. Brief Hospital Course: On admission, there was initial concern for a transfusion reaction. The unit of blood was tested by the blood bank, and testing was NEGATIVE for a transfusion reaction. Taking additional history, his presentation was more consistent with an acute exacerbation of his CHFrEF, and he was grossly volume overloaded on exam. He was diuresed with IV furosemide with improvement in his symptoms. His dry weight was 138.7 lbs, and he is being discharged home with furosemide 80 mg daily and a potassium supplement. He was examined on day of discharge; no lower extremity edema, lungs without crackles, S1, S2, RRR, no m/r/g, and JVP flat. He will follow up with his PCP and his cardiologist; he should have his heart failure medications titrated as possible (adding BB, complicated with his history of VT, increase of ACE-I, possible restarting spironolactone). HOSPITAL COURSE BY PROBLEMS: 1. Acute exacerbation of CHF - dry weight 138.7 - furosemide 80 mg daily, KCL 40 mEq daily, close outpatient follow up - lisinopril 2.5 mg daily 2. Anemia. - received 1 unit PRBCs with no problems - work up for transfusion reaction negative. 3. Leukopenia. The patient's navelbine administration had been complicated by leukopenia in the past. After discussion with Atrius oncology, he received a dose of filgrastim 300 mg with improvement in his counts. 4. Elevated troponin. Likely due to volume overload. Downtreneded with diuresis. 5. History of VT storm - continue amiodarone - continue verapamil 6. Metastatic NSCLC - continue dexamethasone PRN - continue oxycodone PRN - outpatient follow up with Dr. ___ 7. Prolonged QTc 501 msec - held QTc prolonging meds 8. OSA. Home CPAP. TRANSITIONAL ISSUES: [ ] patient needs to weighed daily, dry weight was 138.7. Will likely need adjustment of his diuretics [ ] consider increase ACE-I, BB, spironolactone, given recurrent hospitalizations for heart failure [ ] will follow up with Dr. ___ navelbine therapy. ___ require additional filgrastim and transfusions of PRBCs. > 30 minutes spent on discharge activities. Medications on Admission: The Preadmission Medication list is accurate and complete. 1. Amiodarone 400 mg PO DAILY 2. Aspirin 81 mg PO DAILY 3. Lisinopril 2.5 mg PO DAILY 4. Multivitamins 1 TAB PO DAILY 5. Omeprazole 20 mg PO DAILY 6. Verapamil SR 240 mg PO Q24H 7. Atorvastatin 80 mg PO QPM 8. Magnesium Oxide 400 mg PO DAILY 9. Isosorbide Mononitrate (Extended Release) 30 mg PO DAILY 10. OxyCODONE (Immediate Release) 5 mg PO QHS 11. Dexamethasone 4 mg PO BID:PRN nausea/as appetite stimulant as needed 12. Senna 17.2 mg PO BID 13. Lactulose 15 mL PO Q4H:PRN constipation Discharge Medications: 1. Furosemide 80 mg PO DAILY RX *furosemide 80 mg 1 tablet(s) by mouth once a day Disp #*30 Tablet Refills:*2 2. Potassium Chloride 40 mEq PO DAILY RX *potassium chloride 20 mEq 2 tablets by mouth once a day Disp #*60 Tablet Refills:*0 3. Amiodarone 400 mg PO DAILY 4. Aspirin 81 mg PO DAILY 5. Atorvastatin 80 mg PO QPM 6. Dexamethasone 4 mg PO BID:PRN nausea/as appetite stimulant as needed 7. Isosorbide Mononitrate (Extended Release) 30 mg PO DAILY 8. Lactulose 15 mL PO Q4H:PRN constipation 9. Lisinopril 2.5 mg PO DAILY 10. Magnesium Oxide 400 mg PO DAILY 11. Multivitamins 1 TAB PO DAILY 12. Omeprazole 20 mg PO DAILY 13. OxyCODONE (Immediate Release) 5 mg PO QHS 14. Senna 17.2 mg PO BID 15. Verapamil SR 240 mg PO Q24H Discharge Disposition: Home with Service Discharge Diagnosis: Acute exacerbation of heart failure with reduced ejection fraction. Discharge Condition: Mental Status: Clear and coherent. Level of Consciousness: Alert and interactive. Activity Status: Ambulatory - Independent. Discharge Instructions: You were admitted to the hospital with a heart failure exacerbation. You received furosemide (Lasix), which removed the extra fluid. You were able to walk without needing any oxygen. You are being sent home on a water pill at home (furosemide 80 mg once daily). Please continue to take this daily. Your weight in the hospital prior to discharge was 138.7. When you get home, make sure to weigh yourself on your home scale. This is your DRY WEIGHT. If your weight ever goes 3 lbs above your home dry weight, please call your primary care or your cardiologist; you will need an extra dose of furosemide. Otherwise, you had a blood transfusion and a dose of filgrastim. You did NOT have a transfusion reaction. All of your work up was negative. Your shortness of breath was from your heart failure exacerbation. In the long run, you will need to follow up with your outpatient cardiologist to maximize your heart failure medications to prevent readmissions. Followup Instructions: ___
19716199-DS-11
19,716,199
21,596,391
DS
11
2195-07-22 00:00:00
2195-07-22 21:07:00
Name: ___ Unit No: ___ Admission Date: ___ Discharge Date: ___ Date of Birth: ___ Sex: F Service: MEDICINE Allergies: No Known Allergies / Adverse Drug Reactions Attending: ___. Chief Complaint: Positive Blood Cultures in ED Major Surgical or Invasive Procedure: None History of Present Illness: Ms. ___ is a ___ yo woman no significant PMH who was recently seen in the ED for fever, chills, myalgias. She was given anti-inflammatories and IVF and symptoms improved. Flu swab and U/A were negative and the patient was discharged with recommendations for anti-inflammatories and PO hydration. Blood cultures subsequently grew GNRs and GPCs and the patient was called back to the ED. She reports improving symptoms. In the ED, initial vital signs were: 97.8 107 114/69 18 100% RA Labs were notable for WCC 5.3, normal chemistry panel, normal LFTs Patient was given 1gram Tylenol, 1L NS, ibuprofen 600mg, vancomycin 1 gram, zosyn 4.5mg On Transfer Vitals were: 97.8 101 ___ 99% RA On the floor, patient reports she feels great. She reports her son has been sick with similar illness but has gotten better. Past Medical History: POB: FT SVD x 1 C/S x 1 for NRFRHT per patient SAB x 1, TAB x 3 PGyn: Denies PMed: Denies - has had urine infections in prior pregnancies PSurg: C/S Social History: ___ Family History: NC Physical Exam: ADMISSION PHYSICAL EXAM: ========================= Vitals: T98.4 BP 122/70 HR 92 RR 18 O2 100 RA GENERAL: Alert, oriented, no acute distress HEENT: Sclera anicteric, MMM, oropharynx clear NECK: supple, JVP not elevated, no LAD LUNGS: Clear to auscultation bilaterally, no wheezes, rales, rhonchi CV: Regular rate and rhythm, normal S1 S2, no murmurs, rubs, gallops ABD: soft, non-tender, non-distended, bowel sounds present, no rebound tenderness or guarding, no organomegaly EXT: Warm, well perfused, 2+ pulses, no clubbing, cyanosis or edema SKIN: No cuts/rashes NEURO: Power ___ in all four limbs. Sensation intact. Mentating well DISCHARGE PHYSICAL EXAM: ========================= Vitals: T98.2 BP 128/70-143/77 HR ___ RR 18 O2 100 RA GENERAL: Alert, oriented ___ speaking female no acute distress HEENT: Sclera anicteric, MMM, oropharynx clear NECK: supple, JVP not elevated, no LAD LUNGS: Clear to auscultation bilaterally, no wheezes, rales, rhonchi CV: Regular rate and rhythm, normal S1 S2, no murmurs, rubs, gallops ABD: soft, non-tender, non-distended, bowel sounds present, no rebound tenderness or guarding, no organomegaly EXT: Warm, well perfused, 2+ pulses, no clubbing, cyanosis or edema SKIN: No cuts/rashes NEURO: Power ___ in all four limbs. Sensation intact. Mentating well Pertinent Results: ADMISSION LABS: ================ ___ 04:55PM BLOOD WBC-5.3 RBC-4.28 Hgb-13.0 Hct-38.5 MCV-90 MCH-30.4 MCHC-33.8 RDW-12.8 RDWSD-42.2 Plt ___ ___ 04:55PM BLOOD Neuts-45.5 ___ Monos-13.2* Eos-1.1 Baso-0.6 Im ___ AbsNeut-2.41 AbsLymp-2.09 AbsMono-0.70 AbsEos-0.06 AbsBaso-0.03 ___ 04:55PM BLOOD ___ PTT-30.5 ___ ___ 04:55PM BLOOD Glucose-83 UreaN-8 Creat-0.6 Na-139 K-4.5 Cl-106 HCO3-21* AnGap-17 ___ 04:55PM BLOOD ALT-25 AST-29 AlkPhos-80 TotBili-0.2 ___ 04:55PM BLOOD Albumin-4.0 ___ 05:24PM BLOOD Lactate-1.4 PERTINENT FINDINGS: URINE CULTURE (Final ___: <10,000 organisms/ml. Blood Cultures: ___ x2 - Negative to date at discharge ___ x 2 - Negative to date at discharge ___ x1 - Negative to date at discharge ***Blood Culture ___ FROM ED:**** ENTEROBACTER CLOACAE COMPLEX. FINAL SENSITIVITIES. This organism may develop resistance to third generation cephalosporins during prolonged therapy. Therefore, isolates that are initially susceptible may become resistant within three to four days after initiation of therapy. For serious infections, repeat culture and sensitivity testing may therefore be warranted if third generation cephalosporins were used. ENTEROBACTER CLOACAE COMPLEX. SECOND MORPHOLOGY. FINAL SENSITIVITIES. This organism may develop resistance to third generation cephalosporins during prolonged therapy. Therefore, isolates that are initially susceptible may become resistant within three to four days after initiation of therapy. For serious infections, repeat culture and sensitivity testing may therefore be warranted if third generation cephalosporins were used. ESCHERICHIA COLI. FINAL SENSITIVITIES. ENTEROCOCCUS FAECALIS. FINAL SENSITIVITIES. HIGH LEVEL GENTAMICIN SCREEN: Susceptible to 500 mcg/ml of gentamicin. Screen predicts possible synergy with selected penicillins or vancomycin. Consult ID for details. HIGH LEVEL STREPTOMYCIN SCREEN: Susceptible to 1000mcg/ml of streptomycin. Screen predicts possible synergy with selected penicillins or vancomycin. Consult ID for details.. Daptomycin MIC=3.0MCG/ML Sensitivity testing performed by Etest. SENSITIVITIES: MIC expressed in MCG/ML _________________________________________________________ ENTEROBACTER CLOACAE COMPLEX | ENTEROBACTER CLOACAE COMPLEX | | ESCHERICHIA COLI | | | ENTEROCOCCUS FAE | | | | AMPICILLIN------------ =>32 R <=2 S AMPICILLIN/SULBACTAM-- =>32 R CEFAZOLIN------------- =>64 R CEFEPIME-------------- <=1 S <=1 S <=1 S CEFTAZIDIME----------- <=1 S <=1 S 2 S CEFTRIAXONE----------- <=1 S <=1 S <=1 S CIPROFLOXACIN---------<=0.25 S <=0.25 S <=0.25 S DAPTOMYCIN------------ S GENTAMICIN------------ <=1 S <=1 S <=1 S MEROPENEM-------------<=0.25 S <=0.25 S <=0.25 S PENICILLIN G---------- 2 S PIPERACILLIN/TAZO----- <=4 S <=4 S 8 S TOBRAMYCIN------------ <=1 S <=1 S <=1 S TRIMETHOPRIM/SULFA---- <=1 S <=1 S <=1 S VANCOMYCIN------------ 2 S Anaerobic Bottle Gram Stain (Final ___: GRAM NEGATIVE ROD(S). Reported to and read back by ___ (EW) ___ AT 1136. GRAM POSITIVE COCCI IN PAIRS. Reported to and read back by ___ 10:30AM ___. Aerobic Bottle Gram Stain (Final ___: GRAM NEGATIVE ROD(S). CXR ___: PA and lateral views of the chest provided. New from prior, is consolidation in the left lower lobe which is concerning for pneumonia. No large effusion or pneumothorax. Right lung is clear. Cardiomediastinal silhouette is normal. Bony structures are intact. IMPRESSION: Left lower lobe pneumonia. DISCHARGE LABS: ================= ___ 06:45AM BLOOD WBC-6.4 RBC-4.03 Hgb-12.0 Hct-35.7 MCV-89 MCH-29.8 MCHC-33.6 RDW-12.8 RDWSD-41.8 Plt ___ ___ 06:45AM BLOOD Glucose-84 UreaN-6 Creat-0.5 Na-140 K-3.5 Cl-109* HCO3-22 AnGap-13 ___ 06:45AM BLOOD Calcium-8.9 Phos-3.4 Mg-1.8 Brief Hospital Course: Ms. ___ is a ___ with no significant PMH who was admitted for positive blood cultures from previous ED visit on ___ for further evaluation. #Positive Blood Cultures: Cultures grew ENTEROBACTER CLOACAE, E. Coli, and ENTEROCOCCUS FAE as well as Gram Positive Cocci in Pairs. She was given IVF and initially started on Vancomycin/Cefepime/Flagyl for broad coverage. However, she had no leukocytosis and remained afebrile, hemodynamically stable, with no respiratory or abdominal symptoms. Infectious disease was consulted and it was decided that iven her lack of symptoms and multiple bacteria in only 1 blood culture, this was thought to be contaminant. Other sources considered included UTI (Urine culture negative), gut translocation (no abdominal symptoms), and no respiratory symptoms. CXR was read as LLL pneumonia, but patient had no symptoms and once it was determined blood cultures were likely spurious, further antibiotic treatment was discontinued. Initial symptoms thought to have been viral in nature given short duration and similar symptoms from other family members that also quickly resolved. #Vaginal Itching: Patient complained of new vaginal itching, consistent with previous yeast infections. She was discharged on Micanozole cream TRANSITIONAL ISSUES: ===================== # Patient's home has no heat and has an insect infestation: she met with social work, and was given the phone number for ___ ___ Services # She intermittently complained of lower quadrant pain, but had a benign exam: consider U/S as outpatient if this persists Medications on Admission: The Preadmission Medication list is accurate and complete. 1. Ibuprofen 600 mg PO Q6H:PRN Pain Discharge Medications: 1. Miconazole Nitrate Vag Cream 2% 1 Appl VG QHS Duration: 6 Days RX *miconazole nitrate [Miconazole 7] 100 mg at bedtime Disp #*1 Suppository Refills:*0 2. Ibuprofen 600 mg PO Q6H:PRN Pain Discharge Disposition: Home Discharge Diagnosis: Primary: - contaminated blood culture - cough Discharge Condition: Mental Status: Clear and coherent. Level of Consciousness: Alert and interactive. Activity Status: Ambulatory - Independent. Discharge Instructions: Dear Ms. ___, You were admitted to ___ due to a positive blood culture. In the emergency department on your previous visit, your blood was found to have bacteria. You were initially given antibiotics, but we then realized that this blood culture was most likely contaminated, and you did not have a blood infection. We did give you some medications to improve you cough symptoms, which are most likely from a virus (and would not be helped with antibiotics). It was a pleasure taking care of you during your stay at ___. If you have any questions about the care you received, please do not hesitate to ask. Sincerely, Your ___ Care Team Followup Instructions: ___
19716465-DS-3
19,716,465
23,330,062
DS
3
2175-06-23 00:00:00
2175-06-23 17:09:00
Name: ___ Unit No: ___ Admission Date: ___ Discharge Date: ___ Date of Birth: ___ Sex: F Service: MEDICINE Allergies: codeine / Demerol Attending: ___. Chief Complaint: Mechanical fall C1 and T1 fractures Alcohol use disorder Major Surgical or Invasive Procedure: None History of Present Illness: ___ female with a history of dementia and alcoholism (s/p multiple failed detox) presents as OSH transfer with chronic C1 and T1 fracture after an unwitnessed fall while intoxicated. Patient is poor historian with inattention and poor understanding capacity but endorses bilateral ankle, feet, knee, shoulder, back and neck pain. She does not remember how she fell but was on the ground for about 1 hour. Endorses chronic urinary incontinence over the last year, as she soils herself nightly. No tingling or numbness. Endorses BLE weakness due to all of her falls. She drinks daily. There was concern for SI as patient stated she wanted to die, but on further questioning, patient denied. She was also thought to be going into benzo withdrawal. She was waiting a rehab bed but was able to be placed so was admitted to medicine. In the ED, initial VS: 97.2 84 134/82 14 95% RA Exam notable for: anxious Labs notable for: CBC: WBC 6.2, HGb 11.2, plt 260 Chem: Na 135, K 4.5, Cl 84, BUN 6, Cr 0.7 Ca 8.5, Mg 1.8, P 3.6 UA: large leuks, negative nitrites, 91 WBC, no bacteria Bld cx x2 pending Imaging notable for: CT scan demonstrated chronic C1 fracture and possible small, chronic T1 compression fracture. CXR: 1. No pneumothorax or acute pulmonary disease. 2. Distal right clavicular deformity and focal defect which may be chronic, but correlation with physical examination is recommended as there are no prior studies with which to compare. Consults: Orthopaedic surgery: c collar given neck pain as well as spine clinic follow up in 2 week. Vitals prior to transfer: 98.0 86 121/73 18 98% RA On arrival to the floor, patient confirms much of the above story. Regarding her fall, she was drunk on the day of her admission and believes that she just "tipped over." Regarding her alcohol intake, she drinks about a half a gallon of wine per day. She used to drink about ___ gallon of vodka, but has recently cut back to just wine. Her last drink was on ___, prior to presentation at the ED. Currently, she has about ___ out of 10 pain in her hips, as well as her neck, which has been stable since arrival to the ED. She is hoping to get her Ambien, as well as some benzodiazepine to help her get some sleep. REVIEW OF SYSTEMS: A complete 10-point review of systems was performed and was negative less otherwise noted in the HPI. Past Medical History: Dementia Alcohol use disorder Social History: ___ Family History: Patient has a long family history of alcohol use disorder. Her mother and father both drank heavily. She was told her mother died of a heart attack, but she believes that both her mother and father died from alcohol-related complications. She has 2 brothers, 1 older who drinks daily but is still alive, and one younger who died after a liver transplant for alcoholic cirrhosis. She has 2 sisters both of whom drink, one who passed away from alcohol-related complications as well. Physical Exam: ADMISSION PHYSICAL EXAM: ========================== VS: ___ 2208 Temp: 97.8 PO BP: 133/80 HR: 78 RR: 18 O2 sat: 96% O2 delivery: RA GENERAL: Pleasant, lying in bed comfortably, c-collar in place. Lying flat in bed speaking in full sentences. HEENT: Pupils equal round and reactive, extraocular motions intact. Cervical collar in place. CARDIAC: Regular rate and rhythm, no murmurs, rubs, or gallops LUNG: Appears in no respiratory distress, clear to auscultation bilaterally, no crackles, wheezes, or rhonchi ABD: Normal bowel sounds, soft, nontender, nondistended, no hepatomegaly, no splenomegaly EXT: Warm, well perfused, no lower extremity edema PULSES: 2+ radial pulses, 2+ ___ pulses, 2+ DP pulses NEURO: Alert, oriented, CN II-XII intact, motor and sensory function grossly intact DISCHARGE PHYSICAL EXAM: ========================== 24 HR Data (last updated ___ @ 234) Temp: 97.7 (Tm 97.8), BP: 114/71 (114-133/71-80), HR: 82 (78-82), RR: 18, O2 sat: 95% (95-96), O2 delivery: Ra GENERAL: Pleasant, lying in bed comfortably, c-collar in place. Teary at times during the interview HEENT: Pupils equal round and reactive. Cervical collar in place. EXT: Warm, well perfused, no lower extremity edema. R shoulder with mild tenderness to palpation but no surrounding erythema NEURO: Alert, oriented x3, hand grip ___, dorsiflexion and plantar flexion ___ Pertinent Results: ADMISSION LABS: ==================== ___ 02:10PM URINE COLOR-Straw APPEAR-Hazy* SP ___ ___ 02:10PM URINE BLOOD-NEG NITRITE-NEG PROTEIN-NEG GLUCOSE-NEG KETONE-NEG BILIRUBIN-NEG UROBILNGN-NEG PH-8.0 LEUK-LG* ___ 02:10PM URINE RBC-4* WBC-91* BACTERIA-NONE YEAST-NONE EPI-4 ___ 09:42AM GLUCOSE-76 UREA N-6 CREAT-0.7 SODIUM-135 POTASSIUM-4.5 CHLORIDE-94* TOTAL CO2-29 ANION GAP-12 ___ 09:42AM WBC-6.2 RBC-4.50 HGB-11.2 HCT-37.0 MCV-82 MCH-24.9* MCHC-30.3* RDW-16.6* RDWSD-48.6* ___ 09:42AM NEUTS-68.9 LYMPHS-16.2* MONOS-12.4 EOS-1.1 BASOS-1.1* IM ___ AbsNeut-4.29 AbsLymp-1.01* AbsMono-0.77 AbsEos-0.07 AbsBaso-0.07 ___ 09:42AM PLT COUNT-360 DISCHARGE LABS: ==================== ___ 06:10AM BLOOD WBC-4.2 RBC-3.76* Hgb-9.5* Hct-31.6* MCV-84 MCH-25.3* MCHC-30.1* RDW-16.9* RDWSD-51.6* Plt ___ ___ 06:10AM BLOOD Plt ___ ___ 06:10AM BLOOD Glucose-83 UreaN-13 Creat-0.6 Na-139 K-4.2 Cl-102 HCO3-26 AnGap-11 ___ 06:10AM BLOOD Calcium-9.0 Phos-4.0 Mg-1.8 IMAGING: ==================== ___ PELVIC AND HIP XR IMPRESSION: Minimal degenerative change of the left hip without fracture. Mild-to-moderate change of the right hip ___ CHEST XR IMPRESSION: 1. No pneumothorax or acute pulmonary disease. 2. Distal right clavicular deformity and focal defect which may be chronic, but correlation with physical examination is recommended as there are no prior studies with which to compare. Brief Hospital Course: ___ is a ___ female with a history of alcoholism, who presents to the hospital after a fall likely related to alcohol intoxication with chronic C1 and possible small T1 compression fracture now in a C-spine collar with planned follow-up with orthopedics in 2 weeks. ==================== ACUTE/ACTIVE ISSUES: ==================== # Mechanical fall # C1 and T1 fracture Patient presented with an unwitnessed fall after intoxication. She had a CT cervical spine on ___ at ___ that showed likely chronic C1 and possible small T1 compression fractures. Other imaging negative for acute injury or bleed. No symptoms or exam findings concerning for cord compression. Orthopedics consulted and felt that nothing to do at this moment. They recommended C-spine immobilization with ___ J collar with ortho follow-up in 2 weeks. Given vertebral compression fracture, patient also meets criteria for osteoporosis. She will begin calcium and vitamin D supplementation, as well as consideration for bisphosphonate therapy as an outpatient. # Alcohol use disorder Patient drinks about ___ gallon of wine daily. Her last drink was on ___, and as such she was out of the window for withdrawal seizures. She had no signs or symptoms of withdrawal, nor has she ever undergone withdrawal, or alcohol withdrawal related seizures. The patient reported taking lorazepam nightly to help with sleep, and we continued this to avoid benzodiazepine withdrawal. She is motivated to work towards sobriety again. Patient was seen by social work and she is already connected with ___, who reports that patient is involved with their ___ services team. She has ___ CM and RN through MVES. They are active with her and will continue to follow her throughout her rehab stay at ___ ___. Patient was also given thiamine and folate during this admission. # Suicidal ideation Reportedly, the patient noted some passive suicidal ideation while in the ED. She denied any suicidal ideation subsequently, and felt that she was still intoxicated, and feeling overwhelmed in that moment. # Assymptomatic bacteruria E coli in urine with no symptoms. Patient was treated with nitrofurantoin while in the ED. She was asymptomatic on the day of discharge. # Insomnia Patient reports that she takes Ambien and lorazepam nightly for sleep. Trazodone is in her fill list but she states that she does not use this any more. She was continued on Ativan QHS:PRN. Please consider discontinuing some of these medications in light of her recent fall and alcohol use. ====================== CHRONIC/STABLE ISSUES: ====================== # Hypothyroidism Continued levothyroxine 50 mcg daily ==================== TRANSITIONAL ISSUES: ==================== Medication changes - Patient was started on calcium and vitamin D supplementation [] Please consider bisphosphonate therapy in light of her T1 compression fracture [] Patient reports takes Ativan 1mg QHS. There was a different fill history for Ativan 0.5 mg Q6H for anxiety which was continued on discharge [] Patient reports motivation to quit drinking. She will look into joining AA. Please consider pharmacological treatment for alcohol use disorder if patient feels she may benefit from same. [] Patient to wear ___ collar for the next 2 weeks and follow-up with orthopedics afterwards ====================================== # CODE: full confirmed # CONTACT: ___ (husband) ___ Medications on Admission: The Preadmission Medication list may be inaccurate and requires futher investigation. 1. Levothyroxine Sodium 50 mcg PO DAILY 2. Pantoprazole 40 mg PO Q24H 3. Gabapentin 200 mg PO TID 4. Meclizine 12.5 mg PO DAILY:PRN Nausea 5. Multivitamins 1 TAB PO DAILY 6. Thiamine 200 mg PO DAILY 7. LORazepam 0.5 mg PO Q6H:PRN anxiety 8. Zolpidem Tartrate 5 mg PO QHS Discharge Medications: 1. Calcium Carbonate 500 mg PO DAILY osteoporosis Duration: 30 Days 2. FoLIC Acid 1 mg PO DAILY 3. Vitamin D 800 UNIT PO DAILY 4. Gabapentin 200 mg PO TID 5. Levothyroxine Sodium 50 mcg PO DAILY 6. LORazepam 0.5 mg PO Q6H:PRN anxiety 7. Meclizine 12.5 mg PO DAILY:PRN Nausea 8. Multivitamins 1 TAB PO DAILY 9. Pantoprazole 40 mg PO Q24H 10. Thiamine 200 mg PO DAILY 11. Zolpidem Tartrate 5 mg PO QHS Discharge Disposition: Extended Care Facility: ___ Discharge Diagnosis: ================== PRIMARY DIAGNOSES: ================== Mechanical fall C1 and T1 fractures Alcohol use disorder Discharge Condition: Mental Status: Clear and coherent. Level of Consciousness: Alert and interactive. Activity Status: Out of Bed with assistance to chair or wheelchair. Discharge Instructions: Dear Ms. ___, It was a pleasure taking care of you at the ___ ___. Why did you come to the hospital? - You came to the hospital as you had a fall. What did you receive in the hospital? - You had imaging studies of the head and spine. We saw a fracture in your spine that could be new or chronic. Our orthopedics doctors saw ___ and wanted you to be in a C-spine collar for 2 weeks. - Our physiotherapist also evaluated you. They think you would benefit from going to rehab after discharge from hospital. What should you do once you leave the hospital? - Please follow-up with orthopedic doctors as below. - Per our discussion this morning, please consider joining a program to help with quitting alcohol; your PCP should be able to help with this. We wish you all the best! Your ___ Care Team Followup Instructions: ___
19716704-DS-10
19,716,704
22,564,837
DS
10
2119-06-20 00:00:00
2119-06-21 03:08:00
Name: ___ Unit No: ___ Admission Date: ___ Discharge Date: ___ Date of Birth: ___ Sex: M Service: SURGERY Allergies: Keflex / cefprozil Attending: ___. Chief Complaint: Fall from motorcycle Major Surgical or Invasive Procedure: None History of Present Illness: ___ male with bipolar disorder recently on lithium presenting after motor vehicle accident. Patient was going 80 miles an hour, helmeted, when he hit a ___, slid and fell onto his right side with head strike but no LOC. Patient was seen at an outside hospital where his imaging was notable for a right ulnar contusion, right rib fracture. On arrival, reports pain in his right shoulder and right rib cage and right knee. Denies any nausea, vomiting, chest pain, vision changes, headaches, or dizziness. Past Medical History: Bipolar Disorder Alcohol use Disorder Social History: ___ Family History: Non-contributory Physical Exam: Vitals: T 98.6, BP 104 / 57, HR 68, RR 18, O2 97 Ra GEN: A&O, NAD HEENT: No scleral icterus, mucus membranes moist CHEST: Right ribs and flank tender to touch CV: RRR, No M/G/R PULM: Clear to auscultation b/l, No W/R/R ABD: Soft, nondistended, nontender, no rebound or guarding, normoactive bowel sounds, no palpable masses, scattered abrasions over left flank Ext: No ___ edema, ___ warm and well perfused, right deltoid tender to touch Pertinent Results: ___ 12:45AM BLOOD WBC-14.3* RBC-4.51* Hgb-13.6* Hct-39.5* MCV-88 MCH-30.2 MCHC-34.4 RDW-12.8 RDWSD-41.1 Plt ___ ___ 12:45AM BLOOD ___ PTT-25.9 ___ ___ 12:45AM BLOOD ASA-NEG Ethanol-NEG Acetmnp-NEG Bnzodzp-NEG Barbitr-NEG Tricycl-NEG ___ 12:45AM BLOOD Lipase-13 ___ R shoulder XR:No right shoulder fracture or dislocation identified. Brief Hospital Course: At the OSH, he was Pan scanned, which demonstrated a right pulmonary contusion, right shoulder ac sprain, and left knee punctate injury. He was admitted to ACS for pain management and monitoring given high impact trauma on ___. Throughout the day, his pain medication was adjusted to allow for adequate control. He was tolerating a regular diet and he was moving around the halls with minimal pain - improving throughout the day. At the time of discharge, the patient was doing well, afebrile with stable vital signs. The patient was tolerating a regular diet, ambulating, voiding without assistance, and pain was well controlled. The patient was discharged home without services. The patient received discharge teaching and follow-up instructions with understanding verbalized and agreement with the discharge plan. Medications on Admission: The Preadmission Medication list is accurate and complete. 1. Acamprosate 333 mg PO TID 2. Lithium Carbonate CR (Eskalith) 300 mg PO BID 3. Gabapentin 600 mg PO TID Discharge Medications: 1. Acetaminophen 650 mg PO Q4H 2. Ibuprofen 400 mg PO Q8H 3. OxyCODONE (Immediate Release) 5 mg PO Q4H:PRN Pain - Severe RX *oxycodone 5 mg ___ tablet(s) by mouth every six (6) hours Disp #*30 Tablet Refills:*0 4. Acamprosate 333 mg PO TID 5. Gabapentin 600 mg PO TID 6. Lithium Carbonate CR (Eskalith) 300 mg PO BID Discharge Disposition: Home Discharge Diagnosis: Fall Right lower Lobe contusion Right shoulder AC sprain Discharge Condition: Mental Status: Clear and coherent. Level of Consciousness: Alert and interactive. Activity Status: Ambulatory - Independent. Discharge Instructions: Dear. Mr. ___, You were admitted to the ___ after you sustained a fall on a motorcycle that caused a Right lower lobe lung contusion and Right shoulder joint sprain. Your pain was improved and better controlled and it was felt safe to discharge you from the hospital * You should take your pain medication as directed to stay ahead of the pain otherwise you won't be able to take deep breaths. If the pain medication is too sedating take half the dose and notify your physician. * Symptomatic relief with ice packs or heating pads for short periods may ease the pain. * Narcotic pain medication can cause constipation therefore you should take a stool softener twice daily and increase your fluid and fiber intake if possible. * Do NOT smoke * If your doctor allows, non-steroidal ___ drugs are very effective in controlling pain ( ie, Ibuprofen, Motrin, Advil, Aleve, Naprosyn) but they have their own set of side effects so make sure your doctor approves. * Return to the Emergency Room right away for any acute shortness of breath, increased pain or crackling sensation around your ribs (crepitus). Please call your doctor or nurse practitioner or return to the Emergency Department for any of the following: *You experience new chest pain, pressure, squeezing or tightness. *New or worsening cough, shortness of breath, or wheeze. *If you are vomiting and cannot keep down fluids or your medications. *You are getting dehydrated due to continued vomiting, diarrhea, or other reasons. Signs of dehydration include dry mouth, rapid heartbeat, or feeling dizzy or faint when standing. *You see blood or dark/black material when you vomit or have a bowel movement. *You experience burning when you urinate, have blood in your urine, or experience a discharge. *Your pain in not improving within ___ hours or is not gone within 24 hours. Call or return immediately if your pain is getting worse or changes location or moving to your chest or back. *You have shaking chills, or fever greater than 101.5 degrees Fahrenheit or 38 degrees Celsius. *Any change in your symptoms, or any new symptoms that concern you. Please resume all regular home medications, unless specifically advised not to take a particular medication. Also, please take any new medications as prescribed. Avoid driving or operating heavy machinery while taking pain medications. Followup Instructions: ___
19716747-DS-14
19,716,747
25,019,093
DS
14
2158-05-02 00:00:00
2158-05-02 15:35:00
Name: ___ Unit No: ___ Admission Date: ___ Discharge Date: ___ Date of Birth: ___ Sex: F Service: ORTHOPAEDICS Allergies: No Known Allergies / Adverse Drug Reactions Attending: ___. Chief Complaint: left shoulder dislocation w/ associated greater tuberosity fracture Major Surgical or Invasive Procedure: Closed reduction under general anesthesia and closed treatment of proximal tuberosity fracture with manipulation ___, Dr. ___ History of Present Illness: ___ LHD p/w the above fracture s/p mechanical fall when she tripped over new flooring. Landed on left side, denies HS/LOC. Happened at 8pm ___. Tx from OSH after failed closed redxn attempt under conscious sedation. Denies paresthesias, denies antecedent L shoulder pain. Past Medical History: none Social History: ___ Family History: Non-contributory Physical Exam: Vitals: AFVSS General: A&Ox3, NAD Heart: Regular rate and rhythm peripherally Lungs: Breathing comfortably on room air. Left upper extremity: - Skin intact. Arm in sling. - ecchymosis around the anterior shoulder and arm. - Soft, non-tender arm and forearm - Full, painless active/passive ROM of elbow, wrist, and digits. ROM around shoulder lmited - EPL/FPL/DIO (index) fire - Sensation intact to light touch in axillary/radial/median/ulnar nerve distributions - 2+ radial pulse, fingers warm and well perfused Pertinent Results: ___ 07:24PM GLUCOSE-97 UREA N-23* CREAT-1.0 SODIUM-139 POTASSIUM-4.8 CHLORIDE-106 TOTAL CO2-22 ANION GAP-11 ___ 07:24PM WBC-9.4 RBC-3.89* HGB-11.6 HCT-36.3 MCV-93 MCH-29.8 MCHC-32.0 RDW-13.5 RDWSD-46.5* Brief Hospital Course: The patient presented to the emergency department and was evaluated by the orthopedic surgery team. The patient was found to have a left shoulder dislocation w/ associated greater tuberosity fracture and was admitted to the orthopedic surgery service. The patient was treated nonoperatively under general anesthesia with a closed reduction approach and worked with physical therapy who determined that discharge to home was appropriate. The patient was given anticoagulation per routine, and the patient's home medications were continued throughout this hospitalization. The ___ hospital course was otherwise unremarkable. At the time of discharge the patient's pain was well controlled with oral medications, and the patient was voiding/moving bowels spontaneously. The patient is NWB in the left upper extremity, and will be discharged on no pharmacological medications for DVT prophylaxis but is encouraged to ambulate. The patient will follow up with Dr. ___ routine. A thorough discussion was had with the patient regarding the diagnosis and expected post-discharge course including reasons to call the office or return to the hospital, and all questions were answered. The patient was also given written instructions concerning precautionary instructions and the appropriate follow-up care. The patient expressed readiness for discharge. Medications on Admission: none Discharge Medications: 1. Acetaminophen 650 mg PO Q6H 2. Docusate Sodium 100 mg PO BID RX *docusate sodium 100 mg 1 capsule(s) by mouth twice a day Disp #*10 Capsule Refills:*1 3. OxyCODONE (Immediate Release) ___ mg PO Q4H:PRN pain RX *oxycodone 5 mg 1 tablet(s) by mouth every eight (8) hours Disp #*10 Tablet Refills:*0 Discharge Disposition: Home Discharge Diagnosis: left shoulder dislocation w/ associated greater tuberosity fracture Discharge Condition: Mental Status: Clear and coherent. Level of Consciousness: Alert and interactive. Activity Status: Ambulatory - Independent. AVSS NAD, A&Ox3 left UE: Fires EPL/FPL/FDP/FDS/EDC/DIO. SILT radial/median/ulnar n distributions. 1+ radial pulse, wwp distally. Discharge Instructions: - Resume your regular activities as tolerated, but please follow your weight bearing precautions strictly at all times. ACTIVITY AND WEIGHT BEARING: - Remain in your sling at all times. Do not bear any weight on your left shoulder. Light passive range of motion around your left shoulder is okay. No external rotation or abduction of shoulder. MEDICATIONS: 1) Take Tylenol ___ every 6 hours around the clock. This is an over the counter medication. 2) Add Oxycodone as needed for increased pain. Aim to wean off this medication in 1 week or sooner. This is an example on how to wean down: Take 1 tablet every 3 hours as needed x 1 day, then 1 tablet every 4 hours as needed x 1 day, then 1 tablet every 6 hours as needed x 1 day, then 1 tablet every 8 hours as needed x 2 days, then 1 tablet every 12 hours as needed x 1 day, then 1 tablet every before bedtime as needed x 1 day. Then continue with Tylenol for pain. 3) Do not stop the Tylenol until you are off of the narcotic medication. 4) Per state regulations, we are limited in the amount of narcotics we can prescribe. If you require more, you must contact the office to set up an appointment because we cannot refill this type of pain medication over the phone. 5) Narcotic pain relievers can cause constipation, so you should drink eight 8oz glasses of water daily and continue following the bowel regimen as stated on your medication prescription list. These meds (senna, colace, miralax) are over the counter and may be obtained at any pharmacy. 6) Do not drink alcohol, drive a motor vehicle, or operate machinery while taking narcotic pain relievers. 7) Please take all medications as prescribed by your physicians at discharge. 8) Continue all home medications unless specifically instructed to stop by your surgeon. ANTICOAGULATION: - Please continue to ambulate throughout the day. Physical Therapy: Activity: Activity: Activity as tolerated Activity: Ambulate twice daily if patient able Left upper extremity: Non weight bearing Sling: At all times Encourage turn, cough and deep breathe q2h when awake Treatments Frequency: Call your surgeon's office with any questions. Followup Instructions: ___
19716849-DS-4
19,716,849
25,162,458
DS
4
2153-08-29 00:00:00
2153-08-29 18:06:00
Name: ___ Unit No: ___ Admission Date: ___ Discharge Date: ___ Date of Birth: ___ Sex: F Service: MEDICINE Allergies: No Known Allergies / Adverse Drug Reactions Attending: ___. Chief Complaint: abdominal pain, vaginal bleeding Major Surgical or Invasive Procedure: None History of Present Illness: The patient is a ___ y/o lady with a PMHx significant for DM and uterine fibroids and dysmenorrhea is s/p UAE by ___ on ___ presents with recurrent vaginal bleeding post-procedure. Briefly the patient initially presented with increased uterine bleeding for the past 6 mo. Imaging demonstrated multiple large fibroids. Endometrial bx was neg. She is now s/p bilateral uterine artery embolization by INR. She was observed overnight and discharged the following day. Since discharge she reports persistent vaginal bleeding requiring sanity pads every 3 hours. She has associated shortness of breath, painful right and lower abdominal quadrant pain, nausea. She denies chest pain, fevers, chills. She presented to ___ where she had a CT abdomen and pelvis which did not show any active proceses. Her CBC was stable (___). She was given 16mg morphine and 8mg of zofran prior to transfer from ___ for ___ evaluation. In the ___ ED: Initial Vitals: 98.5 76 132/78 15 95% Labs were significant for: 10.9/34.4 ___ on ___. No further imaging was performed. ___ was consulted who reviewed the imaging and recommended pain control and bedside evaluation in the morning. Vitals on transfer: 98.5 96 136/90 24 95% RA On arrival to the floor vitals were: 98.8 133/57 84 20 100% RA. She is in obvious discomfort. Has not achieved pain control at all since arriving. Notes bleeding has slowed considerably. Past Medical History: constipation costrochondritis obesity headache pre-diabetes Social History: ___ Family History: Noncontributory Physical Exam: ADMISSION PHYSICAL EXAM Vitals - 98.8 133/57 84 20 100% RA. GENERAL: Very kind, in obvious distress and pain, uncomfortable posturing in bed HEENT:EOMI, anicteric sclera, pink conjunctiva, MMM CARDIAC: RRR, S1/S2 LUNG: CTAB ABDOMEN: soft, obese, tender to deep palpation in the bilateraly lower quadrants without rebound. MSK: There is also bilateral low back pain to percussion of the flanks. No bruising noted. EXTREMITIES: no cyanosis, clubbing or edema, moving all 4 extremities with purpose PULSES: 2+ DP pulses bilaterally DISCHARGE PHYSICAL EXAM VS: Tm 99.9 Tc 98.8 123/54 73 18 96% RA GENERAL: appears more comfortable lying in bed HEENT:EOMI, anicteric sclera, pink conjunctiva, MMM CARDIAC: RRR, S1/S2 LUNG: CTAB ABDOMEN: soft, obese, tender to deep palpation in the bilateral lower quadrants without rebound. EXTREMITIES: no cyanosis, clubbing or edema PULSES: 2+ DP pulses bilaterally Pertinent Results: ADMISSION LABS ___ 01:00AM URINE RBC-13* WBC-9* BACTERIA-NONE YEAST-NONE EPI-7 ___ 01:00AM URINE BLOOD-MOD NITRITE-NEG PROTEIN-TR GLUCOSE-NEG KETONE-NEG BILIRUBIN-NEG UROBILNGN-NEG PH-6.5 LEUK-SM ___ 01:00AM URINE COLOR-Straw APPEAR-Clear SP ___ ___ 01:15AM WBC-11.6*# RBC-4.02* HGB-10.9* HCT-34.4* MCV-86 MCH-27.0 MCHC-31.6 RDW-17.6* ___ 01:15AM NEUTS-78.9* LYMPHS-14.1* MONOS-3.5 EOS-3.4 BASOS-0.1 ___ 01:15AM CALCIUM-8.5 PHOSPHATE-3.5 MAGNESIUM-1.8 ___ 01:15AM GLUCOSE-133* UREA N-7 CREAT-0.6 SODIUM-137 POTASSIUM-3.5 CHLORIDE-100 TOTAL CO2-25 ANION GAP-16 ___ 01:22AM LACTATE-1.5 DISCHARGE LABS ___ 06:40AM BLOOD WBC-10.3 RBC-3.89* Hgb-10.2* Hct-32.3* MCV-83 MCH-26.2* MCHC-31.5 RDW-16.7* Plt ___ IMAGING UTERINE EMBO ___ 1. Left uterine artery supplying a large fibroid. No arteriovenous shunting, stenosis, vesical, vaginal or ovarian branches noted. 2. Right uterine artery supplying a large fibroid. No arteriovenous shunting, stenosis, vesical, vaginal or ovarian branches noted. 3. No evidence of ovarian arterial supply to the fibroids. 4. Post-procedure fibroid staining and near stasis confirming successful imaging end point Brief Hospital Course: ___ w/DM, uterine fibroids and dysmenorrhea now s/p UAE by ___ on ___ presenting with recurrent vaginal bleeding and pain post-procedure. ACTIVE ISSUES # Vaginal Bleeding s/p Uterine Artery Embolization: Bleeding was already slowing on arrival to ___ with low level bleeding by time of discharge. Patient was hemodynamically stable and H/H remained stable throughout admission. # Abdominal Pain: CT abdomen/pelvis from ___ showed no acute process; this was reviewed by ___ here. There were no acute findings on exam, and pain was secondary to changes following UAE. Started on IV morphine initially but weaned off to oxycodone, and tolerated this. Discharged home with 1 week supply of oxycodone, and will follow up in HCA in 3 days to ensure pain is controlled. # Constipation: due to opiate use, started on aggressive bowel regimen, and had bowel movement on day of discharge. # Borderline UA: 17 WBC but 4 epis, no leuk esterase or nitrite, and patient not symptomatic, so not treated. Will f/u culture and contact patient if positive. CHRONIC ISSUES # Diabetes: Continued home metformin. TRANSITIONAL ISSUES None. Medications on Admission: The Preadmission Medication list may be inaccurate and requires futher investigation. 1. MetFORMIN (Glucophage) 500 mg PO BID 2. Ibuprofen 600 mg PO Q6H:PRN pain 3. Oxycodone-Acetaminophen (5mg-325mg) 1 TAB PO Q6H:PRN pain Discharge Medications: 1. MetFORMIN (Glucophage) 500 mg PO BID 2. Docusate Sodium 100 mg PO BID constipation RX *docusate sodium 100 mg 1 capsule(s) by mouth twice a day Disp #*30 Capsule Refills:*0 3. OxycoDONE (Immediate Release) ___ mg PO Q6H:PRN pain RX *oxycodone 5 mg ___ tablet(s) by mouth every six (6) hours Disp #*56 Tablet Refills:*0 4. Polyethylene Glycol 17 g PO DAILY constipation RX *polyethylene glycol 3350 17 gram 1 packet by mouth daily Disp #*15 Packet Refills:*0 5. Senna 17.2 mg PO BID constipation RX *sennosides [senna] 8.6 mg 2 tabs by mouth twice a day Disp #*30 Tablet Refills:*0 6. Acetaminophen 650 mg PO Q6H:PRN pain Do not exceed 3000mg per day Discharge Disposition: Home Discharge Diagnosis: Primary 1. Uterine fibroids Discharge Condition: Mental Status: Clear and coherent. Level of Consciousness: Alert and interactive. Activity Status: Ambulatory - Independent. Discharge Instructions: Ms. ___, It was a pleasure taking care of you while you were admitted to ___. You were admitted due to pain and vaginal bleeding related to your uterine artery embolization. The pain is an expected side effect of the uterine artery embolization, and should ease over time. You were started on IV pain medications and then were switched to oral pain medications. Your vaginal bleeding slowed on its own, and your blood counts were stable. You were given three new medications for constipation. They should be taken every day while you are taking the oxycodone, but stop if you are having loose stools. You have appointments to follow up with your primary care doctor's office. Followup Instructions: ___
19716849-DS-5
19,716,849
20,023,835
DS
5
2154-11-04 00:00:00
2154-11-07 16:29:00
Name: ___ Unit No: ___ Admission Date: ___ Discharge Date: ___ Date of Birth: ___ Sex: F Service: MEDICINE Allergies: No Known Allergies / Adverse Drug Reactions Attending: ___ Chief Complaint: abdominal pain Major Surgical or Invasive Procedure: None History of Present Illness: Pt interviewed without aid of interviewer at her request. ___ female with h/o non-insulin dependent DM, known LBBB, hernia repair, with complaint of recurrent abdominal pain after recent hospital admission in ___ for diverticulitis (___). She has had intermittent abdominal pain since ___. At that time CT ordered by ___ with diverticulosis without diverticulitis, managed with miralax, although pt unable to tolerate increased frequency of stooling. In brief, pt presented to ___ with ___ sharp intermittent lower Abd pain ass w N/V no f/c/ns, CT with persistent sigmoid diverticulosis and interval development of proximal sigmoid diverticulitis is seen with signs of perforation or abscess formation. She was treated with IV cipro/metronidazole and per pt completed 7 day course of on ___. She states that her abdominal pain has been persistent since discharge. It worsened two days prior to presentation, primarily on the right side. Continues to have bowel movment with streaks of blood. Last BM day prior to admission. No fever or chills, Denies dysuria on my interview, but with dysuria per her PCP. In the ED, initial vital signs were: 98.9 97 136/84 16 98% RA - Exam was notable for: There is tenderness to palpation in the right lower quadrant without evidence of rebound or guarding - Labs were notable for: WBC 11.1 (N 76.9), LFTs WNL, Lipase 62, lytes WNL. Lactate 2.3. U/A WNL, slightly concentrated spec 1.013 without ketones - Imaging: CT Abd/Pelv: 1. Mild pericolonic stranding and sigmoid diverticula is consistent with provided history of recent diverticulitis. A lobulated focus of air is present in this region, unclear if this is within a diverticula or alternatively extraluminal. No fluid collection or abscess formation. 2. Fibroid uterus, some of which are rim calcified. - The patient was given: 1 L NS, morphine 4mg IV, Zofran 4mg IV, flagyl IV 500 - Consults: none Vitals prior to transfer were: 98.5 82 138/66 18 99% RA Upon arrival to the floor, endorses above history. Endorses chest pain, that has been intermittent since day prior to presentation. First occurred at work (works as ___) with substernal chest pain, radiating down L arm, numb hand, not asso with exertion, not relievd with rest. Occurred for 40 min after putting hand on ice. No asso with N/V/diaphoresis. (Has been having ongoing nausea from abdominal pain). ASA 325 and SLN given on floor, no improvement or change, but does say that cp improved with morphine in ED. ROS of symptoms positive for hoarse voice and URI sx in last two days (nasal congestion, rhinorrhea, and sore throat.) Past Medical History: constipation costrochondritis obesity headache pre-diabetes Social History: ___ Family History: Noncontributory Physical Exam: ADMISSION PHYSICAL EXAM: GENERAL - pleasant, well-appearing, in no apparent distress HEENT - normocephalic, atraumatic, no conjunctival pallor or scleral icterus, PERRLA, EOMI, OP clear NECK - supple, no LAD, no thyromegaly, JVP flat CARDIAC - regular rate & rhythm, normal S1/S2, no murmurs rubs or gallops PULMONARY - clear to auscultation bilaterally, without wheezes or rhonchi ABDOMEN - NABS. Mild to mod tenderness at umbilicus, no masses palpated ++voluntary guarding. No rebound. EXTREMITIES - warm, well-perfused, no cyanosis, clubbing or edema SKIN - without rash NEUROLOGIC - A&Ox3, CN II-XII grossly normal, normal sensation, with strength ___ throughout. Gait assessment deferred PSYCHIATRIC - listen & responds to questions appropriately, pleasant DISCHARGE PHYSICAL EXAM: VS - 98.6 123/68 74 20 96 r/a General: Obese female laying in hospital bed HEENT: PERRL, EOMI CV: RRR, s1 and s2 heard, no m/r/g Lungs: CTABL, no wheezes, rhonci or crackles Abdomen: Obese, soft, mildly tender in the RUQ and RLQ, no rebound or guarding Ext: NO ___ edema Pertinent Results: LABS upon admission: ___ 05:10PM BLOOD WBC-11.1*# RBC-4.16 Hgb-12.5 Hct-38.4 MCV-92 MCH-30.0 MCHC-32.6 RDW-14.3 RDWSD-48.5* Plt ___ ___ 05:10PM BLOOD Glucose-128* UreaN-20 Creat-0.9 Na-142 K-4.0 Cl-102 HCO3-28 AnGap-16 ___ 05:10PM BLOOD ALT-18 AST-19 CK(CPK)-74 AlkPhos-66 TotBili-0.3 ___ 05:10PM BLOOD Lipase-62* ___ 05:10PM BLOOD CK-MB-1 cTropnT-<0.01 ___ 06:03AM BLOOD CK-MB-1 cTropnT-<0.01 ___ 06:23PM BLOOD Lactate-2.3* LABS upon discharge: ___ 06:03AM BLOOD WBC-8.1 RBC-3.91 Hgb-11.8 Hct-36.1 MCV-92 MCH-30.2 MCHC-32.7 RDW-14.3 RDWSD-48.7* Plt ___ ___ 06:03AM BLOOD Glucose-97 UreaN-9 Creat-0.7 Na-138 K-3.3 Cl-102 HCO3-24 AnGap-15 ___ 06:03AM BLOOD CK(CPK)-58 ___ 06:25AM BLOOD Lactate-0.9 IMAGING: ___: IMPRESSION: 1. Minimal pericolonic stranding and sigmoid diverticula is consistent with provided history of recent diverticulitis. A lobulated focus of air is present in this region, unclear if this is within a diverticulum or alternatively extraluminal. No fluid collection or abscess formation. 2. Fibroid uterus, some of which are rim calcified. Brief Hospital Course: ___ female with h/o non-insulin dependent DM, known LBBB, hernia repair, recent episode of diverticulitis p/w recurrent abdominal pain # DIVERTICULITIS: Pt has recent history of diverticulitis and current. CT of the abdomen revealed minimal stranding and sigmoid diverticula c/w diverticulitis. Per radiology, CT scan demonstrates very mild diverticulitis and may be consistent with resolving inflammation. Pt did initially report blood in stools but then reported constipation with her last BM several days ago. Pt endorsing minimal abdominal pain upon discharge. Pt was initially treated with ceftriaxone and flagyl upon admission. Cipro was not used because of QTC of 500. Pt will be discharged on five day course of augmentin. Pt thought to have incompletely treated diverticulitis and pain was minimal upon d/c. # Chest pain: OSH received from ___ and ___. Known LBBB, no Sgarbossa criteria. Chest pain substernal, but constant since day before, not asso with exertion or improved with rest or SLN, improved with morphine. Notable family history. Previous cath in ___ at ___ with minimal CAD. Received aspirin but trops negative x2 and MB flat thought to be non cardiac in etiology. **TRANSITIONAL ISSUES*** -QTC of 484 upon discharge. Please f/u as an outpatient. Please consider cardiology consult if QTC prolonged. -Augmentin upon discharge for five days (end date ___ Medications on Admission: The Preadmission Medication list is accurate and complete. 1. MetFORMIN XR (Glucophage XR) 500 mg PO DAILY Discharge Medications: 1. MetFORMIN XR (Glucophage XR) 500 mg PO DAILY 2. Amoxicillin-Clavulanic Acid ___ mg PO Q12H RX *amoxicillin-pot clavulanate 1,000 mg-62.5 mg 2 tablets by mouth twice per day Disp #*20 Tablet Refills:*0 Discharge Disposition: Home Discharge Diagnosis: Primary diagnosis: Diverticulitis, uncomplicated Prolonged QTC Secondary diagnoses: Diabetes Mellitus Discharge Condition: Mental Status: Clear and coherent. Level of Consciousness: Alert and interactive. Activity Status: Ambulatory - Independent. Discharge Instructions: Dear Ms ___, Why was I admitted to the hospital? --you were admitted with abdominal pain What happened while I was in the hospital? --We took a picture of your abdomen, which shows mild inflammation What should I do when I go home? --You should continue taking your medicines --You should take the antibiotic that we are giving you (augmentin) for five days. You should start taking it tomorrow (___). --You should also call Health Care Associates (___) and follow up with your primary care doctor, ___ ___, Your ___ Followup Instructions: ___
19717200-DS-15
19,717,200
23,241,611
DS
15
2141-07-20 00:00:00
2141-07-23 14:57:00
Name: ___ Unit No: ___ Admission Date: ___ Discharge Date: ___ Date of Birth: ___ Sex: M Service: MEDICINE Allergies: No Known Allergies / Adverse Drug Reactions Attending: ___. Chief Complaint: fall, alcohol withdrawal Major Surgical or Invasive Procedure: None History of Present Illness: ___ with EtOH abuse, h/o EtOH withdrawal seizures who presents s/p fall and with concern for EtOH withdrawal. Patient reports he was walking to a ___ restaurant around midnight on ___ when he fell on some rocks. He believes he lost consciousness for approximately 5 minutes after the fall. A friend who was walking with him reportedly witness the fall and did not appreciate any seizure activity. Patient denies any palpatations prior to the fall, denies bowel or bladder incontinence. Does think he was confused for approximately 10minutes after fall. Of note, patient insists he hit the back of his head in the fall, but was found to be bleeding from his nose and has trauma to his face. Patient thinks he may have been intoxicated at time of the fall, but then reports his last drink was at 9am ___ morning. Patiently typically drinks 1 pint vodka daily. Reports history of withdrawal seizure in police station one year ago, but cannot elaborate. Denies history of hallucinations. In the ED, vital T 97.6, HR 66 BP 138/87 RR 22 O2 100% RA. Patient found to be inattentive, unkempt with diffusely tender abdomen and voluntary guarding, no rebound. Neuro exam was notable for intention tremor. Labs significant WBC 2.2, Hb 12.5, Serum ETOH 97, K 3.2, Mg 1.4. AST 277, ALT 102, Alk Phos 240, Tbili 1.4, INR 1.2. Serum tox positive for benzos. CT head showed no acute intracranial process, but did reveal small R frontal scalp hematoma and small displaced fracture of R orbit. CXR negative for acute cardiopulmonary process. EKG showed normal sinus rhythm.Plastic surgery evaluated patient in ED and determined entrapment. Patient given 2L IVF, KCl, Mg, Lorazepam, thiamine, folic acid and MV in ED and was transferred to medicine for further evaluation and treatment. On the floor, patient markedly tremulous. Reports mild head pain, nausea, vomiting w/one episode of hematemesis in ED (teaspoon of brb), diarrhea, RUQ abdominal pain, chills. Denies chest pain, sob, auditory or visual hallucinations, cough, dysuria, numbness, weakness or tingling. Review of systems: (+) Per HPI. Remainder of 10 point ROS negative. Past Medical History: HTN Alcohol dependence Seizure GERD Social History: ___ Family History: Mother with DM Father reformed alcoholic Physical Exam: Admission Labs ================ Vital Signs: T 98.8 BP 127/76 P 76 RR 18 O2 100% RA General: Visibly tremulous, alert, oriented to self, ___, ___. Thinks month is ___. HEENT: Sclera anicteric, MMM, oropharynx clear, EOMI, PERRL, neck supple, JVP not elevated, no LAD. + lateral nystagmus CV: Regular rate and rhythm, normal S1 + S2, no murmurs, rubs, gallops Lungs: Clear to auscultation bilaterally, no wheezes, rales, rhonchi Abdomen: Soft, non-distended, bowel sounds present. TTP in RUQ, +rebound, no guarding. No HSM. GU: No foley Ext: Warm, well perfused, 2+ pulses, no clubbing, cyanosis or edema. No palmar erythema. Skin: No jaundice or rashes Neuro: CN2-12 intact. No asterixis. Gait deferred given fall risk. Discharge Exam ================= Vitals: Tm:98.5 BP:103/67 P:75 R:18 O2:98% RA General: appears comfortable; lying in bed; alert and cooperative. HEENT: Sclera anicteric, MMM, oropharynx clear, PERRL, neck supple, JVP not elevated, no LAD, no nystagmus. CV: Regular rate and rhythm, normal S1 + S2, no murmurs, rubs, gallops Lungs: Clear to auscultation bilaterally, no wheezes, rales, rhonchi Abdomen: Soft, non-distended, bowel sounds present. Mild TTP in RUQ, no rebound, no guarding, no appreciable organomegaly. Ext: Warm, well perfused, 2+ pulses, no clubbing, cyanosis or edema. No palmar erythema. Skin: No jaundice or rashes, no spider angioma Neuro: No asterixis. Grossly intact. Pertinent Results: Admission Labs ================== ___ 05:07AM BLOOD WBC-2.2*# RBC-3.93* Hgb-12.5* Hct-35.7* MCV-91 MCH-31.8 MCHC-35.0 RDW-15.5 RDWSD-51.8* Plt Ct-58*# ___ 05:07AM BLOOD Neuts-59.9 ___ Monos-10.2 Eos-1.9 Baso-1.4* Im ___ AbsNeut-1.29* AbsLymp-0.53* AbsMono-0.22 AbsEos-0.04 AbsBaso-0.03 ___ 05:07AM BLOOD ___ PTT-30.6 ___ ___ 05:07AM BLOOD Plt Ct-58*# ___ 05:07AM BLOOD Glucose-109* UreaN-9 Creat-0.4* Na-138 K-3.2* Cl-97 HCO3-25 AnGap-19 ___ 07:49PM BLOOD Glucose-105* UreaN-6 Creat-0.5 Na-135 K-3.5 Cl-99 HCO3-24 AnGap-16 ___ 05:07AM BLOOD ALT-102* AST-277* AlkPhos-240* TotBili-1.4 ___ 05:07AM BLOOD Albumin-4.1 Calcium-8.4 Phos-3.1 Mg-1.4* ___ 07:49PM BLOOD Calcium-8.7 Phos-2.4* Mg-1.8 ___ 07:49PM BLOOD VitB12-822 Folate-15.2 ___ 05:07AM BLOOD ASA-NEG Ethanol-97* Acetmnp-NEG Bnzodzp-POS Barbitr-NEG Tricycl-NEG Significant Interim Labs ========================= ___ 05:45AM BLOOD ALT-80* AST-179* LD(LDH)-323* AlkPhos-204* TotBili-2.3* ___ 05:34AM BLOOD ALT-83* AST-181* AlkPhos-222* TotBili-1.9* ___ 05:42AM BLOOD ALT-84* AST-145* AlkPhos-203* TotBili-1.3 ___ 05:42AM BLOOD calTIBC-246* Ferritn-172 TRF-189* ___ 05:45AM BLOOD HBsAg-NEGATIVE HBsAb-NEGATIVE IgM HBc-NEGATIVE IgM HAV-NEGATIVE ___ 05:34AM BLOOD AFP-7.1 ___ 05:34AM BLOOD HIV Ab-Negative ___ 05:45AM BLOOD HCV Ab-NEGATIVE Discharge Labs =================== ___ 04:50AM BLOOD WBC-2.8* RBC-3.98* Hgb-12.7* Hct-37.5* MCV-94 MCH-31.9 MCHC-33.9 RDW-15.6* RDWSD-54.2* Plt Ct-80* ___ 04:50AM BLOOD Neuts-46.5 ___ Monos-15.2* Eos-3.6 Baso-1.1* Im ___ AbsNeut-1.29* AbsLymp-0.92* AbsMono-0.42 AbsEos-0.10 AbsBaso-0.03 ___ 04:50AM BLOOD Plt Ct-80* ___ 04:50AM BLOOD Glucose-84 UreaN-12 Creat-0.5 Na-136 K-3.2* Cl-100 HCO3-24 AnGap-15 ___ 04:50AM BLOOD ALT-79* AST-119* AlkPhos-200* TotBili-1.2 ___ 04:50AM BLOOD Calcium-9.0 Phos-4.0 Mg-2.0 Microbiology ============== Blood cultures ___: No growth to date (pending at discharge). Imaging =============== CXR ___ IMPRESSION: No rib fracture is identified. If there are focal areas of pain dedicated views of those areas are recommended. Head CT ___ IMPRESSION: 1. No acute intracranial process. 2. Small right frontal scalp hematoma. 3. There is a small displaced fracture of the right orbital rim (series 3 images 17 and 18). Abdominal US ___ IMPRESSION: 1. Echogenic and coarsened liver consistent with steatosis. Other forms of liver disease including hepatic fibrosis or cirrhosis or steatohepatitis cannot be excluded on the basis of this examination. 2. 9 mm hypoechoic lesion in the right lobe full which a MRI of the abdomen is recommended for further evaluation given suspected underlying liver disease. MRI abdomen/pelvis ___ IMPRESSION: 1. Cirrhotic appearing liver with innumerable regenerative nodules. No lesion meeting OPTN-5 criteria for ___. 2. Evidence of portal hypertension with mild splenomegaly and varices. No ascites. 3. Abnormal enhancement along the left paraspinal muscles, which is most likely traumatic, given the history of a recent fall. Likely nondisplaced fractures of the L1, L2, and possibly L3 transverse processes. Brief Hospital Course: Mr. ___ is a ___ year old man with EtOH abuse, h/o EtOH withdrawal seizures who presents s/p fall with abdominal pain and concern for EtOH withdrawal. #Fall w/head strike: Thought to be mechanical in nature, as patient intoxicated and reported no dizziness or palpatations prior to the fall. No report of seizure activity surrounding the fall, no bowel or bladder incontinence. EKG normal, no arrythmias. Patient likely fell on face, as he presented with R orbital fracture and frontal scalp hematoma. Head CT negative for intracranial bleed. No focal deficits on neuro exam. Patient seen by plastic surgery and determined no entrapment, no surgical intervention needed. Evaluated by opthalmology, who determined to damage to eye or changes in vision. No falls while inpatient. Patient to follow up with ophtalmology and plastic surgery as outpatient # Abdominal pain: Patient presented with abdominal pain, with TTP in RUQ on exam and elevated LFT's. Patient also reports episode of hemoptysis in ED. Concern for pancreatitis vs. alcoholic hepatitis, versus cholecystitis, vs gastritis/duodenal ulcer. Patient's lipase 85, so pancreatitis unlikely. No fevers on exam, no leukocytosis, so cholecystitis is less likely. AST/ALT 2:1 ratio, consistent with long standing alcohol abuse, patient extremely tender to palpation in RUQ, so alcoholic hepatitis was a consideration. Discriminant factor: 5, so no role for steroids. Finally, patient reported episode of hemoptysis, recent dark stools, so duodenal ulcer, gastritis a concern. RUQ revealed small 9mm mass in liver (f/u MRI recommended), but was otherwise unremarkable. Follow up MRI showed evidence of cirrhosis, but no HCC. Patient's abdominal pain improved without intervention and he was discharged with GI follow up. #Cirrhosis: MRI revealed multinodular liver consistent with cirrhosis. Patient also thrombocytopenic (platelets 58 on admission). INR 1.2. Likely secondary to chronic alcohol abuse, as hepatitis panel negative. Patient had no stigmata of cirrhosis on exam and no evidence of decompensation. The primary team educated the patient on cirrhosis and counselded him to stop drinking. Patient discharged with GI follow up. #Alcohol withdrawal and abuse: Patient's ethanol elevated on arrival to ED, reported drinking 1 pint of vodka daily. Patient reports last drink was day prior to presentation at 9AM, but unlikely, as patient appeared intoxicated on presentation to ED. Reported history of seizure, no DT's. Patient placed on CIWA and required Lorzepam for withdrawal symptoms. Also treated with multivitamin, thiamine and folate. Patient's symptoms improved and he was no longer requiring benzos at discharge. He expressed desire to stop drinking and planned to enroll in AA upon discharge. #Hemoptysis/Melena: Patient reported episode of hemoptysis in ED in setting of nausea, several episodes of vomiting. Also reported recent "dark stools". Most likely ___ tear in setting of vomiting, unlikely acute UGIB as H/H remained stable and guiac negative. No further episodes during admission. #Leukopenia, thrombocytopenia: Stable. Likely secondary to bone marrow suppression in setting of chronic alcohol use. Infection was also a consideration, although patient afebrile. UA, urine culture negative. Primary bone marrow process a possibility, but unlikely. Blood cultures still pending at discharge, but no growth to date. Transitional Issues: =========================== -Patient found to have cirrhotic liver by MRI with evidence of portal hypertension, splenomegaly and varices. Patient should be followed closely by GI. -Patient reports episodes of melena prior to admission. Stool guiaic negative. Consider EGD by GI. -Patient has no immunity to Hepatitis B. Start vaccination series as outpatient. -Patient has R orbital fracture from recent fall. Seen by Optho and Plastics during admission and should follow up with both services as outpatient. -Patient has long history of alcohol abuse. Should consider enrollment in AA or equivalent program to help maintain sobriety, particularly in setting of cirrhosis. -MRI on ___ showed likely nondisplaced fractures of the L1, L2, and possibly L3 transverse processes. Patient asymptomatic. Please follow up as outpatient (consider back imaging in ___ weeks if patient has persistent back pain). Patient neurologically intact with no FNDs during hospital stay and no spinous process tenderness. CODE: Full (confirmed) CONTACT: ___ ___ Medications on Admission: None Discharge Medications: 1. FoLIC Acid 1 mg PO DAILY RX *folic acid 1 mg 1 tablet(s) by mouth daily Disp #*30 Tablet Refills:*1 2. Multivitamins 1 TAB PO DAILY RX *multivitamin 1 tablet(s) by mouth daily Disp #*30 Tablet Refills:*1 3. Thiamine 100 mg PO DAILY RX *thiamine HCl 100 mg 1 tablet(s) by mouth daily Disp #*30 Tablet Refills:*1 Discharge Disposition: Home Discharge Diagnosis: Primary Diagnoses: R orbital fracture Alcohol Withdrawal Cirrhosis of Liver Secondary Diagnoses: Leukopenia Thrombocytopenia Discharge Condition: Mental Status: Clear and coherent. Level of Consciousness: Alert and interactive. Activity Status: Ambulatory - Independent. Discharge Instructions: Dear Mr. ___, It was a pleasure caring for you at ___ ___. You were admitted after a fall. You were found to have a fracture in the bone around your right eye. You were seen by plastic surgery and opthalmology and they determined that there was no damage to your eye or vision. You were found to be withdrawing from alcohol, so you were treated with medication and your sympmtoms improved. You had a scan of your abdomen which revealed cirrhosis of your liver, likely due to longstanding alcohol use. You should enroll in a detox program to aid in your sobriety and follow up with Gastrointestinal doctors for your liver. As we discussed in the hospital, please abstain from alcohol. Given the damage already done to your liver, continued alcohol drinking will result in irreparable harm and death. Do not hesitate to reach out to your physician below or the hospital if you start to feel the urge to drink. You should also follow up with Opthalmology, Plastic surgery and your PCP (see appointments below). It was wonderful meeting you and we wish you all the best in your recovery. Sincerely, Your Medical Team Followup Instructions: ___
19717260-DS-11
19,717,260
26,747,548
DS
11
2120-08-09 00:00:00
2120-08-09 12:06:00
Name: ___ Unit No: ___ Admission Date: ___ Discharge Date: ___ Date of Birth: ___ Sex: F Service: ORTHOPAEDICS Allergies: nickel / latex Attending: ___. Chief Complaint: R hip fracture Major Surgical or Invasive Procedure: ORIF R periprosthetic femur fracture History of Present Illness: ___ female presents with the above fracture s/p mechanical fall. She was in her usual health until this morning, when she arose from bed, was making her bed, and tripped over her blankets. She fell onto her right hip and had instant pain. Denies HS, no LOC, no blood thinners. No other apparent injuries. Initially presented to ___, where she was diagnosed with periprosthetic R hip fracture and transferred here for further evaluation. Patient is very active at baseline. She lives in independent living, uses a walker sometimes in her apartment, and goes out with a cane. She performs all ADL/IADL independently. She still drives. Past Medical History: PMH: Afib, CHF, COPD, atrial fibrillation on ASA, hypertension, hypothyroidism, cardiomyopathy PSH: Cholecystectomy, Vein stripping b/l ___ Social History: ___ Family History: NC Physical Exam: ___ 0402 Temp: 98.1 PO BP: 142/77 HR: 93 RR: 18 O2 sat: 90% O2 delivery: Ra General: Well-appearing, breathing comfortably MSK, RLE: - Dressing c/d/I, no drainage or erythema - Ecchymosis along groin, non-TTP - Thigh and calf soft and compressible - Full, painless ROM at knee, and ankle - Fires ___ - SILT S/S/SP/DP/T distributions - Palpable ___ pulses, foot WWP Pertinent Results: See OMR Brief Hospital Course: The patient presented to the emergency department and was evaluated by the orthopedic surgery team. The patient was found to have a right periprosthetic femur fracture and was admitted to the orthopedic surgery service. The patient was taken to the operating room on ___ for open reduction and internal fixation of the fracture, which the patient tolerated well. For full details of the procedure please see the separately dictated operative report. The patient was taken from the OR to the PACU in stable condition and after satisfactory recovery from anesthesia was transferred to the floor. The patient was initially given IV fluids and IV pain medications, and progressed to a regular diet and oral medications by POD#1. The patient was given ___ antibiotics and anticoagulation per routine. #Anemia: The patient was hypotensive and noted to have a Hct of 20.7 post-operatively. She received 2u of pRBCs and her Hct responded appropriately. The patient was noted to have swelling and ecchymosis of the thigh post-operatively, the likely source of bleeding given the extent of her revision procedure. She was also resuscitated with fluid boluses in the context of her congestive heart failure. Her Hct was stable at the time of her discharge at 26. [ ] restart iron at discharge - dosing recommendation once every other day #Hyponatremia: The patient was noted to have a downtrending sodium to 123 post-operatively. Her home dose of Lasix was held, and urine electrolytes revealed an etiology of likely hypovolemic hyponatremia. The patient responded to intravenous fluid and a free water restriction. Sodium at discharge was measured to be 135. Her Lasix was restarted at the time of discharge. [ ] Encourage high solute intake, 2L restriction #Hypotension The patient's SBP was low post-operatively, responding well to boluses of fluid and blood transfusion. The patient's blood pressure was noted to be SBPs 110s at the time of her discharge; the patient Lisinopril was given hold parameters in the context of recent surgery and risk of orthostasis/falls while recovering at rehab. [ ] restart Lisinopril when medically appropriate given morality benefit in CHF #Afib Rate controlled with metoprolol. Transitioned to metoprolol XL at discharge per medicine recommendations given HR controlled in house, plus once-daily dosing. #Osteoporosis - Continue Vitamin D + Calcium supplementation - Recommend discussion re: bisphosphate in future The patient worked with ___ who determined that discharge to rehab was appropriate. The ___ hospital course was otherwise unremarkable. At the time of discharge the patient's pain was well controlled with oral medications, incisions were clean/dry/intact, and the patient was voiding/moving bowels spontaneously. The patient is weight bearing as tolerated in the left lower extremity, and will be discharged on enoxaparin 40mg daily for DVT prophylaxis. The patient will follow up with Dr. ___ routine. A thorough discussion was had with the patient regarding the diagnosis and expected post-discharge course including reasons to call the office or return to the hospital, and all questions were answered. The patient was also given written instructions concerning precautionary instructions and the appropriate follow-up care. The patient expressed readiness for discharge. Medications on Admission: The Preadmission Medication list is accurate and complete. 1. Albuterol 0.083% Neb Soln 1 NEB IH Q6H:PRN dyspnea wheeze 2. Levothyroxine Sodium 137 mcg PO DAILY 3. Atorvastatin 10 mg PO QPM 4. Lisinopril 2.5 mg PO DAILY 5. Furosemide 20 mg PO DAILY 6. Multivitamins 1 TAB PO DAILY 7. Calcium 600 + D(3) (calcium carbonate-vitamin D3) 500 mg PO DAILY 8. Aspirin 81 mg PO DAILY 9. Digoxin 0.125 mg PO DAILY 10. Metoprolol Succinate XL 100 mg PO DAILY 11. Docusate Sodium 250 mg PO DAILY 12. Fiber Laxative (methylcellulo) (methylcellulose (laxative)) 500 mg oral DAILY 13. Ferrous Sulfate Dose is Unknown PO BID 14. B-12 Compliance (cyanocobalamin (vitamin B-12)) 2500 mcg injection monthly Discharge Medications: 1. Acetaminophen 650 mg PO 5X/DAY 2. Calcium Carbonate 500 mg PO DAILY 3. Enoxaparin Sodium 40 mg SC QPM RX *enoxaparin 40 mg/0.4 mL 40 mg SC daily Disp #*27 Syringe Refills:*0 4. OxyCODONE (Immediate Release) 2.5-5 mg PO Q4H:PRN pain RX *oxycodone 5 mg ___ tablet(s) by mouth every ___ hours as needed Disp #*10 Tablet Refills:*0 5. Senna 17.2 mg PO BID 6. Vitamin D 1000 UNIT PO DAILY 7. Ferrous Sulfate 325 mg PO BID 8. Metoprolol Succinate XL 50 mg PO DAILY 9. Albuterol 0.083% Neb Soln 1 NEB IH Q6H:PRN dyspnea wheeze 10. Aspirin 81 mg PO DAILY 11. Atorvastatin 10 mg PO QPM 12. B-12 Compliance (cyanocobalamin (vitamin B-12)) 2500 mcg injection monthly 13. Calcium 600 + D(3) (calcium carbonate-vitamin D3) 500 mg PO DAILY 14. Digoxin 0.125 mg PO DAILY 15. Docusate Sodium 250 mg PO DAILY 16. Fiber Laxative (methylcellulo) (methylcellulose (laxative)) 500 mg oral DAILY 17. Furosemide 20 mg PO DAILY 18. Levothyroxine Sodium 137 mcg PO DAILY 19. Lisinopril 2.5 mg PO DAILY Hold for SBP < 140, may consider restarting in one week 20. Multivitamins 1 TAB PO DAILY Discharge Disposition: Extended Care Facility: ___ Discharge Diagnosis: Periprosthetic femur fracture Discharge Condition: Mental Status: Clear and coherent. Level of Consciousness: Alert and interactive. Activity Status: Out of Bed with assistance to chair or wheelchair. Discharge Instructions: INSTRUCTIONS AFTER ORTHOPAEDIC SURGERY: - You were in the hospital for orthopedic surgery. It is normal to feel tired or "washed out" after surgery, and this feeling should improve over the first few days to week. - Resume your regular activities as tolerated, but please follow your weight bearing precautions strictly at all times. ACTIVITY AND WEIGHT BEARING: - Weight bearing as tolerated, right lower extremity MEDICATIONS: 1) Take Tylenol ___ every 6 hours around the clock. This is an over the counter medication. 2) Add oxycodone as needed for increased pain. Aim to wean off this medication in 1 week or sooner. Then continue with Tylenol for pain. 3) Do not stop the Tylenol until you are off of the narcotic medication. 4) Per state regulations, we are limited in the amount of narcotics we can prescribe. If you require more, you must contact the office to set up an appointment because we cannot refill this type of pain medication over the phone. 5) Narcotic pain relievers can cause constipation, so you should drink eight 8oz glasses of water daily and continue following the bowel regimen as stated on your medication prescription list. These meds (senna, colace, miralax) are over the counter and may be obtained at any pharmacy. 6) Do not drink alcohol, drive a motor vehicle, or operate machinery while taking narcotic pain relievers. 7) Please take all medications as prescribed by your physicians at discharge. 8) Continue all home medications unless specifically instructed to stop by your surgeon. ANTICOAGULATION: - Please take enoxaparin daily for 4 weeks WOUND CARE: - You may shower. No baths or swimming for at least 4 weeks. - Any stitches or staples that need to be removed will be taken out at your 2-week follow up appointment. - Incision may be left open to air unless actively draining. If draining, you may apply a gauze dressing secured with paper tape. DANGER SIGNS: Please call your PCP or surgeon's office and/or return to the emergency department if you experience any of the following: - Increasing pain that is not controlled with pain medications - Increasing redness, swelling, drainage, or other concerning changes in your incision - Persistent or increasing numbness, tingling, or loss of sensation - Fever > 101.4 - Shaking chills - Chest pain - Shortness of breath - Nausea or vomiting with an inability to keep food, liquid, medications down - Any other medical concerns THIS PATIENT IS EXPECTED TO REQUIRE <30 DAYS OF REHAB Heart Failure: Weigh yourself every morning, call MD if weight goes up more than 3 lbs. Physical Therapy: WBAT BLE No splint or braces needed ROMAT Treatments Frequency: Any staples or superficial sutures you have are to remain in place for at least 2 weeks postoperatively. Incision may be left open to air unless actively draining. If draining, you may apply a gauze dressing secured with paper tape. You may shower and allow water to run over the wound, but please refrain from bathing for at least 4 weeks postoperatively. Followup Instructions: ___
19717536-DS-13
19,717,536
27,027,575
DS
13
2201-02-17 00:00:00
2201-02-19 20:49:00
Name: ___ Unit No: ___ Admission Date: ___ Discharge Date: ___ Date of Birth: ___ Sex: F Service: MEDICINE Allergies: Conray / Citalopram / Vicodin / atorvastatin Attending: ___. Chief Complaint: Respiratory failure Major Surgical or Invasive Procedure: Intubation History of Present Illness: Ms. ___ is a ___ w/ PMH notable for baseline dementia, HF, COPD & SSS s/p PPM who presents as a transfer from ___ w/ dyspnea. The patient initially presented to OSH from her rehab facility w/ AMS & dyspnea and was found to be in respiratory distress requiring non-invasive ventilation. A CXR was concerning for a RML infiltrate & she was started on levofloxacin for empiric PNA coverage. She was transferred to ___ for further care. En route, she developed a narrow-complex tachycardia requiring adenosine. Upon presentation to ___ ED, she remained in respiratory distress w/ hypoxia to the ___ & required intubation for acute hypoxic respiratory failure. She remained intermittently tachycardic w/ intermittent AF w/ RVR to 150s-180s. She was broadened to vancomycin & ceftazadime. She was admitted to the MICU for further support. In ED: -Initial VS & exam: 99.0 177 128/73 42 100% BiPAP "Appears in distress, tachypnea w/ coarse breath sounds & poor air movement bilaterally." -Labs significant for: 148 | 104 | 44 / ---------------- 81 4.9 | 26 | 2.3 \ \ 11.8 / 28.7 ------ 86 / 37.2 \ Lactate 3.6 VBG 7.29/33/61/31 Troponin 0.02 -Patient was given: ___ 20:35 IV Etomidate 20 mg ___ 20:46 IV Succinylcholine 120 mg ___ 21:01 IV DRIP Propofol ___ mcg/kg/min ordered) ___ 21:24 IV CefTAZidime 1 g ___ 21:27 IV DRIP Propofol ___ 21:32 IV DRIP Propofol ___ 21:32 IV Morphine Sulfate 4 mg ___ 21:32 IV BOLUS Midazolam 2 mg ___ 21:32 IV DRIP Midazolam (0.5-2 mg/hr ordered) -Imaging notable for: CXR: 1. The endotracheal tube terminates approximately 3.4 cm above the carina. 2. Re-demonstration of diffuse hazy opacity in the right hemithorax most consistent with pneumonia, not significantly changed compared to prior radiograph. On arrival to the MICU, the patient remained intubated and sedated and was unable to provide further history. Past Medical History: unspecified dementia GERD HFpEF OSA SSS w/ PPM Chronic diastolic heart failure Hypertension. Obesity. Dyslipidemia. Tachybrady syndrome, status post pacemaker. Chronic kidney disease. Polymyalgia rheumatica, on chronic corticosteroid therapy. COPD. Atrial fibrillation, on Xarelto. Obstructive sleep apnea, currently not using CPAP because equipment has been lost. Memory Loss: MOCA ___ on ___ Depression CKD Osteopenia Glaucoma Hyperparathyroidism Social History: ___ Family History: Sister with hypertension. Mother with unknown cardiovascular disease. Physical Exam: ADMISSION: ============ Vitals reviewed in OMR. GENERAL: Intubated, sedated. HEAD: NC/AT, ETT, OG in place. CARDIAC: NSR on monitor. RESPIRATORY: No wheezing anteriorly. ABDOMEN: Obese, soft. EXTREMITIES: 3+ ___ edema to knees bilaterally. DISCHARGE: =========== Vitals: ___ ___ Temp: 97.9 PediatricAxillary BP: 115/72 HR: 66 RR: 20 O2 sat: 92% O2 delivery: Ra General: Asleep, withdraws to pain and to attempts to open eyes Eyes: Sclera anicteric HEENT: MMM, oropharynx clear, resists opening eyes Neck: supple, JVP not elevated Resp: CTAB CV: regular rate and rhythm, normal S1 + S2, no murmurs, rubs, gallops GI: soft NT DD GU: Foley draining clear urine MSK: warm, well perfused, 2+ pulses, no clubbing, cyanosis or edema Neuro: CNs2-12 unable to assess, R-sided facial droop (chronic) Pertinent Results: ADMISSION: ========== ___ 08:23PM BLOOD WBC-28.7* RBC-4.34 Hgb-11.8 Hct-37.2 MCV-86 MCH-27.2 MCHC-31.7* RDW-16.6* RDWSD-51.7* Plt ___ ___ 08:23PM BLOOD Neuts-91* Bands-4 Lymphs-4* Monos-1* Eos-0 Baso-0 ___ Myelos-0 AbsNeut-27.27* AbsLymp-1.15* AbsMono-0.29 AbsEos-0.00* AbsBaso-0.00* ___ 08:23PM BLOOD Hypochr-NORMAL Anisocy-1+* Poiklo-NORMAL Macrocy-NORMAL Microcy-NORMAL Polychr-NORMAL Ovalocy-1+* Tear Dr-1+* ___ 08:23PM BLOOD ___ PTT-30.1 ___ ___ 08:23PM BLOOD Glucose-81 UreaN-44* Creat-2.3* Na-148* K-4.9 Cl-104 HCO3-26 AnGap-18 ___ 08:23PM BLOOD ALT-13 AST-26 AlkPhos-43 TotBili-0.8 ___ 08:23PM BLOOD proBNP-2422* ___ 08:23PM BLOOD cTropnT-0.02* ___ 08:23PM BLOOD Calcium-8.3* Phos-4.8* Mg-1.4* ___ 08:36PM BLOOD ___ pO2-33* pCO2-61* pH-7.29* calTCO2-31* Base XS-0 ___ 08:36PM BLOOD Lactate-3.6* MICROBIOLOGY: ============= ___ URINEURINE CULTURE-FINAL NO GROWTH. ___ SPUTUM GRAM STAIN-FINAL; RESPIRATORY CULTURE-FINAL GRAM STAIN (Final ___: >25 PMNs and <10 epithelial cells/100X field. 1+ (<1 per 1000X FIELD): GRAM NEGATIVE ROD(S). SMEAR REVIEWED; RESULTS CONFIRMED. RESPIRATORY CULTURE (Final ___: NO GROWTH. ___ MRSA SCREENMRSA SCREEN-FINAL No MRSA isolated. ___ URINELegionella Urinary Antigen -FINAL NEGATIVE FOR LEGIONELLA SEROGROUP 1 ANTIGEN. ___ Rapid Respiratory Viral Screen & CultureRespiratory Viral Culture-FINAL; Respiratory Viral Antigen Screen-FINAL No respiratory viruses isolated. Culture screened for Adenovirus, Influenza A & B, Parainfluenza type 1,2 & 3, and Respiratory Syncytial Virus. ___ BLOOD CULTUREBlood Culture, Routine-FINAL NO GROWTH. ___ URINEURINE CULTURE-FINAL MIXED BACTERIAL FLORA ( >= 3 COLONY TYPES), CONSISTENT WITH SKIN AND/OR GENITAL CONTAMINATION. ___ BLOOD CULTUREBlood Culture, Routine-FINAL NO GROWTH. IMAGING: ======== CXR CHEST (PORTABLE AP) ___ 7:59 ___ IMPRESSION: Diffuse hazy opacity in the right hemithorax most consistent with pneumonia. Probable small parapneumonic effusion. CXR CHEST (PORTABLE AP) ___ 8:40 ___ 1. The endotracheal tube terminates approximately 3.4 cm above the carina. 2. Re-demonstration of diffuse hazy opacity in the right hemithorax most consistent with pneumonia, not significantly changed compared to prior radiograph. CT Chest w/o contrast ___ IMPRESSION: -Extensive pneumonia, possibly due to aspiration involving the dependent portions of all 3 right lobes, with small focus of necrotizing pneumonia in the right lower lobe. -In the left partially imaged kidney possible solid round lesion is partially imaged. CT HEAD W/O CONTRAST ___ 12:31 AM IMPRESSION: 1. On slightly motion degraded examination, no evidence of acute large territory infarct or intracranial hemorrhage on noncontrast head CT. No intracranial mass effect. 2. If there are no contraindications, MRI would be more sensitive for sequela and etiology of seizure. 3. Aerosolized mucous in the left maxillary sinus, potentially representing acute sinusitis. Clinical correlation is recommended. UNILAT UP EXT VEINS US ___ 7:56 AM IMPRESSION: No evidence of deep vein thrombosis in the right upper extremity. CHEST (PORTABLE AP) ___ 3:22 AM IMPRESSION: Compared to chest radiographs ___ through ___. Severe pneumonia in the right lung, particularly upper lobe, improved from ___ through ___, and has decreased subsequently. Previous small bilateral pleural effusions are smaller. Moderate cardiomegaly, pulmonary and mediastinal vascular engorgement are stable. No pneumothorax. Right PIC line ends close to the superior cavoatrial junction. Transvenous right atrial and right ventricular pacer leads are unchanged in course from the left pectoral generator. CHEST (PORTABLE AP) ___ 11:53 AM IMPRESSION: In comparison with the earlier study of this date, the cardiomediastinal silhouette is stable. The pulmonary vascular congestion appears increased. There is increased opacification at the right base silhouetting hemidiaphragm, consistent with pleural effusion and underlying compressive atelectasis. Less prominent changes are seen on the left. Dual channel pacer is unchanged. In the appropriate clinical setting, it would be very difficult to exclude superimposed aspiration/pneumonia, especially in the absence of a lateral view. DISCHARGE LABS: ============== ___ 06:04AM BLOOD WBC-8.6 RBC-3.32* Hgb-9.2* Hct-28.2* MCV-85 MCH-27.7 MCHC-32.6 RDW-17.2* RDWSD-51.2* Plt ___ ___ 06:04AM BLOOD Plt ___ ___ 06:04AM BLOOD Glucose-97 UreaN-44* Creat-1.3* Na-143 K-3.8 Cl-101 HCO3-30 AnGap-12 ___ 05:50AM BLOOD UreaN-41* Creat-1.4* K-3.9 ___ 05:50AM BLOOD Mg-1.8 Brief Hospital Course: Ms. ___ is a ___ w/ PMH notable for baseline dementia, HFpEF, COPD & SSS s/p PPM, who p/w SOB, found a significant R-sided PNA, requiring intubation, admitted initially to MICU. Transferred back to the MICU for respiratory distress I/s/o SVTs, re-transferred to floor for continued tx of COPD exacerbation and likely pulmonary edema. #Acute hypoxic respiratory failure #Pneumonia #COPD exacerbation The patient's initial respiratory failure was thought to be likely related to her large right sided pneumonia demonstrated on CT scan. Was thought less likely to be related to a CHF exacerbation or COPD exacerbation as her exam and imaging were not consistent with considerable fluid overload nor was her VBG consistent with significant hypercarbia. She was initially admitted to the MICU and started on broad-spectrum antibiotics with vanc/ceftaz. Sputum gram stain was positive for GNRs, but did not grow anything in cultures. S. pneumo antigen and MRSA screen returned negative. She was narrowed to CTX to complete an 8-day course. The patient was diuresed with boluses of Lasix IV and treated with IV steroids as well. She demonstrated significant respiratory improvement and was extubated without event on ___. Patient was called out to the floor on ___, but re-transferred to ICU for acute pulmonary edema in the setting of tachycardia (discussed below). The patient was maintained on Advair BID, montelukast, and q6h duonebs. She completed a taper of prednisone, starting at 40mg and decreasing by 10mg every two days; she was taking 10mg prednisone on discharge, with a plan for the following taper: 5mg on ___, 5mg on ___. # Acute on chronic diastolic heart failure # SVTs She was called out to the floor on ___. Overnight on ___, she triggered for tachycardia to 150s (?SVT vs Afib) that required diltiazem to break after multiple rounds of metoprolol. She had a similar episode the day prior in the MICU that self-resolved. While on the floor, patient was also felt to have increased work of breathing. O2 requirement increased to 2L NC from RA. Given concern for respiratory status, she was transferred back to the MICU. While in the MICU the second time, patient had no recurrent SVT. CXR showed worsening pulmonary vascular congestion and pleural effusions without new infiltrate. Flash pulmonary edema in setting of SVT was suspected. The patient appeared volume overloaded on exam and had not consistently been receiving diuretics. Following second transfer to the floor, she improved significantly with diuresis with boluses of IV lasix and was weaned to RA. She was continued on her home dose of carvedilol, and home torsemide (80mg qd) was restarted prior to discharge. # Myoclonus MICU course was also complicated by myoclonus on L side of her body. Neuro was consulted, and EEG did not show seizure. She was started on keppra and symptoms resolved. Keppra was discontinued on ___. No further myoclonus was observed. # ___: Baseline unclear though 2.0 @ OSH before transfer. MICU admission Cr was 2.3. BUN/creatinine 19.13, consistent with pre-renal etiology likely ___ sepsis and dehydration. Patient was hydrated with IVF in the MICU. Discharge Cr of 1.4. # Hypernatremia: Na on arrival was 148. Likely secondary to free water loss likely representing dehydration. Patient remained hypernatremic during her stay despite hydration with hypotonic fluids. No D5 available; had been getting FW with ___ NS, but appeared mildly fluid overloaded so this was discontinued. PO intake was encouraged, and hypernatremia resolved spontaneously. # Afib: Rate controlled. Apixaban briefly held on ___ due to concern of GIB, but subsequently restarted. Continued home carvedilol. # Hyperglycemia No history of DM, hyperglycemia felt likely transient and related to prednisone. Controlled on sliding scale while hospitalized, requiring ___ Humalog off sliding scale daily towards end of hospital course. #Anemia #Melena Single hard bowel movement with bright blood noted after first floor transfer. Apixaban was briefly held, continued on home omeprazole. No melena noted afterwards, with subsequent stools consistently loose, brown. Guaiac negative. H/H at baseline, stable. Labs notable for elevated ferritin, low TIBC, normal iron, normal LFTs, inappriately low reticulocyte index, most consistent with anemia of chronic disease. Possibly component of iron deficiency. # GERD - Continued home omeprazole. # HLD - Continued home pravastatin. # Unspecified dementia - Continued home donepezil & sertraline. # Hypothyroidism - Continued home levothyroxine. TRANSITIONAL ISSUES =================== [ ] Recommend Chem 7 + Mg on ___ to follow up electrolytes and Cr on torsemide and K dosing. [ ] Cardiology clinic follow-up as outpatient on ___. [ ] Please weigh daily and consider increasing torsemide vs adding metolazone if gaining weight. [ ] Continue to assess volume status and weight and adjust diuretics as needed. [ ] Consider further anemia work up and iron as outpatient if not already done. MEDICATIONS: - NEW: Complete rednisone taper: 5mg on ___ and ___. - NEW: Insulin sliding scale. ___ discontinue at end of prednisone taper. - NEW: Multivitamin daily. - CHANGED: Potassium decreased to 10mEq daily from 20mEq. # Discharge Cr: 1.4 # Discharge weight: 247.5 lbs Communication: HCP: ___ ___ Code: DNR/DNI Medications on Admission: The Preadmission Medication list is accurate and complete. 1. Aspirin 81 mg PO DAILY 2. Levothyroxine Sodium 75 mcg PO DAILY 3. Pravastatin 80 mg PO QPM 4. Apixaban 2.5 mg PO BID 5. Carvedilol 6.25 mg PO BID 6. Donepezil 5 mg PO QHS 7. Sertraline 50 mg PO DAILY 8. Omeprazole 20 mg PO DAILY 9. budesonide-formoterol 80-4.5 mcg/actuation inhalation BID 10. ipratropium-albuterol 0.5 mg-3 mg(2.5 mg base)/3 mL inhalation Q6H:PRN 11. Polyethylene Glycol 17 g PO DAILY:PRN constipation 12. Senna 17.2 mg PO BID 13. Montelukast 10 mg PO DAILY 14. Tiotropium Bromide 1 CAP IH DAILY 15. Torsemide 80 mg PO DAILY 16. Ventolin HFA (albuterol sulfate) 90 mcg/actuation inhalation Q4H:PRN 17. Potassium Chloride 20 mEq PO DAILY 18. PredniSONE 20 mg PO DAILY Discharge Medications: 1. Insulin SC Sliding Scale Fingerstick QACHS Insulin SC Sliding Scale using HUM Insulin 2. Multivitamins W/minerals 1 TAB PO DAILY 3. PredniSONE 5 mg PO DAILY Duration: 2 Days 4. Potassium Chloride 10 mEq PO DAILY 5. Albuterol Inhaler 2 PUFF IH Q4H:PRN dyspnea 6. Apixaban 2.5 mg PO BID 7. Carvedilol 12.5 mg PO BID 8. Donepezil 5 mg PO QHS 9. Ipratropium Bromide Neb 1 NEB IH Q6H 10. Metolazone 2.5 mg PO 2X/WEEK (___) PRN for weight >255 lbs 11. Montelukast 10 mg PO DAILY 12. Omeprazole 20 mg PO DAILY 13. Polyethylene Glycol 17 g PO DAILY:PRN constipation 14. Pravastatin 80 mg PO QPM 15. Senna 8.6 mg PO BID:PRN constipatin 16. Sertraline 50 mg PO DAILY 17. Symbicort (budesonide-formoterol) 80-4.5 mcg/actuation inhalation BID 18. Tiotropium Bromide 1 CAP IH DAILY 19. Torsemide 80 mg PO DAILY 20. Vitamin D 1000 UNIT PO DAILY Discharge Disposition: Extended Care Facility: ___ Discharge Diagnosis: Respiratory failure Discharge Condition: Mental Status: Clear and coherent. Level of Consciousness: Alert and interactive. Activity Status: Ambulatory - requires assistance or aid (walker or cane). Discharge Instructions: Dear ___, ___ was a pleasure taking care of you at ___. Please see below for information on your time in the hospital. WHY WAS I IN THE HOSPITAL? - You presented to the hospital with respiratory failure requiring intubation. - We believe this was related to a pneumonia and possible a COPD exacerbation, as well as having fluid in your lungs. WHAT HAPPENED IN THE HOSPITAL? -You were initially admitted to the MICU because you required a ventilator to support your breathing. -You were treated with antibiotics for your pneumonia. -You were treated with steroids and nebulizer breathing treatments for a COPD exacerbation. -You were transferred to the MICU a second time because you were having difficulty breathing again, this time because of a fast heart rate, which likely caused fluid to accumulate in your lungs. -You improved with treatment with diuretics to remove the excess fluid. -Your blood sugars were somewhat high because of the prednisone you were taking, so you were given some insulin. WHAT SHOULD I DO WHEN I GO HOME? -Please continue to take the prednisone as prescribed. -Please check your blood sugars and take insulin as needed until the prednisone is stopped. Your care team can help with this. -Please weigh yourself daily, and take your metolazone if your weight is greater than 255 lbs. -Please also tell your doctor if you gain more than 2 pounds in 1 day, or 5 pounds in 1 week. -Please limit your daily sodium intake to less than 2 grams per day. -Your medications and follow up appointments are below. We wish you the best! -Your Care Team at ___ Followup Instructions: ___
19717536-DS-15
19,717,536
22,142,531
DS
15
2202-04-16 00:00:00
2202-07-05 12:29:00
Name: ___ Unit No: ___ Admission Date: ___ Discharge Date: ___ Date of Birth: ___ Sex: F Service: ORTHOPAEDICS Allergies: Conray / Citalopram / Vicodin / atorvastatin Attending: ___. Chief Complaint: Left ankle pain Major Surgical or Invasive Procedure: Open reduction internal fixation of left ankle History of Present Illness: Patient is a pleasant ___ female who sustained an ankle fracture that was initially nondisplaced and is being treated by Dr. ___ at ___ unfortunately it is lost the alignment and she presents to us for definitive management given her medical comorbidities. Past Medical History: - paroxysmal afib on anticoagulation - COPD - HFpEF - dementia - depression - insomnia - CKD stage III - sick sinus syndrome s/p PPM - hypertension - osteopenia - pre-diabetes - osteoarthritis - low back pain - valvular heart disease - OSA - polymyalgia rheumatica - pulmonary nodule - thyroid nodule - hemorrhoids - gastric polyps - glaucoma - hyperparathyriodsim - s/p knee surgery - s/p cataract surgery Social History: ___ Family History: Sister with hypertension. Mother with unknown cardiovascular disease. Physical Exam: ___ 0704 Temp: 98.5 PO BP: 146/70 L Lying HR: 67 RR: 18 O2 sat: 97% O2 delivery: Ra General: Sleeping comfortably this AM MSK: RLE, splinted, wwp. remainder of exam deferred ___ geriatric protocol Pertinent Results: See omr Brief Hospital Course: The patient presented to the emergency department and was evaluated by the orthopedic surgery team. The patient was found to have a left ankle fracture and was admitted to the orthopedic surgery service. The patient was taken to the operating room on ___ for open reduction internal fixation of the left ankle, which the patient tolerated well. For full details of the procedure please see the separately dictated operative report. The patient was taken from the OR to the PACU in stable condition and after satisfactory recovery from anesthesia was transferred to the floor. The patient was initially given IV fluids and IV pain medications, and progressed to a regular diet and oral medications by POD#1. The patient was given ___ antibiotics and anticoagulation per routine. The patient's home medications were continued throughout this hospitalization. The patient worked with ___ who determined that discharge to rehab was appropriate. The patient was followed by geriatrics throughout her admission (see note below). She was more lethargic post-operatively, which was thought to be due to retaining CO2. Strict adherence to bipap while napping or sleeping was encouraged. This will need to be closely monitored at rehab. The ___ hospital course was otherwise unremarkable. At the time of discharge the patient's pain was well controlled with oral medications, incisions were clean/dry/intact, and the patient was voiding/moving bowels spontaneously. The patient is nonweightbearing in the left lower extremity, and will be discharged on home apixaban for DVT prophylaxis. The patient will follow up with Dr. ___ routine. A thorough discussion was had with the patient regarding the diagnosis and expected post-discharge course including reasons to call the office or return to the hospital, and all questions were answered. The patient was also given written instructions concerning precautionary instructions and the appropriate follow-up care. The patient expressed readiness for discharge. Please see below for geriatric note prior to discharge: Note contains an addendum. See bottom. Note Date: ___ Time: 1639 Note Type: Progress note Note Title: Geriatric ___ Progress Note Electronically signed by ___, MD on ___ at 4:42 pm Affiliation: ___ Electronically cosigned by ___, MD on ___ at 1:06 am ====================================== GERIATRIC CONSULT PROGRESS NOTE: ====================================== PCP: ___ ___ Primary Service: Surgery - Orthopedics Geriatric attending: Dr. ___ ___ of information: Patient, OMR Admission date: ___ ====================================== REASON FOR CONSULTATION: co-management of care HISTORY OF PRESENT ILLNESS: Ms. ___ is a an ___ woman with past medical history of dementia, CKD stage III, A. fib on apixaban, COPD, HFpEF, PMR, SSS s/p PPM who presents on ___ for ORIF of left ankle fracture. INTERVAL HISTORY -patient tired this AM -wore CPAP intermittently throughout night -says she has pain in her ankle -eating well CARDIAC HISTORY: Atrial Fibrillation on Apixaban Heart Failure with preserved Ejection fraction Hypertension Mild TR Sick Sinus Syndrome s/p PPM OTHER PAST MEDICAL HISTORY: - COPD - dementia - depression - insomnia - CKD stage III - sick sinus syndrome s/p PPM - hypertension - osteopenia - pre-diabetes - osteoarthritis - low back pain - valvular heart disease - OSA - polymyalgia rheumatica - pulmonary nodule - thyroid nodule - hemorrhoids - gastric polyps - glaucoma - hyperparathyriodsim - s/p knee surgery - s/p cataract surgery INPATIENT MEDICATIONS: --------------- --------------- --------------- --------------- Active Inpatient Medication list as of ___ at 1639: Medications - Standing Donepezil 5 mg PO/NG QHS Sertraline 50 mg PO/NG DAILY Sodium Chloride 0.9% Flush ___ mL IV Q8H and PRN, line flush Docusate Sodium 100 mg PO BID CARVedilol 12.5 mg PO/NG BID Montelukast 10 mg PO/NG DAILY Pravastatin 80 mg PO QPM PredniSONE 8 mg PO/NG DAILY Torsemide 80 mg PO/NG DAILY Tiotropium Bromide 1 CAP IH DAILY Ipratropium-Albuterol Neb 1 NEB IH TID Acetaminophen 1000 mg PO/NG Q8H Polyethylene Glycol 17 g PO/NG DAILY Fluticasone-Salmeterol Diskus (500/50) 1 INH IH BID Omeprazole 20 mg PO DAILY Senna 8.6 mg PO/NG BID Apixaban 2.5 mg PO/NG BID Medications - PRN Bisacodyl 10 mg PR QHS:PRN Constipation - Second Line OxyCODONE (Immediate Release) 2.5-5 mg PO Q4H:PRN Pain Bisacodyl 10 mg PR QHS:PRN Constipation - Second Line --------------- --------------- --------------- --------------- ALLERGIES: Allergies (Last Verified ___ by ___: atorvastatin Citalopram Conray Vicodin (Hydrocodone Bitartrate/Acetaminophen) PHYSICAL EXAM: ___ 1539 Temp: 98.3 PO BP: 114/67 R Sitting HR: 66 RR: 18 O2 sat: 99% O2 delivery: Ra ___ Urine Amt: large inc Bowel Mvmt: liquid BM Gen: NAD, A/O x2 (hospital) HEENT: Anicteric, PER, EOM intact, MMM, oropharynx without erythema or exudate Neck: no JVD CV: irregular rhythm Pulm: coarse breath sounds, unchanged - baseline COPD GI: +BS, NT, ND, no organomegaly Skin: no lesions MSK: Warm, no edema, 2+ pedal pulses , left ankle in cast Neuro: no focal deficits, gait not assessed Psych: Alert, oriented to person/place, pleasant. CAM: 1) Acute onset and fluctuating course: + 2) Inattention: + 3) Disorganized thinking: - 4) Altered level of consciousness: + If yes to criteria 1 and 2 AND either 3 or 4, then positive for delirium Patient appears to have hypoactive delirium. She has baseline dementia. LABS/IMAGING: ___ 08:00AM BLOOD WBC: 7.9 RBC: 3.89* Hgb: 11.3 Hct: 38.2 MCV: 98 MCH: 29.0 MCHC: 29.6* RDW: 14.4 RDWSD: 51.2* Plt Ct: 241 ___ 08:00AM BLOOD Glucose: 88 UreaN: 34* Creat: 1.7* Na: 148* K: 4.3 Cl: 106 HCO3: 27 AnGap: 15 ___ 08:00AM BLOOD Calcium: 9.8 Phos: 4.3 Mg: 1.9 EKG: Atrial paced, no acute ST changes ___ ankle XR IMPRESSION: Intraoperative images were obtained during open reduction internal fixation of the left ankle. Please refer to the operative note for details of the procedure. CXR ___: Hypoinflated lungs with bronchovascular crowding. No focal consolidation concerning for pneumonia. PFTs ___: Mild obstructive ventilatory defect with a moderate gas exchange defect. Compared to the prior study of ___ the DLCO has decreased by 8.48 ml/min/mmHg (-52%). This decrease is greater than would be expected for the change in age. Compared to the prior study of ___ there has been no significant change in FVC and FEV1. ECHO ___: Suboptimal image quality. Normal LV systolic function. Mildly dilated RV, function difficult to assess. Mild mitral regurgitation. Mild aortic regurgitation. Elevated PCWP. Moderate tricuspid regurgitation. Moderate pulmonary hypertension. ASSESSMENT&RECOMMENDATIONS: Ms. ___ is a an ___ woman with past medical history of dementia, CKD stage III, A. fib on apixaban, COPD, HFpEF, PMR, SSS s/p PPM who presents for ORIF. ***SUMMARY OF RECOMMENDATIONS*** #Hypoactive delirium -patient usually more energetic but today falling asleep mid conversation -history of dementia -no evidence of infection -pain improved with regimen -having BM -intermittently compliant with CPAP machine and has known OSA Recommend: -VBG to assess for hypercarbia -encourage CPAP use throughout night #L Ankle fracture s/p ORIF on ___ -surgery delayed because of need to hold anticoagulation for epidural for anaesthesia Recommend: -resume torsemide daily -resumed apixaban -Tylenol 1 g tid scheduled -continue oxycodone 2.5 mg q4h prn for moderate to severe pain -senna 1 tab daily, miralax daily (hold both for loose stools, bisacodyl suppository prn #COPD -provided patient with incentive spirometer today and taught her how to use it. She demonstrated use with success. Recommend: -continue incentive spirometer, every hr do 10 breaths -continue duo-nebs tid -continue Montelukast 10 mg daily -continue tiotropium daily inh #HFpEF -continue carvedilol 12.5 mg bid -continue torsemide 80 mg daily #OSA -she had recent sleep study and she was recommended to wear a CPAP -she has been refusing at home and while admitted #CKD III -hold nephrotoxic agents #Dementia -continue donepezil but change to qAM as can disrupt sleep #PMR -continue daily prednisone #HLD -continue pravastatin 80 qhs #GERD -continue omeprazole #Depression -continue sertraline 50 mg daily #Advanced care planning -MOLST in chart from ___ is DNR/DNI -Daughter, ___ is HCP The plan was discussed with the primary team in detail. These recommendations are preliminary until reviewed by an attending and cosigned below. Please page geriatric ___ with questions. To be staffed with attending Dr. ___ ___, MD ___ Fellow Pager ___ Addendum by ___, MD on ___ at 1:06 am: On ___ I have seen, examined and was physically present with Dr. ___ key portions of the services provided. I agree with Dr. ___ and notes. I would add the following remarks: The patient was not discharged to rehab because of her lethargy. Today she was less interactive than how she was before surgery. She did not have any fever, chills, chest pain, SOB, GI symptoms, or vital sign abnormalities. During the exam, she was falling asleep, consistent with delirium. Cardiopulmonary exam unremarkable. Abdomen soft, BS+, nontender. Able to move her toes and feel light touch in both legs. Given her COPD history, we think it is important to rule out CO2 retention. Continue to monitor her for another day. ___, MD, MPH, ___ Staff Geriatrician Division of Gerontology, Department of ___ Tel: ___ Fax: ___ Medications on Admission: See OMR Discharge Medications: 1. Acetaminophen 1000 mg PO TID for pain 2. Docusate Sodium 100 mg PO BID 3. OxyCODONE (Immediate Release) 2.5-5 mg PO Q4H:PRN Pain RX *oxycodone [Oxaydo] 5 mg ___ tablet(s) by mouth every four (4) hours Disp #*20 Tablet Refills:*0 4. Polyethylene Glycol 17 g PO DAILY 5. Senna 8.6 mg PO BID:PRN Constipation - First Line 6. Apixaban 2.5 mg PO/NG DAILY 7. CARVedilol 12.5 mg PO BID 8. Donepezil 5 mg PO QHS 9. Fluticasone-Salmeterol Diskus (500/50) 1 INH IH BID 10. Montelukast 10 mg PO DAILY 11. Omeprazole 20 mg PO DAILY 12. Pravastatin 80 mg PO QPM 13. PredniSONE 8 mg PO DAILY 14. Sertraline 50 mg PO DAILY 15. Tiotropium Bromide 1 CAP IH DAILY 16. Torsemide 80 mg PO DAILY Discharge Disposition: Extended Care Facility: ___ Discharge Diagnosis: Left ankle fracture Discharge Condition: Mental Status: Confused - sometimes. Level of Consciousness: Alert and interactive. Activity Status: Ambulatory - requires assistance or aid (walker or cane). Discharge Instructions: Weigh yourself every morning, call MD if weight goes up more than 3 lbs. Physical Therapy: Activity: Activity: Activity as tolerated Left lower extremity: Non weight bearing Encourage turn, cough and deep breathe q2h when awake Treatments Frequency: Any staples or superficial sutures you have are to remain in place for at least 2 weeks postoperatively. Incision may be left open to air unless actively draining. If draining, you may apply a gauze dressing secured with paper tape. You may shower and allow water to run over the wound, but please refrain from bathing for at least 4 weeks postoperatively. Followup Instructions: ___
19717536-DS-6
19,717,536
23,365,032
DS
6
2199-08-24 00:00:00
2199-08-28 22:01:00
Name: ___ Unit No: ___ Admission Date: ___ Discharge Date: ___ Date of Birth: ___ Sex: F Service: MEDICINE Allergies: Conray / Citalopram / Vicodin / atorvastatin Attending: ___. Chief Complaint: Dyspnea Major Surgical or Invasive Procedure: none History of Present Illness: ___ PMHx atrial fibrillation on xarelto, tachy-brady syndrome s/p PPM, CKD, HTN, COPD (FEV1 67% in ___, and moderate dementia who presented with dyspnea. She has had a runny nose and productive cough x 1 week. She also had subjective fevers at home. Per family, she's also has sweats for several weeks to months. This morning, she was brought to the hospital due to increasing dyspnea. She has no symptoms of orthopnea per her family. They deny any edema or weight loss or gain. She was born in the ___ and has never traveled abroad. Of note, she was admitted to ___ in late ___ for community acquired PNA. Blood cultures were negative, no sputum culture was done. In the ED, initial vitals: 98.9 66 149/57 20 100% Nasal Cannula. Tmax was 100.0. Labs were significant for leukocytosis to 18.0, troponin < 0.01, creatinine at 1.5 (near baseline), lactate 2.1, proBNP: 794 (prior 453). CXR showed patchy airspace opacities in the left lung base may reflect atelectasis but infection is not excluded. Mild pulmonary vascular congestion. In the ED, she received 1g IV ceftriaxone, 500mg IV azithromycin, 125mg IV solumedrol, and 324mg PO aspirin Vitals prior to transfer: T 99.9, HR 67, BP 134/63, RR 22, 96% Nasal Cannula ROS: No fevers, chills, or weight changes. No changes in vision or hearing, no changes in balance. No chest pain or palpitations. No nausea or vomiting. No diarrhea or constipation. No dysuria or hematuria. No hematochezia, no melena. No numbness or weakness, no focal deficits. Past Medical History: Memory Loss: MOCA ___ on ___ Depression: on sertraline since ___, dose increased ___ Insomnia CKD Rotator Cuff Tear Atrial Fibrillation on warfarin HLD COPD Diastolic CHF: on torsemide HTN Osteopenia: Last DEXA ___ Pre-DM Osteoarthritis Lumbago Valvular Heart Disase: TR and diastolic dysfunction OSA: CPAP use periodically Sick Sinus Syndrome s/p PPM Gait disorder PMR on prednisone Elevated CK Pulmonary Nodule: no further f/u needed Thyroid Nodule: followed by endocrine Hemorrhoids Gastric Polyps Glaucoma Hyperparathyroidism Social History: ___ Family History: Sister with HTN Physical Exam: PHYSICAL EXAM ON ADMISSION: ===================================== VS: T 98.9 BP 162/75 HR 69 RR 25 02 sat: 100% 2L GEN: Alert, diaphoretic, tachypneic, HEENT: Moist MM, anicteric sclerae, no conjunctival pallor NECK: Supple without LAD, JVP difficult to assess PULM: Diffusely rhoncorous, no crackles. COR: RRR (+)S1/S2 no m/r/g ABD: Soft, non-tender, non-distended EXTREM: Warm, well-perfused, no edema NEURO: CN II-XII grossly intact, motor function grossly normal PHYSICAL EXAM ON DISCHARGE: ========================================= Vitals: 97.9 134/47 66 20 97 RA I/O: ___ General: alert, knows she's at ___. HEENT: pinpoint pupils, sclera anicteric, MMM, oropharynx clear Neck: supple, JVP flat PULM: good air movement, minimal wheezing bilaterally COR: RRR (+)S1/S2, soft holosystolic murmur heard over apex ABD: Soft, non-tender, non-distended. no ttp over epigastrium. EXTREM: Warm, well-perfused, pitting edema to ankles. R arm with mild redness at PIV site, but soft to touch. NEURO: CN II-XII grossly intact, motor function grossly normal Pertinent Results: LABS ON ADMISSION: ================================ ___ 01:50PM BLOOD WBC-18.0*# RBC-4.17 Hgb-12.1 Hct-37.2 MCV-89 MCH-29.0 MCHC-32.5 RDW-14.1 RDWSD-45.5 Plt ___ ___ 01:50PM BLOOD Plt ___ ___ 01:50PM BLOOD Glucose-95 UreaN-19 Creat-1.5* Na-142 K-5.1 Cl-102 HCO3-29 AnGap-16 ___ 01:50PM BLOOD ALT-12 AST-36 LD(LDH)-639* AlkPhos-58 TotBili-0.8 ___ 01:50PM BLOOD cTropnT-<0.01 proBNP-794* ___ 01:50PM BLOOD Albumin-3.4* ___ 01:50PM BLOOD TSH-0.71 ___ 08:25AM BLOOD Calcium-9.4 Phos-3.9 Mg-2.2 UricAcd-8.6* ___ 12:11AM BLOOD ___ pO2-62* pCO2-52* pH-7.32* calTCO2-28 Base XS-0 ___ 08:25AM BLOOD CRP-176.0* LABS ON DISCHARGE: ================================= ___ 09:20AM BLOOD LD(LDH)-347* ___ 09:20AM BLOOD PEP-TRACE ABNO IgG-1260 IgA-297 IgM-67 IFE-MONOCLONAL ___ 08:25AM BLOOD WBC-11.1* RBC-3.68* Hgb-10.8* Hct-33.0* MCV-90 MCH-29.3 MCHC-32.7 RDW-14.6 RDWSD-47.5* Plt ___ ___ 08:25AM BLOOD Plt ___ ___ 08:25AM BLOOD Glucose-94 UreaN-43* Creat-1.5* Na-145 K-4.6 Cl-105 HCO3-30 AnGap-15 ___ 08:25AM BLOOD Calcium-9.3 Phos-4.3 Mg-2.4 ___ 06:50AM BLOOD Hapto-216* Brief Hospital Course: **THIS PATIENT WILL NEED LESS THAN 30 DAYS OF REHAB** Ms. ___ is a ___ PMHx atrial fibrillation on xarelto, tachy-brady syndrome s/p PPM, CKD, HTN, COPD, who presented with productive cough and dyspnea concerning for COPD exacerbation superimposed with pneumonia. Her course was complicated by transient episodes of SVT, likely atrial tachycardia and hyperkalemia. #Dyspnea, COPD exacerbation: Presented with cough, dyspnea x 1 week. In ED, her O2 sat was 100% NC, Tmax 100. Exam was notable for diffusely rhoncorous lungs. VBG 7.32/62/52/28. Initial CXR with possible consolidation. BNP was 794. Initially there was concern for HCAP (hospitalization w/n 90 days for pneumonia) and she was treated with Vancomycin/Cefepime. On hospital day 2, she had minimal cough and significant wheezing and her exam was more consistent with COPD exacerbation. She was weaned off oxygen. She was treated with frequent duonebs, advair, montelukast (home medication). She received a 5-day burst of prednisone (40-40-60-60-60mg) from ___. She also received levaquin from ___, which was stopped due to low concern for pneumonia. Her exam showed interval improvement in wheezing and she was discharged to pulmonary rehab for further recovery. Her outpatient pulmonologist recently did a CT trachea which raised concern for upper airway disease. She is scheduled to follow in ___ clinic for further evaluation. ___: Her Cr was 3.2 on ___ and downtrended to 1.5 on discharge (1.5 is her baseline). She had good urine output throughout. Per urine lytes on ___ showed FeNa <1% suggestive of pre-renal etiology. It was thought that her ___ was secondary to low effective circulating volume in setting of fluid losses while being on valsartan. She had no evidence on physical exam for worsening heart failure. Bladder scan and PVR showed complete emptying, so her ___ was unlikely to be post-renal. In addition, there could have been a contribution from vancomycin which she received on admission. Her Cr improved with IV fluids and holding home Torsemide. Given her changing kidney function, xarelto was briefly stopped and she was anticoagulated with heparin. On ___, she was restarted on xarelto 15 mg. Her xarelto dose can be uptitrated by primary care provider, as needed, based on kidney function. She was re-started on home dose Torsemide 10 mg PO daily on ___. Valsartan dose was decreased from 320 mg to 160 mg given ___ and hyperkalemia. # Hyperkalemia: K 5.5 on ___ and 5.7 on ___. Improved with insulin 10 u x1 and kayexelate. Thought to be elevated in setting of ___. She'd had elevated LDH, uric acid however, H&H stable. Haptoglobin 216. On discharge, her K was 4.8. She should have chem7 checked on ___, to make sure her potassium is stable. #Elevated LDH, uric acid: unclear etiology. H&H stable and haptoglobin is not low, so doesn't appear to be hemolysis. Given her subacute symptoms of night sweats, occult malignancy is on our differential. CT Trachea done recently didn't show any mediastinal or hilar LAD. SPEP with trace abnormal band seen in gamma region based on IFE. UPEP neg. Consider CT Abd/Pel as outpatient #SVT: now resolved, seen on tele on ___, likely i/s/o more frequent albuterol nebs. Per Cards, appears to be atrial tachycardia. Pt notes occasional palpitations, but no other symptoms. No further events on tele, HRs in ___. Metoprolol succinate was discontinued and she was placed on carvedilol 6.25mg BID. # Atrial Fibrillation: CHADS of 3. Restarted on xarelto 15mg on ___. Carvedilol 6.25mg BID for rate control. # CHF: history of diastolic CHF, on 10mg torsemide at home. Does not endorse orthopnea, no evidence of significant volume overload on exam. BNP 794. Restarted on Torsemide 10 mg on ___. # HTN: - continue amlodipine, valsartan dose decreased to 160 mg. Also started on carvedilol 6.25mg BID during this admission. # HLD: continued on home dose pravastatin # PMR: Came in on 6mg prednisone, which was supposed to be tapered down. However, she required higher dose prednisone x5 days for COPD exacerbation. She was discharged on 6mg prednisone and can follow up in ___ clinic for continued taper. # Iron Deficiency Anemia: Continue ferrous sulfate # OSA: prescribed for CPAP at home. ======== Transitional issues: 1. Needs chem7 checked on ___, to check her K+ level. 2. Resumed on xarelto 15 mg 3. Decreased valsartan dose from 320mg to 160 mg daily 4. Discontinued metroprolol succinate and restarted on carvedilol 6.25mg BID. 5. Taking prednisone 6mg for PMR at time of admission. She was supposed to be on taper. She got 5-day burst of prednisone (40-40-60-60-60mg) in the hospital. She is being discharged on 6mg and will need to follow up in ___ clinic for tapering. 7. She has had night sweats for the past few months. Labs showed elevated LDH (639) and uric acid (10.0). Hematocrit was stable. CT Trachea done recently didn't show mediastinal or hilar LAD. Please SPEP trace abnormal band seen in gamma region. UPEP was negative for protein. She should get a CT Abd/Pel as an outpatient within ___ months (discussed with Dr. ___ PCP). 8. CT Trachea prior to admission showed narrowed upper airway. She has ___ clinic follow up for further evaluation. Medications on Admission: The Preadmission Medication list is accurate and complete. 1. Albuterol Inhaler 2 PUFF IH Q6H:PRN shortness of breath 2. amLODIPine 10 mg PO DAILY 3. Symbicort (budesonide-formoterol) 160-4.5 mcg/actuation inhalation BID 4. Montelukast 10 mg PO DAILY 5. Pravastatin 80 mg PO QPM 6. PredniSONE 6 mg PO DAILY Tapered dose - DOWN 7. Sertraline 50 mg PO DAILY 8. Torsemide 10 mg PO DAILY 9. Valsartan 320 mg PO DAILY 10. Calcitrate-Vitamin D (calcium citrate-vitamin D3) 315mg-200u oral DAILY 11. Vitamin D 1000 UNIT PO DAILY 12. Ferrous Sulfate Dose is Unknown PO DAILY 13. melatonin 5 mg oral DAILY 14. Rivaroxaban 15 mg PO DAILY 15. Metoprolol Succinate XL 50 mg PO DAILY Discharge Medications: 1. Carvedilol 6.25 mg PO BID 2. Polyethylene Glycol 17 g PO DAILY:PRN Constipation 3. Ferrous Sulfate 325 mg PO DAILY 4. Valsartan 160 mg PO DAILY 5. Albuterol Inhaler 2 PUFF IH Q6H:PRN shortness of breath 6. amLODIPine 10 mg PO DAILY 7. Calcitrate-Vitamin D (calcium citrate-vitamin D3) 315mg-200u oral DAILY 8. melatonin 5 mg oral DAILY 9. Montelukast 10 mg PO DAILY 10. Pravastatin 80 mg PO QPM 11. PredniSONE 6 mg PO DAILY Tapered dose - DOWN 12. Rivaroxaban 15 mg PO DAILY 13. Sertraline 50 mg PO DAILY 14. Symbicort (budesonide-formoterol) 160-4.5 mcg/actuation INHALATION BID 15. Torsemide 10 mg PO DAILY 16. Vitamin D 1000 UNIT PO DAILY 17.CPAP Precription CPAP Prescription: ICD-9 CODE 490 COPD. Autoset CPAP: Minimum 4 Maximum 20. Discharge Disposition: Extended Care Facility: ___ ___ Rehabilitation and Sub-Acute Care) Discharge Diagnosis: PRIMARY DIAGNOSES: COPD exacerbation Acute kidney injury Discharge Condition: Mental Status: Confused - sometimes. Level of Consciousness: Alert and interactive. Activity Status: Ambulatory - requires assistance or aid (walker or cane). Discharge Instructions: Ms. ___, You were admitted to ___ from ___ for difficulty breathing. We diagnosed you with a COPD flare. You were treated with oxygen, inhalers, and steroids. At first, there was concern that you may have a lung infection as well, so you got antibiotics. During the admission, your kidney function got worse because you were dehydrated. We treated this with IV fluids. We stopped xarelto, your blood thinning medicine, for a while until your kidney function improved. You were then re-started on xarelto before leaving the hospital. It is very important to take this medicine. You should also continue to take your COPD inhalers. As a separate issue, we also noted that you've been having night sweats for a couple months. You will need to see your primary doctor (___) for further work up. For better blood pressure and heart rate control, we discontinued metoprolol and started you on a new medicine called carvedilol. We also halved your valsartan dose to 160mg daily. We are also sending you home on prednisone 6 mg for polymyalgia rheumatica (PMR). You will need to see your doctor who will decrease the dose over time. Thank you for letting us be a part of your care! -Your ___ Team Followup Instructions: ___
19717773-DS-12
19,717,773
28,922,574
DS
12
2185-05-11 00:00:00
2185-05-12 10:08:00
Name: ___ Unit No: ___ Admission Date: ___ Discharge Date: ___ Date of Birth: ___ Sex: F Service: NEUROLOGY Allergies: Codeine / Percocet / Pollen/Hayfever / Soap / adhesive tape / prednisone Attending: ___. Chief Complaint: retro-orbital headache Major Surgical or Invasive Procedure: N/A History of Present Illness: ___ is a ___ year-old female with history of diverticulitis and migraine who presents with retro-orbital headache and was found to have a right superior ophthalmic vein thrombosis. She initially presented to ___ on ___ with incoherent speech and left frontal headache. Reportedly, her symptoms resolved in about 5 minutes. She had a CT scan that was unremarkable and was scheduled to get an outpatient MRI of the brain outpatient, and this was also largely unrevealing. She presented again to ___ on ___ with vague complaints after spending some time in a hot house with no air conditioning. She said that "I just feel sick". She had a repeat noncontrast CT had, which showed enlargement of the right superior ophthalmic vein. CTA was obtained, which confirmed this abnormality. She was then transferred to ___ for additional management. Patient is a very poor historian; however, she states that she has been having headaches for at least 3 to 7 days. She is unsure if initially her headache was more consistent with her previous migraines. However, she now believes her headaches are different. She initially had right retro-orbital throbbing pain that was slightly worse with eye movement. She is now started to have pain behind the left eye as well. She denies auras. She is unsure about photophobia or phonophobia. She denies visual loss and photopsia, but she does note intermittent floaters. On neurologic ROS, the pt denies headache, loss of vision, blurred vision, diplopia, dysarthria, dysphagia, lightheadedness, vertigo, tinnitus or hearing difficulty. Denies difficulties producing or comprehending speech. Denies focal weakness, numbness, parasthesiae. No bowel or bladder incontinence or retention. Denies difficulty with gait. On general review of systems, the pt denies recent fever or chills. No night sweats or recent weight loss or gain. Denies cough, shortness of breath. Denies chest pain or tightness, palpitations. Denies nausea, vomiting, diarrhea, constipation or abdominal pain. No recent change in bowel or bladder habits. No dysuria. Denies arthralgias or myalgias. Denies rash. Past Medical History: AWB DONATION Social History: ___ Family History: No pertinent family history of neurological disorders. Physical Exam: ADMISSION EXAM: =============== Vitals: Stable General: Awake, cooperative, NAD. HEENT: Right conjunctive injected with left nasal inferior portion of conjunctive a suffused with a small amount hemorrhage. Neck: Supple, no nuchal rigidity Pulmonary: Non-labored breathing on ambient air Cardiac: RRR, no MRG. Abdomen: Soft, NT/ND, no masses or organomegaly noted. Extremities: Warm, well-perfused, no cyanosis, clubbing or edema bilaterally Skin: no rashes or lesions noted. NEUROLOGIC: ----------- -Mental Status: Appears alert, but subjectively drowsy. Language is fluent without errors. Patient has difficulty recounting her medical history. She forgets many details and does not give a linear account she has no difficulty with months of the year backwards. Is right eye ___ -Cranial Nerves: I: Olfaction not tested. II: OD 3 to 2 mm; ___. OS 4 to 3 mm ___. VFF to confrontation with finger counting. Fundoscopic exam performed, revealed crisp disc margins with no papilledema, exudates, or hemorrhages. III, IV, VI: Full range, conjugate gaze, no nystagmus. Normal saccades. V: Facial sensation intact to light touch. VII: No facial droop, facial musculature symmetric. VIII: Hearing intact to finger-rub bilaterally. IX, X: Palate elevates symmetrically. XI: ___ strength in trapezii and SCM bilaterally. XII: Tongue protrudes in midline. -Motor: Normal bulk, tone throughout. No pronator drift bilaterally. No adventitious movements, such as tremor, noted. No asterixis noted. Delt Bic Tri WrE FFl FE IO IP Quad Ham TA ___ L 5 ___ 5 ___ 5 5 5 5 5 R 5 ___ 5 ___ 5 5 5 5 5 -Sensory: No deficits to light touch, pinprick, cold sensation, proprioception throughout. No extinction to DSS. -Reflexes: Bi Tri ___ Pat Ach L 2 2 2 2 1 R 2 2 2 2 1 Plantar response was flexor bilaterally. -Coordination: No intention tremor, no dysdiadochokinesia noted. No dysmetria on FNF or HKS bilaterally. -Gait: Good initiation. Narrow-based, normal stride and arm swing. Able to walk in tandem without difficulty. Romberg absent. DISCHARGE EXAM: =============== General: Awake, lying comfortably in bed. NAD HEENT: No conjunctival injection Pulmonary: Non-labored breathing on ambient air Cardiac: Warm and well-perfused Neurologic: -Mental Status: Alert and oriented to self, location, and date. Attentive to interview. Language is fluent without paraphrasic errors. -Cranial Nerves: II, III, IV, VI: PERRL, 3 --> 2mm. VFF, EOMI with no nystagmus. Bilateral acuity ___ that corrects to ___ with pinhole. V: Facial sensation intact to light touch. VII: No facial droop, facial musculature symmetric. VIII: Hearing intact to finger-rub bilaterally. IX, X: Palate elevates symmetrically. XI: ___ strength in trapezii bilaterally. XII: Tongue protrudes in midline. -Motor: Normal bulk, tone throughout. No pronator drift bilaterally. -Sensory: No deficits to light touch throughout. No extinction to DSS. -Reflexes: Deferred -Coordination: Deferred -Gait: Deferred Pertinent Results: ADMISSION LABS: ___ 04:20AM BLOOD WBC-6.6 RBC-4.31 Hgb-11.8 Hct-37.4 MCV-87 MCH-27.4 MCHC-31.6* RDW-15.1 RDWSD-48.0* Plt ___ ___ 04:20AM BLOOD Neuts-63.1 ___ Monos-14.7* Eos-1.5 Baso-0.3 Im ___ AbsNeut-4.16 AbsLymp-1.33 AbsMono-0.97* AbsEos-0.10 AbsBaso-0.02 ___ 04:20AM BLOOD Plt ___ ___ 06:40AM BLOOD ___ PTT-27.3 ___ ___ 04:20AM BLOOD Glucose-94 UreaN-17 Creat-1.1 Na-142 K-4.4 Cl-108 HCO3-21* AnGap-13 HYPERCOAG LAB WORKUP: ___ 02:25PM BLOOD Lupus-NOTDETECTE dRVVT-S-0.96 SCT-S-0.74 ___ 02:25PM BLOOD ProtCFn-PND ProtSFn-PND ___ 04:20AM BLOOD ___ CRP-3.5 ___ 04:43PM BLOOD SED RATE-Test ___ 02:25PM BLOOD BETA-2-GLYCOPROTEIN 1 ANTIBODIES (IGA, IGM, IGG)-PND ___ 02:25PM BLOOD CARDIOLIPIN ANTIBODIES (IGG, IGM)-PND ___ 02:25PM BLOOD ANTITHROMBIN ANTIGEN-PND DISCHARGE LABS: ___ 05:10AM BLOOD WBC-5.9 RBC-4.21 Hgb-11.5 Hct-36.1 MCV-86 MCH-27.3 MCHC-31.9* RDW-15.0 RDWSD-46.8* Plt ___ ___ 05:10AM BLOOD Plt ___ ___ 05:10AM BLOOD ___ PTT-62.1* ___ ___ 05:10AM BLOOD Glucose-129* UreaN-19 Creat-1.0 Na-145 K-4.4 Cl-107 HCO3-23 AnGap-15 ___ 05:10AM BLOOD Calcium-9.1 Phos-4.2 Mg-2.1 MR HEAD W&W/O: 1. Dilated right superior ophthalmic vein with a large filling defect compatible with thrombosis. 2. Diminished enhancement of the right cavernous sinus lateral to the cavernous portions of the internal carotid arteries with a questionable filling defect lateral and superior to the right ICA, possibly representing extension of thrombosis into the right cavernous sinus. 3. Questionable central filling defect in the left superior ophthalmic vein. Small thrombus is not excluded. 4. Paranasal sinus disease as detailed above. CT A/P: 1. No specific evidence of malignancy in the abdomen or pelvis. 2. Few scattered high subcentimeter hypodense lesions in the liver are too small to characterize, but statistically likely represent cysts or biliary hamartomas. 3. Please refer to the separate report of CT chest performed on the same day for description of the thoracic findings. CT CHEST: 1. Multiple pulmonary nodules measuring up to 5 mm, are indeterminate. 2. No evidence of intrathoracic lymphadenopathy. 3. Multinodular thyroid gland with the largest thyroid nodule measuring up to 1.6 cm. RECOMMENDATION(S): A follow-up chest CT in 3 months is recommended. Thyroid nodule. Follow up recommended. Absent suspicious imaging features, unless there is additional clinical concern, ___ College of Radiology guidelines do not recommend further evaluation for incidental thyroid nodules less than 1.0 cm in patients under age ___ or less than 1.5 cm in patients age ___ or ___. Brief Hospital Course: TRANSITIONAL ISSUES ======= [] Requires follow-up for hypercoagulable labs. See pending above. Also will need prothrombin gene mutation, Factor V Leiden and homocysteine. [] Requires ongoing follow-up for INR monitoring and warfarin dosing. Goal INR ___. [] Requires follow-up chest-CT in 3 months due to multiple pulmonary nodules up to 5mm and a multinodular thyroid gland with a thyroid nodule. SUMMARY ======= Ms. ___ is an ___ woman with history of migraine and diverticulitis who presented with a progressively worsening retro-orbital headache and was found to have a right superior ophthalmic vein thrombosis. #Superior ophthalmic vein thrombosis Ms. ___ presented with a right retro-orbital headache and right eye pain worsened by extra-ocular eye movements. She was found to have a right superior ophthalmic vein thrombosis on CTA and MRI. Initial neurological exam was notable for anisocoria with intact pupillary light reflex, and right conjunctival injection with small amount of hemorrhage. CT-CHEST and CT-ABDOMEN showed no evidence of malignancy. Hypercoagulability labs (APLS, antithrombin antigen) are still pending. Improvement was noted after initiation of heparin. She was discharged with a lovenox bridge to warfarin, with goal INR ___. She had no headache on discharge. Exam was notable for pupils 3->2, full eye movements, full gross fields to digits and visual acuity: ___ ___ -> ___ with correction. Optho follow-up scheduled for 2 days within discharge. Anticoagulation and follow-up arranged with her PCP ___. Medications on Admission: The Preadmission Medication list is accurate and complete. 1. ALPRAZolam 0.25-0.5 mg PO QHS:PRN insomnia 2. Atorvastatin 10 mg PO QPM 3. Betamethasone Dipro 0.05% Cream 1 Appl TP DAILY 4. Celecoxib 200 mg oral BID:PRN knee pain 5. Levothyroxine Sodium 75 mcg PO DAILY 6. Omeprazole 20 mg PO DAILY 7. Chlorpheniramine Maleate 8 mg PO BID Discharge Medications: 1. Enoxaparin Sodium 60 mg SC BID Start: ___, First Dose: Next Routine Administration Time RX *enoxaparin 80 mg/0.8 mL 0.7 mL subcutaneous once a day Disp #*14 Syringe Refills:*0 RX *enoxaparin 60 mg/0.6 mL 0.6 mL subcutaneous twice a day Disp #*14 Syringe Refills:*0 2. Warfarin 5 mg PO DAILY16 RX *warfarin 5 mg 1 tablet(s) by mouth once a day Disp #*14 Tablet Refills:*0 3. Atorvastatin 10 mg PO QPM 4. Omeprazole 20 mg PO DAILY 5. ALPRAZolam 0.25-0.5 mg PO QHS:PRN insomnia 6. Betamethasone Dipro 0.05% Cream 1 Appl TP DAILY 7. Celecoxib 200 mg oral BID:PRN knee pain 8. Chlorpheniramine Maleate 8 mg PO BID 9. Levothyroxine Sodium 75 mcg PO DAILY 10.Outpatient Lab Work INR ICD-10: ___ ___, MD: FAX ___ 11.Outpatient Lab Work Homocysteine, Factor V Leiden, Prothrombin Gene Mutation ICD-10: ___.___ ___, MD: FAX ___ Discharge Disposition: Home With Service Facility: ___ ___ Address: ___ischarge Diagnosis: Superior ophthalmic vein thrombosis Discharge Condition: Mental Status: Clear and coherent. Level of Consciousness: Alert and interactive. Activity Status: Ambulatory - Independent. Discharge Instructions: Dear Ms. ___, You were hospitalized due to symptoms of right-sided headache and eye pain resulting from a SUPERIOR OPHTHALMIC VEIN THROMBOSIS, a condition where a blood vessel behind your eye was blocked by a clot. Thrombosis can have many different causes, so we assessed you for medical conditions that may raise your risk of having a clot. In order to prevent future clots, we plan to modify those risk factors by giving you a blood-thinner called warfarin (Coumadin). We are changing your medications as follows: - START Warfarin (Coumadin) 5mg daily (for blood thinning) - START Enoxaparin (Lovenox) 70mg daily (for blood thinning) until your INR blood test is at the correct level. Please take your other medications as prescribed. Please follow up with Neurology and your primary care physician as listed below. You need to have your INR checked (blood test) tomorrow, ___. Please come to the ___ lab (or a lab of your choice) to have your blood checked. The result will be faxed to Dr. ___ ___ will advise you regarding warfarin dosing. If you experience any of the symptoms below, please seek emergency medical attention by calling Emergency Medical Services (dialing 911). In particular, since stroke can recur, please pay attention to the sudden onset and persistence of these symptoms: - Sudden partial or complete loss of vision - Sudden loss of the ability to speak words from your mouth - Sudden loss of the ability to understand others speaking to you - Sudden weakness of one side of the body - Sudden drooping of one side of the face - Sudden loss of sensation of one side of the body Sincerely, Your ___ Neurology Team Followup Instructions: ___
19718654-DS-9
19,718,654
24,146,921
DS
9
2188-01-24 00:00:00
2188-01-24 15:01:00
Name: ___ Unit No: ___ Admission Date: ___ Discharge Date: ___ Date of Birth: ___ Sex: M Service: MEDICINE Allergies: No Known Allergies / Adverse Drug Reactions Attending: ___. Chief Complaint: Shortness of breath. Major Surgical or Invasive Procedure: 1. T5, T6, T7 posterior laminectomy, medial facetectomy, and foraminotomy for intraspinal extradural lesion. 2. Biopsy, intraspinal extradural lesion, T6. 3. Open treatment, fracture-dislocation T5-6 and T6-7. 4. Posterior instrumentation, T4-T9. 5. Posterior arthrodesis, T4-T9. 6. Application of allograft and autograft. 7. Spinal cord monitoring. History of Present Illness: Mr ___ is a ___ year-old gentleman with severe back pain since yesterday. He was seen by PCP who took an X-Ray of his thoracic spine which demonstrated a T6 compression fracture. He was given pain medication for conservative management but had a sudden onset of leg weakness while navigating stairs at home. He fell and was subsequently sent to ___ with new onset of lower extremity weakness and paresthesias in both of his lower extremities and retention of urine. He was transferred to ___ for urgent Orthopaedic Surgery evaluation due to concern for cauda equina syndrome. Past Medical History: 1. Severe COPD on 3L of home oxygen and steroid dependent followed by Dr. ___. 2. Recurrent aspiration pneumonia in the setting of GERD and poor diet compliance. 3. Diastolic congestive heart failure with an ejection fraction of 65%, 3+ tricuspid regurgitation, elevated pulmonary artery pressures on his echo from ___. Dry weight approximately 213lb 4. Hypertension. 5. Hyperlipidemia. 6. A complex psychiatric history that includes insomnia from coughing on high doses of trazodone and sertraline. 7. Neuropathy on gabapentin. 8. GERD. Most recent workup for aspiration was done ___ where a modified barium swallow was overall unremarkable. 9. History of paroxysmal atrial fibrillation, but was never confirmed on EKG or telemetry. 11. Hyperglycemia while on steroids. 12. Lumbar decompression and fusion in ___ Social History: ___ Family History: not obtained Physical Exam: Physical Exam on Presentation: AVSS Gen: WD/WN, comfortable, NAD. HEENT: Pupils: normal EOMs Neck: Supple. Lungs: CTA bilaterally. Cardiac: RRR. S1/S2. Abd: Soft, NT, BS+ Extrem: Warm and well-perfused. Neuro: Mental status: Awake and alert, cooperative with exam, normal affect. Orientation: Oriented to person, place, and date. Motor: D B T WE WF IP Q H AT ___ G R ___ 4 4 L ___ 3 3 Sensation: Decreased Sensation in entire left lower extremity with nospecific distribution. Decreased senstation on lasteral aspect of thigh on right lower extremity. Decreased perianal sensation. Reflexes: B T Br Pa Ac Right absent Left absent Propioception diminished Toes mute billaterally Rectal exam decreased sphincter control Physical Exam on Discharge: VS: T98.2, HR101, BP126/77, RR20, O2sat 95% 3LNC Lungs: Coarse breath sounds and wheeze intermittantly throughout lung fields Heart: Irregular Rhythm, no M/R/G Neuro: strength ___ bilateral lower extremities, proximally and distally, sensation to light touch intact Exam otherwise unchanged from admission. Pertinent Results: Lab Results on Presentation: ___ 09:24AM BLOOD WBC-5.4 RBC-3.82* Hgb-10.4* Hct-34.4* MCV-90 MCH-27.2 MCHC-30.1* RDW-15.8* Plt ___ ___ 09:24AM BLOOD Neuts-79.5* Lymphs-13.3* Monos-5.8 Eos-0.6 Baso-0.8 ___ 12:18PM BLOOD ___ PTT-24.4* ___ ___ 09:24AM BLOOD Glucose-115* UreaN-28* Creat-0.9 Na-144 K-4.1 Cl-103 HCO3-34* AnGap-11 ___ 05:10AM BLOOD Calcium-7.9* Phos-2.8 Mg-1.9 ___ 08:40PM BLOOD Type-ART pO2-348* pCO2-48* pH-7.45 calTCO2-34* Base XS-8 Intubat-INTUBATED Vent-CONTROLLED ___ 08:40PM BLOOD Glucose-76 Lactate-1.0 Na-141 K-3.9 Cl-102 ___ 08:40PM BLOOD Hgb-10.3* calcHCT-31 O2 Sat-98 ___ 08:40PM BLOOD freeCa-1.13 ___ 09:24AM URINE Color-Yellow Appear-Clear Sp ___ ___ 09:24AM URINE Blood-NEG Nitrite-NEG Protein-30 Glucose-NEG Ketone-NEG Bilirub-NEG Urobiln-NEG pH-6.0 Leuks-NEG ___ 09:24AM URINE RBC-0 WBC-0 Bacteri-NONE Yeast-NONE Epi-<1 Pathology: Date of Procedure: ___ ___ #: ___ Date Specimen(s) Received: Patient Location: OR ___ ___ Date Reported: ___ Ordering Provider: ___, ___ Responsible Provider: ___ ___, ___ Assigned Pathologist: ___ ___, ___ SURGICAL PATHOLOGY REPORT - Final PATHOLOGIC DIAGNOSIS: Epidural tissue, T6, removal (A): Adipose tissue and dense connective tissue; bone fragments. Imaging: Radiology Report MR ___ SPINE W/O CONTRAST Study Date of ___ 7:14 AM Radiology Report MR THORACIC SPINE W/O CONTRAST Study Date of ___ 7:14 AM IMPRESSION: 1. No cord signal abnormality throughout. 2. Acute T6 compression deformity with mild retropulsion deforming the underlying cord. Contact is increased greater than expected by mild retropulsion due to anterior displacement of cord by multilevel epidural lipomatosis which is focally pronounced. Focality of fat at this level is unusual, and cannot rule out a small fatty herniation into the thecal sac or possibly a small epidural hematoma. 3. T8 compression deformity, age indeterminate, but likely remote with mild retropulsion. again, though milder, focal epidural fat pushes the cord anteriorly increasing the degree of contact 4. L3-L5 posterior fusion w/ laminectomy with fluid signal in L4 disc suggesting discetomy. edema w/in surgical bed suggests surgery was recent. 5. multilevel degenerative change as detailed above Radiology Report CT T-SPINE W/O CONTRAST Study Date of ___ 2:00 ___ FINDINGS: 1. Mild compression fracture of the T6 vertebral body with minimal retropulsion and central canal narrowing, new from ___, but likely present on ___ radiographs suggesting that this is subacute. 2. Mild to moderate compression deformities of T5 and T8, unchanged from ___. 3. Severe emphysema and pulmonary arterial hypertension. Radiology Report CT L-SPINE W/O CONTRAST Study Date of ___ 2:01 ___ IMPRESSION: Status post posterior fusion from L3 to L5. No evidence of acute fracture, subluxation, or hardware complications. Paraspinal soft tissue edema at L4 level, as seen on the MRI from today. Radiology Report MR CERVICAL SPINE W/O CONTRAST Study Date of ___ 3:13 ___ IMPRESSION: 1. No evidence of cord compression or abnormal cord signal. 2. Multilevel degenerative changes of the cervical spine with disc bulges, neural foraminal narrowing, and ligamentum flavum thickening as described above. Radiology Report LUMBAR SP,SINGLE FILM IN O.R. Study Date of ___ 8:03 ___ REPORT: Multiple images were obtained without radiologist present. These show an existing posterior fusion at L3 through L5. There is a compression fracture at approximately T8 through which some spinal markings and posterior transpedicular screws are placed and ultimately multilevel mid thoracic posterior transpedicular screws have been placed, probably in anticipation of laminectomy, although it is uncertain whether this has been performed. For further details, please refer to the operative note. Radiology Report CHEST (PORTABLE AP) Study Date of ___ 1:19 AM IMPRESSION: AP chest compared to ___: In the interim, patient has had spinal stabilization. New intended left internal jugular line passes behind the left clavicle and surgical device, out of view. Tip probably does not enter the transverse portion of the left brachiocephalic vein. ET tube is in standard placement ending at the thoracic inlet. Lung volumes are very low, but left lung appears clear aside from mild basilar atelectasis. On the right, atelectasis is much more severe and there is probably lower lobe collapse, perhaps middle lobe collapse as well, and if they are accompanied by small right pleural effusion that would be unremarkable. There is no pneumothorax. Heart size is indeterminate but not substantially enlarged. Radiology Report CHEST (PORTABLE AP) Study Date of ___ 5:17 AM FINDINGS: Comparison is made to prior study from ___. Spinal hardware is seen in the thoracic spine. There is improved aeration of the right middle lobe. There remains some atelectasis at the lung bases. There is unchanged cardiomegaly. No focal consolidation or pleural effusions are seen. Radiology Report CTA CHEST W&W/O C&RECONS, NON-CORONARY Study Date of ___ 2:29 ___ IMPRESSION: 1. No acute pulmonary embolus seen. 2. Dilated pulmonary arteries consistent with pulmonary arterial hypertension, unchanged compared to the prior study. 3. Right lower lobe consolidation concerning for pneumonia, potentially aspiration pneumonia in the appropriate clinical circumstances. ECG: Cardiovascular Report ECG Study Date of ___ 4:24:58 ___ Baseline artifact. Probable sinus tachycardia with premature atrial contractions. Compared to the previous tracing of ___ ectopy is new. TRACING #1 Cardiovascular Report ECG Study Date of ___ 10:35:06 AM Sinus tachycardia. Arm lead reversal. Occasional premature atrial contractions. Compared to the previous tracing no clear change. TRACING #2 Lab Results on Discharge: ___ 09:08AM BLOOD WBC-9.1 RBC-3.37* Hgb-9.3* Hct-30.4* MCV-90 MCH-27.7 MCHC-30.8* RDW-15.5 Plt ___ ___ 05:00AM BLOOD Glucose-147* UreaN-25* Creat-0.6 Na-144 K-4.4 Cl-104 HCO3-34* AnGap-10 ___ 06:51PM BLOOD cTropnT-<0.01 ___ 11:37AM BLOOD CK-MB-2 cTropnT-<0.01 ___ 05:00AM BLOOD Calcium-8.4 Phos-2.9 Mg-2.3 ___ 08:14AM BLOOD Type-ART Temp-37.1 pO2-95 pCO2-51* pH-7.45 calTCO2-37* Base XS-9 Intubat-NOT INTUBA ___ 08:14AM BLOOD Lactate-1.2 ___ 10:22PM BLOOD Hgb-8.7* calcHCT-26 ___ 04:33PM BLOOD freeCa-1.05* Brief Hospital Course: PRIMARY REASON FOR HOSPITALIZATION: Mr. ___ is a ___ male with PMH of COPD on home O2, chronic prednisone, and azithromycin, dCHF, recurrent aspiration pneumonias, and COPD on nightly Bipap who is ___ s/p T4-T9 decompression and fusion for acute T6 compression fracture with significant neurologic compromise. He initially had a prolonged PACU stay for post-op respiratory decompensation and was transferred to medicine for ongoing managment of COPD in the post-op setting once stable. On the medicine service, he was given a pulse dose of steroids and returned to his home COPD regiment. He clinically improved and was transferred to rehab to complete recovery. ACUTE CARE #T6 acute Compression Fracture: Mr. ___ experienced a day of severe low back pain and his PCP discovered ___ T6 compression fracture on CXR without neurologic compromise. He later developed onset of lower extremity weakness and paresthesias in both of his lower extremities and retention of urine. He presented to the ED. Spine MRI revealed no abnormal spinal cord signal, but did show slight retropulsion of the vertebrae coupled with epidural lipomatosis, causing deformity of the cord. He was taken for urgent decompression procedure. Following the procedure, he was fitted for a TLSO brace and evaluated by ___. He was able to stand with heavy assistance and tolerates the TLSO brace out of bed. His wound was followed daily by the orthopedic service. He was able to void on his own. He was discharged to rehab to complete his recovery. He needs to wear the TLOS brace at all times when out of bed until further instructed by the spine surgeons. #Pneumonia: Found on CT ___. Was intubated for procedure and has been hospitalized. ___ be consistent with aspiration. He was given a day of vancomycin and cefepime and transitioned to levofloxacin with continued improvement. He will complete a 7-day treatment course on discharge. #Tachycardia: Irregular rhythm is noted on tele and ECG to be from multiple atrial foci and organized, not afib. This is consistent with increased albuterol use. He is noted to be more tachycardic sitting upright and when anxious or straining. There is likely a component of deconditioning as well. Theophylline was initially held for concern of toxicity, but tachycardia remained. The patient was assymptomatic and felt well. He was discharged to rehab back on theophylline with plan to check a level in 3 days and adjust as needed. #Chest Discomfort: Mr. ___ experienced bilateral chest discomfort that was worse with inspiration during the admission. On initial evaluation troponin was negativex2, there were no ECG changes, and CTA was negative for PE but did show RLE pneumonia. Pain is felt likely chest wall/musculoskeletal given recent respiratory distress and immobilization. Would advise reconsidering CAD if the pain recurs in a different fashion or with other signs and symptoms of cardiac ischemia such as diaphoresis, nausea, radiation. #COPD on home O2: Mr. ___ had intermittent respiratory distress initially requiring standing nebulizer therapy. He had lung collapse following surgery and had disruption in his home medication regiment in hospitalization. The lung re-expanded but was found to have pneumonia (see above). He received a 3-day pulse of increased steroids. He was transitioned back to his home COPD medications and supplemental oxygen with goal oxygen saturations 88-92%. His breathing improved and he was brought back to his home dose of steorids. Theophylling was initially held, then restarted on discharge (see above). CHRONIC CARE: #Chronic Diastolic CHF: At dry weight 200lb confirmed from PCP ___. Continued home furosemide. #OSA: Continued nightly BIPAP, home settings #Hypertension Stable, continued amlodipine. #GERD: Transitioned to PRN famotidine. ___ consider restarting PPI as outpatient as needed. #Neuropathy: Continued gabapentin TRANSITIONS IN CARE: # CODE STATUS: Presumed Full # He will require followup with Orho-spine and with PCP ___ was held for a few days and restarted on discharge. Level should be checked in 3 days time as outlined on Page1. Medications on Admission: The Preadmission Medication list is accurate and complete. 1. Tiotropium Bromide 1 CAP IH DAILY 2. Furosemide 40 mg PO DAILY 3. Amlodipine 10 mg PO DAILY 4. TraZODone 350 mg PO HS 5. ClonazePAM 0.5 mg PO QHS 6. Symbicort (budesonide-formoterol) 160-4.5 mcg/actuation inhalation 2 puffs BID 7. Sertraline 50 mg PO BID 8. Sertraline 50 mg PO QAM 9. Potassium Chloride 10 mEq PO 3X/WEEK (___) 10. PredniSONE 15 mg PO DAILY 11. Gabapentin 300 mg PO TID 12. Azithromycin 250 mg PO DAILY 13. Albuterol 0.083% Neb Soln 1 NEB IH Q4H:PRN shortness of breath, wheeze 14. budesonide 0.25 mg/2 mL inhalation BID 15. Theophylline SR 100 mg PO BID Discharge Medications: 1. Albuterol 0.083% Neb Soln 1 NEB IH Q4H:PRN shortness of breath, wheeze 2. Amlodipine 10 mg PO DAILY 3. Azithromycin 250 mg PO DAILY 4. ClonazePAM 0.5 mg PO QHS RX *clonazepam 0.5 mg 1 tablet(s) by mouth at bedtime Disp #*4 Tablet Refills:*0 5. Furosemide 40 mg PO DAILY 6. Gabapentin 300 mg PO TID 7. PredniSONE 15 mg PO DAILY 8. Sertraline 50 mg PO BID see other sertaline order. Total morning dose=100mg 9. Sertraline 50 mg PO QAM see other sertaline order. Total morning dose=100mg 10. Symbicort (budesonide-formoterol) 160-4.5 mcg/actuation INHALATION 2 PUFFS BID 11. Tiotropium Bromide 1 CAP IH DAILY 12. TraZODone 350 mg PO HS 13. Acetaminophen 1000 mg PO Q8H 14. Docusate Sodium 100 mg PO BID 15. Heparin 5000 UNIT SC TID 16. Levofloxacin 750 mg PO DAILY Duration: 3 Days 17. Milk of Magnesia 30 mL PO Q6H:PRN constipation 18. OxycoDONE (Immediate Release) ___ mg PO Q4H:PRN pain RX *oxycodone 5 mg ___ tablet(s) by mouth Q4H:PRN Disp #*20 Tablet Refills:*0 19. Budesonide 0.25 mg/2 mL INHALATION BID 20. Potassium Chloride 10 mEq PO 3X/WEEK (___) 21. Senna 1 TAB PO QHS 22. Theophylline SR 100 mg PO BID measure theophylline level on ___ and may need to adjust. 23. Insulin SC Sliding Scale Fingerstick Q6H Insulin SC Sliding Scale using HUM Insulin 24. Famotidine 20 mg PO Q12H:PRN acid reflux Discharge Disposition: Extended Care Facility: ___ ___ Diagnosis: Primary: T6 Vertebral Body Fracture, Epidural Lipomatosis Secondary: Exacerbatiobn of Chronic Obstructive Pulmonary Disease Discharge Condition: Mental Status: Clear and coherent. Level of Consciousness: Alert and interactive. Activity Status: Out of Bed with assistance to chair or wheelchair. Discharge Instructions: Dear Mr. ___, You were admitted to the hospital following a vertbral body fracture that was affecting your nerves. You had surgery to repair this fracture and decompress the nerves and the surgery was successful. You also experienced an exacerbation of your COPD following surgery, along with pneumonia. While in the hospital we treated your COPD exacerbation and pneumonia, and your lung function improved. You are being discharged to a rehab hospital to complete your recovery. Please adhere to the recommended medications, and please keep all discharge appointments. It was a pleasure taking part in your care. Followup Instructions: ___
19718930-DS-5
19,718,930
24,882,516
DS
5
2115-01-30 00:00:00
2115-01-30 19:20:00
Name: ___ Unit No: ___ Admission Date: ___ Discharge Date: ___ Date of Birth: ___ Sex: F Service: NEUROLOGY Allergies: No Known Allergies / Adverse Drug Reactions Attending: ___. Chief Complaint: Weakness, aphasia Major Surgical or Invasive Procedure: Thrombectomy History of Present Illness: ___ is a ___ year old woman with a past medical history of hypertension, HFpEF, recent lung cancer diagnosis (unknown details, no biopsy) with multiple subsequent thrombotic events including R MCA distribution infarct on ___ while on apixaban, NSTEMI ___, with recent hospitalization for CHF exacerbation complicated by thrombocytopenia with platelets of 28 for which apixiban was held on ___ patient transferred to ___ for L MCA syndrome with L ICA occlusion with LKW 5AM ___ for thrombectomy. ___ was hospitalized at ___ for a CHF exacerbation on ___, detailed below. On ___, patient was seen normal at 5 am (per report her baseline is left arm weakness ___, right arm and bilateral legs full strength per recent OT note). At 6:30 AM she was seen to have new right arm plegia, aphasia, and left gaze deviation. CT/CTA revealed a left distal internal carotid occlusion. Patient was transferred to ___ for thrombectomy. Patient arrived at 11:54 AM, CTH showed a few small areas of possible hemorrhagic transformation vs contrast extravasation in areas of encephalomalacia. CTP revealed left MCA distribution increased tmax. Patient taken for thrombectomy, unable to obtain distal reperfusion TICI I. To review patient's recent history, patient had exploratory laparotomy with rectosigmoid resection and end colostomy for diverticulitis in ___. She was discharged and subsequently developed a PE in ___, which was considered to be provoked in the post op period and started on apixiban. She was also diagnosed with lung cancer "recently" per chart review but there are no other details about this in ___ notes. Verbal report from ___ - patient was found to have a lung mass in ___ with no biopsy pursued. On repeat imaging in ___ there was mediastinal involvement of mass. On ___ she had acute onset left sided weakness and was found to have a right MCA stroke (as far as I know she was on apixiban at this time). Apixiban was held for a period of time post stroke and then restarted prior to discharge to rehab on ___. She was readmitted to ___ on ___ for hypoxia and NSTEMI, she had a cardiac cath which was negative. This hospitalization was complicated by a new onset thrombocytopenia; platelets were 180 on ___ and had dropped to 71 on ___. HIT studies were reportedly sent (except not a serotonin release assay) and she was discharged to ___. She presented to ___ on ___ with SOB, found to have T wave inversions in V3, V4 with a troponin elevation to 0.21. Cardiology was consulted, and they were concerned for takotsubo stress cardiomyopathy (attributed positive trops to recent NSTEMI). Therefore, most likely etiology was thought to be CHF exacerbation and was treated with aggressive IV diuresis. There was verbal report of repeat chest imaging that showed a PE at this time, and it was unclear if this was left over from prior PE or a new process; however there is no documentation of this imaging in records available at this time. Her platelets on presentation were 35, and trended down over the ensuing days to 25, then 21, then 28 (repeat on the ___, and ___ respectively). Tick studies and and serotonin release assay were sent. Apixiban was held on ___ because of the low platelets. She was noted to have a leukocytosis on ___ to 13 and was started on vancomycin and meropenem (though no documented fevers there was high clinical suspicion for pneumonia). Per collateral from her son, she has been losing weight recently as she has had no appetite. She went from 140 pounds to 126 pounds, and continues to lose weight. She was a former smoker, quit about 6 months ago. She has not had any coughing up blood or any blood in the stool. He denies any knowledge of cancer, however her records state that she has a history of lung cancer. Unable to obtain ROS due to clinical conditions. Past Medical History: - HTN - HLD - DVT/PE on ___ ___ - Right MCA stroke ___ - Diverticulitis with exploratory laparotomy with rectosigmoid resection and end colostomy ___ - NSTEMI, clean cardiac cath ___ - Lung cancer diagnosis, no known details Social History: ___ Family History: Unknown Physical Exam: Vitals: vitals in the field per report HR ___, BP 130s/80s, SaO2 96% RA General: Awake, thin woman, left gaze deviation, not speaking HEENT: NC/AT, no scleral icterus noted, MMM, no lesions noted in oropharynx Neck: Supple Pulmonary: Normal work of breathing Cardiac: RRR, warm, well-perfused Abdomen: soft, non-distended Extremities: 1+ ___ edema. Skin: no rashes or lesions noted. Neurologic: -Mental Status: Awake eyes open, left gaze deviation. No speech output. No commands. CN: Decreased BTT on the right. Pupils 3-->2 reactive. Left gaze deviation unable to overcome with dolls. Left facial droop. Sensorimotor: LUE drifts to bed when raised manually RUE plegic LLE withdraws to noxious in plane of bed RLE TF to noxious Pertinent Results: ___ 12:00PM BLOOD WBC-11.5* RBC-2.95* Hgb-8.2* Hct-26.5* MCV-90 MCH-27.8 MCHC-30.9* RDW-15.9* RDWSD-51.8* Plt Ct-28* ___ 12:00PM BLOOD Neuts-73.8* Lymphs-9.5* Monos-7.8 Eos-6.7 Baso-0.5 Im ___ AbsNeut-8.47* AbsLymp-1.09* AbsMono-0.89* AbsEos-0.77* AbsBaso-0.06 ___ 03:20PM BLOOD ___ PTT-29.4 ___ ___ 03:20PM BLOOD ___ ___ 03:20PM BLOOD Glucose-118* UreaN-15 Creat-0.7 Na-143 K-3.8 Cl-108 HCO3-19* AnGap-16 ___ 03:20PM BLOOD ALT-10 AST-26 LD(LDH)-960* CK(CPK)-43 AlkPhos-100 TotBili-0.9 DirBili-0.2 IndBili-0.7 ___ 03:20PM BLOOD CK-MB-2 cTropnT-0.06* ___ 12:00PM BLOOD cTropnT-0.03* ___ 03:20PM BLOOD Albumin-3.4* Calcium-8.7 Phos-3.9 Mg-2.0 Cholest-104 ___ 03:20PM BLOOD Hapto-<10* ___ 03:20PM BLOOD %HbA1c-4.8 eAG-91 ___ 03:20PM BLOOD Triglyc-188* HDL-34* CHOL/HD-3.1 LDLcalc-32 ___ 03:20PM BLOOD TSH-0.56 ___ 12:00PM BLOOD ASA-NEG Ethanol-NEG Acetmnp-NEG Tricycl-NEG ___ 12:20PM BLOOD Glucose-90 Creat-0.6 Na-142 K-2.9* Cl-113* calHCO3-20* ___ Imaging CODE STROKE 1. Acute left MCA infarction with increased mismatch volume. 2. Multiple hyperintense foci may represent hemorrhage or underlying mass and MR is recommended for further evaluation. Additionally, areas of low attenuation may suggest ischemic small vessel disease or vasogenic edema from underlying mass. Neurointervention ___ Ultrasound of the right groin demonstrates a pulsatile single-lumennon-compressible vessel over the femoral head. There is evidence of needle access into the arterial lumen. Left internal carotid artery: Reveals a complete occlusion at the left ICA terminus consistent with TICI 0. After 5 passes of stent suction catheter there is unsuccessful recanalization to TICI 1. Right common femoral artery: Arteriotomy is above the bifurcation. There is good distal runoff. There is no evidence of dissection. Vascular caliber is appropriate for closure device. IMPRESSION: Large vessel occlusion stroke with left ICA T occlusion status post unsuccessful recanalization to TICI 1. Brief Hospital Course: ___ with HTN, HpEF, recent dx lung CA, thrombocytopenia (unclear etiology), prior R MCA stroke ___ w/ residual LUE ___ weakness), and NSTEMI on ___, who presented with L MCA syndrome and found to have a L distal ICA occlusion s/p unsuccessful EVT (TICI I after 4 passes). Transitioned to CMO. Medications on Admission: The Preadmission Medication list is accurate and complete. 1. Ondansetron 4 mg PO Q6H:PRN Nausea/Vomiting - First Line 2. Meropenem 500 mg IV Q8H 3. Furosemide 40 mg IV BID 4. Cyanocobalamin 1000 mcg PO DAILY 5. Magnesium Oxide 400 mg PO BID 6. Vitamin D 400 UNIT PO DAILY 7. Ferrous Sulfate 325 mg PO DAILY 8. LORazepam 0.5 mg PO BID:PRN anxiety 9. amLODIPine 2.5 mg PO BID 10. Escitalopram Oxalate 10 mg PO DAILY 11. Lisinopril 30 mg PO DAILY 12. Metoprolol Tartrate 25 mg PO BID 13. Atorvastatin 80 mg PO QPM 14. BusPIRone 5 mg PO BID Discharge Medications: 1. Acetaminophen IV 1000 mg IV Q6H:PRN Pain - Mild 2. Glycopyrrolate 0.1-0.2 mg IV Q4H:PRN excess secretions 3. LORazepam 2 mg IV Q4H 4. LORazepam 2 mg IV Q2H:PRN anxiety, seizures 5. Morphine Sulfate ___ mg IV Q15MIN:PRN moderate-severe pain or respiratory distress 6. Sodium Chloride 0.9% Flush ___ mL IV Q8H and PRN, line flush Discharge Disposition: Extended Care Facility: ___ Discharge Diagnosis: Acute ischemic stroke Discharge Condition: Mental Status: Confused - always. Level of Consciousness: Lethargic and not arousable. Activity Status: Bedbound. Discharge Instructions: Dear Ms. ___ and family, You were admitted after you developed sudden weakness and problems with speech. You were found to have a large stroke. We attempted to remove the clot from your brain, but unfortunately, this was not successful. After discussion with your family, we decided to focus on making you as comfortable as possible. You were transitioned to hospice care. It was a pleasure taking care of you, Your ___ care team Followup Instructions: ___
19718991-DS-24
19,718,991
20,492,199
DS
24
2135-03-02 00:00:00
2135-03-31 10:30:00
Name: ___ Unit No: ___ Admission Date: ___ Discharge Date: ___ Date of Birth: ___ Sex: M Service: SURGERY Allergies: Penicillins Attending: ___ Chief Complaint: ___ Major Surgical or Invasive Procedure: none History of Present Illness: ___ s/p high speed head-on MVC vs ___ barrier, GCS 15 but confused, found to have sm IPH, L 3rd rib fx, L shoulder AC separation; INR 2.4. incidentally found R pharyngeal mass. Past Medical History: VASCULAR HISTORY: Lower Extremity Bypass Graft: Aortobifem. Hypertension, dyslipidemia, coronary artery disease, s/p MI, h/o SBO s/p LOA PAST SURGICAL HISTORY: PSH: Aortobifemoral bypass ___, exlap, LOA ___, ORIF/internal fixation of L wrist fx, s/p PCA to RCA in ___ and LCx in ___, LAD stent (DES) ___ Social History: ___ Family History: Mother - ___. Father - DM2, CAD, MI in his ___, died from cardiac arrest. Physical Exam: PE on discharge AVSS RRR CTA b/l s/nt/nd Pertinent Results: ___ 02:24AM BLOOD WBC-6.9# RBC-4.83 Hgb-14.2 Hct-42.5 MCV-88 MCH-29.3 MCHC-33.4 RDW-14.5 Plt ___ ___ 07:52AM BLOOD WBC-18.5* RBC-4.78 Hgb-14.2 Hct-42.4 MCV-89 MCH-29.6 MCHC-33.4 RDW-14.8 Plt ___ ___ 02:34AM BLOOD WBC-12.9* RBC-5.14 Hgb-15.2 Hct-45.6 MCV-89 MCH-29.7 MCHC-33.4 RDW-14.6 Plt ___ ___ 02:24AM BLOOD ___ ___ 07:52AM BLOOD ___ PTT-31.2 ___ ___ 02:34AM BLOOD ___ PTT-34.2 ___ ___ 07:52AM BLOOD Glucose-126* UreaN-17 Creat-1.1 Na-136 K-4.1 Cl-101 HCO3-25 AnGap-14 CTH: Small focus of parafalcine hemorrhage with probable intraparenchymal/subarachnoid extension seen in the left vertex, in a paramedian location in the left frontal lobe. A small focus of hypodensity in the left corona radiata is compatible with infarct. CT-C-spine: No evidence of fracture or malalignment. Moderate degenerative changes of the cervical spine, as described above. Asymmetry of the pharyngeal tonsillar tissue with an enlarged right tonsil. No cervical lymphadenopathy. CT torso: Minimally displaced fracture of the lateral aspect of the left third rib. No other fracture is identified. No evidence of mediastinal or pulmonary injury. No evidence of laceration of the abdominal solid organs or intestinal injury. Large thyroid nodule in the lower aspect of the thyroid gland has heterogeneous enhancement and should be further assessed with ultrasound. Other hypodense nodules within the gland can be assessed at that time. Dependent bilateral pulmonary consolidation may represent atelectasis although aspiration cannot be excluded. Complete occlusion of the right subclavian-femoral bypass graft and left aorto-femoral bypass graft. Patent left subclavian-femoral bypass graft and right aorto-femoral bypass graft. Upper lobe predominant emphysema, coronary artery calcifications, and atherosclerotic disease of the aorta are chronic condition. X-ray shoulder: No evidence of fracture. Findings compatible with a mild likely type 2 AC joint separation. Repeat head CT: No change in the tiny left parieto-occipital subarachnoid and left parafalcine subdural hemorrhage, compared to the study of 10 hours earlier. Significant bifrontal cortical atrophy, greater than expected for patient's age. Brief Hospital Course: Patient was admitted to ___ because of his small IPH and his rib fractures. By the morning of his admission he was sitting up in a chair and oriented x3. He was brought down for repeat head CT scan that showed no interval increase. This was done because he was on coumadin. On day of discharge he was tolerating a regular diet, ambulating without assistance and safe for discharge home. Medications on Admission: Coumadin Discharge Medications: 1. Acetaminophen 650 mg PO Q6H RX *acetaminophen 650 mg 1 tablet extended release(s) by mouth every six (6) hours Disp #*40 Tablet Refills:*0 2. Docusate Sodium 100 mg PO BID RX *docusate sodium 100 mg 1 tablet(s) by mouth twice a day Disp #*60 Capsule Refills:*0 3. OxycoDONE (Immediate Release) ___ mg PO Q4H:PRN pain RX *oxycodone 5 mg ___ tablet(s) by mouth every four (4) hours Disp #*40 Tablet Refills:*0 4. Senna 1 TAB PO BID RX *sennosides [senna] 8.6 mg 1 tablet by mouth twice a day Disp #*60 Tablet Refills:*0 Discharge Disposition: Home Discharge Diagnosis: Motor Vehicle Crash Intraparenchymal Hemorrhage Rib Fracture Discharge Condition: Mental Status: Clear and coherent. Level of Consciousness: Alert and interactive. Activity Status: Ambulatory - requires assistance or aid (walker or cane). Discharge Instructions: Mr. ___, You were admitted to the ___ department of Acute Care Surgery (___) following your car accident. You were evaluated in the Emergency Department for your numerous injuries. Your head injury was serious enough to warrant an admission to the Intensive Care Unit for observation. The neurosurgery service monitored your injury and felt it was safe for you to be transferred to the general patient floors. Once there, you worked with occupational therapy for any upper extremity weakness. Now that you aer eating a regular diet and your pain is well controlled, you can return home for the remainder of your recovery. Please pay close attention to your discharge instructions. *Diet* You may eat a regular diet. *Activity* You may resume your regulard daily activities as you can tolerate. Please be sure to follow up with occupational therapy as an outpatient if instructed to do so. If you require narcotics for pain control, avoid operating motor vehicles. *Medications* Please take all medications as prescribed. Because of a small bleed in your brain, your coumadin has been discontinued. It is very important that you make all of your follow up appointments regarding this medication as you will likely need to resume this at some point. Narcotics may cause constipation. You may take stool softeners to help alleviate this. We wish you the best of luck and are hopeful for a speedy recovery. *Warning Signs* If you experience any of the symptoms listed below, please notify your physician or go to your nearest emergency department for prompt evaluation. Followup Instructions: ___
19719384-DS-16
19,719,384
25,844,792
DS
16
2133-09-18 00:00:00
2133-09-18 16:51:00
Name: ___ Unit No: ___ Admission Date: ___ Discharge Date: ___ Date of Birth: ___ Sex: M Service: NEUROLOGY Allergies: tamsulosin Attending: ___. Chief Complaint: Difficulty with speech and remembering names. Major Surgical or Invasive Procedure: None History of Present Illness: Mr. ___ is a ___ right-handed man presenting with expressive aphasia and alexia on a background of autonomic dysfunction with labile blood pressure, paroxysmal atrial fibrillation, on Coumadin, chronic renal insufficiency (nephrectomy for renal cell). Mr. ___ was with his wife, walking in the park. He stopped to practice tennis moves, miming them like a shadow boxer. They both then walked home. This was around 4 ___. Earlier in the day he had seen his acupuncturist who had given him some powder to drink, dissolved, for his orthostatic hypotension. He took this and no other remedies at about 1 ___. It is not clear what this substance was. He arrived home and they sat down to a cup of tea. He went upstairs. Soon afterward, he called our to his wife "I'm in trouble." She asked what he meant and he said, "I can't talk". She went up to find him scarce of words and a little exacerbated, sitting on the side of the bed. She noted that he was also unable to read. She called Dr. ___ PCP, and he recommended coming to ___. They drove here. On arriving, he was still having some difficulty communicating. He noted that his right hand felt mildly clumsy and that he signed his name ___ at registration, but the next attempt produced a normal signature. He has ongoing orthostasis, but denies lightheadedness during the event. He has had gradually worsening difficulties with arithmetic and memory. There is no headache, no unusual smells/tastes/emotions. He started to clear over about an hour and now feels essentially back to normal. There were no other neurologic symptoms such as visual difficulties, hearing difficulties, numbness, clumsiness. He is not using CPAP equipment. He states that he needs his sleep and was concerned to be admitted. There were three recent significant events. He had two minor automobile collisions, inappropriately, with ___ indifference, going to the gym after one. He "nose dived into the pavement" in ___ this year, injuring his head. He recalls falling and getting up, but did not trip - thought to be arrhythmia related. Work-up included seeing a neurologist at ___ at ___ and MRI at ___ (normal per patient). No incontinence, confusion afterward. States not recalling very much of automobile incidents above, however. Past Medical History: Paroxysmal atrial fibrillation Orthostatic hypotension diagnosed on autonomic testing in ___ Chronic fatigue syndrome Renal cell carcinoma status post nephrectomy in ___. Chronic renal insufficiency with a baseline creatinine of 1.3 Chronic Pelvic Pain, dx as chronic prostatitis Social History: ___ Family History: Sister with atrial fibrillation. Mother lived to her ___. Physical Exam: Vitals: 98.2 60 198/72 16 100% General Appearance: Comfortable, no apparent distress. HEENT: NC, OP clear, MMM. Neck: Supple. No bruits. Lungs: CTA bilaterally (fine crackles in upper part of left lower lobe cleared). Cardiac: RRR. Normal S1/S2. No M/R/G. Abdominal: Soft, NT, BS+ Extremities: Warm and well-perfused. Neurologic: Mental status: Awake and alert, cooperative with exam, normal affect. Able to perform months of the year backwards. Orientation: Oriented to person, place, date ___, but took some time to think of year, likely away from baseline) and context. Language: Normal fluency, comprehension, repetition, naming. No paraphasic errors. Writing messy on first signing name at registration, but then normal. Able to read. Registration of three words at one trial and recall of two at five minutes without hints. Declines to subtract 19 from 34, states had a lot of difficulty with arithmetic over the last couple of years. Fund of knowledge for recent events within normal limits. Cranial Nerves: I: Not tested. II: Pupils equally round and reactive to light, to mm bilaterally. Visual fields are full to confrontation. III, IV, VI: Extraocular movements intact bilaterally without nystagmus. V, VII: Facial strength and sensation intact and symmetric. VIII: Hearing intact to voice. IX, X: Palatal elevation symmetric. XI: Sternocleidomastoid and trapezius normal bilaterally. XII: Tongue midline without fasciculations. Posture normal and no truncal ataxia. Tone normal throughout. Power D B T WE WF FF FAb | IP Q H AT G/S ___ TF R ___ ___ 5 | ___ ___ 5 L ___ ___ 5 | ___ ___ 5 Reflexes: B T Br Pa Ac Right ___ 2 1 Left ___ 2 1 Toes downgoing bilaterally Sensation intact to light touch, vibration, joint position, pinprick bilaterally. Romberg negative. Normal finger nose, great toe finger, RAM's bilaterally. Gait: Normal initiation, cessation, turn, armswing, base. Able to tandem a few steps. Pertinent Results: ___ 10:45PM %HbA1c-5.7 eAG-117 ___ 07:20PM ___ PTT-52.1* ___ ___ 07:20PM WBC-6.5 RBC-4.77 HGB-13.9* HCT-40.6 MCV-85 MCH-29.2 MCHC-34.3 RDW-13.5 ___ 07:20PM TSH-3.0 ___ 07:20PM ALBUMIN-4.4 CALCIUM-9.2 PHOSPHATE-2.7 MAGNESIUM-2.3 CHOLEST-194 ___ 07:20PM CK-MB-5 cTropnT-<0.01 ___ 07:20PM ALT(SGPT)-21 AST(SGOT)-30 LD(LDH)-222 CK(CPK)-231 ALK PHOS-113 TOT BILI-0.5 ___ 08:10PM URINE RBC-2 WBC-1 BACTERIA-NONE YEAST-NONE EPI-0 Provisional Findings Impression: HBcb MON ___ 12:09 ___ PFI: No evidence of acute ischemic infarct or other acute intracranial abnormality such as hemorrhage or mass. Age-related volume loss as well as sequela of chronic small vessel ischemic disease. Normal MRA of the head and neck. Brief Hospital Course: Mr. ___ was admitted to the neurology service on ___. A code stroke was called upon his arrival to the ED. Given that his NIHSS was 0 and his INR was 2.8 he was not a candidate for tPA. Neuro: MRI showed no evidence of stroke. MRA was unremarkable with no significant stenosis or occlusion. EEG showed no evidence of seizure activity. By the next day transient speech difficulties had resolved and his neurologic exam revealed no deficits. His prior neuro-imaging reports were obtained from ___. ___ and were read as normal. He was continued on coumadin and his INR remained therapeutic. CV: Pt was maintained on telemetry monitoring. Cardiac enzymes were negative. His home Losartan was decreased to 25mg BID and reincreased to his home dose upon discharge. Endocrine HbA1c was 5.7. TSH was 3.0. Respiratory CXR was clear. Patient refused CPAP while in house. Dispo Pt was seen by ___ and OT and determined to be safe to return home upon discharge. He was discharged on ___ in good condition. He will follow up with Dr. ___ in clinic. Medications on Admission: Medications: - Losartan 100 mg QD - Flonase - Warfarin 5 mg QD Discharge Medications: 1. warfarin 5 mg Tablet Sig: One (1) Tablet PO Once Daily at 4 ___. 2. trazodone 50 mg Tablet Sig: 0.5 Tablet PO HS (at bedtime) as needed for insomnia. 3. losartan 100 mg Tablet Sig: One (1) Tablet PO once a day. Discharge Disposition: Home Discharge Diagnosis: Temporary word finding difficulties of undetermined etiology (possible TIA) Discharge Condition: Mental Status: Clear and coherent. Activity Status: Ambulatory - Independent. Level of Consciousness: Alert and interactive. Discharge Instructions: Dear Mr. ___, You were seen and evaluated at ___ Department of Neurology due to difficulty speaking. An MRI and MRA of your brain did not show any findings consistent with a stroke. An EEG showed no evidence of seizure activity. Your symptoms may have been related to a TIA (transient ischemic attack) that did not show up on the MRI, or to a transient decrease in blood flow to your brain. -Please resume your normal home medications. -Please continue to follow up with your PCP/Cardiologist for management of your INR and other general health issues. We made no changes to your medications. If you experience any of the below listed danger signs, please call your doctor or go to the nearest emergency department. Followup Instructions: ___
19719472-DS-16
19,719,472
29,203,371
DS
16
2124-09-25 00:00:00
2124-09-25 11:33:00
Name: ___ Unit No: ___ Admission Date: ___ Discharge Date: ___ Date of Birth: ___ Sex: M Service: NEUROLOGY Allergies: Aspirin / IV Dye, Iodine Containing Contrast Media Attending: ___ Chief Complaint: Headache Major Surgical or Invasive Procedure: Cerebral angiogram History of Present Illness: ___ with a PMH of right parietal IPH in ___ no microbleeds to suggest amyloid on recent MRI ___ and felt to be related to hypertension, 1x GTC seizure in ___ on lamotrigine, lung cancer s/p right lobectomy ___ years ago with chemotherapy with radiation and radiation pneumonitis and periodic bronchospasm now seemingly in remission, Paroxysmal AF not on anticoagulation, CRF, HTN, COPD presented with a 2 day history of right temporal headache followed by acute onset on ___ evaluation ___ of left hemiparesis and difficulty speaking at 7pm with head CT at ___ showing a roughly 3.2x2.9cm right temporal IPH with minimal edema and mass effect and is being admitted to the neuro-ICU. Patient notes being previously assessed at ___ ___ weesk ago where he apparently had a 4 day hospitalisation for headaches where CT head was normal and discharged. He was then at his baseline until 2 days ago when he noted a relatively sudden onset of right temporal headache which was sharp and at times severe.He hadno nausea, vomiting and no visual changes. Thsi worsened ovver this time but the patient was stoical. He was visiting ___ for an unrelated reason where his wife felt he did not look himself. She then took him to the ___ to evaluate his headaches where at just after 6pm he had a CT which showed a right temporal IPH as above. Importantly, per his wife, apparently AFTER this at roughly 7pm he then had onset of left weakness and speech difficulties where initilly he could not move the right side at all. Unfortunately we do not have notes of his current admission from ___ but perreport given to ___, he was loaded with fosphenytoin and given IV ondansetron and fentanyl and transferred to ___ for further evaluation. Since transfer his symptoms have improved. He is now antigravity in both left arm and leg although the arm is weaker than the leg. He also described some numbness and tingling in his left hand and this seemingly subsided. He also felt light-headed and noted cough, SOB and some chest tightness with wheezing while in ___ (has COPD). He still has a fairly significant headache and was given morphine for this in the ___. He is somewhat inattentive and has a right gaze preference but is verbalising well and shows insight into his situation. On neuro ROS, the pt denies loss of vision, blurred vision, diplopia, dysphagia, vertigo, tinnitus or hearing difficulty. Denies difficulties producing or comprehending speech. No bowel or bladder incontinence or retention. On general review of systems, the pt denies recent fever or chills. No night sweats or recent weight loss or gain. Denies chest pain or tightness, palpitations. Denies nausea, vomiting, diarrhea, constipation or abdominal pain. No recent change in bowel or bladder habits. No dysuria. Denies arthralgias or myalgias. Denies rash. Past Medical History: PMH: - Lung cancer s/p right lobectomy ___ years ago with chemotherapy with radiation and radiation pneumonitis and periodicbronchospasm now seemingly in remission - Right parietal IPH in ___ in ___ admitted to the ICU and started on phenytoin for seizure prophylaxis and treated for a week with mannitol as well and went to rehab. Felt to be hypertensive in origin. - Paroxysmal AF not on anticoagulation - CRF - OSH documentation shows previous Cr 1.8 - Seizure disorder since ___ apparently 1x GTC seizure and started on lamotrigine for this - HTN - GERD - Squamous cell carcinoma - COPD and ? asthma PSurgHx: Other than right lobectomy above had an appendectomy Social History: ___ Family History: Mother - died ___ of ICH no associated dementia Father - CAD s/p CABGx3 died ___ after 3xMIs Sibs - brother and sister are well Children - None There is no history of seizures, developmental disability, learning disorders, migraine headaches, strokes less than 50, neuromuscular disorders, or movement disorders. Physical Exam: ADMISSION Physical Exam: Vitals: T:97.4 P:74 R:18 BP:152/87 SaO2:92% 2L General: Awake, some difficulties following commands but generally does well, complains of headache. HEENT: NC/AT, no scleral icterus noted, MMM, no lesions noted in oropharynx Neck: Supple, no carotid bruits appreciated. No nuchal rigidity Pulmonary: Some decreased BS right base and otherwise with prolonged expiratory phase and wheeze Cardiac: RRR, nl. S1S2, no M/R/G noted. Regular also on monitor. Abdomen: soft, NT/ND, normoactive bowel sounds, no masses or organomegaly noted. Extremities: ___ pitting edema to upper shin on left and lower shin on right which is less significant, 2+ radial, DP pulses bilaterally. Skin: no rashes or lesions noted. Neurologic: ___ Stroke Scale score was ___. Level of Consciousness: 0 1b. LOC Question: 0 1c. LOC Commands: 0 2. Best gaze: 1 but mild right gaze preference 3. Visual fields: 1 4. Facial palsy: 2 5a. Motor arm, left: 1 5b. Motor arm, right: 0 6a. Motor leg, left: 0 6b. Motor leg, right: 0 7. Limb Ataxia: 0 8. Sensory: 1 9. Language: 0 10. Dysarthria: 1 11. Extinction and Neglect: ___ - essentially 2 modalities (visual and sensory inattention) but not severe -Mental Status: ORIENTATION - Alert, oriented x 3 but had to think about the month at length The pt. had good knowledge of current events knew current president is ___ and previous was ___. SPEECH Able to relate history with some difficulty but helped by wife. Language is fluent with intact repetition and comprehension. Normal prosody. There were no paraphasic errors. Speech was dysarthric but easily able to understand. NAMING Pt. was able to name both high and low frequency objects on stroke card. READING - Able to read without difficulty on stroke card examples. ATTENTION - Inattentive, able to name ___ forward with pauses and significant difficulty. REGISTRATION and RECALL Pt. was able to register 3 objects and recall 0/ 3 at 5 minutes. COMPREHENSION Able to follow both midline and appendicular commands including 2 step commands. There was no evidence of apraxia but had visual and sensory neglect which was not profound. Patient had intermittent chewing motion which was interruptable and very brief right mentalis twitching with ___ episode of left UE low amplitude jerking. -Cranial Nerves: I: Olfaction not tested. II: Mild anisocoria right pupil1.5mm and left 2mm and brisk. VFF show possible left incongrous homonymous hemianopia essentially in the left eye field to confrontation but may be related to neglect and did not seem to have a field defect on assessment of the right eye field. Funduscopic exam revealed no papilledema, exudates, or hemorrhages but technically challenging and only got brife glimpses of disc. III, IV, VI: Full range of eye movement but non-sustained nystagmus 10 beats on left gaze and 3 beats on right gaze. Saccadic intrusions. Left gaze preference but coyld fully ___ to the left and this was subtle. V: Facial sensation intact to light touch. VII: Left lower facial weakness. Dysarthria. VIII: Hearing intact to finger-rub bilaterally. IX, X: Palate elevates symmetrically. XI: ___ strength in trapezii and SCM on right and 4+/5 on left. XII: Tongue protrudes in midline with noraml movement. -Motor: Normal bulk reduced tone left arm>leg. Left pronator drift. No adventitious movements, such as tremor, noted. No asterixis noted. Delt Bic Tri WrE FFl FE IO IP Quad Ham TA ___ L 4 ___ 4+ ___ 4+ 4 5 4+ 4+ R 5 ___ ___ 5 5 5 5 5 5 -Sensory: No deficits to light touch, pinprick, cold sensation, proprioception on right. On left seemingly normal light touch but noted decreased pinprick whole left side. Decreased vibration to knee on left and ankle on right and decreased proprioception to ankle on left. Left sensory inattention. -DTRs: Bi Tri ___ Pat Ach L 1 1 1 2+ 2 R 1 1 1 2+ 0 Plantar response was flexor on right extensor on left. -Coordination: No intention tremor noted. No dysmetria on FNF or HKS bilaterally in context of significant weakness on left. -Gait: Deferred Pertinent Results: ON ADMISSION: ------------- ___ 08:10PM BLOOD WBC-7.7 RBC-4.88 Hgb-13.9* Hct-42.7 MCV-88 MCH-28.5 MCHC-32.6 RDW-14.4 Plt ___ ___ 08:10PM BLOOD Neuts-75.4* ___ Monos-3.6 Eos-1.1 Baso-0.5 ___ 08:10PM BLOOD ___ PTT-31.2 ___ ___ 08:10PM BLOOD Glucose-123* UreaN-23* Creat-1.7* Na-140 K-4.3 Cl-103 HCO3-29 AnGap-12 ___ 08:10PM BLOOD ALT-17 AST-16 AlkPhos-74 TotBili-0.2 ___ 08:10PM BLOOD Albumin-4.9 ___ 08:10PM BLOOD Phenyto-13.5 IMAGING & STUDIES: ----------------- CT HEAD ___ New right temporoparietal intraparenchymal hemorrhage with no clear subarachnoid or intraventricular extension. Minimal associated mass effect without evidence of herniation or shift of midline structures. Encephalomalacia related to prior right frontoparietal intraparenchymal hemorrhage. CT HEAD ___ Unchanged exam with stable right temporoparietal intraparenchymal hemorrhage with surrounding vasogenic edema and minimally associated mass effect. Further workup to exclude underlying vascular/neopalstic etiology; correlate clinically for coagulopathy/amyloid angiopathy. MR HEAD ___ Noncontrast study Right parietal intraparenchymal hemorrhage with no significant change compared to same day CT. Underlying lesion cannot be excluded. Followup is recommended. CXR ___ Status post right thoracic surgery, most likely lobectomy, recording rib defects and clips in situ. Elevation of the right hemidiaphragm. The cardiac silhouette is of normal size. The left hemithorax is normal. At the site of resection on the right, there is no evidence of recurrence. However, CT should be performed given the substantially higher sensitivity of this technique. EKG ___ Sinus rhythm. Non-specific ST-T wave changes, probably normal variant. Compared to the previous tracing of ___ no change. Rate PR QRS QT/QTc P QRS T 76 176 88 364/392 58 12 55 Cerebral angiogram ___: ___ underwent cerebral angiography which revealed that there were no vascular sources for his right hemispheric hemorrhages, specifically no AVM, arteriovenous fistula or vasculitis was identified. He does have an occlusion of his right common iliac artery just beyond the aortic bifurcation. Hip Film ___ Three views show the bony structures and joint spaces to be within normal limits and symmetric with the opposite side. If there is serious clinical concern for occult fracture, cross-sectional imaging could be considered. MRI L Spine ___: There is normal lumbar vertebral body height and alignment. There is a small hemangioma at L1 vertebral body. The conus medullaris is normal in morphology and intrinsic signal intensity and terminates at the L1-2 level. There is a normal distribution of cauda equine nerve roots. The paravertebral and limited included retroperitoneal soft tissues are grossly unremarkable. At L1-L2 and L2-3 there are mild disc bulges but no spinal canal stenosis or neuroforaminal narrowing. At L3-L4, there is a disc bulge with a left annular tear touching the left L3 nerve root in the left neural foramen. At L4-L5, there is a disc bulge with an annular tear on the left. There is also bilateral facet arthrosis which in combination with the disc bulge is causing compression of the right L4 nerve root and also contacting the left L4 nerve root. There is ligamentum flavum thickening but no spinal canal stenosis. At L5-S1, there is a disc bulge with an annular tear but no spinal canal stenosis or neural foraminal narrowing. Brief Hospital Course: The patient is a ___ yo RHM h/o prior right parietal IPH (___) c/b seizures, lung cancer (s/p right lobectomy, chemotherapy, radiation), PAF, CKD, HTN, COPD p/w severe right periorbital/temporal headache and subsequently sudden onset aphasia and left hemiparesis. He was transferred from an OSH with a finding of a 3.2 x 2.9 cm right temporal IPH and was admitted to the Neuro ICU for close monitoring and blood pressure control. His deficits quickly improved but overnight on ___ he did have some worsening of LLE weakness which had resolved by the morning. Repeat ___ showed no change in size or extent of the hemorrhage. He was continued on lamotrigine at a slightly higher dose (175 mg/150 mg from 150 mg BID) concerning the possibility of increased seizure activity related to the hemorrhage. Given concerns regarding the nature of his hemorrhage, he had an MRI Brain with contrast which (other than the hemorrhage) showed no underlying obvious mass or vascular malformation. Given his stable neurological examinations and hemodynamic stability, he was transferred to the floor wards of the Neurology unit. Neurosurgery was consulted to perform a diagnostic cerebral angiogram to identify a possible arteriovenous dural fistula or other cerebral vascular malformation as a possible etiology of his two hemorrhages. This was done following the administration of steroids, H1 and H2 blockers as well as a bicarbonate preparation given his 1) chronic kidney disease with Cr 1.7-1.8, and 2) history of iodine contrast allergy. This also unfortunately did not identify an etiology of his intraparenchymal hemorrhages. This procedure was complicated a small groin hematoma that was not noticeable the next day. His peripheral pulses remained constant. He did complain of some local right sided hip pain which was limiting motion of his right lower extremity. We obtained hip films and a lumbar spine MRI which showed no acute injury, fracture or radicular/plexus lesion, which was reassuring. He also reassured us that he has had problems with hip pain in the past. On the day of his discharge, he was able to ambulate with one assist. His foley catheter was discontinued. His pain was well controlled with PO analgesics and he obtained good relief from his pain following one dose of IV toradol. TRANSITIONAL ISSUES: - Please be sure to have Mr. ___ follow up with Dr. ___ Dr. ___ at the dates/times listed below. He has been ordered for an outpatient MRI/MRA for follow up. The date for this test has not been scheduled. Please call ___ to clarify date/time of this appointment. Medications on Admission: Lamotrigine 150mg bid Metoprolol 50mg bid Simvastatin 10mg HS Omeprazole 40mg qd Lisinopril 10mg qd Combivent inhaler qid Acetaminophen 650mg qid PRN Discharge Medications: 1. lamotrigine 150 mg Tablet Sig: One (1) Tablet PO QAM (once a day (in the morning)). Disp:*30 Tablet(s)* Refills:*2* 2. lamotrigine 25 mg Tablet Sig: One (1) Tablet PO QAM. Disp:*30 Tablet(s)* Refills:*2* 3. lamotrigine 150 mg Tablet Sig: One (1) Tablet PO QPM (once a day (in the evening)). Disp:*30 Tablet(s)* Refills:*2* 4. lisinopril 10 mg Tablet Sig: One (1) Tablet PO DAILY (Daily). Disp:*30 Tablet(s)* Refills:*2* 5. metoprolol tartrate 25 mg Tablet Sig: One (1) Tablet PO BID (2 times a day). Disp:*60 Tablet(s)* Refills:*2* 6. omeprazole 20 mg Capsule, Delayed Release(E.C.) Sig: Two (2) Capsule, Delayed Release(E.C.) PO DAILY (Daily). Disp:*30 Capsule, Delayed Release(E.C.)(s)* Refills:*2* 7. oxycodone 5 mg Tablet Sig: Two (2) Tablet PO Q3H (every 3 hours) as needed for headache. Disp:*40 Tablet(s)* Refills:*0* 8. benzonatate 100 mg Capsule Sig: One (1) Capsule PO TID (3 times a day) as needed for cough. Disp:*30 Capsule(s)* Refills:*0* Discharge Disposition: Extended Care Facility: ___ Discharge Diagnosis: Main Diagnosis: Intraparenchymal hemorrhage Paroxysmal atrial fibrillation History of lung cancer s/p pneumonectomy Chronic kidney disease Hypertension Discharge Condition: Mental Status: Clear and coherent. Level of Consciousness: Alert and interactive. Activity Status: Out of Bed with assistance to chair or wheelchair. . Neuro exam on discharge: Normal mental status without focal weakness or sensory deficits. No cranial nerve findings save for mild old left ptosis. Discharge Instructions: Dear Mr. ___, It was a pleasure taking care of you during this hospitalization. You were admitted to the ICU after you were found to have an area of bleeding in your brain. We performed a number of neuroimaging tests as well as an angiogram to understand the cause for this bleeding. These tests all showed that the size of your bleed remained stable, which is reassuring. We were able to organize a rehabilitation location for you so that you can spend a few days/weeks building your strength and balance. We have set up follow up appointments for you to see your primary care physician as well as Dr. ___ ___ the division of Stroke Neurology. - We ask that you take all your medications as prescribed below. - Please see the doctors ___ below for ___. - Do not hesitate to contact us should you have any questions or concerns. Followup Instructions: ___
19720007-DS-9
19,720,007
29,113,438
DS
9
2130-06-19 00:00:00
2130-06-19 16:34:00
Name: ___ Unit No: ___ Admission Date: ___ Discharge Date: ___ Date of Birth: ___ Sex: F Service: SURGERY Allergies: Penicillins / codeine Attending: ___. Chief Complaint: Fall from standing Major Surgical or Invasive Procedure: none History of Present Illness: ___ DM, afib on Coumadin s/p fall from standing p/w isolated R displaced proximal humerus fracture. Past Medical History: DM, afib on Coumadin, neuropathy, hypothyroid Social History: ___ Family History: Non-contributory Physical Exam: Admission Physical Exam: Temp: 98.5; P:104; BP:132/77; RR: 18; O2: 985RA General: alert, oriented X3; in no acute distress HEENT: atraumatic, normocephalic, in no acute distress Resp: clear breath sounds bilaterally CV: chronic a fib; no murmurs, rubs or gallops Abd: soft, non-distended, non-tender Extr: R displaced proximal humerus fx, splinted; in sling Discharge Physical Exam: VS:98.9, 100/68, 98, 18, 97% RA General: alert, sitting up in chair. HEENT: no deformity. PERRL. EOMI. mucus membranes pink/moist. trachea midline. neck supple. CV: Irregular rhythm, normal rate. Resp: Clear to auscultation bilaterally. Abd: Soft, non-distended, non-tender, normo-active bowel sounds. Ext: Right upper extremity in splint. Ecchymosis to right bicep. pulses intact 2+, sensation intact. 1+ edema bilateral lower extremity. calves soft/non-tender. Pertinent Results: ___ 04:47AM GLUCOSE-385* UREA N-24* CREAT-0.8 SODIUM-136 POTASSIUM-4.7 CHLORIDE-100 TOTAL CO2-22 ANION GAP-19 ___ 04:47AM CALCIUM-8.5 PHOSPHATE-4.4 MAGNESIUM-1.6 ___ 04:47AM WBC-13.4* RBC-3.58* HGB-11.5 HCT-35.1 MCV-98 MCH-32.1* MCHC-32.8 RDW-13.4 RDWSD-48.4* ___ 04:47AM PLT COUNT-250 ___ 04:47AM ___ PTT-33.0 ___ ___ 02:06AM GLUCOSE-459* UREA N-24* CREAT-0.9 SODIUM-133 POTASSIUM-5.2* CHLORIDE-98 TOTAL CO2-20* ANION GAP-20 ___ 02:06AM PHOSPHATE-4.6* MAGNESIUM-1.6 ___ 02:06AM ___ PO2-140* PCO2-38 PH-7.36 TOTAL CO2-22 BASE XS--3 ___ 02:06AM LACTATE-3.6* ___ 10:23PM URINE COLOR-Yellow APPEAR-Clear SP ___ ___ 10:23PM URINE BLOOD-NEG NITRITE-POS PROTEIN-TR GLUCOSE-1000 KETONE-40 BILIRUBIN-NEG UROBILNGN-NEG PH-6.0 LEUK-TR ___ 10:23PM URINE COLOR-Yellow APPEAR-Clear SP ___ ___ 10:23PM URINE BLOOD-NEG NITRITE-POS PROTEIN-TR GLUCOSE-1000 KETONE-40 BILIRUBIN-NEG UROBILNGN-NEG PH-6.0 LEUK-TR ___ 10:23PM URINE RBC-2 WBC-9* BACTERIA-MOD YEAST-NONE EPI-1 ___ 09:50PM GLUCOSE-421* UREA N-22* CREAT-0.8 SODIUM-133 POTASSIUM-4.5 CHLORIDE-96 TOTAL CO2-19* ANION GAP-23* ___ 09:50PM estGFR-Using this ___ 09:50PM DIGOXIN-1.2 ___ 09:50PM WBC-18.8* RBC-3.93 HGB-12.8 HCT-38.1 MCV-97 MCH-32.6* MCHC-33.6 RDW-13.3 RDWSD-47.8* ___ 09:50PM NEUTS-86.6* LYMPHS-7.2* MONOS-4.8* EOS-0.0* BASOS-0.2 IM ___ AbsNeut-16.31* AbsLymp-1.35 AbsMono-0.91* AbsEos-0.00* AbsBaso-0.04 ___ 09:50PM PLT COUNT-278 ___ 09:50PM ___ PTT-35.2 ___ ___ DX SHOULDER & HUMERUS IMPRESSION: Obliquely oriented fracture through the proximal right humeral diaphysis, with lateral displacement of the distal fracture fragment and approximately 1-2 cm of foreshortening. Extension of fracture line to involve the right greater tuberosity. Suspected extension through through the surgical neck. ___ CT AB/PELVIS No evidence of traumatic injury in the abdomen or pelvis. Fatty liver. ___ Right Knee xray Degenerative changes without acute fracture ___ ECG: Atrial fibrillation with a rapid ventricular response. Diffuse ST-T wave abnormalities. No previous tracing available for comparison. Brief Hospital Course: Ms. ___ is a ___ year old female admitted to the Acute Care Trauma surgical service with right arm pain. An Xray showed a right humerus fracture. The orthopedic surgery team was consulted and recommended a brace, non-weight bearing, and out patent follow up in clinic. Upon admission her blood glucose was elevated in the 400's, ketones in her urine, and hyperkalemia. She was admitted to the ICU for further medical management related to elevated blood glucose. ___ Diabetes specialist was consulted for diabetic management. The patient was placed on insulin drip and resuscitated in the ICU. On HD2, the patient was discharged from the ICU after being transitioned to insulin therapy. The patient has been followed by physical and occupation therapy who recommend acute rehabilitation post discharge. The remainder of the hospital course is as follows: Neuro: The patient was alert and oriented throughout hospitalization; pain was initially managed with a IV dilaudid and then transitioned to oral Tylenol and oxycodone once tolerating a diet. CV: The patient remained stable from a cardiovascular standpoint; vital signs were routinely monitored. Coumdin was held in the setting of potential surgical intervention for her fracture. Pulmonary: The patient remained stable from a pulmonary standpoint; vital signs were routinely monitored. Good pulmonary toilet, early ambulation and incentive spirometry were encouraged throughout hospitalization. GI/GU/FEN: The patient tolerated a regular diabetic diet. Intake and output were closely monitored. She was found to have a urinary tract infection and prescribed a 3 day course of ciprofloxacin. ID: The patient's fever curves were closely watched for signs of infection, of which there were none. HEME: The patient's blood counts were closely watched for signs of bleeding, of which there were none. Prophylaxis: The patient received subcutaneous heparin and ___ dyne boots were used during this stay and was encouraged to get up and ambulate as early as possible. At the time of discharge, the patient was doing well, afebrile and hemodynamically stable. The patient was tolerating a diet, ambulating with assistance, voiding, and pain was well controlled. The patient received discharge teaching and follow-up instructions with understanding verbalized and agreement with the discharge plan. Follow up appointments were scheduled with the orthopedic surgery team. She should follow up with her primary care to address her diabetic management. Her Coumadin can be restarted ___ after her course of ciprofloxacin is complete. Medications on Admission: Coumadin 7.5mg ___, 5mg ___ Levothyroxine 112mcg daily Atenolol 25mg daily Digoxin 0.25mg daily Lisinopril 10mg daily Metformin 1000mg BID Glimepiride 4mg BID Januvia 1mg daily HCTZ 25mg 3x/wk Discharge Medications: 1. Atenolol 25 mg PO DAILY 2. Digoxin 0.25 mg PO DAILY 3. Hydrochlorothiazide 25 mg PO 3X/WEEK (___) 4. Levothyroxine Sodium 112 mcg PO DAILY 5. Lisinopril 10 mg PO DAILY 6. Warfarin 7.5 mg PO 4X/WEEK (___) Please resume on ___. 7. Warfarin 5 mg PO 3X/WEEK (___) Please resume on ___. 8. Acetaminophen 650 mg PO Q6H:PRN pain 9. Docusate Sodium 100 mg PO BID hold for diarrhea 10. Senna 8.6 mg PO BID:PRN constipation 11. sitaGLIPtin 100 mg oral DAILY 12. MetFORMIN (Glucophage) ___ mg PO BID 13. glimepiride 4 mg ORAL BID 14. Ciprofloxacin HCl 500 mg PO Q12H RX *ciprofloxacin HCl 500 mg 1 tablet(s) by mouth every twelve (12) hours Disp #*2 Tablet Refills:*0 15. Heparin 5000 UNIT SC BID until INR therapeutic on Coumadin. Discharge Disposition: Extended Care Facility: ___ Discharge Diagnosis: Right humerus fracture Discharge Condition: Mental Status: Clear and coherent. Level of Consciousness: Alert and interactive. Activity Status: Ambulatory - requires assistance or aid (walker or cane). Discharge Instructions: Please call your doctor or nurse practitioner or return to the Emergency Department for any of the following: *You experience new chest pain, pressure, squeezing or tightness. *New or worsening cough, shortness of breath, or wheeze. *If you are vomiting and cannot keep down fluids or your medications. *You are getting dehydrated due to continued vomiting, diarrhea, or other reasons. Signs of dehydration include dry mouth, rapid heartbeat, or feeling dizzy or faint when standing. *You see blood or dark/black material when you vomit or have a bowel movement. *You experience burning when you urinate, have blood in your urine, or experience a discharge. *Your pain in not improving within ___ hours or is not gone within 24 hours. Call or return immediately if your pain is getting worse or changes location or moving to your chest or back. *You have shaking chills, or fever greater than 101.5 degrees Fahrenheit or 38 degrees Celsius. *Any change in your symptoms, or any new symptoms that concern you. Please resume all regular home medications, unless specifically advised not to take a particular medication. Also, please take any new medications as prescribed. Please get plenty of rest, continue to ambulate several times per day, and drink adequate amounts of fluids. Avoid driving or operating heavy machinery while taking pain medications. Followup Instructions: ___
19720119-DS-7
19,720,119
28,060,710
DS
7
2180-12-20 00:00:00
2180-12-20 18:58:00
Name: ___ Unit No: ___ Admission Date: ___ Discharge Date: ___ Date of Birth: ___ Sex: F Service: MEDICINE Allergies: Augmentin Attending: ___. Chief Complaint: cough Major Surgical or Invasive Procedure: intubation ___ extubation ___ ICP bolt placement ___ ICP bolt removed ___ Lumbar puncture ___ History of Present Illness: Ms. ___ is a ___ year old female with uncertain PMHx who presents as a transfer from ___ for multi-organ failure. By ED report, she was recently treated for a pneumonia. Based on a medication history review she was prescribed Augmentin x 7 days. She was doing better but remained slightly dyspneic, which began worsening the day prior to admission. She went to ___. ___ and was found to have grossly abnormal labs prompting transfer to ___. According to their records, she had new onset bilateral peripheral edema. In our ED, her initial vitals were: T 100, HR 112, BP 120/91, RR 28, O2 100% RA. She had progressively increased work of breathing and was intubated. After intubation she was started on norepinephrine for hypotension. Her labs were notable for: 131 | 90 | 33 ---------------< 63 AG = 33 4.4 | 12 | 1.7 23.7 > 5.2/18.4 < 188 MCV 76, N 86.8 INR 3.1, PTT 33.3, Fibrinogen 130 BNP 28409, Trop-T 0.60 AST ___ ALT 8270 AP 116 TBili 1.6 Lip 61 Alb 3.5 Negative serum tox screen. Urine tox positive for benzodiazepines. Negative HCG. VBG: ___ with lactate 7.3 POCUS: "no effusion, LVEF ~45%, no noted RWMA, RV dilatation (1:1) with hypokinesis, plethoric IVC. c/w toxic-metabolic biV dysfunction, less so PE" She was given: ___ 00:54 IV DRIP Acetylcysteine (IV) (3000 mg ordered) Started 62.5 mL/hr ___ 01:24 IV Ketamine (For Intubation) 100 mg ___ 01:24 IV Succinylcholine 100 mg ___ 01:24 IV DRIP Midazolam ___ mg/hr ordered) Started 2 mg/hr ___ 01:57 IV Dextrose 50% 25 gm ___ 02:22 IVF D5NS ( 1000 mL ordered) Started 125 mL/hr ___ 02:35 IV Vecuronium Bromide 10 mg ___ 02:39 IV DRIP Midazolam Confirmed Rate Changed to 4 mg/hr ___ 02:39 IV DRIP Fentanyl Citrate (100-200 mcg/hr ordered)Started 100 mcg/hr ___ 02:39 IVF NS ( 500 mL ordered) ___ 02:39 IV DRIP NORepinephrine (0.03-0.25 mcg/kg/min ordered) Started 0.12 mcg/kg/min On arrival to the MICU, the patient was intubated and sedated. Review of systems: See HPI. Otherwise unable to obtain. Past Medical History: -allergies -asthma -depression -history of hospitalizations: anorexia as a teenager -anorexia with laxative use -no history of drug overdose -no history of alcohol abuse Social History: ___ Family History: -mom: breast cancer -father: healthy no know family history of hepatitis, cirrhosis, need for transplantation, gastrointestinal or liver malignancies Physical Exam: ADMISSION EXAM ============== Vitals: T: 100.7 BP: 116/80 P: 107 R: 28 O2: 100% on ventilator GENERAL: Intubated and sedated HEENT: Sclera anicteric, PERRL, MMM, oropharynx clear NECK: R IJ CVL in place LUNGS: Clear to auscultation bilaterally, no wheezes, rales, rhonchi CV: Regular rate and rhythm, normal S1 S2, no murmurs, rubs, gallops ABD: soft, non-tender, non-distended EXT: Warm, well perfused, 2+ edema bilaterally SKIN: No rashes or bruising DISCHARGE EXAM ============== Pertinent Results: ADMISSION LABS ============== ___ 12:16AM BLOOD WBC-23.7* RBC-2.42* Hgb-5.2* Hct-18.4* MCV-76* MCH-21.5* MCHC-28.3* RDW-19.9* RDWSD-54.3* Plt ___ ___ 12:16AM BLOOD ___ PTT-33.3 ___ ___ 12:16AM BLOOD ___ ___ 01:50PM BLOOD Fibrino-97* ___ 12:56PM BLOOD Parst S-NEGATIVE ___ 12:16AM BLOOD Glucose-63* UreaN-33* Creat-1.7* Na-131* K-4.4 Cl-90* HCO3-12* AnGap-33* ___ 12:16AM BLOOD ALT-8270* ___ AlkPhos-116* TotBili-1.6* ___ 12:16AM BLOOD Lipase-61* ___ 12:16AM BLOOD ___ ___ 02:15AM BLOOD UricAcd-16.9* Iron-24* ___ 02:15AM BLOOD HBsAg-Negative HBsAb-Negative HAV Ab-Negative IgM HBc-Negative IgM HAV-Negative ___ 12:16AM BLOOD HCG-<5 ___ 04:49AM BLOOD AMA-NEGATIVE Smooth-NEGATIVE ___ 11:51AM BLOOD CEA-2.0 AFP-2.3 ___ 04:49AM BLOOD ___ ___ 12:56PM BLOOD HIV Ab-Negative ___ 02:15AM BLOOD HCV Ab-Negative ___ 02:15AM BLOOD HBV VL-NOT DETECT HCV VL-NOT DETECT ___ 12:22AM BLOOD Type-CENTRAL VE Temp-37.8 pO2-33* pCO2-25* pH-7.37 calTCO2-15* Base XS--9 Intubat-NOT INTUBA ___ 12:22AM BLOOD Lactate-7.3* K-4.2 IMAGING ======= RUQ US ___. Patent hepatic vasculature and IVC. 2. Slightly echogenic liver and gallbladder wall edema without gallbladder distention are compatible with provided history of liver failure. CT CHEST ___. Mild cardiomegaly without pericardial effusion. Suggestion of anemia. 2. Suggestion of pulmonary hypertension. 3. Moderate bibasilar atelectasis and mild mucous plugging, right greater than left. An underlying infection or aspiration cannot be excluded in the proper clinical setting. 4. Subpleural posterior consolidation in the left upper lobe could reflect atelectasis but warrants follow-up in 3 months to exclude an underlying malignancy. 5. No acute abnormality in the abdomen. Nondistended gallbladder with gallbladder wall thickening likely related to to clinical history of liver disease, or systemic causes ; cholecystitis is unlikely. ECHO ___ The left atrium is elongated. No atrial septal defect is seen by 2D or color Doppler. Left ventricular wall thicknesses and cavity size are normal. Overall left ventricular systolic function is moderately depressed (LVEF= 35 %). There is no ventricular septal defect. The right ventricular free wall is hypertrophied. The right ventricular cavity is mildly dilated with moderate global free wall hypokinesis (fractional area change = 25%). There is abnormal diastolic septal motion/position consistent with right ventricular volume overload. The number of aortic valve leaflets cannot be determined. There is no aortic valve stenosis. Trace aortic regurgitation is seen. The mitral valve leaflets are structurally normal. Mild to moderate (___) mitral regurgitation is seen. Moderate [2+] tricuspid regurgitation is seen (may be underestimated due to suboptimal imaging). There is mild pulmonary artery systolic hypertension. There is a trivial/physiologic pericardial effusion. There are no echocardiographic signs of tamponade. ECHO ___ The left atrium is elongated. Left ventricular wall thicknesses are normal. The left ventricular cavity size is normal. Overall left ventricular systolic function is severely depressed (LVEF= 20 %). The right ventricular free wall thickness is normal. Right ventricular chamber size is normal with depressed free wall contractility. The diameters of aorta at the sinus, ascending and arch levels are normal. The aortic valve leaflets (3) appear structurally normal with good leaflet excursion and no aortic stenosis or aortic regurgitation. The mitral valve leaflets are structurally normal. Moderate (2+) mitral regurgitation is seen. Moderate [2+] tricuspid regurgitation is seen. There is moderate pulmonary artery systolic hypertension. There is no pericardial effusion. ECHO ___ Left ventricular wall thicknesses and cavity size are normal. There is moderate global left ventricular hypokinesis (biplane LVEF = 33 %). The right ventricular cavity size is milldy increased with low normal free wall motino. The mitral valve leaflets are structurally normal. There is no mitral valve prolapse. Mild to moderate (___) mitral regurgitation is seen. There is mild pulmonary artery systolic hypertension. There is a trivial/physiologic pericardial effusion. IMPRESSION: Normal left ventricular cavity size with moderate global hypokinesis in a pattern most c/w a non-ischemic cardiomyopathy. Mild-moderate mitral regurgitation. Mild pulmonary artery systolic hypertension. Compared with the prior study (images reviewed) of ___, global left ventricular systolic function has improved. The severity of mitral regurgitation, tricuspid regurgitation and the estimated PA systolic pressure are now slightly lower. The heart rate is also now lower. VQ Scan ___. Low likelihood ratio for pulmonary embolism. NCCT Head ___. Suggestion of early global cerebral swelling. No evidence of hemorrhage or infarction. NCCT HEAD ___ No acute intracranial process. CT Abd/pelvis ___ Suggestion of acute pancreatitis involving pancreatic tail. Diffuse soft tissue edema. CT Chest 1. Proximal right mainstem bronchus intubation, endotracheal tube should be pulled back. 2. Consolidation, adjacent nodularity in the posterior left upper lobe is unchanged, is indeterminate, follow-up exam is recommended. 3. Improvement in bibasilar atelectasis ; residual ground-glass opacities may be sequela of re-expansion; infection is less likely. . 4. No new acute abnormality in the chest. RECOMMENDATION(S): Follow-up of left upper lobe consolidation with CT in 3 months time. CSF: NEGATIVE FOR MALIGNANT CELLS. Lymphocytes and monocytes. MRI HEAD ___ There is no evidence of intracranial hemorrhage, mass, mass effect or shifting of the normally midline structures. The ventricles and sulci are normal in size and configuration for the patient's age. No diffusion abnormalities are detected. Small subependymal hyperintense areas are noted adjacent to the left ventricular horns (for example image 14, series 10), which are nonspecific and may represent some gliotic areas and of doubtful clinical significance. The major vascular flow voids are present and demonstrate normal distribution. The orbits are unremarkable, the paranasal sinuses are notable for mucosal thickening in the maxillary sinuses, more significant on the right, frontoethmoidal recesses, frontal sinus, sphenoid sinus. Bilateral mucosal thickening is present mastoid air cells, more significant on the left. ___ U/S ABD/PELVIS 1. Patent hepatic vasculature. Pulsatile waveforms within the portal veins could be due to right heart failure. 2. Small stones and sludge noted in the gallbladder. There is no sonographic sign of cholecystitis and there is no biliary dilation. 3. Scant trace ascites seen only in the perihepatic space. 4. Normal sonographic appearance of the pancreas with no evidence of secondary sequelae of acute pancreatitis. OTHER LABS/STUDIES ================== HIV-Ab: Negative RPR: Negative FluAPCR: Negative FluBPCR: Negative Hepatitis B Surface Antigen Negative Hepatitis B Surface Antibody Negative Hepatitis A Virus Antibody Negative Hepatitis B Core Antibody, IgM Negative Hepatitis A Virus IgM Antibody Negative Hepatitis C Virus Antibody Negative HBV VL undetectable HCV VL undetectable immunogloblulins relatively normal tox neg ___ VIRUS: RESULTS INDICATIVE OF PAST EBV INFECTION. CA ___: 20 (<34) Anti-Mitochondrial Antibody NEG Anti-Smooth Muscle Antibody NEG Anti-Nuclear Antibody NEG Herpesvirus 6 Antibody, IgG and IgM: PAST INFECTION Hepatitis E Antibody (IgG) NEG Parvovirus B19 Antibodies: IgG positive, IgM NEG CMV IgG ANTIBODY: Neg CMV IgM ANTIBODY: Neg VARICELLA-ZOSTER IgG SEROLOGY: Neg ___: negative Paraneoplastic panel: negative DISCHARGE LABS ============== ___ 07:26AM BLOOD WBC-8.4 RBC-3.23* Hgb-8.3* Hct-28.2* MCV-87 MCH-25.7* MCHC-29.4* RDW-30.2* RDWSD-92.0* Plt ___ ___ 08:06AM BLOOD ___ PTT-28.4 ___ ___ 07:26AM BLOOD Plt ___ ___ 03:02AM BLOOD ___ ___ 03:24AM BLOOD QG6PD->19.5* ___ 05:21AM BLOOD Ret Aut-5.0* Abs Ret-0.16* ___ 07:26AM BLOOD Glucose-80 UreaN-9 Creat-1.1 Na-139 K-4.4 Cl-100 HCO3-23 AnGap-20 ___ 07:26AM BLOOD ALT-69* ___ 07:26AM BLOOD Calcium-9.0 Phos-4.7* Mg-1.5* Brief Hospital Course: Ms ___ is a ___ with h/o asthma, depression, anorexia w/ laxative abuse who was recently treated for PNA with Augmentin initially went to her PCP and then an outside hospital for shortness of breath and new peripheral edema. Her work up at the OSH showed a Troponin of 7, BNP of 30000, Creat of 1.35, and a marked transaminitis concerning for acute liver failure. She was transferred to ___ for further care and eval for liver transplant. Tox screen negative, but she was empirically given NAC given abnormal LFTs and concern for drug toxicity. She also had an ECHO which showed an EF of 35% consistent with new systolic heart failure. She was also found to have ATN, with Cr peaking at 7.2; ALT/AST 8000s/12000s. She was intubated ___ mental status change thought to be due to hepatic encephalopathy. A head CT was obtained which demonstrated early global cerebral swelling. Pt was started on EEG and neurology was consulted. EEG showed irritability but no frank seizures; she was started on keppra. LP done on ___ which showed elevated opening pressure, but negative otherwise. Patient was extubated ___ with improved mental status. She was transferred to the floor. LFTs, renal function improved. Repeat echos with nadir at 25%, though EF improved to 33% prior to DC. Patient worked with ___. She was seen by psych in the setting of significant h/o depression, anorexia and laxative abuse. They did not feel she was SI/HI or had a purposeful ingestion. Pt's mental status continued to improve prior to discharge, A+Ox3, without asterixis. She was on rifaximin and lactulose per Hepatology, but this was discontinued once her LFTs and mental status normalized. Heme-Onc was consulted for severe anemia on presentation, along with questionable hyper-coaguable state, pt will f/u with Hematology as outpatient. She will also follow-up with cardiology upon discharge for her new heart failure with systolic dysfunction. #Acute respiratory failure: Patient was intubated x 2 during MICU course. Initial intubation was in ED for unclear reasons, and patient weaned off ventilator in a few days. Patient then became increasingly altered and tachypneic, with sustained RR in ___. Imaging showed possible evidence of pneumonia and she was treated with antibiotics. Also attributed to possible encephalopathy. As mental status improved she was able to be weaned from the vent and was extubated on ___. #Acute liver failure: Her initial lab work showed AST > 12k and ALT > 8k with elevated INR and Tbili. ALT/LDH ratio <1.5 and rapid rise of LDH with associated ATN point to possible ischemic etiology. Serum acetaminophen and ETOH negative. Broad workup initiated which was mostly unremarkable for causes of acute liver failure. Patient does have known history of laxative abuse and was reportedly taking "handfuls" of bisacodyl which could have contributed. She was treated with NAC until INR downtrended below 2. She did have evidence of cerebral edema on CT Head and patient had altered mental status and was treated with lactulose/rifaximin. LFTs trended down during hospital course and coags normalized. Her lactulose/rifaximin were discontinued after her mental status and LFTs normalized. #Acute renal failure, acute tubular necrosis: Her creatinine peaked in the 7's, though patient never lost the ability to make urine. Consideration was given for dialysis for uremia/altered mental status but deferred as UOP picked up and encephalopathy improved. Cr 1.1 on discharge. #Toxic metabolic encephalopathy: After initial extubation, patient became increasingly altered and would not follow commands and would not speak. With concomitant tachypnea, she was intubated. CT Head showed possible early global cerebral edema. LP performed had elevated opening pressure to 34. CSF studies unremarkable. EEG with generalized cortical irritability, and neurology recommended starting her on Keppra. Neurosurgery placed an intracranial bolt for ICP monitoring and this was normal. Lactulose/rifaximin continued in case hepatic encephalopathy. Abx given at meningitic doses, with ___ompleted. Her encephalopathy improved throughout hospital course and she became more responsive and oriented. She had some asterixis, but upon discharge this was gone and she was A+Ox3 and able to say days of week backwards. #Acute systolic CHF: Patient's initial echo showed EF 35% with global hypokinesis. As patient worsened, repeat echo showed EF 20% with again global hypokinesis. Cardiology consulted for questionable cardiac biopsy but deferred as thought to be low-yield in terms of providing info for overall picture of patient and in setting of ___. Patient will have follow-up with heart failure specialist who can consider MR vs. biopsy. Repeat echo prior to d/c with EF 33%. Patient was started on coreg 12.5 mg BID and lisinopril 2.5 mg qd. #Microcytic Anemia: From collateral from PCP prior labs ___/ MCV 83, H&H ___ (normocytic anemia). No Fe studies per outpt PCP. RI on ___ with RI<2% likely rep of underproduction. However, repeat RI > 2% w/ normal hapto and no evidence of acute blood loss. Fe snl, TIBC wnl and ferritin normal. Fe/TIBC 21% which is not c/w Fe def anemia. Fe/TIBC 21% could be c/w anemia of chronic inflammation, but ferritin nrm and Fe and TIBC wnl. Started Fe supplement per heme-onc. # h/o Depression # h/o Anorexia/bulimia w/ laxative use On disability for depression and anorexia. Collateral from family indicates she may have been using at home. Unclear if possible ingestion contributed to presentation and multi-organ failure. Patient denies SI/HI prior to hospitalization. Does report large ingestions of laxatives. Psych consulted and strongly advises patient to have psych/SW follow-up for rehab. She also recs DMH referral. Held home mirtazapine, amitriptyline, alprazolam, venlafaxine, sertraline per psychiatry. # h/o anorexia w/ laxative abuse and depression. Per her parents/patient, was abusing bisacodyl prior to presentation # Pancreatitis: Unknown etiology. Abdomen has remained non-tender. # Nutrition continued S/S eval as patient transitions to rehab and consider DMP as part of dc planning. # Elevated intracranial pressure- resolved: Discovered on LP w/ some evidence of cerebral edema on CT head. Initially had ICP monitoring w/ normal pressures. D/c bolt on ___. CHRONIC ISSUES: ================ # Migraine Patient with migraines for many years. She responded well w/ po tylenol and hot packs. # Asthma: continued Albuterol Q4H PRN and Advair BID TRANSITIONAL ISSUES: =================== #NEW MEDICATIONS: Carvedilol 12.5 mg BID, Lisinopril 2.5 mg qd, Ferrous Sulfate 325mg qd, Keppra 500mg BID # HELD MEDICATIONS: Pravastatin 20mg qhs, OCP # STOPPED MEDICATIONS: Xanax 1mg tid, Amitryptiline 75mg qhs:prn, Mirtazipine 45mg qhs, Montelukast 10mg qd, Omeprazole 20mg qd, Potassium 10 mEq BID, Promethazine 25mg q6h:prn, Sertraline 200mg qd, Venlafaxine 300mg qd -Incidental Finding on CT-Chest: Subpleural posterior consolidation in the left upper lobe could reflect atelectasis but warrants follow-up in ___ weeks per Heme-Onc to exclude an underlying malignancy. (___) [] per neurology, AMS most likely ___ toxic metabolic encephalopathy ___ overall picture. EEG ___ discharges, but c/w 500mg keppra bid. Will f/u as outpatient ___ EEG, if wnl, can d/c keppra at that time. ___ mo from discharge) [] Recommend rifaximin/lactulose if she develops signs or symptoms of hepatic encephalopathy, was previously on these meds over admission though ended prior to DC with encephalopathy improvement, will f/u with Hepatology as outpatient [] pt with new cardiomyopathy, unclear etiology, improved prior to DC. Pt was started on Carvedilol 12.5 mg BID, lisinopril 2.5 mg qd and will f/u with Heart Failure Cardiology clinic and likely repeat TTE (as her EF was improving) [] pt will require pysch f/u-- Psychiatry team recommended SW/psych follow-up. Psychiatry also recommended discontinuing all prior home psych meds until psych f/u apt. Patient given a list of mental health providers in her area by SW. [] would recommend weekly labs to check electrolytes (sodium, K, BUN/Cr), CBC, and Liver Function tests to confirm continued downtrend/normalization [] pt started on PO iron per Heme-Onc as has mixed iron deficiency anemia with chronic disease picture. pt will f/u with Hematology to f/u anemia, started on Ferrous Sulfate. Heme-Onc consult did not recommend hyper-coaguable ___ while inpatient [] pt will f/u with ___ clinic as outpatient for ATN. Cr peaked >7, though was resolving prior to DC -DC WEIGHT: 69.4 kg (153 lb) #Communication: ___ (Brother) ___, ___ (mom) ___ or ___ #Code: Full Medications on Admission: The Preadmission Medication list may be inaccurate and requires futher investigation. 1. ALPRAZolam 1 mg PO TID 2. Albuterol Inhaler 2 PUFF IH Q6H:PRN wheezing 3. Amitriptyline 75 mg PO QHS:PRN per instruction 4. Mirtazapine 45 mg PO QHS 5. Fluticasone-Salmeterol Diskus (500/50) 1 INH IH BID 6. Omeprazole 20 mg PO DAILY 7. Montelukast 10 mg PO DAILY 8. Pravastatin 20 mg PO QPM 9. Venlafaxine XR 300 mg PO DAILY Discharge Medications: 1. Carvedilol 12.5 mg PO BID RX *carvedilol 12.5 mg 1 tablet(s) by mouth twice a day Disp #*60 Tablet Refills:*0 2. Ferrous Sulfate 325 mg PO DAILY RX *ferrous sulfate 325 mg (65 mg iron) 1 tablet(s) by mouth daily Disp #*30 Tablet Refills:*0 3. LevETIRAcetam 500 mg PO BID RX *levetiracetam 500 mg 1 tablet(s) by mouth twice a day Disp #*60 Tablet Refills:*0 4. Lisinopril 2.5 mg PO DAILY RX *lisinopril 2.5 mg 1 tablet(s) by mouth daily Disp #*30 Tablet Refills:*0 5. Acetaminophen 500 mg PO Q6H:PRN Pain - Mild 6. Albuterol Inhaler 2 PUFF IH Q6H:PRN wheezing 7. Fluticasone-Salmeterol Diskus (500/50) 1 INH IH BID 8. HELD- Montelukast 10 mg PO DAILY This medication was held. Do not restart Montelukast until told to do so by your doctor 9. HELD- Trivora (28) (levonorg-eth estrad triphasic) ___ (6)/75-40 (5)/125-30(10) oral daily This medication was held. Do not restart Trivora (28) until told to do so by your doctor Discharge Disposition: Home With Service Facility: ___ Discharge Diagnosis: PRIMARY DIAGNOSIS ================== acute systolic CHF acute liver failure acute tubular necrosis toxic metabolic encephalopathy SECONDARY DIAGNOSIS =================== depression anorexia microcytic anemia Discharge Condition: Mental Status: Clear and coherent. Level of Consciousness: Lethargic but arousable. Activity Status: Ambulatory - requires assistance or aid (walker or cane). Discharge Instructions: Dear Ms. ___, You were in the hospital because you developed failure of multiple organs. While you were in the hospital you had blood work and tests to determine what caused the organ failure. You were seen by multiple specialists including a liver doctor, ___, brain doctor and blood doctor. Many tests were done to determine what caused your organ failures. The tests came back negative for infection, blood clots, and autoimmune disease. At this point, the cause of your organ failure is now known. However, your organs began to recover during your hospitalization. We have put a list of mental health workers in your area that we would like you to contact and visit as soon as possible at home. The information is below. Please follow-up at the appointments below. We wish you the best, - Your ___ Team ___, ___ ___ Counseling ___ ___ Counseling ___ Phone: ___ Followup Instructions: ___
19720832-DS-11
19,720,832
23,036,537
DS
11
2139-10-08 00:00:00
2139-10-08 18:00:00
Name: ___ Unit No: ___ Admission Date: ___ Discharge Date: ___ Date of Birth: ___ Sex: F Service: MEDICINE Allergies: Penicillins / acetaminophen Attending: ___ ___ Complaint: Oxygen desaturation Major Surgical or Invasive Procedure: None History of Present Illness: Ms. ___ is a ___ year old female with a history of left pontine stroke with residual right sided weakness and recent admission to ___ from ___ to ___ who presents from rehab with fever to 101 and desaturation to 89% on 2.5L NC at rehab. She had a left lower lobe opacity on her CXR in our ED and was started on hospital acquired pneumonia coverage, receiving cefepime/levofloxacin in the ED and vancomycin when she came up to the floor. . Her admission from ___ to ___ was for hypoxemia. She was treated empirically for heart failure with iv diuresis. She was also treated for community acquired pneumonia at that time and was discharged on levofloxacin, which she was to take through ___ at rehab. She was getting levofoxacin daily per the ___ records. . She has not had shaking chills or subjective fevers. She has a stable productive cough that has persisted since her prior admission. . In the ED 97.3 ___ 100% 15L Non-Rebreather. Above abx given. Vitals on transfer: t 97, p98, 95/39 94% 6L NC. Currently, she has no acute complaints. Past Medical History: - CVAs in ___, with residual R-hand and arm weakness for ___ year afterwards - Left-sided progressive weakness - Meningioma - Hyperlipidemia Social History: ___ Family History: daughter had NHL, now in remission ___, mother died from breast ca, father from colon ca Physical Exam: ADMISSION EXAM: General Appearance: Well nourished, No acute distress HEENT: PERRL Cardiovascular: RR, nml S1/S2, no murmurs Respiratory: Decreased BS at bases, no wheezes Abdominal: Soft, Non-tender, Bowel sounds present, no organomegaly Extremities: WWP, no ___ edema Neurologic: A&Ox3, mild chronic right facial droop, unable to move right hand, ___ strength in the right shoulder, sensation grossly intact . DISCHARGE EXAM: Pertinent Results: ADMISSION LABS: ___ 04:52AM BLOOD WBC-7.1 RBC-3.60* Hgb-10.8* Hct-31.8* MCV-89 MCH-29.9 MCHC-33.8 RDW-14.2 Plt ___ ___ 04:52AM BLOOD Neuts-75.3* Lymphs-12.7* Monos-10.9 Eos-0.6 Baso-0.4 ___ 04:52AM BLOOD Glucose-151* UreaN-21* Creat-0.8 Na-132* K-3.5 Cl-97 HCO3-23 AnGap-16 ___ 04:59AM BLOOD Lactate-1.3 . DISCHARGE LABS: . MICRO: ___ Blood cultures: no growth to date . IMAGING: ___ CXR: Portable upright view of the chest demonstrates ill-defined opacity in the lateral right lung base, slightly more conspicuous since ___. Similar opacities seen in the left lung base, has progressed since prior. Prominence of interstitial markings persists. Hilar and mediastinal silhouettes are unremarkable. The descending aorta is mildly tortuous. Heart size is normal. There is no pneumothorax. Healing remote left-sided rib fracture is noted. IMPRESSION: Ill-defined opacities in bilateral lung bases, more conspicuous since ___ exam, could be atypical infection. . ___ ECHO: The left atrium is normal in size. No atrial septal defect is seen by 2D or color Doppler. The estimated right atrial pressure is ___ mmHg. Left ventricular wall thicknesses and cavity size are normal. Left ventricular systolic function is hyperdynamic (EF>75%) with normal regional left ventricular wall motion. The estimated cardiac index is normal (>=2.5L/min/m2). Right ventricular chamber size and free wall motion are normal. The diameters of aorta at the sinus, ascending and arch levels are normal. The aortic valve leaflets (3) appear structurally normal with good leaflet excursion and no aortic stenosis. Trace aortic regurgitation is seen. The mitral valve leaflets are mildly thickened. Physiologic mitral regurgitation is seen (within normal limits). There is a very small pericardial effusion. IMPRESSION: Normal biventricular cavity sizes with preserved global and regional biventricular systolic function. . ___ CT Chest w/o con: 1. Moderately severe emphysema with an inflammatory interstitial component. 2. Scattered areas of alveolar opacification, have not worsened since recent conventional radiographs, could have been due to aspiration or no longer active infection. Alternatively, if the patient continues to smoke, the findings could be due to desquamative interstitial pneumonia or drug reaction. 3. Widespread atherosclerosis, including large plaques in head and neck vessels, left main coronary artery and branches, and minimally aneurysmal upper abdominal aorta. 4. Diffuse esophageal wall thickening could be due to reflux or other causes of esophagitis Brief Hospital Course: ___ year old female with a history of left pontine stroke with residual right sided weakness and recent admission to ___ from ___ to ___ for ?CHF and pneumonia, who presents from rehab with fever and hypoxia. . # Fever/Hypoxia: Patient had no fevers documented during this admission. Her initial CXR showed diffuse interstitial abnormalities bilaterally and a questionable right base opacity suggesting pneumonia. We continued the levofloxacin which she had been taking and added vancomycin/cefepime for possible HCAP. A CT chest showed moderately severe emphysema with an inflammatory interstitial component, also scattered areas of alveolar opacification which could be due to desquamative interstitial pneumonia or drug reaction. Given this, and her lack of fevers/leukocytosis, and lack of improvement on the levofloxacin, this was felt unlikely to be a bacterial pneumonia so the antibiotics were stopped on ___. A respiratory viral swab was ordered and a bronch was done with BAL, which did not grow any organisms and revealed pale airways suggesting an interstitial process. The cell differential on the bronchoscopy indicated a possible inflammatory process such as AIP. She was started on methylprednisolone 1000mg daily for 3 days (day one recieved in the MICU on ___ and will require a slow taper over the period of a month if her shortness of breath is improving. . # H/o left pontine stroke: Patient has residual right upper and lower extremity weakness which remained stable with no new focal findings on neuro exam. We continued aspirin 325mg and atorvastatin 80mg. . # Right frontotemporal mass: Likely meningioma. Stable neuro exam. Continued keppra for seizure prophylaxis. . # Hyperlipidemia: Continued atorvastatin. . # Restless Leg Syndrome: Continued carbidopa-levodopa. # Goals of care: Ms. ___ and ___ family are currently leaning towards ___ care going further. They were amenable to PICC placement for IV steroids in case this will improve Ms. ___ respiratory symptoms, but overall are interested in measures to make Ms. ___ more comfortable. ___ from ___ worked with the patient and her family while she was here, and will email the ___ care department at her ___ nursing facility to update them as to her progress. It may prudent to transition to comfort measures only in the coming days depending on her response to steroids. Transitional Issues: - Ms. ___ was started on IV methylprednisolone 1gm x 3 days(day ___, and she will start prednisone 60mg daily on ___. She will likely need a long (1 month) taper to be predicated by her respiratory response to the steroids. - Goals of care will need to be re-addressed pending the response to the steroids. The family is currently amenable to ___ focused care, but this will need to be re-confirmed. Medications on Admission: 1. Aspirin 325 mg PO DAILY 2. Atorvastatin 80 mg PO HS 3. Bisacodyl ___AILY:PRN constipation 4. Carbidopa-Levodopa (___) 0.5 TAB PO TID for restless leg syndrome 5. Dexamethasone 1 mg PO Q12H Duration: 2 Days Continue through ___ Tapered dose - DOWN 6. Docusate Sodium 100 mg PO BID 7. NPH 3 Units Breakfast NPH 3 Units Dinner Insulin SC Sliding Scale using REG Insulin 8. LeVETiracetam 500 mg PO BID 9. Omeprazole 20 mg PO DAILY 10. Polyethylene Glycol 17 g PO BID:PRN constipation 11. Senna 2 TAB PO BID:PRN constipation 12. Sodium Chloride 1 gm PO TID chronic hyponatremia 13. traZODONE 50 mg PO HS:PRN insomnia 14. dalteparin (porcine) *NF* 5,000 unit/0.2 mL Subcutaneous daily DVT prophylaxis 15. magnesium hydroxide *NF* 2400 mg Oral daily:PRN reflux 2400 mg/30ml 16. Nystatin Powder *NF* 15 GM Mucous Membrane qshift 17. polyvinyl alcohol *NF* 1.4 % ___ 6 drops 18. Levofloxacin 750 mg PO DAILY Duration: 7 Days End ___ Discharge Medications: 1. Aspirin 325 mg PO DAILY 2. Atorvastatin 80 mg PO DAILY 3. Bisacodyl 10 mg PR HS:PRN constipation 4. Carbidopa-Levodopa (___) 0.5 TAB PO TID 5. Docusate Sodium 100 mg PO BID 6. NPH 3 Units Breakfast NPH 3 Units Dinner Insulin SC Sliding Scale using HUM Insulin 7. LeVETiracetam 500 mg PO BID 8. Omeprazole 20 mg PO DAILY 9. Polyethylene Glycol 17 g PO DAILY:PRN constipation 10. Senna 2 TAB PO BID:PRN constipation 11. Sodium Chloride 1 gm PO TID chronic hyponatremia 12. traZODONE 50 mg PO HS:PRN insomnia 13. dalteparin (porcine) *NF* 5000 Subcutaneous daily 14. magnesium hydroxide *NF* 2,400 mg/10 mL Oral daily reflux symptoms 15. polyvinyl alcohol *NF* 1.4 % ___ 6 drops ___ 16. MethylPREDNISolone Sodium Succ 1000 mg IV Q24H Duration: 2 Days Total of 3 day course, recieved day 1 dose on ___ at ___ 17. PredniSONE 60 mg PO DAILY start on ___ after IV methylpred has been completed. Taper as respiratory status improves. Discharge Disposition: Extended Care Facility: ___ Discharge Diagnosis: Interstitial Lung Disease of unknown cause Discharge Condition: Mental Status: Clear and coherent. Level of Consciousness: Alert and interactive. Activity Status: Ambulatory - Independent. Discharge Instructions: Dear Ms. ___, It was a pleasure taking care of you at ___. You were admitted with shortness of breath which is likely due to an inflammatory disease involving your lungs. We started you on a course of steroids which will hopefully improve your symptoms. The following medication changes have been made: STOP Dexamethasone and levofloxacin as these medications are no longer necessary START methylprednisolone 1000mg IV daily for a total of 3 days. You will require 2 more days, as you recieved 1 of 3 days in the ICU at ___ START Prednisone 60mg daily. This dose will need to be tapered by your doctors at rehab. Followup Instructions: ___
19720832-DS-12
19,720,832
29,747,350
DS
12
2140-01-08 00:00:00
2140-01-08 16:39:00
Name: ___ Unit No: ___ Admission Date: ___ Discharge Date: ___ Date of Birth: ___ Sex: F Service: MEDICINE Allergies: Penicillins / acetaminophen Attending: ___. Chief Complaint: weakness and confusion Major Surgical or Invasive Procedure: none History of Present Illness: Ms. ___ is a ___ year old female with a history of left pontine stroke with residual right sided weakness, DM, Htn, urinary retention and recent admission to ___ from ___ - ___ ___s admission to OSH ___ who presents from ___ with increased lethargy and weakness and inability to take PO meds. Per records she has been feeling more weak and confused for several days. Also, per chart she noted R arm pain and swelling for several days although she says the pain only begain today once her arm was put in a cast. She has mild abdominal pain, nausea and vomiting. She denies any diarrhea, constipation, chest pain, shortness of breath, or headache. She says she has had a dry cough for a while, not sure exactly how long. Her most recent admission at OSH she was diagnosed with urosepsis, acute on chronic blood loss anemia (was transfused one unit for Hgb of 7.6), etiology unknown. She has a foley in place for urinary retention. In the ED, initial vs were 98.0 po, po, 99, 16, 110/51, 100% RA. Her exam was notable for bilateral rhonchi and crackles, mildly ttp diffusely, RUE w/swelling and eccymosis especially at wrist, R side +1 strength and L +4 strength, AAOx3. Because of her right wrist pain, xrays were obtained which were negative for any acute fracture, however her R arm was put in a cast. Her CXR was unchanged from prior but commented on interstitial lung disease with small pleural effusions, no focal consolidation. Her EKG was notable for new deep T waves and troponins were 0.02 (baseline <0.01). UA was negative with blood and urine cultures pending. Of note, pt also had an outpatient brain MRI on ___ which noted interval multifocal subacute left cerebellar and right occipital infarcts, likely emboli in etiology given the distribution; Interval evolution of the known left paramedian pontine infarct. No evidence of intracranial hemorrhage; Large right frontal meningioma with similar mass effect and vasogenic edema on to the adjacent parenchyma. On arrival to the floor, patient reports pain all over her body, weakness of the R side of her body which is not new. She says "there is something wrong with my head", is tearful, and did not fully cooperate with exam or interview. Past Medical History: -OSH admission ___ for sepsis of urologic origin, also noted to have bilateral lower lobe infiltrates on CT abd/pelvis with no clinical pneumonia, as well as bilateral hydronephrosis which resolved after foley placement, discharged on levofloxacin for 5 days. -meningioma -urinary retention with foley in place since last hospitalization - CVAs in ___, with residual R-hand and arm weakness for ___ year afterwards - left paramedian pontine infarct ___ with current R sided weakness, numbness and tingling - Left-sided progressive weakness - right frontotemporal meningioma - Hyperlipidemia - COPD - DM controlled - Acute on chronic blood loss anemia, etiology unknown, transfused one unit RBC's on last admission -dysuria -h/o alcohol abuse -"other malignant lymphomas" per ___ record -diverticulosis -generalized abdominal pain Social History: ___ Family History: daughter had NHL, now in remission ___, mother died from breast ca, father from colon ca Physical Exam: VS T: 97, HR 93, BP 109/50, RR16, O2 99% on 2L GEN Alert and oriented x3, tearful, refusing to answer some questions, "everything hurts" HEENT NCAT MMM EOMI sclera anicteric, OP clear, R sided facial droop NECK supple, no JVD, no LAD PULM Coarse crackles throughout lungs CV RRR normal S1/S2, no mrg ABD soft NT ND normoactive bowel sounds, no r/g, foley in place EXT WWP 2+ pulses palpable bilaterally, no c/c/e NEURO: AOx3, naming intact, dysarthric but speech fluent. Gait could not be assessed. ___ strength in R arm and leg. Facial droop on R. 3+ strength in L arm and leg. Hyperactive DTR's R>L. Several beats of clonus at R achilles. Sensation decreased on R side of body, intact on left. RAM intact in L hand. Patient would not attempt FTN. EOMI, PERRL. Visual acuity grossly intact. Visual fields intact. Hearing intact. Normal elevation of soft palate. SKIN no ulcers or lesions Discharge Exam VS T: 97.9, HR 80, 137/56, RR18, O2 96% on RA GEN awake, alert, NAD HEENT NCAT MMM EOMI sclera anicteric, OP clear, R sided facial droop PULM clear to auscultation anteriorly CV RRR normal S1/S2, no mrg ABD soft NT ND normoactive bowel sounds, no r/g EXT WWP 2+ pulses palpable bilaterally, no c/c/e Ext: R wrist in splint. R hand very swollen (3+ edema) and red. L hand normal. Pertinent Results: Admission Labs: ___ 02:41PM BLOOD WBC-7.5 RBC-4.00* Hgb-12.0 Hct-37.1 MCV-93 MCH-30.1 MCHC-32.4 RDW-13.3 Plt ___ ___ 02:41PM BLOOD Neuts-68.1 Lymphs-17.7* Monos-12.5* Eos-1.2 Baso-0.4 ___ 02:41PM BLOOD Glucose-89 UreaN-6 Creat-0.4 Na-139 K-3.6 Cl-104 HCO3-24 AnGap-15 ___ 02:41PM BLOOD ALT-8 AST-21 CK(CPK)-31 AlkPhos-49 TotBili-0.3 ___ 09:45PM BLOOD CK(CPK)-16* ___ 02:41PM BLOOD CK-MB-2 ___ 02:41PM BLOOD cTropnT-0.02* ___ 09:45PM BLOOD CK-MB-2 cTropnT-0.02* ___ 08:20AM BLOOD cTropnT-0.02* ___ 02:41PM BLOOD Albumin-3.2* Calcium-8.6 Phos-3.6 Mg-1.5* ___ 02:49PM BLOOD Lactate-1.2 K-3.1* ___ 03:55PM URINE Blood-NEG Nitrite-NEG Protein-NEG Glucose-NEG Ketone-NEG Bilirub-NEG Urobiln-NEG pH-7.5 Leuks-NEG ___ 3:55 pm URINE **FINAL REPORT ___ URINE CULTURE (Final ___: NO GROWTH. Video Speech and Swallow: (preliminary report) Video fluoroscopic oropharyngeal swallowing exam was performed in Preliminary Reportconjunction with speech and swallow division. Multiple consistencies of Preliminary Reportbarium were administered, demonstrating aspiration with crackers and nectar Preliminary Reportconsistency. There is also penetration with nectar consistency. For further Preliminary Reportdetails, please refer to speech and swallow report in the OMR. Preliminary ReportIMPRESSION: Aspiration and penetration with nectar consistency. Aspiration Preliminary Reportwith solid consistency. EKG Sinus rhythm. Anterolateral ST segment depressions and T wave inversions raise concern for anterolateral ischemia. Clinical correlation is suggested. Compared to the previous tracing of ___ the anterolateral ST-T wave changes are new and the heart rate is decreased. TRACING #1 Read ___. IntervalsAxes ___ ___ Sinus rhythm. Anterolateral ST segment depression and T wave inversions suggest myocardial ischemia. Compared to tracing #2 the T wave inversions are deeper. TRACING #3 Read ___. IntervalsAxes ___ ___ CXR ___ IMPRESSION: Interstitial lung disease, similar to prior, with new small pleural effusions. No focal consolidation. Xrays of R shoulder, elbow, forearm, wrist and hand all negative for fracture. Brain MRI ___ IMPRESSION: 1. Interval multifocal subacute left cerebellar and right occipital infarcts, likely emboli in etiology given the distribution. 2. Interval evolution of the known left paramedian pontine infarct. No evidence of intracranial hemorrhage. 3. Large right frontal meningioma with similar mass effect and vasogenic edema on to the adjacent parenchyma. Discharge Labs: ___ 10:20AM BLOOD WBC-5.2 RBC-3.36* Hgb-9.8* Hct-31.3* MCV-93 MCH-29.2 MCHC-31.4 RDW-13.2 Plt ___ ___ 05:10PM BLOOD Glucose-88 UreaN-4* Creat-0.3* Na-130* K-4.0 Cl-103 HCO3-20* AnGap-11 ___ 05:10PM BLOOD Calcium-7.1* Phos-2.3* Mg-1.6 ___ 02:24PM URINE Color-Straw Appear-Clear Sp ___ ___ 02:24PM URINE Blood-NEG Nitrite-NEG Protein-NEG Glucose-NEG Ketone-NEG Bilirub-NEG Urobiln-NEG pH-7.5 Leuks-SM ___ 02:24PM URINE RBC-<1 WBC-3 Bacteri-FEW Yeast-NONE Epi-0 ___ 02:24PM URINE Hours-RANDOM Creat-19 Na-158 K-17 Cl-150 ___ 02:24PM URINE Osmo___-___ Brief Hospital Course: Summary: ___ yo female with complicated past medical history and numerous recent hospitalizations who was admitted from rehab for decreased alertness and inability to take PO. Mental status improved when holding sedating medications, patient eventually decided to focus her care on comfort and does not want to be readmitted to a hospital. Active Issues: # Goals of care: At last hospitalization here in ___, documented that patient and her family were leaning towards comfort care. In further conversation with ___ PA at ___ it appears that she was leaning towards palliative care while at ___. ___ the attending, Dr. ___ spoke with the patient and she clearly stated the following: -she does not want to be anticoagulated -she understands that eating and drinking may lead to pneumonia and death but she does not want a feeding tube or PEG and wants to continue eating and drinking -she wants her pain controlled with morphine even if it makes her sedated -she wants to focus her care on comfort and does not want to be rehospitalized She remains DNR/DNI She was also seen by palliative care and confirmed the above information. She also confirmed that she wanted to make these decisions for herself. She refused most oral medications during her stay. # lethargy: Patient was progressively lethargic before discharge per records from her facility. Since holding sedating meds she improved and then became lethargic after receiving morphine. Sedating medications likely contributing. Urine cx negative. CXR unrevealing. #Electrolyte Abnormalities: Electrolytes morning of ___ while on ___ as she has been were abnormal with Na of 129, Ca of 6.8, Phos 2.5, Mg 1.5 and patient is not taking good PO. Urine lytes showed FeNa of approximately 2%, consistent with SIADH. IVF discontinued per patient's wishes to focus on comfort care. #Dsyphagia and Nausea: Patient reports difficulty swallowing and nausea after swallowing. Bedside speech and swallow performed, patient refused barium swallow study and wanted to continue to take PO despite risks which were explained to her. However, ___ she agreed to go for video swallow study and she aspirated everything including ___ crackers. The only safe solution for her given her stroke would be to become permanently NPO with a g-tube, however the patient does not want this even after we discussed the risks of continuing to eat and drink. She was switched to a regular diet and thin liquids per her request and goals of care as she has expressed them. # TWI: New TWI on EKG since ___ with trop 0.02 (baseline <0.01). Pt denies any chest pain and MB has been flat, Troponin stable at .02. Repeat EKG's unchanged. T wave changes in anterolateral leads possibly consistent with myocardial ischemia, although also possibly due to stroke. Patient has stated she would not want to be anticoagulated, and if she was cathed she would require anticoagulation. Intervention would not be in line with her goals of care. # R upper extremity pain: Patient unable to provide history of trauma. No fx in shoulder, forearm, wrist or hand on plain films. When I tried to remove splint morning of ___ it was exquisitely painful - she points to anatomical snuff box and ___ and ___ metacarpals in particular and was seen by ortho who provided a new splint for comfort, and recommended treating her for a presumed scaphoid fracture by leaving the thumb ___ splint in place. She may desire follow up with ortho in ___ weeks and repeat an xray in 1 week. Pain was ultimately controlled with liquid morphine despite sedating the patient (as above). No discharge appointment was set up given her goals of care. #Subacute embolic stroke: Pt had thorough work up at admission in ___, which included stroke workup including CTA of the head and neck showed some minor atherosclerotic disease in the aortic arch as well as intracranial atherosclerosis involving bilateral posterior cerebral arteries and middle cerebral arteries. Her cardiac echo did not reveal any embolic source. She has been on an enteric-coated aspirin as well as high doses of statin. On neuro exam, her strength seems to correlate more with alertness than anything else. Reflexes were hyperactive on admission, and hypoactive by discharge. No anticoagulation per patient's wishes (as above). Chronic Issues: #History of acute blood loss anemia on previous hospitalization: pt has recent hospitalization for acute blood loss, etiology never determined. Hct currently stable and increased from previous hospitalization when she was transfused 1 unit RBC's for HgB of 7.6. FOB negative while in ___, active type and screen maintained but HCT was stable and she was not transfused. # H/o left pontine stroke: Patient has residual right upper and lower extremity weakness which seems to be stable on exam. She was continued on ASA 325mg and Atorvastatin # Right frontotemporal meningioma: Pt had been planned for surgery in ___ but had stroke day prior to surgery so this has been postponed. She does not want to have surgery at this time. # Hyperlipidemia: Continued atorvastatin. # diabetes, controlled Transitional Issues: #Possible scaphoid fracture - if desired by patient, may follow up with ortho in ___ weeks and repeat xray of R wrist in 1 week - appointment not set up given goals of care. #Comfort - follow up with hospice and palliative care already involved at ___ Medications on Admission: Preadmission medications listed are correct and complete. Information was obtained from chart from ___. 1. Atorvastatin 20 mg PO DAILY 2. LeVETiracetam 250 mg PO BID 3. Lorazepam 0.5 mg PO HS:PRN insomnia 4. Ondansetron 4 mg PO Q8H:PRN nausea 5. Potassium Chloride 10 mEq PO DAILY Duration: 24 Hours Hold for K > 6. Prochlorperazine 10 mg PO Q8H:PRN nausea and vomiting 7. Aspirin 81 mg PO DAILY 8. Bisacodyl 10 mg PO DAILY 9. Artificial Tears ___ DROP BOTH EYES PRN dry eyes 10. Docusate Sodium 100 mg PO BID 11. Insulin SC Sliding Scale Insulin SC Sliding Scale using REG Insulin 12. Mirtazapine 7.5 mg PO HS 13. Morphine Sulfate (Concentrated Oral Soln) 5 mg PO Q4H:PRN pain 14. TraMADOL (Ultram) 50 mg PO Q4H:PRN pain 15. Aspirin 325 mg PO DAILY:PRN pain 16. Calcium Carbonate 500 mg PO QID:PRN GI distress 17. Milk of Magnesia 30 mL PO DAILY:PRN constipation 18. Polyethylene Glycol 17 g PO DAILY:PRN constipation 19. Senna 1 TAB PO BID:PRN constipation 20. Ranitidine 150 mg PO HS Discharge Medications: 1. Artificial Tears ___ DROP BOTH EYES PRN dry eyes 2. Aspirin 81 mg PO DAILY 3. Atorvastatin 20 mg PO DAILY 4. Bisacodyl 10 mg PO DAILY 5. Calcium Carbonate 500 mg PO QID:PRN GI distress 6. Docusate Sodium 100 mg PO BID 7. Polyethylene Glycol 17 g PO DAILY:PRN constipation 8. Ranitidine 150 mg PO HS 9. Senna 1 TAB PO BID:PRN constipation 10. TraMADOL (Ultram) 50 mg PO Q4H:PRN pain 11. Aspirin 325 mg PO DAILY:PRN pain 12. Lorazepam 0.5 mg PO HS:PRN insomnia 13. Milk of Magnesia 30 mL PO DAILY:PRN constipation 14. Ondansetron 4 mg PO Q8H:PRN nausea 15. Potassium Chloride 10 mEq PO DAILY Duration: 24 Hours Hold for K > 16. Prochlorperazine 10 mg PO Q8H:PRN nausea and vomiting 17. LeVETiracetam 250 mg PO BID 18. Mirtazapine 7.5 mg PO HS 19. Morphine Sulfate (Oral Soln.) 0.5-1 mg PO Q4H:PRN pain Discharge Disposition: Extended Care Facility: ___ Discharge Diagnosis: Primary Diagnosis: lethargy, secondary diagnoses: subacute embolic stroke, aspiration, possible scaphoid fracture Discharge Condition: Mental Status: Confused - sometimes. Level of Consciousness: waxing and waning, depending on morphine administration Activity Status: Bedbound. Discharge Instructions: Ms. ___, It was a pleasure taking care of you at ___ ___. You were admitted with increased sleepiness. In the hospital we held all medications that can make you sleepy (morphine, benzodiazepenes) and you became more alert. While here, you had trouble swallowing. A swallow study showed that you were aspirating (food going into your lungs instead of your stomach). We explained that if you continue to eat and drink that you may get pneumonia and die; however, you expressed that you would like to continue eating and drinking as opposed to having a permanent feeding tube or tube directly inserted into your stomach. During your stay you also had pain in your arm and wanted morphine to control the pain. The morphine made you sleepy (which is why you came to the hospital), but you told us that this was okay, that you wanted to focus on being comfortable. Images of your brain showed that you were having continued strokes; you could be anticoagulated to help prevent future strokes but this would cause a risk of bleeding and require frequent blood draws and you said you would rather not do this. You were found to have bruising and pain in your arm. X-rays were negative for fracture, but given your tenderness you are being treated with a splint for comfort. You also told us that you did not want to come back to a hospital again, but would prefer to spend the rest of your time trying to be comfortable. You will continue to get care at ___ and work with ___ care who saw you while you were here in the hospital. Followup Instructions: ___